data_2djm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2djm _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo . . . . . 0 C--O 1.233 0.272 0 CA-C-O 120.913 0.297 . . . . 0.0 112.768 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.7 t -152.77 -63.88 0.16 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.324 -176.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.6 m -69.31 -62.69 1.28 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.122 0.487 . . . . 0.0 110.041 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.99 -158.2 0.89 Allowed 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.8 m -64.79 -24.82 67.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.563 0.697 . . . . 0.0 109.221 173.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.826 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.5 p -129.24 155.43 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.584 -178.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -143.81 137.97 28.38 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 34.8 tp -70.55 126.54 29.91 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.121 0.486 . . . . 0.0 111.175 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -74.21 -62.22 1.59 Allowed 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.825 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.2 p 176.55 167.25 0.48 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.214 -175.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 22' ' ' SER . 49.0 p90 -157.8 160.34 37.69 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.306 -1.315 . . . . 0.0 107.8 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -126.09 163.24 23.52 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.979 0.419 . . . . 0.0 110.326 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 20' ' ' THR . 37.5 t80 -152.5 149.59 28.7 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.284 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -179.76 126.14 0.08 Allowed 'General case' 0 C--N 1.321 -0.644 0 O-C-N 123.715 0.634 . . . . 0.0 109.376 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.44 -105.8 0.99 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 -170.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.532 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 20.4 m -133.35 86.08 2.27 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 166.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 96.2 m -148.07 136.07 21.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.709 177.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.515 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 23.8 t80 -117.32 138.88 51.47 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 171.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 25.9 p -150.04 109.87 4.08 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.77 149.47 19.72 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.15 -1.024 . . . . 0.0 113.057 -166.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.602 ' HB3' HG22 ' A' ' 71' ' ' THR . 24.3 pttm -140.34 154.69 46.85 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.607 HD11 HG21 ' A' ' 84' ' ' ILE . 19.0 mt -134.91 154.63 36.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.071 -165.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -123.24 99.32 6.29 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.255 -174.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.826 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 1.7 m -136.25 149.95 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.337 0.589 . . . . 0.0 112.372 -170.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.628 ' HB2' ' CE1' ' A' ' 67' ' ' TYR . 7.7 ttmm -81.25 144.19 31.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.642 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -82.96 103.82 12.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.65 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.9 HG12 ' HH ' ' A' ' 86' ' ' TYR . 19.0 mm -81.68 -59.29 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.43 -151.86 0.49 Allowed 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 114.033 -1.44 . . . . 0.0 107.706 174.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -109.04 -44.95 3.86 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.049 -0.661 . . . . 0.0 111.46 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.4 t -76.93 82.27 3.48 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.589 0.709 . . . . 0.0 109.898 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.431 ' HE3' ' HB2' ' A' ' 34' ' ' LYS . 28.1 mtmt -110.67 152.41 26.55 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.968 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -142.31 110.12 5.83 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 122.277 1.037 . . . . 0.0 109.021 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.0 t -92.12 124.73 44.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.593 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.751 ' HB ' HG13 ' A' ' 53' ' ' ILE . 59.2 p -123.27 117.4 25.18 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.244 -170.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.79 HG11 ' CD2' ' A' ' 40' ' ' TYR . 57.3 t -73.38 141.24 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.019 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 170.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -124.6 100.1 7.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 159.102 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.79 ' CD2' HG11 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -119.21 126.08 50.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 122.218 1.009 . . . . 0.0 110.684 179.112 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.479 ' HB3' ' CZ3' ' A' ' 47' ' ' TRP . . . -86.59 151.13 23.72 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.768 -164.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 44' ' ' SER . 2.8 m-20 -72.85 177.5 4.83 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.154 -1.839 . . . . 0.0 110.863 -166.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.36 33.8 1.34 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.805 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 42' ' ' ASP . 22.7 t -112.26 -10.52 13.82 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 175.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 16.6 t70 76.58 91.26 0.07 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 113.535 -1.666 . . . . 0.0 110.341 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 45' ' ' ASP . 22.9 t-20 84.69 154.64 0.09 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.996 170.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.594 ' HE1' ' HB2' ' A' ' 52' ' ' ASN . 8.2 m-90 -72.48 124.47 25.25 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -172.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -78.22 74.25 4.76 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.264 -1.334 . . . . 0.0 108.691 167.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.1 t30 47.86 34.08 3.71 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.676 0.75 . . . . 0.0 110.781 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -119.15 174.46 6.32 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -173.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -141.78 77.32 0.3 Allowed Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 119.808 -1.187 . . . . 0.0 112.213 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.594 ' HB2' ' HE1' ' A' ' 47' ' ' TRP . 78.3 m-20 -79.84 95.11 5.95 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 121.229 0.538 . . . . 0.0 111.515 -178.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.751 HG13 ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -108.49 142.64 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.006 -177.18 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.529 ' CG2' ' HB ' ' A' ' 38' ' ' VAL . 17.5 tt -135.99 122.74 32.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.307 173.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.52 134.5 43.85 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.024 0.44 . . . . 0.0 111.756 -170.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -91.32 164.83 13.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.691 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -128.36 140.13 52.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.062 0.458 . . . . 0.0 110.063 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -71.46 145.58 49.15 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.231 0.539 . . . . 0.0 110.642 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.1 t -107.59 -44.26 4.32 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.888 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.44 170.52 36.35 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.969 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -70.13 140.84 42.23 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.855 2.37 . . . . 0.0 111.666 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.542 HG12 ' HB2' ' A' ' 69' ' ' TYR . 28.8 mt -78.71 105.99 8.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.097 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.7 m -65.85 117.09 7.75 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.365 0.603 . . . . 0.0 110.636 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.408 ' C ' ' HG ' ' A' ' 65' ' ' SER . . . 121.28 -14.69 9.4 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.41 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.408 ' HG ' ' C ' ' A' ' 64' ' ' GLY . 16.9 m -150.25 164.76 34.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.955 0.407 . . . . 0.0 110.711 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -89.89 62.07 5.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.429 0.633 . . . . 0.0 109.443 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.628 ' CE1' ' HB2' ' A' ' 28' ' ' LYS . 1.7 m-85 -138.52 169.59 17.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.466 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.441 ' HG2' ' H ' ' A' ' 69' ' ' TYR . 22.0 tt0 -122.09 171.6 8.86 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.542 ' HB2' HG12 ' A' ' 62' ' ' ILE . 1.5 t80 -140.28 122.11 15.46 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -163.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.635 ' CD1' HG12 ' A' ' 27' ' ' VAL . 7.1 m95 -121.28 144.56 48.56 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.015 -165.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.602 HG22 ' HB3' ' A' ' 24' ' ' LYS . 21.3 p -145.81 153.45 40.92 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 122.9 0.125 . . . . 0.0 110.74 -178.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -173.01 155.72 3.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.219 0.533 . . . . 0.0 111.209 167.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.2 m -112.15 145.21 40.23 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.543 175.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.515 ' HB1' ' HB3' ' A' ' 21' ' ' PHE . . . -137.51 144.89 42.4 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.36 -175.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.3 t -99.95 99.15 9.88 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 173.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.532 ' O ' ' HB3' ' A' ' 19' ' ' SER . 3.9 m -103.48 138.34 28.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 3.7 mptp? -101.95 -11.4 18.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.233 -173.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -179.66 105.98 0.2 Allowed Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.54 HG12 HG22 ' A' ' 104' ' ' VAL . 11.1 tt -128.92 158.36 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.48 ' HA ' ' HE2' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -147.56 -42.07 0.17 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.289 -178.146 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -135.32 164.69 27.16 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 118.56 -0.733 . . . . 0.0 109.086 -171.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.47 ' CB ' ' HA ' ' A' ' 40' ' ' TYR . 36.4 p90 -173.36 178.85 2.29 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 119.378 -0.929 . . . . 0.0 113.379 171.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.639 ' O ' HG22 ' A' ' 39' ' ' VAL . 1.0 OUTLIER -164.28 144.99 8.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.412 -1.722 . . . . 0.0 107.704 167.368 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.607 HG21 HD11 ' A' ' 25' ' ' ILE . 28.3 mm -103.23 137.0 33.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.56 -174.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -104.13 146.12 29.2 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.774 0.797 . . . . 0.0 110.925 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.9 ' HH ' HG12 ' A' ' 30' ' ' ILE . 10.3 t80 -108.89 100.17 9.42 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.454 175.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -110.38 120.79 43.55 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.628 0.728 . . . . 0.0 109.38 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.566 ' C ' ' H ' ' A' ' 90' ' ' GLY . 86.4 t -121.72 155.92 26.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.207 -174.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.9 t -77.01 31.95 0.14 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 122.019 0.914 . . . . 0.0 109.677 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -158.83 -33.14 0.02 OUTLIER Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.91 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.432 ' HE3' ' H ' ' A' ' 92' ' ' THR . 13.3 mmmt -145.66 178.8 7.87 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.82 0.819 . . . . 0.0 112.138 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.432 ' H ' ' HE3' ' A' ' 91' ' ' LYS . 5.6 m -149.27 143.62 25.97 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.086 174.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.447 ' CD1' ' HD2' ' A' ' 86' ' ' TYR . 25.9 m-85 -143.36 -172.26 3.66 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -145.24 138.44 26.46 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.609 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -111.25 104.24 12.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 165.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 98' ' ' ASN . 49.6 t30 -151.93 87.45 1.35 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.613 -171.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 42.22 -68.2 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.465 1.906 . . . . 0.0 115.343 168.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 96' ' ' ASN . 54.8 t30 -159.92 -49.6 0.05 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -177.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.0 p -174.48 20.31 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.859 175.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.15 -87.31 0.54 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -169.17 147.84 3.87 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.348 0.659 . . . . 0.0 109.812 -169.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.444 ' CE2' ' HA ' ' A' ' 96' ' ' ASN . 77.1 m-85 -85.88 122.96 30.68 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 170.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -77.26 122.48 25.14 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.54 HG22 HG12 ' A' ' 79' ' ' ILE . 47.5 t -78.16 132.21 32.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.8 m -73.47 77.07 1.43 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.15 0.5 . . . . 0.0 110.913 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 m . . . . . 0 C--O 1.246 0.9 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.49 176.31 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.625 ' HG2' ' CZ ' ' A' ' 67' ' ' TYR . 45.4 Cg_endo . . . . . 0 CA--C 1.528 0.196 0 CA-C-O 121.021 0.342 . . . . 0.0 112.365 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.7 t -128.81 -13.43 4.67 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.354 0.597 . . . . 0.0 109.987 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.1 m -90.1 -6.77 55.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.113 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.34 28.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.576 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.476 ' HB3' HD11 ' A' ' 30' ' ' ILE . 1.6 m -92.88 -27.23 17.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.558 0.694 . . . . 0.0 109.228 175.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.763 HG21 ' HB ' ' A' ' 27' ' ' VAL . 2.2 p -149.89 146.64 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.015 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -135.7 128.76 31.58 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.497 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.492 HD21 ' CD1' ' A' ' 14' ' ' TYR . 36.9 tp -71.85 133.56 45.55 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.172 174.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -81.27 -64.02 1.27 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.969 177.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.6 p 177.32 166.52 0.6 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.851 -177.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.492 ' CD1' HD21 ' A' ' 11' ' ' LEU . 50.3 p90 -157.47 163.9 37.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.056 -177.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -153.18 163.89 39.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.938 0.399 . . . . 0.0 110.989 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.549 ' HD1' ' HD1' ' A' ' 21' ' ' PHE . 35.6 t80 -131.38 149.39 52.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.668 -176.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -174.71 117.82 0.2 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.226 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.0 -99.77 0.34 Allowed Glycine 0 CA--C 1.511 -0.208 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.6 t -135.47 83.46 2.02 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 164.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 62.6 m -148.42 134.33 19.08 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.503 172.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.549 ' HD1' ' HD1' ' A' ' 16' ' ' TYR . 7.8 t80 -132.74 102.34 5.63 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 169.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.4 t -139.04 167.42 22.1 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.952 -171.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.22 -154.35 25.33 Favored Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -155.64 173.49 16.65 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.433 0.635 . . . . 0.0 112.007 179.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.614 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 83.4 mt -136.53 153.37 30.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.58 -167.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.6 ' N ' HG23 ' A' ' 25' ' ' ILE . 6.8 t80 -130.58 100.39 5.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.93 -174.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.763 ' HB ' HG21 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -141.79 145.77 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -169.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.62 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 21.2 ptmt -97.62 154.56 17.47 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.805 -175.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.885 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 20.1 p-10 -75.1 115.7 15.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.96 177.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.647 HG12 ' OH ' ' A' ' 86' ' ' TYR . 34.4 mm -77.81 -56.07 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 167.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.49 -86.4 0.41 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.778 171.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -163.77 -68.47 0.04 OUTLIER 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 172.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m -80.71 124.33 28.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.861 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.885 ' HE3' ' HA ' ' A' ' 29' ' ' ASN . 37.8 mttp -122.81 176.66 5.86 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.341 0.591 . . . . 0.0 111.166 -172.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.832 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 96.4 mttt -121.14 136.54 54.96 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 166.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.3 t -127.66 113.63 32.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 122.014 0.911 . . . . 0.0 109.739 171.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 1.016 ' HB ' HD13 ' A' ' 53' ' ' ILE . 1.0 OUTLIER -131.48 136.14 47.67 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.148 -1.387 . . . . 0.0 110.413 -175.142 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 1.007 ' HB ' HG23 ' A' ' 54' ' ' ILE . 69.3 t -93.4 132.71 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.451 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.556 ' O ' ' HH2' ' A' ' 47' ' ' TRP . 2.7 m -112.8 104.77 17.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 165.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.641 ' CD1' HG13 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -122.18 120.87 35.46 Favored 'General case' 0 N--CA 1.4 -2.974 0 CA-C-N 114.902 -1.044 . . . . 0.0 110.054 -170.107 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.597 ' HB3' ' CZ3' ' A' ' 47' ' ' TRP . . . -76.5 129.0 35.87 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.53 -169.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -67.42 179.91 1.19 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.523 -1.672 . . . . 0.0 111.354 -168.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.582 ' HA2' ' HG2' ' A' ' 80' ' ' LYS . . . -68.0 -0.28 14.02 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.079 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.0 m -66.45 -22.75 66.21 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.013 0.435 . . . . 0.0 110.044 174.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 t70 64.69 37.66 7.47 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.133 -0.939 . . . . 0.0 108.98 177.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -173.86 140.28 0.73 Allowed 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -172.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.597 ' CZ3' ' HB3' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -89.39 85.88 6.66 Favored 'General case' 0 N--CA 1.421 -1.893 0 C-N-CA 118.608 -1.237 . . . . 0.0 112.516 -173.204 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -56.66 132.32 51.56 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.37 165.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -72.12 70.22 0.79 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.849 0.833 . . . . 0.0 111.317 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -112.74 -17.86 12.45 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.652 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.47 -58.34 3.05 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.709 -176.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 92.4 m-20 59.83 76.3 0.37 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.655 -0.773 . . . . 0.0 110.144 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 1.016 HD13 ' HB ' ' A' ' 37' ' ' THR . 5.7 tp -109.07 148.89 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-O 121.816 0.817 . . . . 0.0 112.044 -176.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 1.007 HG23 ' HB ' ' A' ' 38' ' ' VAL . 3.4 tp -133.03 140.34 47.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.494 -1.23 . . . . 0.0 107.712 167.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -92.84 116.42 29.01 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.287 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.12 156.28 39.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.215 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.8 t -114.83 144.8 42.94 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -174.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -71.25 142.06 50.56 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.283 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.4 t -109.12 -42.27 4.46 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.81 171.8 21.94 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.569 173.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.15 142.75 42.58 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.403 2.068 . . . . 0.0 110.637 173.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.533 HG12 ' HB2' ' A' ' 69' ' ' TYR . 9.7 mt -83.63 83.83 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.8 m -53.5 126.41 21.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.385 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 113.31 -32.42 6.11 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.252 -173.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -127.24 165.99 18.61 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -95.43 55.01 1.66 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.135 0.493 . . . . 0.0 110.863 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.625 ' CZ ' ' HG2' ' A' ' 4' ' ' PRO . 2.4 m-85 -137.04 159.3 42.31 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.328 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -107.29 173.59 6.26 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.922 176.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.533 ' HB2' HG12 ' A' ' 62' ' ' ILE . 3.1 t80 -143.5 120.84 11.61 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -165.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.614 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 20.6 m95 -127.79 138.65 52.81 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.922 -166.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.5 p -124.33 133.25 53.51 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -125.93 136.97 53.64 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.488 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.7 p -125.7 139.44 53.54 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.236 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.411 ' HB3' HG12 ' A' ' 54' ' ' ILE . . . -152.97 118.99 5.43 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.782 -175.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.9 t -82.57 99.4 9.5 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.427 ' CG2' ' HE1' ' A' ' 16' ' ' TYR . 13.8 m -99.48 144.66 11.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.375 -173.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.01 8.39 43.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.279 0.562 . . . . 0.0 110.563 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 156.81 145.8 4.3 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.639 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.676 HG12 HG22 ' A' ' 104' ' ' VAL . 7.3 tt -168.09 142.47 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.309 0.576 . . . . 0.0 110.873 177.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.582 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 3.7 mmmp? -125.48 -38.7 2.24 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.28 -177.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 29.4 mt-10 -141.65 167.22 22.67 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.641 ' HB2' ' HA ' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -171.89 170.45 5.44 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.017 -0.673 . . . . 0.0 112.056 172.197 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.655 ' HD2' ' HB3' ' A' ' 96' ' ' ASN . 0.1 OUTLIER -159.46 148.54 18.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.195 169.092 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.801 HD12 HG23 ' A' ' 38' ' ' VAL . 21.5 mm -95.01 140.76 16.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.706 -169.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.6 mtmt -90.7 114.09 26.33 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.157 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.647 ' OH ' HG12 ' A' ' 30' ' ' ILE . 10.5 t80 -91.95 99.72 12.51 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 172.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.832 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 9.3 tt0 -109.63 107.84 18.04 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.63 0.729 . . . . 0.0 110.206 -174.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 20.6 t -87.21 164.02 2.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.061 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -43.51 -40.86 4.11 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.405 0.44 . . . . 0.0 111.156 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -136.37 23.64 3.28 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.185 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.458 ' HB2' ' HB ' ' A' ' 88' ' ' VAL . 16.5 mmtp -141.74 175.44 9.7 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.772 0.796 . . . . 0.0 111.758 177.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.8 m -149.19 138.83 21.78 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.614 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.424 ' HD2' ' CD2' ' A' ' 86' ' ' TYR . 60.7 m-85 -140.6 -169.25 2.75 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -148.07 145.49 28.46 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.147 0.498 . . . . 0.0 111.503 -173.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.404 ' OD2' ' HB2' ' A' ' 11' ' ' LEU . 17.6 t70 -107.78 97.68 7.37 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 167.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.655 ' HB3' ' HD2' ' A' ' 83' ' ' TYR . 34.0 p30 -144.03 31.98 1.25 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -172.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 67.88 -67.6 0.18 Allowed 'General case' 0 CA--C 1.532 0.275 0 O-C-N 123.629 0.58 . . . . 0.0 111.403 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -171.66 40.25 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -175.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.6 t 63.64 46.6 4.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.954 -167.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -102.3 -38.55 7.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.99 -176.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 7.3 m-20 67.94 115.1 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.781 0.676 . . . . 0.0 110.282 -174.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.462 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 7.9 m-85 -77.14 133.21 39.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.437 -174.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -79.19 129.63 34.65 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.676 HG22 HG12 ' A' ' 79' ' ' ILE . 96.3 t -79.25 133.84 29.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.677 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.1 p -77.14 77.01 3.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.725 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.248 1.008 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.177 178.652 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo . . . . . 0 N--CA 1.456 -0.687 0 CA-C-O 121.028 0.345 . . . . 0.0 112.014 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.4 m -128.44 -54.96 1.25 Allowed 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.33 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.6 m -106.09 -68.62 0.87 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.351 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.28 -172.8 2.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 120.908 0.385 . . . . 0.0 111.862 -173.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 m -64.86 -26.56 68.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.214 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.724 ' CB ' ' HB ' ' A' ' 27' ' ' VAL . 2.2 p -120.57 148.31 23.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.382 0.61 . . . . 0.0 112.015 -174.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.429 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 28.0 tt0 -143.72 132.22 22.26 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.474 173.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.624 HD21 ' CD1' ' A' ' 14' ' ' TYR . 40.5 tp -70.03 130.76 43.02 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.099 0.476 . . . . 0.0 110.238 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -76.84 -63.9 1.25 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.901 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.5 m -178.96 159.87 1.04 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.622 -174.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.624 ' CD1' HD21 ' A' ' 11' ' ' LEU . 53.7 p90 -157.95 163.49 37.78 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.654 -177.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -151.32 164.95 35.5 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -176.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.601 ' HA ' ' O ' ' A' ' 20' ' ' THR . 97.6 m-85 -138.92 138.34 37.28 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.754 -176.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -136.53 124.62 22.95 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.54 -99.44 0.18 Allowed Glycine 0 C--N 1.331 0.265 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -167.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.1 t -139.86 87.85 2.19 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 163.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.601 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 73.0 m -145.96 133.3 20.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.422 177.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.659 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 14.8 t80 -90.57 126.49 35.96 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 174.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.9 p -144.92 126.19 14.78 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.593 175.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 173.68 -154.14 19.14 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.384 -177.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.517 ' HB3' HG22 ' A' ' 71' ' ' THR . 0.4 OUTLIER -161.85 166.07 26.86 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.196 0.522 . . . . 0.0 111.018 -177.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 33.8 mt -127.72 156.04 39.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.16 -172.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -126.9 96.32 4.59 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.866 -172.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.724 ' HB ' ' CB ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -147.91 143.23 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -172.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.53 ' HE3' ' CE1' ' A' ' 67' ' ' TYR . 17.0 ptpt -85.05 148.43 26.17 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.365 176.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -86.64 132.58 33.85 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.998 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.459 HG12 ' OH ' ' A' ' 86' ' ' TYR . 39.0 mm -80.33 -55.28 9.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.486 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.813 ' HB2' ' HE3' ' A' ' 34' ' ' LYS . . . -103.84 -81.18 0.52 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.026 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -159.31 -73.25 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.285 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.597 ' C ' ' HE2' ' A' ' 34' ' ' LYS . 10.0 t -95.87 62.78 2.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.34 0.591 . . . . 0.0 109.913 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.843 ' HD2' HG12 ' A' ' 88' ' ' VAL . 6.3 mmpt? -80.68 157.1 26.02 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.475 ' HG3' ' HB3' ' A' ' 87' ' ' GLU . 18.3 pttp -124.81 141.34 52.18 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.167 -175.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.3 t -115.73 116.57 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.787 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.589 HG22 HD13 ' A' ' 53' ' ' ILE . 5.4 p -114.17 119.43 37.04 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.866 -170.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.86 ' HB ' HG22 ' A' ' 54' ' ' ILE . 96.8 t -84.19 113.63 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.89 176.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 0.3 OUTLIER -107.6 107.09 21.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 172.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.584 ' HA ' ' HB3' ' A' ' 82' ' ' PHE . 4.3 p90 -109.26 137.61 46.88 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-O 122.494 1.14 . . . . 0.0 110.075 177.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.718 ' HB3' ' CE3' ' A' ' 47' ' ' TRP . . . -89.38 110.67 21.45 Favored 'General case' 0 N--CA 1.401 -2.894 0 CA-C-N 112.863 -1.971 . . . . 0.0 107.599 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -40.7 167.22 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 112.484 -2.143 . . . . 0.0 112.081 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.756 ' HA2' ' HB2' ' A' ' 80' ' ' LYS . . . -67.69 1.69 7.23 Favored Glycine 0 CA--C 1.518 0.264 0 CA-C-N 115.241 -0.891 . . . . 0.0 114.849 -163.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 30.7 t -87.49 -12.72 45.15 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 117.088 0.444 . . . . 0.0 111.009 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.603 ' OD1' ' HG2' ' A' ' 80' ' ' LYS . 5.3 m-20 74.27 48.75 0.12 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 124.038 0.836 . . . . 0.0 110.271 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -155.51 134.3 11.99 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.198 -171.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.718 ' CE3' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -105.03 85.7 2.32 Favored 'General case' 0 N--CA 1.425 -1.705 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.681 178.019 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -71.85 145.43 48.59 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 167.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -61.71 90.8 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.301 0.572 . . . . 0.0 110.75 -176.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -152.22 147.12 26.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.092 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.03 59.46 4.94 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.897 -176.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -71.36 56.71 0.24 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.357 0.598 . . . . 0.0 109.843 172.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.62 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -116.25 141.1 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.436 -176.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.86 HG22 ' HB ' ' A' ' 38' ' ' VAL . 8.5 tp -121.76 130.3 74.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.034 -0.984 . . . . 0.0 108.372 173.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.71 128.62 34.84 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.011 -173.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.74 158.36 28.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.977 178.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 t -122.63 121.93 37.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 29.1 p90 -82.4 138.29 34.49 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 121.708 0.766 . . . . 0.0 111.363 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 65.8 m -97.03 -41.32 8.43 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 172.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 68' ' ' GLU . . . 118.55 -87.5 0.42 Allowed Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.18 -0.918 . . . . 0.0 113.541 170.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -52.98 119.66 6.44 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 124.295 3.33 . . . . 0.0 115.959 -167.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.449 ' HB ' ' O ' ' A' ' 67' ' ' TYR . 21.6 mt -124.05 90.57 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.217 162.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.5 m -71.52 117.8 13.53 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.804 -174.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.68 -14.01 6.1 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.965 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -155.5 167.01 31.79 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -92.13 66.4 4.88 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.716 0.769 . . . . 0.0 109.438 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.53 ' CE1' ' HE3' ' A' ' 28' ' ' LYS . 2.2 m-85 -136.52 153.15 51.09 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.732 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.571 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 7.4 mp0 -106.44 174.78 5.74 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.888 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -137.55 115.75 11.75 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -166.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.684 ' NE1' HG12 ' A' ' 27' ' ' VAL . 8.0 m95 -116.16 121.85 43.32 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.649 -164.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.517 HG22 ' HB3' ' A' ' 24' ' ' LYS . 2.9 p -128.94 147.74 50.87 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 110.562 -0.162 . . . . 0.0 110.562 -171.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.407 ' HB3' ' O ' ' A' ' 71' ' ' THR . 2.5 p90 -174.58 159.72 2.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.444 0.64 . . . . 0.0 112.202 174.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.2 m -115.24 146.45 41.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.54 169.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.844 ' HB3' HG12 ' A' ' 54' ' ' ILE . . . -138.77 128.84 25.38 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -174.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.0 t -81.76 100.9 9.79 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 172.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.52 HG11 ' HB2' ' A' ' 21' ' ' PHE . 22.4 m -98.32 151.88 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.921 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.42 11.49 38.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.042 0.449 . . . . 0.0 111.032 -172.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 124.99 102.55 1.4 Allowed Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.929 HG12 HG22 ' A' ' 104' ' ' VAL . 12.3 tt -115.6 156.38 16.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 120.657 0.265 . . . . 0.0 110.986 -174.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.756 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 4.8 tppp? -139.66 -45.86 0.45 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.145 0.497 . . . . 0.0 111.75 -177.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.665 ' HG3' ' HB2' ' A' ' 41' ' ' ALA . 4.7 pt-20 -147.77 156.86 43.19 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.315 -176.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.584 ' HB3' ' HA ' ' A' ' 40' ' ' TYR . 55.7 p90 -171.86 179.27 2.79 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 119.774 -0.77 . . . . 0.0 112.815 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.46 149.83 30.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.503 167.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.455 HG21 HD11 ' A' ' 25' ' ' ILE . 25.6 mm -102.57 130.83 51.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.42 -177.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -96.42 147.61 23.64 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.845 0.831 . . . . 0.0 111.073 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.592 ' HD2' ' HD2' ' A' ' 93' ' ' TYR . 12.0 t80 -109.91 101.21 10.07 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.245 -1.343 . . . . 0.0 107.893 172.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.475 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . 10.8 tt0 -103.85 107.79 18.82 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 122.002 0.906 . . . . 0.0 110.702 -169.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.843 HG12 ' HD2' ' A' ' 34' ' ' LYS . 15.2 t -110.63 162.22 8.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.271 -1.331 . . . . 0.0 108.369 -177.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.5 m -70.22 -14.93 62.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.756 0.313 . . . . 0.0 111.389 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.35 -3.61 2.71 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.061 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm -142.11 160.44 40.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.099 0.476 . . . . 0.0 111.435 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 86' ' ' TYR . 7.5 m -148.99 143.58 26.21 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.909 172.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.592 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 20.4 m-85 -137.67 -172.07 3.15 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 175.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -148.03 127.07 12.82 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.781 -175.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.429 ' OD1' ' HA ' ' A' ' 10' ' ' GLN . 23.2 t70 -93.26 94.02 8.55 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 166.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.47 ' C ' ' H ' ' A' ' 98' ' ' ASN . 30.4 p-10 -128.12 41.72 3.45 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.851 -164.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 71.83 -33.58 0.27 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.325 1.05 . . . . 0.0 112.087 178.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.47 ' H ' ' C ' ' A' ' 96' ' ' ASN . 28.4 t-20 171.42 -59.55 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 65.2 m -160.25 26.95 0.17 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.586 174.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.1 -92.1 0.19 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -174.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.419 ' ND2' HE22 ' A' ' 103' ' ' GLN . 0.3 OUTLIER -174.25 150.49 1.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.069 -168.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.567 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 81.5 m-85 -88.98 140.79 29.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.294 175.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.419 HE22 ' ND2' ' A' ' 101' ' ' ASN . 1.8 mp0 -97.28 120.43 37.63 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 123.612 0.57 . . . . 0.0 109.905 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.929 HG22 HG12 ' A' ' 79' ' ' ILE . 86.9 t -83.5 126.27 40.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.062 0.458 . . . . 0.0 111.234 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.3 p -87.71 67.3 9.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.892 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.525 HG23 HG13 ' A' ' 104' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.601 -0.714 . . . . 0.0 111.116 178.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 N--CA 1.446 -1.265 0 N-CA-C 111.231 -0.334 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.2 t -145.61 -66.7 0.3 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.2 m -103.74 -30.95 10.09 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 173.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -122.6 174.75 6.88 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.302 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.462 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 70.3 m -96.75 11.36 35.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.571 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.706 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 0.9 OUTLIER -149.92 152.53 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.736 -175.056 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.431 ' O ' ' HB3' ' A' ' 26' ' ' TYR . 8.0 tt0 -149.83 112.1 4.67 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.123 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.641 ' CD1' HG12 ' A' ' 25' ' ' ILE . 7.8 tt -67.82 132.32 47.18 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.983 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.449 ' OD1' ' HE2' ' A' ' 24' ' ' LYS . 15.5 t70 -68.85 -61.43 1.81 Allowed 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.293 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.2 m -168.35 154.45 7.11 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.087 -168.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.514 ' HD2' HD23 ' A' ' 11' ' ' LEU . 42.1 p90 -157.08 152.66 26.72 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.396 -1.274 . . . . 0.0 109.198 177.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -127.86 164.74 21.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.094 0.473 . . . . 0.0 110.927 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' A' ' 20' ' ' THR . 56.1 t80 -145.56 151.95 38.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.838 176.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -172.85 121.94 0.4 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.759 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.71 -98.28 0.12 Allowed Glycine 0 CA--C 1.51 -0.265 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -172.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 49.3 m -139.47 85.84 2.08 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 161.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 3.9 m -145.52 140.09 27.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.114 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.608 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 25.0 t80 -118.25 139.59 51.08 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 172.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 p -160.22 126.48 4.2 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.668 176.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 14' ' ' TYR . . . 177.82 -159.17 24.79 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 119.798 -1.191 . . . . 0.0 112.917 -178.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.581 ' HB3' HG22 ' A' ' 71' ' ' THR . 0.0 OUTLIER -160.49 160.22 31.75 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.342 0.591 . . . . 0.0 110.721 -178.51 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.641 HG12 ' CD1' ' A' ' 11' ' ' LEU . 31.2 mt -128.94 156.11 41.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.635 -170.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.431 ' HB3' ' O ' ' A' ' 10' ' ' GLN . 4.2 t80 -130.7 115.88 17.28 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -175.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.706 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 1.0 OUTLIER -139.4 149.15 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 121.679 -0.638 . . . . 0.0 111.513 -177.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.547 ' HB2' ' HZ2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -93.45 152.69 18.93 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.374 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -79.66 126.21 30.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.786 -176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.647 HG12 ' OH ' ' A' ' 86' ' ' TYR . 26.6 mm -93.29 -48.64 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 167.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.05 -156.13 0.73 Allowed 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.949 -1.478 . . . . 0.0 107.868 174.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -110.3 -51.78 2.84 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.44 -177.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.4 m -82.35 85.46 6.87 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.224 0.535 . . . . 0.0 110.096 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.514 ' HB2' ' HE3' ' A' ' 34' ' ' LYS . 25.7 mtmt -102.9 174.86 5.69 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.084 0.468 . . . . 0.0 110.903 -174.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.828 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 88.7 mttt -131.63 139.16 49.06 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.133 174.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 68.8 t -130.83 108.51 15.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 121.954 0.883 . . . . 0.0 109.919 171.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.778 HG22 HD13 ' A' ' 53' ' ' ILE . 19.4 p -122.39 122.99 40.31 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.523 -174.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.718 HG23 HD12 ' A' ' 84' ' ' ILE . 84.6 t -83.58 135.17 25.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.871 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.8 m -135.21 122.03 34.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.779 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.686 ' HE1' ' HA ' ' A' ' 42' ' ' ASP . 5.3 p90 -115.9 171.14 7.96 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 119.599 -0.841 . . . . 0.0 112.192 -174.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.719 ' HB3' ' CH2' ' A' ' 47' ' ' TRP . . . -93.36 86.58 5.32 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 170.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.718 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 38.0 t70 6.53 -95.42 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 O-C-N 127.336 2.898 . . . . 0.0 114.846 174.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.57 -28.37 0.35 Allowed Glycine 0 C--N 1.316 -0.542 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.692 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.2 t -109.6 -60.75 1.73 Allowed 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 174.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.553 ' HA ' ' HB1' ' A' ' 41' ' ' ALA . 8.0 p-10 175.46 38.28 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.135 -176.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -91.68 113.2 25.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.076 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.719 ' CH2' ' HB3' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -124.17 118.74 27.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.545 0.688 . . . . 0.0 110.062 167.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.46 ' O ' ' HB3' ' A' ' 49' ' ' ASN . 66.3 t30 -81.59 56.76 3.09 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 170.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 48' ' ' ASN . 33.8 t30 69.07 -55.61 0.55 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -154.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -124.83 -72.34 0.67 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.308 164.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.85 -40.53 3.08 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.248 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -134.49 98.91 4.2 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.484 0.659 . . . . 0.0 110.969 -175.464 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.778 HD13 HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -122.42 143.91 33.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.682 -178.055 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.602 HG22 ' HB ' ' A' ' 38' ' ' VAL . 20.1 tt -131.57 128.45 60.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.195 173.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.23 132.95 35.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.781 0.324 . . . . 0.0 110.801 -176.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.79 159.66 33.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.614 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.3 m -112.3 128.98 56.43 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -71.5 138.74 49.17 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.276 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.8 m -99.55 -46.14 5.56 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 170.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.73 175.26 21.82 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.583 173.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.76 134.55 58.05 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.248 1.965 . . . . 0.0 110.945 174.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.4 HG12 ' HB2' ' A' ' 69' ' ' TYR . 62.9 mt -75.82 106.63 5.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 28.4 m -49.66 125.24 11.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.063 -174.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.89 7.08 60.12 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.168 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.504 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 50.8 m -151.68 172.27 16.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.137 0.494 . . . . 0.0 111.124 -178.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -101.65 20.37 16.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.225 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.504 ' CD2' ' HB3' ' A' ' 65' ' ' SER . 6.7 m-85 -103.71 154.95 18.98 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -114.14 162.58 16.33 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.4 ' HB2' HG12 ' A' ' 62' ' ' ILE . 8.8 t80 -122.6 119.44 30.81 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -167.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.527 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 3.7 m95 -116.28 126.76 54.01 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.491 -173.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.581 HG22 ' HB3' ' A' ' 24' ' ' LYS . 40.2 p -134.51 152.9 52.09 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.419 ' HB3' ' O ' ' A' ' 71' ' ' THR . 3.1 p90 -174.22 150.78 1.55 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.703 0.763 . . . . 0.0 111.79 168.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.0 m -112.43 138.42 49.19 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.014 169.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.608 ' HB1' ' HB3' ' A' ' 21' ' ' PHE . . . -132.64 135.78 46.08 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.936 0.398 . . . . 0.0 111.865 -168.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.9 t -88.31 98.18 11.45 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 170.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 19' ' ' SER . 20.1 m -104.21 139.94 23.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -177.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 3.8 mptp? -106.3 39.82 1.73 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.433 0.635 . . . . 0.0 109.93 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 129.71 136.77 4.12 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.063 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.729 HG12 HG22 ' A' ' 104' ' ' VAL . 12.8 tt -160.78 143.8 4.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.014 0.435 . . . . 0.0 110.137 176.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -114.85 -56.16 2.41 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.985 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.467 ' HG2' ' HB2' ' A' ' 41' ' ' ALA . 12.6 pt-20 -150.78 174.51 12.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 117.889 -1.053 . . . . 0.0 108.735 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.557 ' CB ' ' HA ' ' A' ' 40' ' ' TYR . 46.8 p90 -172.76 179.95 2.25 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 120.413 1.461 . . . . 0.0 113.51 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.61 ' CB ' ' HB3' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -161.39 154.67 21.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 113.558 -1.655 . . . . 0.0 108.704 174.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.718 HD12 HG23 ' A' ' 38' ' ' VAL . 20.4 mm -99.98 147.43 7.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.979 -173.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.753 ' HB2' ' HG1' ' A' ' 37' ' ' THR . 3.6 mmmp? -102.06 106.52 17.43 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.833 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.647 ' OH ' HG12 ' A' ' 30' ' ' ILE . 17.2 t80 -86.84 101.07 13.01 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 174.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.828 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 17.5 tt0 -109.5 117.58 34.35 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.383 0.611 . . . . 0.0 110.534 -173.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.1 t -115.47 106.22 20.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.393 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.8 t 53.8 23.92 4.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.419 0.628 . . . . 0.0 110.869 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.49 5.4 48.75 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.927 -177.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.722 ' O ' ' HA ' ' A' ' 87' ' ' GLU . 19.8 tptp -99.24 150.91 21.6 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.9 m -126.28 141.39 51.93 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 122.27 1.033 . . . . 0.0 112.842 -174.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.484 ' HD2' ' CD2' ' A' ' 86' ' ' TYR . 29.4 m-85 -134.8 -174.63 3.65 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 113.286 -1.779 . . . . 0.0 106.791 167.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.499 ' HE1' ' HD3' ' A' ' 85' ' ' LYS . 61.9 m-85 -144.58 137.03 26.47 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -169.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -127.99 112.54 14.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.567 171.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.61 ' HB3' ' CB ' ' A' ' 83' ' ' TYR . 29.4 p-10 -139.31 -43.35 0.45 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.484 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.609 ' HB3' ' O ' ' A' ' 96' ' ' ASN . 4.0 p-10 159.82 -45.18 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 168.15 -65.06 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 65.8 m -158.97 51.18 0.38 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.398 174.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.553 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -137.36 -31.74 0.8 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.553 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 95.7 m-20 84.18 150.77 0.08 Allowed 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.836 0.71 . . . . 0.0 110.156 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -69.68 101.33 1.64 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.242 177.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.06 124.88 28.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.908 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.729 HG22 HG12 ' A' ' 79' ' ' ILE . 15.6 t -94.97 147.24 5.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.015 0.436 . . . . 0.0 110.487 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.4 m -93.75 112.41 24.27 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.791 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.251 1.153 0 CA-C-O 119.264 -0.398 . . . . 0.0 111.001 -177.734 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo . . . . . 0 N--CA 1.461 -0.392 0 N-CA-C 111.052 -0.403 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.7 t 68.19 7.41 5.88 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.181 0.593 . . . . 0.0 111.664 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.6 m -113.92 -64.69 1.27 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 172.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -153.55 -167.32 2.65 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.53 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 5.0 m -84.4 -17.42 39.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.623 0.725 . . . . 0.0 109.17 173.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.632 HG21 HG13 ' A' ' 27' ' ' VAL . 1.5 p -148.97 153.57 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.287 -176.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -143.01 127.97 18.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.333 177.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.435 HD21 ' CD2' ' A' ' 14' ' ' TYR . 42.9 tp -69.39 137.8 53.09 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.968 0.413 . . . . 0.0 110.319 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.507 ' OD1' ' HE2' ' A' ' 24' ' ' LYS . 12.9 t70 -83.58 -61.78 1.75 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.366 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.2 p -178.86 164.13 1.47 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.735 -176.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.435 ' CD2' HD21 ' A' ' 11' ' ' LEU . 45.9 p90 -158.33 163.14 37.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.772 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -143.81 166.5 24.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.825 0.345 . . . . 0.0 111.287 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.709 ' HD1' ' HD1' ' A' ' 21' ' ' PHE . 8.1 t80 -129.45 141.86 50.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.446 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -150.63 97.87 2.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.079 -176.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.98 -98.26 0.35 Allowed Glycine 0 CA--C 1.508 -0.379 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -172.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -129.64 84.26 2.2 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 162.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 95.5 m -147.45 134.72 20.6 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.065 175.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.709 ' HD1' ' HD1' ' A' ' 16' ' ' TYR . 2.9 t80 -132.88 109.54 9.68 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.0 m -135.6 149.63 49.43 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.926 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 179.6 -167.93 38.11 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -150.99 160.83 43.68 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.046 0.451 . . . . 0.0 111.307 -179.046 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.598 HD11 HG21 ' A' ' 84' ' ' ILE . 17.6 mt -127.3 153.23 36.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.072 -170.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.451 ' N ' HG23 ' A' ' 25' ' ' ILE . 0.7 OUTLIER -124.97 111.85 15.89 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.632 HG13 HG21 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -133.3 155.23 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.902 -176.021 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 8' ' ' SER . 17.6 ptpt -93.49 152.19 19.23 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.029 175.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -94.92 102.17 13.99 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.756 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.564 HD13 ' HE2' ' A' ' 86' ' ' TYR . 3.8 mp -80.79 -44.52 21.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 172.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.485 ' HB3' ' CG2' ' A' ' 88' ' ' VAL . . . -132.64 159.95 38.09 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.461 -1.245 . . . . 0.0 107.65 174.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -85.26 -29.78 24.33 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.176 -0.466 . . . . 0.0 112.033 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 p -91.67 96.92 10.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.17 0.51 . . . . 0.0 110.274 176.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.481 ' HZ1' ' CD ' ' A' ' 68' ' ' GLU . 41.4 mttt -111.78 171.09 7.7 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.442 -174.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.756 ' HG3' ' HB3' ' A' ' 87' ' ' GLU . 17.0 ptmt -155.73 103.95 2.3 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.0 0.905 . . . . 0.0 109.578 174.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.7 t -98.21 129.14 48.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-O 121.407 0.622 . . . . 0.0 109.979 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 1.032 ' HB ' HD13 ' A' ' 53' ' ' ILE . 1.2 p -137.52 134.91 36.23 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.764 -172.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.984 ' HB ' HG23 ' A' ' 54' ' ' ILE . 78.2 t -91.96 135.46 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.202 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.546 ' N ' HG13 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -114.96 75.3 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 170.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.959 ' CD2' HG11 ' A' ' 38' ' ' VAL 0.256 0.1 OUTLIER -102.65 118.36 36.68 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 122.398 1.094 . . . . 0.0 111.081 -176.749 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.922 ' HA ' ' CZ2' ' A' ' 47' ' ' TRP . . . -76.36 146.0 39.08 Favored 'General case' 0 CA--C 1.497 -1.073 0 CA-C-N 113.719 -1.582 . . . . 0.0 112.357 -168.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 44' ' ' SER . 5.5 p-10 -79.34 163.7 24.65 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.607 -172.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.785 ' HA2' ' HB2' ' A' ' 80' ' ' LYS . . . -73.17 41.71 0.92 Allowed Glycine 0 C--N 1.329 0.146 0 O-C-N 123.421 0.451 . . . . 0.0 113.694 -171.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.413 ' H ' ' C ' ' A' ' 42' ' ' ASP . 50.0 m -121.29 -16.58 7.88 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.952 0.405 . . . . 0.0 110.502 176.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.523 ' OD1' ' HG2' ' A' ' 80' ' ' LYS . 3.8 m-20 66.39 47.5 1.73 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.671 177.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.505 ' O ' ' HD1' ' A' ' 47' ' ' TRP . 12.3 t-20 -143.22 87.84 1.99 Allowed 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.837 -171.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.922 ' CZ2' ' HA ' ' A' ' 41' ' ' ALA . 2.4 m0 -124.0 92.73 3.73 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -170.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -101.71 71.53 1.32 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.79 173.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.3 t30 49.52 24.1 1.05 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.504 0.669 . . . . 0.0 111.469 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -69.19 -36.76 77.65 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 173.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 57.97 70.22 1.05 Allowed Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 114.171 -1.377 . . . . 0.0 114.008 168.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.709 ' HB2' ' HZ2' ' A' ' 47' ' ' TRP . 38.2 m-80 -64.83 108.1 1.66 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 174.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 1.032 HD13 ' HB ' ' A' ' 37' ' ' THR . 5.4 tp -107.68 152.51 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 121.56 0.695 . . . . 0.0 112.031 -169.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.984 HG23 ' HB ' ' A' ' 38' ' ' VAL . 13.0 tt -142.29 140.5 29.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.031 167.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.45 130.14 35.26 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.723 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.06 153.72 36.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.667 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -105.2 130.66 53.3 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.431 0.634 . . . . 0.0 110.287 -176.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.4 ' H ' ' HD1' ' A' ' 58' ' ' PHE . 1.5 m-85 -71.21 143.16 50.55 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.389 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.0 m -114.65 -37.97 4.12 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 171.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.6 -178.25 17.99 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.773 172.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.02 138.62 78.92 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.461 2.107 . . . . 0.0 111.305 175.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.943 HG12 ' HB2' ' A' ' 69' ' ' TYR . 10.6 mt -81.78 126.56 39.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.63 -174.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.3 m -64.09 117.11 6.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.97 0.414 . . . . 0.0 109.989 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.0 -17.26 32.38 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.657 -176.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.421 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 19.8 m -128.05 173.23 10.23 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -107.56 4.9 26.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.273 0.559 . . . . 0.0 110.429 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.419 ' CE1' ' HB2' ' A' ' 28' ' ' LYS . 20.7 m-85 -100.79 -178.56 3.81 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.329 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.481 ' CD ' ' HZ1' ' A' ' 34' ' ' LYS . 22.1 tt0 -113.54 170.69 8.06 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.54 -170.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.943 ' HB2' HG12 ' A' ' 62' ' ' ILE . 4.1 t80 -138.53 126.37 22.36 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -162.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.564 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 5.8 m95 -126.54 135.81 51.76 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.013 -170.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.494 HG22 ' HB3' ' A' ' 24' ' ' LYS . 20.8 p -135.88 153.77 51.36 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -178.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -158.85 164.15 35.98 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.875 0.845 . . . . 0.0 112.153 171.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 p -142.15 139.52 32.15 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.38 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.89 133.57 17.81 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -173.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.6 t -82.04 100.34 9.68 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 168.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.663 HG13 ' HH ' ' A' ' 40' ' ' TYR . 26.7 m -92.05 151.11 3.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.284 0.564 . . . . 0.0 110.574 -176.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -98.94 37.59 1.5 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.796 -177.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.63 116.26 3.96 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.551 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.733 HD13 ' HB2' ' A' ' 40' ' ' TYR . 4.2 tt -126.63 152.86 34.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.099 0.476 . . . . 0.0 110.494 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.785 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 17.6 tppt? -131.72 -42.46 1.02 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.22 -174.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 11.3 pt-20 -156.29 172.02 19.2 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-O 118.482 -0.77 . . . . 0.0 109.512 -176.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.666 ' CB ' ' HA ' ' A' ' 40' ' ' TYR . 55.4 p90 -173.01 178.15 2.59 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.44 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -155.4 137.11 14.31 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 113.478 -1.692 . . . . 0.0 107.71 164.219 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.666 HD12 HG23 ' A' ' 38' ' ' VAL . 22.8 mm -91.1 137.31 22.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 O-C-N 121.637 -0.665 . . . . 0.0 109.86 -175.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -92.97 129.49 38.87 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 122.048 0.928 . . . . 0.0 111.318 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.696 ' HD2' ' HD2' ' A' ' 93' ' ' TYR . 20.5 t80 -98.65 99.61 10.75 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 113.517 -1.674 . . . . 0.0 107.548 168.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.756 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . 4.2 tt0 -117.13 135.46 53.74 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -176.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.593 ' C ' ' H ' ' A' ' 90' ' ' GLY . 0.4 OUTLIER -146.72 162.61 8.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -178.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.1 t -72.39 32.71 0.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 122.066 0.936 . . . . 0.0 110.769 -174.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.593 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -147.28 -53.43 0.02 OUTLIER Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 114.638 -1.165 . . . . 0.0 111.34 175.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 91' ' ' LYS . 29.2 mmtp -132.01 -175.83 3.86 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.904 0.859 . . . . 0.0 113.158 -176.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.456 HG23 ' HG3' ' A' ' 87' ' ' GLU . 7.1 m -151.5 141.96 22.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.209 -1.36 . . . . 0.0 110.481 175.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.696 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 18.1 m-85 -145.16 -170.65 3.48 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -149.11 127.17 11.97 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.235 0.334 . . . . 0.0 111.526 -173.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -80.51 79.05 7.18 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 167.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -118.55 -70.05 0.81 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.065 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.444 ' HB2' ' HB2' ' A' ' 100' ' ' ALA . 0.7 OUTLIER 148.35 -53.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 -172.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.9 t30 175.82 -56.26 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.225 -1.807 . . . . 0.0 106.993 174.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.5 p -156.73 43.63 0.38 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.501 173.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -106.9 -53.37 2.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.788 -172.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 5.9 m-20 72.19 128.73 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.56 0.537 . . . . 0.0 110.079 -175.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 96.6 m-85 -74.27 118.68 17.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.239 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.83 124.52 28.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.998 0.428 . . . . 0.0 110.501 177.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.6 t -79.71 144.16 11.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 173.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.4 t -84.81 65.74 9.29 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.222 0.534 . . . . 0.0 110.66 -172.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.482 -0.77 . . . . 0.0 110.769 178.377 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.551 ' HB3' ' HE1' ' A' ' 67' ' ' TYR . 58.6 Cg_endo . . . . . 0 N--CA 1.463 -0.301 0 N-CA-C 111.072 -0.395 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.5 t -150.85 -55.89 0.16 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.796 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.3 m -69.18 -77.7 0.08 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -175.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.33 -165.2 2.21 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 122.251 -0.281 . . . . 0.0 110.605 -177.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.516 ' HA ' ' HE2' ' A' ' 28' ' ' LYS . 14.6 m -69.39 -18.16 63.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.374 0.607 . . . . 0.0 110.334 176.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.436 ' CG1' ' HB2' ' A' ' 86' ' ' TYR . 2.8 p -149.68 147.33 16.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -143.99 143.76 31.36 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.753 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.44 ' CD1' ' HD2' ' A' ' 14' ' ' TYR . 3.8 tp -69.49 132.99 47.17 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.908 0.385 . . . . 0.0 110.685 172.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.63 -64.94 1.08 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 169.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.4 m -166.45 153.19 9.14 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.993 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.44 ' HD2' ' CD1' ' A' ' 11' ' ' LEU . 20.3 p90 -142.34 157.82 44.39 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 173.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -119.56 157.44 28.37 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.794 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.658 ' HA ' ' O ' ' A' ' 20' ' ' THR . 50.3 t80 -137.92 146.6 43.47 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 172.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -179.25 114.94 0.06 Allowed 'General case' 0 C--N 1.315 -0.924 0 O-C-N 123.683 0.615 . . . . 0.0 109.733 -174.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.73 -103.36 0.31 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -168.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.635 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 24.8 m -124.3 88.47 2.91 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 165.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 89.4 m -143.6 135.64 26.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.638 176.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.469 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 11.4 t80 -134.01 145.02 49.07 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 120.732 0.301 . . . . 0.0 110.596 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.619 ' HG ' ' HB2' ' A' ' 74' ' ' ALA . 48.1 m 94.6 178.4 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 164.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -171.98 -78.61 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.573 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.516 ' HB3' HG22 ' A' ' 71' ' ' THR . 0.4 OUTLIER -166.55 169.02 14.13 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.977 0.418 . . . . 0.0 111.406 176.724 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 53.4 mt -132.07 154.0 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.577 -170.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -116.13 105.82 13.03 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -178.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 p -125.91 145.17 33.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 O-C-N 121.772 -0.58 . . . . 0.0 112.56 -165.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.516 ' HE2' ' HA ' ' A' ' 8' ' ' SER . 16.3 ttmm -86.41 151.75 23.28 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -101.97 117.63 35.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.415 0.626 . . . . 0.0 111.126 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.601 HG12 ' OH ' ' A' ' 86' ' ' TYR . 28.2 mm -88.24 -48.61 14.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.38 -154.03 0.61 Allowed 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 171.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -104.69 -48.72 3.71 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.25 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.1 m -74.41 80.01 1.9 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.033 176.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.601 ' HE2' ' CZ2' ' A' ' 70' ' ' TRP . 30.3 mtmm -103.74 157.59 16.97 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.597 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 24.9 mtpp -127.66 123.74 36.29 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.06 0.457 . . . . 0.0 109.889 176.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.7 t -117.13 125.53 73.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.97 ' HB ' HD13 ' A' ' 53' ' ' ILE . 0.8 OUTLIER -138.64 129.44 26.48 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.014 -169.619 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.918 ' HB ' HG22 ' A' ' 54' ' ' ILE . 7.1 t -95.53 124.09 47.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.518 0.675 . . . . 0.0 110.742 -178.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.59 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -102.97 108.4 24.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 114.482 -1.236 . . . . 0.0 107.842 177.091 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.677 ' HB2' HG13 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -101.71 147.97 25.83 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-O 122.688 1.232 . . . . 0.0 112.448 174.454 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.07 93.98 9.13 Favored 'General case' 0 N--CA 1.407 -2.577 0 CA-C-N 113.431 -1.713 . . . . 0.0 106.382 165.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.5 ' CG ' ' H ' ' A' ' 43' ' ' GLY . 12.0 t70 -54.53 -163.79 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 111.441 -2.618 . . . . 0.0 112.778 -172.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.5 ' H ' ' CG ' ' A' ' 42' ' ' ASP . . . -58.1 -15.7 22.97 Favored Glycine 0 C--N 1.333 0.361 0 N-CA-C 111.981 -0.448 . . . . 0.0 111.981 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.5 t -58.98 -26.06 64.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 122.408 0.283 . . . . 0.0 110.357 173.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.8 t0 70.21 14.97 7.59 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-O 122.155 0.979 . . . . 0.0 109.243 174.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -159.89 152.49 21.22 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.737 -169.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -95.82 95.39 8.25 Favored 'General case' 0 N--CA 1.419 -2.009 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.217 173.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.618 ' OD1' ' HB2' ' A' ' 50' ' ' ASN . 5.1 p30 -82.97 22.61 0.92 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.498 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 51.19 65.88 1.35 Allowed 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.321 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.618 ' HB2' ' OD1' ' A' ' 48' ' ' ASN . 14.2 t30 -115.66 -61.75 1.69 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.874 -172.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.37 74.9 0.12 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -175.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.646 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 65.9 m-20 -117.34 83.91 2.06 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -175.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.97 HD13 ' HB ' ' A' ' 37' ' ' THR . 8.0 tp -119.38 149.93 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-O 121.446 0.641 . . . . 0.0 112.344 -171.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.918 HG22 ' HB ' ' A' ' 38' ' ' VAL . 8.5 tp -128.0 137.62 57.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 169.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.93 140.88 32.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.228 0.537 . . . . 0.0 111.773 -175.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.454 ' HA ' ' HB3' ' A' ' 72' ' ' PHE . . . -94.57 146.62 23.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.552 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.2 p -109.43 148.41 31.19 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.489 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -71.7 141.77 49.84 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -176.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.548 ' C ' ' HD2' ' A' ' 61' ' ' PRO . 23.0 t -114.95 -45.2 2.98 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.422 ' N ' ' HD2' ' A' ' 61' ' ' PRO . . . 116.6 -68.31 0.29 Allowed Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.924 -0.931 . . . . 0.0 114.594 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.548 ' HD2' ' C ' ' A' ' 59' ' ' SER . 13.9 Cg_exo -12.71 -42.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.384 1 C-N-CA 128.244 5.963 . . . . 0.0 120.362 -166.168 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.742 HG13 ' HB2' ' A' ' 69' ' ' TYR . 7.2 mt -71.08 88.34 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 119.353 0.979 . . . . 0.0 110.441 -177.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.6 t -114.32 163.56 15.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.494 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.13 21.66 78.77 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.6 m -155.68 174.16 15.68 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -92.32 32.38 1.19 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.068 0.461 . . . . 0.0 110.372 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.551 ' HE1' ' HB3' ' A' ' 4' ' ' PRO . 6.4 m-85 -129.76 -179.33 5.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.207 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -153.4 151.77 30.29 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.303 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.742 ' HB2' HG13 ' A' ' 62' ' ' ILE . 3.2 t80 -104.54 128.93 52.63 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -174.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.601 ' CZ2' ' HE2' ' A' ' 34' ' ' LYS . 15.6 m0 -124.38 151.21 44.68 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 24' ' ' LYS . 7.7 p -129.94 147.3 51.68 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 -178.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.454 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -160.79 142.35 12.12 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.549 177.621 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 42.1 m -124.85 146.49 49.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.375 176.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.619 ' HB2' ' HG ' ' A' ' 22' ' ' SER . . . -138.15 112.99 9.03 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -174.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.9 t -78.5 100.47 6.9 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 169.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.635 ' O ' ' HB3' ' A' ' 19' ' ' SER . 30.0 m -103.83 156.44 5.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.397 -177.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.733 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -102.9 -7.42 21.53 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.551 174.67 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 172.6 142.09 3.67 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.615 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.677 HG13 ' HB2' ' A' ' 40' ' ' TYR . 6.0 tt -160.26 142.14 4.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 177.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -121.87 -46.79 2.21 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.594 -174.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 9.8 pt-20 -152.51 162.22 41.5 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -176.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.59 ' HB2' ' O ' ' A' ' 39' ' ' VAL . 42.5 p90 -170.79 173.62 5.21 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.7 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.409 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.1 OUTLIER -155.69 153.78 30.51 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 172.524 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.5 mt -92.6 151.91 3.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.562 0.696 . . . . 0.0 112.219 -170.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 18.8 mmtp -107.46 114.09 27.87 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.341 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.804 ' HD2' ' HD2' ' A' ' 93' ' ' TYR . 14.9 t80 -91.59 101.29 13.93 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 174.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.498 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 23.2 tt0 -105.83 111.17 23.73 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.47 0.652 . . . . 0.0 109.693 -172.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.551 ' C ' ' H ' ' A' ' 90' ' ' GLY . 14.6 t -108.94 159.84 8.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.211 -176.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.9 t -79.3 33.67 0.24 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 122.002 0.906 . . . . 0.0 109.046 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.551 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -164.23 -47.43 0.02 OUTLIER Glycine 0 N--CA 1.436 -1.338 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.805 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.533 ' H ' ' HB ' ' A' ' 88' ' ' VAL . 30.5 mmmt -127.0 -173.87 3.0 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.926 0.869 . . . . 0.0 112.284 -176.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 86' ' ' TYR . 6.9 m -150.79 140.79 22.02 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.167 175.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.804 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 48.5 m-85 -144.43 -166.07 2.29 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -144.26 160.32 41.19 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.75 0.31 . . . . 0.0 111.029 -174.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -126.24 115.93 20.5 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 162.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -146.95 -66.89 0.27 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.039 -170.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 155.53 -56.91 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -173.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 50.0 t30 176.14 -48.95 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 112.871 -1.968 . . . . 0.0 106.614 176.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.6 t -170.84 64.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.586 170.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -126.38 -44.85 1.69 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.49 -173.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 91.1 m-20 70.9 144.63 0.06 Allowed 'General case' 0 N--CA 1.471 0.602 0 O-C-N 123.677 0.61 . . . . 0.0 110.597 -175.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 98.3 m-85 -79.95 111.27 16.12 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.759 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.583 ' N ' HE21 ' A' ' 103' ' ' GLN . 0.0 OUTLIER -79.87 110.69 15.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.094 178.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.482 HG22 HD11 ' A' ' 79' ' ' ILE . 25.3 t -79.76 142.12 14.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.205 -177.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.8 t -90.96 106.3 18.42 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -176.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.667 -0.683 . . . . 0.0 110.87 -174.94 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo . . . . . 0 C--O 1.233 0.26 0 CA-C-O 120.884 0.285 . . . . 0.0 112.231 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.9 t -130.69 -67.21 0.73 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.328 -0.397 . . . . 0.0 109.999 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.7 t -88.57 -68.96 0.73 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.231 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.49 -159.05 0.93 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.57 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.1 m -62.98 -32.68 74.07 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.553 0.692 . . . . 0.0 109.622 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.853 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.3 p -115.95 150.42 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.574 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.444 ' O ' ' HB3' ' A' ' 26' ' ' TYR . 9.3 tt0 -145.66 125.24 13.25 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.988 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.4 tp -68.18 131.66 45.79 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.209 0.528 . . . . 0.0 110.856 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -81.14 -61.83 1.84 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.853 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.6 p -175.95 160.03 2.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.938 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -152.04 161.39 42.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.808 177.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -129.29 165.3 21.7 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.734 0.302 . . . . 0.0 110.681 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.599 ' HD1' ' HD1' ' A' ' 21' ' ' PHE . 51.7 t80 -145.6 153.08 40.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.142 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -177.63 129.23 0.15 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.12 -102.56 0.36 Allowed Glycine 0 C--N 1.331 0.275 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -173.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.2 m -136.83 85.66 2.15 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 163.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 6.5 m -144.8 131.05 19.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.354 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.599 ' HD1' ' HD1' ' A' ' 16' ' ' TYR . 1.4 t80 -133.44 102.47 5.54 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.689 0.757 . . . . 0.0 109.302 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.6 m -134.65 160.08 39.23 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.809 -174.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.28 -143.32 8.66 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.447 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -162.56 159.96 25.39 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.093 0.473 . . . . 0.0 110.966 178.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.45 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 20.9 mt -122.25 155.53 27.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.179 -173.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.444 ' HB3' ' O ' ' A' ' 10' ' ' GLN . 7.5 t80 -129.05 101.56 6.1 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -172.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.853 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 2.0 m -135.35 145.65 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 O-C-N 121.493 -0.754 . . . . 0.0 112.52 -171.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 67' ' ' TYR . 40.1 ttmt -68.43 133.41 48.6 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.186 177.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.517 ' HB3' ' HB2' ' A' ' 68' ' ' GLU . 24.1 p-10 -95.18 84.51 4.09 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.752 0.787 . . . . 0.0 110.544 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.5 mp -63.72 -47.74 89.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 175.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.44 -176.12 2.83 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.697 171.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -109.99 -55.82 2.4 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.465 -177.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.8 m -75.8 73.58 2.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.379 0.609 . . . . 0.0 110.43 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.582 ' HZ1' ' CD ' ' A' ' 68' ' ' GLU . 28.9 mtmm -102.75 -171.63 1.99 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.761 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -151.63 144.4 24.37 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.9 t -125.53 120.24 57.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.524 0.678 . . . . 0.0 110.552 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.628 ' HB ' HG13 ' A' ' 53' ' ' ILE . 2.1 p -116.17 110.34 18.69 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.261 -176.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 1.058 ' HB ' HG22 ' A' ' 54' ' ' ILE . 81.0 t -83.28 108.35 15.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.78 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.579 HG12 ' HB ' ' A' ' 53' ' ' ILE . 26.5 m -108.77 121.19 61.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.226 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.423 ' HB2' HG13 ' A' ' 79' ' ' ILE . 7.6 p90 -118.39 148.59 42.37 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.631 0.729 . . . . 0.0 111.7 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.516 ' HB2' ' HG2' ' A' ' 81' ' ' GLU . . . -81.59 83.87 6.92 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 171.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -48.59 -166.47 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 111.337 -2.665 . . . . 0.0 113.932 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.2 -21.17 46.07 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-N 116.259 -0.428 . . . . 0.0 113.062 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -65.91 -19.86 66.02 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.654 -0.321 . . . . 0.0 110.526 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.2 t70 72.85 21.98 3.21 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.444 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -168.3 148.96 4.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.493 -175.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.437 ' CZ3' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -87.81 83.74 7.1 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 173.654 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.574 ' C ' ' H ' ' A' ' 50' ' ' ASN . 6.4 t-20 -78.11 55.49 1.49 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.2 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.0 t30 69.04 -26.77 0.15 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.204 0.601 . . . . 0.0 110.865 -176.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.574 ' H ' ' C ' ' A' ' 48' ' ' ASN . 4.6 p30 -62.14 -43.17 99.43 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.374 174.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 49.97 62.5 4.92 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -176.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 28.8 m-80 -41.78 106.76 0.06 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.882 0.873 . . . . 0.0 111.982 -174.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.652 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -117.3 138.48 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.833 0.825 . . . . 0.0 112.658 -171.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 1.058 HG22 ' HB ' ' A' ' 38' ' ' VAL . 5.2 tp -111.37 133.99 55.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 168.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.61 113.24 22.34 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.263 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.84 154.47 29.79 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -130.48 130.83 44.71 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.699 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 38.0 p90 -78.27 137.66 38.21 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.902 0.858 . . . . 0.0 111.013 -178.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.9 t -87.1 -26.77 23.49 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.276 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.88 168.91 18.87 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.508 172.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 68' ' ' GLU . 26.1 Cg_exo -63.39 141.87 83.01 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.676 2.251 . . . . 0.0 111.42 174.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.475 HG12 ' HB2' ' A' ' 69' ' ' TYR . 21.8 mt -84.62 109.25 17.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.337 -177.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.6 m -63.11 126.18 26.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.869 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.34 -7.28 34.58 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.166 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.7 m -151.26 165.47 33.9 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -92.71 52.58 1.89 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.953 0.882 . . . . 0.0 109.124 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 4.0 m-85 -130.21 169.24 15.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.536 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.582 ' CD ' ' HZ1' ' A' ' 34' ' ' LYS . 9.0 tt0 -125.2 171.54 10.25 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.585 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.475 ' HB2' HG12 ' A' ' 62' ' ' ILE . 3.1 t80 -138.86 111.15 7.43 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -163.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.699 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 11.8 m95 -112.57 130.47 56.01 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.985 -168.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 p -120.26 144.27 47.86 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -155.34 155.9 34.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.848 0.832 . . . . 0.0 112.549 177.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.6 p -142.51 142.46 32.26 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.011 174.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.68 138.76 18.22 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -175.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 31.3 t -90.58 101.23 13.97 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 166.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.406 HG11 ' CB ' ' A' ' 21' ' ' PHE . 32.0 m -89.66 160.48 2.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.42 -171.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.514 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -90.37 29.72 1.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.638 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.29 146.23 13.35 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -170.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.651 HG12 HG22 ' A' ' 104' ' ' VAL . 2.8 tt -143.28 126.81 13.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.775 0.798 . . . . 0.0 111.409 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 103' ' ' GLN . 28.0 mmtp -93.5 -41.45 9.77 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.22 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 13.8 pt-20 -160.68 168.27 25.22 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.408 ' HB3' HD13 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -169.39 172.76 6.95 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.657 178.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.47 ' HD2' ' HB3' ' A' ' 96' ' ' ASN . 0.1 OUTLIER -164.72 150.04 9.89 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.573 -1.194 . . . . 0.0 107.854 175.116 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.693 HD12 HG21 ' A' ' 38' ' ' VAL . 9.6 mm -93.3 136.29 25.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.017 -172.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.816 ' HD2' ' HE1' ' A' ' 94' ' ' TYR . 15.6 mmmt -94.4 104.95 16.92 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.605 ' CD2' ' HD2' ' A' ' 93' ' ' TYR . 23.9 t80 -86.76 102.14 13.98 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.338 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -114.42 123.15 48.73 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.638 0.732 . . . . 0.0 109.952 -173.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.538 ' C ' ' H ' ' A' ' 90' ' ' GLY . 9.4 t -112.76 163.79 9.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 t -72.25 20.79 0.06 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.197 0.523 . . . . 0.0 111.082 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.538 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -162.85 -40.88 0.02 OUTLIER Glycine 0 N--CA 1.438 -1.232 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.891 178.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -117.35 167.6 11.1 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -174.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.1 m -146.05 145.5 30.6 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.605 ' HD2' ' CD2' ' A' ' 86' ' ' TYR . 60.9 m-85 -142.58 -168.28 2.71 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 175.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.816 ' HE1' ' HD2' ' A' ' 85' ' ' LYS . 21.5 m-85 -146.42 140.39 26.26 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.551 -173.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.425 ' HB2' HG23 ' A' ' 9' ' ' VAL . 24.2 t70 -110.12 96.24 6.1 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.55 ' O ' ' HB2' ' A' ' 97' ' ' ASN . 27.0 p-10 -137.55 39.17 2.44 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.763 -174.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.55 ' HB2' ' O ' ' A' ' 96' ' ' ASN . 21.8 m-80 70.95 -62.88 0.44 Allowed 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.737 0.648 . . . . 0.0 109.907 -169.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -177.67 -55.78 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 52.8 m -157.02 59.58 0.52 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.448 170.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.611 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -137.86 -49.16 0.57 Allowed 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -170.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.611 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 12.9 m-20 74.14 143.22 0.07 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -169.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.655 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 3.4 m-85 -91.46 97.29 10.98 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -76.95 110.82 11.88 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.651 HG22 HG12 ' A' ' 79' ' ' ILE . 22.0 t -79.71 148.84 5.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.742 -167.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.5 m -86.85 81.35 8.18 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.211 176.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.509 HG21 ' CZ ' ' A' ' 16' ' ' TYR . 0.6 OUTLIER . . . . . 0 C--O 1.254 1.302 0 CA-C-O 118.495 -0.764 . . . . 0.0 111.13 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--O 1.237 0.458 0 CA-C-O 121.234 0.431 . . . . 0.0 111.886 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.5 t -95.67 -64.03 1.1 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.643 -174.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.0 t -81.95 -49.74 9.94 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.44 151.33 46.61 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.224 178.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.425 ' HB3' HD13 ' A' ' 30' ' ' ILE . 17.0 m -93.36 -7.79 43.75 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.649 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.726 HG21 HG11 ' A' ' 27' ' ' VAL . 1.7 p -148.44 151.74 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.321 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -142.96 151.67 41.16 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.453 ' HG ' ' N ' ' A' ' 12' ' ' ASP . 2.5 tp -77.37 142.59 39.24 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.453 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 31.7 t70 -93.1 -64.54 1.08 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 175.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.881 ' HB2' ' HE3' ' A' ' 24' ' ' LYS . 41.4 m -166.75 155.54 10.48 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.259 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.475 ' CZ ' ' HZ ' ' A' ' 82' ' ' PHE . 18.6 p90 -157.17 150.97 24.44 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.635 177.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -130.33 157.54 42.26 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.656 ' HA ' ' O ' ' A' ' 20' ' ' THR . 4.3 m-85 -137.53 153.78 49.94 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.702 -175.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -137.98 75.84 1.55 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.52 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.76 -84.29 0.67 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -171.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.421 ' HB3' HG22 ' A' ' 76' ' ' VAL . 33.1 m -132.41 86.01 2.29 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.57 0.7 . . . . 0.0 109.414 163.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.656 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 26.1 m -146.79 126.02 13.01 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 170.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.775 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 36.7 t80 -107.2 133.48 51.72 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.436 0.636 . . . . 0.0 110.078 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.2 p -153.65 151.26 29.48 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.832 173.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.406 ' C ' ' HD3' ' A' ' 24' ' ' LYS . . . 159.08 -151.33 22.23 Favored Glycine 0 CA--C 1.506 -0.522 0 C-N-CA 119.09 -1.528 . . . . 0.0 113.391 -178.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.881 ' HE3' ' HB2' ' A' ' 13' ' ' SER . 0.2 OUTLIER -166.34 168.83 14.68 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.745 0.418 . . . . 0.0 110.409 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.504 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 17.0 mt -131.61 160.76 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.732 -172.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.476 ' N ' HG21 ' A' ' 25' ' ' ILE . 4.0 t80 -130.59 98.56 4.7 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.349 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.726 HG11 HG21 ' A' ' 9' ' ' VAL . 0.7 OUTLIER -118.56 156.7 20.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.956 -176.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -94.72 141.68 28.34 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.424 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.666 HD22 ' HB2' ' A' ' 68' ' ' GLU . 46.1 m-80 -89.79 101.02 13.72 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.823 0.344 . . . . 0.0 111.561 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.535 HD11 ' HE2' ' A' ' 86' ' ' TYR . 4.1 mp -88.64 -34.5 7.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 173.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.95 -178.96 5.68 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.874 174.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -109.86 -15.52 14.08 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.474 -173.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.8 m -100.0 85.55 3.07 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.407 ' HZ2' ' CD ' ' A' ' 68' ' ' GLU . 17.4 mtmt -110.36 153.61 24.69 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.721 -174.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.589 ' CG ' ' HB3' ' A' ' 87' ' ' GLU . 18.4 ptpt -130.84 129.52 42.44 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 166.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.5 t -119.55 115.75 48.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-O 121.74 0.781 . . . . 0.0 109.604 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.727 ' HG1' ' HB2' ' A' ' 85' ' ' LYS . 11.0 p -131.91 114.0 14.13 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.449 -170.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.726 ' HB ' HG22 ' A' ' 54' ' ' ILE . 54.6 t -79.66 125.43 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.9 m -122.06 120.89 62.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.894 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.626 ' HB3' ' HB3' ' A' ' 82' ' ' PHE . 9.9 p90 -125.97 148.29 49.29 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.399 -171.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.474 ' HB1' ' CZ2' ' A' ' 47' ' ' TRP . . . -72.18 97.56 1.98 Allowed 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 170.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.48 ' HA ' ' HE1' ' A' ' 40' ' ' TYR . 0.9 OUTLIER -48.84 -178.55 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.469 -1.696 . . . . 0.0 112.119 171.232 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.36 -22.89 52.35 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.956 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.1 t -85.94 -15.76 40.59 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 122.274 0.23 . . . . 0.0 111.441 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 68.42 30.25 5.43 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.535 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -106.7 99.09 8.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.335 -173.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.474 ' CZ2' ' HB1' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -90.92 110.64 21.88 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 168.835 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -66.8 -139.84 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 170.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -55.3 -45.83 76.25 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 158.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -138.08 -59.06 0.65 Allowed 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 113.343 -1.753 . . . . 0.0 108.435 159.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.27 -50.88 4.4 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.158 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.39 105.57 9.93 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.348 0.594 . . . . 0.0 110.729 -177.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.723 HG13 ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -138.4 141.72 36.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.886 -174.062 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.726 HG22 ' HB ' ' A' ' 38' ' ' VAL . 9.4 tp -115.43 118.37 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.24 136.16 37.72 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.529 -177.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.474 ' HA ' ' CE1' ' A' ' 72' ' ' PHE . . . -78.02 150.93 33.77 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.653 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -108.07 131.54 54.49 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -70.9 137.92 49.7 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.265 0.555 . . . . 0.0 110.377 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.2 t -106.57 -43.18 4.8 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 146.49 165.42 11.57 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.5 173.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.5 135.69 62.6 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.217 1.944 . . . . 0.0 110.795 175.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.53 HD11 ' HB2' ' A' ' 67' ' ' TYR . 55.5 mt -68.29 108.86 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.8 m -52.46 117.78 3.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.224 -171.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.65 2.58 49.9 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.423 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.575 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 63.6 m -146.84 170.75 16.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.226 0.536 . . . . 0.0 111.318 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -96.12 19.79 11.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.344 1.069 . . . . 0.0 109.459 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.575 ' CD2' ' HB3' ' A' ' 65' ' ' SER . 14.2 m-85 -100.24 157.22 16.75 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.402 178.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.666 ' HB2' HD22 ' A' ' 29' ' ' ASN . 13.2 tt0 -126.03 168.64 13.68 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.571 -175.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -130.11 125.69 35.75 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -167.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.553 ' NE1' HG13 ' A' ' 27' ' ' VAL . 5.9 m95 -127.59 126.43 42.07 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -172.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 p -110.49 152.43 26.36 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 117.909 0.322 . . . . 0.0 111.825 -172.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.548 ' HZ ' HG22 ' A' ' 38' ' ' VAL . 10.5 m-85 -128.52 152.84 47.81 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 -175.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.7 m -163.18 121.84 2.05 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 111.525 -2.58 . . . . 0.0 107.381 165.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.775 ' HB1' ' HB3' ' A' ' 21' ' ' PHE . . . -149.2 132.54 16.54 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.679 -167.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.8 t -98.56 99.25 10.37 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 169.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.469 HG11 ' HB2' ' A' ' 21' ' ' PHE . 19.2 m -89.82 144.35 9.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.211 0.529 . . . . 0.0 110.809 -172.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -89.19 32.45 0.83 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.835 -173.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.66 142.13 12.87 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -176.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.468 HG12 HG22 ' A' ' 104' ' ' VAL . 7.8 tt -153.68 144.13 14.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.379 0.609 . . . . 0.0 111.693 -175.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -104.64 -53.5 2.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.109 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.716 ' HB2' ' HA ' ' A' ' 102' ' ' TYR . 12.8 pt-20 -156.54 161.37 39.99 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.448 -175.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.922 ' HE1' ' HA ' ' A' ' 101' ' ' ASN . 0.1 OUTLIER -145.15 168.0 21.41 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 119.362 0.983 . . . . 0.0 112.594 177.517 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.483 ' HB3' ' HE1' ' A' ' 102' ' ' TYR . 0.3 OUTLIER -152.23 158.42 42.81 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 165.073 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.447 HD12 HG23 ' A' ' 38' ' ' VAL . 5.1 mm -101.12 145.58 11.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 119.359 -0.936 . . . . 0.0 112.194 -165.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.727 ' HB2' ' HG1' ' A' ' 37' ' ' THR . 13.9 mmmt -102.93 108.38 19.54 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.223 -178.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.535 ' HE2' HD11 ' A' ' 30' ' ' ILE . 13.4 t80 -99.34 99.75 10.73 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 173.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.589 ' HB3' ' CG ' ' A' ' 35' ' ' LYS . 28.5 tt0 -116.51 131.04 57.05 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.962 -175.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.443 HG13 ' H ' ' A' ' 89' ' ' SER . 2.8 t -121.37 165.59 16.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.007 -171.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.443 ' H ' HG13 ' A' ' 88' ' ' VAL . 1.5 p -46.99 -37.43 9.11 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -126.83 -18.34 2.16 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.514 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.404 ' HG3' ' N ' ' A' ' 92' ' ' THR . 13.1 tppt? -118.52 167.11 11.91 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 117.488 0.644 . . . . 0.0 110.465 -174.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.404 ' N ' ' HG3' ' A' ' 91' ' ' LYS . 10.4 m -148.76 145.88 27.8 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 172.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.516 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 37.5 m-85 -136.19 -177.85 4.89 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 174.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -150.4 126.97 10.85 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.625 -173.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -131.29 143.92 50.89 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.099 0.475 . . . . 0.0 111.038 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -127.34 10.54 6.8 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 62.89 -75.16 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.902 -173.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.0 t30 173.38 -62.15 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.6 m -139.6 19.77 2.53 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.192 173.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.44 -36.2 15.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.644 0.735 . . . . 0.0 109.617 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.922 ' HA ' ' HE1' ' A' ' 82' ' ' PHE . 15.6 m120 -91.66 178.81 5.82 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.248 173.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.716 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 2.6 m-85 73.02 -111.48 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 124.495 1.122 . . . . 0.0 110.614 -173.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.26 106.79 0.26 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.03 0.919 . . . . 0.0 112.471 -171.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.468 HG22 HG12 ' A' ' 79' ' ' ILE . 97.4 t -79.95 114.05 20.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.016 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.4 m -92.01 104.67 17.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.439 HG21 HG13 ' A' ' 104' ' ' VAL . 9.6 t . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.688 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.668 ' HA ' ' HH ' ' A' ' 67' ' ' TYR . 11.5 Cg_endo . . . . . 0 N--CA 1.452 -0.935 0 CA-C-O 120.842 0.268 . . . . 0.0 112.504 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.1 t -150.69 -71.41 0.17 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.885 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.6 m -124.61 -44.82 1.95 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.081 0.467 . . . . 0.0 110.538 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.5 136.25 33.02 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.477 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.7 m -81.85 -16.94 49.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.832 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.661 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.7 p -144.91 149.81 16.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.704 -176.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -143.36 131.29 21.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.024 177.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.795 HD12 HD13 ' A' ' 84' ' ' ILE . 51.4 tp -69.55 132.54 46.42 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.393 0.616 . . . . 0.0 110.216 175.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -80.24 -61.04 2.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.38 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.1 p -177.58 162.24 1.79 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.202 -174.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.497 ' CD2' HD21 ' A' ' 11' ' ' LEU . 47.7 p90 -158.16 163.41 37.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.849 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -148.73 162.03 40.59 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.217 0.532 . . . . 0.0 110.254 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.583 ' HD1' ' HD1' ' A' ' 21' ' ' PHE . 30.2 t80 -124.59 142.9 51.02 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.736 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -161.2 124.12 3.18 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.64 -103.96 0.43 Allowed Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -169.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.1 t -137.75 82.65 1.93 Allowed 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 163.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 56.7 m -148.04 140.67 24.57 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.377 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.583 ' HD1' ' HD1' ' A' ' 16' ' ' TYR . 2.5 t80 -128.16 108.18 10.41 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.979 0.895 . . . . 0.0 109.302 176.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.0 p -137.2 148.76 46.75 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.918 -173.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.8 -144.61 5.54 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.874 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.42 ' HB3' HG22 ' A' ' 71' ' ' THR . 5.0 ptmm? -164.71 168.24 18.18 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.981 0.42 . . . . 0.0 111.014 -177.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.729 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 8.3 mt -138.58 158.17 30.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.87 -167.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -133.02 97.18 3.94 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.338 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.661 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 1.5 m -136.16 149.33 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 O-C-N 121.499 -0.75 . . . . 0.0 112.135 -172.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.654 ' HB3' ' HZ2' ' A' ' 28' ' ' LYS . 6.7 ttpm? -99.53 133.49 43.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.888 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -87.88 119.9 28.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.0 0.429 . . . . 0.0 111.775 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.518 HG12 ' OH ' ' A' ' 86' ' ' TYR . 32.8 mm -63.66 -45.25 97.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 122.199 0.999 . . . . 0.0 108.634 173.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.653 ' HB3' ' HZ3' ' A' ' 34' ' ' LYS . . . -137.48 143.87 41.96 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 172.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.41 ' HE1' ' OE1' ' A' ' 68' ' ' GLU . 40.6 t80 -60.16 -42.62 95.33 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -164.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.9 m -80.07 69.44 6.46 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.649 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 1.041 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -87.0 -175.4 5.34 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.077 0.465 . . . . 0.0 110.97 176.77 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.859 ' HG3' ' HB3' ' A' ' 87' ' ' GLU . 18.7 ptmt -148.32 126.55 12.19 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.405 HG23 ' CZ3' ' A' ' 70' ' ' TRP . 58.3 t -119.71 121.41 66.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-O 121.655 0.741 . . . . 0.0 110.983 -171.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.695 ' HG1' ' HB2' ' A' ' 85' ' ' LYS . 72.4 p -128.15 117.78 22.2 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.754 -172.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.944 ' HB ' HG22 ' A' ' 54' ' ' ILE . 16.5 t -82.91 129.14 37.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.14 176.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.3 m -122.35 125.01 72.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.393 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.464 ' HB2' HG13 ' A' ' 79' ' ' ILE . 2.0 p90 -115.77 149.99 37.61 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.357 0.598 . . . . 0.0 112.038 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.634 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . . . -80.45 62.1 4.43 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.056 175.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.738 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 6.6 t70 34.88 -139.51 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 O-C-N 126.357 2.286 . . . . 0.0 111.095 173.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.34 1.26 31.05 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 168.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.517 ' O ' ' HB3' ' A' ' 45' ' ' ASP . 34.4 t -103.55 -17.33 15.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.026 -0.587 . . . . 0.0 112.568 -170.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.549 ' OD1' ' HG3' ' A' ' 81' ' ' GLU . 25.4 t70 77.22 55.96 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -173.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -158.7 141.58 14.54 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.522 -1.217 . . . . 0.0 108.952 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.5 ' CZ2' ' HB1' ' A' ' 41' ' ' ALA . 5.0 m95 -106.39 81.47 1.61 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.268 1.033 . . . . 0.0 109.041 -178.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -88.8 153.67 20.88 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.81 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -74.48 48.79 0.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.596 0.712 . . . . 0.0 110.548 176.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.53 ' HB3' ' OD1' ' A' ' 52' ' ' ASN . 26.7 t30 -86.48 -21.03 27.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.63 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.13 44.89 1.54 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -171.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.53 ' OD1' ' HB3' ' A' ' 50' ' ' ASN . 10.0 m-20 -89.98 40.05 0.99 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.939 -0.63 . . . . 0.0 110.736 -171.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -126.25 144.62 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.53 -176.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.944 HG22 ' HB ' ' A' ' 38' ' ' VAL . 6.6 tp -128.53 136.15 60.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 174.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.27 132.0 34.67 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.638 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.87 161.59 14.43 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.517 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.8 t -130.63 138.32 50.04 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.637 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 33.7 p90 -90.89 143.66 26.49 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.068 0.461 . . . . 0.0 110.18 176.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.5 m -94.86 -22.73 17.83 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.423 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 157.01 173.29 25.25 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.972 173.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -68.13 147.29 72.8 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.564 2.176 . . . . 0.0 111.31 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.494 HG12 ' HB2' ' A' ' 69' ' ' TYR . 28.9 mt -85.28 95.9 4.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.3 m -57.14 127.93 34.43 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.214 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.82 6.8 60.39 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.605 -177.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.0 m -148.8 173.17 13.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.716 0.293 . . . . 0.0 110.222 178.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -94.79 4.24 54.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.277 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.668 ' HH ' ' HA ' ' A' ' 4' ' ' PRO . 3.8 m-85 -108.7 167.44 10.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.667 0.746 . . . . 0.0 111.838 -172.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.423 ' HG3' ' H ' ' A' ' 69' ' ' TYR . 1.7 tt0 -108.85 169.94 8.36 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.447 -1.252 . . . . 0.0 108.883 175.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.494 ' HB2' HG12 ' A' ' 62' ' ' ILE . 1.1 t80 -128.37 111.04 12.91 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -164.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.729 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 9.0 m95 -114.68 145.81 41.61 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.537 -168.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.42 HG22 ' HB3' ' A' ' 24' ' ' LYS . 10.4 p -138.3 134.86 34.84 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -137.03 147.4 46.17 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.824 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.5 p -126.23 142.96 51.32 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.921 175.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.663 ' HB3' HG12 ' A' ' 54' ' ' ILE . . . -150.67 114.22 4.93 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.086 0.469 . . . . 0.0 110.939 -174.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.5 t -78.28 99.78 6.43 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 171.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.9 m -101.89 149.29 6.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.296 -173.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -75.34 -21.9 58.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.916 0.865 . . . . 0.0 108.817 173.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.12 172.93 28.0 Favored Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 114.086 -1.415 . . . . 0.0 109.617 -175.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.738 ' HA ' ' O ' ' A' ' 42' ' ' ASP . 3.8 tt -169.92 125.79 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.849 0.833 . . . . 0.0 110.967 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -97.99 -56.74 2.4 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.698 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.634 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 11.7 mm-40 -131.15 170.29 14.75 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.567 ' CE2' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -173.43 158.61 3.53 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 119.271 0.941 . . . . 0.0 111.669 -179.5 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.714 ' HB3' ' HB3' ' A' ' 96' ' ' ASN . 1.5 p90 -159.91 158.04 30.08 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 168.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.795 HD13 HD12 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -94.79 142.75 13.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.505 -172.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.695 ' HB2' ' HG1' ' A' ' 37' ' ' THR . 16.7 mtmt -96.81 123.38 40.49 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.138 172.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.518 ' OH ' HG12 ' A' ' 30' ' ' ILE . 18.6 t80 -93.96 100.76 12.85 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 170.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.859 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . 6.7 tp10 -103.65 130.9 51.19 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.451 0.643 . . . . 0.0 109.282 -172.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 1.013 HG12 ' HE2' ' A' ' 34' ' ' LYS . 21.8 t -127.19 163.18 30.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.581 -173.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.42 26.77 0.08 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.32 0.648 . . . . 0.0 111.111 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -170.69 -37.36 0.03 OUTLIER Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.595 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.494 ' HG3' ' N ' ' A' ' 92' ' ' THR . 26.8 tptp -127.85 168.29 15.38 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -173.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.494 ' N ' ' HG3' ' A' ' 91' ' ' LYS . 4.0 m -138.06 146.36 42.87 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 172.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.516 ' HD1' ' HD2' ' A' ' 86' ' ' TYR . 33.3 m-85 -137.22 -174.36 3.72 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 171.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -149.22 141.57 24.18 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.062 -174.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -122.67 121.2 35.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.298 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.714 ' HB3' ' HB3' ' A' ' 83' ' ' TYR . 10.9 p30 -145.14 -103.21 0.11 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.925 177.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -113.5 -50.13 2.86 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 122.107 0.956 . . . . 0.0 108.723 -175.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -172.27 -48.56 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.2 p -160.73 47.52 0.23 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.748 172.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.79 -109.24 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.136 -174.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 174.84 142.1 0.05 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.793 -167.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.527 ' CE2' ' HA ' ' A' ' 96' ' ' ASN . 84.2 m-85 -78.39 142.31 37.71 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 173.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.22 125.0 53.67 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.7 0.762 . . . . 0.0 110.517 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.627 HG22 HG12 ' A' ' 79' ' ' ILE . 3.7 t -94.36 129.96 43.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.7 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.9 t -66.89 95.32 0.36 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.124 0.488 . . . . 0.0 110.626 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.128 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.763 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo . . . . . 0 N--CA 1.459 -0.528 0 CA-C-O 121.161 0.4 . . . . 0.0 111.926 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.5 t -110.38 -85.93 0.54 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.666 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.0 m -96.58 -64.26 1.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.654 0.264 . . . . 0.0 110.639 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.48 -174.13 2.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.975 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 28' ' ' LYS . 26.1 m -76.52 -31.96 57.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.091 0.472 . . . . 0.0 110.362 177.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.886 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.2 p -114.68 150.65 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 121.352 0.596 . . . . 0.0 111.818 -173.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -143.05 141.25 31.26 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.667 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.401 ' HG ' ' N ' ' A' ' 12' ' ' ASP . 3.5 tp -69.43 140.39 54.1 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.021 0.438 . . . . 0.0 110.107 175.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.401 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 28.2 t70 -90.94 -67.86 0.83 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.579 172.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.7 m -167.18 157.82 11.53 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.868 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.428 ' CE2' ' HZ ' ' A' ' 82' ' ' PHE . 34.3 p90 -156.87 155.82 32.1 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.705 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -130.25 163.19 27.3 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.834 0.35 . . . . 0.0 111.084 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.517 ' HE2' HG23 ' A' ' 106' ' ' THR . 1.7 t80 -128.74 147.06 50.74 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -154.89 101.55 2.29 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -175.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.24 -96.69 0.14 Allowed Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 -168.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.486 ' HA ' ' CE1' ' A' ' 16' ' ' TYR . 10.4 t -136.2 89.51 2.48 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 158.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.1 m -144.38 139.64 28.56 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.501 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.557 ' HB2' HG11 ' A' ' 76' ' ' VAL . 17.8 t80 -108.58 129.27 55.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.8 p -151.39 123.7 8.3 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.074 0.464 . . . . 0.0 109.974 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' A' ' 14' ' ' TYR . . . -177.91 -157.93 19.73 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.262 -0.97 . . . . 0.0 112.155 -176.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.598 ' HB3' HG22 ' A' ' 71' ' ' THR . 21.2 pttm -159.81 162.3 34.74 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.215 0.531 . . . . 0.0 111.214 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.605 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 11.0 mt -124.67 159.5 30.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.573 -170.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -131.44 100.19 5.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -174.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.886 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 1.9 m -135.77 147.93 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.706 -169.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 79.0 tttt -79.55 131.32 35.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.029 177.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.612 HD21 ' HB2' ' A' ' 68' ' ' GLU . 7.3 p30 -91.17 122.61 33.95 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.294 0.569 . . . . 0.0 110.349 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.3 mm -76.76 -56.82 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.016 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.619 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . . . -107.34 -80.96 0.56 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.864 173.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -166.47 -73.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.666 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.422 ' C ' ' HD2' ' A' ' 34' ' ' LYS . 20.1 m -83.59 68.73 9.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.309 0.576 . . . . 0.0 110.691 -178.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.661 ' HG3' HG12 ' A' ' 88' ' ' VAL . 6.3 mmmt -94.97 172.51 8.1 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.831 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 89.7 mttt -101.19 129.36 47.1 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.765 -173.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 65.3 t -121.44 107.92 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-O 121.873 0.844 . . . . 0.0 109.288 171.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.724 HG22 HD13 ' A' ' 53' ' ' ILE . 3.1 p -120.3 116.03 24.74 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.552 -173.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.806 HG23 HD12 ' A' ' 84' ' ' ILE . 72.2 t -77.02 136.64 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.006 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.152 176.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.29 107.79 19.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.53 176.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.487 ' HA ' ' CB ' ' A' ' 82' ' ' PHE . 0.9 OUTLIER -111.71 137.17 49.97 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 122.58 1.181 . . . . 0.0 110.387 174.736 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.558 ' HB3' ' CE3' ' A' ' 47' ' ' TRP . . . -89.76 97.02 10.95 Favored 'General case' 0 N--CA 1.412 -2.371 0 CA-C-N 113.086 -1.87 . . . . 0.0 107.101 178.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.734 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 1.3 p30 -44.01 163.36 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 O-C-N 124.767 1.292 . . . . 0.0 112.541 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.39 -13.04 14.71 Favored Glycine 0 N--CA 1.464 0.537 0 CA-C-N 115.536 -0.756 . . . . 0.0 114.358 -167.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -110.47 -18.87 13.12 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.407 ' HB2' ' OD2' ' A' ' 42' ' ' ASP . 48.1 t0 -74.03 -92.47 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.084 -1.416 . . . . 0.0 112.278 -173.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 51.95 98.58 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -159.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.558 ' CE3' ' HB3' ' A' ' 41' ' ' ALA . 7.1 m-90 -42.7 113.13 0.43 Allowed 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 -152.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.481 ' ND2' ' HB2' ' A' ' 50' ' ' ASN . 9.0 p30 -84.03 31.98 0.49 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 113.364 -1.744 . . . . 0.0 108.484 161.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.402 ' H ' ' C ' ' A' ' 47' ' ' TRP . 66.5 t30 59.35 46.42 12.63 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 122.19 0.995 . . . . 0.0 108.449 -164.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.481 ' HB2' ' ND2' ' A' ' 48' ' ' ASN . 49.9 t30 -83.4 -57.59 3.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.647 -174.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.85 96.68 1.55 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.304 -0.951 . . . . 0.0 113.216 174.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 40' ' ' TYR . 86.8 m-20 -135.02 106.69 6.92 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.724 HD13 HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -117.91 144.45 25.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.381 0.61 . . . . 0.0 111.94 -172.06 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.582 ' CG2' ' HB ' ' A' ' 38' ' ' VAL . 8.1 tp -132.61 116.34 27.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.398 171.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.18 137.96 45.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.889 0.376 . . . . 0.0 111.425 -174.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.31 163.37 23.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.548 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.6 m -121.22 141.57 50.74 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -70.75 139.88 51.19 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.372 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.8 t -108.78 -39.13 5.44 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.45 154.77 7.14 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.545 173.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.36 136.13 49.62 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.198 1.932 . . . . 0.0 111.447 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 67.9 mt -80.59 91.92 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.8 p -60.65 120.92 10.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.642 -172.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 132.65 -34.53 2.47 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.515 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.2 m -134.9 172.53 12.86 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.65 39.15 0.46 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.956 0.407 . . . . 0.0 110.999 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.45 ' CZ ' ' HB2' ' A' ' 28' ' ' LYS . 3.9 m-85 -115.27 159.25 21.24 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.719 0.771 . . . . 0.0 111.369 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.612 ' HB2' HD21 ' A' ' 29' ' ' ASN . 11.2 tt0 -131.12 170.38 14.61 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.11 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.23 122.7 26.98 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -165.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.696 ' CD1' HG12 ' A' ' 27' ' ' VAL . 20.8 m95 -121.9 134.82 54.86 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.813 -169.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.598 HG22 ' HB3' ' A' ' 24' ' ' LYS . 18.0 p -138.21 150.63 46.92 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -173.3 164.1 4.65 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.451 0.643 . . . . 0.0 111.928 172.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.4 p -124.56 144.24 50.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.271 173.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' A' ' 21' ' ' PHE . . . -137.56 126.5 24.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.573 -174.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.5 t -81.98 99.41 9.1 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 170.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.557 HG11 ' HB2' ' A' ' 21' ' ' PHE . 21.0 m -92.35 154.28 3.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.884 -176.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -116.99 48.22 1.35 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.04 126.18 4.42 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.857 -174.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.713 HG12 HG22 ' A' ' 104' ' ' VAL . 4.8 tt -136.3 128.33 44.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.592 0.711 . . . . 0.0 111.034 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.734 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -83.82 -61.7 1.76 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.947 -175.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 16.1 mt-10 -150.83 176.17 11.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.13 -1.395 . . . . 0.0 107.994 -177.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.487 ' CB ' ' HA ' ' A' ' 40' ' ' TYR . 30.3 p90 -169.43 173.47 6.51 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 119.12 -1.032 . . . . 0.0 113.484 174.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.49 154.17 24.4 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.08 173.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.806 HD12 HG23 ' A' ' 38' ' ' VAL . 16.3 mm -99.2 151.82 4.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.435 ' HG3' ' HG1' ' A' ' 37' ' ' THR . 49.4 pttt -131.32 149.54 52.51 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 121.88 0.848 . . . . 0.0 110.413 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.681 ' HD2' ' HD1' ' A' ' 93' ' ' TYR . 21.8 t80 -114.63 108.36 16.72 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 113.78 -1.554 . . . . 0.0 109.675 -174.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.831 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 31.1 tt0 -105.8 116.78 32.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.173 0.511 . . . . 0.0 109.958 -175.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.661 HG12 ' HG3' ' A' ' 34' ' ' LYS . 1.3 t -123.29 166.28 18.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.994 -175.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.442 ' H ' HG13 ' A' ' 88' ' ' VAL . 1.5 m -48.15 -46.45 34.5 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.492 0.495 . . . . 0.0 111.553 -177.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -120.79 -9.22 7.69 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.305 -0.95 . . . . 0.0 113.749 -176.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.409 ' C ' ' HG1' ' A' ' 92' ' ' THR . 12.3 mmtm -128.11 173.81 9.77 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -177.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 86' ' ' TYR . 8.3 m -152.9 143.78 22.92 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 113.226 -1.807 . . . . 0.0 109.43 176.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.681 ' HD1' ' HD2' ' A' ' 86' ' ' TYR . 28.1 m-85 -144.01 -173.53 4.02 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -150.14 148.08 28.53 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.437 -174.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -118.18 90.24 3.29 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 169.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -131.14 31.05 4.47 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.957 -172.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 68.3 -59.84 0.43 Allowed 'General case' 0 CA--C 1.532 0.259 0 O-C-N 123.733 0.646 . . . . 0.0 110.535 -172.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -179.68 -53.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.4 t -172.69 69.24 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.191 -1.368 . . . . 0.0 107.518 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -147.64 -37.87 0.2 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.969 -170.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 78.3 m-20 70.05 149.08 0.08 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -171.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 95.9 m-85 -83.67 106.32 15.29 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 175.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -68.61 116.06 8.7 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.043 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.713 HG22 HG12 ' A' ' 79' ' ' ILE . 2.8 t -100.21 133.65 42.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.1 t -151.5 148.65 28.3 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.517 HG23 ' HE2' ' A' ' 16' ' ' TYR . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.572 -0.728 . . . . 0.0 110.331 177.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 C--O 1.233 0.239 0 CA-C-O 120.849 0.27 . . . . 0.0 112.08 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.6 t -122.03 -28.32 4.43 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.301 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.9 p -70.23 -73.63 0.16 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.761 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.83 174.5 7.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.283 0.564 . . . . 0.0 111.567 -176.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.656 ' HB3' HD11 ' A' ' 30' ' ' ILE . 20.3 m -80.53 -15.53 56.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.07 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.715 HG21 HG11 ' A' ' 27' ' ' VAL . 2.2 p -140.7 151.42 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 120.758 0.313 . . . . 0.0 110.343 -178.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -145.16 128.87 17.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.242 -176.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.411 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 26.0 tp -69.8 137.22 51.66 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 172.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.59 -49.04 6.07 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.909 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.8 p 174.82 160.02 0.19 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 123.705 0.628 . . . . 0.0 111.744 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -156.33 159.67 39.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.726 177.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -151.89 164.22 37.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.618 0.247 . . . . 0.0 110.442 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.414 ' CZ ' ' HA ' ' A' ' 19' ' ' SER . 5.3 t80 -115.96 143.33 45.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.034 -174.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -144.17 101.67 3.75 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -175.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.4 -97.78 0.25 Allowed Glycine 0 C--N 1.333 0.368 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -170.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.414 ' HA ' ' CZ ' ' A' ' 16' ' ' TYR . 71.4 m -134.43 85.73 2.21 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 158.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.8 m -146.51 138.52 24.84 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.088 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.443 ' HB2' HG11 ' A' ' 76' ' ' VAL . 20.4 t80 -95.52 140.37 30.46 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 171.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 85.7 p -155.58 126.01 6.78 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 174.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.8 -161.85 29.94 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.159 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -160.05 162.75 34.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.835 0.35 . . . . 0.0 110.947 -176.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 25.9 mt -132.38 156.51 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.894 -172.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -126.14 115.83 20.4 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.715 HG11 HG21 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -128.67 149.73 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.022 179.288 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.486 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 92.9 mttt -80.26 152.14 29.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.498 174.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -94.74 85.02 4.33 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.773 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.656 HD11 ' HB3' ' A' ' 8' ' ' SER . 3.8 mm -64.51 -56.84 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.65 -150.7 0.47 Allowed 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 106.725 -1.584 . . . . 0.0 106.725 168.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.452 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 42.9 t80 -112.31 -56.89 2.34 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.514 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.2 t -65.4 111.45 3.06 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 123.301 0.376 . . . . 0.0 110.412 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.508 ' HB2' ' HH2' ' A' ' 70' ' ' TRP . 12.4 mmtp -112.62 167.61 10.33 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 121.121 0.486 . . . . 0.0 110.473 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.784 ' HB3' ' HZ1' ' A' ' 35' ' ' LYS . 0.6 OUTLIER -151.88 111.15 3.91 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 171.785 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.4 t -106.7 112.27 39.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-O 121.817 0.818 . . . . 0.0 110.435 -173.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.918 HG22 HD13 ' A' ' 53' ' ' ILE . 14.0 p -119.07 107.99 14.17 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.653 -172.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.684 ' O ' ' HA ' ' A' ' 53' ' ' ILE . 71.7 t -76.45 111.01 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.463 175.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.651 ' HB ' ' CZ2' ' A' ' 47' ' ' TRP . 0.0 OUTLIER -102.62 113.66 39.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.122 170.781 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.614 ' HA ' ' CB ' ' A' ' 82' ' ' PHE . 0.6 OUTLIER -108.24 145.14 34.73 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 122.075 0.941 . . . . 0.0 110.385 171.742 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.67 99.08 11.06 Favored 'General case' 0 N--CA 1.409 -2.498 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.368 169.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -40.27 165.2 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 112.893 -1.958 . . . . 0.0 112.875 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.445 ' HA2' ' HB2' ' A' ' 80' ' ' LYS . . . -62.22 2.18 1.17 Allowed Glycine 0 C--N 1.334 0.426 0 CA-C-N 114.956 -1.02 . . . . 0.0 114.656 -167.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.8 t -80.87 -22.7 39.62 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 116.954 0.377 . . . . 0.0 110.321 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.7 t70 77.52 43.85 0.1 Allowed 'General case' 0 C--N 1.351 0.641 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -142.64 146.47 34.51 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.351 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.651 ' CZ2' ' HB ' ' A' ' 39' ' ' VAL . 0.1 OUTLIER -122.16 120.66 34.87 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 119.399 -0.92 . . . . 0.0 112.438 173.177 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -90.93 16.02 10.28 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 169.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 67.03 4.02 3.4 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.354 -1.293 . . . . 0.0 111.6 -175.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.42 HD21 ' HA ' ' A' ' 50' ' ' ASN . 0.1 OUTLIER -168.8 179.34 4.22 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -171.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.11 27.48 64.13 Favored Glycine 0 CA--C 1.505 -0.536 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.093 178.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -166.57 56.67 0.09 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.263 0.554 . . . . 0.0 109.975 -175.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.918 HD13 HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -133.92 131.15 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-O 122.048 0.928 . . . . 0.0 109.643 -174.071 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.474 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 10.4 mm -110.92 129.76 65.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.982 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.11 96.35 7.77 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 118.263 -1.375 . . . . 0.0 108.255 167.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -47.63 153.88 0.53 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.76 170.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -115.55 131.71 56.85 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.716 -174.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -71.32 143.85 50.14 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.254 177.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.9 t -106.4 -37.51 6.49 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 145.82 173.68 17.3 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.356 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -53.86 134.58 59.8 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 123.037 2.491 . . . . 0.0 111.633 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 1.056 HG12 ' HB2' ' A' ' 69' ' ' TYR . 4.7 mt -83.92 119.07 32.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.695 -172.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.5 p -62.77 118.37 7.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.019 0.438 . . . . 0.0 110.251 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 117.46 -12.44 13.87 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -176.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.5 m -151.94 -179.53 7.55 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -112.11 30.21 7.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.652 0.739 . . . . 0.0 109.9 177.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.486 ' CD1' ' HA ' ' A' ' 28' ' ' LYS . 17.2 m-85 -105.0 -178.37 3.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.792 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.483 ' O ' HD12 ' A' ' 62' ' ' ILE . 15.6 tp10 -111.84 150.9 29.73 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.7 -171.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 1.056 ' HB2' HG12 ' A' ' 62' ' ' ILE . 8.7 t80 -125.2 116.52 22.13 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -165.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.577 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 12.7 m95 -108.68 133.43 52.77 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.469 -170.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.416 ' O ' ' HB3' ' A' ' 72' ' ' PHE . 22.5 p -139.76 148.53 42.39 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -176.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 71' ' ' THR . 3.3 p90 -174.02 151.67 1.78 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.913 0.863 . . . . 0.0 112.409 170.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.2 p -117.81 137.55 52.67 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.277 -1.329 . . . . 0.0 107.923 166.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.51 122.14 28.65 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.891 -168.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.71 99.45 1.33 Allowed 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 171.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 21' ' ' PHE . 28.6 m -103.3 150.24 6.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.659 -175.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.636 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -104.62 38.12 1.97 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.614 0.721 . . . . 0.0 109.65 175.47 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 112.71 149.82 10.8 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.054 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.554 HD11 HG22 ' A' ' 104' ' ' VAL . 9.7 tt -154.88 156.41 5.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.445 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 18.2 tptm -140.67 -47.4 0.42 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.953 0.406 . . . . 0.0 111.26 -176.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.438 ' O ' ' HB3' ' A' ' 82' ' ' PHE . 20.8 mt-10 -141.7 162.27 35.88 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -178.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.614 ' CB ' ' HA ' ' A' ' 40' ' ' TYR . 43.1 p90 -172.63 179.26 2.47 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 119.101 -1.039 . . . . 0.0 112.76 169.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.532 ' HB3' ' HB3' ' A' ' 96' ' ' ASN . 0.2 OUTLIER -160.94 143.15 12.43 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 113.519 -1.673 . . . . 0.0 108.38 171.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.573 HD12 HG21 ' A' ' 38' ' ' VAL . 14.2 mm -90.48 132.45 35.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.783 -177.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.495 ' HB2' ' OG1' ' A' ' 37' ' ' THR . 1.1 mtmp? -89.8 107.0 18.84 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.719 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.537 ' HB2' HG11 ' A' ' 9' ' ' VAL . 20.2 t80 -85.99 99.16 11.25 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.718 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . 7.9 tt0 -116.73 124.12 48.88 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.072 -174.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 23.1 t -104.6 162.62 4.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.8 t -59.09 -11.48 3.69 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -143.62 2.46 1.48 Allowed Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.834 177.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.8 tptt -141.65 163.6 32.48 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 117.823 0.811 . . . . 0.0 110.438 -176.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.8 m -144.73 142.89 30.39 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.163 0.506 . . . . 0.0 110.874 174.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.494 ' HD2' ' CD2' ' A' ' 86' ' ' TYR . 49.1 m-85 -141.35 -168.62 2.68 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -144.99 143.71 30.65 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.711 0.291 . . . . 0.0 111.246 -174.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.411 ' OD2' ' HB2' ' A' ' 11' ' ' LEU . 29.6 t70 -122.19 98.69 6.05 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 169.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.532 ' HB3' ' HB3' ' A' ' 83' ' ' TYR . 4.9 p30 -123.18 -45.25 2.12 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.754 -173.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.521 ' HB3' ' O ' ' A' ' 96' ' ' ASN . 26.4 p-10 166.23 -37.67 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 175.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 178.58 -44.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.4 t -174.09 38.95 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.286 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.26 -90.54 0.11 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 p30 178.77 158.7 0.55 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.845 0.355 . . . . 0.0 110.458 -171.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -90.52 100.65 13.45 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 169.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.471 ' H ' ' CD ' ' A' ' 103' ' ' GLN . 0.0 OUTLIER -81.06 107.52 13.94 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.513 0.673 . . . . 0.0 110.18 179.579 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.554 HG22 HD11 ' A' ' 79' ' ' ILE . 21.5 t -91.43 114.86 29.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.963 -178.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 21.8 m -69.72 102.54 1.92 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.698 -0.668 . . . . 0.0 110.876 -177.592 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.976 0.323 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.9 t -157.94 -60.08 0.08 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.895 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.9 t -78.35 -74.49 0.27 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.519 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -141.22 -160.32 1.07 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -68.48 -30.99 69.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.683 HG22 HG13 ' A' ' 27' ' ' VAL . 2.1 p -128.0 151.43 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.816 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -143.26 129.51 19.85 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.277 178.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.505 HD21 ' CD2' ' A' ' 14' ' ' TYR . 15.2 tp -69.07 140.04 54.85 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.066 0.46 . . . . 0.0 110.08 174.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -88.37 -63.85 1.24 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.101 178.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.0 m -170.58 159.84 6.95 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.196 -176.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.505 ' CD2' HD21 ' A' ' 11' ' ' LEU . 12.4 p90 -158.11 155.92 30.05 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.407 174.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -113.43 154.75 26.46 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 120.829 0.347 . . . . 0.0 110.873 175.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.827 ' HH ' HG11 ' A' ' 76' ' ' VAL . 1.1 m-85 -160.03 139.21 10.89 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 124.71 1.256 . . . . 0.0 110.412 -175.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 16.8 t70 -175.54 71.31 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.973 167.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 51.7 38.9 45.42 Favored Glycine 0 CA--C 1.507 -0.455 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -170.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.6 m -155.58 158.99 39.3 Favored 'General case' 0 N--CA 1.394 -3.268 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 -161.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.51 HG23 ' HA ' ' A' ' 75' ' ' SER . 52.9 m -60.32 143.78 52.14 Favored 'General case' 0 C--N 1.263 -3.191 0 CA-C-N 112.899 -1.955 . . . . 0.0 111.219 -173.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.659 ' HD2' ' CZ ' ' A' ' 16' ' ' TYR . 2.1 t80 -78.59 141.87 37.74 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.6 m -161.54 124.89 3.19 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.736 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.73 -153.03 9.95 Favored Glycine 0 N--CA 1.438 -1.167 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -176.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.742 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -160.05 163.61 33.82 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.014 0.435 . . . . 0.0 111.371 -177.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.713 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 24.9 mt -127.55 156.81 39.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.645 -170.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -132.77 107.29 8.27 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.114 0.565 . . . . 0.0 109.647 -172.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.683 HG13 HG22 ' A' ' 9' ' ' VAL . 0.7 OUTLIER -133.95 151.89 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.208 -0.932 . . . . 0.0 112.178 -172.062 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.425 ' HD3' ' CE1' ' A' ' 67' ' ' TYR . 23.8 tptm -76.35 129.29 36.4 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 172.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.561 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 23.7 p-10 -86.6 103.86 15.49 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.574 0.702 . . . . 0.0 110.376 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.497 HG12 ' OH ' ' A' ' 86' ' ' TYR . 16.3 mm -72.99 -60.3 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-N 115.47 -0.787 . . . . 0.0 108.882 -176.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.78 -135.05 0.35 Allowed 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.148 172.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -120.54 -52.4 2.14 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.022 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.5 t -78.16 116.21 18.45 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.754 ' HB2' ' HH2' ' A' ' 70' ' ' TRP . 27.5 mmtm -116.76 167.33 11.19 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.24 0.543 . . . . 0.0 110.619 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.612 ' HB3' ' HZ3' ' A' ' 35' ' ' LYS . 9.0 mtpm? -138.42 97.72 3.43 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.786 173.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.9 t -98.75 124.44 51.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.9 0.857 . . . . 0.0 110.713 -178.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.769 ' HB ' HG13 ' A' ' 53' ' ' ILE . 45.2 p -132.69 116.4 16.57 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.286 -1.324 . . . . 0.0 110.638 -170.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.787 ' HB ' HG22 ' A' ' 54' ' ' ILE . 44.9 t -84.92 132.75 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-O 121.322 0.582 . . . . 0.0 109.514 173.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.683 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -118.9 111.61 34.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.161 175.015 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.587 ' HA ' ' CB ' ' A' ' 82' ' ' PHE . 5.1 p90 -115.05 139.58 49.76 Favored 'General case' 0 CA--C 1.485 -1.528 0 CA-C-O 122.667 1.222 . . . . 0.0 110.901 175.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.504 ' HB3' ' CZ3' ' A' ' 47' ' ' TRP . . . -86.2 103.0 14.43 Favored 'General case' 0 N--CA 1.405 -2.714 0 CA-C-N 112.69 -2.05 . . . . 0.0 107.462 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.66 ' HB2' ' ND2' ' A' ' 52' ' ' ASN . 3.4 t70 -48.15 -168.49 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 111.694 -2.503 . . . . 0.0 113.796 -174.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.53 -17.9 28.2 Favored Glycine 0 C--N 1.335 0.5 0 O-C-N 122.106 -0.371 . . . . 0.0 112.513 -177.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 41.6 t -65.83 -16.59 63.96 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 122.825 0.45 . . . . 0.0 110.823 175.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.498 ' HB3' ' HG3' ' A' ' 80' ' ' LYS . 3.7 p30 51.46 33.77 10.91 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.632 1.173 . . . . 0.0 110.632 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -163.63 139.76 6.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.436 -169.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.504 ' CZ3' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -91.33 88.94 7.06 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 120.029 -0.668 . . . . 0.0 112.326 174.516 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.63 47.3 1.35 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.641 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 60.12 31.63 20.63 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.113 -172.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -92.37 127.4 37.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.231 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -96.37 60.43 1.3 Allowed Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.56 -174.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.66 ' ND2' ' HB2' ' A' ' 42' ' ' ASP . 87.2 m-20 -76.78 75.9 3.41 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.795 0.331 . . . . 0.0 110.431 175.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.769 HG13 ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -109.23 136.21 45.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.331 0.586 . . . . 0.0 110.737 178.751 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.787 HG22 ' HB ' ' A' ' 38' ' ' VAL . 8.0 tp -117.24 121.92 68.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.638 174.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.66 134.01 37.17 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.912 0.387 . . . . 0.0 110.411 -176.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.07 161.2 18.28 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.977 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 m -114.44 176.05 5.22 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.692 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 0.4 OUTLIER -139.22 146.47 40.53 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.782 0.801 . . . . 0.0 111.517 -174.167 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.8 t -88.39 -36.11 16.75 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.329 -1.305 . . . . 0.0 108.712 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 143.46 -172.08 24.96 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.288 174.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -65.85 138.25 52.41 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.75 2.3 . . . . 0.0 111.404 175.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.627 HG12 ' HB2' ' A' ' 69' ' ' TYR . 20.0 mt -81.24 109.84 16.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.408 -176.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.5 p -65.64 135.48 55.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.272 0.558 . . . . 0.0 111.274 -176.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.89 -4.64 81.81 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.459 -0.657 . . . . 0.0 111.459 -177.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.6 m -140.72 171.52 13.98 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -108.31 46.29 0.97 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.17 0.509 . . . . 0.0 110.002 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.425 ' CE1' ' HD3' ' A' ' 28' ' ' LYS . 2.3 m-85 -125.88 172.33 9.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.425 -178.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 29' ' ' ASN . 17.5 tt0 -120.39 167.07 12.72 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.627 ' HB2' HG12 ' A' ' 62' ' ' ILE . 4.3 t80 -141.59 121.72 13.81 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -164.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.754 ' HH2' ' HB2' ' A' ' 34' ' ' LYS . 25.4 m95 -118.46 145.55 45.17 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.798 -168.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.483 HG22 ' HB3' ' A' ' 24' ' ' LYS . 1.4 p -147.29 142.38 27.1 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 123.744 0.652 . . . . 0.0 109.527 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.4 ' HB3' ' O ' ' A' ' 71' ' ' THR . 2.7 p90 -173.99 159.49 3.33 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.442 0.639 . . . . 0.0 112.585 173.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.3 p -117.67 143.98 45.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.416 172.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.593 ' HB3' HG12 ' A' ' 54' ' ' ILE . . . -142.25 106.09 4.71 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -171.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.51 ' HA ' HG23 ' A' ' 20' ' ' THR . 13.3 t -68.6 109.13 3.62 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 174.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.827 HG11 ' HH ' ' A' ' 16' ' ' TYR . 12.2 m -100.52 155.59 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.002 -173.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -86.36 -24.01 25.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.21 -175.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.36 107.08 0.35 Allowed Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -177.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.651 HG12 HG22 ' A' ' 104' ' ' VAL . 8.9 tt -112.34 138.04 42.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.418 0.628 . . . . 0.0 111.722 -172.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.498 ' HG3' ' HB3' ' A' ' 45' ' ' ASP . 74.5 mmtt -117.0 -47.42 2.69 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.213 -176.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.459 ' OE1' ' HB3' ' A' ' 103' ' ' GLN . 11.7 mm-40 -146.21 154.02 41.28 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -175.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.683 ' HB2' ' O ' ' A' ' 39' ' ' VAL . 3.9 p90 -172.14 -179.06 2.24 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 118.521 -1.272 . . . . 0.0 114.032 174.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.589 ' HA ' ' CE1' ' A' ' 102' ' ' TYR . 0.2 OUTLIER -162.17 164.7 27.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 113.48 -1.691 . . . . 0.0 108.644 176.632 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.781 HD11 HG23 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -104.23 144.24 14.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.958 -177.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.517 ' HB2' ' OG1' ' A' ' 37' ' ' THR . 6.6 mtmp? -104.86 130.07 53.07 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 121.069 0.461 . . . . 0.0 109.905 176.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.711 ' HD2' ' HD2' ' A' ' 93' ' ' TYR . 19.4 t80 -102.63 102.17 12.37 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.46 177.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.526 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 28.5 tt0 -108.64 129.35 55.33 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.592 ' C ' ' H ' ' A' ' 90' ' ' GLY . 2.6 t -122.06 166.47 16.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -174.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.43 ' H ' HG13 ' A' ' 88' ' ' VAL . 40.8 p -66.45 28.08 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.344 0.592 . . . . 0.0 112.262 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.592 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . 171.96 -34.61 0.14 Allowed Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.851 177.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.529 ' HA ' ' HE3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -102.44 164.47 11.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.841 0.353 . . . . 0.0 111.338 -177.33 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.4 m -148.59 142.92 26.21 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 173.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.711 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 47.3 m-85 -141.41 -168.1 2.56 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.6 133.87 15.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.628 -170.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -118.98 94.92 4.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.225 0.536 . . . . 0.0 109.995 172.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 97' ' ' ASN . 28.9 p-10 -125.36 27.62 6.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.275 -178.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 96' ' ' ASN . 2.9 m-20 72.65 -58.06 0.61 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.748 -172.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 177.69 -48.95 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 176.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.1 p -164.89 29.69 0.06 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.124 174.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -104.27 -37.45 7.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.411 -171.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.408 HD21 ' HB3' ' A' ' 81' ' ' GLU . 2.0 p-10 47.49 101.56 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 O-C-N 123.965 0.79 . . . . 0.0 112.891 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.589 ' CE1' ' HA ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -50.78 116.49 1.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.91 -168.694 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.459 ' HB3' ' OE1' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -88.85 124.96 34.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.533 0.682 . . . . 0.0 110.292 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.651 HG22 HG12 ' A' ' 79' ' ' ILE . 3.4 t -97.38 148.65 5.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.722 -1.127 . . . . 0.0 110.564 -174.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.2 m -95.38 75.36 3.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.418 0.628 . . . . 0.0 110.275 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.9 m . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.307 -0.854 . . . . 0.0 109.653 178.032 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo . . . . . 0 C--O 1.234 0.298 0 CA-C-O 120.919 0.3 . . . . 0.0 112.331 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.8 t -129.72 -54.17 1.15 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.683 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.9 t -108.42 -74.99 0.64 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.772 -0.194 . . . . 0.0 110.617 -178.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.77 -173.13 2.25 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.523 0.201 . . . . 0.0 111.186 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.9 m -65.44 -36.07 82.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.217 0.532 . . . . 0.0 110.528 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.701 HG21 HG13 ' A' ' 27' ' ' VAL . 1.7 p -123.8 152.11 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.5 -176.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.403 HE21 ' HB3' ' A' ' 10' ' ' GLN . 5.9 tt0 -142.57 132.5 24.31 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.094 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.431 HD21 ' CD2' ' A' ' 14' ' ' TYR . 34.8 tp -71.13 136.04 47.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.064 0.459 . . . . 0.0 110.304 176.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -88.12 -58.86 2.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.94 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.3 p -179.54 160.46 0.96 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.8 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.443 ' CE2' ' HZ ' ' A' ' 82' ' ' PHE . 44.1 p90 -157.54 163.14 38.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.481 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -133.46 158.57 42.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.929 0.395 . . . . 0.0 110.623 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.725 ' CE2' ' HB ' ' A' ' 106' ' ' THR . 0.5 OUTLIER -139.53 138.42 36.29 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.57 -179.041 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -166.5 130.59 2.07 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.78 -104.18 0.36 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -168.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.2 t -140.86 85.05 1.97 Allowed 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 161.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.523 ' O ' ' HD1' ' A' ' 16' ' ' TYR . 88.9 m -147.31 130.23 16.24 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.411 173.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.479 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 3.5 t80 -128.3 104.05 7.51 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.567 0.699 . . . . 0.0 109.56 -174.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.6 m -138.32 150.1 46.28 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.797 -176.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.32 -141.5 3.75 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 -178.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 2.6 ptpp? -162.6 166.82 24.17 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.825 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.699 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 38.3 mt -133.66 157.16 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 -170.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -133.03 110.14 10.03 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.31 0.644 . . . . 0.0 109.657 -173.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.701 HG13 HG21 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -137.97 151.49 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.206 -0.934 . . . . 0.0 113.101 -172.393 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 46.4 tptt -78.83 140.86 38.11 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.899 174.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.507 ' OD1' ' HB2' ' A' ' 68' ' ' GLU . 7.2 m-20 -88.31 96.76 10.7 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.696 0.284 . . . . 0.0 110.783 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.593 HG12 ' OH ' ' A' ' 86' ' ' TYR . 7.7 mm -75.98 -54.84 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 176.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.89 -157.5 0.62 Allowed 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.201 -1.363 . . . . 0.0 107.906 172.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -113.33 -59.03 2.07 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.603 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.6 m -76.85 87.82 3.44 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 175.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.431 ' HE2' ' CZ2' ' A' ' 70' ' ' TRP . 27.9 mtmm -104.34 158.4 16.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.456 -174.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.743 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 47.8 mttp -123.79 138.46 54.5 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 175.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.1 t -128.0 115.52 39.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.331 0.586 . . . . 0.0 110.115 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.885 ' HB ' HG13 ' A' ' 53' ' ' ILE . 69.1 p -119.74 120.3 36.15 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.494 -171.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 1.062 ' HB ' HG22 ' A' ' 54' ' ' ILE . 79.6 t -88.52 110.42 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.703 177.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.686 HG21 ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -97.13 120.29 46.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 170.686 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.683 ' HA ' ' HZ2' ' A' ' 47' ' ' TRP . 5.3 p90 -119.99 138.23 53.61 Favored 'General case' 0 CA--C 1.49 -1.347 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.032 171.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.49 ' N ' ' CZ2' ' A' ' 47' ' ' TRP . . . -76.9 88.06 3.47 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 113.133 -1.849 . . . . 0.0 108.017 -175.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.536 ' CG ' ' H ' ' A' ' 43' ' ' GLY . 42.8 t0 -43.75 -170.37 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 109.221 -3.627 . . . . 0.0 113.007 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.536 ' H ' ' CG ' ' A' ' 42' ' ' ASP . . . -61.5 -10.39 22.98 Favored Glycine 0 CA--C 1.522 0.469 0 O-C-N 121.983 -0.448 . . . . 0.0 112.721 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -76.11 -14.19 60.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.904 0.383 . . . . 0.0 110.148 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 76.06 12.59 2.8 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.122 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -170.81 179.35 3.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.951 -178.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.683 ' HZ2' ' HA ' ' A' ' 40' ' ' TYR . 23.0 m-90 -105.19 107.93 19.18 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.501 169.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -76.45 -162.82 0.27 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 170.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -75.11 58.31 0.89 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.438 0.637 . . . . 0.0 109.72 171.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -128.58 -50.68 1.26 Allowed 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.187 -174.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.66 76.2 0.95 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.95 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -77.94 80.11 4.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.885 HG13 ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -119.58 138.45 50.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.555 0.693 . . . . 0.0 112.822 -170.312 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 1.062 HG22 ' HB ' ' A' ' 38' ' ' VAL . 8.4 tp -112.31 133.47 57.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 169.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.65 126.7 34.13 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.614 -177.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.56 158.85 22.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.461 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.0 t -130.04 133.44 46.73 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 31.2 p90 -76.29 141.11 41.73 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 121.456 0.646 . . . . 0.0 110.267 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.4 t -93.48 -26.36 17.21 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.842 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 160.52 171.08 25.96 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.796 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.37 144.23 61.06 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.447 2.098 . . . . 0.0 110.843 174.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.564 HG12 ' HB2' ' A' ' 69' ' ' TYR . 20.7 mt -79.98 109.74 14.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.198 0.523 . . . . 0.0 109.9 -178.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.5 p -66.54 122.74 18.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.692 -175.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.02 -2.37 30.05 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.5 m -153.28 179.34 8.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -107.1 38.68 2.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.937 0.875 . . . . 0.0 109.899 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.447 ' HB3' HD11 ' A' ' 62' ' ' ILE . 1.8 m-85 -102.41 168.76 9.11 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.222 177.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.507 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . 10.0 tt0 -124.02 165.1 18.05 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.564 ' HB2' HG12 ' A' ' 62' ' ' ILE . 2.0 t80 -136.32 111.25 8.84 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -161.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.699 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 8.0 m95 -111.56 144.92 40.02 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.288 -166.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.427 ' HA ' ' HB2' ' A' ' 24' ' ' LYS . 5.0 p -133.04 131.86 41.14 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -132.6 151.06 52.06 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 118.884 -1.126 . . . . 0.0 111.733 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.2 m -131.68 141.29 49.54 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.053 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.526 ' HB3' HG12 ' A' ' 54' ' ' ILE . . . -150.56 113.74 4.85 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.069 0.461 . . . . 0.0 111.167 -175.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.2 t -77.7 99.07 5.69 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 168.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.462 HG21 HG23 ' A' ' 79' ' ' ILE . 32.6 m -95.15 157.22 3.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.416 0.627 . . . . 0.0 111.26 -169.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -96.42 -16.77 21.03 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.018 -175.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.17 82.63 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.942 -0.646 . . . . 0.0 111.969 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.589 HG12 HG22 ' A' ' 104' ' ' VAL . 4.5 tt -90.49 133.19 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.485 0.66 . . . . 0.0 111.108 -178.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -114.47 -40.38 3.63 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.298 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 37.0 mm-40 -141.37 167.19 22.76 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.443 ' HZ ' ' CE2' ' A' ' 14' ' ' TYR . 28.2 p90 -172.1 170.71 5.17 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 119.338 0.972 . . . . 0.0 111.864 174.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.661 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 0.7 OUTLIER -162.9 150.7 13.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.235 168.09 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.524 HD12 HG21 ' A' ' 38' ' ' VAL . 10.2 mm -100.94 139.46 22.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.673 -174.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.686 ' HE3' HG21 ' A' ' 39' ' ' VAL . 88.8 mttt -103.86 151.83 22.65 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.471 0.653 . . . . 0.0 110.269 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.66 ' HD2' ' HD2' ' A' ' 93' ' ' TYR . 25.0 t80 -123.24 106.66 10.92 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.765 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.743 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -103.19 128.47 50.15 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.304 0.573 . . . . 0.0 110.218 -176.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.4 t -126.54 158.04 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.735 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.9 m -67.32 -3.18 7.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -176.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -136.61 -27.87 0.37 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.512 176.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.1 mmtt -129.73 177.62 7.11 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 122.189 0.995 . . . . 0.0 112.483 -174.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.5 m -150.39 141.9 23.47 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.232 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.66 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 33.0 m-85 -143.82 -172.73 3.8 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -150.47 148.43 28.72 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.187 -174.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -119.79 98.82 6.29 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 169.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.661 ' HB3' ' HB2' ' A' ' 83' ' ' TYR . 23.0 p-10 -145.01 61.9 1.31 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.418 -174.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 71.13 -65.4 0.34 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.933 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -157.91 -53.81 0.07 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 174.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.6 m -157.17 44.69 0.37 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.706 -1.133 . . . . 0.0 110.001 169.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.42 -109.08 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -176.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 176.07 146.26 0.09 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.777 0.831 . . . . 0.0 108.831 -168.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -85.54 142.84 28.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.656 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -92.88 106.66 18.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.348 -175.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.589 HG22 HG12 ' A' ' 79' ' ' ILE . 22.0 t -94.39 107.44 19.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.7 m -90.66 57.62 3.65 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -171.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.725 ' HB ' ' CE2' ' A' ' 16' ' ' TYR . 87.9 m . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.689 175.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.581 ' HG3' ' CE1' ' A' ' 26' ' ' TYR . 13.5 Cg_endo . . . . . 0 N--CA 1.46 -0.487 0 CA-C-O 121.637 0.599 . . . . 0.0 112.69 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.4 t -85.85 49.61 1.81 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.761 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.52 ' OG ' ' HB2' ' A' ' 10' ' ' GLN . 13.6 t -108.45 -175.4 2.76 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.244 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.21 -151.0 0.27 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.294 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.1 -29.54 69.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.125 0.488 . . . . 0.0 110.603 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.595 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.3 p -150.24 149.06 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.725 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.52 ' HB2' ' OG ' ' A' ' 6' ' ' SER . 10.9 tt0 -138.75 154.78 48.56 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.472 HD21 ' CD2' ' A' ' 14' ' ' TYR . 16.4 tp -85.55 143.11 28.69 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.025 0.44 . . . . 0.0 110.012 172.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -87.41 -65.66 0.99 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.602 173.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.2 p -177.68 160.38 1.54 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.587 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.472 ' CD2' HD21 ' A' ' 11' ' ' LEU . 43.5 p90 -152.12 162.25 41.4 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.269 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -132.6 157.12 45.58 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -133.17 146.61 51.69 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.159 -174.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.452 ' CG ' ' H ' ' A' ' 18' ' ' GLY . 13.8 t70 -123.56 -150.35 0.45 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.671 -1.149 . . . . 0.0 107.954 -177.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.452 ' H ' ' CG ' ' A' ' 17' ' ' ASP . . . -50.61 -64.43 3.69 Favored Glycine 0 N--CA 1.458 0.111 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 171.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.2 t -145.63 86.76 1.75 Allowed 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 161.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.6 m -146.42 140.3 26.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.033 178.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.702 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 12.2 t80 -116.38 139.55 50.29 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.4 m -163.17 133.93 4.66 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 174.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.86 -150.34 12.37 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.116 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.583 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 18.5 pttp -159.41 168.74 25.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.185 0.517 . . . . 0.0 111.451 -177.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.741 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 12.9 mt -132.78 160.78 42.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.644 -167.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.581 ' CE1' ' HG3' ' A' ' 4' ' ' PRO . 5.6 t80 -132.5 96.23 3.8 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 122.769 0.428 . . . . 0.0 110.317 -173.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.734 HG12 ' CD1' ' A' ' 70' ' ' TRP . 1.8 m -136.99 151.92 27.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 121.166 -0.959 . . . . 0.0 112.022 -170.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -72.69 143.88 47.92 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.746 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -102.28 95.03 6.03 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.732 0.777 . . . . 0.0 111.096 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.6 mt -75.78 -57.8 5.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.464 -178.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.81 -160.87 0.75 Allowed 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.433 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 18.9 t80 -116.48 -23.48 8.26 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.838 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.0 m -78.02 68.2 4.01 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 169.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.468 ' HZ1' ' CD ' ' A' ' 68' ' ' GLU . 27.6 mtmt -90.9 125.55 35.79 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.874 -176.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.756 ' HB3' ' HZ3' ' A' ' 35' ' ' LYS . 9.4 mtpm? -126.28 113.57 17.13 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.489 HG23 ' CZ3' ' A' ' 70' ' ' TRP . 69.9 t -113.24 113.41 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-O 121.781 0.801 . . . . 0.0 110.375 -173.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.855 ' HB ' HG13 ' A' ' 53' ' ' ILE . 6.6 p -122.42 111.61 17.07 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.364 -173.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 1.044 ' HB ' HG22 ' A' ' 54' ' ' ILE . 95.0 t -79.66 111.62 16.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.375 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.681 HG11 ' O ' ' A' ' 51' ' ' GLY . 1.0 OUTLIER -107.66 110.08 30.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.663 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.763 ' CE1' ' HB2' ' A' ' 42' ' ' ASP . 0.3 OUTLIER -105.19 154.48 20.15 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.915 0.865 . . . . 0.0 112.875 -174.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.26 76.29 4.77 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 168.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.763 ' HB2' ' CE1' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -54.08 159.06 1.94 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 112.351 -2.204 . . . . 0.0 112.399 176.732 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.49 -109.29 1.88 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 113.744 -1.571 . . . . 0.0 113.455 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.507 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 16.0 m -89.41 -48.0 7.63 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 -175.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.453 ' HB3' ' O ' ' A' ' 44' ' ' SER . 6.1 p-10 170.69 28.73 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.523 0.729 . . . . 0.0 110.29 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -107.15 114.68 28.89 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -163.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -101.93 83.9 2.45 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -74.95 44.3 0.23 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.886 -178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 51.09 33.52 9.35 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.664 0.745 . . . . 0.0 110.785 -176.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -110.73 -16.68 13.54 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.681 ' O ' HG11 ' A' ' 39' ' ' VAL . . . 77.12 -60.18 3.52 Favored Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.487 -174.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.541 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 82.6 m-20 74.83 73.57 0.1 Allowed 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.855 HG13 ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -109.0 138.84 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.943 -163.009 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 1.044 HG22 ' HB ' ' A' ' 38' ' ' VAL . 8.9 tp -116.12 127.9 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 114.322 -1.308 . . . . 0.0 108.03 168.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.5 129.84 34.99 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.888 -176.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -97.45 158.39 15.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.986 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 99.0 p -123.94 175.57 6.86 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.671 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 19.3 p90 -127.97 145.6 50.92 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.266 0.555 . . . . 0.0 111.472 -178.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.1 m -84.08 -37.7 21.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.11 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 157.35 161.73 11.07 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.315 175.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.849 ' HA ' ' HA ' ' A' ' 68' ' ' GLU . 28.5 Cg_endo -58.19 152.16 54.53 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 123.065 2.51 . . . . 0.0 112.028 177.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 23.9 mt -86.75 103.56 13.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.177 -175.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.5 p -62.93 120.54 11.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.211 0.529 . . . . 0.0 111.063 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.66 -7.54 29.9 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -175.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -141.87 171.37 14.15 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -105.21 38.19 2.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.641 0.734 . . . . 0.0 110.133 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -120.3 177.37 5.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.747 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.849 ' HA ' ' HA ' ' A' ' 61' ' ' PRO . 12.3 tt0 -128.3 166.98 17.58 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.347 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -124.58 114.81 19.87 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 -169.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.741 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 14.4 m95 -111.88 148.05 34.49 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.818 -167.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.548 HG22 ' HB3' ' A' ' 24' ' ' LYS . 1.6 p -150.51 146.37 26.56 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.322 0.388 . . . . 0.0 110.496 -172.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.409 ' HE2' HG23 ' A' ' 54' ' ' ILE . 4.2 p90 -175.19 157.57 2.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.578 0.704 . . . . 0.0 112.016 172.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.1 p -114.62 146.31 40.97 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.702 ' HB1' ' HB3' ' A' ' 21' ' ' PHE . . . -139.02 113.68 9.1 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -173.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.5 m -72.87 100.49 2.92 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 169.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.7 m -103.45 157.27 5.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.341 -176.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.18 14.44 10.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.495 0.664 . . . . 0.0 110.482 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.66 138.93 2.56 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.974 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 14.9 tt -171.49 153.23 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.216 0.532 . . . . 0.0 110.25 177.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 44' ' ' SER . 16.2 tppt? -135.64 -47.97 0.69 Allowed 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.725 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 14.3 pt-20 -149.2 176.42 10.52 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.466 ' CB ' ' HA ' ' A' ' 40' ' ' TYR . 55.5 p90 -170.02 168.68 8.42 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 119.382 0.992 . . . . 0.0 112.316 -178.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.881 ' HB3' ' HB3' ' A' ' 96' ' ' ASN . 0.2 OUTLIER -146.48 143.93 29.3 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.542 169.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.536 HD12 HG21 ' A' ' 38' ' ' VAL . 17.6 mm -89.43 138.76 18.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.225 -174.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.485 ' HE2' ' HE1' ' A' ' 94' ' ' TYR . 32.3 mmtp -97.7 107.75 20.32 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.438 0.637 . . . . 0.0 109.289 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.58 ' O ' ' HA ' ' A' ' 92' ' ' THR . 8.4 t80 -89.28 100.9 13.59 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.656 -1.157 . . . . 0.0 109.917 -177.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.55 ' HA ' ' O ' ' A' ' 91' ' ' LYS . 26.4 tt0 -104.24 113.88 27.73 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.818 -176.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.2 t -119.9 105.69 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.609 -177.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.6 t 50.95 27.14 3.02 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 123.646 0.591 . . . . 0.0 111.155 177.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.58 -18.09 17.8 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.335 -176.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 87' ' ' GLU . 21.2 mmtm -81.81 176.8 9.3 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 117.598 0.699 . . . . 0.0 111.508 -176.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 86' ' ' TYR . 18.0 m -150.59 141.06 22.47 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.662 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.445 ' HD2' ' CD2' ' A' ' 86' ' ' TYR . 63.8 m-85 -146.05 -171.71 3.77 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 170.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.485 ' HE1' ' HE2' ' A' ' 85' ' ' LYS . 51.0 m-85 -146.19 141.23 27.23 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.895 0.379 . . . . 0.0 111.601 -172.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -130.16 112.92 13.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.461 167.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.881 ' HB3' ' HB3' ' A' ' 83' ' ' TYR . 36.3 p-10 -130.09 -29.68 2.04 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.15 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.559 HD22 ' HB2' ' A' ' 100' ' ' ALA . 26.1 p-10 159.12 -42.9 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.544 1.137 . . . . 0.0 108.198 172.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 175.49 -37.13 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.421 174.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.2 p -178.06 23.94 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.559 ' HB2' HD22 ' A' ' 97' ' ' ASN . . . -138.06 -17.14 1.23 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -175.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.737 ' HA ' ' HB2' ' A' ' 96' ' ' ASN . 77.5 m-20 87.73 142.65 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.894 0.478 . . . . 0.0 110.739 173.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 85.0 m-85 -71.76 120.96 18.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.969 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -83.71 129.61 34.95 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 174.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.406 HG22 HG12 ' A' ' 79' ' ' ILE . 22.0 t -80.59 153.39 4.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.1 p -74.71 56.75 0.72 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.459 0.647 . . . . 0.0 111.824 -177.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.31 177.544 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo . . . . . 0 C--O 1.233 0.258 0 CA-C-O 121.283 0.451 . . . . 0.0 112.928 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.9 t -166.35 -51.92 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.912 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.7 m -83.65 -77.35 0.26 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.194 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -139.4 -173.89 3.73 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 120.645 0.259 . . . . 0.0 111.208 -176.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -67.26 -30.91 70.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.42 0.629 . . . . 0.0 109.962 177.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.642 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.4 p -140.68 148.89 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.299 -178.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -140.9 129.35 22.55 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.859 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.435 HD21 ' HD2' ' A' ' 14' ' ' TYR . 23.7 tp -69.06 141.94 54.65 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.213 0.53 . . . . 0.0 110.957 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.473 ' HB3' ' O ' ' A' ' 24' ' ' LYS . 30.0 t70 -85.68 -68.77 0.71 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.752 175.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.7 p -175.94 164.74 2.9 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.741 -177.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.436 ' CD2' ' HZ ' ' A' ' 82' ' ' PHE . 53.2 p90 -156.64 154.42 30.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.564 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -130.55 159.9 35.77 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.125 0.488 . . . . 0.0 110.468 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.466 ' HA ' ' O ' ' A' ' 20' ' ' THR . 10.4 t80 -122.33 138.25 54.58 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 170.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -153.76 115.06 4.14 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.234 -174.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.01 -95.78 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -168.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.621 ' OG ' ' HA ' ' A' ' 77' ' ' LYS . 10.4 t -139.6 88.13 2.23 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 162.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 87.8 m -146.35 139.97 26.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.47 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.851 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 24.3 t80 -115.06 99.25 7.31 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-O 121.672 0.749 . . . . 0.0 109.278 176.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 17.7 p -126.42 150.01 48.92 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.27 -175.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.86 -162.3 36.07 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.723 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 0.6 OUTLIER -158.42 163.66 37.0 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -177.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.707 HD12 HG11 ' A' ' 36' ' ' VAL . 24.7 mt -135.79 160.29 39.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.927 0.394 . . . . 0.0 111.774 -168.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -132.85 103.09 5.91 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.433 0.693 . . . . 0.0 109.798 -174.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.642 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 1.5 m -136.65 151.89 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 121.39 -0.819 . . . . 0.0 111.492 -172.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.483 ' HB2' ' HZ2' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -76.45 152.95 36.01 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 178.317 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -104.6 121.94 44.57 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.345 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.485 HD12 ' OH ' ' A' ' 86' ' ' TYR . 7.1 mt -106.98 -52.83 6.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.823 0.821 . . . . 0.0 109.561 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.504 ' HB3' HG11 ' A' ' 88' ' ' VAL . . . -133.72 152.34 51.85 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 105.283 -2.118 . . . . 0.0 105.283 173.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.418 ' O ' ' C ' ' A' ' 33' ' ' SER . 12.1 m-85 -59.04 -83.93 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 117.768 -1.11 . . . . 0.0 113.068 -170.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 32' ' ' TYR . 24.8 m -21.85 104.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 124.49 1.119 . . . . 0.0 111.647 -174.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.722 ' HB3' ' CH2' ' A' ' 70' ' ' TRP . 84.5 mttt -94.77 111.43 23.21 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 124.882 2.277 . . . . 0.0 115.88 -148.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.874 ' HD3' HG12 ' A' ' 88' ' ' VAL 0.489 4.6 pttm -56.84 79.93 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.006 1 CA-C-N 108.264 -4.062 . . . . 0.0 120.545 169.8 . . . . . . . . 4 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.707 HG11 HD12 ' A' ' 25' ' ' ILE . 52.1 t -142.47 113.65 3.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-O 121.5 0.667 . . . . 0.0 111.599 154.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.646 HG22 HD13 ' A' ' 53' ' ' ILE . 2.5 p -131.53 102.79 6.07 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.804 173.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.929 ' HB ' HG22 ' A' ' 54' ' ' ILE . 61.4 t -73.83 104.2 2.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.377 -176.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.494 HG12 ' HB ' ' A' ' 53' ' ' ILE . 4.5 m -102.94 110.28 29.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -105.18 150.86 24.72 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.14 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.22 82.58 1.84 Allowed 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 172.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -49.95 -172.48 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 113.065 -1.879 . . . . 0.0 113.669 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -54.35 -28.98 45.27 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 116.046 -0.524 . . . . 0.0 113.784 -175.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.2 t -72.11 -16.83 62.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.834 0.317 . . . . 0.0 111.069 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.7 t70 67.57 36.01 3.9 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.819 0.819 . . . . 0.0 109.072 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -147.75 160.67 42.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.263 -176.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.449 ' HZ3' ' O ' ' A' ' 39' ' ' VAL . 5.7 m95 -115.9 82.31 1.75 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.669 0.747 . . . . 0.0 110.38 -176.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.629 ' ND2' ' HB2' ' A' ' 50' ' ' ASN . 2.5 p-10 -116.45 168.94 9.71 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.239 173.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -79.51 57.53 2.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.942 0.877 . . . . 0.0 111.062 -175.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.629 ' HB2' ' ND2' ' A' ' 48' ' ' ASN . 59.3 t30 -88.93 11.75 17.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.32 -177.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.67 33.32 52.16 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -176.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -93.63 34.49 1.18 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.551 0.691 . . . . 0.0 110.526 -175.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.687 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -122.15 139.32 49.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.881 179.23 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.929 HG22 ' HB ' ' A' ' 38' ' ' VAL . 5.8 tp -116.2 126.51 73.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 170.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -89.6 126.58 35.67 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.673 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.61 168.69 17.9 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.931 -174.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.7 t -128.0 132.87 49.12 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -77.75 145.81 36.27 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.39 0.614 . . . . 0.0 110.921 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.3 m -92.16 -33.37 14.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.97 172.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 160.84 169.2 23.78 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.455 172.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.49 133.6 28.47 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.562 2.175 . . . . 0.0 110.152 171.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 65' ' ' SER . 42.4 mt -71.03 122.13 22.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 120.981 0.42 . . . . 0.0 110.729 -172.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.5 p -58.03 128.1 35.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.915 -174.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 70.85 15.56 73.93 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.355 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.519 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 26.4 m -130.46 166.54 20.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.958 0.409 . . . . 0.0 110.671 -178.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -102.47 17.77 22.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.554 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 5.7 m-85 -120.18 169.32 10.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.326 -176.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -117.33 170.74 8.46 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.002 -1.454 . . . . 0.0 108.705 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -138.15 110.4 7.37 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -162.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.722 ' CH2' ' HB3' ' A' ' 34' ' ' LYS . 18.7 m95 -111.86 147.67 35.29 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.063 -168.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.456 ' HA ' ' HB2' ' A' ' 24' ' ' LYS . 5.7 p -141.74 142.96 33.28 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -154.07 169.45 23.5 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.099 -1.041 . . . . 0.0 112.913 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.6 p -144.24 137.29 27.2 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.179 173.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.851 ' HB1' ' HB3' ' A' ' 21' ' ' PHE . . . -134.09 120.82 20.65 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.436 -173.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.8 t -78.42 99.36 6.37 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 172.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.476 HG21 ' HB2' ' A' ' 21' ' ' PHE . 4.8 m -120.16 151.5 22.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -176.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.621 ' HA ' ' OG ' ' A' ' 19' ' ' SER . 0.2 OUTLIER -141.35 31.33 1.72 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.46 0.648 . . . . 0.0 110.366 174.413 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.09 95.52 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.725 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.423 HD11 HG21 ' A' ' 79' ' ' ILE . 7.8 tt -151.82 141.77 15.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.36 0.6 . . . . 0.0 110.276 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -115.18 -54.32 2.56 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.956 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.479 ' OE1' ' HB3' ' A' ' 103' ' ' GLN . 13.2 mm-40 -135.08 176.8 8.33 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -173.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.436 ' HZ ' ' CD2' ' A' ' 14' ' ' TYR . 28.3 p90 -168.7 160.53 10.69 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.703 171.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.42 ' HB3' HD21 ' A' ' 96' ' ' ASN . 0.1 OUTLIER -147.22 144.03 28.61 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.434 168.681 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.791 HD12 HG21 ' A' ' 38' ' ' VAL . 14.4 mm -91.28 134.81 28.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.687 -172.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.558 ' HB2' ' OG1' ' A' ' 37' ' ' THR . 4.5 mtmp? -88.3 114.87 25.35 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.61 0.719 . . . . 0.0 109.857 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.613 ' CD2' ' HD1' ' A' ' 93' ' ' TYR . 9.5 t80 -86.15 100.04 11.94 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.327 -1.306 . . . . 0.0 107.518 178.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.675 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 30.1 tt0 -124.04 104.23 8.76 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 122.108 0.956 . . . . 0.0 113.043 -162.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.874 HG12 ' HD3' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -110.1 164.53 6.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.408 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.3 m -77.06 40.17 0.25 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.856 0.836 . . . . 0.0 111.235 -177.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.495 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . 177.5 -34.07 0.08 OUTLIER Glycine 0 N--CA 1.436 -1.332 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.517 175.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.458 ' O ' HG23 ' A' ' 88' ' ' VAL . 12.9 mptt -110.98 149.43 30.69 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 120.794 0.331 . . . . 0.0 111.325 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 86' ' ' TYR . 7.3 m -149.3 138.44 21.37 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.358 0.599 . . . . 0.0 110.965 174.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.613 ' HD1' ' CD2' ' A' ' 86' ' ' TYR . 18.6 m-85 -146.5 -166.65 2.54 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 176.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -144.03 140.47 29.57 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.885 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -96.19 92.89 6.61 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 168.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.42 HD21 ' HB3' ' A' ' 83' ' ' TYR . 3.6 t-20 -129.56 18.53 5.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.097 -174.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 65.97 -68.12 0.13 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.278 -171.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -159.01 -56.07 0.06 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.0 t -167.74 38.72 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 170.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -99.41 -37.99 9.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.09 -169.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 93.0 m-20 72.62 142.28 0.06 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.351 0.596 . . . . 0.0 110.496 -174.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -95.1 100.18 12.05 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.169 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.479 ' HB3' ' OE1' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -76.61 131.98 39.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.436 179.821 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.8 t -85.24 152.08 3.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.985 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.3 t -83.83 71.42 10.45 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.8 p . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.87 176.909 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.038 0 CA-C-O 120.794 0.33 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.4 m -102.42 112.84 25.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.124 0.488 . . . . 0.0 110.103 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.612 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 47.7 mm -78.94 -53.86 1.1 Allowed Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.265 -178.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.612 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 73.3 Cg_exo -50.01 135.3 36.83 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 122.211 1.941 . . . . 0.0 112.768 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.7 t -152.77 -63.88 0.16 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.324 -176.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.6 m -69.31 -62.69 1.28 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.122 0.487 . . . . 0.0 110.041 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.99 -158.2 0.89 Allowed 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.8 m -64.79 -24.82 67.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.563 0.697 . . . . 0.0 109.221 173.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.826 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.5 p -129.24 155.43 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.584 -178.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -143.81 137.97 28.38 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 34.8 tp -70.55 126.54 29.91 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.121 0.486 . . . . 0.0 111.175 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -74.21 -62.22 1.59 Allowed 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.825 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.2 p 176.55 167.25 0.48 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.214 -175.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 22' ' ' SER . 49.0 p90 -157.8 160.34 37.69 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.306 -1.315 . . . . 0.0 107.8 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -126.09 163.24 23.52 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.979 0.419 . . . . 0.0 110.326 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 20' ' ' THR . 37.5 t80 -152.5 149.59 28.7 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.284 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -179.76 126.14 0.08 Allowed 'General case' 0 C--N 1.321 -0.644 0 O-C-N 123.715 0.634 . . . . 0.0 109.376 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.44 -105.8 0.99 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 -170.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.532 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 20.4 m -133.35 86.08 2.27 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 166.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 96.2 m -148.07 136.07 21.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.709 177.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.515 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 23.8 t80 -117.32 138.88 51.47 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 171.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 25.9 p -150.04 109.87 4.08 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.77 149.47 19.72 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.15 -1.024 . . . . 0.0 113.057 -166.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.602 ' HB3' HG22 ' A' ' 71' ' ' THR . 24.3 pttm -140.34 154.69 46.85 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.607 HD11 HG21 ' A' ' 84' ' ' ILE . 19.0 mt -134.91 154.63 36.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.071 -165.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -123.24 99.32 6.29 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.255 -174.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.826 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 1.7 m -136.25 149.95 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.337 0.589 . . . . 0.0 112.372 -170.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.628 ' HB2' ' CE1' ' A' ' 67' ' ' TYR . 7.7 ttmm -81.25 144.19 31.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.642 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -82.96 103.82 12.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.65 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.9 HG12 ' HH ' ' A' ' 86' ' ' TYR . 19.0 mm -81.68 -59.29 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.43 -151.86 0.49 Allowed 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 114.033 -1.44 . . . . 0.0 107.706 174.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -109.04 -44.95 3.86 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.049 -0.661 . . . . 0.0 111.46 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.4 t -76.93 82.27 3.48 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.589 0.709 . . . . 0.0 109.898 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.431 ' HE3' ' HB2' ' A' ' 34' ' ' LYS . 28.1 mtmt -110.67 152.41 26.55 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.968 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -142.31 110.12 5.83 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 122.277 1.037 . . . . 0.0 109.021 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.0 t -92.12 124.73 44.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.593 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.751 ' HB ' HG13 ' A' ' 53' ' ' ILE . 59.2 p -123.27 117.4 25.18 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.244 -170.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.79 HG11 ' CD2' ' A' ' 40' ' ' TYR . 57.3 t -73.38 141.24 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.019 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 170.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -124.6 100.1 7.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 159.102 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.79 ' CD2' HG11 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -119.21 126.08 50.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 122.218 1.009 . . . . 0.0 110.684 179.112 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.479 ' HB3' ' CZ3' ' A' ' 47' ' ' TRP . . . -86.59 151.13 23.72 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.768 -164.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 44' ' ' SER . 2.8 m-20 -72.85 177.5 4.83 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.154 -1.839 . . . . 0.0 110.863 -166.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.36 33.8 1.34 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.805 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 42' ' ' ASP . 22.7 t -112.26 -10.52 13.82 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 175.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 16.6 t70 76.58 91.26 0.07 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 113.535 -1.666 . . . . 0.0 110.341 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 45' ' ' ASP . 22.9 t-20 84.69 154.64 0.09 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.996 170.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.594 ' HE1' ' HB2' ' A' ' 52' ' ' ASN . 8.2 m-90 -72.48 124.47 25.25 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -172.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -78.22 74.25 4.76 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.264 -1.334 . . . . 0.0 108.691 167.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.1 t30 47.86 34.08 3.71 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.676 0.75 . . . . 0.0 110.781 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -119.15 174.46 6.32 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -173.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -141.78 77.32 0.3 Allowed Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 119.808 -1.187 . . . . 0.0 112.213 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.594 ' HB2' ' HE1' ' A' ' 47' ' ' TRP . 78.3 m-20 -79.84 95.11 5.95 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 121.229 0.538 . . . . 0.0 111.515 -178.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.751 HG13 ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -108.49 142.64 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.006 -177.18 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.529 ' CG2' ' HB ' ' A' ' 38' ' ' VAL . 17.5 tt -135.99 122.74 32.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.307 173.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.52 134.5 43.85 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.024 0.44 . . . . 0.0 111.756 -170.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -91.32 164.83 13.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.691 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -128.36 140.13 52.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.062 0.458 . . . . 0.0 110.063 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -71.46 145.58 49.15 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.231 0.539 . . . . 0.0 110.642 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.1 t -107.59 -44.26 4.32 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.888 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.44 170.52 36.35 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.969 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -70.13 140.84 42.23 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.855 2.37 . . . . 0.0 111.666 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.542 HG12 ' HB2' ' A' ' 69' ' ' TYR . 28.8 mt -78.71 105.99 8.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.097 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.7 m -65.85 117.09 7.75 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.365 0.603 . . . . 0.0 110.636 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.408 ' C ' ' HG ' ' A' ' 65' ' ' SER . . . 121.28 -14.69 9.4 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.41 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.408 ' HG ' ' C ' ' A' ' 64' ' ' GLY . 16.9 m -150.25 164.76 34.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.955 0.407 . . . . 0.0 110.711 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -89.89 62.07 5.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.429 0.633 . . . . 0.0 109.443 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.628 ' CE1' ' HB2' ' A' ' 28' ' ' LYS . 1.7 m-85 -138.52 169.59 17.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.466 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.441 ' HG2' ' H ' ' A' ' 69' ' ' TYR . 22.0 tt0 -122.09 171.6 8.86 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.542 ' HB2' HG12 ' A' ' 62' ' ' ILE . 1.5 t80 -140.28 122.11 15.46 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -163.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.635 ' CD1' HG12 ' A' ' 27' ' ' VAL . 7.1 m95 -121.28 144.56 48.56 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.015 -165.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.602 HG22 ' HB3' ' A' ' 24' ' ' LYS . 21.3 p -145.81 153.45 40.92 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 122.9 0.125 . . . . 0.0 110.74 -178.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -173.01 155.72 3.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.219 0.533 . . . . 0.0 111.209 167.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.2 m -112.15 145.21 40.23 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.543 175.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.515 ' HB1' ' HB3' ' A' ' 21' ' ' PHE . . . -137.51 144.89 42.4 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.36 -175.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.3 t -99.95 99.15 9.88 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 173.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.532 ' O ' ' HB3' ' A' ' 19' ' ' SER . 3.9 m -103.48 138.34 28.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 3.7 mptp? -101.95 -11.4 18.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.233 -173.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -179.66 105.98 0.2 Allowed Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.54 HG12 HG22 ' A' ' 104' ' ' VAL . 11.1 tt -128.92 158.36 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.48 ' HA ' ' HE2' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -147.56 -42.07 0.17 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.289 -178.146 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -135.32 164.69 27.16 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 118.56 -0.733 . . . . 0.0 109.086 -171.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.47 ' CB ' ' HA ' ' A' ' 40' ' ' TYR . 36.4 p90 -173.36 178.85 2.29 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 119.378 -0.929 . . . . 0.0 113.379 171.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.639 ' O ' HG22 ' A' ' 39' ' ' VAL . 1.0 OUTLIER -164.28 144.99 8.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.412 -1.722 . . . . 0.0 107.704 167.368 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.607 HG21 HD11 ' A' ' 25' ' ' ILE . 28.3 mm -103.23 137.0 33.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.56 -174.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -104.13 146.12 29.2 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.774 0.797 . . . . 0.0 110.925 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.9 ' HH ' HG12 ' A' ' 30' ' ' ILE . 10.3 t80 -108.89 100.17 9.42 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.454 175.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -110.38 120.79 43.55 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.628 0.728 . . . . 0.0 109.38 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.566 ' C ' ' H ' ' A' ' 90' ' ' GLY . 86.4 t -121.72 155.92 26.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.207 -174.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.9 t -77.01 31.95 0.14 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 122.019 0.914 . . . . 0.0 109.677 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -158.83 -33.14 0.02 OUTLIER Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.91 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.432 ' HE3' ' H ' ' A' ' 92' ' ' THR . 13.3 mmmt -145.66 178.8 7.87 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.82 0.819 . . . . 0.0 112.138 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.432 ' H ' ' HE3' ' A' ' 91' ' ' LYS . 5.6 m -149.27 143.62 25.97 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.086 174.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.447 ' CD1' ' HD2' ' A' ' 86' ' ' TYR . 25.9 m-85 -143.36 -172.26 3.66 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -145.24 138.44 26.46 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.609 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -111.25 104.24 12.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 165.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 98' ' ' ASN . 49.6 t30 -151.93 87.45 1.35 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.613 -171.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 42.22 -68.2 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.465 1.906 . . . . 0.0 115.343 168.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 96' ' ' ASN . 54.8 t30 -159.92 -49.6 0.05 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -177.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.0 p -174.48 20.31 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.859 175.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.15 -87.31 0.54 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -169.17 147.84 3.87 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.348 0.659 . . . . 0.0 109.812 -169.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.444 ' CE2' ' HA ' ' A' ' 96' ' ' ASN . 77.1 m-85 -85.88 122.96 30.68 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 170.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -77.26 122.48 25.14 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.54 HG22 HG12 ' A' ' 79' ' ' ILE . 47.5 t -78.16 132.21 32.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.8 m -73.47 77.07 1.43 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.15 0.5 . . . . 0.0 110.913 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 m . . . . . 0 C--O 1.246 0.9 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.49 176.31 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.7 m -66.29 158.49 28.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.706 0.288 . . . . 0.0 110.74 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.44 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 3.7 mp -103.56 107.34 55.85 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.908 0.385 . . . . 0.0 110.602 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.625 ' HG2' ' CZ ' ' A' ' 67' ' ' TYR . 45.4 Cg_endo -68.16 143.26 58.64 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 123.036 2.49 . . . . 0.0 112.365 175.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.7 t -128.81 -13.43 4.67 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.354 0.597 . . . . 0.0 109.987 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.1 m -90.1 -6.77 55.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.113 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.34 28.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.576 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.476 ' HB3' HD11 ' A' ' 30' ' ' ILE . 1.6 m -92.88 -27.23 17.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.558 0.694 . . . . 0.0 109.228 175.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.763 HG21 ' HB ' ' A' ' 27' ' ' VAL . 2.2 p -149.89 146.64 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.015 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -135.7 128.76 31.58 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.497 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.492 HD21 ' CD1' ' A' ' 14' ' ' TYR . 36.9 tp -71.85 133.56 45.55 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.172 174.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -81.27 -64.02 1.27 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.969 177.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.6 p 177.32 166.52 0.6 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.851 -177.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.492 ' CD1' HD21 ' A' ' 11' ' ' LEU . 50.3 p90 -157.47 163.9 37.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.056 -177.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -153.18 163.89 39.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.938 0.399 . . . . 0.0 110.989 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.549 ' HD1' ' HD1' ' A' ' 21' ' ' PHE . 35.6 t80 -131.38 149.39 52.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.668 -176.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -174.71 117.82 0.2 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.226 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.0 -99.77 0.34 Allowed Glycine 0 CA--C 1.511 -0.208 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.6 t -135.47 83.46 2.02 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 164.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 62.6 m -148.42 134.33 19.08 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.503 172.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.549 ' HD1' ' HD1' ' A' ' 16' ' ' TYR . 7.8 t80 -132.74 102.34 5.63 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 169.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.4 t -139.04 167.42 22.1 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.952 -171.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.22 -154.35 25.33 Favored Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -155.64 173.49 16.65 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.433 0.635 . . . . 0.0 112.007 179.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.614 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 83.4 mt -136.53 153.37 30.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.58 -167.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.6 ' N ' HG23 ' A' ' 25' ' ' ILE . 6.8 t80 -130.58 100.39 5.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.93 -174.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.763 ' HB ' HG21 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -141.79 145.77 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -169.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.62 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 21.2 ptmt -97.62 154.56 17.47 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.805 -175.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.885 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 20.1 p-10 -75.1 115.7 15.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.96 177.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.647 HG12 ' OH ' ' A' ' 86' ' ' TYR . 34.4 mm -77.81 -56.07 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 167.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.49 -86.4 0.41 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.778 171.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -163.77 -68.47 0.04 OUTLIER 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 172.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m -80.71 124.33 28.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.861 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.885 ' HE3' ' HA ' ' A' ' 29' ' ' ASN . 37.8 mttp -122.81 176.66 5.86 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.341 0.591 . . . . 0.0 111.166 -172.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.832 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 96.4 mttt -121.14 136.54 54.96 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 166.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.3 t -127.66 113.63 32.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 122.014 0.911 . . . . 0.0 109.739 171.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 1.016 ' HB ' HD13 ' A' ' 53' ' ' ILE . 1.0 OUTLIER -131.48 136.14 47.67 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.148 -1.387 . . . . 0.0 110.413 -175.142 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 1.007 ' HB ' HG23 ' A' ' 54' ' ' ILE . 69.3 t -93.4 132.71 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.451 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.556 ' O ' ' HH2' ' A' ' 47' ' ' TRP . 2.7 m -112.8 104.77 17.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 165.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.641 ' CD1' HG13 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -122.18 120.87 35.46 Favored 'General case' 0 N--CA 1.4 -2.974 0 CA-C-N 114.902 -1.044 . . . . 0.0 110.054 -170.107 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.597 ' HB3' ' CZ3' ' A' ' 47' ' ' TRP . . . -76.5 129.0 35.87 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.53 -169.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -67.42 179.91 1.19 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.523 -1.672 . . . . 0.0 111.354 -168.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.582 ' HA2' ' HG2' ' A' ' 80' ' ' LYS . . . -68.0 -0.28 14.02 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.079 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.0 m -66.45 -22.75 66.21 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.013 0.435 . . . . 0.0 110.044 174.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 t70 64.69 37.66 7.47 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.133 -0.939 . . . . 0.0 108.98 177.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -173.86 140.28 0.73 Allowed 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -172.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.597 ' CZ3' ' HB3' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -89.39 85.88 6.66 Favored 'General case' 0 N--CA 1.421 -1.893 0 C-N-CA 118.608 -1.237 . . . . 0.0 112.516 -173.204 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -56.66 132.32 51.56 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.37 165.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -72.12 70.22 0.79 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.849 0.833 . . . . 0.0 111.317 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -112.74 -17.86 12.45 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.652 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.47 -58.34 3.05 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.709 -176.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 92.4 m-20 59.83 76.3 0.37 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.655 -0.773 . . . . 0.0 110.144 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 1.016 HD13 ' HB ' ' A' ' 37' ' ' THR . 5.7 tp -109.07 148.89 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-O 121.816 0.817 . . . . 0.0 112.044 -176.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 1.007 HG23 ' HB ' ' A' ' 38' ' ' VAL . 3.4 tp -133.03 140.34 47.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.494 -1.23 . . . . 0.0 107.712 167.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -92.84 116.42 29.01 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.287 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.12 156.28 39.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.215 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.8 t -114.83 144.8 42.94 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -174.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -71.25 142.06 50.56 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.283 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.4 t -109.12 -42.27 4.46 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.81 171.8 21.94 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.569 173.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.15 142.75 42.58 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.403 2.068 . . . . 0.0 110.637 173.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.533 HG12 ' HB2' ' A' ' 69' ' ' TYR . 9.7 mt -83.63 83.83 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.8 m -53.5 126.41 21.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.385 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 113.31 -32.42 6.11 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.252 -173.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -127.24 165.99 18.61 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -95.43 55.01 1.66 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.135 0.493 . . . . 0.0 110.863 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.625 ' CZ ' ' HG2' ' A' ' 4' ' ' PRO . 2.4 m-85 -137.04 159.3 42.31 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.328 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -107.29 173.59 6.26 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.922 176.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.533 ' HB2' HG12 ' A' ' 62' ' ' ILE . 3.1 t80 -143.5 120.84 11.61 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -165.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.614 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 20.6 m95 -127.79 138.65 52.81 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.922 -166.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.5 p -124.33 133.25 53.51 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -125.93 136.97 53.64 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.488 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.7 p -125.7 139.44 53.54 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.236 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.411 ' HB3' HG12 ' A' ' 54' ' ' ILE . . . -152.97 118.99 5.43 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.782 -175.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.9 t -82.57 99.4 9.5 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.427 ' CG2' ' HE1' ' A' ' 16' ' ' TYR . 13.8 m -99.48 144.66 11.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.375 -173.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.01 8.39 43.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.279 0.562 . . . . 0.0 110.563 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 156.81 145.8 4.3 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.639 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.676 HG12 HG22 ' A' ' 104' ' ' VAL . 7.3 tt -168.09 142.47 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.309 0.576 . . . . 0.0 110.873 177.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.582 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 3.7 mmmp? -125.48 -38.7 2.24 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.28 -177.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 29.4 mt-10 -141.65 167.22 22.67 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.641 ' HB2' ' HA ' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -171.89 170.45 5.44 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.017 -0.673 . . . . 0.0 112.056 172.197 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.655 ' HD2' ' HB3' ' A' ' 96' ' ' ASN . 0.1 OUTLIER -159.46 148.54 18.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.195 169.092 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.801 HD12 HG23 ' A' ' 38' ' ' VAL . 21.5 mm -95.01 140.76 16.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.706 -169.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.6 mtmt -90.7 114.09 26.33 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.157 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.647 ' OH ' HG12 ' A' ' 30' ' ' ILE . 10.5 t80 -91.95 99.72 12.51 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 172.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.832 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 9.3 tt0 -109.63 107.84 18.04 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.63 0.729 . . . . 0.0 110.206 -174.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 20.6 t -87.21 164.02 2.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.061 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 m -43.51 -40.86 4.11 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.405 0.44 . . . . 0.0 111.156 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -136.37 23.64 3.28 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.185 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.458 ' HB2' ' HB ' ' A' ' 88' ' ' VAL . 16.5 mmtp -141.74 175.44 9.7 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.772 0.796 . . . . 0.0 111.758 177.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.8 m -149.19 138.83 21.78 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.614 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.424 ' HD2' ' CD2' ' A' ' 86' ' ' TYR . 60.7 m-85 -140.6 -169.25 2.75 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -148.07 145.49 28.46 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.147 0.498 . . . . 0.0 111.503 -173.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.404 ' OD2' ' HB2' ' A' ' 11' ' ' LEU . 17.6 t70 -107.78 97.68 7.37 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 167.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.655 ' HB3' ' HD2' ' A' ' 83' ' ' TYR . 34.0 p30 -144.03 31.98 1.25 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -172.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 67.88 -67.6 0.18 Allowed 'General case' 0 CA--C 1.532 0.275 0 O-C-N 123.629 0.58 . . . . 0.0 111.403 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -171.66 40.25 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -175.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.6 t 63.64 46.6 4.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.954 -167.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -102.3 -38.55 7.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.99 -176.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 7.3 m-20 67.94 115.1 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.781 0.676 . . . . 0.0 110.282 -174.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.462 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 7.9 m-85 -77.14 133.21 39.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.437 -174.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -79.19 129.63 34.65 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.676 HG22 HG12 ' A' ' 79' ' ' ILE . 96.3 t -79.25 133.84 29.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.677 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.1 p -77.14 77.01 3.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.725 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.248 1.008 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.177 178.652 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.904 0.383 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.9 p -105.18 168.79 8.83 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.881 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.806 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 3.4 mp -72.74 -59.8 2.21 Favored Pre-proline 0 C--N 1.323 -0.562 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.635 178.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.806 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 1.9 Cg_endo -84.22 144.8 10.68 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.42 2.08 . . . . 0.0 112.014 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.4 m -128.44 -54.96 1.25 Allowed 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.33 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.6 m -106.09 -68.62 0.87 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.351 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.28 -172.8 2.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 120.908 0.385 . . . . 0.0 111.862 -173.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 m -64.86 -26.56 68.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.214 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.724 ' CB ' ' HB ' ' A' ' 27' ' ' VAL . 2.2 p -120.57 148.31 23.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.382 0.61 . . . . 0.0 112.015 -174.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.429 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 28.0 tt0 -143.72 132.22 22.26 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.474 173.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.624 HD21 ' CD1' ' A' ' 14' ' ' TYR . 40.5 tp -70.03 130.76 43.02 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.099 0.476 . . . . 0.0 110.238 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -76.84 -63.9 1.25 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.901 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.5 m -178.96 159.87 1.04 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.622 -174.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.624 ' CD1' HD21 ' A' ' 11' ' ' LEU . 53.7 p90 -157.95 163.49 37.78 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.654 -177.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -151.32 164.95 35.5 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -176.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.601 ' HA ' ' O ' ' A' ' 20' ' ' THR . 97.6 m-85 -138.92 138.34 37.28 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.754 -176.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -136.53 124.62 22.95 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.54 -99.44 0.18 Allowed Glycine 0 C--N 1.331 0.265 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -167.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.1 t -139.86 87.85 2.19 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 163.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.601 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 73.0 m -145.96 133.3 20.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.422 177.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.659 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 14.8 t80 -90.57 126.49 35.96 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 174.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.9 p -144.92 126.19 14.78 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.593 175.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 173.68 -154.14 19.14 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.384 -177.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.517 ' HB3' HG22 ' A' ' 71' ' ' THR . 0.4 OUTLIER -161.85 166.07 26.86 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.196 0.522 . . . . 0.0 111.018 -177.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 33.8 mt -127.72 156.04 39.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.16 -172.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -126.9 96.32 4.59 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.866 -172.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.724 ' HB ' ' CB ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -147.91 143.23 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -172.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.53 ' HE3' ' CE1' ' A' ' 67' ' ' TYR . 17.0 ptpt -85.05 148.43 26.17 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.365 176.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -86.64 132.58 33.85 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.998 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.459 HG12 ' OH ' ' A' ' 86' ' ' TYR . 39.0 mm -80.33 -55.28 9.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.486 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.813 ' HB2' ' HE3' ' A' ' 34' ' ' LYS . . . -103.84 -81.18 0.52 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.026 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -159.31 -73.25 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.285 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.597 ' C ' ' HE2' ' A' ' 34' ' ' LYS . 10.0 t -95.87 62.78 2.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.34 0.591 . . . . 0.0 109.913 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.843 ' HD2' HG12 ' A' ' 88' ' ' VAL . 6.3 mmpt? -80.68 157.1 26.02 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.475 ' HG3' ' HB3' ' A' ' 87' ' ' GLU . 18.3 pttp -124.81 141.34 52.18 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.167 -175.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.3 t -115.73 116.57 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.787 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.589 HG22 HD13 ' A' ' 53' ' ' ILE . 5.4 p -114.17 119.43 37.04 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.866 -170.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.86 ' HB ' HG22 ' A' ' 54' ' ' ILE . 96.8 t -84.19 113.63 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.89 176.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 0.3 OUTLIER -107.6 107.09 21.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 172.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.584 ' HA ' ' HB3' ' A' ' 82' ' ' PHE . 4.3 p90 -109.26 137.61 46.88 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-O 122.494 1.14 . . . . 0.0 110.075 177.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.718 ' HB3' ' CE3' ' A' ' 47' ' ' TRP . . . -89.38 110.67 21.45 Favored 'General case' 0 N--CA 1.401 -2.894 0 CA-C-N 112.863 -1.971 . . . . 0.0 107.599 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -40.7 167.22 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 112.484 -2.143 . . . . 0.0 112.081 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.756 ' HA2' ' HB2' ' A' ' 80' ' ' LYS . . . -67.69 1.69 7.23 Favored Glycine 0 CA--C 1.518 0.264 0 CA-C-N 115.241 -0.891 . . . . 0.0 114.849 -163.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 30.7 t -87.49 -12.72 45.15 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 117.088 0.444 . . . . 0.0 111.009 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.603 ' OD1' ' HG2' ' A' ' 80' ' ' LYS . 5.3 m-20 74.27 48.75 0.12 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 124.038 0.836 . . . . 0.0 110.271 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -155.51 134.3 11.99 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.198 -171.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.718 ' CE3' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -105.03 85.7 2.32 Favored 'General case' 0 N--CA 1.425 -1.705 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.681 178.019 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -71.85 145.43 48.59 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 167.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -61.71 90.8 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.301 0.572 . . . . 0.0 110.75 -176.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -152.22 147.12 26.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.092 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.03 59.46 4.94 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.897 -176.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -71.36 56.71 0.24 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.357 0.598 . . . . 0.0 109.843 172.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.62 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -116.25 141.1 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.436 -176.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.86 HG22 ' HB ' ' A' ' 38' ' ' VAL . 8.5 tp -121.76 130.3 74.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.034 -0.984 . . . . 0.0 108.372 173.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.71 128.62 34.84 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.011 -173.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.74 158.36 28.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.977 178.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 t -122.63 121.93 37.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 29.1 p90 -82.4 138.29 34.49 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 121.708 0.766 . . . . 0.0 111.363 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 65.8 m -97.03 -41.32 8.43 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 172.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 68' ' ' GLU . . . 118.55 -87.5 0.42 Allowed Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.18 -0.918 . . . . 0.0 113.541 170.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -52.98 119.66 6.44 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 124.295 3.33 . . . . 0.0 115.959 -167.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.449 ' HB ' ' O ' ' A' ' 67' ' ' TYR . 21.6 mt -124.05 90.57 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.217 162.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.5 m -71.52 117.8 13.53 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.804 -174.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.68 -14.01 6.1 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.965 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -155.5 167.01 31.79 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -92.13 66.4 4.88 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.716 0.769 . . . . 0.0 109.438 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.53 ' CE1' ' HE3' ' A' ' 28' ' ' LYS . 2.2 m-85 -136.52 153.15 51.09 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.732 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.571 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 7.4 mp0 -106.44 174.78 5.74 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.888 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -137.55 115.75 11.75 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -166.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.684 ' NE1' HG12 ' A' ' 27' ' ' VAL . 8.0 m95 -116.16 121.85 43.32 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.649 -164.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.517 HG22 ' HB3' ' A' ' 24' ' ' LYS . 2.9 p -128.94 147.74 50.87 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 110.562 -0.162 . . . . 0.0 110.562 -171.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.407 ' HB3' ' O ' ' A' ' 71' ' ' THR . 2.5 p90 -174.58 159.72 2.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.444 0.64 . . . . 0.0 112.202 174.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.2 m -115.24 146.45 41.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.54 169.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.844 ' HB3' HG12 ' A' ' 54' ' ' ILE . . . -138.77 128.84 25.38 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -174.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.0 t -81.76 100.9 9.79 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 172.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.52 HG11 ' HB2' ' A' ' 21' ' ' PHE . 22.4 m -98.32 151.88 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.921 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.42 11.49 38.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.042 0.449 . . . . 0.0 111.032 -172.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 124.99 102.55 1.4 Allowed Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.929 HG12 HG22 ' A' ' 104' ' ' VAL . 12.3 tt -115.6 156.38 16.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 120.657 0.265 . . . . 0.0 110.986 -174.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.756 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 4.8 tppp? -139.66 -45.86 0.45 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.145 0.497 . . . . 0.0 111.75 -177.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.665 ' HG3' ' HB2' ' A' ' 41' ' ' ALA . 4.7 pt-20 -147.77 156.86 43.19 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.315 -176.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.584 ' HB3' ' HA ' ' A' ' 40' ' ' TYR . 55.7 p90 -171.86 179.27 2.79 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 119.774 -0.77 . . . . 0.0 112.815 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.46 149.83 30.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.503 167.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.455 HG21 HD11 ' A' ' 25' ' ' ILE . 25.6 mm -102.57 130.83 51.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.42 -177.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -96.42 147.61 23.64 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.845 0.831 . . . . 0.0 111.073 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.592 ' HD2' ' HD2' ' A' ' 93' ' ' TYR . 12.0 t80 -109.91 101.21 10.07 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.245 -1.343 . . . . 0.0 107.893 172.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.475 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . 10.8 tt0 -103.85 107.79 18.82 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 122.002 0.906 . . . . 0.0 110.702 -169.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.843 HG12 ' HD2' ' A' ' 34' ' ' LYS . 15.2 t -110.63 162.22 8.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.271 -1.331 . . . . 0.0 108.369 -177.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.5 m -70.22 -14.93 62.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.756 0.313 . . . . 0.0 111.389 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.35 -3.61 2.71 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.061 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm -142.11 160.44 40.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.099 0.476 . . . . 0.0 111.435 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 86' ' ' TYR . 7.5 m -148.99 143.58 26.21 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.909 172.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.592 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 20.4 m-85 -137.67 -172.07 3.15 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 175.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -148.03 127.07 12.82 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.781 -175.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.429 ' OD1' ' HA ' ' A' ' 10' ' ' GLN . 23.2 t70 -93.26 94.02 8.55 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 166.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.47 ' C ' ' H ' ' A' ' 98' ' ' ASN . 30.4 p-10 -128.12 41.72 3.45 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.851 -164.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 71.83 -33.58 0.27 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.325 1.05 . . . . 0.0 112.087 178.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.47 ' H ' ' C ' ' A' ' 96' ' ' ASN . 28.4 t-20 171.42 -59.55 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 65.2 m -160.25 26.95 0.17 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.586 174.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.1 -92.1 0.19 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -174.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.419 ' ND2' HE22 ' A' ' 103' ' ' GLN . 0.3 OUTLIER -174.25 150.49 1.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.069 -168.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.567 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 81.5 m-85 -88.98 140.79 29.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.294 175.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.419 HE22 ' ND2' ' A' ' 101' ' ' ASN . 1.8 mp0 -97.28 120.43 37.63 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 123.612 0.57 . . . . 0.0 109.905 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.929 HG22 HG12 ' A' ' 79' ' ' ILE . 86.9 t -83.5 126.27 40.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.062 0.458 . . . . 0.0 111.234 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.3 p -87.71 67.3 9.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.892 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.525 HG23 HG13 ' A' ' 104' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.601 -0.714 . . . . 0.0 111.116 178.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.2 t -147.05 -176.32 5.16 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.802 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 3.0 mp -57.47 -56.53 33.15 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 123.39 0.431 . . . . 0.0 110.454 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.802 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 40.8 Cg_endo -92.82 137.28 1.49 Allowed 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 122.068 1.845 . . . . 0.0 111.231 170.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.2 t -145.61 -66.7 0.3 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.2 m -103.74 -30.95 10.09 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 173.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -122.6 174.75 6.88 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.302 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.462 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 70.3 m -96.75 11.36 35.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.571 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.706 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 0.9 OUTLIER -149.92 152.53 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.736 -175.056 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.431 ' O ' ' HB3' ' A' ' 26' ' ' TYR . 8.0 tt0 -149.83 112.1 4.67 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.123 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.641 ' CD1' HG12 ' A' ' 25' ' ' ILE . 7.8 tt -67.82 132.32 47.18 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.983 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.449 ' OD1' ' HE2' ' A' ' 24' ' ' LYS . 15.5 t70 -68.85 -61.43 1.81 Allowed 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.293 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.2 m -168.35 154.45 7.11 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.087 -168.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.514 ' HD2' HD23 ' A' ' 11' ' ' LEU . 42.1 p90 -157.08 152.66 26.72 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.396 -1.274 . . . . 0.0 109.198 177.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -127.86 164.74 21.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.094 0.473 . . . . 0.0 110.927 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' A' ' 20' ' ' THR . 56.1 t80 -145.56 151.95 38.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.838 176.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -172.85 121.94 0.4 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.759 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.71 -98.28 0.12 Allowed Glycine 0 CA--C 1.51 -0.265 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -172.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 49.3 m -139.47 85.84 2.08 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 161.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 3.9 m -145.52 140.09 27.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.114 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.608 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 25.0 t80 -118.25 139.59 51.08 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 172.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 p -160.22 126.48 4.2 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.668 176.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 14' ' ' TYR . . . 177.82 -159.17 24.79 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 119.798 -1.191 . . . . 0.0 112.917 -178.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.581 ' HB3' HG22 ' A' ' 71' ' ' THR . 0.0 OUTLIER -160.49 160.22 31.75 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.342 0.591 . . . . 0.0 110.721 -178.51 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.641 HG12 ' CD1' ' A' ' 11' ' ' LEU . 31.2 mt -128.94 156.11 41.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.635 -170.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.431 ' HB3' ' O ' ' A' ' 10' ' ' GLN . 4.2 t80 -130.7 115.88 17.28 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -175.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.706 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 1.0 OUTLIER -139.4 149.15 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 121.679 -0.638 . . . . 0.0 111.513 -177.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.547 ' HB2' ' HZ2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -93.45 152.69 18.93 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.374 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -79.66 126.21 30.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.786 -176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.647 HG12 ' OH ' ' A' ' 86' ' ' TYR . 26.6 mm -93.29 -48.64 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 167.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.05 -156.13 0.73 Allowed 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.949 -1.478 . . . . 0.0 107.868 174.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -110.3 -51.78 2.84 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.44 -177.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.4 m -82.35 85.46 6.87 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.224 0.535 . . . . 0.0 110.096 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.514 ' HB2' ' HE3' ' A' ' 34' ' ' LYS . 25.7 mtmt -102.9 174.86 5.69 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.084 0.468 . . . . 0.0 110.903 -174.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.828 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 88.7 mttt -131.63 139.16 49.06 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.133 174.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 68.8 t -130.83 108.51 15.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 121.954 0.883 . . . . 0.0 109.919 171.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.778 HG22 HD13 ' A' ' 53' ' ' ILE . 19.4 p -122.39 122.99 40.31 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.523 -174.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.718 HG23 HD12 ' A' ' 84' ' ' ILE . 84.6 t -83.58 135.17 25.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.871 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.8 m -135.21 122.03 34.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.779 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.686 ' HE1' ' HA ' ' A' ' 42' ' ' ASP . 5.3 p90 -115.9 171.14 7.96 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 119.599 -0.841 . . . . 0.0 112.192 -174.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.719 ' HB3' ' CH2' ' A' ' 47' ' ' TRP . . . -93.36 86.58 5.32 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 170.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.718 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 38.0 t70 6.53 -95.42 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 O-C-N 127.336 2.898 . . . . 0.0 114.846 174.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.57 -28.37 0.35 Allowed Glycine 0 C--N 1.316 -0.542 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.692 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.2 t -109.6 -60.75 1.73 Allowed 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 174.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.553 ' HA ' ' HB1' ' A' ' 41' ' ' ALA . 8.0 p-10 175.46 38.28 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.135 -176.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -91.68 113.2 25.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.076 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.719 ' CH2' ' HB3' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -124.17 118.74 27.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.545 0.688 . . . . 0.0 110.062 167.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.46 ' O ' ' HB3' ' A' ' 49' ' ' ASN . 66.3 t30 -81.59 56.76 3.09 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 170.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 48' ' ' ASN . 33.8 t30 69.07 -55.61 0.55 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -154.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -124.83 -72.34 0.67 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.308 164.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.85 -40.53 3.08 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.248 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -134.49 98.91 4.2 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.484 0.659 . . . . 0.0 110.969 -175.464 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.778 HD13 HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -122.42 143.91 33.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.682 -178.055 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.602 HG22 ' HB ' ' A' ' 38' ' ' VAL . 20.1 tt -131.57 128.45 60.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.195 173.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.23 132.95 35.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.781 0.324 . . . . 0.0 110.801 -176.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.79 159.66 33.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.614 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.3 m -112.3 128.98 56.43 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -71.5 138.74 49.17 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.276 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.8 m -99.55 -46.14 5.56 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 170.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.73 175.26 21.82 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.583 173.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.76 134.55 58.05 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.248 1.965 . . . . 0.0 110.945 174.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.4 HG12 ' HB2' ' A' ' 69' ' ' TYR . 62.9 mt -75.82 106.63 5.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 28.4 m -49.66 125.24 11.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.063 -174.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.89 7.08 60.12 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.168 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.504 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 50.8 m -151.68 172.27 16.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.137 0.494 . . . . 0.0 111.124 -178.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -101.65 20.37 16.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.225 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.504 ' CD2' ' HB3' ' A' ' 65' ' ' SER . 6.7 m-85 -103.71 154.95 18.98 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -114.14 162.58 16.33 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.4 ' HB2' HG12 ' A' ' 62' ' ' ILE . 8.8 t80 -122.6 119.44 30.81 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -167.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.527 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 3.7 m95 -116.28 126.76 54.01 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.491 -173.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.581 HG22 ' HB3' ' A' ' 24' ' ' LYS . 40.2 p -134.51 152.9 52.09 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.419 ' HB3' ' O ' ' A' ' 71' ' ' THR . 3.1 p90 -174.22 150.78 1.55 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.703 0.763 . . . . 0.0 111.79 168.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.0 m -112.43 138.42 49.19 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.014 169.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.608 ' HB1' ' HB3' ' A' ' 21' ' ' PHE . . . -132.64 135.78 46.08 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.936 0.398 . . . . 0.0 111.865 -168.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.9 t -88.31 98.18 11.45 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 170.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 19' ' ' SER . 20.1 m -104.21 139.94 23.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -177.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 3.8 mptp? -106.3 39.82 1.73 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.433 0.635 . . . . 0.0 109.93 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 129.71 136.77 4.12 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.063 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.729 HG12 HG22 ' A' ' 104' ' ' VAL . 12.8 tt -160.78 143.8 4.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.014 0.435 . . . . 0.0 110.137 176.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -114.85 -56.16 2.41 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.985 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.467 ' HG2' ' HB2' ' A' ' 41' ' ' ALA . 12.6 pt-20 -150.78 174.51 12.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 117.889 -1.053 . . . . 0.0 108.735 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.557 ' CB ' ' HA ' ' A' ' 40' ' ' TYR . 46.8 p90 -172.76 179.95 2.25 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 120.413 1.461 . . . . 0.0 113.51 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.61 ' CB ' ' HB3' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -161.39 154.67 21.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 113.558 -1.655 . . . . 0.0 108.704 174.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.718 HD12 HG23 ' A' ' 38' ' ' VAL . 20.4 mm -99.98 147.43 7.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.979 -173.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.753 ' HB2' ' HG1' ' A' ' 37' ' ' THR . 3.6 mmmp? -102.06 106.52 17.43 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.833 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.647 ' OH ' HG12 ' A' ' 30' ' ' ILE . 17.2 t80 -86.84 101.07 13.01 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 174.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.828 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 17.5 tt0 -109.5 117.58 34.35 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.383 0.611 . . . . 0.0 110.534 -173.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.1 t -115.47 106.22 20.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.393 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.8 t 53.8 23.92 4.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.419 0.628 . . . . 0.0 110.869 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.49 5.4 48.75 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.927 -177.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.722 ' O ' ' HA ' ' A' ' 87' ' ' GLU . 19.8 tptp -99.24 150.91 21.6 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.9 m -126.28 141.39 51.93 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 122.27 1.033 . . . . 0.0 112.842 -174.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.484 ' HD2' ' CD2' ' A' ' 86' ' ' TYR . 29.4 m-85 -134.8 -174.63 3.65 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 113.286 -1.779 . . . . 0.0 106.791 167.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.499 ' HE1' ' HD3' ' A' ' 85' ' ' LYS . 61.9 m-85 -144.58 137.03 26.47 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -169.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -127.99 112.54 14.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.567 171.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.61 ' HB3' ' CB ' ' A' ' 83' ' ' TYR . 29.4 p-10 -139.31 -43.35 0.45 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.484 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.609 ' HB3' ' O ' ' A' ' 96' ' ' ASN . 4.0 p-10 159.82 -45.18 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 168.15 -65.06 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 65.8 m -158.97 51.18 0.38 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.398 174.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.553 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -137.36 -31.74 0.8 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.553 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 95.7 m-20 84.18 150.77 0.08 Allowed 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.836 0.71 . . . . 0.0 110.156 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -69.68 101.33 1.64 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.242 177.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.06 124.88 28.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.908 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.729 HG22 HG12 ' A' ' 79' ' ' ILE . 15.6 t -94.97 147.24 5.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.015 0.436 . . . . 0.0 110.487 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.4 m -93.75 112.41 24.27 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.791 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.251 1.153 0 CA-C-O 119.264 -0.398 . . . . 0.0 111.001 -177.734 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.856 0.36 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 p -102.27 130.33 48.94 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.664 -178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.969 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 3.8 mp -89.6 -58.86 0.25 Allowed Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 174.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.969 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 15.4 Cg_exo -69.91 155.24 65.94 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.03 1.82 . . . . 0.0 111.052 172.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.7 t 68.19 7.41 5.88 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.181 0.593 . . . . 0.0 111.664 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.6 m -113.92 -64.69 1.27 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 172.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -153.55 -167.32 2.65 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.53 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 5.0 m -84.4 -17.42 39.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.623 0.725 . . . . 0.0 109.17 173.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.632 HG21 HG13 ' A' ' 27' ' ' VAL . 1.5 p -148.97 153.57 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.287 -176.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -143.01 127.97 18.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.333 177.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.435 HD21 ' CD2' ' A' ' 14' ' ' TYR . 42.9 tp -69.39 137.8 53.09 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.968 0.413 . . . . 0.0 110.319 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.507 ' OD1' ' HE2' ' A' ' 24' ' ' LYS . 12.9 t70 -83.58 -61.78 1.75 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.366 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.2 p -178.86 164.13 1.47 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.735 -176.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.435 ' CD2' HD21 ' A' ' 11' ' ' LEU . 45.9 p90 -158.33 163.14 37.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.772 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -143.81 166.5 24.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.825 0.345 . . . . 0.0 111.287 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.709 ' HD1' ' HD1' ' A' ' 21' ' ' PHE . 8.1 t80 -129.45 141.86 50.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.446 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -150.63 97.87 2.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.079 -176.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.98 -98.26 0.35 Allowed Glycine 0 CA--C 1.508 -0.379 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -172.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -129.64 84.26 2.2 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 162.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 95.5 m -147.45 134.72 20.6 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.065 175.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.709 ' HD1' ' HD1' ' A' ' 16' ' ' TYR . 2.9 t80 -132.88 109.54 9.68 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.0 m -135.6 149.63 49.43 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.926 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 179.6 -167.93 38.11 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -150.99 160.83 43.68 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.046 0.451 . . . . 0.0 111.307 -179.046 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.598 HD11 HG21 ' A' ' 84' ' ' ILE . 17.6 mt -127.3 153.23 36.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.072 -170.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.533 ' CE1' HG12 ' A' ' 3' ' ' ILE . 0.7 OUTLIER -124.97 111.85 15.89 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.632 HG13 HG21 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -133.3 155.23 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.902 -176.021 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 8' ' ' SER . 17.6 ptpt -93.49 152.19 19.23 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.029 175.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -94.92 102.17 13.99 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.756 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.564 HD13 ' HE2' ' A' ' 86' ' ' TYR . 3.8 mp -80.79 -44.52 21.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 172.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.485 ' HB3' ' CG2' ' A' ' 88' ' ' VAL . . . -132.64 159.95 38.09 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.461 -1.245 . . . . 0.0 107.65 174.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -85.26 -29.78 24.33 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.176 -0.466 . . . . 0.0 112.033 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 p -91.67 96.92 10.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.17 0.51 . . . . 0.0 110.274 176.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.481 ' HZ1' ' CD ' ' A' ' 68' ' ' GLU . 41.4 mttt -111.78 171.09 7.7 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.442 -174.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.756 ' HG3' ' HB3' ' A' ' 87' ' ' GLU . 17.0 ptmt -155.73 103.95 2.3 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.0 0.905 . . . . 0.0 109.578 174.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.7 t -98.21 129.14 48.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-O 121.407 0.622 . . . . 0.0 109.979 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 1.032 ' HB ' HD13 ' A' ' 53' ' ' ILE . 1.2 p -137.52 134.91 36.23 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.764 -172.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.984 ' HB ' HG23 ' A' ' 54' ' ' ILE . 78.2 t -91.96 135.46 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.202 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.546 ' N ' HG13 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -114.96 75.3 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 170.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.959 ' CD2' HG11 ' A' ' 38' ' ' VAL 0.256 0.1 OUTLIER -102.65 118.36 36.68 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 122.398 1.094 . . . . 0.0 111.081 -176.749 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.922 ' HA ' ' CZ2' ' A' ' 47' ' ' TRP . . . -76.36 146.0 39.08 Favored 'General case' 0 CA--C 1.497 -1.073 0 CA-C-N 113.719 -1.582 . . . . 0.0 112.357 -168.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 44' ' ' SER . 5.5 p-10 -79.34 163.7 24.65 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.607 -172.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.785 ' HA2' ' HB2' ' A' ' 80' ' ' LYS . . . -73.17 41.71 0.92 Allowed Glycine 0 C--N 1.329 0.146 0 O-C-N 123.421 0.451 . . . . 0.0 113.694 -171.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.413 ' H ' ' C ' ' A' ' 42' ' ' ASP . 50.0 m -121.29 -16.58 7.88 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.952 0.405 . . . . 0.0 110.502 176.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.523 ' OD1' ' HG2' ' A' ' 80' ' ' LYS . 3.8 m-20 66.39 47.5 1.73 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.671 177.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.505 ' O ' ' HD1' ' A' ' 47' ' ' TRP . 12.3 t-20 -143.22 87.84 1.99 Allowed 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.837 -171.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.922 ' CZ2' ' HA ' ' A' ' 41' ' ' ALA . 2.4 m0 -124.0 92.73 3.73 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -170.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -101.71 71.53 1.32 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.79 173.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.3 t30 49.52 24.1 1.05 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.504 0.669 . . . . 0.0 111.469 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -69.19 -36.76 77.65 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 173.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 57.97 70.22 1.05 Allowed Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 114.171 -1.377 . . . . 0.0 114.008 168.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.709 ' HB2' ' HZ2' ' A' ' 47' ' ' TRP . 38.2 m-80 -64.83 108.1 1.66 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 174.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 1.032 HD13 ' HB ' ' A' ' 37' ' ' THR . 5.4 tp -107.68 152.51 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 121.56 0.695 . . . . 0.0 112.031 -169.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.984 HG23 ' HB ' ' A' ' 38' ' ' VAL . 13.0 tt -142.29 140.5 29.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.031 167.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.45 130.14 35.26 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.723 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.06 153.72 36.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.667 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -105.2 130.66 53.3 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.431 0.634 . . . . 0.0 110.287 -176.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.4 ' H ' ' HD1' ' A' ' 58' ' ' PHE . 1.5 m-85 -71.21 143.16 50.55 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.389 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.0 m -114.65 -37.97 4.12 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 171.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.6 -178.25 17.99 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.773 172.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.02 138.62 78.92 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.461 2.107 . . . . 0.0 111.305 175.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.943 HG12 ' HB2' ' A' ' 69' ' ' TYR . 10.6 mt -81.78 126.56 39.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.63 -174.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.3 m -64.09 117.11 6.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.97 0.414 . . . . 0.0 109.989 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.0 -17.26 32.38 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.657 -176.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.421 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 19.8 m -128.05 173.23 10.23 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -107.56 4.9 26.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.273 0.559 . . . . 0.0 110.429 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.419 ' CE1' ' HB2' ' A' ' 28' ' ' LYS . 20.7 m-85 -100.79 -178.56 3.81 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.329 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.481 ' CD ' ' HZ1' ' A' ' 34' ' ' LYS . 22.1 tt0 -113.54 170.69 8.06 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.54 -170.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.943 ' HB2' HG12 ' A' ' 62' ' ' ILE . 4.1 t80 -138.53 126.37 22.36 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -162.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.564 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 5.8 m95 -126.54 135.81 51.76 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.013 -170.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.494 HG22 ' HB3' ' A' ' 24' ' ' LYS . 20.8 p -135.88 153.77 51.36 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -178.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -158.85 164.15 35.98 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.875 0.845 . . . . 0.0 112.153 171.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 p -142.15 139.52 32.15 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.38 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.89 133.57 17.81 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -173.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.6 t -82.04 100.34 9.68 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 168.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.663 HG13 ' HH ' ' A' ' 40' ' ' TYR . 26.7 m -92.05 151.11 3.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.284 0.564 . . . . 0.0 110.574 -176.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -98.94 37.59 1.5 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.796 -177.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.63 116.26 3.96 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.551 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.733 HD13 ' HB2' ' A' ' 40' ' ' TYR . 4.2 tt -126.63 152.86 34.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.099 0.476 . . . . 0.0 110.494 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.785 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 17.6 tppt? -131.72 -42.46 1.02 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.22 -174.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 11.3 pt-20 -156.29 172.02 19.2 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-O 118.482 -0.77 . . . . 0.0 109.512 -176.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.666 ' CB ' ' HA ' ' A' ' 40' ' ' TYR . 55.4 p90 -173.01 178.15 2.59 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.44 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -155.4 137.11 14.31 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 113.478 -1.692 . . . . 0.0 107.71 164.219 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.666 HD12 HG23 ' A' ' 38' ' ' VAL . 22.8 mm -91.1 137.31 22.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 O-C-N 121.637 -0.665 . . . . 0.0 109.86 -175.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -92.97 129.49 38.87 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 122.048 0.928 . . . . 0.0 111.318 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.696 ' HD2' ' HD2' ' A' ' 93' ' ' TYR . 20.5 t80 -98.65 99.61 10.75 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 113.517 -1.674 . . . . 0.0 107.548 168.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.756 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . 4.2 tt0 -117.13 135.46 53.74 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -176.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.593 ' C ' ' H ' ' A' ' 90' ' ' GLY . 0.4 OUTLIER -146.72 162.61 8.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -178.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.1 t -72.39 32.71 0.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 122.066 0.936 . . . . 0.0 110.769 -174.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.593 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -147.28 -53.43 0.02 OUTLIER Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 114.638 -1.165 . . . . 0.0 111.34 175.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 91' ' ' LYS . 29.2 mmtp -132.01 -175.83 3.86 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.904 0.859 . . . . 0.0 113.158 -176.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.456 HG23 ' HG3' ' A' ' 87' ' ' GLU . 7.1 m -151.5 141.96 22.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.209 -1.36 . . . . 0.0 110.481 175.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.696 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 18.1 m-85 -145.16 -170.65 3.48 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -149.11 127.17 11.97 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.235 0.334 . . . . 0.0 111.526 -173.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -80.51 79.05 7.18 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 167.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -118.55 -70.05 0.81 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.065 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.444 ' HB2' ' HB2' ' A' ' 100' ' ' ALA . 0.7 OUTLIER 148.35 -53.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 -172.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.9 t30 175.82 -56.26 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.225 -1.807 . . . . 0.0 106.993 174.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.5 p -156.73 43.63 0.38 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.501 173.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -106.9 -53.37 2.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.788 -172.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 5.9 m-20 72.19 128.73 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.56 0.537 . . . . 0.0 110.079 -175.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 96.6 m-85 -74.27 118.68 17.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.239 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.83 124.52 28.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.998 0.428 . . . . 0.0 110.501 177.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.6 t -79.71 144.16 11.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 173.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.4 t -84.81 65.74 9.29 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.222 0.534 . . . . 0.0 110.66 -172.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.482 -0.77 . . . . 0.0 110.769 178.377 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.3 p -52.44 116.09 2.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.31 0.576 . . . . 0.0 110.899 178.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.637 HG22 ' HD3' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -69.55 -40.36 14.06 Favored Pre-proline 0 N--CA 1.435 -1.224 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.494 -178.165 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.637 ' HD3' HG22 ' A' ' 3' ' ' ILE . 58.6 Cg_endo -73.18 134.83 21.78 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.133 1.222 . . . . 0.0 111.072 171.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.5 t -150.85 -55.89 0.16 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.796 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.3 m -69.18 -77.7 0.08 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -175.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.33 -165.2 2.21 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 122.251 -0.281 . . . . 0.0 110.605 -177.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.516 ' HA ' ' HE2' ' A' ' 28' ' ' LYS . 14.6 m -69.39 -18.16 63.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.374 0.607 . . . . 0.0 110.334 176.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.436 ' CG1' ' HB2' ' A' ' 86' ' ' TYR . 2.8 p -149.68 147.33 16.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -143.99 143.76 31.36 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.753 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.44 ' CD1' ' HD2' ' A' ' 14' ' ' TYR . 3.8 tp -69.49 132.99 47.17 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.908 0.385 . . . . 0.0 110.685 172.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.63 -64.94 1.08 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 169.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.4 m -166.45 153.19 9.14 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.993 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.44 ' HD2' ' CD1' ' A' ' 11' ' ' LEU . 20.3 p90 -142.34 157.82 44.39 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 173.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -119.56 157.44 28.37 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.794 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.658 ' HA ' ' O ' ' A' ' 20' ' ' THR . 50.3 t80 -137.92 146.6 43.47 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 172.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -179.25 114.94 0.06 Allowed 'General case' 0 C--N 1.315 -0.924 0 O-C-N 123.683 0.615 . . . . 0.0 109.733 -174.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.73 -103.36 0.31 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -168.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.635 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 24.8 m -124.3 88.47 2.91 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 165.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 89.4 m -143.6 135.64 26.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.638 176.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.469 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 11.4 t80 -134.01 145.02 49.07 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 120.732 0.301 . . . . 0.0 110.596 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.619 ' HG ' ' HB2' ' A' ' 74' ' ' ALA . 48.1 m 94.6 178.4 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 164.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -171.98 -78.61 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.573 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.516 ' HB3' HG22 ' A' ' 71' ' ' THR . 0.4 OUTLIER -166.55 169.02 14.13 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.977 0.418 . . . . 0.0 111.406 176.724 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 53.4 mt -132.07 154.0 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.577 -170.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -116.13 105.82 13.03 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -178.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 p -125.91 145.17 33.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 O-C-N 121.772 -0.58 . . . . 0.0 112.56 -165.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.516 ' HE2' ' HA ' ' A' ' 8' ' ' SER . 16.3 ttmm -86.41 151.75 23.28 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -101.97 117.63 35.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.415 0.626 . . . . 0.0 111.126 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.601 HG12 ' OH ' ' A' ' 86' ' ' TYR . 28.2 mm -88.24 -48.61 14.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.38 -154.03 0.61 Allowed 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 171.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -104.69 -48.72 3.71 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.25 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.1 m -74.41 80.01 1.9 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.033 176.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.601 ' HE2' ' CZ2' ' A' ' 70' ' ' TRP . 30.3 mtmm -103.74 157.59 16.97 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.597 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 24.9 mtpp -127.66 123.74 36.29 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.06 0.457 . . . . 0.0 109.889 176.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.7 t -117.13 125.53 73.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.97 ' HB ' HD13 ' A' ' 53' ' ' ILE . 0.8 OUTLIER -138.64 129.44 26.48 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.014 -169.619 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.918 ' HB ' HG22 ' A' ' 54' ' ' ILE . 7.1 t -95.53 124.09 47.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.518 0.675 . . . . 0.0 110.742 -178.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.59 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -102.97 108.4 24.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 114.482 -1.236 . . . . 0.0 107.842 177.091 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.677 ' HB2' HG13 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -101.71 147.97 25.83 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-O 122.688 1.232 . . . . 0.0 112.448 174.454 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.07 93.98 9.13 Favored 'General case' 0 N--CA 1.407 -2.577 0 CA-C-N 113.431 -1.713 . . . . 0.0 106.382 165.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.5 ' CG ' ' H ' ' A' ' 43' ' ' GLY . 12.0 t70 -54.53 -163.79 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 111.441 -2.618 . . . . 0.0 112.778 -172.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.5 ' H ' ' CG ' ' A' ' 42' ' ' ASP . . . -58.1 -15.7 22.97 Favored Glycine 0 C--N 1.333 0.361 0 N-CA-C 111.981 -0.448 . . . . 0.0 111.981 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.5 t -58.98 -26.06 64.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 122.408 0.283 . . . . 0.0 110.357 173.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.8 t0 70.21 14.97 7.59 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-O 122.155 0.979 . . . . 0.0 109.243 174.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -159.89 152.49 21.22 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.737 -169.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -95.82 95.39 8.25 Favored 'General case' 0 N--CA 1.419 -2.009 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.217 173.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.618 ' OD1' ' HB2' ' A' ' 50' ' ' ASN . 5.1 p30 -82.97 22.61 0.92 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.498 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 51.19 65.88 1.35 Allowed 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.321 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.618 ' HB2' ' OD1' ' A' ' 48' ' ' ASN . 14.2 t30 -115.66 -61.75 1.69 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.874 -172.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.37 74.9 0.12 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -175.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.646 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 65.9 m-20 -117.34 83.91 2.06 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -175.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.97 HD13 ' HB ' ' A' ' 37' ' ' THR . 8.0 tp -119.38 149.93 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-O 121.446 0.641 . . . . 0.0 112.344 -171.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.918 HG22 ' HB ' ' A' ' 38' ' ' VAL . 8.5 tp -128.0 137.62 57.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 169.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.93 140.88 32.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.228 0.537 . . . . 0.0 111.773 -175.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.454 ' HA ' ' HB3' ' A' ' 72' ' ' PHE . . . -94.57 146.62 23.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.552 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.2 p -109.43 148.41 31.19 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.489 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -71.7 141.77 49.84 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -176.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.548 ' C ' ' HD2' ' A' ' 61' ' ' PRO . 23.0 t -114.95 -45.2 2.98 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.422 ' N ' ' HD2' ' A' ' 61' ' ' PRO . . . 116.6 -68.31 0.29 Allowed Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.924 -0.931 . . . . 0.0 114.594 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.548 ' HD2' ' C ' ' A' ' 59' ' ' SER . 13.9 Cg_exo -12.71 -42.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.384 1 C-N-CA 128.244 5.963 . . . . 0.0 120.362 -166.168 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.742 HG13 ' HB2' ' A' ' 69' ' ' TYR . 7.2 mt -71.08 88.34 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 119.353 0.979 . . . . 0.0 110.441 -177.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.6 t -114.32 163.56 15.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.494 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.13 21.66 78.77 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.6 m -155.68 174.16 15.68 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -92.32 32.38 1.19 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.068 0.461 . . . . 0.0 110.372 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.551 ' HE1' ' HB3' ' A' ' 4' ' ' PRO . 6.4 m-85 -129.76 -179.33 5.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.207 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -153.4 151.77 30.29 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.303 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.742 ' HB2' HG13 ' A' ' 62' ' ' ILE . 3.2 t80 -104.54 128.93 52.63 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -174.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.601 ' CZ2' ' HE2' ' A' ' 34' ' ' LYS . 15.6 m0 -124.38 151.21 44.68 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 24' ' ' LYS . 7.7 p -129.94 147.3 51.68 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 -178.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.454 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -160.79 142.35 12.12 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.549 177.621 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 42.1 m -124.85 146.49 49.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.375 176.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.619 ' HB2' ' HG ' ' A' ' 22' ' ' SER . . . -138.15 112.99 9.03 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -174.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.9 t -78.5 100.47 6.9 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 169.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.635 ' O ' ' HB3' ' A' ' 19' ' ' SER . 30.0 m -103.83 156.44 5.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.397 -177.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.733 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -102.9 -7.42 21.53 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.551 174.67 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 172.6 142.09 3.67 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.615 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.677 HG13 ' HB2' ' A' ' 40' ' ' TYR . 6.0 tt -160.26 142.14 4.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 177.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -121.87 -46.79 2.21 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.594 -174.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 9.8 pt-20 -152.51 162.22 41.5 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -176.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.59 ' HB2' ' O ' ' A' ' 39' ' ' VAL . 42.5 p90 -170.79 173.62 5.21 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.7 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.409 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.1 OUTLIER -155.69 153.78 30.51 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 172.524 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.5 mt -92.6 151.91 3.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.562 0.696 . . . . 0.0 112.219 -170.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 18.8 mmtp -107.46 114.09 27.87 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.341 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.804 ' HD2' ' HD2' ' A' ' 93' ' ' TYR . 14.9 t80 -91.59 101.29 13.93 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 174.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.498 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 23.2 tt0 -105.83 111.17 23.73 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.47 0.652 . . . . 0.0 109.693 -172.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.551 ' C ' ' H ' ' A' ' 90' ' ' GLY . 14.6 t -108.94 159.84 8.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.211 -176.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.9 t -79.3 33.67 0.24 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 122.002 0.906 . . . . 0.0 109.046 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.551 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -164.23 -47.43 0.02 OUTLIER Glycine 0 N--CA 1.436 -1.338 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.805 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.533 ' H ' ' HB ' ' A' ' 88' ' ' VAL . 30.5 mmmt -127.0 -173.87 3.0 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.926 0.869 . . . . 0.0 112.284 -176.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 86' ' ' TYR . 6.9 m -150.79 140.79 22.02 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.167 175.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.804 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 48.5 m-85 -144.43 -166.07 2.29 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -144.26 160.32 41.19 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.75 0.31 . . . . 0.0 111.029 -174.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -126.24 115.93 20.5 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 162.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -146.95 -66.89 0.27 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.039 -170.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 155.53 -56.91 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -173.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 50.0 t30 176.14 -48.95 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 112.871 -1.968 . . . . 0.0 106.614 176.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.6 t -170.84 64.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.586 170.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -126.38 -44.85 1.69 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.49 -173.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 91.1 m-20 70.9 144.63 0.06 Allowed 'General case' 0 N--CA 1.471 0.602 0 O-C-N 123.677 0.61 . . . . 0.0 110.597 -175.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 98.3 m-85 -79.95 111.27 16.12 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.759 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.583 ' N ' HE21 ' A' ' 103' ' ' GLN . 0.0 OUTLIER -79.87 110.69 15.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.094 178.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.482 HG22 HD11 ' A' ' 79' ' ' ILE . 25.3 t -79.76 142.12 14.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.205 -177.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.8 t -90.96 106.3 18.42 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -176.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.667 -0.683 . . . . 0.0 110.87 -174.94 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 121.026 0.441 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.7 p -97.91 130.33 44.79 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.069 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.622 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 38.7 mm -62.4 -48.85 86.12 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.338 174.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.622 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 51.2 Cg_exo -55.83 140.23 84.91 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.195 1.93 . . . . 0.0 112.231 175.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.9 t -130.69 -67.21 0.73 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.328 -0.397 . . . . 0.0 109.999 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.7 t -88.57 -68.96 0.73 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.231 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.49 -159.05 0.93 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.57 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.1 m -62.98 -32.68 74.07 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.553 0.692 . . . . 0.0 109.622 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.853 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.3 p -115.95 150.42 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.574 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.444 ' O ' ' HB3' ' A' ' 26' ' ' TYR . 9.3 tt0 -145.66 125.24 13.25 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.988 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.4 tp -68.18 131.66 45.79 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.209 0.528 . . . . 0.0 110.856 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -81.14 -61.83 1.84 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.853 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.6 p -175.95 160.03 2.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.938 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -152.04 161.39 42.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.808 177.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -129.29 165.3 21.7 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.734 0.302 . . . . 0.0 110.681 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.599 ' HD1' ' HD1' ' A' ' 21' ' ' PHE . 51.7 t80 -145.6 153.08 40.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.142 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -177.63 129.23 0.15 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.12 -102.56 0.36 Allowed Glycine 0 C--N 1.331 0.275 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -173.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.2 m -136.83 85.66 2.15 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 163.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 6.5 m -144.8 131.05 19.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.354 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.599 ' HD1' ' HD1' ' A' ' 16' ' ' TYR . 1.4 t80 -133.44 102.47 5.54 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.689 0.757 . . . . 0.0 109.302 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.6 m -134.65 160.08 39.23 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.809 -174.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.28 -143.32 8.66 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.447 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -162.56 159.96 25.39 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.093 0.473 . . . . 0.0 110.966 178.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.45 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 20.9 mt -122.25 155.53 27.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.179 -173.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.444 ' HB3' ' O ' ' A' ' 10' ' ' GLN . 7.5 t80 -129.05 101.56 6.1 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -172.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.853 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 2.0 m -135.35 145.65 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 O-C-N 121.493 -0.754 . . . . 0.0 112.52 -171.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 67' ' ' TYR . 40.1 ttmt -68.43 133.41 48.6 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.186 177.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.517 ' HB3' ' HB2' ' A' ' 68' ' ' GLU . 24.1 p-10 -95.18 84.51 4.09 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.752 0.787 . . . . 0.0 110.544 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.5 mp -63.72 -47.74 89.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 175.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.44 -176.12 2.83 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.697 171.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -109.99 -55.82 2.4 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.465 -177.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.8 m -75.8 73.58 2.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.379 0.609 . . . . 0.0 110.43 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.582 ' HZ1' ' CD ' ' A' ' 68' ' ' GLU . 28.9 mtmm -102.75 -171.63 1.99 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.761 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -151.63 144.4 24.37 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.9 t -125.53 120.24 57.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.524 0.678 . . . . 0.0 110.552 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.628 ' HB ' HG13 ' A' ' 53' ' ' ILE . 2.1 p -116.17 110.34 18.69 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.261 -176.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 1.058 ' HB ' HG22 ' A' ' 54' ' ' ILE . 81.0 t -83.28 108.35 15.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.78 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.579 HG12 ' HB ' ' A' ' 53' ' ' ILE . 26.5 m -108.77 121.19 61.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.226 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.423 ' HB2' HG13 ' A' ' 79' ' ' ILE . 7.6 p90 -118.39 148.59 42.37 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.631 0.729 . . . . 0.0 111.7 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.516 ' HB2' ' HG2' ' A' ' 81' ' ' GLU . . . -81.59 83.87 6.92 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 171.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -48.59 -166.47 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 111.337 -2.665 . . . . 0.0 113.932 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.2 -21.17 46.07 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-N 116.259 -0.428 . . . . 0.0 113.062 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -65.91 -19.86 66.02 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.654 -0.321 . . . . 0.0 110.526 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.2 t70 72.85 21.98 3.21 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.444 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -168.3 148.96 4.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.493 -175.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.437 ' CZ3' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -87.81 83.74 7.1 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 173.654 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.574 ' C ' ' H ' ' A' ' 50' ' ' ASN . 6.4 t-20 -78.11 55.49 1.49 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.2 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.0 t30 69.04 -26.77 0.15 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.204 0.601 . . . . 0.0 110.865 -176.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.574 ' H ' ' C ' ' A' ' 48' ' ' ASN . 4.6 p30 -62.14 -43.17 99.43 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.374 174.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 49.97 62.5 4.92 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -176.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 28.8 m-80 -41.78 106.76 0.06 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.882 0.873 . . . . 0.0 111.982 -174.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.652 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -117.3 138.48 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.833 0.825 . . . . 0.0 112.658 -171.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 1.058 HG22 ' HB ' ' A' ' 38' ' ' VAL . 5.2 tp -111.37 133.99 55.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 168.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.61 113.24 22.34 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.263 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.84 154.47 29.79 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -130.48 130.83 44.71 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.699 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 38.0 p90 -78.27 137.66 38.21 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.902 0.858 . . . . 0.0 111.013 -178.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.9 t -87.1 -26.77 23.49 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.276 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.88 168.91 18.87 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.508 172.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 68' ' ' GLU . 26.1 Cg_exo -63.39 141.87 83.01 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.676 2.251 . . . . 0.0 111.42 174.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.475 HG12 ' HB2' ' A' ' 69' ' ' TYR . 21.8 mt -84.62 109.25 17.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.337 -177.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.6 m -63.11 126.18 26.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.869 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.34 -7.28 34.58 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.166 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.7 m -151.26 165.47 33.9 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -92.71 52.58 1.89 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.953 0.882 . . . . 0.0 109.124 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 4.0 m-85 -130.21 169.24 15.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.536 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.582 ' CD ' ' HZ1' ' A' ' 34' ' ' LYS . 9.0 tt0 -125.2 171.54 10.25 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.585 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.475 ' HB2' HG12 ' A' ' 62' ' ' ILE . 3.1 t80 -138.86 111.15 7.43 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -163.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.699 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 11.8 m95 -112.57 130.47 56.01 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.985 -168.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 p -120.26 144.27 47.86 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -155.34 155.9 34.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.848 0.832 . . . . 0.0 112.549 177.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.6 p -142.51 142.46 32.26 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.011 174.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.68 138.76 18.22 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -175.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 31.3 t -90.58 101.23 13.97 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 166.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.406 HG11 ' CB ' ' A' ' 21' ' ' PHE . 32.0 m -89.66 160.48 2.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.42 -171.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.514 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -90.37 29.72 1.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.638 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.29 146.23 13.35 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -170.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.651 HG12 HG22 ' A' ' 104' ' ' VAL . 2.8 tt -143.28 126.81 13.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.775 0.798 . . . . 0.0 111.409 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 103' ' ' GLN . 28.0 mmtp -93.5 -41.45 9.77 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.22 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 13.8 pt-20 -160.68 168.27 25.22 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.408 ' HB3' HD13 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -169.39 172.76 6.95 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.657 178.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.47 ' HD2' ' HB3' ' A' ' 96' ' ' ASN . 0.1 OUTLIER -164.72 150.04 9.89 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.573 -1.194 . . . . 0.0 107.854 175.116 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.693 HD12 HG21 ' A' ' 38' ' ' VAL . 9.6 mm -93.3 136.29 25.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.017 -172.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.816 ' HD2' ' HE1' ' A' ' 94' ' ' TYR . 15.6 mmmt -94.4 104.95 16.92 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.605 ' CD2' ' HD2' ' A' ' 93' ' ' TYR . 23.9 t80 -86.76 102.14 13.98 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.338 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -114.42 123.15 48.73 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.638 0.732 . . . . 0.0 109.952 -173.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.538 ' C ' ' H ' ' A' ' 90' ' ' GLY . 9.4 t -112.76 163.79 9.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 t -72.25 20.79 0.06 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.197 0.523 . . . . 0.0 111.082 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.538 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -162.85 -40.88 0.02 OUTLIER Glycine 0 N--CA 1.438 -1.232 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.891 178.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -117.35 167.6 11.1 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -174.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.1 m -146.05 145.5 30.6 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.605 ' HD2' ' CD2' ' A' ' 86' ' ' TYR . 60.9 m-85 -142.58 -168.28 2.71 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 175.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.816 ' HE1' ' HD2' ' A' ' 85' ' ' LYS . 21.5 m-85 -146.42 140.39 26.26 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.551 -173.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.425 ' HB2' HG23 ' A' ' 9' ' ' VAL . 24.2 t70 -110.12 96.24 6.1 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.55 ' O ' ' HB2' ' A' ' 97' ' ' ASN . 27.0 p-10 -137.55 39.17 2.44 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.763 -174.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.55 ' HB2' ' O ' ' A' ' 96' ' ' ASN . 21.8 m-80 70.95 -62.88 0.44 Allowed 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.737 0.648 . . . . 0.0 109.907 -169.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -177.67 -55.78 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 52.8 m -157.02 59.58 0.52 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.448 170.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.611 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -137.86 -49.16 0.57 Allowed 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -170.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.611 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 12.9 m-20 74.14 143.22 0.07 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -169.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.655 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 3.4 m-85 -91.46 97.29 10.98 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -76.95 110.82 11.88 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.651 HG22 HG12 ' A' ' 79' ' ' ILE . 22.0 t -79.71 148.84 5.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.742 -167.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.5 m -86.85 81.35 8.18 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.211 176.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.509 HG21 ' CZ ' ' A' ' 16' ' ' TYR . 0.6 OUTLIER . . . . . 0 C--O 1.254 1.302 0 CA-C-O 118.495 -0.764 . . . . 0.0 111.13 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.757 0.313 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.9 m -112.03 141.95 45.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.155 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.811 HD11 ' HH ' ' A' ' 67' ' ' TYR . 43.6 mt -49.46 129.33 18.35 Favored Pre-proline 0 N--CA 1.466 0.338 0 O-C-N 123.495 0.497 . . . . 0.0 111.207 177.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.12 133.3 52.19 Favored 'Trans proline' 0 C--O 1.237 0.458 0 C-N-CA 122.866 2.377 . . . . 0.0 111.886 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.5 t -95.67 -64.03 1.1 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.643 -174.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.0 t -81.95 -49.74 9.94 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.44 151.33 46.61 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.224 178.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.425 ' HB3' HD13 ' A' ' 30' ' ' ILE . 17.0 m -93.36 -7.79 43.75 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.649 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.726 HG21 HG11 ' A' ' 27' ' ' VAL . 1.7 p -148.44 151.74 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.321 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -142.96 151.67 41.16 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.453 ' HG ' ' N ' ' A' ' 12' ' ' ASP . 2.5 tp -77.37 142.59 39.24 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.453 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 31.7 t70 -93.1 -64.54 1.08 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 175.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.881 ' HB2' ' HE3' ' A' ' 24' ' ' LYS . 41.4 m -166.75 155.54 10.48 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.259 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.475 ' CZ ' ' HZ ' ' A' ' 82' ' ' PHE . 18.6 p90 -157.17 150.97 24.44 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.635 177.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -130.33 157.54 42.26 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.656 ' HA ' ' O ' ' A' ' 20' ' ' THR . 4.3 m-85 -137.53 153.78 49.94 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.702 -175.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -137.98 75.84 1.55 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.52 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.76 -84.29 0.67 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -171.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.421 ' HB3' HG22 ' A' ' 76' ' ' VAL . 33.1 m -132.41 86.01 2.29 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.57 0.7 . . . . 0.0 109.414 163.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.656 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 26.1 m -146.79 126.02 13.01 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 170.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.775 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 36.7 t80 -107.2 133.48 51.72 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.436 0.636 . . . . 0.0 110.078 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.2 p -153.65 151.26 29.48 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.832 173.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.406 ' C ' ' HD3' ' A' ' 24' ' ' LYS . . . 159.08 -151.33 22.23 Favored Glycine 0 CA--C 1.506 -0.522 0 C-N-CA 119.09 -1.528 . . . . 0.0 113.391 -178.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.881 ' HE3' ' HB2' ' A' ' 13' ' ' SER . 0.2 OUTLIER -166.34 168.83 14.68 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.745 0.418 . . . . 0.0 110.409 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.504 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 17.0 mt -131.61 160.76 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.732 -172.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.476 ' N ' HG21 ' A' ' 25' ' ' ILE . 4.0 t80 -130.59 98.56 4.7 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.349 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.726 HG11 HG21 ' A' ' 9' ' ' VAL . 0.7 OUTLIER -118.56 156.7 20.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.956 -176.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -94.72 141.68 28.34 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.424 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.666 HD22 ' HB2' ' A' ' 68' ' ' GLU . 46.1 m-80 -89.79 101.02 13.72 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.823 0.344 . . . . 0.0 111.561 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.535 HD11 ' HE2' ' A' ' 86' ' ' TYR . 4.1 mp -88.64 -34.5 7.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 173.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.95 -178.96 5.68 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.874 174.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -109.86 -15.52 14.08 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.474 -173.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.8 m -100.0 85.55 3.07 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.407 ' HZ2' ' CD ' ' A' ' 68' ' ' GLU . 17.4 mtmt -110.36 153.61 24.69 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.721 -174.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.589 ' CG ' ' HB3' ' A' ' 87' ' ' GLU . 18.4 ptpt -130.84 129.52 42.44 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 166.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.5 t -119.55 115.75 48.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-O 121.74 0.781 . . . . 0.0 109.604 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.727 ' HG1' ' HB2' ' A' ' 85' ' ' LYS . 11.0 p -131.91 114.0 14.13 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.449 -170.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.726 ' HB ' HG22 ' A' ' 54' ' ' ILE . 54.6 t -79.66 125.43 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.9 m -122.06 120.89 62.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.894 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.626 ' HB3' ' HB3' ' A' ' 82' ' ' PHE . 9.9 p90 -125.97 148.29 49.29 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.399 -171.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.474 ' HB1' ' CZ2' ' A' ' 47' ' ' TRP . . . -72.18 97.56 1.98 Allowed 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 170.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.48 ' HA ' ' HE1' ' A' ' 40' ' ' TYR . 0.9 OUTLIER -48.84 -178.55 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.469 -1.696 . . . . 0.0 112.119 171.232 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.36 -22.89 52.35 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.956 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.1 t -85.94 -15.76 40.59 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 122.274 0.23 . . . . 0.0 111.441 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 68.42 30.25 5.43 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.535 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -106.7 99.09 8.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.335 -173.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.474 ' CZ2' ' HB1' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -90.92 110.64 21.88 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 168.835 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -66.8 -139.84 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 170.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -55.3 -45.83 76.25 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 158.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -138.08 -59.06 0.65 Allowed 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 113.343 -1.753 . . . . 0.0 108.435 159.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.27 -50.88 4.4 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.158 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.39 105.57 9.93 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.348 0.594 . . . . 0.0 110.729 -177.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.723 HG13 ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -138.4 141.72 36.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.886 -174.062 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.726 HG22 ' HB ' ' A' ' 38' ' ' VAL . 9.4 tp -115.43 118.37 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.24 136.16 37.72 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.529 -177.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.474 ' HA ' ' CE1' ' A' ' 72' ' ' PHE . . . -78.02 150.93 33.77 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.653 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -108.07 131.54 54.49 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -70.9 137.92 49.7 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.265 0.555 . . . . 0.0 110.377 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.2 t -106.57 -43.18 4.8 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 146.49 165.42 11.57 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.5 173.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.5 135.69 62.6 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.217 1.944 . . . . 0.0 110.795 175.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.53 HD11 ' HB2' ' A' ' 67' ' ' TYR . 55.5 mt -68.29 108.86 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.8 m -52.46 117.78 3.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.224 -171.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.65 2.58 49.9 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.423 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.575 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 63.6 m -146.84 170.75 16.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.226 0.536 . . . . 0.0 111.318 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -96.12 19.79 11.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.344 1.069 . . . . 0.0 109.459 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.811 ' HH ' HD11 ' A' ' 3' ' ' ILE . 14.2 m-85 -100.24 157.22 16.75 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.402 178.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.666 ' HB2' HD22 ' A' ' 29' ' ' ASN . 13.2 tt0 -126.03 168.64 13.68 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.571 -175.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -130.11 125.69 35.75 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -167.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.553 ' NE1' HG13 ' A' ' 27' ' ' VAL . 5.9 m95 -127.59 126.43 42.07 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -172.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 p -110.49 152.43 26.36 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 117.909 0.322 . . . . 0.0 111.825 -172.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.548 ' HZ ' HG22 ' A' ' 38' ' ' VAL . 10.5 m-85 -128.52 152.84 47.81 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 -175.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.7 m -163.18 121.84 2.05 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 111.525 -2.58 . . . . 0.0 107.381 165.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.775 ' HB1' ' HB3' ' A' ' 21' ' ' PHE . . . -149.2 132.54 16.54 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.679 -167.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.8 t -98.56 99.25 10.37 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 169.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.469 HG11 ' HB2' ' A' ' 21' ' ' PHE . 19.2 m -89.82 144.35 9.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.211 0.529 . . . . 0.0 110.809 -172.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -89.19 32.45 0.83 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.835 -173.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.66 142.13 12.87 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -176.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.468 HG12 HG22 ' A' ' 104' ' ' VAL . 7.8 tt -153.68 144.13 14.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.379 0.609 . . . . 0.0 111.693 -175.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -104.64 -53.5 2.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.109 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.716 ' HB2' ' HA ' ' A' ' 102' ' ' TYR . 12.8 pt-20 -156.54 161.37 39.99 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.448 -175.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.922 ' HE1' ' HA ' ' A' ' 101' ' ' ASN . 0.1 OUTLIER -145.15 168.0 21.41 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 119.362 0.983 . . . . 0.0 112.594 177.517 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.483 ' HB3' ' HE1' ' A' ' 102' ' ' TYR . 0.3 OUTLIER -152.23 158.42 42.81 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 165.073 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.447 HD12 HG23 ' A' ' 38' ' ' VAL . 5.1 mm -101.12 145.58 11.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 119.359 -0.936 . . . . 0.0 112.194 -165.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.727 ' HB2' ' HG1' ' A' ' 37' ' ' THR . 13.9 mmmt -102.93 108.38 19.54 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.223 -178.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.535 ' HE2' HD11 ' A' ' 30' ' ' ILE . 13.4 t80 -99.34 99.75 10.73 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 173.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.589 ' HB3' ' CG ' ' A' ' 35' ' ' LYS . 28.5 tt0 -116.51 131.04 57.05 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.962 -175.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.443 HG13 ' H ' ' A' ' 89' ' ' SER . 2.8 t -121.37 165.59 16.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.007 -171.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.443 ' H ' HG13 ' A' ' 88' ' ' VAL . 1.5 p -46.99 -37.43 9.11 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -126.83 -18.34 2.16 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.514 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.404 ' HG3' ' N ' ' A' ' 92' ' ' THR . 13.1 tppt? -118.52 167.11 11.91 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 117.488 0.644 . . . . 0.0 110.465 -174.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.404 ' N ' ' HG3' ' A' ' 91' ' ' LYS . 10.4 m -148.76 145.88 27.8 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 172.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.516 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 37.5 m-85 -136.19 -177.85 4.89 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 174.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -150.4 126.97 10.85 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.625 -173.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -131.29 143.92 50.89 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.099 0.475 . . . . 0.0 111.038 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -127.34 10.54 6.8 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 62.89 -75.16 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.902 -173.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.0 t30 173.38 -62.15 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.6 m -139.6 19.77 2.53 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.192 173.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.44 -36.2 15.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.644 0.735 . . . . 0.0 109.617 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.922 ' HA ' ' HE1' ' A' ' 82' ' ' PHE . 15.6 m120 -91.66 178.81 5.82 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.248 173.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.716 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 2.6 m-85 73.02 -111.48 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 124.495 1.122 . . . . 0.0 110.614 -173.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.26 106.79 0.26 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.03 0.919 . . . . 0.0 112.471 -171.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.468 HG22 HG12 ' A' ' 79' ' ' ILE . 97.4 t -79.95 114.05 20.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.016 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.4 m -92.01 104.67 17.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.439 HG21 HG13 ' A' ' 104' ' ' VAL . 9.6 t . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.688 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.7 m -98.79 113.8 26.06 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.741 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 34.6 mm -78.87 -53.52 1.16 Allowed Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.707 -175.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.741 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 11.5 Cg_endo -90.93 141.0 2.96 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.265 1.977 . . . . 0.0 112.504 175.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.1 t -150.69 -71.41 0.17 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.885 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.6 m -124.61 -44.82 1.95 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.081 0.467 . . . . 0.0 110.538 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.5 136.25 33.02 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.477 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.7 m -81.85 -16.94 49.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.832 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.661 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.7 p -144.91 149.81 16.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.704 -176.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -143.36 131.29 21.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.024 177.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.795 HD12 HD13 ' A' ' 84' ' ' ILE . 51.4 tp -69.55 132.54 46.42 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.393 0.616 . . . . 0.0 110.216 175.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -80.24 -61.04 2.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.38 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.1 p -177.58 162.24 1.79 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.202 -174.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.497 ' CD2' HD21 ' A' ' 11' ' ' LEU . 47.7 p90 -158.16 163.41 37.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.849 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -148.73 162.03 40.59 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.217 0.532 . . . . 0.0 110.254 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.583 ' HD1' ' HD1' ' A' ' 21' ' ' PHE . 30.2 t80 -124.59 142.9 51.02 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.736 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -161.2 124.12 3.18 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.64 -103.96 0.43 Allowed Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -169.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.1 t -137.75 82.65 1.93 Allowed 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 163.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 56.7 m -148.04 140.67 24.57 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.377 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.583 ' HD1' ' HD1' ' A' ' 16' ' ' TYR . 2.5 t80 -128.16 108.18 10.41 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.979 0.895 . . . . 0.0 109.302 176.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.0 p -137.2 148.76 46.75 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.918 -173.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.8 -144.61 5.54 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.874 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.42 ' HB3' HG22 ' A' ' 71' ' ' THR . 5.0 ptmm? -164.71 168.24 18.18 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.981 0.42 . . . . 0.0 111.014 -177.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.729 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 8.3 mt -138.58 158.17 30.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.87 -167.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -133.02 97.18 3.94 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.338 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.661 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 1.5 m -136.16 149.33 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 O-C-N 121.499 -0.75 . . . . 0.0 112.135 -172.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.654 ' HB3' ' HZ2' ' A' ' 28' ' ' LYS . 6.7 ttpm? -99.53 133.49 43.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.888 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -87.88 119.9 28.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.0 0.429 . . . . 0.0 111.775 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.518 HG12 ' OH ' ' A' ' 86' ' ' TYR . 32.8 mm -63.66 -45.25 97.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 122.199 0.999 . . . . 0.0 108.634 173.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.653 ' HB3' ' HZ3' ' A' ' 34' ' ' LYS . . . -137.48 143.87 41.96 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 172.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.41 ' HE1' ' OE1' ' A' ' 68' ' ' GLU . 40.6 t80 -60.16 -42.62 95.33 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -164.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.9 m -80.07 69.44 6.46 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.649 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 1.041 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -87.0 -175.4 5.34 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.077 0.465 . . . . 0.0 110.97 176.77 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.859 ' HG3' ' HB3' ' A' ' 87' ' ' GLU . 18.7 ptmt -148.32 126.55 12.19 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.405 HG23 ' CZ3' ' A' ' 70' ' ' TRP . 58.3 t -119.71 121.41 66.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-O 121.655 0.741 . . . . 0.0 110.983 -171.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.695 ' HG1' ' HB2' ' A' ' 85' ' ' LYS . 72.4 p -128.15 117.78 22.2 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.754 -172.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.944 ' HB ' HG22 ' A' ' 54' ' ' ILE . 16.5 t -82.91 129.14 37.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.14 176.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.3 m -122.35 125.01 72.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.393 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.464 ' HB2' HG13 ' A' ' 79' ' ' ILE . 2.0 p90 -115.77 149.99 37.61 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.357 0.598 . . . . 0.0 112.038 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.634 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . . . -80.45 62.1 4.43 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.056 175.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.738 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 6.6 t70 34.88 -139.51 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 O-C-N 126.357 2.286 . . . . 0.0 111.095 173.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.34 1.26 31.05 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 168.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.517 ' O ' ' HB3' ' A' ' 45' ' ' ASP . 34.4 t -103.55 -17.33 15.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.026 -0.587 . . . . 0.0 112.568 -170.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.549 ' OD1' ' HG3' ' A' ' 81' ' ' GLU . 25.4 t70 77.22 55.96 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -173.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -158.7 141.58 14.54 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.522 -1.217 . . . . 0.0 108.952 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.5 ' CZ2' ' HB1' ' A' ' 41' ' ' ALA . 5.0 m95 -106.39 81.47 1.61 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.268 1.033 . . . . 0.0 109.041 -178.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -88.8 153.67 20.88 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.81 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -74.48 48.79 0.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.596 0.712 . . . . 0.0 110.548 176.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.53 ' HB3' ' OD1' ' A' ' 52' ' ' ASN . 26.7 t30 -86.48 -21.03 27.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.63 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.13 44.89 1.54 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -171.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.53 ' OD1' ' HB3' ' A' ' 50' ' ' ASN . 10.0 m-20 -89.98 40.05 0.99 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.939 -0.63 . . . . 0.0 110.736 -171.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -126.25 144.62 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.53 -176.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.944 HG22 ' HB ' ' A' ' 38' ' ' VAL . 6.6 tp -128.53 136.15 60.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 174.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.27 132.0 34.67 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.638 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.87 161.59 14.43 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.517 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.8 t -130.63 138.32 50.04 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.637 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 33.7 p90 -90.89 143.66 26.49 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.068 0.461 . . . . 0.0 110.18 176.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.5 m -94.86 -22.73 17.83 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.423 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 157.01 173.29 25.25 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.972 173.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -68.13 147.29 72.8 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.564 2.176 . . . . 0.0 111.31 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.494 HG12 ' HB2' ' A' ' 69' ' ' TYR . 28.9 mt -85.28 95.9 4.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.3 m -57.14 127.93 34.43 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.214 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.82 6.8 60.39 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.605 -177.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.0 m -148.8 173.17 13.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.716 0.293 . . . . 0.0 110.222 178.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -94.79 4.24 54.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.277 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.668 ' HH ' ' HA ' ' A' ' 4' ' ' PRO . 3.8 m-85 -108.7 167.44 10.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.667 0.746 . . . . 0.0 111.838 -172.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.423 ' HG3' ' H ' ' A' ' 69' ' ' TYR . 1.7 tt0 -108.85 169.94 8.36 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.447 -1.252 . . . . 0.0 108.883 175.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.494 ' HB2' HG12 ' A' ' 62' ' ' ILE . 1.1 t80 -128.37 111.04 12.91 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -164.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.729 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 9.0 m95 -114.68 145.81 41.61 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.537 -168.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.42 HG22 ' HB3' ' A' ' 24' ' ' LYS . 10.4 p -138.3 134.86 34.84 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -137.03 147.4 46.17 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.824 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.5 p -126.23 142.96 51.32 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.921 175.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.663 ' HB3' HG12 ' A' ' 54' ' ' ILE . . . -150.67 114.22 4.93 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.086 0.469 . . . . 0.0 110.939 -174.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.5 t -78.28 99.78 6.43 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 171.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.9 m -101.89 149.29 6.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.296 -173.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -75.34 -21.9 58.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.916 0.865 . . . . 0.0 108.817 173.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.12 172.93 28.0 Favored Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 114.086 -1.415 . . . . 0.0 109.617 -175.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.738 ' HA ' ' O ' ' A' ' 42' ' ' ASP . 3.8 tt -169.92 125.79 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.849 0.833 . . . . 0.0 110.967 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -97.99 -56.74 2.4 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.698 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.634 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 11.7 mm-40 -131.15 170.29 14.75 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.567 ' CE2' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -173.43 158.61 3.53 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 119.271 0.941 . . . . 0.0 111.669 -179.5 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.714 ' HB3' ' HB3' ' A' ' 96' ' ' ASN . 1.5 p90 -159.91 158.04 30.08 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 168.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.795 HD13 HD12 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -94.79 142.75 13.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.505 -172.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.695 ' HB2' ' HG1' ' A' ' 37' ' ' THR . 16.7 mtmt -96.81 123.38 40.49 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.138 172.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.518 ' OH ' HG12 ' A' ' 30' ' ' ILE . 18.6 t80 -93.96 100.76 12.85 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 170.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.859 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . 6.7 tp10 -103.65 130.9 51.19 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.451 0.643 . . . . 0.0 109.282 -172.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 1.013 HG12 ' HE2' ' A' ' 34' ' ' LYS . 21.8 t -127.19 163.18 30.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.581 -173.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.42 26.77 0.08 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.32 0.648 . . . . 0.0 111.111 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -170.69 -37.36 0.03 OUTLIER Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.595 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.494 ' HG3' ' N ' ' A' ' 92' ' ' THR . 26.8 tptp -127.85 168.29 15.38 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -173.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.494 ' N ' ' HG3' ' A' ' 91' ' ' LYS . 4.0 m -138.06 146.36 42.87 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 172.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.516 ' HD1' ' HD2' ' A' ' 86' ' ' TYR . 33.3 m-85 -137.22 -174.36 3.72 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 171.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -149.22 141.57 24.18 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.062 -174.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -122.67 121.2 35.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.298 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.714 ' HB3' ' HB3' ' A' ' 83' ' ' TYR . 10.9 p30 -145.14 -103.21 0.11 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.925 177.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -113.5 -50.13 2.86 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 122.107 0.956 . . . . 0.0 108.723 -175.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -172.27 -48.56 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.2 p -160.73 47.52 0.23 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.748 172.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.79 -109.24 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.136 -174.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 174.84 142.1 0.05 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.793 -167.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.527 ' CE2' ' HA ' ' A' ' 96' ' ' ASN . 84.2 m-85 -78.39 142.31 37.71 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 173.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.22 125.0 53.67 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.7 0.762 . . . . 0.0 110.517 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.627 HG22 HG12 ' A' ' 79' ' ' ILE . 3.7 t -94.36 129.96 43.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.7 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.9 t -66.89 95.32 0.36 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.124 0.488 . . . . 0.0 110.626 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.128 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.763 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.1 p -69.87 134.19 48.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.09 0.471 . . . . 0.0 111.179 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.581 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 46.9 mm -70.6 -55.58 7.18 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.902 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.581 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 37.5 Cg_endo -73.56 135.21 21.66 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.656 1.571 . . . . 0.0 111.926 177.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.5 t -110.38 -85.93 0.54 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.666 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.0 m -96.58 -64.26 1.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.654 0.264 . . . . 0.0 110.639 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.48 -174.13 2.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.975 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 28' ' ' LYS . 26.1 m -76.52 -31.96 57.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.091 0.472 . . . . 0.0 110.362 177.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.886 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.2 p -114.68 150.65 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 121.352 0.596 . . . . 0.0 111.818 -173.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -143.05 141.25 31.26 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.667 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.401 ' HG ' ' N ' ' A' ' 12' ' ' ASP . 3.5 tp -69.43 140.39 54.1 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.021 0.438 . . . . 0.0 110.107 175.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.401 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 28.2 t70 -90.94 -67.86 0.83 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.579 172.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.7 m -167.18 157.82 11.53 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.868 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.428 ' CE2' ' HZ ' ' A' ' 82' ' ' PHE . 34.3 p90 -156.87 155.82 32.1 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.705 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -130.25 163.19 27.3 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.834 0.35 . . . . 0.0 111.084 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.517 ' HE2' HG23 ' A' ' 106' ' ' THR . 1.7 t80 -128.74 147.06 50.74 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -154.89 101.55 2.29 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -175.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.24 -96.69 0.14 Allowed Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 -168.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.486 ' HA ' ' CE1' ' A' ' 16' ' ' TYR . 10.4 t -136.2 89.51 2.48 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 158.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.1 m -144.38 139.64 28.56 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.501 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.557 ' HB2' HG11 ' A' ' 76' ' ' VAL . 17.8 t80 -108.58 129.27 55.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.8 p -151.39 123.7 8.3 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.074 0.464 . . . . 0.0 109.974 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' A' ' 14' ' ' TYR . . . -177.91 -157.93 19.73 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.262 -0.97 . . . . 0.0 112.155 -176.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.598 ' HB3' HG22 ' A' ' 71' ' ' THR . 21.2 pttm -159.81 162.3 34.74 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.215 0.531 . . . . 0.0 111.214 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.605 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 11.0 mt -124.67 159.5 30.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.573 -170.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -131.44 100.19 5.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -174.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.886 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 1.9 m -135.77 147.93 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.706 -169.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 79.0 tttt -79.55 131.32 35.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.029 177.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.612 HD21 ' HB2' ' A' ' 68' ' ' GLU . 7.3 p30 -91.17 122.61 33.95 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.294 0.569 . . . . 0.0 110.349 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.3 mm -76.76 -56.82 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.016 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.619 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . . . -107.34 -80.96 0.56 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.864 173.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -166.47 -73.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.666 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.422 ' C ' ' HD2' ' A' ' 34' ' ' LYS . 20.1 m -83.59 68.73 9.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.309 0.576 . . . . 0.0 110.691 -178.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.661 ' HG3' HG12 ' A' ' 88' ' ' VAL . 6.3 mmmt -94.97 172.51 8.1 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.831 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 89.7 mttt -101.19 129.36 47.1 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.765 -173.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 65.3 t -121.44 107.92 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-O 121.873 0.844 . . . . 0.0 109.288 171.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.724 HG22 HD13 ' A' ' 53' ' ' ILE . 3.1 p -120.3 116.03 24.74 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.552 -173.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.806 HG23 HD12 ' A' ' 84' ' ' ILE . 72.2 t -77.02 136.64 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.006 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.152 176.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.29 107.79 19.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.53 176.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.487 ' HA ' ' CB ' ' A' ' 82' ' ' PHE . 0.9 OUTLIER -111.71 137.17 49.97 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 122.58 1.181 . . . . 0.0 110.387 174.736 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.558 ' HB3' ' CE3' ' A' ' 47' ' ' TRP . . . -89.76 97.02 10.95 Favored 'General case' 0 N--CA 1.412 -2.371 0 CA-C-N 113.086 -1.87 . . . . 0.0 107.101 178.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.734 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 1.3 p30 -44.01 163.36 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 O-C-N 124.767 1.292 . . . . 0.0 112.541 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.39 -13.04 14.71 Favored Glycine 0 N--CA 1.464 0.537 0 CA-C-N 115.536 -0.756 . . . . 0.0 114.358 -167.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -110.47 -18.87 13.12 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.407 ' HB2' ' OD2' ' A' ' 42' ' ' ASP . 48.1 t0 -74.03 -92.47 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.084 -1.416 . . . . 0.0 112.278 -173.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 51.95 98.58 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -159.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.558 ' CE3' ' HB3' ' A' ' 41' ' ' ALA . 7.1 m-90 -42.7 113.13 0.43 Allowed 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 -152.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.481 ' ND2' ' HB2' ' A' ' 50' ' ' ASN . 9.0 p30 -84.03 31.98 0.49 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 113.364 -1.744 . . . . 0.0 108.484 161.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.402 ' H ' ' C ' ' A' ' 47' ' ' TRP . 66.5 t30 59.35 46.42 12.63 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 122.19 0.995 . . . . 0.0 108.449 -164.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.481 ' HB2' ' ND2' ' A' ' 48' ' ' ASN . 49.9 t30 -83.4 -57.59 3.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.647 -174.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.85 96.68 1.55 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.304 -0.951 . . . . 0.0 113.216 174.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 40' ' ' TYR . 86.8 m-20 -135.02 106.69 6.92 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.724 HD13 HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -117.91 144.45 25.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.381 0.61 . . . . 0.0 111.94 -172.06 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.582 ' CG2' ' HB ' ' A' ' 38' ' ' VAL . 8.1 tp -132.61 116.34 27.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.398 171.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.18 137.96 45.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.889 0.376 . . . . 0.0 111.425 -174.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.31 163.37 23.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.548 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.6 m -121.22 141.57 50.74 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -70.75 139.88 51.19 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.372 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.8 t -108.78 -39.13 5.44 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.45 154.77 7.14 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.545 173.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.36 136.13 49.62 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.198 1.932 . . . . 0.0 111.447 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 67.9 mt -80.59 91.92 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.8 p -60.65 120.92 10.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.642 -172.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 132.65 -34.53 2.47 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.515 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.2 m -134.9 172.53 12.86 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.65 39.15 0.46 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.956 0.407 . . . . 0.0 110.999 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.45 ' CZ ' ' HB2' ' A' ' 28' ' ' LYS . 3.9 m-85 -115.27 159.25 21.24 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.719 0.771 . . . . 0.0 111.369 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.612 ' HB2' HD21 ' A' ' 29' ' ' ASN . 11.2 tt0 -131.12 170.38 14.61 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.11 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.23 122.7 26.98 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -165.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.696 ' CD1' HG12 ' A' ' 27' ' ' VAL . 20.8 m95 -121.9 134.82 54.86 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.813 -169.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.598 HG22 ' HB3' ' A' ' 24' ' ' LYS . 18.0 p -138.21 150.63 46.92 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -173.3 164.1 4.65 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.451 0.643 . . . . 0.0 111.928 172.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.4 p -124.56 144.24 50.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.271 173.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' A' ' 21' ' ' PHE . . . -137.56 126.5 24.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.573 -174.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.5 t -81.98 99.41 9.1 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 170.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.557 HG11 ' HB2' ' A' ' 21' ' ' PHE . 21.0 m -92.35 154.28 3.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.884 -176.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -116.99 48.22 1.35 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.04 126.18 4.42 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.857 -174.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.713 HG12 HG22 ' A' ' 104' ' ' VAL . 4.8 tt -136.3 128.33 44.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.592 0.711 . . . . 0.0 111.034 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.734 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -83.82 -61.7 1.76 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.947 -175.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 16.1 mt-10 -150.83 176.17 11.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.13 -1.395 . . . . 0.0 107.994 -177.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.487 ' CB ' ' HA ' ' A' ' 40' ' ' TYR . 30.3 p90 -169.43 173.47 6.51 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 119.12 -1.032 . . . . 0.0 113.484 174.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.49 154.17 24.4 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.08 173.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.806 HD12 HG23 ' A' ' 38' ' ' VAL . 16.3 mm -99.2 151.82 4.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.435 ' HG3' ' HG1' ' A' ' 37' ' ' THR . 49.4 pttt -131.32 149.54 52.51 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 121.88 0.848 . . . . 0.0 110.413 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.681 ' HD2' ' HD1' ' A' ' 93' ' ' TYR . 21.8 t80 -114.63 108.36 16.72 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 113.78 -1.554 . . . . 0.0 109.675 -174.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.831 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 31.1 tt0 -105.8 116.78 32.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.173 0.511 . . . . 0.0 109.958 -175.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.661 HG12 ' HG3' ' A' ' 34' ' ' LYS . 1.3 t -123.29 166.28 18.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.994 -175.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.442 ' H ' HG13 ' A' ' 88' ' ' VAL . 1.5 m -48.15 -46.45 34.5 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.492 0.495 . . . . 0.0 111.553 -177.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -120.79 -9.22 7.69 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.305 -0.95 . . . . 0.0 113.749 -176.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.409 ' C ' ' HG1' ' A' ' 92' ' ' THR . 12.3 mmtm -128.11 173.81 9.77 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -177.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 86' ' ' TYR . 8.3 m -152.9 143.78 22.92 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 113.226 -1.807 . . . . 0.0 109.43 176.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.681 ' HD1' ' HD2' ' A' ' 86' ' ' TYR . 28.1 m-85 -144.01 -173.53 4.02 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -150.14 148.08 28.53 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.437 -174.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -118.18 90.24 3.29 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 169.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -131.14 31.05 4.47 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.957 -172.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 68.3 -59.84 0.43 Allowed 'General case' 0 CA--C 1.532 0.259 0 O-C-N 123.733 0.646 . . . . 0.0 110.535 -172.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -179.68 -53.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.4 t -172.69 69.24 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.191 -1.368 . . . . 0.0 107.518 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -147.64 -37.87 0.2 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.969 -170.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 78.3 m-20 70.05 149.08 0.08 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -171.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 95.9 m-85 -83.67 106.32 15.29 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 175.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -68.61 116.06 8.7 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.043 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.713 HG22 HG12 ' A' ' 79' ' ' ILE . 2.8 t -100.21 133.65 42.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.1 t -151.5 148.65 28.3 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.517 HG23 ' HE2' ' A' ' 16' ' ' TYR . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.572 -0.728 . . . . 0.0 110.331 177.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 120.407 0.146 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -62.53 156.7 22.31 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.857 0.36 . . . . 0.0 111.364 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.483 HG12 ' HH ' ' A' ' 26' ' ' TYR . 67.1 mt -83.61 121.81 76.49 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.442 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.77 145.0 79.74 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.709 2.273 . . . . 0.0 112.08 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.6 t -122.03 -28.32 4.43 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.301 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.9 p -70.23 -73.63 0.16 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.761 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.83 174.5 7.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.283 0.564 . . . . 0.0 111.567 -176.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.656 ' HB3' HD11 ' A' ' 30' ' ' ILE . 20.3 m -80.53 -15.53 56.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.07 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.715 HG21 HG11 ' A' ' 27' ' ' VAL . 2.2 p -140.7 151.42 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 120.758 0.313 . . . . 0.0 110.343 -178.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -145.16 128.87 17.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.242 -176.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.411 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 26.0 tp -69.8 137.22 51.66 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 172.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.59 -49.04 6.07 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.909 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.8 p 174.82 160.02 0.19 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 123.705 0.628 . . . . 0.0 111.744 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -156.33 159.67 39.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.726 177.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -151.89 164.22 37.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.618 0.247 . . . . 0.0 110.442 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.414 ' CZ ' ' HA ' ' A' ' 19' ' ' SER . 5.3 t80 -115.96 143.33 45.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.034 -174.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -144.17 101.67 3.75 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -175.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.4 -97.78 0.25 Allowed Glycine 0 C--N 1.333 0.368 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -170.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.414 ' HA ' ' CZ ' ' A' ' 16' ' ' TYR . 71.4 m -134.43 85.73 2.21 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 158.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.8 m -146.51 138.52 24.84 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.088 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.443 ' HB2' HG11 ' A' ' 76' ' ' VAL . 20.4 t80 -95.52 140.37 30.46 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 171.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 85.7 p -155.58 126.01 6.78 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 174.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.8 -161.85 29.94 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.159 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -160.05 162.75 34.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.835 0.35 . . . . 0.0 110.947 -176.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 25.9 mt -132.38 156.51 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.894 -172.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.483 ' HH ' HG12 ' A' ' 3' ' ' ILE . 2.4 t80 -126.14 115.83 20.4 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.715 HG11 HG21 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -128.67 149.73 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.022 179.288 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.486 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 92.9 mttt -80.26 152.14 29.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.498 174.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -94.74 85.02 4.33 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.773 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.656 HD11 ' HB3' ' A' ' 8' ' ' SER . 3.8 mm -64.51 -56.84 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.65 -150.7 0.47 Allowed 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 106.725 -1.584 . . . . 0.0 106.725 168.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.452 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 42.9 t80 -112.31 -56.89 2.34 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.514 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.2 t -65.4 111.45 3.06 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 123.301 0.376 . . . . 0.0 110.412 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.508 ' HB2' ' HH2' ' A' ' 70' ' ' TRP . 12.4 mmtp -112.62 167.61 10.33 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 121.121 0.486 . . . . 0.0 110.473 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.784 ' HB3' ' HZ1' ' A' ' 35' ' ' LYS . 0.6 OUTLIER -151.88 111.15 3.91 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 171.785 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.4 t -106.7 112.27 39.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-O 121.817 0.818 . . . . 0.0 110.435 -173.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.918 HG22 HD13 ' A' ' 53' ' ' ILE . 14.0 p -119.07 107.99 14.17 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.653 -172.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.684 ' O ' ' HA ' ' A' ' 53' ' ' ILE . 71.7 t -76.45 111.01 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.463 175.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.651 ' HB ' ' CZ2' ' A' ' 47' ' ' TRP . 0.0 OUTLIER -102.62 113.66 39.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.122 170.781 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.614 ' HA ' ' CB ' ' A' ' 82' ' ' PHE . 0.6 OUTLIER -108.24 145.14 34.73 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 122.075 0.941 . . . . 0.0 110.385 171.742 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.67 99.08 11.06 Favored 'General case' 0 N--CA 1.409 -2.498 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.368 169.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -40.27 165.2 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 112.893 -1.958 . . . . 0.0 112.875 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.445 ' HA2' ' HB2' ' A' ' 80' ' ' LYS . . . -62.22 2.18 1.17 Allowed Glycine 0 C--N 1.334 0.426 0 CA-C-N 114.956 -1.02 . . . . 0.0 114.656 -167.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.8 t -80.87 -22.7 39.62 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 116.954 0.377 . . . . 0.0 110.321 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.7 t70 77.52 43.85 0.1 Allowed 'General case' 0 C--N 1.351 0.641 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -142.64 146.47 34.51 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.351 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.651 ' CZ2' ' HB ' ' A' ' 39' ' ' VAL . 0.1 OUTLIER -122.16 120.66 34.87 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 119.399 -0.92 . . . . 0.0 112.438 173.177 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -90.93 16.02 10.28 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 169.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 67.03 4.02 3.4 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.354 -1.293 . . . . 0.0 111.6 -175.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.42 HD21 ' HA ' ' A' ' 50' ' ' ASN . 0.1 OUTLIER -168.8 179.34 4.22 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -171.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.11 27.48 64.13 Favored Glycine 0 CA--C 1.505 -0.536 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.093 178.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -166.57 56.67 0.09 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.263 0.554 . . . . 0.0 109.975 -175.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.918 HD13 HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -133.92 131.15 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-O 122.048 0.928 . . . . 0.0 109.643 -174.071 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.474 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 10.4 mm -110.92 129.76 65.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.982 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.11 96.35 7.77 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 118.263 -1.375 . . . . 0.0 108.255 167.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -47.63 153.88 0.53 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.76 170.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -115.55 131.71 56.85 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.716 -174.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -71.32 143.85 50.14 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.254 177.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.9 t -106.4 -37.51 6.49 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 145.82 173.68 17.3 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.356 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -53.86 134.58 59.8 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 123.037 2.491 . . . . 0.0 111.633 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 1.056 HG12 ' HB2' ' A' ' 69' ' ' TYR . 4.7 mt -83.92 119.07 32.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.695 -172.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.5 p -62.77 118.37 7.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.019 0.438 . . . . 0.0 110.251 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 117.46 -12.44 13.87 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -176.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.5 m -151.94 -179.53 7.55 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -112.11 30.21 7.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.652 0.739 . . . . 0.0 109.9 177.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.486 ' CD1' ' HA ' ' A' ' 28' ' ' LYS . 17.2 m-85 -105.0 -178.37 3.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.792 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.483 ' O ' HD12 ' A' ' 62' ' ' ILE . 15.6 tp10 -111.84 150.9 29.73 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.7 -171.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 1.056 ' HB2' HG12 ' A' ' 62' ' ' ILE . 8.7 t80 -125.2 116.52 22.13 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -165.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.577 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 12.7 m95 -108.68 133.43 52.77 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.469 -170.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.416 ' O ' ' HB3' ' A' ' 72' ' ' PHE . 22.5 p -139.76 148.53 42.39 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -176.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 71' ' ' THR . 3.3 p90 -174.02 151.67 1.78 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.913 0.863 . . . . 0.0 112.409 170.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.2 p -117.81 137.55 52.67 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.277 -1.329 . . . . 0.0 107.923 166.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.51 122.14 28.65 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.891 -168.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.71 99.45 1.33 Allowed 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 171.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 21' ' ' PHE . 28.6 m -103.3 150.24 6.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.659 -175.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.636 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -104.62 38.12 1.97 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.614 0.721 . . . . 0.0 109.65 175.47 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 112.71 149.82 10.8 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.054 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.554 HD11 HG22 ' A' ' 104' ' ' VAL . 9.7 tt -154.88 156.41 5.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.445 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 18.2 tptm -140.67 -47.4 0.42 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.953 0.406 . . . . 0.0 111.26 -176.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.438 ' O ' ' HB3' ' A' ' 82' ' ' PHE . 20.8 mt-10 -141.7 162.27 35.88 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -178.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.614 ' CB ' ' HA ' ' A' ' 40' ' ' TYR . 43.1 p90 -172.63 179.26 2.47 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 119.101 -1.039 . . . . 0.0 112.76 169.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.532 ' HB3' ' HB3' ' A' ' 96' ' ' ASN . 0.2 OUTLIER -160.94 143.15 12.43 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 113.519 -1.673 . . . . 0.0 108.38 171.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.573 HD12 HG21 ' A' ' 38' ' ' VAL . 14.2 mm -90.48 132.45 35.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.783 -177.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.495 ' HB2' ' OG1' ' A' ' 37' ' ' THR . 1.1 mtmp? -89.8 107.0 18.84 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.719 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.537 ' HB2' HG11 ' A' ' 9' ' ' VAL . 20.2 t80 -85.99 99.16 11.25 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.718 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . 7.9 tt0 -116.73 124.12 48.88 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.072 -174.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 23.1 t -104.6 162.62 4.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.8 t -59.09 -11.48 3.69 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -143.62 2.46 1.48 Allowed Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.834 177.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.8 tptt -141.65 163.6 32.48 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 117.823 0.811 . . . . 0.0 110.438 -176.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.8 m -144.73 142.89 30.39 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.163 0.506 . . . . 0.0 110.874 174.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.494 ' HD2' ' CD2' ' A' ' 86' ' ' TYR . 49.1 m-85 -141.35 -168.62 2.68 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -144.99 143.71 30.65 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.711 0.291 . . . . 0.0 111.246 -174.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.411 ' OD2' ' HB2' ' A' ' 11' ' ' LEU . 29.6 t70 -122.19 98.69 6.05 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 169.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.532 ' HB3' ' HB3' ' A' ' 83' ' ' TYR . 4.9 p30 -123.18 -45.25 2.12 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.754 -173.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.521 ' HB3' ' O ' ' A' ' 96' ' ' ASN . 26.4 p-10 166.23 -37.67 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 175.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 178.58 -44.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.4 t -174.09 38.95 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.286 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.26 -90.54 0.11 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 p30 178.77 158.7 0.55 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.845 0.355 . . . . 0.0 110.458 -171.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -90.52 100.65 13.45 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 169.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.471 ' H ' ' CD ' ' A' ' 103' ' ' GLN . 0.0 OUTLIER -81.06 107.52 13.94 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.513 0.673 . . . . 0.0 110.18 179.579 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.554 HG22 HD11 ' A' ' 79' ' ' ILE . 21.5 t -91.43 114.86 29.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.963 -178.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 21.8 m -69.72 102.54 1.92 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.698 -0.668 . . . . 0.0 110.876 -177.592 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.1 m -60.11 148.74 34.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.128 0.489 . . . . 0.0 110.462 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.601 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 44.2 mm -71.32 -49.34 12.18 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.621 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.601 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 39.5 Cg_exo -58.01 142.43 96.73 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 122.064 1.843 . . . . 0.0 112.42 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.9 t -157.94 -60.08 0.08 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.895 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.9 t -78.35 -74.49 0.27 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.519 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -141.22 -160.32 1.07 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -68.48 -30.99 69.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.683 HG22 HG13 ' A' ' 27' ' ' VAL . 2.1 p -128.0 151.43 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.816 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -143.26 129.51 19.85 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.277 178.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.505 HD21 ' CD2' ' A' ' 14' ' ' TYR . 15.2 tp -69.07 140.04 54.85 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.066 0.46 . . . . 0.0 110.08 174.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -88.37 -63.85 1.24 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.101 178.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.0 m -170.58 159.84 6.95 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.196 -176.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.505 ' CD2' HD21 ' A' ' 11' ' ' LEU . 12.4 p90 -158.11 155.92 30.05 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.407 174.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -113.43 154.75 26.46 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 120.829 0.347 . . . . 0.0 110.873 175.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.827 ' HH ' HG11 ' A' ' 76' ' ' VAL . 1.1 m-85 -160.03 139.21 10.89 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 124.71 1.256 . . . . 0.0 110.412 -175.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 16.8 t70 -175.54 71.31 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.973 167.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 51.7 38.9 45.42 Favored Glycine 0 CA--C 1.507 -0.455 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -170.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.6 m -155.58 158.99 39.3 Favored 'General case' 0 N--CA 1.394 -3.268 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 -161.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.51 HG23 ' HA ' ' A' ' 75' ' ' SER . 52.9 m -60.32 143.78 52.14 Favored 'General case' 0 C--N 1.263 -3.191 0 CA-C-N 112.899 -1.955 . . . . 0.0 111.219 -173.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.659 ' HD2' ' CZ ' ' A' ' 16' ' ' TYR . 2.1 t80 -78.59 141.87 37.74 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.6 m -161.54 124.89 3.19 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.736 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.73 -153.03 9.95 Favored Glycine 0 N--CA 1.438 -1.167 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -176.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.742 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -160.05 163.61 33.82 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.014 0.435 . . . . 0.0 111.371 -177.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.713 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 24.9 mt -127.55 156.81 39.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.645 -170.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -132.77 107.29 8.27 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.114 0.565 . . . . 0.0 109.647 -172.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.683 HG13 HG22 ' A' ' 9' ' ' VAL . 0.7 OUTLIER -133.95 151.89 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.208 -0.932 . . . . 0.0 112.178 -172.062 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.425 ' HD3' ' CE1' ' A' ' 67' ' ' TYR . 23.8 tptm -76.35 129.29 36.4 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 172.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.561 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 23.7 p-10 -86.6 103.86 15.49 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.574 0.702 . . . . 0.0 110.376 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.497 HG12 ' OH ' ' A' ' 86' ' ' TYR . 16.3 mm -72.99 -60.3 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-N 115.47 -0.787 . . . . 0.0 108.882 -176.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.78 -135.05 0.35 Allowed 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.148 172.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -120.54 -52.4 2.14 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.022 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.5 t -78.16 116.21 18.45 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.754 ' HB2' ' HH2' ' A' ' 70' ' ' TRP . 27.5 mmtm -116.76 167.33 11.19 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.24 0.543 . . . . 0.0 110.619 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.612 ' HB3' ' HZ3' ' A' ' 35' ' ' LYS . 9.0 mtpm? -138.42 97.72 3.43 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.786 173.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.9 t -98.75 124.44 51.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.9 0.857 . . . . 0.0 110.713 -178.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.769 ' HB ' HG13 ' A' ' 53' ' ' ILE . 45.2 p -132.69 116.4 16.57 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.286 -1.324 . . . . 0.0 110.638 -170.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.787 ' HB ' HG22 ' A' ' 54' ' ' ILE . 44.9 t -84.92 132.75 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-O 121.322 0.582 . . . . 0.0 109.514 173.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.683 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -118.9 111.61 34.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.161 175.015 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.587 ' HA ' ' CB ' ' A' ' 82' ' ' PHE . 5.1 p90 -115.05 139.58 49.76 Favored 'General case' 0 CA--C 1.485 -1.528 0 CA-C-O 122.667 1.222 . . . . 0.0 110.901 175.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.504 ' HB3' ' CZ3' ' A' ' 47' ' ' TRP . . . -86.2 103.0 14.43 Favored 'General case' 0 N--CA 1.405 -2.714 0 CA-C-N 112.69 -2.05 . . . . 0.0 107.462 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.66 ' HB2' ' ND2' ' A' ' 52' ' ' ASN . 3.4 t70 -48.15 -168.49 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 111.694 -2.503 . . . . 0.0 113.796 -174.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.53 -17.9 28.2 Favored Glycine 0 C--N 1.335 0.5 0 O-C-N 122.106 -0.371 . . . . 0.0 112.513 -177.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 41.6 t -65.83 -16.59 63.96 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 122.825 0.45 . . . . 0.0 110.823 175.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.498 ' HB3' ' HG3' ' A' ' 80' ' ' LYS . 3.7 p30 51.46 33.77 10.91 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.632 1.173 . . . . 0.0 110.632 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -163.63 139.76 6.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.436 -169.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.504 ' CZ3' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -91.33 88.94 7.06 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 120.029 -0.668 . . . . 0.0 112.326 174.516 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.63 47.3 1.35 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.641 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 60.12 31.63 20.63 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.113 -172.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -92.37 127.4 37.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.231 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -96.37 60.43 1.3 Allowed Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.56 -174.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.66 ' ND2' ' HB2' ' A' ' 42' ' ' ASP . 87.2 m-20 -76.78 75.9 3.41 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.795 0.331 . . . . 0.0 110.431 175.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.769 HG13 ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -109.23 136.21 45.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.331 0.586 . . . . 0.0 110.737 178.751 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.787 HG22 ' HB ' ' A' ' 38' ' ' VAL . 8.0 tp -117.24 121.92 68.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.638 174.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.66 134.01 37.17 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.912 0.387 . . . . 0.0 110.411 -176.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.07 161.2 18.28 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.977 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 m -114.44 176.05 5.22 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.692 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 0.4 OUTLIER -139.22 146.47 40.53 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.782 0.801 . . . . 0.0 111.517 -174.167 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.8 t -88.39 -36.11 16.75 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.329 -1.305 . . . . 0.0 108.712 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 143.46 -172.08 24.96 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.288 174.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -65.85 138.25 52.41 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.75 2.3 . . . . 0.0 111.404 175.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.627 HG12 ' HB2' ' A' ' 69' ' ' TYR . 20.0 mt -81.24 109.84 16.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.408 -176.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.5 p -65.64 135.48 55.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.272 0.558 . . . . 0.0 111.274 -176.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.89 -4.64 81.81 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.459 -0.657 . . . . 0.0 111.459 -177.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.6 m -140.72 171.52 13.98 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -108.31 46.29 0.97 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.17 0.509 . . . . 0.0 110.002 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.425 ' CE1' ' HD3' ' A' ' 28' ' ' LYS . 2.3 m-85 -125.88 172.33 9.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.425 -178.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 29' ' ' ASN . 17.5 tt0 -120.39 167.07 12.72 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.627 ' HB2' HG12 ' A' ' 62' ' ' ILE . 4.3 t80 -141.59 121.72 13.81 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -164.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.754 ' HH2' ' HB2' ' A' ' 34' ' ' LYS . 25.4 m95 -118.46 145.55 45.17 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.798 -168.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.483 HG22 ' HB3' ' A' ' 24' ' ' LYS . 1.4 p -147.29 142.38 27.1 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 123.744 0.652 . . . . 0.0 109.527 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.4 ' HB3' ' O ' ' A' ' 71' ' ' THR . 2.7 p90 -173.99 159.49 3.33 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.442 0.639 . . . . 0.0 112.585 173.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.3 p -117.67 143.98 45.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.416 172.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.593 ' HB3' HG12 ' A' ' 54' ' ' ILE . . . -142.25 106.09 4.71 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -171.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.51 ' HA ' HG23 ' A' ' 20' ' ' THR . 13.3 t -68.6 109.13 3.62 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 174.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.827 HG11 ' HH ' ' A' ' 16' ' ' TYR . 12.2 m -100.52 155.59 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.002 -173.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -86.36 -24.01 25.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.21 -175.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.36 107.08 0.35 Allowed Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -177.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.651 HG12 HG22 ' A' ' 104' ' ' VAL . 8.9 tt -112.34 138.04 42.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.418 0.628 . . . . 0.0 111.722 -172.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.498 ' HG3' ' HB3' ' A' ' 45' ' ' ASP . 74.5 mmtt -117.0 -47.42 2.69 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.213 -176.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.459 ' OE1' ' HB3' ' A' ' 103' ' ' GLN . 11.7 mm-40 -146.21 154.02 41.28 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -175.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.683 ' HB2' ' O ' ' A' ' 39' ' ' VAL . 3.9 p90 -172.14 -179.06 2.24 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 118.521 -1.272 . . . . 0.0 114.032 174.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.589 ' HA ' ' CE1' ' A' ' 102' ' ' TYR . 0.2 OUTLIER -162.17 164.7 27.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 113.48 -1.691 . . . . 0.0 108.644 176.632 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.781 HD11 HG23 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -104.23 144.24 14.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.958 -177.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.517 ' HB2' ' OG1' ' A' ' 37' ' ' THR . 6.6 mtmp? -104.86 130.07 53.07 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 121.069 0.461 . . . . 0.0 109.905 176.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.711 ' HD2' ' HD2' ' A' ' 93' ' ' TYR . 19.4 t80 -102.63 102.17 12.37 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.46 177.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.526 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 28.5 tt0 -108.64 129.35 55.33 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.592 ' C ' ' H ' ' A' ' 90' ' ' GLY . 2.6 t -122.06 166.47 16.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -174.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.43 ' H ' HG13 ' A' ' 88' ' ' VAL . 40.8 p -66.45 28.08 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.344 0.592 . . . . 0.0 112.262 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.592 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . 171.96 -34.61 0.14 Allowed Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.851 177.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.529 ' HA ' ' HE3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -102.44 164.47 11.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.841 0.353 . . . . 0.0 111.338 -177.33 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.4 m -148.59 142.92 26.21 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 173.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.711 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 47.3 m-85 -141.41 -168.1 2.56 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.6 133.87 15.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.628 -170.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -118.98 94.92 4.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.225 0.536 . . . . 0.0 109.995 172.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 97' ' ' ASN . 28.9 p-10 -125.36 27.62 6.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.275 -178.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 96' ' ' ASN . 2.9 m-20 72.65 -58.06 0.61 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.748 -172.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 177.69 -48.95 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 176.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.1 p -164.89 29.69 0.06 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.124 174.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -104.27 -37.45 7.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.411 -171.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.408 HD21 ' HB3' ' A' ' 81' ' ' GLU . 2.0 p-10 47.49 101.56 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 O-C-N 123.965 0.79 . . . . 0.0 112.891 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.589 ' CE1' ' HA ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -50.78 116.49 1.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.91 -168.694 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.459 ' HB3' ' OE1' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -88.85 124.96 34.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.533 0.682 . . . . 0.0 110.292 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.651 HG22 HG12 ' A' ' 79' ' ' ILE . 3.4 t -97.38 148.65 5.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.722 -1.127 . . . . 0.0 110.564 -174.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.2 m -95.38 75.36 3.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.418 0.628 . . . . 0.0 110.275 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.9 m . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.307 -0.854 . . . . 0.0 109.653 178.032 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.855 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.3 m -96.47 163.95 12.83 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.287 -178.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.711 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 23.0 mm -53.12 -54.0 49.39 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.711 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 36.2 Cg_exo -60.09 138.27 80.78 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.078 1.852 . . . . 0.0 112.331 178.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.8 t -129.72 -54.17 1.15 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.683 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.9 t -108.42 -74.99 0.64 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.772 -0.194 . . . . 0.0 110.617 -178.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.77 -173.13 2.25 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.523 0.201 . . . . 0.0 111.186 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.9 m -65.44 -36.07 82.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.217 0.532 . . . . 0.0 110.528 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.701 HG21 HG13 ' A' ' 27' ' ' VAL . 1.7 p -123.8 152.11 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.5 -176.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.403 HE21 ' HB3' ' A' ' 10' ' ' GLN . 5.9 tt0 -142.57 132.5 24.31 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.094 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.431 HD21 ' CD2' ' A' ' 14' ' ' TYR . 34.8 tp -71.13 136.04 47.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.064 0.459 . . . . 0.0 110.304 176.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -88.12 -58.86 2.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.94 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.3 p -179.54 160.46 0.96 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.8 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.443 ' CE2' ' HZ ' ' A' ' 82' ' ' PHE . 44.1 p90 -157.54 163.14 38.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.481 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -133.46 158.57 42.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.929 0.395 . . . . 0.0 110.623 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.725 ' CE2' ' HB ' ' A' ' 106' ' ' THR . 0.5 OUTLIER -139.53 138.42 36.29 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.57 -179.041 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -166.5 130.59 2.07 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.78 -104.18 0.36 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -168.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.2 t -140.86 85.05 1.97 Allowed 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 161.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.523 ' O ' ' HD1' ' A' ' 16' ' ' TYR . 88.9 m -147.31 130.23 16.24 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.411 173.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.479 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 3.5 t80 -128.3 104.05 7.51 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.567 0.699 . . . . 0.0 109.56 -174.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.6 m -138.32 150.1 46.28 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.797 -176.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.32 -141.5 3.75 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 -178.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 2.6 ptpp? -162.6 166.82 24.17 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.825 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.699 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 38.3 mt -133.66 157.16 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 -170.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -133.03 110.14 10.03 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.31 0.644 . . . . 0.0 109.657 -173.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.701 HG13 HG21 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -137.97 151.49 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.206 -0.934 . . . . 0.0 113.101 -172.393 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 46.4 tptt -78.83 140.86 38.11 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.899 174.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.507 ' OD1' ' HB2' ' A' ' 68' ' ' GLU . 7.2 m-20 -88.31 96.76 10.7 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.696 0.284 . . . . 0.0 110.783 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.593 HG12 ' OH ' ' A' ' 86' ' ' TYR . 7.7 mm -75.98 -54.84 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 176.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.89 -157.5 0.62 Allowed 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.201 -1.363 . . . . 0.0 107.906 172.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -113.33 -59.03 2.07 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.603 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.6 m -76.85 87.82 3.44 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 175.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.431 ' HE2' ' CZ2' ' A' ' 70' ' ' TRP . 27.9 mtmm -104.34 158.4 16.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.456 -174.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.743 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 47.8 mttp -123.79 138.46 54.5 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 175.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.1 t -128.0 115.52 39.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.331 0.586 . . . . 0.0 110.115 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.885 ' HB ' HG13 ' A' ' 53' ' ' ILE . 69.1 p -119.74 120.3 36.15 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.494 -171.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 1.062 ' HB ' HG22 ' A' ' 54' ' ' ILE . 79.6 t -88.52 110.42 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.703 177.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.686 HG21 ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -97.13 120.29 46.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 170.686 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.683 ' HA ' ' HZ2' ' A' ' 47' ' ' TRP . 5.3 p90 -119.99 138.23 53.61 Favored 'General case' 0 CA--C 1.49 -1.347 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.032 171.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.49 ' N ' ' CZ2' ' A' ' 47' ' ' TRP . . . -76.9 88.06 3.47 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 113.133 -1.849 . . . . 0.0 108.017 -175.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.536 ' CG ' ' H ' ' A' ' 43' ' ' GLY . 42.8 t0 -43.75 -170.37 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 109.221 -3.627 . . . . 0.0 113.007 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.536 ' H ' ' CG ' ' A' ' 42' ' ' ASP . . . -61.5 -10.39 22.98 Favored Glycine 0 CA--C 1.522 0.469 0 O-C-N 121.983 -0.448 . . . . 0.0 112.721 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -76.11 -14.19 60.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.904 0.383 . . . . 0.0 110.148 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 76.06 12.59 2.8 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.122 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -170.81 179.35 3.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.951 -178.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.683 ' HZ2' ' HA ' ' A' ' 40' ' ' TYR . 23.0 m-90 -105.19 107.93 19.18 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.501 169.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -76.45 -162.82 0.27 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 170.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -75.11 58.31 0.89 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.438 0.637 . . . . 0.0 109.72 171.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -128.58 -50.68 1.26 Allowed 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.187 -174.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.66 76.2 0.95 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.95 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -77.94 80.11 4.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.885 HG13 ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -119.58 138.45 50.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.555 0.693 . . . . 0.0 112.822 -170.312 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 1.062 HG22 ' HB ' ' A' ' 38' ' ' VAL . 8.4 tp -112.31 133.47 57.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 169.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.65 126.7 34.13 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.614 -177.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.56 158.85 22.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.461 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.0 t -130.04 133.44 46.73 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 31.2 p90 -76.29 141.11 41.73 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 121.456 0.646 . . . . 0.0 110.267 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.4 t -93.48 -26.36 17.21 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.842 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 160.52 171.08 25.96 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.796 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.37 144.23 61.06 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.447 2.098 . . . . 0.0 110.843 174.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.564 HG12 ' HB2' ' A' ' 69' ' ' TYR . 20.7 mt -79.98 109.74 14.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.198 0.523 . . . . 0.0 109.9 -178.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.5 p -66.54 122.74 18.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.692 -175.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.02 -2.37 30.05 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.5 m -153.28 179.34 8.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -107.1 38.68 2.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.937 0.875 . . . . 0.0 109.899 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.447 ' HB3' HD11 ' A' ' 62' ' ' ILE . 1.8 m-85 -102.41 168.76 9.11 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.222 177.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.507 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . 10.0 tt0 -124.02 165.1 18.05 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.564 ' HB2' HG12 ' A' ' 62' ' ' ILE . 2.0 t80 -136.32 111.25 8.84 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -161.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.699 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 8.0 m95 -111.56 144.92 40.02 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.288 -166.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.427 ' HA ' ' HB2' ' A' ' 24' ' ' LYS . 5.0 p -133.04 131.86 41.14 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -132.6 151.06 52.06 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 118.884 -1.126 . . . . 0.0 111.733 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.2 m -131.68 141.29 49.54 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.053 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.526 ' HB3' HG12 ' A' ' 54' ' ' ILE . . . -150.56 113.74 4.85 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.069 0.461 . . . . 0.0 111.167 -175.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.2 t -77.7 99.07 5.69 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 168.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.462 HG21 HG23 ' A' ' 79' ' ' ILE . 32.6 m -95.15 157.22 3.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.416 0.627 . . . . 0.0 111.26 -169.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -96.42 -16.77 21.03 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.018 -175.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.17 82.63 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.942 -0.646 . . . . 0.0 111.969 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.589 HG12 HG22 ' A' ' 104' ' ' VAL . 4.5 tt -90.49 133.19 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.485 0.66 . . . . 0.0 111.108 -178.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -114.47 -40.38 3.63 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.298 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 37.0 mm-40 -141.37 167.19 22.76 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.443 ' HZ ' ' CE2' ' A' ' 14' ' ' TYR . 28.2 p90 -172.1 170.71 5.17 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 119.338 0.972 . . . . 0.0 111.864 174.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.661 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 0.7 OUTLIER -162.9 150.7 13.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.235 168.09 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.524 HD12 HG21 ' A' ' 38' ' ' VAL . 10.2 mm -100.94 139.46 22.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.673 -174.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.686 ' HE3' HG21 ' A' ' 39' ' ' VAL . 88.8 mttt -103.86 151.83 22.65 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.471 0.653 . . . . 0.0 110.269 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.66 ' HD2' ' HD2' ' A' ' 93' ' ' TYR . 25.0 t80 -123.24 106.66 10.92 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.765 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.743 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -103.19 128.47 50.15 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.304 0.573 . . . . 0.0 110.218 -176.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.4 t -126.54 158.04 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.735 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.9 m -67.32 -3.18 7.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -176.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -136.61 -27.87 0.37 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.512 176.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.1 mmtt -129.73 177.62 7.11 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 122.189 0.995 . . . . 0.0 112.483 -174.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.5 m -150.39 141.9 23.47 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.232 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.66 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 33.0 m-85 -143.82 -172.73 3.8 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -150.47 148.43 28.72 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.187 -174.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -119.79 98.82 6.29 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 169.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.661 ' HB3' ' HB2' ' A' ' 83' ' ' TYR . 23.0 p-10 -145.01 61.9 1.31 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.418 -174.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 71.13 -65.4 0.34 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.933 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -157.91 -53.81 0.07 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 174.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.6 m -157.17 44.69 0.37 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.706 -1.133 . . . . 0.0 110.001 169.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.42 -109.08 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -176.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 176.07 146.26 0.09 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.777 0.831 . . . . 0.0 108.831 -168.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -85.54 142.84 28.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.656 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -92.88 106.66 18.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.348 -175.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.589 HG22 HG12 ' A' ' 79' ' ' ILE . 22.0 t -94.39 107.44 19.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.7 m -90.66 57.62 3.65 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -171.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.725 ' HB ' ' CE2' ' A' ' 16' ' ' TYR . 87.9 m . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.689 175.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 120.65 0.262 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.9 m -87.63 81.91 7.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.393 1.092 . . . . 0.0 110.532 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.415 HD13 HD21 ' A' ' 66' ' ' ASN . 66.4 mt -117.58 135.7 23.35 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.429 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.581 ' HG3' ' CE1' ' A' ' 26' ' ' TYR . 13.5 Cg_endo -57.54 156.94 24.51 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.936 2.424 . . . . 0.0 112.69 176.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.4 t -85.85 49.61 1.81 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.761 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.52 ' OG ' ' HB2' ' A' ' 10' ' ' GLN . 13.6 t -108.45 -175.4 2.76 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.244 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.21 -151.0 0.27 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.294 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.1 -29.54 69.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.125 0.488 . . . . 0.0 110.603 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.595 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.3 p -150.24 149.06 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.725 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.52 ' HB2' ' OG ' ' A' ' 6' ' ' SER . 10.9 tt0 -138.75 154.78 48.56 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.472 HD21 ' CD2' ' A' ' 14' ' ' TYR . 16.4 tp -85.55 143.11 28.69 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.025 0.44 . . . . 0.0 110.012 172.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -87.41 -65.66 0.99 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.602 173.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.2 p -177.68 160.38 1.54 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.587 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.472 ' CD2' HD21 ' A' ' 11' ' ' LEU . 43.5 p90 -152.12 162.25 41.4 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.269 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -132.6 157.12 45.58 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -133.17 146.61 51.69 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.159 -174.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.452 ' CG ' ' H ' ' A' ' 18' ' ' GLY . 13.8 t70 -123.56 -150.35 0.45 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.671 -1.149 . . . . 0.0 107.954 -177.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.452 ' H ' ' CG ' ' A' ' 17' ' ' ASP . . . -50.61 -64.43 3.69 Favored Glycine 0 N--CA 1.458 0.111 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 171.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.2 t -145.63 86.76 1.75 Allowed 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 161.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.6 m -146.42 140.3 26.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.033 178.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.702 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 12.2 t80 -116.38 139.55 50.29 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.4 m -163.17 133.93 4.66 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 174.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.86 -150.34 12.37 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.116 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.583 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 18.5 pttp -159.41 168.74 25.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.185 0.517 . . . . 0.0 111.451 -177.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.741 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 12.9 mt -132.78 160.78 42.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.644 -167.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.581 ' CE1' ' HG3' ' A' ' 4' ' ' PRO . 5.6 t80 -132.5 96.23 3.8 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 122.769 0.428 . . . . 0.0 110.317 -173.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.734 HG12 ' CD1' ' A' ' 70' ' ' TRP . 1.8 m -136.99 151.92 27.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 121.166 -0.959 . . . . 0.0 112.022 -170.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -72.69 143.88 47.92 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.746 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -102.28 95.03 6.03 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.732 0.777 . . . . 0.0 111.096 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.6 mt -75.78 -57.8 5.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.464 -178.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.81 -160.87 0.75 Allowed 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.433 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 18.9 t80 -116.48 -23.48 8.26 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.838 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.0 m -78.02 68.2 4.01 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 169.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.468 ' HZ1' ' CD ' ' A' ' 68' ' ' GLU . 27.6 mtmt -90.9 125.55 35.79 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.874 -176.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.756 ' HB3' ' HZ3' ' A' ' 35' ' ' LYS . 9.4 mtpm? -126.28 113.57 17.13 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.489 HG23 ' CZ3' ' A' ' 70' ' ' TRP . 69.9 t -113.24 113.41 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-O 121.781 0.801 . . . . 0.0 110.375 -173.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.855 ' HB ' HG13 ' A' ' 53' ' ' ILE . 6.6 p -122.42 111.61 17.07 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.364 -173.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 1.044 ' HB ' HG22 ' A' ' 54' ' ' ILE . 95.0 t -79.66 111.62 16.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.375 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.681 HG11 ' O ' ' A' ' 51' ' ' GLY . 1.0 OUTLIER -107.66 110.08 30.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.663 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.763 ' CE1' ' HB2' ' A' ' 42' ' ' ASP . 0.3 OUTLIER -105.19 154.48 20.15 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.915 0.865 . . . . 0.0 112.875 -174.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.26 76.29 4.77 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 168.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.763 ' HB2' ' CE1' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -54.08 159.06 1.94 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 112.351 -2.204 . . . . 0.0 112.399 176.732 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.49 -109.29 1.88 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 113.744 -1.571 . . . . 0.0 113.455 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.507 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 16.0 m -89.41 -48.0 7.63 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 -175.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.453 ' HB3' ' O ' ' A' ' 44' ' ' SER . 6.1 p-10 170.69 28.73 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.523 0.729 . . . . 0.0 110.29 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -107.15 114.68 28.89 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -163.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -101.93 83.9 2.45 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -74.95 44.3 0.23 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.886 -178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 51.09 33.52 9.35 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.664 0.745 . . . . 0.0 110.785 -176.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -110.73 -16.68 13.54 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.681 ' O ' HG11 ' A' ' 39' ' ' VAL . . . 77.12 -60.18 3.52 Favored Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.487 -174.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.541 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 82.6 m-20 74.83 73.57 0.1 Allowed 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.855 HG13 ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -109.0 138.84 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.943 -163.009 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 1.044 HG22 ' HB ' ' A' ' 38' ' ' VAL . 8.9 tp -116.12 127.9 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 114.322 -1.308 . . . . 0.0 108.03 168.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.5 129.84 34.99 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.888 -176.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -97.45 158.39 15.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.986 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 99.0 p -123.94 175.57 6.86 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.671 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 19.3 p90 -127.97 145.6 50.92 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.266 0.555 . . . . 0.0 111.472 -178.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.1 m -84.08 -37.7 21.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.11 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 157.35 161.73 11.07 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.315 175.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.849 ' HA ' ' HA ' ' A' ' 68' ' ' GLU . 28.5 Cg_endo -58.19 152.16 54.53 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 123.065 2.51 . . . . 0.0 112.028 177.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 23.9 mt -86.75 103.56 13.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.177 -175.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.5 p -62.93 120.54 11.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.211 0.529 . . . . 0.0 111.063 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.66 -7.54 29.9 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -175.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -141.87 171.37 14.15 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.415 HD21 HD13 ' A' ' 3' ' ' ILE . 39.1 m-80 -105.21 38.19 2.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.641 0.734 . . . . 0.0 110.133 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -120.3 177.37 5.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.747 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.849 ' HA ' ' HA ' ' A' ' 61' ' ' PRO . 12.3 tt0 -128.3 166.98 17.58 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.347 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -124.58 114.81 19.87 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 -169.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.741 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 14.4 m95 -111.88 148.05 34.49 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.818 -167.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.548 HG22 ' HB3' ' A' ' 24' ' ' LYS . 1.6 p -150.51 146.37 26.56 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.322 0.388 . . . . 0.0 110.496 -172.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.409 ' HE2' HG23 ' A' ' 54' ' ' ILE . 4.2 p90 -175.19 157.57 2.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.578 0.704 . . . . 0.0 112.016 172.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.1 p -114.62 146.31 40.97 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.702 ' HB1' ' HB3' ' A' ' 21' ' ' PHE . . . -139.02 113.68 9.1 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -173.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.5 m -72.87 100.49 2.92 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 169.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.7 m -103.45 157.27 5.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.341 -176.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.18 14.44 10.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.495 0.664 . . . . 0.0 110.482 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.66 138.93 2.56 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.974 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 14.9 tt -171.49 153.23 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.216 0.532 . . . . 0.0 110.25 177.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 44' ' ' SER . 16.2 tppt? -135.64 -47.97 0.69 Allowed 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.725 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 14.3 pt-20 -149.2 176.42 10.52 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.466 ' CB ' ' HA ' ' A' ' 40' ' ' TYR . 55.5 p90 -170.02 168.68 8.42 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 119.382 0.992 . . . . 0.0 112.316 -178.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.881 ' HB3' ' HB3' ' A' ' 96' ' ' ASN . 0.2 OUTLIER -146.48 143.93 29.3 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.542 169.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.536 HD12 HG21 ' A' ' 38' ' ' VAL . 17.6 mm -89.43 138.76 18.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.225 -174.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.485 ' HE2' ' HE1' ' A' ' 94' ' ' TYR . 32.3 mmtp -97.7 107.75 20.32 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.438 0.637 . . . . 0.0 109.289 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.58 ' O ' ' HA ' ' A' ' 92' ' ' THR . 8.4 t80 -89.28 100.9 13.59 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.656 -1.157 . . . . 0.0 109.917 -177.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.55 ' HA ' ' O ' ' A' ' 91' ' ' LYS . 26.4 tt0 -104.24 113.88 27.73 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.818 -176.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.2 t -119.9 105.69 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.609 -177.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.6 t 50.95 27.14 3.02 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 123.646 0.591 . . . . 0.0 111.155 177.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.58 -18.09 17.8 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.335 -176.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 87' ' ' GLU . 21.2 mmtm -81.81 176.8 9.3 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 117.598 0.699 . . . . 0.0 111.508 -176.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 86' ' ' TYR . 18.0 m -150.59 141.06 22.47 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.662 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.445 ' HD2' ' CD2' ' A' ' 86' ' ' TYR . 63.8 m-85 -146.05 -171.71 3.77 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 170.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.485 ' HE1' ' HE2' ' A' ' 85' ' ' LYS . 51.0 m-85 -146.19 141.23 27.23 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.895 0.379 . . . . 0.0 111.601 -172.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -130.16 112.92 13.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.461 167.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.881 ' HB3' ' HB3' ' A' ' 83' ' ' TYR . 36.3 p-10 -130.09 -29.68 2.04 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.15 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.559 HD22 ' HB2' ' A' ' 100' ' ' ALA . 26.1 p-10 159.12 -42.9 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.544 1.137 . . . . 0.0 108.198 172.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 175.49 -37.13 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.421 174.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.2 p -178.06 23.94 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.559 ' HB2' HD22 ' A' ' 97' ' ' ASN . . . -138.06 -17.14 1.23 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -175.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.737 ' HA ' ' HB2' ' A' ' 96' ' ' ASN . 77.5 m-20 87.73 142.65 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.894 0.478 . . . . 0.0 110.739 173.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 85.0 m-85 -71.76 120.96 18.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.969 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -83.71 129.61 34.95 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 174.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.406 HG22 HG12 ' A' ' 79' ' ' ILE . 22.0 t -80.59 153.39 4.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.1 p -74.71 56.75 0.72 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.459 0.647 . . . . 0.0 111.824 -177.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.31 177.544 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 121.049 0.452 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -91.28 -175.78 4.36 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.845 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.496 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 21.4 mm -54.63 -55.64 35.73 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.345 177.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 3' ' ' ILE . 9.4 Cg_endo -54.74 134.88 65.05 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.241 1.96 . . . . 0.0 112.928 -177.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.9 t -166.35 -51.92 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.912 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.7 m -83.65 -77.35 0.26 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.194 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -139.4 -173.89 3.73 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 120.645 0.259 . . . . 0.0 111.208 -176.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -67.26 -30.91 70.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.42 0.629 . . . . 0.0 109.962 177.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.642 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.4 p -140.68 148.89 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.299 -178.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -140.9 129.35 22.55 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.859 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.435 HD21 ' HD2' ' A' ' 14' ' ' TYR . 23.7 tp -69.06 141.94 54.65 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.213 0.53 . . . . 0.0 110.957 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.473 ' HB3' ' O ' ' A' ' 24' ' ' LYS . 30.0 t70 -85.68 -68.77 0.71 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.752 175.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.7 p -175.94 164.74 2.9 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.741 -177.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.436 ' CD2' ' HZ ' ' A' ' 82' ' ' PHE . 53.2 p90 -156.64 154.42 30.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.564 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -130.55 159.9 35.77 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.125 0.488 . . . . 0.0 110.468 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.466 ' HA ' ' O ' ' A' ' 20' ' ' THR . 10.4 t80 -122.33 138.25 54.58 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 170.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -153.76 115.06 4.14 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.234 -174.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.01 -95.78 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -168.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.621 ' OG ' ' HA ' ' A' ' 77' ' ' LYS . 10.4 t -139.6 88.13 2.23 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 162.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 87.8 m -146.35 139.97 26.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.47 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.851 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 24.3 t80 -115.06 99.25 7.31 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-O 121.672 0.749 . . . . 0.0 109.278 176.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 17.7 p -126.42 150.01 48.92 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.27 -175.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.86 -162.3 36.07 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.723 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 0.6 OUTLIER -158.42 163.66 37.0 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -177.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.707 HD12 HG11 ' A' ' 36' ' ' VAL . 24.7 mt -135.79 160.29 39.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.927 0.394 . . . . 0.0 111.774 -168.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -132.85 103.09 5.91 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.433 0.693 . . . . 0.0 109.798 -174.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.642 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 1.5 m -136.65 151.89 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 121.39 -0.819 . . . . 0.0 111.492 -172.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.483 ' HB2' ' HZ2' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -76.45 152.95 36.01 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 178.317 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -104.6 121.94 44.57 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.345 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.485 HD12 ' OH ' ' A' ' 86' ' ' TYR . 7.1 mt -106.98 -52.83 6.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.823 0.821 . . . . 0.0 109.561 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.504 ' HB3' HG11 ' A' ' 88' ' ' VAL . . . -133.72 152.34 51.85 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 105.283 -2.118 . . . . 0.0 105.283 173.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.418 ' O ' ' C ' ' A' ' 33' ' ' SER . 12.1 m-85 -59.04 -83.93 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 117.768 -1.11 . . . . 0.0 113.068 -170.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 32' ' ' TYR . 24.8 m -21.85 104.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 124.49 1.119 . . . . 0.0 111.647 -174.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.722 ' HB3' ' CH2' ' A' ' 70' ' ' TRP . 84.5 mttt -94.77 111.43 23.21 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 124.882 2.277 . . . . 0.0 115.88 -148.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.874 ' HD3' HG12 ' A' ' 88' ' ' VAL 0.489 4.6 pttm -56.84 79.93 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.006 1 CA-C-N 108.264 -4.062 . . . . 0.0 120.545 169.8 . . . . . . . . 4 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.707 HG11 HD12 ' A' ' 25' ' ' ILE . 52.1 t -142.47 113.65 3.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-O 121.5 0.667 . . . . 0.0 111.599 154.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.646 HG22 HD13 ' A' ' 53' ' ' ILE . 2.5 p -131.53 102.79 6.07 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.804 173.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.929 ' HB ' HG22 ' A' ' 54' ' ' ILE . 61.4 t -73.83 104.2 2.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.377 -176.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.494 HG12 ' HB ' ' A' ' 53' ' ' ILE . 4.5 m -102.94 110.28 29.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -105.18 150.86 24.72 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.14 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.22 82.58 1.84 Allowed 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 172.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -49.95 -172.48 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 113.065 -1.879 . . . . 0.0 113.669 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -54.35 -28.98 45.27 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 116.046 -0.524 . . . . 0.0 113.784 -175.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.2 t -72.11 -16.83 62.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.834 0.317 . . . . 0.0 111.069 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.7 t70 67.57 36.01 3.9 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.819 0.819 . . . . 0.0 109.072 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -147.75 160.67 42.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.263 -176.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.449 ' HZ3' ' O ' ' A' ' 39' ' ' VAL . 5.7 m95 -115.9 82.31 1.75 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.669 0.747 . . . . 0.0 110.38 -176.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.629 ' ND2' ' HB2' ' A' ' 50' ' ' ASN . 2.5 p-10 -116.45 168.94 9.71 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.239 173.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -79.51 57.53 2.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.942 0.877 . . . . 0.0 111.062 -175.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.629 ' HB2' ' ND2' ' A' ' 48' ' ' ASN . 59.3 t30 -88.93 11.75 17.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.32 -177.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.67 33.32 52.16 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -176.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -93.63 34.49 1.18 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.551 0.691 . . . . 0.0 110.526 -175.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.687 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -122.15 139.32 49.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.881 179.23 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.929 HG22 ' HB ' ' A' ' 38' ' ' VAL . 5.8 tp -116.2 126.51 73.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 170.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -89.6 126.58 35.67 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.673 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.61 168.69 17.9 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.931 -174.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.7 t -128.0 132.87 49.12 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -77.75 145.81 36.27 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.39 0.614 . . . . 0.0 110.921 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.3 m -92.16 -33.37 14.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.97 172.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 160.84 169.2 23.78 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.455 172.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.49 133.6 28.47 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.562 2.175 . . . . 0.0 110.152 171.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 65' ' ' SER . 42.4 mt -71.03 122.13 22.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 120.981 0.42 . . . . 0.0 110.729 -172.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.5 p -58.03 128.1 35.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.915 -174.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 70.85 15.56 73.93 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.355 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.519 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 26.4 m -130.46 166.54 20.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.958 0.409 . . . . 0.0 110.671 -178.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -102.47 17.77 22.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.554 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 5.7 m-85 -120.18 169.32 10.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.326 -176.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -117.33 170.74 8.46 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.002 -1.454 . . . . 0.0 108.705 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -138.15 110.4 7.37 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -162.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.722 ' CH2' ' HB3' ' A' ' 34' ' ' LYS . 18.7 m95 -111.86 147.67 35.29 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.063 -168.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.456 ' HA ' ' HB2' ' A' ' 24' ' ' LYS . 5.7 p -141.74 142.96 33.28 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -154.07 169.45 23.5 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.099 -1.041 . . . . 0.0 112.913 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.6 p -144.24 137.29 27.2 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.179 173.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.851 ' HB1' ' HB3' ' A' ' 21' ' ' PHE . . . -134.09 120.82 20.65 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.436 -173.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.8 t -78.42 99.36 6.37 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 172.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.476 HG21 ' HB2' ' A' ' 21' ' ' PHE . 4.8 m -120.16 151.5 22.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -176.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.621 ' HA ' ' OG ' ' A' ' 19' ' ' SER . 0.2 OUTLIER -141.35 31.33 1.72 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.46 0.648 . . . . 0.0 110.366 174.413 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.09 95.52 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.725 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.423 HD11 HG21 ' A' ' 79' ' ' ILE . 7.8 tt -151.82 141.77 15.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.36 0.6 . . . . 0.0 110.276 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -115.18 -54.32 2.56 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.956 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.479 ' OE1' ' HB3' ' A' ' 103' ' ' GLN . 13.2 mm-40 -135.08 176.8 8.33 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -173.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.436 ' HZ ' ' CD2' ' A' ' 14' ' ' TYR . 28.3 p90 -168.7 160.53 10.69 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.703 171.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.42 ' HB3' HD21 ' A' ' 96' ' ' ASN . 0.1 OUTLIER -147.22 144.03 28.61 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.434 168.681 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.791 HD12 HG21 ' A' ' 38' ' ' VAL . 14.4 mm -91.28 134.81 28.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.687 -172.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.558 ' HB2' ' OG1' ' A' ' 37' ' ' THR . 4.5 mtmp? -88.3 114.87 25.35 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.61 0.719 . . . . 0.0 109.857 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.613 ' CD2' ' HD1' ' A' ' 93' ' ' TYR . 9.5 t80 -86.15 100.04 11.94 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.327 -1.306 . . . . 0.0 107.518 178.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.675 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 30.1 tt0 -124.04 104.23 8.76 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 122.108 0.956 . . . . 0.0 113.043 -162.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.874 HG12 ' HD3' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -110.1 164.53 6.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.408 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.3 m -77.06 40.17 0.25 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.856 0.836 . . . . 0.0 111.235 -177.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.495 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . 177.5 -34.07 0.08 OUTLIER Glycine 0 N--CA 1.436 -1.332 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.517 175.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.458 ' O ' HG23 ' A' ' 88' ' ' VAL . 12.9 mptt -110.98 149.43 30.69 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 120.794 0.331 . . . . 0.0 111.325 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 86' ' ' TYR . 7.3 m -149.3 138.44 21.37 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.358 0.599 . . . . 0.0 110.965 174.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.613 ' HD1' ' CD2' ' A' ' 86' ' ' TYR . 18.6 m-85 -146.5 -166.65 2.54 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 176.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -144.03 140.47 29.57 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.885 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -96.19 92.89 6.61 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 168.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.42 HD21 ' HB3' ' A' ' 83' ' ' TYR . 3.6 t-20 -129.56 18.53 5.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.097 -174.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 65.97 -68.12 0.13 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.278 -171.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -159.01 -56.07 0.06 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.0 t -167.74 38.72 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 170.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -99.41 -37.99 9.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.09 -169.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 93.0 m-20 72.62 142.28 0.06 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.351 0.596 . . . . 0.0 110.496 -174.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -95.1 100.18 12.05 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.169 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.479 ' HB3' ' OE1' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -76.61 131.98 39.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.436 179.821 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.8 t -85.24 152.08 3.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.985 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.3 t -83.83 71.42 10.45 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.8 p . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.87 176.909 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo . . . . . 0 C--O 1.233 0.272 0 CA-C-O 120.913 0.297 . . . . 0.0 112.768 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.7 t -152.77 -63.88 0.16 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.324 -176.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.6 m -69.31 -62.69 1.28 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.122 0.487 . . . . 0.0 110.041 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.99 -158.2 0.89 Allowed 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.8 m -64.79 -24.82 67.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.563 0.697 . . . . 0.0 109.221 173.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.853 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.5 p -129.24 155.43 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.584 -178.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -143.81 137.97 28.38 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.451 HD21 ' HD2' ' A' ' 14' ' ' TYR . 34.8 tp -70.55 126.54 29.91 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.121 0.486 . . . . 0.0 111.175 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -74.21 -62.22 1.59 Allowed 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.825 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.2 p 176.55 167.25 0.48 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.214 -175.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.483 ' HA ' ' O ' ' A' ' 22' ' ' SER . 49.0 p90 -157.8 160.34 37.69 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.306 -1.315 . . . . 0.0 107.8 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -126.09 163.24 23.52 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.979 0.419 . . . . 0.0 110.326 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.486 ' HA ' ' O ' ' A' ' 20' ' ' THR . 37.5 t80 -152.5 149.59 28.7 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.284 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -179.76 126.14 0.08 Allowed 'General case' 0 C--N 1.321 -0.644 0 O-C-N 123.715 0.634 . . . . 0.0 109.376 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.44 -105.8 0.99 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 -170.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.542 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 20.4 m -133.35 86.08 2.27 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 166.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 96.2 m -148.07 136.07 21.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.709 177.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.728 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 23.8 t80 -117.32 138.88 51.47 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 171.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 25.9 p -150.04 109.87 4.08 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 14' ' ' TYR . . . -133.77 149.47 19.72 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.15 -1.024 . . . . 0.0 113.057 -166.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.662 ' HB3' HG22 ' A' ' 71' ' ' THR . 24.3 pttm -140.34 154.69 46.85 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.63 HD13 HG21 ' A' ' 84' ' ' ILE . 19.0 mt -134.91 154.63 36.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.071 -165.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -123.24 99.32 6.29 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.255 -174.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.853 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 1.7 m -136.25 149.95 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.337 0.589 . . . . 0.0 112.372 -170.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.633 ' HB2' ' CE1' ' A' ' 67' ' ' TYR . 7.7 ttmm -81.25 144.19 31.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.642 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -82.96 103.82 12.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.65 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.663 HG12 ' OH ' ' A' ' 86' ' ' TYR . 19.0 mm -81.68 -59.29 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.43 -151.86 0.49 Allowed 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 114.033 -1.44 . . . . 0.0 107.706 174.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -109.04 -44.95 3.86 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.049 -0.661 . . . . 0.0 111.46 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.4 t -76.93 82.27 3.48 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.589 0.709 . . . . 0.0 109.898 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 34' ' ' LYS . 28.1 mtmt -110.67 152.41 26.55 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.968 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -142.31 110.12 5.83 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 122.277 1.037 . . . . 0.0 109.021 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.0 t -92.12 124.73 44.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.593 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.763 ' HB ' HG13 ' A' ' 53' ' ' ILE . 59.2 p -123.27 117.4 25.18 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.244 -170.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.811 HG11 ' CD2' ' A' ' 40' ' ' TYR . 57.3 t -73.38 141.24 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.019 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 170.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -124.6 100.1 7.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 159.102 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.811 ' CD2' HG11 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -119.21 126.08 50.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 122.218 1.009 . . . . 0.0 110.684 179.112 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.51 ' HB2' ' CZ3' ' A' ' 47' ' ' TRP . . . -86.59 151.13 23.72 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.768 -164.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.454 ' C ' ' H ' ' A' ' 44' ' ' SER . 2.8 m-20 -72.85 177.5 4.83 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.154 -1.839 . . . . 0.0 110.863 -166.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.36 33.8 1.34 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.805 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.454 ' H ' ' C ' ' A' ' 42' ' ' ASP . 22.7 t -112.26 -10.52 13.82 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 175.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 16.6 t70 76.58 91.26 0.07 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 113.535 -1.666 . . . . 0.0 110.341 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.446 ' HB3' ' O ' ' A' ' 45' ' ' ASP . 22.9 t-20 84.69 154.64 0.09 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.996 170.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.617 ' HE1' ' HB2' ' A' ' 52' ' ' ASN . 8.2 m-90 -72.48 124.47 25.25 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -172.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -78.22 74.25 4.76 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.264 -1.334 . . . . 0.0 108.691 167.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.1 t30 47.86 34.08 3.71 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.676 0.75 . . . . 0.0 110.781 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -119.15 174.46 6.32 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -173.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -141.78 77.32 0.3 Allowed Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 119.808 -1.187 . . . . 0.0 112.213 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.617 ' HB2' ' HE1' ' A' ' 47' ' ' TRP . 78.3 m-20 -79.84 95.11 5.95 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 121.229 0.538 . . . . 0.0 111.515 -178.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.763 HG13 ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -108.49 142.64 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.006 -177.18 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.495 ' CG2' ' HB ' ' A' ' 38' ' ' VAL . 17.5 tt -135.99 122.74 32.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.307 173.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.52 134.5 43.85 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.024 0.44 . . . . 0.0 111.756 -170.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -91.32 164.83 13.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.691 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -128.36 140.13 52.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.062 0.458 . . . . 0.0 110.063 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -71.46 145.58 49.15 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.231 0.539 . . . . 0.0 110.642 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.1 t -107.59 -44.26 4.32 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.888 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.44 170.52 36.35 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.969 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -70.13 140.84 42.23 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.855 2.37 . . . . 0.0 111.666 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.661 HD12 ' HB3' ' A' ' 67' ' ' TYR . 28.8 mt -78.71 105.99 8.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.097 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.7 m -65.85 117.09 7.75 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.365 0.603 . . . . 0.0 110.636 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.28 -14.69 9.4 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.41 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.9 m -150.25 164.76 34.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.955 0.407 . . . . 0.0 110.711 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -89.89 62.07 5.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.429 0.633 . . . . 0.0 109.443 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.661 ' HB3' HD12 ' A' ' 62' ' ' ILE . 1.7 m-85 -138.52 169.59 17.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.466 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -122.09 171.6 8.86 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.554 ' HB2' HG12 ' A' ' 62' ' ' ILE . 1.5 t80 -140.28 122.11 15.46 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -163.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.647 ' CD1' HG13 ' A' ' 27' ' ' VAL . 7.1 m95 -121.28 144.56 48.56 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.015 -165.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.662 HG22 ' HB3' ' A' ' 24' ' ' LYS . 21.3 p -145.81 153.45 40.92 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 122.9 0.125 . . . . 0.0 110.74 -178.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -173.01 155.72 3.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.219 0.533 . . . . 0.0 111.209 167.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.2 m -112.15 145.21 40.23 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.543 175.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.728 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -137.51 144.89 42.4 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.36 -175.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.3 t -99.95 99.15 9.88 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 173.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.542 ' O ' ' HB3' ' A' ' 19' ' ' SER . 3.9 m -103.48 138.34 28.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 3.7 mptp? -101.95 -11.4 18.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.233 -173.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 42' ' ' ASP . . . -179.66 105.98 0.2 Allowed Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.494 HG12 HG21 ' A' ' 104' ' ' VAL . 11.1 tt -128.92 158.36 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.495 ' HA ' ' HE2' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -147.56 -42.07 0.17 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.289 -178.146 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 82' ' ' PHE . 23.0 mm-40 -135.32 164.69 27.16 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 118.56 -0.733 . . . . 0.0 109.086 -171.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.518 ' CB ' ' HA ' ' A' ' 40' ' ' TYR . 36.4 p90 -173.36 178.85 2.29 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 119.378 -0.929 . . . . 0.0 113.379 171.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.667 ' O ' HG23 ' A' ' 39' ' ' VAL . 1.0 OUTLIER -164.28 144.99 8.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.412 -1.722 . . . . 0.0 107.704 167.368 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.63 HG21 HD13 ' A' ' 25' ' ' ILE . 28.3 mm -103.23 137.0 33.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.56 -174.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -104.13 146.12 29.2 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.774 0.797 . . . . 0.0 110.925 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.665 ' HB2' HG11 ' A' ' 9' ' ' VAL . 10.3 t80 -108.89 100.17 9.42 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.454 175.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -110.38 120.79 43.55 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.628 0.728 . . . . 0.0 109.38 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.538 ' C ' ' H ' ' A' ' 90' ' ' GLY . 86.4 t -121.72 155.92 26.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.207 -174.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.9 t -77.01 31.95 0.14 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 122.019 0.914 . . . . 0.0 109.677 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.538 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -158.83 -33.14 0.02 OUTLIER Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.91 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.445 ' HE3' ' H ' ' A' ' 92' ' ' THR . 13.3 mmmt -145.66 178.8 7.87 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.82 0.819 . . . . 0.0 112.138 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.445 ' H ' ' HE3' ' A' ' 91' ' ' LYS . 5.6 m -149.27 143.62 25.97 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.086 174.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.448 ' CD1' ' HD2' ' A' ' 86' ' ' TYR . 25.9 m-85 -143.36 -172.26 3.66 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -145.24 138.44 26.46 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.609 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -111.25 104.24 12.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 165.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 98' ' ' ASN . 49.6 t30 -151.93 87.45 1.35 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.613 -171.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.565 HD21 ' HB3' ' A' ' 100' ' ' ALA . 13.4 p-10 42.22 -68.2 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.465 1.906 . . . . 0.0 115.343 168.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 96' ' ' ASN . 54.8 t30 -159.92 -49.6 0.05 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -177.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.0 p -174.48 20.31 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.859 175.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.565 ' HB3' HD21 ' A' ' 97' ' ' ASN . . . -129.15 -87.31 0.54 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -174.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -169.17 147.84 3.87 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.348 0.659 . . . . 0.0 109.812 -169.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.463 ' CE2' ' HA ' ' A' ' 96' ' ' ASN . 77.1 m-85 -85.88 122.96 30.68 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 170.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -77.26 122.48 25.14 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.494 HG21 HG12 ' A' ' 79' ' ' ILE . 47.5 t -78.16 132.21 32.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.8 m -73.47 77.07 1.43 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.15 0.5 . . . . 0.0 110.913 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 m . . . . . 0 C--O 1.246 0.9 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.49 176.31 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.63 ' HG2' ' CZ ' ' A' ' 67' ' ' TYR . 45.4 Cg_endo . . . . . 0 CA--C 1.528 0.196 0 CA-C-O 121.021 0.342 . . . . 0.0 112.365 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.7 t -128.81 -13.43 4.67 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.354 0.597 . . . . 0.0 109.987 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.1 m -90.1 -6.77 55.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.113 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.34 28.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.576 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.494 ' HB3' HD11 ' A' ' 30' ' ' ILE . 1.6 m -92.88 -27.23 17.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.558 0.694 . . . . 0.0 109.228 175.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.758 HG23 ' HB ' ' A' ' 27' ' ' VAL . 2.2 p -149.89 146.64 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.015 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -135.7 128.76 31.58 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.497 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.502 HD21 ' CD1' ' A' ' 14' ' ' TYR . 36.9 tp -71.85 133.56 45.55 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.172 174.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -81.27 -64.02 1.27 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.969 177.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.6 p 177.32 166.52 0.6 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.851 -177.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.502 ' CD1' HD21 ' A' ' 11' ' ' LEU . 50.3 p90 -157.47 163.9 37.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.056 -177.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -153.18 163.89 39.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.938 0.399 . . . . 0.0 110.989 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.548 ' HD1' ' HD1' ' A' ' 21' ' ' PHE . 35.6 t80 -131.38 149.39 52.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.668 -176.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -174.71 117.82 0.2 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.226 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.0 -99.77 0.34 Allowed Glycine 0 CA--C 1.511 -0.208 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.6 t -135.47 83.46 2.02 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 164.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 62.6 m -148.42 134.33 19.08 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.503 172.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.548 ' HD1' ' HD1' ' A' ' 16' ' ' TYR . 7.8 t80 -132.74 102.34 5.63 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 169.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.4 t -139.04 167.42 22.1 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.952 -171.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.22 -154.35 25.33 Favored Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.564 ' HB3' HG22 ' A' ' 71' ' ' THR . 0.0 OUTLIER -155.64 173.49 16.65 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.433 0.635 . . . . 0.0 112.007 179.809 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.643 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 83.4 mt -136.53 153.37 30.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.58 -167.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -130.58 100.39 5.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.93 -174.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.758 ' HB ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -141.79 145.77 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -169.795 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.633 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 21.2 ptmt -97.62 154.56 17.47 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.805 -175.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.918 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 20.1 p-10 -75.1 115.7 15.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.96 177.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.659 HG12 ' OH ' ' A' ' 86' ' ' TYR . 34.4 mm -77.81 -56.07 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 167.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.49 -86.4 0.41 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.778 171.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -163.77 -68.47 0.04 OUTLIER 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 172.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m -80.71 124.33 28.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.861 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.918 ' HE3' ' HA ' ' A' ' 29' ' ' ASN . 37.8 mttp -122.81 176.66 5.86 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.341 0.591 . . . . 0.0 111.166 -172.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.856 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 96.4 mttt -121.14 136.54 54.96 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 166.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.3 t -127.66 113.63 32.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 122.014 0.911 . . . . 0.0 109.739 171.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . 1.116 ' HB ' HD11 ' A' ' 53' ' ' ILE . 1.0 OUTLIER -131.48 136.14 47.67 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.148 -1.387 . . . . 0.0 110.413 -175.142 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 1.018 ' HB ' HG22 ' A' ' 54' ' ' ILE . 69.3 t -93.4 132.71 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.451 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.569 ' O ' ' HH2' ' A' ' 47' ' ' TRP . 2.7 m -112.8 104.77 17.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 165.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.719 ' CD1' HG12 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -122.18 120.87 35.46 Favored 'General case' 0 N--CA 1.4 -2.974 0 CA-C-N 114.902 -1.044 . . . . 0.0 110.054 -170.107 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.649 ' HB2' ' CE3' ' A' ' 47' ' ' TRP . . . -76.5 129.0 35.87 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.53 -169.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -67.42 179.91 1.19 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.523 -1.672 . . . . 0.0 111.354 -168.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.604 ' HA2' ' HG2' ' A' ' 80' ' ' LYS . . . -68.0 -0.28 14.02 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.079 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.0 m -66.45 -22.75 66.21 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.013 0.435 . . . . 0.0 110.044 174.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 t70 64.69 37.66 7.47 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.133 -0.939 . . . . 0.0 108.98 177.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -173.86 140.28 0.73 Allowed 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -172.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.649 ' CE3' ' HB2' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -89.39 85.88 6.66 Favored 'General case' 0 N--CA 1.421 -1.893 0 C-N-CA 118.608 -1.237 . . . . 0.0 112.516 -173.204 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -56.66 132.32 51.56 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.37 165.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -72.12 70.22 0.79 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.849 0.833 . . . . 0.0 111.317 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -112.74 -17.86 12.45 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.652 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.47 -58.34 3.05 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.709 -176.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 92.4 m-20 59.83 76.3 0.37 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.655 -0.773 . . . . 0.0 110.144 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 1.116 HD11 ' HB ' ' A' ' 37' ' ' THR . 5.7 tp -109.07 148.89 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-O 121.816 0.817 . . . . 0.0 112.044 -176.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 1.018 HG22 ' HB ' ' A' ' 38' ' ' VAL . 3.4 tp -133.03 140.34 47.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.494 -1.23 . . . . 0.0 107.712 167.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -92.84 116.42 29.01 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.287 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.12 156.28 39.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.215 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.8 t -114.83 144.8 42.94 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -174.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -71.25 142.06 50.56 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.283 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.4 t -109.12 -42.27 4.46 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.81 171.8 21.94 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.569 173.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.15 142.75 42.58 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.403 2.068 . . . . 0.0 110.637 173.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.55 HG12 ' HB2' ' A' ' 69' ' ' TYR . 9.7 mt -83.63 83.83 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.8 m -53.5 126.41 21.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.385 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 113.31 -32.42 6.11 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.252 -173.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -127.24 165.99 18.61 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -95.43 55.01 1.66 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.135 0.493 . . . . 0.0 110.863 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.633 ' CE1' ' HB3' ' A' ' 28' ' ' LYS . 2.4 m-85 -137.04 159.3 42.31 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.328 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -107.29 173.59 6.26 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.922 176.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.55 ' HB2' HG12 ' A' ' 62' ' ' ILE . 3.1 t80 -143.5 120.84 11.61 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -165.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.643 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 20.6 m95 -127.79 138.65 52.81 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.922 -166.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.564 HG22 ' HB3' ' A' ' 24' ' ' LYS . 6.5 p -124.33 133.25 53.51 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -125.93 136.97 53.64 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.488 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.7 p -125.7 139.44 53.54 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.236 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.97 118.99 5.43 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.782 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.9 t -82.57 99.4 9.5 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.429 ' CG2' ' HE1' ' A' ' 16' ' ' TYR . 13.8 m -99.48 144.66 11.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.375 -173.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.01 8.39 43.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.279 0.562 . . . . 0.0 110.563 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 156.81 145.8 4.3 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.639 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.602 HG12 HG21 ' A' ' 104' ' ' VAL . 7.3 tt -168.09 142.47 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.309 0.576 . . . . 0.0 110.873 177.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.604 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 3.7 mmmp? -125.48 -38.7 2.24 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.28 -177.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 29.4 mt-10 -141.65 167.22 22.67 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.635 ' HB2' ' HA ' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -171.89 170.45 5.44 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.017 -0.673 . . . . 0.0 112.056 172.197 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.651 ' HD2' ' HB3' ' A' ' 96' ' ' ASN . 0.1 OUTLIER -159.46 148.54 18.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.195 169.092 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.904 HD12 HG22 ' A' ' 38' ' ' VAL . 21.5 mm -95.01 140.76 16.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.706 -169.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.6 mtmt -90.7 114.09 26.33 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.157 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.659 ' OH ' HG12 ' A' ' 30' ' ' ILE . 10.5 t80 -91.95 99.72 12.51 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 172.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.856 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 9.3 tt0 -109.63 107.84 18.04 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.63 0.729 . . . . 0.0 110.206 -174.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.469 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 20.6 t -87.21 164.02 2.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.061 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.429 ' N ' HG12 ' A' ' 88' ' ' VAL . 1.1 m -43.51 -40.86 4.11 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.405 0.44 . . . . 0.0 111.156 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -136.37 23.64 3.28 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.185 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.469 ' HB2' ' HB ' ' A' ' 88' ' ' VAL . 16.5 mmtp -141.74 175.44 9.7 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.772 0.796 . . . . 0.0 111.758 177.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.8 m -149.19 138.83 21.78 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.614 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.421 ' HD2' ' CD2' ' A' ' 86' ' ' TYR . 60.7 m-85 -140.6 -169.25 2.75 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -148.07 145.49 28.46 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.147 0.498 . . . . 0.0 111.503 -173.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.417 ' OD2' ' HB2' ' A' ' 11' ' ' LEU . 17.6 t70 -107.78 97.68 7.37 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 167.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.651 ' HB3' ' HD2' ' A' ' 83' ' ' TYR . 34.0 p30 -144.03 31.98 1.25 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -172.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 67.88 -67.6 0.18 Allowed 'General case' 0 CA--C 1.532 0.275 0 O-C-N 123.629 0.58 . . . . 0.0 111.403 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -171.66 40.25 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -175.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.6 t 63.64 46.6 4.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.954 -167.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -102.3 -38.55 7.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.99 -176.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 7.3 m-20 67.94 115.1 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.781 0.676 . . . . 0.0 110.282 -174.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 7.9 m-85 -77.14 133.21 39.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.437 -174.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -79.19 129.63 34.65 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.602 HG21 HG12 ' A' ' 79' ' ' ILE . 96.3 t -79.25 133.84 29.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.677 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.1 p -77.14 77.01 3.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.725 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.248 1.008 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.177 178.652 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo . . . . . 0 N--CA 1.456 -0.687 0 CA-C-O 121.028 0.345 . . . . 0.0 112.014 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.4 m -128.44 -54.96 1.25 Allowed 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.33 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.6 m -106.09 -68.62 0.87 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.351 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.28 -172.8 2.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 120.908 0.385 . . . . 0.0 111.862 -173.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 m -64.86 -26.56 68.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.214 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.728 ' CB ' ' HB ' ' A' ' 27' ' ' VAL . 2.2 p -120.57 148.31 23.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.382 0.61 . . . . 0.0 112.015 -174.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.425 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 28.0 tt0 -143.72 132.22 22.26 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.474 173.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.671 HD21 ' CD1' ' A' ' 14' ' ' TYR . 40.5 tp -70.03 130.76 43.02 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.099 0.476 . . . . 0.0 110.238 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -76.84 -63.9 1.25 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.901 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.5 m -178.96 159.87 1.04 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.622 -174.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.671 ' CD1' HD21 ' A' ' 11' ' ' LEU . 53.7 p90 -157.95 163.49 37.78 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.654 -177.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -151.32 164.95 35.5 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -176.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.61 ' HA ' ' O ' ' A' ' 20' ' ' THR . 97.6 m-85 -138.92 138.34 37.28 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.754 -176.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -136.53 124.62 22.95 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.54 -99.44 0.18 Allowed Glycine 0 C--N 1.331 0.265 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -167.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.1 t -139.86 87.85 2.19 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 163.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.61 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 73.0 m -145.96 133.3 20.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.422 177.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.957 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 14.8 t80 -90.57 126.49 35.96 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 174.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.9 p -144.92 126.19 14.78 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.593 175.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.422 ' HA3' ' HA ' ' A' ' 14' ' ' TYR . . . 173.68 -154.14 19.14 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.384 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.609 ' HB3' HG22 ' A' ' 71' ' ' THR . 0.4 OUTLIER -161.85 166.07 26.86 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.196 0.522 . . . . 0.0 111.018 -177.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 33.8 mt -127.72 156.04 39.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.16 -172.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -126.9 96.32 4.59 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.866 -172.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.728 ' HB ' ' CB ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -147.91 143.23 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -172.017 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.553 ' HE3' ' CE1' ' A' ' 67' ' ' TYR . 17.0 ptpt -85.05 148.43 26.17 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.365 176.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.422 HD22 ' CD ' ' A' ' 68' ' ' GLU . 4.4 p30 -86.64 132.58 33.85 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.998 176.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.466 HG12 ' OH ' ' A' ' 86' ' ' TYR . 39.0 mm -80.33 -55.28 9.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.486 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.819 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . . . -103.84 -81.18 0.52 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.026 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -159.31 -73.25 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.285 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.611 ' C ' ' HE2' ' A' ' 34' ' ' LYS . 10.0 t -95.87 62.78 2.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.34 0.591 . . . . 0.0 109.913 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.926 ' HD2' HG13 ' A' ' 88' ' ' VAL . 6.3 mmpt? -80.68 157.1 26.02 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.496 ' HG3' ' HB3' ' A' ' 87' ' ' GLU . 18.3 pttp -124.81 141.34 52.18 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.167 -175.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.3 t -115.73 116.57 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.787 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.616 HG22 HD11 ' A' ' 53' ' ' ILE . 5.4 p -114.17 119.43 37.04 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.866 -170.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.824 HG22 HD12 ' A' ' 84' ' ' ILE . 96.8 t -84.19 113.63 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.89 176.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 0.3 OUTLIER -107.6 107.09 21.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 172.793 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.649 ' HA ' ' HB3' ' A' ' 82' ' ' PHE . 4.3 p90 -109.26 137.61 46.88 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-O 122.494 1.14 . . . . 0.0 110.075 177.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.717 ' HB2' ' CZ3' ' A' ' 47' ' ' TRP . . . -89.38 110.67 21.45 Favored 'General case' 0 N--CA 1.401 -2.894 0 CA-C-N 112.863 -1.971 . . . . 0.0 107.599 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -40.7 167.22 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 112.484 -2.143 . . . . 0.0 112.081 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.78 ' HA2' ' HB2' ' A' ' 80' ' ' LYS . . . -67.69 1.69 7.23 Favored Glycine 0 CA--C 1.518 0.264 0 CA-C-N 115.241 -0.891 . . . . 0.0 114.849 -163.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 30.7 t -87.49 -12.72 45.15 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 117.088 0.444 . . . . 0.0 111.009 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.616 ' OD1' ' HG2' ' A' ' 80' ' ' LYS . 5.3 m-20 74.27 48.75 0.12 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 124.038 0.836 . . . . 0.0 110.271 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -155.51 134.3 11.99 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.198 -171.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.717 ' CZ3' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -105.03 85.7 2.32 Favored 'General case' 0 N--CA 1.425 -1.705 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.681 178.019 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -71.85 145.43 48.59 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 167.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -61.71 90.8 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.301 0.572 . . . . 0.0 110.75 -176.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -152.22 147.12 26.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.092 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.03 59.46 4.94 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.897 -176.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -71.36 56.71 0.24 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.357 0.598 . . . . 0.0 109.843 172.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.629 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -116.25 141.1 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.436 -176.927 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.82 HG22 ' HB ' ' A' ' 38' ' ' VAL . 8.5 tp -121.76 130.3 74.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.034 -0.984 . . . . 0.0 108.372 173.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.71 128.62 34.84 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.011 -173.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.74 158.36 28.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.977 178.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 t -122.63 121.93 37.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 29.1 p90 -82.4 138.29 34.49 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 121.708 0.766 . . . . 0.0 111.363 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.402 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 65.8 m -97.03 -41.32 8.43 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 172.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.584 ' O ' ' HA ' ' A' ' 68' ' ' GLU . . . 118.55 -87.5 0.42 Allowed Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.18 -0.918 . . . . 0.0 113.541 170.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.402 ' HD2' ' O ' ' A' ' 59' ' ' SER . 18.6 Cg_endo -52.98 119.66 6.44 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 124.295 3.33 . . . . 0.0 115.959 -167.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.462 ' HB ' ' O ' ' A' ' 67' ' ' TYR . 21.6 mt -124.05 90.57 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.217 162.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.5 m -71.52 117.8 13.53 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.804 -174.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.68 -14.01 6.1 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.965 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -155.5 167.01 31.79 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -92.13 66.4 4.88 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.716 0.769 . . . . 0.0 109.438 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.553 ' CE1' ' HE3' ' A' ' 28' ' ' LYS . 2.2 m-85 -136.52 153.15 51.09 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.732 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 7.4 mp0 -106.44 174.78 5.74 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.888 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -137.55 115.75 11.75 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -166.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.689 ' NE1' HG13 ' A' ' 27' ' ' VAL . 8.0 m95 -116.16 121.85 43.32 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.649 -164.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.609 HG22 ' HB3' ' A' ' 24' ' ' LYS . 2.9 p -128.94 147.74 50.87 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 110.562 -0.162 . . . . 0.0 110.562 -171.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.503 ' HZ ' HG21 ' A' ' 38' ' ' VAL . 2.5 p90 -174.58 159.72 2.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.444 0.64 . . . . 0.0 112.202 174.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.2 m -115.24 146.45 41.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.54 169.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.957 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -138.77 128.84 25.38 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -174.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.0 t -81.76 100.9 9.79 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 172.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' A' ' 21' ' ' PHE . 22.4 m -98.32 151.88 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.921 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.42 11.49 38.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.042 0.449 . . . . 0.0 111.032 -172.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 124.99 102.55 1.4 Allowed Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.844 HG12 HG21 ' A' ' 104' ' ' VAL . 12.3 tt -115.6 156.38 16.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 120.657 0.265 . . . . 0.0 110.986 -174.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.78 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 4.8 tppp? -139.66 -45.86 0.45 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.145 0.497 . . . . 0.0 111.75 -177.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.709 ' HG3' ' HB3' ' A' ' 41' ' ' ALA . 4.7 pt-20 -147.77 156.86 43.19 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.315 -176.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.649 ' HB3' ' HA ' ' A' ' 40' ' ' TYR . 55.7 p90 -171.86 179.27 2.79 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 119.774 -0.77 . . . . 0.0 112.815 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.46 149.83 30.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.503 167.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.824 HD12 HG22 ' A' ' 38' ' ' VAL . 25.6 mm -102.57 130.83 51.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.42 -177.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -96.42 147.61 23.64 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.845 0.831 . . . . 0.0 111.073 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.603 ' HD2' ' HD2' ' A' ' 93' ' ' TYR . 12.0 t80 -109.91 101.21 10.07 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.245 -1.343 . . . . 0.0 107.893 172.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.496 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . 10.8 tt0 -103.85 107.79 18.82 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 122.002 0.906 . . . . 0.0 110.702 -169.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.926 HG13 ' HD2' ' A' ' 34' ' ' LYS . 15.2 t -110.63 162.22 8.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.271 -1.331 . . . . 0.0 108.369 -177.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.5 m -70.22 -14.93 62.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.756 0.313 . . . . 0.0 111.389 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.35 -3.61 2.71 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.061 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.4 ' H ' ' HB ' ' A' ' 88' ' ' VAL . 1.7 mmtm -142.11 160.44 40.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.099 0.476 . . . . 0.0 111.435 -177.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 86' ' ' TYR . 7.5 m -148.99 143.58 26.21 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.909 172.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.603 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 20.4 m-85 -137.67 -172.07 3.15 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 175.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -148.03 127.07 12.82 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.781 -175.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.425 ' OD1' ' HA ' ' A' ' 10' ' ' GLN . 23.2 t70 -93.26 94.02 8.55 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 166.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.443 ' C ' ' H ' ' A' ' 98' ' ' ASN . 30.4 p-10 -128.12 41.72 3.45 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.851 -164.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 71.83 -33.58 0.27 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.325 1.05 . . . . 0.0 112.087 178.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.443 ' H ' ' C ' ' A' ' 96' ' ' ASN . 28.4 t-20 171.42 -59.55 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 65.2 m -160.25 26.95 0.17 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.586 174.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.1 -92.1 0.19 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -174.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -174.25 150.49 1.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.069 -168.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.581 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 81.5 m-85 -88.98 140.79 29.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.294 175.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -97.28 120.43 37.63 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 123.612 0.57 . . . . 0.0 109.905 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.844 HG21 HG12 ' A' ' 79' ' ' ILE . 86.9 t -83.5 126.27 40.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.062 0.458 . . . . 0.0 111.234 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.3 p -87.71 67.3 9.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.892 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.494 HG23 HG12 ' A' ' 104' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.601 -0.714 . . . . 0.0 111.116 178.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 N--CA 1.446 -1.265 0 N-CA-C 111.231 -0.334 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.2 t -145.61 -66.7 0.3 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.2 m -103.74 -30.95 10.09 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 173.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -122.6 174.75 6.88 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.302 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.475 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 70.3 m -96.75 11.36 35.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.571 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.728 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 0.9 OUTLIER -149.92 152.53 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.736 -175.056 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.445 ' O ' ' HB3' ' A' ' 26' ' ' TYR . 57.6 tt0 -149.83 112.1 4.67 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.123 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.639 ' CD1' HG12 ' A' ' 25' ' ' ILE . 7.8 tt -67.82 132.32 47.18 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.983 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.469 ' OD1' ' HE2' ' A' ' 24' ' ' LYS . 15.5 t70 -68.85 -61.43 1.81 Allowed 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.293 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.436 ' N ' HD23 ' A' ' 11' ' ' LEU . 32.2 m -168.35 154.45 7.11 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.087 -168.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.46 ' HA ' ' HA3' ' A' ' 23' ' ' GLY . 42.1 p90 -157.08 152.66 26.72 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.396 -1.274 . . . . 0.0 109.198 177.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -127.86 164.74 21.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.094 0.473 . . . . 0.0 110.927 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.515 ' HA ' ' O ' ' A' ' 20' ' ' THR . 56.1 t80 -145.56 151.95 38.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.838 176.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -172.85 121.94 0.4 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.759 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.71 -98.28 0.12 Allowed Glycine 0 CA--C 1.51 -0.265 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -172.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.499 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 49.3 m -139.47 85.84 2.08 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 161.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 3.9 m -145.52 140.09 27.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.114 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.909 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 25.0 t80 -118.25 139.59 51.08 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 172.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 p -160.22 126.48 4.2 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.668 176.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 14' ' ' TYR . . . 177.82 -159.17 24.79 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 119.798 -1.191 . . . . 0.0 112.917 -178.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.636 ' HB3' HG22 ' A' ' 71' ' ' THR . 0.0 OUTLIER -160.49 160.22 31.75 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.342 0.591 . . . . 0.0 110.721 -178.51 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.639 HG12 ' CD1' ' A' ' 11' ' ' LEU . 31.2 mt -128.94 156.11 41.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.635 -170.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.445 ' HB3' ' O ' ' A' ' 10' ' ' GLN . 4.2 t80 -130.7 115.88 17.28 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -175.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.728 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 1.0 OUTLIER -139.4 149.15 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 121.679 -0.638 . . . . 0.0 111.513 -177.627 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 8' ' ' SER . 0.0 OUTLIER -93.45 152.69 18.93 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.374 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -79.66 126.21 30.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.786 -176.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.662 HG12 ' OH ' ' A' ' 86' ' ' TYR . 26.6 mm -93.29 -48.64 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 167.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.05 -156.13 0.73 Allowed 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.949 -1.478 . . . . 0.0 107.868 174.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -110.3 -51.78 2.84 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.44 -177.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.4 m -82.35 85.46 6.87 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.224 0.535 . . . . 0.0 110.096 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.496 ' HB2' ' HE3' ' A' ' 34' ' ' LYS . 25.7 mtmt -102.9 174.86 5.69 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.084 0.468 . . . . 0.0 110.903 -174.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.853 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 88.7 mttt -131.63 139.16 49.06 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.133 174.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 68.8 t -130.83 108.51 15.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 121.954 0.883 . . . . 0.0 109.919 171.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.529 HG22 HD11 ' A' ' 53' ' ' ILE . 19.4 p -122.39 122.99 40.31 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.523 -174.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.827 HG22 HD12 ' A' ' 84' ' ' ILE . 84.6 t -83.58 135.17 25.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.871 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.8 m -135.21 122.03 34.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.779 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.697 ' HE1' ' HA ' ' A' ' 42' ' ' ASP . 5.3 p90 -115.9 171.14 7.96 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 119.599 -0.841 . . . . 0.0 112.192 -174.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.756 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -93.36 86.58 5.32 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 170.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.723 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 38.0 t70 6.53 -95.42 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 O-C-N 127.336 2.898 . . . . 0.0 114.846 174.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.57 -28.37 0.35 Allowed Glycine 0 C--N 1.316 -0.542 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.692 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.2 t -109.6 -60.75 1.73 Allowed 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 174.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.645 ' HA ' ' HB1' ' A' ' 41' ' ' ALA . 8.0 p-10 175.46 38.28 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.135 -176.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -91.68 113.2 25.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.076 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.756 ' CH2' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -124.17 118.74 27.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.545 0.688 . . . . 0.0 110.062 167.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.467 ' O ' ' HB3' ' A' ' 49' ' ' ASN . 66.3 t30 -81.59 56.76 3.09 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 170.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 48' ' ' ASN . 33.8 t30 69.07 -55.61 0.55 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -154.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -124.83 -72.34 0.67 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.308 164.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.417 ' CA ' ' HB3' ' A' ' 48' ' ' ASN . . . 86.85 -40.53 3.08 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.248 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -134.49 98.91 4.2 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.484 0.659 . . . . 0.0 110.969 -175.464 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -122.42 143.91 33.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.682 -178.055 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.592 HG22 ' HB ' ' A' ' 38' ' ' VAL . 20.1 tt -131.57 128.45 60.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.195 173.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.23 132.95 35.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.781 0.324 . . . . 0.0 110.801 -176.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.79 159.66 33.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.614 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.3 m -112.3 128.98 56.43 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.444 ' H ' ' HD1' ' A' ' 58' ' ' PHE . 2.1 m-85 -71.5 138.74 49.17 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.276 -177.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.8 m -99.55 -46.14 5.56 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 170.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.73 175.26 21.82 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.583 173.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.76 134.55 58.05 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.248 1.965 . . . . 0.0 110.945 174.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.597 HD12 ' HB2' ' A' ' 67' ' ' TYR . 62.9 mt -75.82 106.63 5.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 28.4 m -49.66 125.24 11.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.063 -174.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.89 7.08 60.12 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.168 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.521 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 50.8 m -151.68 172.27 16.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.137 0.494 . . . . 0.0 111.124 -178.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -101.65 20.37 16.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.225 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.597 ' HB2' HD12 ' A' ' 62' ' ' ILE . 6.7 m-85 -103.71 154.95 18.98 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -114.14 162.58 16.33 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.414 ' HB2' HG12 ' A' ' 62' ' ' ILE . 8.8 t80 -122.6 119.44 30.81 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -167.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.559 ' NE1' HG13 ' A' ' 27' ' ' VAL . 3.7 m95 -116.28 126.76 54.01 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.491 -173.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.636 HG22 ' HB3' ' A' ' 24' ' ' LYS . 40.2 p -134.51 152.9 52.09 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.426 ' HB3' ' O ' ' A' ' 71' ' ' THR . 3.1 p90 -174.22 150.78 1.55 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.703 0.763 . . . . 0.0 111.79 168.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.0 m -112.43 138.42 49.19 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.014 169.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.909 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -132.64 135.78 46.08 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.936 0.398 . . . . 0.0 111.865 -168.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.9 t -88.31 98.18 11.45 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 170.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 19' ' ' SER . 20.1 m -104.21 139.94 23.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -177.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 3.8 mptp? -106.3 39.82 1.73 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.433 0.635 . . . . 0.0 109.93 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 129.71 136.77 4.12 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.063 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.723 ' HA ' ' O ' ' A' ' 42' ' ' ASP . 12.8 tt -160.78 143.8 4.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.014 0.435 . . . . 0.0 110.137 176.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -114.85 -56.16 2.41 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.985 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.644 ' HG2' ' HB3' ' A' ' 41' ' ' ALA . 12.6 pt-20 -150.78 174.51 12.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 117.889 -1.053 . . . . 0.0 108.735 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.562 ' CB ' ' HA ' ' A' ' 40' ' ' TYR . 46.8 p90 -172.76 179.95 2.25 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 120.413 1.461 . . . . 0.0 113.51 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.624 ' CB ' ' HB3' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -161.39 154.67 21.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 113.558 -1.655 . . . . 0.0 108.704 174.776 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.827 HD12 HG22 ' A' ' 38' ' ' VAL . 20.4 mm -99.98 147.43 7.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.979 -173.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.519 ' HD3' ' HE1' ' A' ' 94' ' ' TYR . 3.6 mmmp? -102.06 106.52 17.43 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.833 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.662 ' OH ' HG12 ' A' ' 30' ' ' ILE . 17.2 t80 -86.84 101.07 13.01 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 174.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.853 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 17.5 tt0 -109.5 117.58 34.35 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.383 0.611 . . . . 0.0 110.534 -173.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.1 t -115.47 106.22 20.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.393 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.8 t 53.8 23.92 4.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.419 0.628 . . . . 0.0 110.869 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.49 5.4 48.75 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.927 -177.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.733 ' O ' ' HA ' ' A' ' 87' ' ' GLU . 19.8 tptp -99.24 150.91 21.6 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.9 m -126.28 141.39 51.93 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 122.27 1.033 . . . . 0.0 112.842 -174.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.492 ' HD2' ' CD2' ' A' ' 86' ' ' TYR . 29.4 m-85 -134.8 -174.63 3.65 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 113.286 -1.779 . . . . 0.0 106.791 167.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.519 ' HE1' ' HD3' ' A' ' 85' ' ' LYS . 61.9 m-85 -144.58 137.03 26.47 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -169.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -127.99 112.54 14.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.567 171.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.624 ' HB3' ' CB ' ' A' ' 83' ' ' TYR . 29.4 p-10 -139.31 -43.35 0.45 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.484 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.606 ' HB3' ' O ' ' A' ' 96' ' ' ASN . 4.0 p-10 159.82 -45.18 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 168.15 -65.06 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 65.8 m -158.97 51.18 0.38 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.398 174.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.55 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -137.36 -31.74 0.8 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.55 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 95.7 m-20 84.18 150.77 0.08 Allowed 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.836 0.71 . . . . 0.0 110.156 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 78.3 m-85 -69.68 101.33 1.64 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.242 177.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.06 124.88 28.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.908 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.6 HG21 HG12 ' A' ' 79' ' ' ILE . 15.6 t -94.97 147.24 5.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.015 0.436 . . . . 0.0 110.487 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.4 m -93.75 112.41 24.27 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.791 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.251 1.153 0 CA-C-O 119.264 -0.398 . . . . 0.0 111.001 -177.734 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo . . . . . 0 N--CA 1.461 -0.392 0 N-CA-C 111.052 -0.403 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.7 t 68.19 7.41 5.88 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.181 0.593 . . . . 0.0 111.664 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.6 m -113.92 -64.69 1.27 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 172.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -153.55 -167.32 2.65 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.546 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 5.0 m -84.4 -17.42 39.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.623 0.725 . . . . 0.0 109.17 173.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.64 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.5 p -148.97 153.57 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.287 -176.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -143.01 127.97 18.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.333 177.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.524 HD21 ' CD2' ' A' ' 14' ' ' TYR . 42.9 tp -69.39 137.8 53.09 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.968 0.413 . . . . 0.0 110.319 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.512 ' OD1' ' HE2' ' A' ' 24' ' ' LYS . 12.9 t70 -83.58 -61.78 1.75 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.366 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.2 p -178.86 164.13 1.47 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.735 -176.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.524 ' CD2' HD21 ' A' ' 11' ' ' LEU . 45.9 p90 -158.33 163.14 37.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.772 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -143.81 166.5 24.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.825 0.345 . . . . 0.0 111.287 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.713 ' HD1' ' HD1' ' A' ' 21' ' ' PHE . 8.1 t80 -129.45 141.86 50.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.446 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -150.63 97.87 2.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.079 -176.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.98 -98.26 0.35 Allowed Glycine 0 CA--C 1.508 -0.379 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -172.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -129.64 84.26 2.2 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 162.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 95.5 m -147.45 134.72 20.6 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.065 175.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.713 ' HD1' ' HD1' ' A' ' 16' ' ' TYR . 2.9 t80 -132.88 109.54 9.68 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.0 m -135.6 149.63 49.43 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.926 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 179.6 -167.93 38.11 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.564 ' HB3' HG22 ' A' ' 71' ' ' THR . 0.0 OUTLIER -150.99 160.83 43.68 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.046 0.451 . . . . 0.0 111.307 -179.046 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 17.6 mt -127.3 153.23 36.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.072 -170.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -124.97 111.85 15.89 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.64 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 0.9 OUTLIER -133.3 155.23 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.902 -176.021 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' A' ' 8' ' ' SER . 17.6 ptpt -93.49 152.19 19.23 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.029 175.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -94.92 102.17 13.99 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.756 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.557 HD13 ' HE2' ' A' ' 86' ' ' TYR . 3.8 mp -80.79 -44.52 21.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 172.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.494 ' HB3' ' CG2' ' A' ' 88' ' ' VAL . . . -132.64 159.95 38.09 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.461 -1.245 . . . . 0.0 107.65 174.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -85.26 -29.78 24.33 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.176 -0.466 . . . . 0.0 112.033 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 p -91.67 96.92 10.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.17 0.51 . . . . 0.0 110.274 176.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -111.78 171.09 7.7 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.442 -174.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.786 ' HG3' ' HB3' ' A' ' 87' ' ' GLU . 17.0 ptmt -155.73 103.95 2.3 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.0 0.905 . . . . 0.0 109.578 174.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.7 t -98.21 129.14 48.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-O 121.407 0.622 . . . . 0.0 109.979 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . 1.081 ' HB ' HD11 ' A' ' 53' ' ' ILE . 1.2 p -137.52 134.91 36.23 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.764 -172.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 1.02 ' HB ' HG22 ' A' ' 54' ' ' ILE . 78.2 t -91.96 135.46 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.202 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.441 HG12 ' CZ3' ' A' ' 47' ' ' TRP . 0.1 OUTLIER -114.96 75.3 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 170.788 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.953 ' CD2' HG11 ' A' ' 38' ' ' VAL 0.256 0.1 OUTLIER -102.65 118.36 36.68 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 122.398 1.094 . . . . 0.0 111.081 -176.749 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.917 ' HA ' ' CZ2' ' A' ' 47' ' ' TRP . . . -76.36 146.0 39.08 Favored 'General case' 0 CA--C 1.497 -1.073 0 CA-C-N 113.719 -1.582 . . . . 0.0 112.357 -168.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -79.34 163.7 24.65 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.607 -172.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.813 ' HA2' ' HB2' ' A' ' 80' ' ' LYS . . . -73.17 41.71 0.92 Allowed Glycine 0 C--N 1.329 0.146 0 O-C-N 123.421 0.451 . . . . 0.0 113.694 -171.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.0 m -121.29 -16.58 7.88 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.952 0.405 . . . . 0.0 110.502 176.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.531 ' OD1' ' HG2' ' A' ' 80' ' ' LYS . 3.8 m-20 66.39 47.5 1.73 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.671 177.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.498 ' O ' ' HD1' ' A' ' 47' ' ' TRP . 12.3 t-20 -143.22 87.84 1.99 Allowed 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.837 -171.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.917 ' CZ2' ' HA ' ' A' ' 41' ' ' ALA . 2.4 m0 -124.0 92.73 3.73 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -170.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -101.71 71.53 1.32 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.79 173.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.3 t30 49.52 24.1 1.05 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.504 0.669 . . . . 0.0 111.469 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -69.19 -36.76 77.65 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 173.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 57.97 70.22 1.05 Allowed Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 114.171 -1.377 . . . . 0.0 114.008 168.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.733 ' HB2' ' HZ2' ' A' ' 47' ' ' TRP . 38.2 m-80 -64.83 108.1 1.66 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 174.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 1.081 HD11 ' HB ' ' A' ' 37' ' ' THR . 5.4 tp -107.68 152.51 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 121.56 0.695 . . . . 0.0 112.031 -169.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 1.02 HG22 ' HB ' ' A' ' 38' ' ' VAL . 13.0 tt -142.29 140.5 29.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.031 167.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.45 130.14 35.26 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.723 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.06 153.72 36.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.667 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -105.2 130.66 53.3 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.431 0.634 . . . . 0.0 110.287 -176.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.449 ' H ' ' HD1' ' A' ' 58' ' ' PHE . 1.5 m-85 -71.21 143.16 50.55 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.389 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.0 m -114.65 -37.97 4.12 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 171.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.6 -178.25 17.99 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.773 172.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.02 138.62 78.92 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.461 2.107 . . . . 0.0 111.305 175.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.957 HG12 ' HB2' ' A' ' 69' ' ' TYR . 10.6 mt -81.78 126.56 39.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.63 -174.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.3 m -64.09 117.11 6.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.97 0.414 . . . . 0.0 109.989 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.0 -17.26 32.38 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.657 -176.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.433 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 19.8 m -128.05 173.23 10.23 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -107.56 4.9 26.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.273 0.559 . . . . 0.0 110.429 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.439 ' CE1' ' HB2' ' A' ' 28' ' ' LYS . 20.7 m-85 -100.79 -178.56 3.81 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.329 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' A' ' 69' ' ' TYR . 22.1 tt0 -113.54 170.69 8.06 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.54 -170.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.957 ' HB2' HG12 ' A' ' 62' ' ' ILE . 4.1 t80 -138.53 126.37 22.36 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -162.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.572 ' CD1' HG13 ' A' ' 27' ' ' VAL . 5.8 m95 -126.54 135.81 51.76 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.013 -170.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.564 HG22 ' HB3' ' A' ' 24' ' ' LYS . 20.8 p -135.88 153.77 51.36 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -178.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -158.85 164.15 35.98 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.875 0.845 . . . . 0.0 112.153 171.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 p -142.15 139.52 32.15 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.38 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.89 133.57 17.81 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -173.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.6 t -82.04 100.34 9.68 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 168.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.7 m -92.05 151.11 3.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.284 0.564 . . . . 0.0 110.574 -176.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -98.94 37.59 1.5 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.796 -177.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.63 116.26 3.96 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.551 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.848 HD11 ' HB2' ' A' ' 40' ' ' TYR . 4.2 tt -126.63 152.86 34.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.099 0.476 . . . . 0.0 110.494 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.813 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 17.6 tppt? -131.72 -42.46 1.02 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.22 -174.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 11.3 pt-20 -156.29 172.02 19.2 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-O 118.482 -0.77 . . . . 0.0 109.512 -176.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.75 ' HB3' ' HA ' ' A' ' 40' ' ' TYR . 55.4 p90 -173.01 178.15 2.59 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.427 ' O ' HG23 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -155.4 137.11 14.31 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 113.478 -1.692 . . . . 0.0 107.71 164.219 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.807 HD12 HG22 ' A' ' 38' ' ' VAL . 22.8 mm -91.1 137.31 22.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 O-C-N 121.637 -0.665 . . . . 0.0 109.86 -175.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.41 ' HG2' ' CD1' ' A' ' 94' ' ' TYR . 41.0 mtmt -92.97 129.49 38.87 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 122.048 0.928 . . . . 0.0 111.318 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.7 ' HD2' ' HD2' ' A' ' 93' ' ' TYR . 20.5 t80 -98.65 99.61 10.75 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 113.517 -1.674 . . . . 0.0 107.548 168.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.786 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . 4.2 tt0 -117.13 135.46 53.74 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -176.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.557 ' C ' ' H ' ' A' ' 90' ' ' GLY . 0.4 OUTLIER -146.72 162.61 8.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -178.679 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.1 t -72.39 32.71 0.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 122.066 0.936 . . . . 0.0 110.769 -174.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -147.28 -53.43 0.02 OUTLIER Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 114.638 -1.165 . . . . 0.0 111.34 175.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.493 ' H ' HG13 ' A' ' 88' ' ' VAL . 29.2 mmtp -132.01 -175.83 3.86 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.904 0.859 . . . . 0.0 113.158 -176.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.507 HG23 ' HG3' ' A' ' 87' ' ' GLU . 7.1 m -151.5 141.96 22.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.209 -1.36 . . . . 0.0 110.481 175.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.7 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 18.1 m-85 -145.16 -170.65 3.48 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.41 ' CD1' ' HG2' ' A' ' 85' ' ' LYS . 79.4 m-85 -149.11 127.17 11.97 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.235 0.334 . . . . 0.0 111.526 -173.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -80.51 79.05 7.18 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 167.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -118.55 -70.05 0.81 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.065 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 100' ' ' ALA . 0.7 OUTLIER 148.35 -53.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 -172.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.9 t30 175.82 -56.26 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.225 -1.807 . . . . 0.0 106.993 174.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.5 p -156.73 43.63 0.38 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.501 173.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -106.9 -53.37 2.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.788 -172.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 5.9 m-20 72.19 128.73 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.56 0.537 . . . . 0.0 110.079 -175.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 96.6 m-85 -74.27 118.68 17.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.239 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -78.83 124.52 28.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.998 0.428 . . . . 0.0 110.501 177.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.47 HG21 HD13 ' A' ' 79' ' ' ILE . 41.6 t -79.71 144.16 11.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 173.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.4 t -84.81 65.74 9.29 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.222 0.534 . . . . 0.0 110.66 -172.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.482 -0.77 . . . . 0.0 110.769 178.377 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.551 ' HB3' ' HE1' ' A' ' 67' ' ' TYR . 58.6 Cg_endo . . . . . 0 N--CA 1.463 -0.301 0 N-CA-C 111.072 -0.395 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.5 t -150.85 -55.89 0.16 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.796 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.3 m -69.18 -77.7 0.08 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -175.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.33 -165.2 2.21 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 122.251 -0.281 . . . . 0.0 110.605 -177.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.542 ' HA ' ' HE2' ' A' ' 28' ' ' LYS . 14.6 m -69.39 -18.16 63.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.374 0.607 . . . . 0.0 110.334 176.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.605 HG11 ' HB2' ' A' ' 86' ' ' TYR . 2.8 p -149.68 147.33 16.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -143.99 143.76 31.36 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.753 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.546 HD11 ' HD2' ' A' ' 14' ' ' TYR . 3.8 tp -69.49 132.99 47.17 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.908 0.385 . . . . 0.0 110.685 172.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.63 -64.94 1.08 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 169.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.4 m -166.45 153.19 9.14 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.993 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.546 ' HD2' HD11 ' A' ' 11' ' ' LEU . 20.3 p90 -142.34 157.82 44.39 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 173.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -119.56 157.44 28.37 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.794 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.686 ' HA ' ' O ' ' A' ' 20' ' ' THR . 50.3 t80 -137.92 146.6 43.47 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 172.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -179.25 114.94 0.06 Allowed 'General case' 0 C--N 1.315 -0.924 0 O-C-N 123.683 0.615 . . . . 0.0 109.733 -174.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.73 -103.36 0.31 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -168.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.651 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 24.8 m -124.3 88.47 2.91 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 165.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.686 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 89.4 m -143.6 135.64 26.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.638 176.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.533 ' HZ ' HG11 ' A' ' 38' ' ' VAL . 11.4 t80 -134.01 145.02 49.07 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 120.732 0.301 . . . . 0.0 110.596 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.491 ' HA ' ' HB2' ' A' ' 14' ' ' TYR . 48.1 m 94.6 178.4 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 164.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -171.98 -78.61 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.573 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.607 ' HB3' HG22 ' A' ' 71' ' ' THR . 0.4 OUTLIER -166.55 169.02 14.13 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.977 0.418 . . . . 0.0 111.406 176.724 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 53.4 mt -132.07 154.0 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.577 -170.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -116.13 105.82 13.03 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -178.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 p -125.91 145.17 33.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 O-C-N 121.772 -0.58 . . . . 0.0 112.56 -165.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.542 ' HE2' ' HA ' ' A' ' 8' ' ' SER . 16.3 ttmm -86.41 151.75 23.28 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -101.97 117.63 35.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.415 0.626 . . . . 0.0 111.126 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.614 HG12 ' OH ' ' A' ' 86' ' ' TYR . 28.2 mm -88.24 -48.61 14.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.38 -154.03 0.61 Allowed 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 171.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -104.69 -48.72 3.71 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.25 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.1 m -74.41 80.01 1.9 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.033 176.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.611 ' HE2' ' CZ2' ' A' ' 70' ' ' TRP . 30.3 mtmm -103.74 157.59 16.97 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.597 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 24.9 mtpp -127.66 123.74 36.29 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.06 0.457 . . . . 0.0 109.889 176.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.7 t -117.13 125.53 73.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . 1.008 ' HB ' HD11 ' A' ' 53' ' ' ILE . 0.8 OUTLIER -138.64 129.44 26.48 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.014 -169.619 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.904 ' HB ' HG22 ' A' ' 54' ' ' ILE . 7.1 t -95.53 124.09 47.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.518 0.675 . . . . 0.0 110.742 -178.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.61 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -102.97 108.4 24.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 114.482 -1.236 . . . . 0.0 107.842 177.091 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.681 ' HB2' HG13 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -101.71 147.97 25.83 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-O 122.688 1.232 . . . . 0.0 112.448 174.454 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.787 ' HB3' ' HG2' ' A' ' 81' ' ' GLU . . . -86.07 93.98 9.13 Favored 'General case' 0 N--CA 1.407 -2.577 0 CA-C-N 113.431 -1.713 . . . . 0.0 106.382 165.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.458 ' CG ' ' H ' ' A' ' 43' ' ' GLY . 12.0 t70 -54.53 -163.79 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 111.441 -2.618 . . . . 0.0 112.778 -172.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.458 ' H ' ' CG ' ' A' ' 42' ' ' ASP . . . -58.1 -15.7 22.97 Favored Glycine 0 C--N 1.333 0.361 0 N-CA-C 111.981 -0.448 . . . . 0.0 111.981 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.5 t -58.98 -26.06 64.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 122.408 0.283 . . . . 0.0 110.357 173.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.8 t0 70.21 14.97 7.59 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-O 122.155 0.979 . . . . 0.0 109.243 174.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -159.89 152.49 21.22 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.737 -169.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.499 ' CE3' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -95.82 95.39 8.25 Favored 'General case' 0 N--CA 1.419 -2.009 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.217 173.041 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.63 ' OD1' ' HB2' ' A' ' 50' ' ' ASN . 5.1 p30 -82.97 22.61 0.92 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.498 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 51.19 65.88 1.35 Allowed 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.321 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.63 ' HB2' ' OD1' ' A' ' 48' ' ' ASN . 14.2 t30 -115.66 -61.75 1.69 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.874 -172.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.37 74.9 0.12 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -175.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.66 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 65.9 m-20 -117.34 83.91 2.06 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -175.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 1.008 HD11 ' HB ' ' A' ' 37' ' ' THR . 8.0 tp -119.38 149.93 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-O 121.446 0.641 . . . . 0.0 112.344 -171.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.904 HG22 ' HB ' ' A' ' 38' ' ' VAL . 8.5 tp -128.0 137.62 57.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 169.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.93 140.88 32.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.228 0.537 . . . . 0.0 111.773 -175.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.467 ' HA ' ' HB3' ' A' ' 72' ' ' PHE . . . -94.57 146.62 23.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.552 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.2 p -109.43 148.41 31.19 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.489 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -71.7 141.77 49.84 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -176.752 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.563 ' C ' ' HD2' ' A' ' 61' ' ' PRO . 23.0 t -114.95 -45.2 2.98 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.428 ' N ' ' HD2' ' A' ' 61' ' ' PRO . . . 116.6 -68.31 0.29 Allowed Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.924 -0.931 . . . . 0.0 114.594 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.563 ' HD2' ' C ' ' A' ' 59' ' ' SER . 13.9 Cg_exo -12.71 -42.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.384 1 C-N-CA 128.244 5.963 . . . . 0.0 120.362 -166.168 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.754 HG13 ' HB2' ' A' ' 69' ' ' TYR . 7.2 mt -71.08 88.34 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 119.353 0.979 . . . . 0.0 110.441 -177.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.6 t -114.32 163.56 15.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.494 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.13 21.66 78.77 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.6 m -155.68 174.16 15.68 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -92.32 32.38 1.19 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.068 0.461 . . . . 0.0 110.372 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.551 ' HE1' ' HB3' ' A' ' 4' ' ' PRO . 6.4 m-85 -129.76 -179.33 5.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.207 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -153.4 151.77 30.29 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.303 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.754 ' HB2' HG13 ' A' ' 62' ' ' ILE . 3.2 t80 -104.54 128.93 52.63 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -174.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.611 ' CZ2' ' HE2' ' A' ' 34' ' ' LYS . 15.6 m0 -124.38 151.21 44.68 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.607 HG22 ' HB3' ' A' ' 24' ' ' LYS . 7.7 p -129.94 147.3 51.68 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 -178.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.467 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -160.79 142.35 12.12 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.549 177.621 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 42.1 m -124.85 146.49 49.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.375 176.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.15 112.99 9.03 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -174.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.9 t -78.5 100.47 6.9 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 169.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.651 ' O ' ' HB3' ' A' ' 19' ' ' SER . 30.0 m -103.83 156.44 5.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.397 -177.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.811 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -102.9 -7.42 21.53 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.551 174.67 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 172.6 142.09 3.67 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.615 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.681 HG13 ' HB2' ' A' ' 40' ' ' TYR . 6.0 tt -160.26 142.14 4.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 177.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -121.87 -46.79 2.21 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.594 -174.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.787 ' HG2' ' HB3' ' A' ' 41' ' ' ALA . 9.8 pt-20 -152.51 162.22 41.5 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -176.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.61 ' HB2' ' O ' ' A' ' 39' ' ' VAL . 42.5 p90 -170.79 173.62 5.21 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.7 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.424 ' O ' HG23 ' A' ' 39' ' ' VAL . 0.1 OUTLIER -155.69 153.78 30.51 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 172.524 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.408 HG22 ' N ' ' A' ' 85' ' ' LYS . 2.5 mt -92.6 151.91 3.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.562 0.696 . . . . 0.0 112.219 -170.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.408 ' N ' HG22 ' A' ' 84' ' ' ILE . 18.8 mmtp -107.46 114.09 27.87 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.341 176.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.797 ' HD2' ' HD2' ' A' ' 93' ' ' TYR . 14.9 t80 -91.59 101.29 13.93 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 174.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 23.2 tt0 -105.83 111.17 23.73 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.47 0.652 . . . . 0.0 109.693 -172.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.617 ' HB ' ' H ' ' A' ' 91' ' ' LYS . 14.6 t -108.94 159.84 8.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.211 -176.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.9 t -79.3 33.67 0.24 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 122.002 0.906 . . . . 0.0 109.046 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -164.23 -47.43 0.02 OUTLIER Glycine 0 N--CA 1.436 -1.338 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.805 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.617 ' H ' ' HB ' ' A' ' 88' ' ' VAL . 30.5 mmmt -127.0 -173.87 3.0 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.926 0.869 . . . . 0.0 112.284 -176.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.9 m -150.79 140.79 22.02 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.167 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.797 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 48.5 m-85 -144.43 -166.07 2.29 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -144.26 160.32 41.19 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.75 0.31 . . . . 0.0 111.029 -174.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.463 ' HB2' HG13 ' A' ' 9' ' ' VAL . 25.8 t70 -126.24 115.93 20.5 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 162.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -146.95 -66.89 0.27 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.039 -170.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 155.53 -56.91 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -173.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 50.0 t30 176.14 -48.95 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 112.871 -1.968 . . . . 0.0 106.614 176.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.6 t -170.84 64.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.586 170.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -126.38 -44.85 1.69 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.49 -173.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 91.1 m-20 70.9 144.63 0.06 Allowed 'General case' 0 N--CA 1.471 0.602 0 O-C-N 123.677 0.61 . . . . 0.0 110.597 -175.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.539 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 98.3 m-85 -79.95 111.27 16.12 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.759 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.87 110.69 15.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.094 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.424 HG21 HD13 ' A' ' 79' ' ' ILE . 25.3 t -79.76 142.12 14.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.205 -177.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.8 t -90.96 106.3 18.42 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -176.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.667 -0.683 . . . . 0.0 110.87 -174.94 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo . . . . . 0 C--O 1.233 0.26 0 CA-C-O 120.884 0.285 . . . . 0.0 112.231 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.9 t -130.69 -67.21 0.73 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.328 -0.397 . . . . 0.0 109.999 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.7 t -88.57 -68.96 0.73 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.231 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.49 -159.05 0.93 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.57 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.1 m -62.98 -32.68 74.07 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.553 0.692 . . . . 0.0 109.622 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.868 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.3 p -115.95 150.42 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.574 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.455 ' O ' ' HB3' ' A' ' 26' ' ' TYR . 63.3 tt0 -145.66 125.24 13.25 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.988 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.543 HD21 ' CD2' ' A' ' 14' ' ' TYR . 15.4 tp -68.18 131.66 45.79 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.209 0.528 . . . . 0.0 110.856 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.416 ' OD1' ' HE2' ' A' ' 24' ' ' LYS . 16.0 t70 -81.14 -61.83 1.84 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.853 176.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.6 p -175.95 160.03 2.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.938 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.543 ' CD2' HD21 ' A' ' 11' ' ' LEU . 12.7 p90 -152.04 161.39 42.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.808 177.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -129.29 165.3 21.7 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.734 0.302 . . . . 0.0 110.681 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.601 ' HD1' ' HD1' ' A' ' 21' ' ' PHE . 51.7 t80 -145.6 153.08 40.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.142 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -177.63 129.23 0.15 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.12 -102.56 0.36 Allowed Glycine 0 C--N 1.331 0.275 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -173.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.2 m -136.83 85.66 2.15 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 163.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.56 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 6.5 m -144.8 131.05 19.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.354 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.601 ' HD1' ' HD1' ' A' ' 16' ' ' TYR . 1.4 t80 -133.44 102.47 5.54 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.689 0.757 . . . . 0.0 109.302 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.6 m -134.65 160.08 39.23 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.809 -174.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.28 -143.32 8.66 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.447 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.563 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -162.56 159.96 25.39 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.093 0.473 . . . . 0.0 110.966 178.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.463 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 20.9 mt -122.25 155.53 27.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.179 -173.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.455 ' HB3' ' O ' ' A' ' 10' ' ' GLN . 7.5 t80 -129.05 101.56 6.1 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -172.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.868 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 2.0 m -135.35 145.65 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 O-C-N 121.493 -0.754 . . . . 0.0 112.52 -171.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 67' ' ' TYR . 40.1 ttmt -68.43 133.41 48.6 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.186 177.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.524 ' HB3' ' HB2' ' A' ' 68' ' ' GLU . 24.1 p-10 -95.18 84.51 4.09 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.752 0.787 . . . . 0.0 110.544 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.5 mp -63.72 -47.74 89.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 175.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.44 -176.12 2.83 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.697 171.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -109.99 -55.82 2.4 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.465 -177.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.8 m -75.8 73.58 2.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.379 0.609 . . . . 0.0 110.43 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.405 ' HE2' ' CZ2' ' A' ' 70' ' ' TRP . 28.9 mtmm -102.75 -171.63 1.99 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.761 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -151.63 144.4 24.37 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.9 t -125.53 120.24 57.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.524 0.678 . . . . 0.0 110.552 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.64 ' HB ' HG13 ' A' ' 53' ' ' ILE . 2.1 p -116.17 110.34 18.69 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.261 -176.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 1.058 ' HB ' HG22 ' A' ' 54' ' ' ILE . 81.0 t -83.28 108.35 15.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.78 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.672 HG12 ' HB ' ' A' ' 53' ' ' ILE . 26.5 m -108.77 121.19 61.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.226 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.419 ' HB2' HG13 ' A' ' 79' ' ' ILE . 7.6 p90 -118.39 148.59 42.37 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.631 0.729 . . . . 0.0 111.7 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.727 ' HB3' ' HG2' ' A' ' 81' ' ' GLU . . . -81.59 83.87 6.92 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 171.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -48.59 -166.47 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 111.337 -2.665 . . . . 0.0 113.932 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.2 -21.17 46.07 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-N 116.259 -0.428 . . . . 0.0 113.062 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -65.91 -19.86 66.02 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.654 -0.321 . . . . 0.0 110.526 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.2 t70 72.85 21.98 3.21 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.444 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -168.3 148.96 4.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.493 -175.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.437 ' CZ3' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -87.81 83.74 7.1 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 173.654 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' A' ' 50' ' ' ASN . 6.4 t-20 -78.11 55.49 1.49 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.2 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.0 t30 69.04 -26.77 0.15 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.204 0.601 . . . . 0.0 110.865 -176.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.542 ' H ' ' C ' ' A' ' 48' ' ' ASN . 4.6 p30 -62.14 -43.17 99.43 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.374 174.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 49.97 62.5 4.92 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -176.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 28.8 m-80 -41.78 106.76 0.06 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.882 0.873 . . . . 0.0 111.982 -174.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.672 ' HB ' HG12 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -117.3 138.48 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.833 0.825 . . . . 0.0 112.658 -171.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 1.058 HG22 ' HB ' ' A' ' 38' ' ' VAL . 5.2 tp -111.37 133.99 55.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 168.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.61 113.24 22.34 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.263 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.84 154.47 29.79 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -130.48 130.83 44.71 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.74 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 38.0 p90 -78.27 137.66 38.21 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.902 0.858 . . . . 0.0 111.013 -178.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.9 t -87.1 -26.77 23.49 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.276 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.88 168.91 18.87 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.508 172.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.554 ' HA ' ' HA ' ' A' ' 68' ' ' GLU . 26.1 Cg_exo -63.39 141.87 83.01 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.676 2.251 . . . . 0.0 111.42 174.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.49 HG12 ' HB2' ' A' ' 69' ' ' TYR . 21.8 mt -84.62 109.25 17.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.337 -177.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.6 m -63.11 126.18 26.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.869 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.34 -7.28 34.58 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.166 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.7 m -151.26 165.47 33.9 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -92.71 52.58 1.89 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.953 0.882 . . . . 0.0 109.124 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 4.0 m-85 -130.21 169.24 15.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.536 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 61' ' ' PRO . 9.0 tt0 -125.2 171.54 10.25 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.585 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.49 ' HB2' HG12 ' A' ' 62' ' ' ILE . 3.1 t80 -138.86 111.15 7.43 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -163.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.74 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 11.8 m95 -112.57 130.47 56.01 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.985 -168.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 p -120.26 144.27 47.86 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -155.34 155.9 34.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.848 0.832 . . . . 0.0 112.549 177.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.6 p -142.51 142.46 32.26 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.011 174.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.512 ' HB2' HG12 ' A' ' 54' ' ' ILE . . . -152.68 138.76 18.22 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -175.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 31.3 t -90.58 101.23 13.97 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 166.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.0 m -89.66 160.48 2.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.42 -171.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.55 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -90.37 29.72 1.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.638 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.29 146.23 13.35 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -170.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.419 HG13 ' HB2' ' A' ' 40' ' ' TYR . 2.8 tt -143.28 126.81 13.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.775 0.798 . . . . 0.0 111.409 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 103' ' ' GLN . 28.0 mmtp -93.5 -41.45 9.77 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.22 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.727 ' HG2' ' HB3' ' A' ' 41' ' ' ALA . 13.8 pt-20 -160.68 168.27 25.22 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -169.39 172.76 6.95 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.657 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.472 ' HD2' ' HB3' ' A' ' 96' ' ' ASN . 0.1 OUTLIER -164.72 150.04 9.89 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.573 -1.194 . . . . 0.0 107.854 175.116 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.946 HD12 HG22 ' A' ' 38' ' ' VAL . 9.6 mm -93.3 136.29 25.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.017 -172.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.809 ' HD2' ' HE1' ' A' ' 94' ' ' TYR . 15.6 mmmt -94.4 104.95 16.92 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.602 ' CD2' ' HD2' ' A' ' 93' ' ' TYR . 23.9 t80 -86.76 102.14 13.98 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.338 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -114.42 123.15 48.73 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.638 0.732 . . . . 0.0 109.952 -173.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.506 ' C ' ' H ' ' A' ' 90' ' ' GLY . 9.4 t -112.76 163.79 9.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 t -72.25 20.79 0.06 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.197 0.523 . . . . 0.0 111.082 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -162.85 -40.88 0.02 OUTLIER Glycine 0 N--CA 1.438 -1.232 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.891 178.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.402 ' H ' ' HB ' ' A' ' 88' ' ' VAL . 19.6 tptm -117.35 167.6 11.1 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -174.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.1 m -146.05 145.5 30.6 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.602 ' HD2' ' CD2' ' A' ' 86' ' ' TYR . 60.9 m-85 -142.58 -168.28 2.71 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 175.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.809 ' HE1' ' HD2' ' A' ' 85' ' ' LYS . 21.5 m-85 -146.42 140.39 26.26 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.551 -173.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -110.12 96.24 6.1 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.557 ' O ' ' HB2' ' A' ' 97' ' ' ASN . 27.0 p-10 -137.55 39.17 2.44 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.763 -174.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.557 ' HB2' ' O ' ' A' ' 96' ' ' ASN . 21.8 m-80 70.95 -62.88 0.44 Allowed 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.737 0.648 . . . . 0.0 109.907 -169.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -177.67 -55.78 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 52.8 m -157.02 59.58 0.52 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.448 170.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.611 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -137.86 -49.16 0.57 Allowed 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -170.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.611 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 12.9 m-20 74.14 143.22 0.07 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -169.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.678 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 3.4 m-85 -91.46 97.29 10.98 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 2.5 pm0 -76.95 110.82 11.88 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.427 HG11 ' HE1' ' A' ' 21' ' ' PHE . 22.0 t -79.71 148.84 5.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.742 -167.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.5 m -86.85 81.35 8.18 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.211 176.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.516 HG22 ' CZ ' ' A' ' 16' ' ' TYR . 0.6 OUTLIER . . . . . 0 C--O 1.254 1.302 0 CA-C-O 118.495 -0.764 . . . . 0.0 111.13 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--O 1.237 0.458 0 CA-C-O 121.234 0.431 . . . . 0.0 111.886 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.5 t -95.67 -64.03 1.1 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.643 -174.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.0 t -81.95 -49.74 9.94 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.44 151.33 46.61 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.224 178.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.429 ' HB3' HD11 ' A' ' 30' ' ' ILE . 17.0 m -93.36 -7.79 43.75 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.649 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.78 HG23 HG12 ' A' ' 27' ' ' VAL . 1.7 p -148.44 151.74 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.321 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -142.96 151.67 41.16 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.488 HD11 ' HD2' ' A' ' 14' ' ' TYR . 2.5 tp -77.37 142.59 39.24 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.459 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 31.7 t70 -93.1 -64.54 1.08 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 175.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.906 ' HB2' ' HE3' ' A' ' 24' ' ' LYS . 41.4 m -166.75 155.54 10.48 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.259 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.488 ' HD2' HD11 ' A' ' 11' ' ' LEU . 18.6 p90 -157.17 150.97 24.44 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.635 177.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -130.33 157.54 42.26 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.661 ' HA ' ' O ' ' A' ' 20' ' ' THR . 4.3 m-85 -137.53 153.78 49.94 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.702 -175.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -137.98 75.84 1.55 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.52 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.76 -84.29 0.67 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -171.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.1 m -132.41 86.01 2.29 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.57 0.7 . . . . 0.0 109.414 163.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.661 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 26.1 m -146.79 126.02 13.01 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 170.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 1.005 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 36.7 t80 -107.2 133.48 51.72 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.436 0.636 . . . . 0.0 110.078 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.2 p -153.65 151.26 29.48 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.832 173.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.414 ' C ' ' HD3' ' A' ' 24' ' ' LYS . . . 159.08 -151.33 22.23 Favored Glycine 0 CA--C 1.506 -0.522 0 C-N-CA 119.09 -1.528 . . . . 0.0 113.391 -178.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.906 ' HE3' ' HB2' ' A' ' 13' ' ' SER . 0.2 OUTLIER -166.34 168.83 14.68 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.745 0.418 . . . . 0.0 110.409 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.523 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 17.0 mt -131.61 160.76 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.732 -172.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.458 ' N ' HG22 ' A' ' 25' ' ' ILE . 4.0 t80 -130.59 98.56 4.7 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.349 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.78 HG12 HG23 ' A' ' 9' ' ' VAL . 0.7 OUTLIER -118.56 156.7 20.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.956 -176.723 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -94.72 141.68 28.34 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.424 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.719 HD21 ' HB2' ' A' ' 68' ' ' GLU . 46.1 m-80 -89.79 101.02 13.72 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.823 0.344 . . . . 0.0 111.561 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.547 HD13 ' HE2' ' A' ' 86' ' ' TYR . 4.1 mp -88.64 -34.5 7.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 173.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.422 ' HB3' ' CG1' ' A' ' 88' ' ' VAL . . . -139.95 -178.96 5.68 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.874 174.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -109.86 -15.52 14.08 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.474 -173.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.8 m -100.0 85.55 3.07 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.4 mtmt -110.36 153.61 24.69 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.721 -174.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.593 ' CG ' ' HB3' ' A' ' 87' ' ' GLU . 18.4 ptpt -130.84 129.52 42.44 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 166.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.5 t -119.55 115.75 48.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-O 121.74 0.781 . . . . 0.0 109.604 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.744 ' HB ' HG13 ' A' ' 53' ' ' ILE . 11.0 p -131.91 114.0 14.13 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.449 -170.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.734 HG22 HD12 ' A' ' 84' ' ' ILE . 54.6 t -79.66 125.43 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.467 HG12 ' HB ' ' A' ' 53' ' ' ILE . 29.9 m -122.06 120.89 62.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.894 -176.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.652 ' HB3' ' HB3' ' A' ' 82' ' ' PHE . 9.9 p90 -125.97 148.29 49.29 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.399 -171.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.863 ' HB2' ' CZ2' ' A' ' 47' ' ' TRP . . . -72.18 97.56 1.98 Allowed 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 170.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.468 ' HA ' ' HE1' ' A' ' 40' ' ' TYR . 0.9 OUTLIER -48.84 -178.55 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.469 -1.696 . . . . 0.0 112.119 171.232 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.36 -22.89 52.35 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.956 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.1 t -85.94 -15.76 40.59 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 122.274 0.23 . . . . 0.0 111.441 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.657 ' HA ' ' HB1' ' A' ' 41' ' ' ALA . 3.7 m-20 68.42 30.25 5.43 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.535 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -106.7 99.09 8.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.335 -173.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.863 ' CZ2' ' HB2' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -90.92 110.64 21.88 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 168.835 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -66.8 -139.84 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 170.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -55.3 -45.83 76.25 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 158.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -138.08 -59.06 0.65 Allowed 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 113.343 -1.753 . . . . 0.0 108.435 159.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.27 -50.88 4.4 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.158 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.419 ' ND2' ' H ' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -123.39 105.57 9.93 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.348 0.594 . . . . 0.0 110.729 -177.355 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.744 HG13 ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -138.4 141.72 36.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.886 -174.062 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.723 HG22 ' HB ' ' A' ' 38' ' ' VAL . 9.4 tp -115.43 118.37 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.24 136.16 37.72 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.529 -177.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.47 ' HA ' ' CE1' ' A' ' 72' ' ' PHE . . . -78.02 150.93 33.77 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.653 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -108.07 131.54 54.49 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -70.9 137.92 49.7 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.265 0.555 . . . . 0.0 110.377 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.2 t -106.57 -43.18 4.8 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 146.49 165.42 11.57 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.5 173.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.5 135.69 62.6 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.217 1.944 . . . . 0.0 110.795 175.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.58 HD12 ' HB2' ' A' ' 67' ' ' TYR . 55.5 mt -68.29 108.86 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.8 m -52.46 117.78 3.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.224 -171.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.65 2.58 49.9 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.423 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.583 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 63.6 m -146.84 170.75 16.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.226 0.536 . . . . 0.0 111.318 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -96.12 19.79 11.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.344 1.069 . . . . 0.0 109.459 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.583 ' CD2' ' HB3' ' A' ' 65' ' ' SER . 14.2 m-85 -100.24 157.22 16.75 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.402 178.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.719 ' HB2' HD21 ' A' ' 29' ' ' ASN . 13.2 tt0 -126.03 168.64 13.68 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.571 -175.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -130.11 125.69 35.75 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -167.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.575 ' NE1' HG13 ' A' ' 27' ' ' VAL . 5.9 m95 -127.59 126.43 42.07 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -172.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 p -110.49 152.43 26.36 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 117.909 0.322 . . . . 0.0 111.825 -172.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.544 ' CD2' ' HE1' ' A' ' 21' ' ' PHE . 10.5 m-85 -128.52 152.84 47.81 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 -175.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.7 m -163.18 121.84 2.05 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 111.525 -2.58 . . . . 0.0 107.381 165.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 1.005 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -149.2 132.54 16.54 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.679 -167.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.8 t -98.56 99.25 10.37 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 169.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.2 m -89.82 144.35 9.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.211 0.529 . . . . 0.0 110.809 -172.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -89.19 32.45 0.83 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.835 -173.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.66 142.13 12.87 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -176.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.42 HD11 ' CD2' ' A' ' 82' ' ' PHE . 7.8 tt -153.68 144.13 14.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.379 0.609 . . . . 0.0 111.693 -175.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -104.64 -53.5 2.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.109 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.77 ' HB2' ' HA ' ' A' ' 102' ' ' TYR . 12.8 pt-20 -156.54 161.37 39.99 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.448 -175.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.895 ' HE1' ' HA ' ' A' ' 101' ' ' ASN . 0.1 OUTLIER -145.15 168.0 21.41 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 119.362 0.983 . . . . 0.0 112.594 177.517 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.482 ' HB3' ' HE1' ' A' ' 102' ' ' TYR . 0.3 OUTLIER -152.23 158.42 42.81 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 165.073 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.734 HD12 HG22 ' A' ' 38' ' ' VAL . 5.1 mm -101.12 145.58 11.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 119.359 -0.936 . . . . 0.0 112.194 -165.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 37' ' ' THR . 13.9 mmmt -102.93 108.38 19.54 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.223 -178.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.547 ' HE2' HD13 ' A' ' 30' ' ' ILE . 13.4 t80 -99.34 99.75 10.73 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 173.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.593 ' HB3' ' CG ' ' A' ' 35' ' ' LYS . 28.5 tt0 -116.51 131.04 57.05 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.962 -175.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.422 ' CG1' ' HB3' ' A' ' 31' ' ' ALA . 2.8 t -121.37 165.59 16.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.007 -171.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.41 ' H ' HG12 ' A' ' 88' ' ' VAL . 1.5 p -46.99 -37.43 9.11 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -126.83 -18.34 2.16 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.514 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -118.52 167.11 11.91 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 117.488 0.644 . . . . 0.0 110.465 -174.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.4 m -148.76 145.88 27.8 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 172.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.513 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 37.5 m-85 -136.19 -177.85 4.89 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 174.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.429 ' CE1' ' HD2' ' A' ' 85' ' ' LYS . 71.0 m-85 -150.4 126.97 10.85 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.625 -173.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -131.29 143.92 50.89 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.099 0.475 . . . . 0.0 111.038 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -127.34 10.54 6.8 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 62.89 -75.16 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.902 -173.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.0 t30 173.38 -62.15 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.6 m -139.6 19.77 2.53 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.192 173.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.44 -36.2 15.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.644 0.735 . . . . 0.0 109.617 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.895 ' HA ' ' HE1' ' A' ' 82' ' ' PHE . 15.6 m120 -91.66 178.81 5.82 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.248 173.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.77 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 2.6 m-85 73.02 -111.48 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 124.495 1.122 . . . . 0.0 110.614 -173.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.26 106.79 0.26 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.03 0.919 . . . . 0.0 112.471 -171.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.449 HG12 HG22 ' A' ' 106' ' ' THR . 97.4 t -79.95 114.05 20.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.016 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.4 m -92.01 104.67 17.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.449 HG22 HG12 ' A' ' 104' ' ' VAL . 9.6 t . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.688 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo . . . . . 0 N--CA 1.452 -0.935 0 CA-C-O 120.842 0.268 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.1 t -150.69 -71.41 0.17 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.885 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.6 m -124.61 -44.82 1.95 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.081 0.467 . . . . 0.0 110.538 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.5 136.25 33.02 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.477 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.7 m -81.85 -16.94 49.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.832 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.702 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.7 p -144.91 149.81 16.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.704 -176.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -143.36 131.29 21.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.024 177.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.663 HD13 HD11 ' A' ' 84' ' ' ILE . 51.4 tp -69.55 132.54 46.42 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.393 0.616 . . . . 0.0 110.216 175.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -80.24 -61.04 2.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.38 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.1 p -177.58 162.24 1.79 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.202 -174.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.579 ' CD2' HD21 ' A' ' 11' ' ' LEU . 47.7 p90 -158.16 163.41 37.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.849 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -148.73 162.03 40.59 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.217 0.532 . . . . 0.0 110.254 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.582 ' HD1' ' HD1' ' A' ' 21' ' ' PHE . 30.2 t80 -124.59 142.9 51.02 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.736 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -161.2 124.12 3.18 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.64 -103.96 0.43 Allowed Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -169.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.1 t -137.75 82.65 1.93 Allowed 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 163.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 56.7 m -148.04 140.67 24.57 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.377 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.582 ' HD1' ' HD1' ' A' ' 16' ' ' TYR . 2.5 t80 -128.16 108.18 10.41 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.979 0.895 . . . . 0.0 109.302 176.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.0 p -137.2 148.76 46.75 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.918 -173.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.8 -144.61 5.54 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.874 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.523 ' HB3' HG22 ' A' ' 71' ' ' THR . 5.0 ptmm? -164.71 168.24 18.18 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.981 0.42 . . . . 0.0 111.014 -177.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.744 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 8.3 mt -138.58 158.17 30.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.87 -167.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -133.02 97.18 3.94 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.338 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.702 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 1.5 m -136.16 149.33 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 O-C-N 121.499 -0.75 . . . . 0.0 112.135 -172.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.488 ' HD3' ' CE1' ' A' ' 67' ' ' TYR . 6.7 ttpm? -99.53 133.49 43.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.888 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -87.88 119.9 28.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.0 0.429 . . . . 0.0 111.775 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.525 HG12 ' OH ' ' A' ' 86' ' ' TYR . 32.8 mm -63.66 -45.25 97.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 122.199 0.999 . . . . 0.0 108.634 173.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.592 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . -137.48 143.87 41.96 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 172.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.411 ' HE1' ' OE1' ' A' ' 68' ' ' GLU . 40.6 t80 -60.16 -42.62 95.33 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -164.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.9 m -80.07 69.44 6.46 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.649 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 1.046 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -87.0 -175.4 5.34 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.077 0.465 . . . . 0.0 110.97 176.77 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.862 ' HG3' ' HB3' ' A' ' 87' ' ' GLU . 18.7 ptmt -148.32 126.55 12.19 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.3 t -119.71 121.41 66.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-O 121.655 0.741 . . . . 0.0 110.983 -171.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.622 ' OG1' ' HE3' ' A' ' 85' ' ' LYS . 72.4 p -128.15 117.78 22.2 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.754 -172.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.96 HG22 HD13 ' A' ' 84' ' ' ILE . 16.5 t -82.91 129.14 37.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.14 176.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.3 m -122.35 125.01 72.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.393 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.468 ' HB2' HG13 ' A' ' 79' ' ' ILE . 2.0 p90 -115.77 149.99 37.61 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.357 0.598 . . . . 0.0 112.038 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.683 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . . . -80.45 62.1 4.43 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.056 175.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.731 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 6.6 t70 34.88 -139.51 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 O-C-N 126.357 2.286 . . . . 0.0 111.095 173.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.34 1.26 31.05 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 168.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.528 ' O ' ' HB3' ' A' ' 45' ' ' ASP . 34.4 t -103.55 -17.33 15.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.026 -0.587 . . . . 0.0 112.568 -170.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.567 ' OD1' ' HG3' ' A' ' 81' ' ' GLU . 25.4 t70 77.22 55.96 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -173.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -158.7 141.58 14.54 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.522 -1.217 . . . . 0.0 108.952 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.516 ' CZ2' ' HB2' ' A' ' 41' ' ' ALA . 5.0 m95 -106.39 81.47 1.61 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.268 1.033 . . . . 0.0 109.041 -178.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -88.8 153.67 20.88 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.81 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -74.48 48.79 0.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.596 0.712 . . . . 0.0 110.548 176.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.523 ' HB3' ' OD1' ' A' ' 52' ' ' ASN . 26.7 t30 -86.48 -21.03 27.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.63 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.13 44.89 1.54 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -171.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.523 ' OD1' ' HB3' ' A' ' 50' ' ' ASN . 10.0 m-20 -89.98 40.05 0.99 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.939 -0.63 . . . . 0.0 110.736 -171.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -126.25 144.62 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.53 -176.923 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.933 HG22 ' HB ' ' A' ' 38' ' ' VAL . 6.6 tp -128.53 136.15 60.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 174.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.27 132.0 34.67 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.638 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.87 161.59 14.43 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.517 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.8 t -130.63 138.32 50.04 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.683 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 33.7 p90 -90.89 143.66 26.49 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.068 0.461 . . . . 0.0 110.18 176.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.5 m -94.86 -22.73 17.83 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.423 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 157.01 173.29 25.25 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.972 173.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 68' ' ' GLU . 16.1 Cg_exo -68.13 147.29 72.8 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.564 2.176 . . . . 0.0 111.31 176.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.5 HG12 ' HB2' ' A' ' 69' ' ' TYR . 28.9 mt -85.28 95.9 4.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.3 m -57.14 127.93 34.43 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.214 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.82 6.8 60.39 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.605 -177.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.0 m -148.8 173.17 13.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.716 0.293 . . . . 0.0 110.222 178.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -94.79 4.24 54.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.277 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.488 ' CE1' ' HD3' ' A' ' 28' ' ' LYS . 3.8 m-85 -108.7 167.44 10.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.667 0.746 . . . . 0.0 111.838 -172.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.439 ' HG3' ' H ' ' A' ' 69' ' ' TYR . 1.7 tt0 -108.85 169.94 8.36 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.447 -1.252 . . . . 0.0 108.883 175.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.5 ' HB2' HG12 ' A' ' 62' ' ' ILE . 1.1 t80 -128.37 111.04 12.91 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -164.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.744 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 9.0 m95 -114.68 145.81 41.61 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.537 -168.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.523 HG22 ' HB3' ' A' ' 24' ' ' LYS . 10.4 p -138.3 134.86 34.84 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -137.03 147.4 46.17 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.824 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.5 p -126.23 142.96 51.32 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.921 175.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.523 ' HB2' HG12 ' A' ' 54' ' ' ILE . . . -150.67 114.22 4.93 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.086 0.469 . . . . 0.0 110.939 -174.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.5 t -78.28 99.78 6.43 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 171.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.9 m -101.89 149.29 6.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.296 -173.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -75.34 -21.9 58.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.916 0.865 . . . . 0.0 108.817 173.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.12 172.93 28.0 Favored Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 114.086 -1.415 . . . . 0.0 109.617 -175.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.731 ' HA ' ' O ' ' A' ' 42' ' ' ASP . 3.8 tt -169.92 125.79 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.849 0.833 . . . . 0.0 110.967 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -97.99 -56.74 2.4 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.698 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.683 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 11.7 mm-40 -131.15 170.29 14.75 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.544 ' CE2' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -173.43 158.61 3.53 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 119.271 0.941 . . . . 0.0 111.669 -179.5 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.743 ' HB3' ' HB3' ' A' ' 96' ' ' ASN . 1.5 p90 -159.91 158.04 30.08 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 168.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.96 HD13 HG22 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -94.79 142.75 13.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.505 -172.754 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.622 ' HE3' ' OG1' ' A' ' 37' ' ' THR . 16.7 mtmt -96.81 123.38 40.49 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.138 172.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.525 ' OH ' HG12 ' A' ' 30' ' ' ILE . 18.6 t80 -93.96 100.76 12.85 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 170.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.862 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . 6.7 tp10 -103.65 130.9 51.19 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.451 0.643 . . . . 0.0 109.282 -172.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.959 HG13 ' HE2' ' A' ' 34' ' ' LYS . 21.8 t -127.19 163.18 30.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.581 -173.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.403 ' N ' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -74.42 26.77 0.08 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.32 0.648 . . . . 0.0 111.111 -178.919 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -170.69 -37.36 0.03 OUTLIER Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.595 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.48 ' HG3' ' N ' ' A' ' 92' ' ' THR . 26.8 tptp -127.85 168.29 15.38 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -173.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.48 ' N ' ' HG3' ' A' ' 91' ' ' LYS . 4.0 m -138.06 146.36 42.87 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 172.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.512 ' HD1' ' HD2' ' A' ' 86' ' ' TYR . 33.3 m-85 -137.22 -174.36 3.72 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 171.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -149.22 141.57 24.18 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.062 -174.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -122.67 121.2 35.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.298 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.743 ' HB3' ' HB3' ' A' ' 83' ' ' TYR . 10.9 p30 -145.14 -103.21 0.11 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.925 177.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -113.5 -50.13 2.86 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 122.107 0.956 . . . . 0.0 108.723 -175.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -172.27 -48.56 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.2 p -160.73 47.52 0.23 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.748 172.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.79 -109.24 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.136 -174.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 174.84 142.1 0.05 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.793 -167.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.537 ' CE2' ' HA ' ' A' ' 96' ' ' ASN . 84.2 m-85 -78.39 142.31 37.71 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 173.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.22 125.0 53.67 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.7 0.762 . . . . 0.0 110.517 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.504 HG21 HG12 ' A' ' 79' ' ' ILE . 3.7 t -94.36 129.96 43.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.7 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.9 t -66.89 95.32 0.36 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.124 0.488 . . . . 0.0 110.626 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.128 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.763 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo . . . . . 0 N--CA 1.459 -0.528 0 CA-C-O 121.161 0.4 . . . . 0.0 111.926 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.5 t -110.38 -85.93 0.54 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.666 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.0 m -96.58 -64.26 1.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.654 0.264 . . . . 0.0 110.639 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.48 -174.13 2.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.975 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.422 ' HB3' ' HB3' ' A' ' 28' ' ' LYS . 26.1 m -76.52 -31.96 57.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.091 0.472 . . . . 0.0 110.362 177.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.906 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.2 p -114.68 150.65 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 121.352 0.596 . . . . 0.0 111.818 -173.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -143.05 141.25 31.26 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.667 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.485 HD11 ' HD2' ' A' ' 14' ' ' TYR . 3.5 tp -69.43 140.39 54.1 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.021 0.438 . . . . 0.0 110.107 175.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.406 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 28.2 t70 -90.94 -67.86 0.83 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.579 172.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.7 m -167.18 157.82 11.53 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.868 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.485 ' HD2' HD11 ' A' ' 11' ' ' LEU . 34.3 p90 -156.87 155.82 32.1 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.705 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -130.25 163.19 27.3 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.834 0.35 . . . . 0.0 111.084 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.635 ' HE2' HG23 ' A' ' 106' ' ' THR . 1.7 t80 -128.74 147.06 50.74 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -154.89 101.55 2.29 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -175.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.24 -96.69 0.14 Allowed Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 -168.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.503 ' HA ' ' CE1' ' A' ' 16' ' ' TYR . 10.4 t -136.2 89.51 2.48 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 158.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 16.1 m -144.38 139.64 28.56 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.501 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.829 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 17.8 t80 -108.58 129.27 55.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.8 p -151.39 123.7 8.3 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.074 0.464 . . . . 0.0 109.974 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 14' ' ' TYR . . . -177.91 -157.93 19.73 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.262 -0.97 . . . . 0.0 112.155 -176.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.668 ' HB3' HG22 ' A' ' 71' ' ' THR . 21.2 pttm -159.81 162.3 34.74 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.215 0.531 . . . . 0.0 111.214 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.622 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 11.0 mt -124.67 159.5 30.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.573 -170.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -131.44 100.19 5.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -174.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.906 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 1.9 m -135.77 147.93 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.706 -169.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 79.0 tttt -79.55 131.32 35.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.029 177.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.17 122.61 33.95 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.294 0.569 . . . . 0.0 110.349 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.403 HG12 ' OH ' ' A' ' 86' ' ' TYR . 25.3 mm -76.76 -56.82 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.016 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.649 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . . . -107.34 -80.96 0.56 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.864 173.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -166.47 -73.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.666 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.415 ' C ' ' HD2' ' A' ' 34' ' ' LYS . 20.1 m -83.59 68.73 9.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.309 0.576 . . . . 0.0 110.691 -178.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.654 ' HG3' HG13 ' A' ' 88' ' ' VAL . 6.3 mmmt -94.97 172.51 8.1 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.854 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 89.7 mttt -101.19 129.36 47.1 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.765 -173.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 65.3 t -121.44 107.92 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-O 121.873 0.844 . . . . 0.0 109.288 171.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.574 HG22 HD11 ' A' ' 53' ' ' ILE . 3.1 p -120.3 116.03 24.74 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.552 -173.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.91 HG22 HD12 ' A' ' 84' ' ' ILE . 72.2 t -77.02 136.64 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.006 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.152 176.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.41 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -124.29 107.79 19.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.53 176.811 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.535 ' HA ' ' CB ' ' A' ' 82' ' ' PHE . 0.9 OUTLIER -111.71 137.17 49.97 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 122.58 1.181 . . . . 0.0 110.387 174.736 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.571 ' HB2' ' CE3' ' A' ' 47' ' ' TRP . . . -89.76 97.02 10.95 Favored 'General case' 0 N--CA 1.412 -2.371 0 CA-C-N 113.086 -1.87 . . . . 0.0 107.101 178.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.722 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 1.3 p30 -44.01 163.36 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 O-C-N 124.767 1.292 . . . . 0.0 112.541 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.39 -13.04 14.71 Favored Glycine 0 N--CA 1.464 0.537 0 CA-C-N 115.536 -0.756 . . . . 0.0 114.358 -167.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -110.47 -18.87 13.12 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.426 ' OD1' ' HA ' ' A' ' 47' ' ' TRP . 48.1 t0 -74.03 -92.47 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.084 -1.416 . . . . 0.0 112.278 -173.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 51.95 98.58 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -159.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.571 ' CE3' ' HB2' ' A' ' 41' ' ' ALA . 7.1 m-90 -42.7 113.13 0.43 Allowed 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 -152.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -84.03 31.98 0.49 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 113.364 -1.744 . . . . 0.0 108.484 161.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.5 t30 59.35 46.42 12.63 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 122.19 0.995 . . . . 0.0 108.449 -164.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -83.4 -57.59 3.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.647 -174.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.426 ' H ' ' HD1' ' A' ' 47' ' ' TRP . . . 93.85 96.68 1.55 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.304 -0.951 . . . . 0.0 113.216 174.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 40' ' ' TYR . 86.8 m-20 -135.02 106.69 6.92 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.574 HD11 HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -117.91 144.45 25.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.381 0.61 . . . . 0.0 111.94 -172.06 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.617 HG23 ' HB ' ' A' ' 38' ' ' VAL . 8.1 tp -132.61 116.34 27.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.398 171.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.18 137.96 45.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.889 0.376 . . . . 0.0 111.425 -174.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.31 163.37 23.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.548 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.6 m -121.22 141.57 50.74 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -70.75 139.88 51.19 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.372 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.8 t -108.78 -39.13 5.44 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.45 154.77 7.14 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.545 173.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.36 136.13 49.62 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.198 1.932 . . . . 0.0 111.447 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.589 HD12 ' HB3' ' A' ' 67' ' ' TYR . 67.9 mt -80.59 91.92 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.8 p -60.65 120.92 10.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.642 -172.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 132.65 -34.53 2.47 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.515 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.2 m -134.9 172.53 12.86 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.65 39.15 0.46 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.956 0.407 . . . . 0.0 110.999 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.589 ' HB3' HD12 ' A' ' 62' ' ' ILE . 3.9 m-85 -115.27 159.25 21.24 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.719 0.771 . . . . 0.0 111.369 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -131.12 170.38 14.61 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.11 -178.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.23 122.7 26.98 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -165.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.702 ' CD1' HG13 ' A' ' 27' ' ' VAL . 20.8 m95 -121.9 134.82 54.86 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.813 -169.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.668 HG22 ' HB3' ' A' ' 24' ' ' LYS . 18.0 p -138.21 150.63 46.92 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.508 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 6.6 p90 -173.3 164.1 4.65 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.451 0.643 . . . . 0.0 111.928 172.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.4 p -124.56 144.24 50.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.271 173.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.829 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -137.56 126.5 24.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.573 -174.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.5 t -81.98 99.41 9.1 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 170.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.429 HG11 ' HB2' ' A' ' 21' ' ' PHE . 21.0 m -92.35 154.28 3.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.884 -176.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -116.99 48.22 1.35 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.04 126.18 4.42 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.857 -174.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.639 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 4.8 tt -136.3 128.33 44.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.592 0.711 . . . . 0.0 111.034 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.722 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -83.82 -61.7 1.76 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.947 -175.858 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 16.1 mt-10 -150.83 176.17 11.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.13 -1.395 . . . . 0.0 107.994 -177.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.535 ' CB ' ' HA ' ' A' ' 40' ' ' TYR . 30.3 p90 -169.43 173.47 6.51 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 119.12 -1.032 . . . . 0.0 113.484 174.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.49 154.17 24.4 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.08 173.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.91 HD12 HG22 ' A' ' 38' ' ' VAL . 16.3 mm -99.2 151.82 4.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.438 ' HE3' ' OG1' ' A' ' 37' ' ' THR . 49.4 pttt -131.32 149.54 52.51 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 121.88 0.848 . . . . 0.0 110.413 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.699 ' HD2' ' HD1' ' A' ' 93' ' ' TYR . 21.8 t80 -114.63 108.36 16.72 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 113.78 -1.554 . . . . 0.0 109.675 -174.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.854 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 31.1 tt0 -105.8 116.78 32.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.173 0.511 . . . . 0.0 109.958 -175.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.654 HG13 ' HG3' ' A' ' 34' ' ' LYS . 1.3 t -123.29 166.28 18.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.994 -175.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m -48.15 -46.45 34.5 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.492 0.495 . . . . 0.0 111.553 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -120.79 -9.22 7.69 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.305 -0.95 . . . . 0.0 113.749 -176.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.3 mmtm -128.11 173.81 9.77 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 86' ' ' TYR . 8.3 m -152.9 143.78 22.92 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 113.226 -1.807 . . . . 0.0 109.43 176.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.699 ' HD1' ' HD2' ' A' ' 86' ' ' TYR . 28.1 m-85 -144.01 -173.53 4.02 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -150.14 148.08 28.53 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.437 -174.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -118.18 90.24 3.29 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 169.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -131.14 31.05 4.47 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.957 -172.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 68.3 -59.84 0.43 Allowed 'General case' 0 CA--C 1.532 0.259 0 O-C-N 123.733 0.646 . . . . 0.0 110.535 -172.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -179.68 -53.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.4 t -172.69 69.24 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.191 -1.368 . . . . 0.0 107.518 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.64 -37.87 0.2 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.969 -170.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 70.05 149.08 0.08 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -171.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 95.9 m-85 -83.67 106.32 15.29 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 175.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -68.61 116.06 8.7 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.043 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.566 HG21 HG12 ' A' ' 79' ' ' ILE . 2.8 t -100.21 133.65 42.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.1 t -151.5 148.65 28.3 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.635 HG23 ' HE2' ' A' ' 16' ' ' TYR . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.572 -0.728 . . . . 0.0 110.331 177.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.403 ' HB3' ' HB2' ' A' ' 10' ' ' GLN . 36.9 Cg_endo . . . . . 0 C--O 1.233 0.239 0 CA-C-O 120.849 0.27 . . . . 0.0 112.08 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.6 t -122.03 -28.32 4.43 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.301 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.9 p -70.23 -73.63 0.16 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.761 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.83 174.5 7.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.283 0.564 . . . . 0.0 111.567 -176.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.659 ' HB3' HD11 ' A' ' 30' ' ' ILE . 20.3 m -80.53 -15.53 56.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.07 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.752 HG23 HG12 ' A' ' 27' ' ' VAL . 2.2 p -140.7 151.42 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 120.758 0.313 . . . . 0.0 110.343 -178.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 4' ' ' PRO . 15.1 tt0 -145.16 128.87 17.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.242 -176.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.566 HD21 ' CD2' ' A' ' 14' ' ' TYR . 26.0 tp -69.8 137.22 51.66 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 172.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.59 -49.04 6.07 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.909 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.8 p 174.82 160.02 0.19 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 123.705 0.628 . . . . 0.0 111.744 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.566 ' CD2' HD21 ' A' ' 11' ' ' LEU . 30.4 p90 -156.33 159.67 39.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.726 177.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -151.89 164.22 37.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.618 0.247 . . . . 0.0 110.442 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 19' ' ' SER . 5.3 t80 -115.96 143.33 45.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.034 -174.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -144.17 101.67 3.75 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -175.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.4 -97.78 0.25 Allowed Glycine 0 C--N 1.333 0.368 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -170.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 16' ' ' TYR . 71.4 m -134.43 85.73 2.21 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 158.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 13.8 m -146.51 138.52 24.84 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.088 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.818 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 20.4 t80 -95.52 140.37 30.46 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 171.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 85.7 p -155.58 126.01 6.78 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 174.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.8 -161.85 29.94 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.159 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -160.05 162.75 34.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.835 0.35 . . . . 0.0 110.947 -176.82 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.594 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 25.9 mt -132.38 156.51 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.894 -172.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -126.14 115.83 20.4 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.752 HG12 HG23 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -128.67 149.73 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.022 179.288 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.491 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 92.9 mttt -80.26 152.14 29.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.498 174.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -94.74 85.02 4.33 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.773 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.659 HD11 ' HB3' ' A' ' 8' ' ' SER . 3.8 mm -64.51 -56.84 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.65 -150.7 0.47 Allowed 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 106.725 -1.584 . . . . 0.0 106.725 168.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.467 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 42.9 t80 -112.31 -56.89 2.34 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.514 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.2 t -65.4 111.45 3.06 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 123.301 0.376 . . . . 0.0 110.412 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.54 ' HB2' ' HH2' ' A' ' 70' ' ' TRP . 12.4 mmtp -112.62 167.61 10.33 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 121.121 0.486 . . . . 0.0 110.473 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.755 ' HG3' ' HB3' ' A' ' 87' ' ' GLU . 0.6 OUTLIER -151.88 111.15 3.91 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 171.785 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.4 t -106.7 112.27 39.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-O 121.817 0.818 . . . . 0.0 110.435 -173.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.742 HG22 HD11 ' A' ' 53' ' ' ILE . 14.0 p -119.07 107.99 14.17 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.653 -172.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.992 HG22 HD12 ' A' ' 84' ' ' ILE . 71.7 t -76.45 111.01 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.463 175.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.647 ' HB ' ' CZ2' ' A' ' 47' ' ' TRP . 0.0 OUTLIER -102.62 113.66 39.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.122 170.781 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.657 ' HA ' ' CB ' ' A' ' 82' ' ' PHE . 0.6 OUTLIER -108.24 145.14 34.73 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 122.075 0.941 . . . . 0.0 110.385 171.742 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.709 ' HB2' ' CE3' ' A' ' 47' ' ' TRP . . . -85.67 99.08 11.06 Favored 'General case' 0 N--CA 1.409 -2.498 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.368 169.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -40.27 165.2 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 112.893 -1.958 . . . . 0.0 112.875 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 80' ' ' LYS . . . -62.22 2.18 1.17 Allowed Glycine 0 C--N 1.334 0.426 0 CA-C-N 114.956 -1.02 . . . . 0.0 114.656 -167.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.8 t -80.87 -22.7 39.62 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 116.954 0.377 . . . . 0.0 110.321 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.7 t70 77.52 43.85 0.1 Allowed 'General case' 0 C--N 1.351 0.641 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -142.64 146.47 34.51 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.351 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.709 ' CE3' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -122.16 120.66 34.87 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 119.399 -0.92 . . . . 0.0 112.438 173.177 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -90.93 16.02 10.28 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 169.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 67.03 4.02 3.4 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.354 -1.293 . . . . 0.0 111.6 -175.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -168.8 179.34 4.22 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -171.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.11 27.48 64.13 Favored Glycine 0 CA--C 1.505 -0.536 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.093 178.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -166.57 56.67 0.09 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.263 0.554 . . . . 0.0 109.975 -175.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.742 HD11 HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -133.92 131.15 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-O 122.048 0.928 . . . . 0.0 109.643 -174.071 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.517 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 10.4 mm -110.92 129.76 65.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.982 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.11 96.35 7.77 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 118.263 -1.375 . . . . 0.0 108.255 167.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -47.63 153.88 0.53 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.76 170.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -115.55 131.71 56.85 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.716 -174.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -71.32 143.85 50.14 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.254 177.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.9 t -106.4 -37.51 6.49 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 145.82 173.68 17.3 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.356 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -53.86 134.58 59.8 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 123.037 2.491 . . . . 0.0 111.633 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 1.069 HG12 ' HB2' ' A' ' 69' ' ' TYR . 4.7 mt -83.92 119.07 32.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.695 -172.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.5 p -62.77 118.37 7.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.019 0.438 . . . . 0.0 110.251 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 117.46 -12.44 13.87 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -176.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.5 m -151.94 -179.53 7.55 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -112.11 30.21 7.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.652 0.739 . . . . 0.0 109.9 177.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.491 ' CD1' ' HA ' ' A' ' 28' ' ' LYS . 17.2 m-85 -105.0 -178.37 3.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.792 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.488 ' O ' HD11 ' A' ' 62' ' ' ILE . 15.6 tp10 -111.84 150.9 29.73 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.7 -171.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 1.069 ' HB2' HG12 ' A' ' 62' ' ' ILE . 8.7 t80 -125.2 116.52 22.13 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -165.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.662 ' HE1' HG22 ' A' ' 27' ' ' VAL . 12.7 m95 -108.68 133.43 52.77 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.469 -170.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.42 ' O ' ' HB3' ' A' ' 72' ' ' PHE . 22.5 p -139.76 148.53 42.39 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -176.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.464 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 3.3 p90 -174.02 151.67 1.78 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.913 0.863 . . . . 0.0 112.409 170.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.2 p -117.81 137.55 52.67 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.277 -1.329 . . . . 0.0 107.923 166.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.818 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -129.51 122.14 28.65 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.891 -168.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.71 99.45 1.33 Allowed 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 171.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.407 HG11 ' HB2' ' A' ' 21' ' ' PHE . 28.6 m -103.3 150.24 6.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.659 -175.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.676 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -104.62 38.12 1.97 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.614 0.721 . . . . 0.0 109.65 175.47 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 112.71 149.82 10.8 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.054 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.534 HG13 ' HB2' ' A' ' 40' ' ' TYR . 9.7 tt -154.88 156.41 5.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.466 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 18.2 tptm -140.67 -47.4 0.42 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.953 0.406 . . . . 0.0 111.26 -176.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.443 ' O ' ' HB3' ' A' ' 82' ' ' PHE . 20.8 mt-10 -141.7 162.27 35.88 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -178.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.657 ' CB ' ' HA ' ' A' ' 40' ' ' TYR . 43.1 p90 -172.63 179.26 2.47 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 119.101 -1.039 . . . . 0.0 112.76 169.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.568 ' HB3' ' HB3' ' A' ' 96' ' ' ASN . 0.2 OUTLIER -160.94 143.15 12.43 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 113.519 -1.673 . . . . 0.0 108.38 171.808 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.992 HD12 HG22 ' A' ' 38' ' ' VAL . 14.2 mm -90.48 132.45 35.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.783 -177.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.511 ' HB2' ' OG1' ' A' ' 37' ' ' THR . 1.1 mtmp? -89.8 107.0 18.84 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.719 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.683 ' HB2' HG11 ' A' ' 9' ' ' VAL . 20.2 t80 -85.99 99.16 11.25 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.755 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . 7.9 tt0 -116.73 124.12 48.88 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.072 -174.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 23.1 t -104.6 162.62 4.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.8 t -59.09 -11.48 3.69 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -143.62 2.46 1.48 Allowed Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.834 177.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.8 tptt -141.65 163.6 32.48 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 117.823 0.811 . . . . 0.0 110.438 -176.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.8 m -144.73 142.89 30.39 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.163 0.506 . . . . 0.0 110.874 174.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.497 ' HD2' ' CD2' ' A' ' 86' ' ' TYR . 49.1 m-85 -141.35 -168.62 2.68 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -144.99 143.71 30.65 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.711 0.291 . . . . 0.0 111.246 -174.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.425 ' OD2' ' HB2' ' A' ' 11' ' ' LEU . 29.6 t70 -122.19 98.69 6.05 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 169.068 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.568 ' HB3' ' HB3' ' A' ' 83' ' ' TYR . 4.9 p30 -123.18 -45.25 2.12 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.754 -173.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.519 ' HB3' ' O ' ' A' ' 96' ' ' ASN . 26.4 p-10 166.23 -37.67 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 175.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 178.58 -44.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.4 t -174.09 38.95 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.286 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.26 -90.54 0.11 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 p30 178.77 158.7 0.55 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.845 0.355 . . . . 0.0 110.458 -171.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -90.52 100.65 13.45 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 169.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.558 ' H ' ' CD ' ' A' ' 103' ' ' GLN . 3.1 pm0 -81.06 107.52 13.94 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.513 0.673 . . . . 0.0 110.18 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.5 t -91.43 114.86 29.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.963 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 21.8 m -69.72 102.54 1.92 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.698 -0.668 . . . . 0.0 110.876 -177.592 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.976 0.323 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.9 t -157.94 -60.08 0.08 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.895 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.9 t -78.35 -74.49 0.27 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.519 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -141.22 -160.32 1.07 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -68.48 -30.99 69.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.804 HG23 HG12 ' A' ' 27' ' ' VAL . 2.1 p -128.0 151.43 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.816 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -143.26 129.51 19.85 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.277 178.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.585 HD21 ' CD2' ' A' ' 14' ' ' TYR . 15.2 tp -69.07 140.04 54.85 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.066 0.46 . . . . 0.0 110.08 174.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -88.37 -63.85 1.24 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.101 178.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.0 m -170.58 159.84 6.95 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.196 -176.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.585 ' CD2' HD21 ' A' ' 11' ' ' LEU . 12.4 p90 -158.11 155.92 30.05 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.407 174.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -113.43 154.75 26.46 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 120.829 0.347 . . . . 0.0 110.873 175.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.808 ' CZ ' HG21 ' A' ' 79' ' ' ILE . 1.1 m-85 -160.03 139.21 10.89 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 124.71 1.256 . . . . 0.0 110.412 -175.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 16.8 t70 -175.54 71.31 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.973 167.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 51.7 38.9 45.42 Favored Glycine 0 CA--C 1.507 -0.455 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -170.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.6 m -155.58 158.99 39.3 Favored 'General case' 0 N--CA 1.394 -3.268 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 -161.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.516 HG23 ' HA ' ' A' ' 75' ' ' SER . 52.9 m -60.32 143.78 52.14 Favored 'General case' 0 C--N 1.263 -3.191 0 CA-C-N 112.899 -1.955 . . . . 0.0 111.219 -173.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.659 ' HD2' ' CZ ' ' A' ' 16' ' ' TYR . 2.1 t80 -78.59 141.87 37.74 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.6 m -161.54 124.89 3.19 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.736 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.73 -153.03 9.95 Favored Glycine 0 N--CA 1.438 -1.167 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -176.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.754 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -160.05 163.61 33.82 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.014 0.435 . . . . 0.0 111.371 -177.834 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.726 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 24.9 mt -127.55 156.81 39.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.645 -170.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -132.77 107.29 8.27 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.114 0.565 . . . . 0.0 109.647 -172.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.804 HG12 HG23 ' A' ' 9' ' ' VAL . 0.7 OUTLIER -133.95 151.89 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.208 -0.932 . . . . 0.0 112.178 -172.062 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.446 ' HD3' ' CE1' ' A' ' 67' ' ' TYR . 23.8 tptm -76.35 129.29 36.4 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 172.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.611 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 23.7 p-10 -86.6 103.86 15.49 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.574 0.702 . . . . 0.0 110.376 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.512 HG12 ' OH ' ' A' ' 86' ' ' TYR . 16.3 mm -72.99 -60.3 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-N 115.47 -0.787 . . . . 0.0 108.882 -176.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.78 -135.05 0.35 Allowed 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.148 172.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -120.54 -52.4 2.14 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.022 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.5 t -78.16 116.21 18.45 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.784 ' HB2' ' HH2' ' A' ' 70' ' ' TRP . 27.5 mmtm -116.76 167.33 11.19 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.24 0.543 . . . . 0.0 110.619 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.537 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 9.0 mtpm? -138.42 97.72 3.43 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.786 173.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.9 t -98.75 124.44 51.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.9 0.857 . . . . 0.0 110.713 -178.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.784 ' HB ' HG13 ' A' ' 53' ' ' ILE . 45.2 p -132.69 116.4 16.57 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.286 -1.324 . . . . 0.0 110.638 -170.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.901 HG22 HD13 ' A' ' 84' ' ' ILE . 44.9 t -84.92 132.75 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-O 121.322 0.582 . . . . 0.0 109.514 173.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.701 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -118.9 111.61 34.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.161 175.015 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.62 ' HA ' ' CB ' ' A' ' 82' ' ' PHE . 5.1 p90 -115.05 139.58 49.76 Favored 'General case' 0 CA--C 1.485 -1.528 0 CA-C-O 122.667 1.222 . . . . 0.0 110.901 175.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.518 ' HB2' ' CZ3' ' A' ' 47' ' ' TRP . . . -86.2 103.0 14.43 Favored 'General case' 0 N--CA 1.405 -2.714 0 CA-C-N 112.69 -2.05 . . . . 0.0 107.462 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.521 ' HB2' ' OD1' ' A' ' 52' ' ' ASN . 3.4 t70 -48.15 -168.49 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 111.694 -2.503 . . . . 0.0 113.796 -174.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.53 -17.9 28.2 Favored Glycine 0 C--N 1.335 0.5 0 O-C-N 122.106 -0.371 . . . . 0.0 112.513 -177.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 41.6 t -65.83 -16.59 63.96 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 122.825 0.45 . . . . 0.0 110.823 175.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.495 ' HB3' ' HG3' ' A' ' 80' ' ' LYS . 3.7 p30 51.46 33.77 10.91 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.632 1.173 . . . . 0.0 110.632 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -163.63 139.76 6.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.436 -169.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.518 ' CZ3' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -91.33 88.94 7.06 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 120.029 -0.668 . . . . 0.0 112.326 174.516 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.63 47.3 1.35 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.641 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 60.12 31.63 20.63 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.113 -172.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -92.37 127.4 37.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.231 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -96.37 60.43 1.3 Allowed Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.56 -174.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.521 ' OD1' ' HB2' ' A' ' 42' ' ' ASP . 13.5 m120 -76.78 75.9 3.41 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.795 0.331 . . . . 0.0 110.431 175.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.784 HG13 ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -109.23 136.21 45.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.331 0.586 . . . . 0.0 110.737 178.751 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.73 HG22 ' HB ' ' A' ' 38' ' ' VAL . 8.0 tp -117.24 121.92 68.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.638 174.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.66 134.01 37.17 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.912 0.387 . . . . 0.0 110.411 -176.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.07 161.2 18.28 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.977 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 m -114.44 176.05 5.22 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.741 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 0.4 OUTLIER -139.22 146.47 40.53 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.782 0.801 . . . . 0.0 111.517 -174.167 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.8 t -88.39 -36.11 16.75 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.329 -1.305 . . . . 0.0 108.712 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 143.46 -172.08 24.96 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.288 174.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -65.85 138.25 52.41 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.75 2.3 . . . . 0.0 111.404 175.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.644 HG12 ' HB2' ' A' ' 69' ' ' TYR . 20.0 mt -81.24 109.84 16.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.408 -176.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.5 p -65.64 135.48 55.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.272 0.558 . . . . 0.0 111.274 -176.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.89 -4.64 81.81 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.459 -0.657 . . . . 0.0 111.459 -177.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.6 m -140.72 171.52 13.98 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -108.31 46.29 0.97 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.17 0.509 . . . . 0.0 110.002 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.502 ' HB3' HD12 ' A' ' 62' ' ' ILE . 2.3 m-85 -125.88 172.33 9.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.425 -178.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 29' ' ' ASN . 17.5 tt0 -120.39 167.07 12.72 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.644 ' HB2' HG12 ' A' ' 62' ' ' ILE . 4.3 t80 -141.59 121.72 13.81 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -164.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.784 ' HH2' ' HB2' ' A' ' 34' ' ' LYS . 25.4 m95 -118.46 145.55 45.17 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.798 -168.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.533 HG22 ' HB3' ' A' ' 24' ' ' LYS . 1.4 p -147.29 142.38 27.1 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 123.744 0.652 . . . . 0.0 109.527 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.406 ' HB3' ' O ' ' A' ' 71' ' ' THR . 2.7 p90 -173.99 159.49 3.33 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.442 0.639 . . . . 0.0 112.585 173.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.3 p -117.67 143.98 45.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.416 172.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -142.25 106.09 4.71 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -171.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.516 ' HA ' HG23 ' A' ' 20' ' ' THR . 13.3 t -68.6 109.13 3.62 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 174.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.578 HG21 ' HE1' ' A' ' 16' ' ' TYR . 12.2 m -100.52 155.59 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.002 -173.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -86.36 -24.01 25.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.21 -175.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.36 107.08 0.35 Allowed Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -177.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.808 HG21 ' CZ ' ' A' ' 16' ' ' TYR . 8.9 tt -112.34 138.04 42.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.418 0.628 . . . . 0.0 111.722 -172.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.495 ' HG3' ' HB3' ' A' ' 45' ' ' ASP . 74.5 mmtt -117.0 -47.42 2.69 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.213 -176.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.473 ' OE1' ' HB3' ' A' ' 103' ' ' GLN . 11.7 mm-40 -146.21 154.02 41.28 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -175.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.701 ' HB2' ' O ' ' A' ' 39' ' ' VAL . 3.9 p90 -172.14 -179.06 2.24 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 118.521 -1.272 . . . . 0.0 114.032 174.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.582 ' HA ' ' CE1' ' A' ' 102' ' ' TYR . 0.2 OUTLIER -162.17 164.7 27.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 113.48 -1.691 . . . . 0.0 108.644 176.632 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.901 HD13 HG22 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -104.23 144.24 14.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.958 -177.993 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.531 ' HB2' ' OG1' ' A' ' 37' ' ' THR . 6.6 mtmp? -104.86 130.07 53.07 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 121.069 0.461 . . . . 0.0 109.905 176.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.715 ' HD2' ' HD2' ' A' ' 93' ' ' TYR . 19.4 t80 -102.63 102.17 12.37 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.46 177.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.537 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 28.5 tt0 -108.64 129.35 55.33 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.566 ' C ' ' H ' ' A' ' 90' ' ' GLY . 2.6 t -122.06 166.47 16.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -174.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.8 p -66.45 28.08 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.344 0.592 . . . . 0.0 112.262 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . 171.96 -34.61 0.14 Allowed Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.851 177.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.531 ' HA ' ' HE3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -102.44 164.47 11.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.841 0.353 . . . . 0.0 111.338 -177.33 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.4 m -148.59 142.92 26.21 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 173.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.715 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 47.3 m-85 -141.41 -168.1 2.56 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.6 133.87 15.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.628 -170.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -118.98 94.92 4.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.225 0.536 . . . . 0.0 109.995 172.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.468 ' O ' ' HB2' ' A' ' 97' ' ' ASN . 28.9 p-10 -125.36 27.62 6.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.275 -178.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 96' ' ' ASN . 2.9 m-20 72.65 -58.06 0.61 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.748 -172.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.2 t30 177.69 -48.95 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 176.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.1 p -164.89 29.69 0.06 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.124 174.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -104.27 -37.45 7.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.411 -171.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.2 p30 47.49 101.56 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 O-C-N 123.965 0.79 . . . . 0.0 112.891 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.582 ' CE1' ' HA ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -50.78 116.49 1.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.91 -168.694 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.473 ' HB3' ' OE1' ' A' ' 81' ' ' GLU . 0.4 OUTLIER -88.85 124.96 34.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.533 0.682 . . . . 0.0 110.292 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.476 HG21 HG12 ' A' ' 79' ' ' ILE . 3.4 t -97.38 148.65 5.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.722 -1.127 . . . . 0.0 110.564 -174.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.2 m -95.38 75.36 3.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.418 0.628 . . . . 0.0 110.275 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.9 m . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.307 -0.854 . . . . 0.0 109.653 178.032 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo . . . . . 0 C--O 1.234 0.298 0 CA-C-O 120.919 0.3 . . . . 0.0 112.331 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.8 t -129.72 -54.17 1.15 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.683 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.9 t -108.42 -74.99 0.64 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.772 -0.194 . . . . 0.0 110.617 -178.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.77 -173.13 2.25 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.523 0.201 . . . . 0.0 111.186 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.9 m -65.44 -36.07 82.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.217 0.532 . . . . 0.0 110.528 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.698 HG23 HG12 ' A' ' 27' ' ' VAL . 1.7 p -123.8 152.11 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.5 -176.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -142.57 132.5 24.31 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.094 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.482 HD21 ' CD2' ' A' ' 14' ' ' TYR . 34.8 tp -71.13 136.04 47.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.064 0.459 . . . . 0.0 110.304 176.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -88.12 -58.86 2.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.94 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.3 p -179.54 160.46 0.96 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.8 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.482 ' CD2' HD21 ' A' ' 11' ' ' LEU . 44.1 p90 -157.54 163.14 38.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.481 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -133.46 158.57 42.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.929 0.395 . . . . 0.0 110.623 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.733 ' CE2' ' HB ' ' A' ' 106' ' ' THR . 0.5 OUTLIER -139.53 138.42 36.29 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.57 -179.041 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -166.5 130.59 2.07 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.78 -104.18 0.36 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -168.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.2 t -140.86 85.05 1.97 Allowed 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 161.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.528 ' O ' ' HD1' ' A' ' 16' ' ' TYR . 88.9 m -147.31 130.23 16.24 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.411 173.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.462 ' HD1' ' CD1' ' A' ' 16' ' ' TYR . 3.5 t80 -128.3 104.05 7.51 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.567 0.699 . . . . 0.0 109.56 -174.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.6 m -138.32 150.1 46.28 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.797 -176.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.32 -141.5 3.75 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 -178.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 2.6 ptpp? -162.6 166.82 24.17 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.825 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.709 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 38.3 mt -133.66 157.16 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 -170.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -133.03 110.14 10.03 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.31 0.644 . . . . 0.0 109.657 -173.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.698 HG12 HG23 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -137.97 151.49 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.206 -0.934 . . . . 0.0 113.101 -172.393 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 46.4 tptt -78.83 140.86 38.11 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.899 174.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.537 ' OD1' ' HB2' ' A' ' 68' ' ' GLU . 7.2 m-20 -88.31 96.76 10.7 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.696 0.284 . . . . 0.0 110.783 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.606 HG12 ' OH ' ' A' ' 86' ' ' TYR . 7.7 mm -75.98 -54.84 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 176.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.89 -157.5 0.62 Allowed 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.201 -1.363 . . . . 0.0 107.906 172.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -113.33 -59.03 2.07 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.603 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.6 m -76.85 87.82 3.44 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 175.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.454 ' HE2' ' CZ2' ' A' ' 70' ' ' TRP . 27.9 mtmm -104.34 158.4 16.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.456 -174.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.766 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 47.8 mttp -123.79 138.46 54.5 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 175.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.1 t -128.0 115.52 39.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.331 0.586 . . . . 0.0 110.115 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.903 ' HB ' HG13 ' A' ' 53' ' ' ILE . 69.1 p -119.74 120.3 36.15 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.494 -171.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 1.005 ' HB ' HG22 ' A' ' 54' ' ' ILE . 79.6 t -88.52 110.42 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.703 177.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.706 HG21 ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -97.13 120.29 46.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 170.686 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.612 ' HA ' ' HZ2' ' A' ' 47' ' ' TRP . 5.3 p90 -119.99 138.23 53.61 Favored 'General case' 0 CA--C 1.49 -1.347 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.032 171.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.603 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . . . -76.9 88.06 3.47 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 113.133 -1.849 . . . . 0.0 108.017 -175.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' A' ' 43' ' ' GLY . 42.8 t0 -43.75 -170.37 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 109.221 -3.627 . . . . 0.0 113.007 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.502 ' H ' ' CG ' ' A' ' 42' ' ' ASP . . . -61.5 -10.39 22.98 Favored Glycine 0 CA--C 1.522 0.469 0 O-C-N 121.983 -0.448 . . . . 0.0 112.721 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -76.11 -14.19 60.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.904 0.383 . . . . 0.0 110.148 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 76.06 12.59 2.8 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.122 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -170.81 179.35 3.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.951 -178.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.612 ' HZ2' ' HA ' ' A' ' 40' ' ' TYR . 23.0 m-90 -105.19 107.93 19.18 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.501 169.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -76.45 -162.82 0.27 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 170.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -75.11 58.31 0.89 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.438 0.637 . . . . 0.0 109.72 171.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -128.58 -50.68 1.26 Allowed 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.187 -174.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.66 76.2 0.95 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.95 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.402 ' H ' ' HD1' ' A' ' 47' ' ' TRP . 3.5 m-20 -77.94 80.11 4.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.903 HG13 ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -119.58 138.45 50.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.555 0.693 . . . . 0.0 112.822 -170.312 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 1.005 HG22 ' HB ' ' A' ' 38' ' ' VAL . 8.4 tp -112.31 133.47 57.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 169.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.65 126.7 34.13 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.614 -177.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.56 158.85 22.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.461 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.0 t -130.04 133.44 46.73 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.624 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 31.2 p90 -76.29 141.11 41.73 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 121.456 0.646 . . . . 0.0 110.267 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.4 t -93.48 -26.36 17.21 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.842 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 160.52 171.08 25.96 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.796 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.37 144.23 61.06 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.447 2.098 . . . . 0.0 110.843 174.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.743 HD12 ' HB3' ' A' ' 67' ' ' TYR . 20.7 mt -79.98 109.74 14.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.198 0.523 . . . . 0.0 109.9 -178.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.5 p -66.54 122.74 18.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.692 -175.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.02 -2.37 30.05 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.5 m -153.28 179.34 8.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -107.1 38.68 2.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.937 0.875 . . . . 0.0 109.899 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.743 ' HB3' HD12 ' A' ' 62' ' ' ILE . 1.8 m-85 -102.41 168.76 9.11 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.222 177.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.537 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . 10.0 tt0 -124.02 165.1 18.05 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.579 ' HB2' HG12 ' A' ' 62' ' ' ILE . 2.0 t80 -136.32 111.25 8.84 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -161.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.709 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 8.0 m95 -111.56 144.92 40.02 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.288 -166.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.439 ' HA ' ' HB2' ' A' ' 24' ' ' LYS . 5.0 p -133.04 131.86 41.14 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -132.6 151.06 52.06 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 118.884 -1.126 . . . . 0.0 111.733 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.2 m -131.68 141.29 49.54 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.053 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -150.56 113.74 4.85 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.069 0.461 . . . . 0.0 111.167 -175.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.2 t -77.7 99.07 5.69 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 168.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.6 m -95.15 157.22 3.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.416 0.627 . . . . 0.0 111.26 -169.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -96.42 -16.77 21.03 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.018 -175.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.17 82.63 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.942 -0.646 . . . . 0.0 111.969 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.471 HG12 HG21 ' A' ' 104' ' ' VAL . 4.5 tt -90.49 133.19 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.485 0.66 . . . . 0.0 111.108 -178.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -114.47 -40.38 3.63 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.298 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.603 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 37.0 mm-40 -141.37 167.19 22.76 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.443 ' HZ ' ' CE2' ' A' ' 14' ' ' TYR . 28.2 p90 -172.1 170.71 5.17 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 119.338 0.972 . . . . 0.0 111.864 174.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.683 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 0.7 OUTLIER -162.9 150.7 13.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.235 168.09 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.979 HD12 HG22 ' A' ' 38' ' ' VAL . 10.2 mm -100.94 139.46 22.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.673 -174.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.706 ' HE3' HG21 ' A' ' 39' ' ' VAL . 88.8 mttt -103.86 151.83 22.65 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.471 0.653 . . . . 0.0 110.269 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.655 ' HD2' ' HD2' ' A' ' 93' ' ' TYR . 25.0 t80 -123.24 106.66 10.92 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.765 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.766 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -103.19 128.47 50.15 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.304 0.573 . . . . 0.0 110.218 -176.966 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.452 ' HB ' ' H ' ' A' ' 91' ' ' LYS . 11.4 t -126.54 158.04 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.735 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.9 m -67.32 -3.18 7.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -176.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -136.61 -27.87 0.37 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.512 176.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.452 ' H ' ' HB ' ' A' ' 88' ' ' VAL . 28.1 mmtt -129.73 177.62 7.11 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 122.189 0.995 . . . . 0.0 112.483 -174.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.5 m -150.39 141.9 23.47 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.232 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.655 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 33.0 m-85 -143.82 -172.73 3.8 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -150.47 148.43 28.72 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.187 -174.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -119.79 98.82 6.29 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 169.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.683 ' HB3' ' HB2' ' A' ' 83' ' ' TYR . 23.0 p-10 -145.01 61.9 1.31 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.418 -174.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 71.13 -65.4 0.34 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.933 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -157.91 -53.81 0.07 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 174.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.6 m -157.17 44.69 0.37 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.706 -1.133 . . . . 0.0 110.001 169.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.42 -109.08 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -176.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 176.07 146.26 0.09 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.777 0.831 . . . . 0.0 108.831 -168.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -85.54 142.84 28.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.656 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -92.88 106.66 18.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.348 -175.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.471 HG21 HG12 ' A' ' 79' ' ' ILE . 22.0 t -94.39 107.44 19.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.7 m -90.66 57.62 3.65 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -171.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.733 ' HB ' ' CE2' ' A' ' 16' ' ' TYR . 87.9 m . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.689 175.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.609 ' HG3' ' CE1' ' A' ' 26' ' ' TYR . 13.5 Cg_endo . . . . . 0 N--CA 1.46 -0.487 0 CA-C-O 121.637 0.599 . . . . 0.0 112.69 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.4 t -85.85 49.61 1.81 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.761 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.519 ' OG ' ' HB2' ' A' ' 10' ' ' GLN . 13.6 t -108.45 -175.4 2.76 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.244 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.21 -151.0 0.27 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.294 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.1 -29.54 69.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.125 0.488 . . . . 0.0 110.603 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.629 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.3 p -150.24 149.06 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.725 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.519 ' HB2' ' OG ' ' A' ' 6' ' ' SER . 10.9 tt0 -138.75 154.78 48.56 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.597 HD21 ' CD2' ' A' ' 14' ' ' TYR . 16.4 tp -85.55 143.11 28.69 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.025 0.44 . . . . 0.0 110.012 172.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -87.41 -65.66 0.99 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.602 173.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.2 p -177.68 160.38 1.54 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.587 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.597 ' CD2' HD21 ' A' ' 11' ' ' LEU . 43.5 p90 -152.12 162.25 41.4 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.269 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -132.6 157.12 45.58 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -133.17 146.61 51.69 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.159 -174.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 18' ' ' GLY . 13.8 t70 -123.56 -150.35 0.45 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.671 -1.149 . . . . 0.0 107.954 -177.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.413 ' H ' ' CG ' ' A' ' 17' ' ' ASP . . . -50.61 -64.43 3.69 Favored Glycine 0 N--CA 1.458 0.111 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 171.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.2 t -145.63 86.76 1.75 Allowed 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 161.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.6 m -146.42 140.3 26.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.033 178.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.838 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 12.2 t80 -116.38 139.55 50.29 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.4 m -163.17 133.93 4.66 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 174.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 14' ' ' TYR . . . 172.86 -150.34 12.37 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.116 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.599 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 18.5 pttp -159.41 168.74 25.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.185 0.517 . . . . 0.0 111.451 -177.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.776 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 12.9 mt -132.78 160.78 42.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.644 -167.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.609 ' CE1' ' HG3' ' A' ' 4' ' ' PRO . 5.6 t80 -132.5 96.23 3.8 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 122.769 0.428 . . . . 0.0 110.317 -173.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.741 HG13 ' CD1' ' A' ' 70' ' ' TRP . 1.8 m -136.99 151.92 27.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 121.166 -0.959 . . . . 0.0 112.022 -170.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -72.69 143.88 47.92 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.746 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -102.28 95.03 6.03 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.732 0.777 . . . . 0.0 111.096 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.408 HD12 HG21 ' A' ' 88' ' ' VAL . 62.6 mt -75.78 -57.8 5.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.464 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.81 -160.87 0.75 Allowed 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.456 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 18.9 t80 -116.48 -23.48 8.26 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.838 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.0 m -78.02 68.2 4.01 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 169.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.456 ' HE2' ' HA ' ' A' ' 32' ' ' TYR . 27.6 mtmt -90.9 125.55 35.79 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.874 -176.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.514 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 9.4 mtpm? -126.28 113.57 17.13 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 69.9 t -113.24 113.41 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-O 121.781 0.801 . . . . 0.0 110.375 -173.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.867 ' HB ' HG13 ' A' ' 53' ' ' ILE . 6.6 p -122.42 111.61 17.07 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.364 -173.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 1.058 ' HB ' HG22 ' A' ' 54' ' ' ILE . 95.0 t -79.66 111.62 16.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.375 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 51' ' ' GLY . 1.0 OUTLIER -107.66 110.08 30.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.663 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.799 ' CE1' ' HB2' ' A' ' 42' ' ' ASP . 0.3 OUTLIER -105.19 154.48 20.15 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.915 0.865 . . . . 0.0 112.875 -174.779 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.728 ' HB2' ' CZ2' ' A' ' 47' ' ' TRP . . . -78.26 76.29 4.77 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 168.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.799 ' HB2' ' CE1' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -54.08 159.06 1.94 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 112.351 -2.204 . . . . 0.0 112.399 176.732 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.49 -109.29 1.88 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 113.744 -1.571 . . . . 0.0 113.455 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.491 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 16.0 m -89.41 -48.0 7.63 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 -175.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 44' ' ' SER . 6.1 p-10 170.69 28.73 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.523 0.729 . . . . 0.0 110.29 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -107.15 114.68 28.89 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -163.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.728 ' CZ2' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -101.93 83.9 2.45 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.986 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -74.95 44.3 0.23 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.886 -178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 51.09 33.52 9.35 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.664 0.745 . . . . 0.0 110.785 -176.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -110.73 -16.68 13.54 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.696 ' O ' HG13 ' A' ' 39' ' ' VAL . . . 77.12 -60.18 3.52 Favored Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.487 -174.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.56 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 82.6 m-20 74.83 73.57 0.1 Allowed 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.867 HG13 ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -109.0 138.84 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.943 -163.009 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 1.058 HG22 ' HB ' ' A' ' 38' ' ' VAL . 8.9 tp -116.12 127.9 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 114.322 -1.308 . . . . 0.0 108.03 168.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.5 129.84 34.99 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.888 -176.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -97.45 158.39 15.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.986 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 99.0 p -123.94 175.57 6.86 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.732 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 19.3 p90 -127.97 145.6 50.92 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.266 0.555 . . . . 0.0 111.472 -178.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.1 m -84.08 -37.7 21.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.11 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 157.35 161.73 11.07 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.315 175.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.898 ' HA ' ' HA ' ' A' ' 68' ' ' GLU . 28.5 Cg_endo -58.19 152.16 54.53 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 123.065 2.51 . . . . 0.0 112.028 177.11 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 23.9 mt -86.75 103.56 13.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.177 -175.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.5 p -62.93 120.54 11.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.211 0.529 . . . . 0.0 111.063 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.66 -7.54 29.9 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -175.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -141.87 171.37 14.15 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -105.21 38.19 2.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.641 0.734 . . . . 0.0 110.133 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -120.3 177.37 5.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.747 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.898 ' HA ' ' HA ' ' A' ' 61' ' ' PRO . 12.3 tt0 -128.3 166.98 17.58 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.347 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -124.58 114.81 19.87 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 -169.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.776 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 14.4 m95 -111.88 148.05 34.49 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.818 -167.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.592 HG22 ' HB3' ' A' ' 24' ' ' LYS . 1.6 p -150.51 146.37 26.56 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.322 0.388 . . . . 0.0 110.496 -172.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.414 ' HB3' ' O ' ' A' ' 71' ' ' THR . 4.2 p90 -175.19 157.57 2.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.578 0.704 . . . . 0.0 112.016 172.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.1 p -114.62 146.31 40.97 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.838 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -139.02 113.68 9.1 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -173.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.5 m -72.87 100.49 2.92 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 169.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.7 m -103.45 157.27 5.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.341 -176.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.18 14.44 10.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.495 0.664 . . . . 0.0 110.482 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.66 138.93 2.56 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.974 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.567 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 14.9 tt -171.49 153.23 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.216 0.532 . . . . 0.0 110.25 177.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 44' ' ' SER . 16.2 tppt? -135.64 -47.97 0.69 Allowed 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.725 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 14.3 pt-20 -149.2 176.42 10.52 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.454 ' CB ' ' HA ' ' A' ' 40' ' ' TYR . 55.5 p90 -170.02 168.68 8.42 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 119.382 0.992 . . . . 0.0 112.316 -178.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.91 ' HB3' ' HB3' ' A' ' 96' ' ' ASN . 0.2 OUTLIER -146.48 143.93 29.3 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.542 169.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.951 HD12 HG22 ' A' ' 38' ' ' VAL . 17.6 mm -89.43 138.76 18.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.225 -174.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.477 ' HE2' ' HE1' ' A' ' 94' ' ' TYR . 32.3 mmtp -97.7 107.75 20.32 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.438 0.637 . . . . 0.0 109.289 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.594 ' O ' ' HA ' ' A' ' 92' ' ' THR . 8.4 t80 -89.28 100.9 13.59 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.656 -1.157 . . . . 0.0 109.917 -177.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 91' ' ' LYS . 26.4 tt0 -104.24 113.88 27.73 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.818 -176.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.408 HG21 HD12 ' A' ' 30' ' ' ILE . 5.2 t -119.9 105.69 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.609 -177.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.6 t 50.95 27.14 3.02 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 123.646 0.591 . . . . 0.0 111.155 177.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.58 -18.09 17.8 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.335 -176.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 87' ' ' GLU . 21.2 mmtm -81.81 176.8 9.3 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 117.598 0.699 . . . . 0.0 111.508 -176.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 86' ' ' TYR . 18.0 m -150.59 141.06 22.47 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.662 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.446 ' HD2' ' CD2' ' A' ' 86' ' ' TYR . 63.8 m-85 -146.05 -171.71 3.77 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 170.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.477 ' HE1' ' HE2' ' A' ' 85' ' ' LYS . 51.0 m-85 -146.19 141.23 27.23 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.895 0.379 . . . . 0.0 111.601 -172.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.524 ' HB2' HG13 ' A' ' 9' ' ' VAL . 35.5 t70 -130.16 112.92 13.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.461 167.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.91 ' HB3' ' HB3' ' A' ' 83' ' ' TYR . 36.3 p-10 -130.09 -29.68 2.04 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.15 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.561 HD21 ' HB3' ' A' ' 100' ' ' ALA . 26.1 p-10 159.12 -42.9 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.544 1.137 . . . . 0.0 108.198 172.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 175.49 -37.13 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.421 174.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.2 p -178.06 23.94 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.561 ' HB3' HD21 ' A' ' 97' ' ' ASN . . . -138.06 -17.14 1.23 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -175.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.768 ' HA ' ' HB2' ' A' ' 96' ' ' ASN . 77.5 m-20 87.73 142.65 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.894 0.478 . . . . 0.0 110.739 173.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.562 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 85.0 m-85 -71.76 120.96 18.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.969 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -83.71 129.61 34.95 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 174.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.59 153.39 4.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.1 p -74.71 56.75 0.72 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.459 0.647 . . . . 0.0 111.824 -177.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.31 177.544 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo . . . . . 0 C--O 1.233 0.258 0 CA-C-O 121.283 0.451 . . . . 0.0 112.928 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.9 t -166.35 -51.92 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.912 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.7 m -83.65 -77.35 0.26 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.194 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -139.4 -173.89 3.73 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 120.645 0.259 . . . . 0.0 111.208 -176.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -67.26 -30.91 70.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.42 0.629 . . . . 0.0 109.962 177.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.667 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.4 p -140.68 148.89 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.299 -178.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -140.9 129.35 22.55 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.859 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.586 HD21 ' HD2' ' A' ' 14' ' ' TYR . 23.7 tp -69.06 141.94 54.65 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.213 0.53 . . . . 0.0 110.957 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.497 ' HB3' ' O ' ' A' ' 24' ' ' LYS . 30.0 t70 -85.68 -68.77 0.71 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.752 175.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.7 p -175.94 164.74 2.9 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.741 -177.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.586 ' HD2' HD21 ' A' ' 11' ' ' LEU . 53.2 p90 -156.64 154.42 30.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.564 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -130.55 159.9 35.77 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.125 0.488 . . . . 0.0 110.468 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 20' ' ' THR . 10.4 t80 -122.33 138.25 54.58 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 170.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -153.76 115.06 4.14 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.234 -174.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.01 -95.78 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -168.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.639 ' OG ' ' HA ' ' A' ' 77' ' ' LYS . 10.4 t -139.6 88.13 2.23 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 162.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 87.8 m -146.35 139.97 26.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.47 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.73 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 24.3 t80 -115.06 99.25 7.31 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-O 121.672 0.749 . . . . 0.0 109.278 176.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 17.7 p -126.42 150.01 48.92 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.27 -175.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.86 -162.3 36.07 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.723 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 0.6 OUTLIER -158.42 163.66 37.0 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -177.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.605 HD12 HG11 ' A' ' 36' ' ' VAL . 24.7 mt -135.79 160.29 39.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.927 0.394 . . . . 0.0 111.774 -168.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.418 ' N ' HG22 ' A' ' 25' ' ' ILE . 6.4 t80 -132.85 103.09 5.91 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.433 0.693 . . . . 0.0 109.798 -174.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.667 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 1.5 m -136.65 151.89 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 121.39 -0.819 . . . . 0.0 111.492 -172.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -76.45 152.95 36.01 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 178.317 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -104.6 121.94 44.57 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.345 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.478 HD12 ' OH ' ' A' ' 86' ' ' TYR . 7.1 mt -106.98 -52.83 6.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.823 0.821 . . . . 0.0 109.561 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.72 152.34 51.85 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 105.283 -2.118 . . . . 0.0 105.283 173.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.418 ' O ' ' C ' ' A' ' 33' ' ' SER . 12.1 m-85 -59.04 -83.93 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 117.768 -1.11 . . . . 0.0 113.068 -170.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 32' ' ' TYR . 24.8 m -21.85 104.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 124.49 1.119 . . . . 0.0 111.647 -174.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.751 ' HB3' ' CH2' ' A' ' 70' ' ' TRP . 84.5 mttt -94.77 111.43 23.21 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 124.882 2.277 . . . . 0.0 115.88 -148.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.806 ' HD3' HG13 ' A' ' 88' ' ' VAL 0.489 4.6 pttm -56.84 79.93 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.006 1 CA-C-N 108.264 -4.062 . . . . 0.0 120.545 169.8 . . . . . . . . 4 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.605 HG11 HD12 ' A' ' 25' ' ' ILE . 52.1 t -142.47 113.65 3.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-O 121.5 0.667 . . . . 0.0 111.599 154.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.628 ' HB ' HG13 ' A' ' 53' ' ' ILE . 2.5 p -131.53 102.79 6.07 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.804 173.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.95 ' HB ' HG22 ' A' ' 54' ' ' ILE . 61.4 t -73.83 104.2 2.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.377 -176.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.621 HG12 ' HB ' ' A' ' 53' ' ' ILE . 4.5 m -102.94 110.28 29.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -105.18 150.86 24.72 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.14 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.663 ' HB2' ' CZ2' ' A' ' 47' ' ' TRP . . . -74.22 82.58 1.84 Allowed 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 172.062 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -49.95 -172.48 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 113.065 -1.879 . . . . 0.0 113.669 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -54.35 -28.98 45.27 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 116.046 -0.524 . . . . 0.0 113.784 -175.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.2 t -72.11 -16.83 62.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.834 0.317 . . . . 0.0 111.069 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.7 t70 67.57 36.01 3.9 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.819 0.819 . . . . 0.0 109.072 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -147.75 160.67 42.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.263 -176.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.663 ' CZ2' ' HB2' ' A' ' 41' ' ' ALA . 5.7 m95 -115.9 82.31 1.75 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.669 0.747 . . . . 0.0 110.38 -176.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.503 ' OD1' ' HB2' ' A' ' 50' ' ' ASN . 1.7 p30 -116.45 168.94 9.71 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.239 173.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -79.51 57.53 2.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.942 0.877 . . . . 0.0 111.062 -175.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.503 ' HB2' ' OD1' ' A' ' 48' ' ' ASN . 59.3 t30 -88.93 11.75 17.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.32 -177.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.67 33.32 52.16 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -176.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -93.63 34.49 1.18 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.551 0.691 . . . . 0.0 110.526 -175.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.692 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -122.15 139.32 49.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.881 179.23 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.95 HG22 ' HB ' ' A' ' 38' ' ' VAL . 5.8 tp -116.2 126.51 73.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 170.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -89.6 126.58 35.67 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.673 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.61 168.69 17.9 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.931 -174.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.7 t -128.0 132.87 49.12 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -77.75 145.81 36.27 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.39 0.614 . . . . 0.0 110.921 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.3 m -92.16 -33.37 14.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.97 172.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 160.84 169.2 23.78 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.455 172.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 68' ' ' GLU . 16.5 Cg_exo -68.49 133.6 28.47 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.562 2.175 . . . . 0.0 110.152 171.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 65' ' ' SER . 42.4 mt -71.03 122.13 22.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 120.981 0.42 . . . . 0.0 110.729 -172.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.5 p -58.03 128.1 35.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.915 -174.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 70.85 15.56 73.93 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.355 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.541 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 26.4 m -130.46 166.54 20.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.958 0.409 . . . . 0.0 110.671 -178.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -102.47 17.77 22.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.554 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 5.7 m-85 -120.18 169.32 10.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.326 -176.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 61' ' ' PRO . 19.6 tt0 -117.33 170.74 8.46 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.002 -1.454 . . . . 0.0 108.705 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -138.15 110.4 7.37 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -162.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.751 ' CH2' ' HB3' ' A' ' 34' ' ' LYS . 18.7 m95 -111.86 147.67 35.29 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.063 -168.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.47 ' HA ' ' HB2' ' A' ' 24' ' ' LYS . 5.7 p -141.74 142.96 33.28 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -154.07 169.45 23.5 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.099 -1.041 . . . . 0.0 112.913 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.6 p -144.24 137.29 27.2 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.179 173.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.73 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -134.09 120.82 20.65 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.436 -173.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.8 t -78.42 99.36 6.37 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 172.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.464 HG13 ' HB3' ' A' ' 21' ' ' PHE . 4.8 m -120.16 151.5 22.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -176.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.639 ' HA ' ' OG ' ' A' ' 19' ' ' SER . 0.2 OUTLIER -141.35 31.33 1.72 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.46 0.648 . . . . 0.0 110.366 174.413 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.09 95.52 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.725 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.8 tt -151.82 141.77 15.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.36 0.6 . . . . 0.0 110.276 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -115.18 -54.32 2.56 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.956 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.487 ' OE1' ' HB3' ' A' ' 103' ' ' GLN . 13.2 mm-40 -135.08 176.8 8.33 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -173.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.436 ' HZ ' ' CD2' ' A' ' 14' ' ' TYR . 28.3 p90 -168.7 160.53 10.69 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.703 171.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.446 ' HB3' HD22 ' A' ' 96' ' ' ASN . 0.1 OUTLIER -147.22 144.03 28.61 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.434 168.681 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.909 HD12 HG22 ' A' ' 38' ' ' VAL . 14.4 mm -91.28 134.81 28.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.687 -172.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.578 ' HB2' ' OG1' ' A' ' 37' ' ' THR . 4.5 mtmp? -88.3 114.87 25.35 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.61 0.719 . . . . 0.0 109.857 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.608 ' CD2' ' HD1' ' A' ' 93' ' ' TYR . 9.5 t80 -86.15 100.04 11.94 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.327 -1.306 . . . . 0.0 107.518 178.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.519 ' C ' ' HB3' ' A' ' 35' ' ' LYS . 30.1 tt0 -124.04 104.23 8.76 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 122.108 0.956 . . . . 0.0 113.043 -162.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.806 HG13 ' HD3' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -110.1 164.53 6.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.408 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.3 m -77.06 40.17 0.25 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.856 0.836 . . . . 0.0 111.235 -177.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . 177.5 -34.07 0.08 OUTLIER Glycine 0 N--CA 1.436 -1.332 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.517 175.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.478 ' O ' HG23 ' A' ' 88' ' ' VAL . 12.9 mptt -110.98 149.43 30.69 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 120.794 0.331 . . . . 0.0 111.325 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.3 m -149.3 138.44 21.37 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.358 0.599 . . . . 0.0 110.965 174.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.608 ' HD1' ' CD2' ' A' ' 86' ' ' TYR . 18.6 m-85 -146.5 -166.65 2.54 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 176.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -144.03 140.47 29.57 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.885 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -96.19 92.89 6.61 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 168.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.446 HD22 ' HB3' ' A' ' 83' ' ' TYR . 3.6 t-20 -129.56 18.53 5.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.097 -174.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 65.97 -68.12 0.13 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.278 -171.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -159.01 -56.07 0.06 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.0 t -167.74 38.72 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 170.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -99.41 -37.99 9.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.09 -169.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 93.0 m-20 72.62 142.28 0.06 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.351 0.596 . . . . 0.0 110.496 -174.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -95.1 100.18 12.05 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.169 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.487 ' HB3' ' OE1' ' A' ' 81' ' ' GLU . 2.3 pm0 -76.61 131.98 39.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.436 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.8 t -85.24 152.08 3.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.985 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.3 t -83.83 71.42 10.45 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.8 p . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.87 176.909 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.038 0 CA-C-O 120.794 0.33 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.4 m -102.42 112.84 25.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.124 0.488 . . . . 0.0 110.103 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.63 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 47.7 mm -78.94 -53.86 1.1 Allowed Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.265 -178.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.63 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 73.3 Cg_exo -50.01 135.3 36.83 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 122.211 1.941 . . . . 0.0 112.768 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.7 t -152.77 -63.88 0.16 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.324 -176.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.6 m -69.31 -62.69 1.28 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.122 0.487 . . . . 0.0 110.041 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.99 -158.2 0.89 Allowed 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.8 m -64.79 -24.82 67.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.563 0.697 . . . . 0.0 109.221 173.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.853 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.5 p -129.24 155.43 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.584 -178.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -143.81 137.97 28.38 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.451 HD21 ' HD2' ' A' ' 14' ' ' TYR . 34.8 tp -70.55 126.54 29.91 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.121 0.486 . . . . 0.0 111.175 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -74.21 -62.22 1.59 Allowed 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.825 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.2 p 176.55 167.25 0.48 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.214 -175.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.483 ' HA ' ' O ' ' A' ' 22' ' ' SER . 49.0 p90 -157.8 160.34 37.69 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.306 -1.315 . . . . 0.0 107.8 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -126.09 163.24 23.52 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.979 0.419 . . . . 0.0 110.326 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.486 ' HA ' ' O ' ' A' ' 20' ' ' THR . 37.5 t80 -152.5 149.59 28.7 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.284 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -179.76 126.14 0.08 Allowed 'General case' 0 C--N 1.321 -0.644 0 O-C-N 123.715 0.634 . . . . 0.0 109.376 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.44 -105.8 0.99 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 -170.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.542 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 20.4 m -133.35 86.08 2.27 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 166.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 96.2 m -148.07 136.07 21.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.709 177.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.728 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 23.8 t80 -117.32 138.88 51.47 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 171.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 25.9 p -150.04 109.87 4.08 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 14' ' ' TYR . . . -133.77 149.47 19.72 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.15 -1.024 . . . . 0.0 113.057 -166.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.662 ' HB3' HG22 ' A' ' 71' ' ' THR . 24.3 pttm -140.34 154.69 46.85 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.63 HD13 HG21 ' A' ' 84' ' ' ILE . 19.0 mt -134.91 154.63 36.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.071 -165.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -123.24 99.32 6.29 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.255 -174.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.853 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 1.7 m -136.25 149.95 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.337 0.589 . . . . 0.0 112.372 -170.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.633 ' HB2' ' CE1' ' A' ' 67' ' ' TYR . 7.7 ttmm -81.25 144.19 31.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.642 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -82.96 103.82 12.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.65 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.663 HG12 ' OH ' ' A' ' 86' ' ' TYR . 19.0 mm -81.68 -59.29 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.43 -151.86 0.49 Allowed 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 114.033 -1.44 . . . . 0.0 107.706 174.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -109.04 -44.95 3.86 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.049 -0.661 . . . . 0.0 111.46 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.4 t -76.93 82.27 3.48 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.589 0.709 . . . . 0.0 109.898 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 34' ' ' LYS . 28.1 mtmt -110.67 152.41 26.55 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.968 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -142.31 110.12 5.83 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 122.277 1.037 . . . . 0.0 109.021 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.0 t -92.12 124.73 44.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.593 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.763 ' HB ' HG13 ' A' ' 53' ' ' ILE . 59.2 p -123.27 117.4 25.18 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.244 -170.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.811 HG11 ' CD2' ' A' ' 40' ' ' TYR . 57.3 t -73.38 141.24 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.019 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 170.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -124.6 100.1 7.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 159.102 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.811 ' CD2' HG11 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -119.21 126.08 50.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 122.218 1.009 . . . . 0.0 110.684 179.112 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.51 ' HB2' ' CZ3' ' A' ' 47' ' ' TRP . . . -86.59 151.13 23.72 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.768 -164.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.454 ' C ' ' H ' ' A' ' 44' ' ' SER . 2.8 m-20 -72.85 177.5 4.83 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.154 -1.839 . . . . 0.0 110.863 -166.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.36 33.8 1.34 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.805 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.454 ' H ' ' C ' ' A' ' 42' ' ' ASP . 22.7 t -112.26 -10.52 13.82 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 175.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 16.6 t70 76.58 91.26 0.07 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 113.535 -1.666 . . . . 0.0 110.341 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.446 ' HB3' ' O ' ' A' ' 45' ' ' ASP . 22.9 t-20 84.69 154.64 0.09 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.996 170.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.617 ' HE1' ' HB2' ' A' ' 52' ' ' ASN . 8.2 m-90 -72.48 124.47 25.25 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -172.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -78.22 74.25 4.76 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.264 -1.334 . . . . 0.0 108.691 167.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.1 t30 47.86 34.08 3.71 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.676 0.75 . . . . 0.0 110.781 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -119.15 174.46 6.32 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -173.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -141.78 77.32 0.3 Allowed Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 119.808 -1.187 . . . . 0.0 112.213 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.617 ' HB2' ' HE1' ' A' ' 47' ' ' TRP . 78.3 m-20 -79.84 95.11 5.95 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 121.229 0.538 . . . . 0.0 111.515 -178.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.763 HG13 ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -108.49 142.64 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.006 -177.18 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.495 ' CG2' ' HB ' ' A' ' 38' ' ' VAL . 17.5 tt -135.99 122.74 32.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.307 173.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.52 134.5 43.85 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.024 0.44 . . . . 0.0 111.756 -170.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -91.32 164.83 13.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.691 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -128.36 140.13 52.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.062 0.458 . . . . 0.0 110.063 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -71.46 145.58 49.15 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.231 0.539 . . . . 0.0 110.642 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.1 t -107.59 -44.26 4.32 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.888 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.44 170.52 36.35 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.969 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -70.13 140.84 42.23 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.855 2.37 . . . . 0.0 111.666 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.661 HD12 ' HB3' ' A' ' 67' ' ' TYR . 28.8 mt -78.71 105.99 8.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.097 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.7 m -65.85 117.09 7.75 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.365 0.603 . . . . 0.0 110.636 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.28 -14.69 9.4 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.41 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.9 m -150.25 164.76 34.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.955 0.407 . . . . 0.0 110.711 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -89.89 62.07 5.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.429 0.633 . . . . 0.0 109.443 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.661 ' HB3' HD12 ' A' ' 62' ' ' ILE . 1.7 m-85 -138.52 169.59 17.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.466 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -122.09 171.6 8.86 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.554 ' HB2' HG12 ' A' ' 62' ' ' ILE . 1.5 t80 -140.28 122.11 15.46 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -163.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.647 ' CD1' HG13 ' A' ' 27' ' ' VAL . 7.1 m95 -121.28 144.56 48.56 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.015 -165.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.662 HG22 ' HB3' ' A' ' 24' ' ' LYS . 21.3 p -145.81 153.45 40.92 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 122.9 0.125 . . . . 0.0 110.74 -178.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -173.01 155.72 3.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.219 0.533 . . . . 0.0 111.209 167.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.2 m -112.15 145.21 40.23 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.543 175.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.728 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -137.51 144.89 42.4 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.36 -175.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.3 t -99.95 99.15 9.88 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 173.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.542 ' O ' ' HB3' ' A' ' 19' ' ' SER . 3.9 m -103.48 138.34 28.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 3.7 mptp? -101.95 -11.4 18.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.233 -173.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 42' ' ' ASP . . . -179.66 105.98 0.2 Allowed Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.494 HG12 HG21 ' A' ' 104' ' ' VAL . 11.1 tt -128.92 158.36 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.495 ' HA ' ' HE2' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -147.56 -42.07 0.17 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.289 -178.146 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 82' ' ' PHE . 23.0 mm-40 -135.32 164.69 27.16 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 118.56 -0.733 . . . . 0.0 109.086 -171.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.518 ' CB ' ' HA ' ' A' ' 40' ' ' TYR . 36.4 p90 -173.36 178.85 2.29 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 119.378 -0.929 . . . . 0.0 113.379 171.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.667 ' O ' HG23 ' A' ' 39' ' ' VAL . 1.0 OUTLIER -164.28 144.99 8.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.412 -1.722 . . . . 0.0 107.704 167.368 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.63 HG21 HD13 ' A' ' 25' ' ' ILE . 28.3 mm -103.23 137.0 33.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.56 -174.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -104.13 146.12 29.2 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.774 0.797 . . . . 0.0 110.925 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.665 ' HB2' HG11 ' A' ' 9' ' ' VAL . 10.3 t80 -108.89 100.17 9.42 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.454 175.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -110.38 120.79 43.55 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.628 0.728 . . . . 0.0 109.38 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.538 ' C ' ' H ' ' A' ' 90' ' ' GLY . 86.4 t -121.72 155.92 26.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.207 -174.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.9 t -77.01 31.95 0.14 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 122.019 0.914 . . . . 0.0 109.677 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.538 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -158.83 -33.14 0.02 OUTLIER Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.91 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.445 ' HE3' ' H ' ' A' ' 92' ' ' THR . 13.3 mmmt -145.66 178.8 7.87 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.82 0.819 . . . . 0.0 112.138 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.445 ' H ' ' HE3' ' A' ' 91' ' ' LYS . 5.6 m -149.27 143.62 25.97 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.086 174.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.448 ' CD1' ' HD2' ' A' ' 86' ' ' TYR . 25.9 m-85 -143.36 -172.26 3.66 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -145.24 138.44 26.46 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.609 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -111.25 104.24 12.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 165.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 98' ' ' ASN . 49.6 t30 -151.93 87.45 1.35 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.613 -171.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.565 HD21 ' HB3' ' A' ' 100' ' ' ALA . 13.4 p-10 42.22 -68.2 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.465 1.906 . . . . 0.0 115.343 168.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 96' ' ' ASN . 54.8 t30 -159.92 -49.6 0.05 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -177.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.0 p -174.48 20.31 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.859 175.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.565 ' HB3' HD21 ' A' ' 97' ' ' ASN . . . -129.15 -87.31 0.54 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -174.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -169.17 147.84 3.87 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.348 0.659 . . . . 0.0 109.812 -169.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.463 ' CE2' ' HA ' ' A' ' 96' ' ' ASN . 77.1 m-85 -85.88 122.96 30.68 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 170.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -77.26 122.48 25.14 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.494 HG21 HG12 ' A' ' 79' ' ' ILE . 47.5 t -78.16 132.21 32.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.8 m -73.47 77.07 1.43 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.15 0.5 . . . . 0.0 110.913 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 m . . . . . 0 C--O 1.246 0.9 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.49 176.31 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.7 m -66.29 158.49 28.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.706 0.288 . . . . 0.0 110.74 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.448 HD12 ' N ' ' A' ' 3' ' ' ILE . 3.7 mp -103.56 107.34 55.85 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.908 0.385 . . . . 0.0 110.602 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.63 ' HG2' ' CZ ' ' A' ' 67' ' ' TYR . 45.4 Cg_endo -68.16 143.26 58.64 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 123.036 2.49 . . . . 0.0 112.365 175.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.7 t -128.81 -13.43 4.67 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.354 0.597 . . . . 0.0 109.987 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.1 m -90.1 -6.77 55.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.113 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.34 28.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.576 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.494 ' HB3' HD11 ' A' ' 30' ' ' ILE . 1.6 m -92.88 -27.23 17.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.558 0.694 . . . . 0.0 109.228 175.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.758 HG23 ' HB ' ' A' ' 27' ' ' VAL . 2.2 p -149.89 146.64 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.015 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -135.7 128.76 31.58 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.497 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.502 HD21 ' CD1' ' A' ' 14' ' ' TYR . 36.9 tp -71.85 133.56 45.55 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.172 174.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -81.27 -64.02 1.27 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.969 177.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.6 p 177.32 166.52 0.6 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.851 -177.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.502 ' CD1' HD21 ' A' ' 11' ' ' LEU . 50.3 p90 -157.47 163.9 37.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.056 -177.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -153.18 163.89 39.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.938 0.399 . . . . 0.0 110.989 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.548 ' HD1' ' HD1' ' A' ' 21' ' ' PHE . 35.6 t80 -131.38 149.39 52.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.668 -176.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -174.71 117.82 0.2 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.226 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.0 -99.77 0.34 Allowed Glycine 0 CA--C 1.511 -0.208 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.6 t -135.47 83.46 2.02 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 164.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 62.6 m -148.42 134.33 19.08 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.503 172.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.548 ' HD1' ' HD1' ' A' ' 16' ' ' TYR . 7.8 t80 -132.74 102.34 5.63 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 169.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.4 t -139.04 167.42 22.1 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.952 -171.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.22 -154.35 25.33 Favored Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.564 ' HB3' HG22 ' A' ' 71' ' ' THR . 0.0 OUTLIER -155.64 173.49 16.65 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.433 0.635 . . . . 0.0 112.007 179.809 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.643 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 83.4 mt -136.53 153.37 30.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.58 -167.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -130.58 100.39 5.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.93 -174.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.758 ' HB ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -141.79 145.77 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -169.795 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.633 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 21.2 ptmt -97.62 154.56 17.47 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.805 -175.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.918 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 20.1 p-10 -75.1 115.7 15.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.96 177.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.659 HG12 ' OH ' ' A' ' 86' ' ' TYR . 34.4 mm -77.81 -56.07 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 167.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.49 -86.4 0.41 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.778 171.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -163.77 -68.47 0.04 OUTLIER 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 172.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m -80.71 124.33 28.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.861 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.918 ' HE3' ' HA ' ' A' ' 29' ' ' ASN . 37.8 mttp -122.81 176.66 5.86 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.341 0.591 . . . . 0.0 111.166 -172.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.856 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 96.4 mttt -121.14 136.54 54.96 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 166.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.3 t -127.66 113.63 32.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 122.014 0.911 . . . . 0.0 109.739 171.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . 1.116 ' HB ' HD11 ' A' ' 53' ' ' ILE . 1.0 OUTLIER -131.48 136.14 47.67 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.148 -1.387 . . . . 0.0 110.413 -175.142 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 1.018 ' HB ' HG22 ' A' ' 54' ' ' ILE . 69.3 t -93.4 132.71 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.451 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.569 ' O ' ' HH2' ' A' ' 47' ' ' TRP . 2.7 m -112.8 104.77 17.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 165.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.719 ' CD1' HG12 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -122.18 120.87 35.46 Favored 'General case' 0 N--CA 1.4 -2.974 0 CA-C-N 114.902 -1.044 . . . . 0.0 110.054 -170.107 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.649 ' HB2' ' CE3' ' A' ' 47' ' ' TRP . . . -76.5 129.0 35.87 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.53 -169.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -67.42 179.91 1.19 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.523 -1.672 . . . . 0.0 111.354 -168.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.604 ' HA2' ' HG2' ' A' ' 80' ' ' LYS . . . -68.0 -0.28 14.02 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.079 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.0 m -66.45 -22.75 66.21 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.013 0.435 . . . . 0.0 110.044 174.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 t70 64.69 37.66 7.47 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.133 -0.939 . . . . 0.0 108.98 177.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -173.86 140.28 0.73 Allowed 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -172.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.649 ' CE3' ' HB2' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -89.39 85.88 6.66 Favored 'General case' 0 N--CA 1.421 -1.893 0 C-N-CA 118.608 -1.237 . . . . 0.0 112.516 -173.204 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -56.66 132.32 51.56 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.37 165.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -72.12 70.22 0.79 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.849 0.833 . . . . 0.0 111.317 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -112.74 -17.86 12.45 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.652 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.47 -58.34 3.05 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.709 -176.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 92.4 m-20 59.83 76.3 0.37 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.655 -0.773 . . . . 0.0 110.144 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 1.116 HD11 ' HB ' ' A' ' 37' ' ' THR . 5.7 tp -109.07 148.89 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-O 121.816 0.817 . . . . 0.0 112.044 -176.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 1.018 HG22 ' HB ' ' A' ' 38' ' ' VAL . 3.4 tp -133.03 140.34 47.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.494 -1.23 . . . . 0.0 107.712 167.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -92.84 116.42 29.01 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.287 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.12 156.28 39.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.215 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.8 t -114.83 144.8 42.94 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -174.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -71.25 142.06 50.56 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.283 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.4 t -109.12 -42.27 4.46 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.81 171.8 21.94 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.569 173.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.15 142.75 42.58 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.403 2.068 . . . . 0.0 110.637 173.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.55 HG12 ' HB2' ' A' ' 69' ' ' TYR . 9.7 mt -83.63 83.83 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.8 m -53.5 126.41 21.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.385 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 113.31 -32.42 6.11 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.252 -173.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -127.24 165.99 18.61 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -95.43 55.01 1.66 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.135 0.493 . . . . 0.0 110.863 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.633 ' CE1' ' HB3' ' A' ' 28' ' ' LYS . 2.4 m-85 -137.04 159.3 42.31 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.328 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -107.29 173.59 6.26 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.922 176.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.55 ' HB2' HG12 ' A' ' 62' ' ' ILE . 3.1 t80 -143.5 120.84 11.61 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -165.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.643 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 20.6 m95 -127.79 138.65 52.81 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.922 -166.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.564 HG22 ' HB3' ' A' ' 24' ' ' LYS . 6.5 p -124.33 133.25 53.51 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -125.93 136.97 53.64 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.488 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.7 p -125.7 139.44 53.54 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.236 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.97 118.99 5.43 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.782 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.9 t -82.57 99.4 9.5 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.429 ' CG2' ' HE1' ' A' ' 16' ' ' TYR . 13.8 m -99.48 144.66 11.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.375 -173.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.01 8.39 43.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.279 0.562 . . . . 0.0 110.563 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 156.81 145.8 4.3 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.639 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.602 HG12 HG21 ' A' ' 104' ' ' VAL . 7.3 tt -168.09 142.47 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.309 0.576 . . . . 0.0 110.873 177.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.604 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 3.7 mmmp? -125.48 -38.7 2.24 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.28 -177.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 29.4 mt-10 -141.65 167.22 22.67 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.635 ' HB2' ' HA ' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -171.89 170.45 5.44 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.017 -0.673 . . . . 0.0 112.056 172.197 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.651 ' HD2' ' HB3' ' A' ' 96' ' ' ASN . 0.1 OUTLIER -159.46 148.54 18.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.195 169.092 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.904 HD12 HG22 ' A' ' 38' ' ' VAL . 21.5 mm -95.01 140.76 16.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.706 -169.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.6 mtmt -90.7 114.09 26.33 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.157 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.659 ' OH ' HG12 ' A' ' 30' ' ' ILE . 10.5 t80 -91.95 99.72 12.51 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 172.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.856 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 9.3 tt0 -109.63 107.84 18.04 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.63 0.729 . . . . 0.0 110.206 -174.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.469 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 20.6 t -87.21 164.02 2.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.061 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.429 ' N ' HG12 ' A' ' 88' ' ' VAL . 1.1 m -43.51 -40.86 4.11 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.405 0.44 . . . . 0.0 111.156 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -136.37 23.64 3.28 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.185 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.469 ' HB2' ' HB ' ' A' ' 88' ' ' VAL . 16.5 mmtp -141.74 175.44 9.7 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.772 0.796 . . . . 0.0 111.758 177.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.8 m -149.19 138.83 21.78 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.614 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.421 ' HD2' ' CD2' ' A' ' 86' ' ' TYR . 60.7 m-85 -140.6 -169.25 2.75 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -148.07 145.49 28.46 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.147 0.498 . . . . 0.0 111.503 -173.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.417 ' OD2' ' HB2' ' A' ' 11' ' ' LEU . 17.6 t70 -107.78 97.68 7.37 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 167.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.651 ' HB3' ' HD2' ' A' ' 83' ' ' TYR . 34.0 p30 -144.03 31.98 1.25 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -172.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 67.88 -67.6 0.18 Allowed 'General case' 0 CA--C 1.532 0.275 0 O-C-N 123.629 0.58 . . . . 0.0 111.403 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -171.66 40.25 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -175.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.6 t 63.64 46.6 4.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.954 -167.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -102.3 -38.55 7.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.99 -176.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 7.3 m-20 67.94 115.1 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.781 0.676 . . . . 0.0 110.282 -174.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 7.9 m-85 -77.14 133.21 39.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.437 -174.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -79.19 129.63 34.65 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.602 HG21 HG12 ' A' ' 79' ' ' ILE . 96.3 t -79.25 133.84 29.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.677 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.1 p -77.14 77.01 3.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.725 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.248 1.008 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.177 178.652 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.904 0.383 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.9 p -105.18 168.79 8.83 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.881 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.812 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 3.4 mp -72.74 -59.8 2.21 Favored Pre-proline 0 C--N 1.323 -0.562 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.635 178.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.812 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 1.9 Cg_endo -84.22 144.8 10.68 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.42 2.08 . . . . 0.0 112.014 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.4 m -128.44 -54.96 1.25 Allowed 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.33 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.6 m -106.09 -68.62 0.87 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.351 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.28 -172.8 2.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 120.908 0.385 . . . . 0.0 111.862 -173.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 m -64.86 -26.56 68.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.214 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.728 ' CB ' ' HB ' ' A' ' 27' ' ' VAL . 2.2 p -120.57 148.31 23.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.382 0.61 . . . . 0.0 112.015 -174.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.425 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 28.0 tt0 -143.72 132.22 22.26 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.474 173.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.671 HD21 ' CD1' ' A' ' 14' ' ' TYR . 40.5 tp -70.03 130.76 43.02 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.099 0.476 . . . . 0.0 110.238 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -76.84 -63.9 1.25 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.901 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.5 m -178.96 159.87 1.04 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.622 -174.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.671 ' CD1' HD21 ' A' ' 11' ' ' LEU . 53.7 p90 -157.95 163.49 37.78 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.654 -177.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -151.32 164.95 35.5 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -176.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.61 ' HA ' ' O ' ' A' ' 20' ' ' THR . 97.6 m-85 -138.92 138.34 37.28 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.754 -176.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -136.53 124.62 22.95 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.54 -99.44 0.18 Allowed Glycine 0 C--N 1.331 0.265 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -167.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.1 t -139.86 87.85 2.19 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 163.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.61 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 73.0 m -145.96 133.3 20.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.422 177.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.957 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 14.8 t80 -90.57 126.49 35.96 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 174.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.9 p -144.92 126.19 14.78 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.593 175.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.422 ' HA3' ' HA ' ' A' ' 14' ' ' TYR . . . 173.68 -154.14 19.14 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.384 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.609 ' HB3' HG22 ' A' ' 71' ' ' THR . 0.4 OUTLIER -161.85 166.07 26.86 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.196 0.522 . . . . 0.0 111.018 -177.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 33.8 mt -127.72 156.04 39.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.16 -172.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -126.9 96.32 4.59 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.866 -172.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.728 ' HB ' ' CB ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -147.91 143.23 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -172.017 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.553 ' HE3' ' CE1' ' A' ' 67' ' ' TYR . 17.0 ptpt -85.05 148.43 26.17 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.365 176.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.422 HD22 ' CD ' ' A' ' 68' ' ' GLU . 4.4 p30 -86.64 132.58 33.85 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.998 176.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.466 HG12 ' OH ' ' A' ' 86' ' ' TYR . 39.0 mm -80.33 -55.28 9.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.486 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.819 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . . . -103.84 -81.18 0.52 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.026 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -159.31 -73.25 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.285 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.611 ' C ' ' HE2' ' A' ' 34' ' ' LYS . 10.0 t -95.87 62.78 2.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.34 0.591 . . . . 0.0 109.913 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.926 ' HD2' HG13 ' A' ' 88' ' ' VAL . 6.3 mmpt? -80.68 157.1 26.02 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.496 ' HG3' ' HB3' ' A' ' 87' ' ' GLU . 18.3 pttp -124.81 141.34 52.18 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.167 -175.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.3 t -115.73 116.57 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.787 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.616 HG22 HD11 ' A' ' 53' ' ' ILE . 5.4 p -114.17 119.43 37.04 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.866 -170.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.824 HG22 HD12 ' A' ' 84' ' ' ILE . 96.8 t -84.19 113.63 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.89 176.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 0.3 OUTLIER -107.6 107.09 21.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 172.793 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.649 ' HA ' ' HB3' ' A' ' 82' ' ' PHE . 4.3 p90 -109.26 137.61 46.88 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-O 122.494 1.14 . . . . 0.0 110.075 177.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.717 ' HB2' ' CZ3' ' A' ' 47' ' ' TRP . . . -89.38 110.67 21.45 Favored 'General case' 0 N--CA 1.401 -2.894 0 CA-C-N 112.863 -1.971 . . . . 0.0 107.599 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -40.7 167.22 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 112.484 -2.143 . . . . 0.0 112.081 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.78 ' HA2' ' HB2' ' A' ' 80' ' ' LYS . . . -67.69 1.69 7.23 Favored Glycine 0 CA--C 1.518 0.264 0 CA-C-N 115.241 -0.891 . . . . 0.0 114.849 -163.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 30.7 t -87.49 -12.72 45.15 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 117.088 0.444 . . . . 0.0 111.009 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.616 ' OD1' ' HG2' ' A' ' 80' ' ' LYS . 5.3 m-20 74.27 48.75 0.12 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 124.038 0.836 . . . . 0.0 110.271 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -155.51 134.3 11.99 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.198 -171.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.717 ' CZ3' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -105.03 85.7 2.32 Favored 'General case' 0 N--CA 1.425 -1.705 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.681 178.019 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -71.85 145.43 48.59 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 167.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -61.71 90.8 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.301 0.572 . . . . 0.0 110.75 -176.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -152.22 147.12 26.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.092 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.03 59.46 4.94 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.897 -176.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -71.36 56.71 0.24 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.357 0.598 . . . . 0.0 109.843 172.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.629 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -116.25 141.1 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.436 -176.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.82 HG22 ' HB ' ' A' ' 38' ' ' VAL . 8.5 tp -121.76 130.3 74.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.034 -0.984 . . . . 0.0 108.372 173.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.71 128.62 34.84 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.011 -173.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.74 158.36 28.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.977 178.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 t -122.63 121.93 37.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 29.1 p90 -82.4 138.29 34.49 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 121.708 0.766 . . . . 0.0 111.363 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.402 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 65.8 m -97.03 -41.32 8.43 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 172.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.584 ' O ' ' HA ' ' A' ' 68' ' ' GLU . . . 118.55 -87.5 0.42 Allowed Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.18 -0.918 . . . . 0.0 113.541 170.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.402 ' HD2' ' O ' ' A' ' 59' ' ' SER . 18.6 Cg_endo -52.98 119.66 6.44 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 124.295 3.33 . . . . 0.0 115.959 -167.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.462 ' HB ' ' O ' ' A' ' 67' ' ' TYR . 21.6 mt -124.05 90.57 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.217 162.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.5 m -71.52 117.8 13.53 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.804 -174.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.68 -14.01 6.1 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.965 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -155.5 167.01 31.79 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -92.13 66.4 4.88 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.716 0.769 . . . . 0.0 109.438 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.553 ' CE1' ' HE3' ' A' ' 28' ' ' LYS . 2.2 m-85 -136.52 153.15 51.09 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.732 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 7.4 mp0 -106.44 174.78 5.74 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.888 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -137.55 115.75 11.75 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -166.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.689 ' NE1' HG13 ' A' ' 27' ' ' VAL . 8.0 m95 -116.16 121.85 43.32 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.649 -164.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.609 HG22 ' HB3' ' A' ' 24' ' ' LYS . 2.9 p -128.94 147.74 50.87 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 110.562 -0.162 . . . . 0.0 110.562 -171.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.503 ' HZ ' HG21 ' A' ' 38' ' ' VAL . 2.5 p90 -174.58 159.72 2.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.444 0.64 . . . . 0.0 112.202 174.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.2 m -115.24 146.45 41.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.54 169.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.957 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -138.77 128.84 25.38 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -174.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.0 t -81.76 100.9 9.79 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 172.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' A' ' 21' ' ' PHE . 22.4 m -98.32 151.88 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.921 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.42 11.49 38.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.042 0.449 . . . . 0.0 111.032 -172.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 124.99 102.55 1.4 Allowed Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.844 HG12 HG21 ' A' ' 104' ' ' VAL . 12.3 tt -115.6 156.38 16.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 120.657 0.265 . . . . 0.0 110.986 -174.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.78 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 4.8 tppp? -139.66 -45.86 0.45 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.145 0.497 . . . . 0.0 111.75 -177.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.709 ' HG3' ' HB3' ' A' ' 41' ' ' ALA . 4.7 pt-20 -147.77 156.86 43.19 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.315 -176.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.649 ' HB3' ' HA ' ' A' ' 40' ' ' TYR . 55.7 p90 -171.86 179.27 2.79 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 119.774 -0.77 . . . . 0.0 112.815 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.46 149.83 30.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.503 167.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.824 HD12 HG22 ' A' ' 38' ' ' VAL . 25.6 mm -102.57 130.83 51.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.42 -177.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -96.42 147.61 23.64 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.845 0.831 . . . . 0.0 111.073 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.603 ' HD2' ' HD2' ' A' ' 93' ' ' TYR . 12.0 t80 -109.91 101.21 10.07 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.245 -1.343 . . . . 0.0 107.893 172.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.496 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . 10.8 tt0 -103.85 107.79 18.82 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 122.002 0.906 . . . . 0.0 110.702 -169.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.926 HG13 ' HD2' ' A' ' 34' ' ' LYS . 15.2 t -110.63 162.22 8.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.271 -1.331 . . . . 0.0 108.369 -177.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.5 m -70.22 -14.93 62.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.756 0.313 . . . . 0.0 111.389 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.35 -3.61 2.71 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.061 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.4 ' H ' ' HB ' ' A' ' 88' ' ' VAL . 1.7 mmtm -142.11 160.44 40.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.099 0.476 . . . . 0.0 111.435 -177.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 86' ' ' TYR . 7.5 m -148.99 143.58 26.21 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.909 172.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.603 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 20.4 m-85 -137.67 -172.07 3.15 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 175.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -148.03 127.07 12.82 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.781 -175.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.425 ' OD1' ' HA ' ' A' ' 10' ' ' GLN . 23.2 t70 -93.26 94.02 8.55 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 166.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.443 ' C ' ' H ' ' A' ' 98' ' ' ASN . 30.4 p-10 -128.12 41.72 3.45 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.851 -164.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 71.83 -33.58 0.27 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.325 1.05 . . . . 0.0 112.087 178.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.443 ' H ' ' C ' ' A' ' 96' ' ' ASN . 28.4 t-20 171.42 -59.55 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 65.2 m -160.25 26.95 0.17 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.586 174.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.1 -92.1 0.19 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -174.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -174.25 150.49 1.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.069 -168.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.581 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 81.5 m-85 -88.98 140.79 29.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.294 175.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -97.28 120.43 37.63 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 123.612 0.57 . . . . 0.0 109.905 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.844 HG21 HG12 ' A' ' 79' ' ' ILE . 86.9 t -83.5 126.27 40.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.062 0.458 . . . . 0.0 111.234 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.3 p -87.71 67.3 9.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.892 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.494 HG23 HG12 ' A' ' 104' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.601 -0.714 . . . . 0.0 111.116 178.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.2 t -147.05 -176.32 5.16 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.811 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 3.0 mp -57.47 -56.53 33.15 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 123.39 0.431 . . . . 0.0 110.454 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.811 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 40.8 Cg_endo -92.82 137.28 1.49 Allowed 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 122.068 1.845 . . . . 0.0 111.231 170.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.2 t -145.61 -66.7 0.3 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.2 m -103.74 -30.95 10.09 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 173.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -122.6 174.75 6.88 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.302 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.475 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 70.3 m -96.75 11.36 35.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.571 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.728 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 0.9 OUTLIER -149.92 152.53 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.736 -175.056 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.445 ' O ' ' HB3' ' A' ' 26' ' ' TYR . 57.6 tt0 -149.83 112.1 4.67 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.123 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.639 ' CD1' HG12 ' A' ' 25' ' ' ILE . 7.8 tt -67.82 132.32 47.18 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.983 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.469 ' OD1' ' HE2' ' A' ' 24' ' ' LYS . 15.5 t70 -68.85 -61.43 1.81 Allowed 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.293 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.436 ' N ' HD23 ' A' ' 11' ' ' LEU . 32.2 m -168.35 154.45 7.11 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.087 -168.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.46 ' HA ' ' HA3' ' A' ' 23' ' ' GLY . 42.1 p90 -157.08 152.66 26.72 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.396 -1.274 . . . . 0.0 109.198 177.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -127.86 164.74 21.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.094 0.473 . . . . 0.0 110.927 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.515 ' HA ' ' O ' ' A' ' 20' ' ' THR . 56.1 t80 -145.56 151.95 38.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.838 176.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -172.85 121.94 0.4 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.759 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.71 -98.28 0.12 Allowed Glycine 0 CA--C 1.51 -0.265 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -172.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.499 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 49.3 m -139.47 85.84 2.08 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 161.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 3.9 m -145.52 140.09 27.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.114 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.909 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 25.0 t80 -118.25 139.59 51.08 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 172.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 p -160.22 126.48 4.2 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.668 176.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 14' ' ' TYR . . . 177.82 -159.17 24.79 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 119.798 -1.191 . . . . 0.0 112.917 -178.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.636 ' HB3' HG22 ' A' ' 71' ' ' THR . 0.0 OUTLIER -160.49 160.22 31.75 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.342 0.591 . . . . 0.0 110.721 -178.51 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.639 HG12 ' CD1' ' A' ' 11' ' ' LEU . 31.2 mt -128.94 156.11 41.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.635 -170.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.445 ' HB3' ' O ' ' A' ' 10' ' ' GLN . 4.2 t80 -130.7 115.88 17.28 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -175.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.728 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 1.0 OUTLIER -139.4 149.15 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 121.679 -0.638 . . . . 0.0 111.513 -177.627 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 8' ' ' SER . 0.0 OUTLIER -93.45 152.69 18.93 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.374 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -79.66 126.21 30.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.786 -176.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.662 HG12 ' OH ' ' A' ' 86' ' ' TYR . 26.6 mm -93.29 -48.64 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 167.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.05 -156.13 0.73 Allowed 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.949 -1.478 . . . . 0.0 107.868 174.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -110.3 -51.78 2.84 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.44 -177.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.4 m -82.35 85.46 6.87 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.224 0.535 . . . . 0.0 110.096 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.496 ' HB2' ' HE3' ' A' ' 34' ' ' LYS . 25.7 mtmt -102.9 174.86 5.69 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.084 0.468 . . . . 0.0 110.903 -174.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.853 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 88.7 mttt -131.63 139.16 49.06 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.133 174.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 68.8 t -130.83 108.51 15.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 121.954 0.883 . . . . 0.0 109.919 171.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.529 HG22 HD11 ' A' ' 53' ' ' ILE . 19.4 p -122.39 122.99 40.31 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.523 -174.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.827 HG22 HD12 ' A' ' 84' ' ' ILE . 84.6 t -83.58 135.17 25.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.871 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.8 m -135.21 122.03 34.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.779 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.697 ' HE1' ' HA ' ' A' ' 42' ' ' ASP . 5.3 p90 -115.9 171.14 7.96 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 119.599 -0.841 . . . . 0.0 112.192 -174.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.756 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -93.36 86.58 5.32 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 170.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.723 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 38.0 t70 6.53 -95.42 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 O-C-N 127.336 2.898 . . . . 0.0 114.846 174.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.57 -28.37 0.35 Allowed Glycine 0 C--N 1.316 -0.542 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.692 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.2 t -109.6 -60.75 1.73 Allowed 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 174.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.645 ' HA ' ' HB1' ' A' ' 41' ' ' ALA . 8.0 p-10 175.46 38.28 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.135 -176.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -91.68 113.2 25.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.076 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.756 ' CH2' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -124.17 118.74 27.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.545 0.688 . . . . 0.0 110.062 167.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.467 ' O ' ' HB3' ' A' ' 49' ' ' ASN . 66.3 t30 -81.59 56.76 3.09 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 170.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 48' ' ' ASN . 33.8 t30 69.07 -55.61 0.55 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -154.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -124.83 -72.34 0.67 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.308 164.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.417 ' CA ' ' HB3' ' A' ' 48' ' ' ASN . . . 86.85 -40.53 3.08 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.248 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -134.49 98.91 4.2 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.484 0.659 . . . . 0.0 110.969 -175.464 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -122.42 143.91 33.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.682 -178.055 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.592 HG22 ' HB ' ' A' ' 38' ' ' VAL . 20.1 tt -131.57 128.45 60.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.195 173.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.23 132.95 35.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.781 0.324 . . . . 0.0 110.801 -176.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.79 159.66 33.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.614 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.3 m -112.3 128.98 56.43 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.444 ' H ' ' HD1' ' A' ' 58' ' ' PHE . 2.1 m-85 -71.5 138.74 49.17 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.276 -177.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.8 m -99.55 -46.14 5.56 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 170.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.73 175.26 21.82 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.583 173.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.76 134.55 58.05 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.248 1.965 . . . . 0.0 110.945 174.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.597 HD12 ' HB2' ' A' ' 67' ' ' TYR . 62.9 mt -75.82 106.63 5.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 28.4 m -49.66 125.24 11.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.063 -174.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.89 7.08 60.12 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.168 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.521 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 50.8 m -151.68 172.27 16.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.137 0.494 . . . . 0.0 111.124 -178.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -101.65 20.37 16.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.225 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.597 ' HB2' HD12 ' A' ' 62' ' ' ILE . 6.7 m-85 -103.71 154.95 18.98 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -114.14 162.58 16.33 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.414 ' HB2' HG12 ' A' ' 62' ' ' ILE . 8.8 t80 -122.6 119.44 30.81 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -167.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.559 ' NE1' HG13 ' A' ' 27' ' ' VAL . 3.7 m95 -116.28 126.76 54.01 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.491 -173.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.636 HG22 ' HB3' ' A' ' 24' ' ' LYS . 40.2 p -134.51 152.9 52.09 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.426 ' HB3' ' O ' ' A' ' 71' ' ' THR . 3.1 p90 -174.22 150.78 1.55 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.703 0.763 . . . . 0.0 111.79 168.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.0 m -112.43 138.42 49.19 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.014 169.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.909 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -132.64 135.78 46.08 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.936 0.398 . . . . 0.0 111.865 -168.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.9 t -88.31 98.18 11.45 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 170.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 19' ' ' SER . 20.1 m -104.21 139.94 23.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -177.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 3.8 mptp? -106.3 39.82 1.73 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.433 0.635 . . . . 0.0 109.93 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 129.71 136.77 4.12 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.063 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.723 ' HA ' ' O ' ' A' ' 42' ' ' ASP . 12.8 tt -160.78 143.8 4.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.014 0.435 . . . . 0.0 110.137 176.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -114.85 -56.16 2.41 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.985 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.644 ' HG2' ' HB3' ' A' ' 41' ' ' ALA . 12.6 pt-20 -150.78 174.51 12.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 117.889 -1.053 . . . . 0.0 108.735 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.562 ' CB ' ' HA ' ' A' ' 40' ' ' TYR . 46.8 p90 -172.76 179.95 2.25 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 120.413 1.461 . . . . 0.0 113.51 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.624 ' CB ' ' HB3' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -161.39 154.67 21.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 113.558 -1.655 . . . . 0.0 108.704 174.776 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.827 HD12 HG22 ' A' ' 38' ' ' VAL . 20.4 mm -99.98 147.43 7.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.979 -173.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.519 ' HD3' ' HE1' ' A' ' 94' ' ' TYR . 3.6 mmmp? -102.06 106.52 17.43 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.833 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.662 ' OH ' HG12 ' A' ' 30' ' ' ILE . 17.2 t80 -86.84 101.07 13.01 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 174.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.853 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 17.5 tt0 -109.5 117.58 34.35 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.383 0.611 . . . . 0.0 110.534 -173.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.1 t -115.47 106.22 20.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.393 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.8 t 53.8 23.92 4.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.419 0.628 . . . . 0.0 110.869 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.49 5.4 48.75 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.927 -177.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.733 ' O ' ' HA ' ' A' ' 87' ' ' GLU . 19.8 tptp -99.24 150.91 21.6 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.9 m -126.28 141.39 51.93 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 122.27 1.033 . . . . 0.0 112.842 -174.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.492 ' HD2' ' CD2' ' A' ' 86' ' ' TYR . 29.4 m-85 -134.8 -174.63 3.65 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 113.286 -1.779 . . . . 0.0 106.791 167.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.519 ' HE1' ' HD3' ' A' ' 85' ' ' LYS . 61.9 m-85 -144.58 137.03 26.47 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -169.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -127.99 112.54 14.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.567 171.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.624 ' HB3' ' CB ' ' A' ' 83' ' ' TYR . 29.4 p-10 -139.31 -43.35 0.45 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.484 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.606 ' HB3' ' O ' ' A' ' 96' ' ' ASN . 4.0 p-10 159.82 -45.18 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 168.15 -65.06 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 65.8 m -158.97 51.18 0.38 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.398 174.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.55 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -137.36 -31.74 0.8 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.55 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 95.7 m-20 84.18 150.77 0.08 Allowed 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.836 0.71 . . . . 0.0 110.156 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 78.3 m-85 -69.68 101.33 1.64 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.242 177.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.06 124.88 28.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.908 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.6 HG21 HG12 ' A' ' 79' ' ' ILE . 15.6 t -94.97 147.24 5.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.015 0.436 . . . . 0.0 110.487 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.4 m -93.75 112.41 24.27 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.791 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.251 1.153 0 CA-C-O 119.264 -0.398 . . . . 0.0 111.001 -177.734 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.856 0.36 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 p -102.27 130.33 48.94 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.664 -178.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.982 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 3.8 mp -89.6 -58.86 0.25 Allowed Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 174.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.982 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 15.4 Cg_exo -69.91 155.24 65.94 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.03 1.82 . . . . 0.0 111.052 172.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.7 t 68.19 7.41 5.88 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.181 0.593 . . . . 0.0 111.664 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.6 m -113.92 -64.69 1.27 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 172.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -153.55 -167.32 2.65 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.546 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 5.0 m -84.4 -17.42 39.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.623 0.725 . . . . 0.0 109.17 173.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.64 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.5 p -148.97 153.57 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.287 -176.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -143.01 127.97 18.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.333 177.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.524 HD21 ' CD2' ' A' ' 14' ' ' TYR . 42.9 tp -69.39 137.8 53.09 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.968 0.413 . . . . 0.0 110.319 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.512 ' OD1' ' HE2' ' A' ' 24' ' ' LYS . 12.9 t70 -83.58 -61.78 1.75 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.366 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.2 p -178.86 164.13 1.47 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.735 -176.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.524 ' CD2' HD21 ' A' ' 11' ' ' LEU . 45.9 p90 -158.33 163.14 37.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.772 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -143.81 166.5 24.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.825 0.345 . . . . 0.0 111.287 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.713 ' HD1' ' HD1' ' A' ' 21' ' ' PHE . 8.1 t80 -129.45 141.86 50.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.446 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -150.63 97.87 2.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.079 -176.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.98 -98.26 0.35 Allowed Glycine 0 CA--C 1.508 -0.379 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -172.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -129.64 84.26 2.2 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 162.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 95.5 m -147.45 134.72 20.6 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.065 175.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.713 ' HD1' ' HD1' ' A' ' 16' ' ' TYR . 2.9 t80 -132.88 109.54 9.68 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.0 m -135.6 149.63 49.43 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.926 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 179.6 -167.93 38.11 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.564 ' HB3' HG22 ' A' ' 71' ' ' THR . 0.0 OUTLIER -150.99 160.83 43.68 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.046 0.451 . . . . 0.0 111.307 -179.046 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 17.6 mt -127.3 153.23 36.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.072 -170.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.548 ' CE1' HG12 ' A' ' 3' ' ' ILE . 0.7 OUTLIER -124.97 111.85 15.89 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.64 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 0.9 OUTLIER -133.3 155.23 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.902 -176.021 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' A' ' 8' ' ' SER . 17.6 ptpt -93.49 152.19 19.23 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.029 175.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -94.92 102.17 13.99 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.756 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.557 HD13 ' HE2' ' A' ' 86' ' ' TYR . 3.8 mp -80.79 -44.52 21.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 172.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.494 ' HB3' ' CG2' ' A' ' 88' ' ' VAL . . . -132.64 159.95 38.09 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.461 -1.245 . . . . 0.0 107.65 174.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -85.26 -29.78 24.33 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.176 -0.466 . . . . 0.0 112.033 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 p -91.67 96.92 10.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.17 0.51 . . . . 0.0 110.274 176.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -111.78 171.09 7.7 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.442 -174.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.786 ' HG3' ' HB3' ' A' ' 87' ' ' GLU . 17.0 ptmt -155.73 103.95 2.3 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.0 0.905 . . . . 0.0 109.578 174.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.7 t -98.21 129.14 48.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-O 121.407 0.622 . . . . 0.0 109.979 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . 1.081 ' HB ' HD11 ' A' ' 53' ' ' ILE . 1.2 p -137.52 134.91 36.23 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.764 -172.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 1.02 ' HB ' HG22 ' A' ' 54' ' ' ILE . 78.2 t -91.96 135.46 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.202 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.441 HG12 ' CZ3' ' A' ' 47' ' ' TRP . 0.1 OUTLIER -114.96 75.3 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 170.788 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.953 ' CD2' HG11 ' A' ' 38' ' ' VAL 0.256 0.1 OUTLIER -102.65 118.36 36.68 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 122.398 1.094 . . . . 0.0 111.081 -176.749 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.917 ' HA ' ' CZ2' ' A' ' 47' ' ' TRP . . . -76.36 146.0 39.08 Favored 'General case' 0 CA--C 1.497 -1.073 0 CA-C-N 113.719 -1.582 . . . . 0.0 112.357 -168.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -79.34 163.7 24.65 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.607 -172.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.813 ' HA2' ' HB2' ' A' ' 80' ' ' LYS . . . -73.17 41.71 0.92 Allowed Glycine 0 C--N 1.329 0.146 0 O-C-N 123.421 0.451 . . . . 0.0 113.694 -171.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.0 m -121.29 -16.58 7.88 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.952 0.405 . . . . 0.0 110.502 176.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.531 ' OD1' ' HG2' ' A' ' 80' ' ' LYS . 3.8 m-20 66.39 47.5 1.73 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.671 177.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.498 ' O ' ' HD1' ' A' ' 47' ' ' TRP . 12.3 t-20 -143.22 87.84 1.99 Allowed 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.837 -171.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.917 ' CZ2' ' HA ' ' A' ' 41' ' ' ALA . 2.4 m0 -124.0 92.73 3.73 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -170.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -101.71 71.53 1.32 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.79 173.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.3 t30 49.52 24.1 1.05 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.504 0.669 . . . . 0.0 111.469 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -69.19 -36.76 77.65 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 173.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 57.97 70.22 1.05 Allowed Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 114.171 -1.377 . . . . 0.0 114.008 168.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.733 ' HB2' ' HZ2' ' A' ' 47' ' ' TRP . 38.2 m-80 -64.83 108.1 1.66 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 174.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 1.081 HD11 ' HB ' ' A' ' 37' ' ' THR . 5.4 tp -107.68 152.51 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 121.56 0.695 . . . . 0.0 112.031 -169.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 1.02 HG22 ' HB ' ' A' ' 38' ' ' VAL . 13.0 tt -142.29 140.5 29.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.031 167.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.45 130.14 35.26 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.723 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.06 153.72 36.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.667 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -105.2 130.66 53.3 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.431 0.634 . . . . 0.0 110.287 -176.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.449 ' H ' ' HD1' ' A' ' 58' ' ' PHE . 1.5 m-85 -71.21 143.16 50.55 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.389 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.0 m -114.65 -37.97 4.12 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 171.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.6 -178.25 17.99 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.773 172.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.02 138.62 78.92 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.461 2.107 . . . . 0.0 111.305 175.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.957 HG12 ' HB2' ' A' ' 69' ' ' TYR . 10.6 mt -81.78 126.56 39.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.63 -174.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.3 m -64.09 117.11 6.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.97 0.414 . . . . 0.0 109.989 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.0 -17.26 32.38 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.657 -176.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.433 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 19.8 m -128.05 173.23 10.23 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -107.56 4.9 26.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.273 0.559 . . . . 0.0 110.429 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.439 ' CE1' ' HB2' ' A' ' 28' ' ' LYS . 20.7 m-85 -100.79 -178.56 3.81 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.329 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' A' ' 69' ' ' TYR . 22.1 tt0 -113.54 170.69 8.06 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.54 -170.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.957 ' HB2' HG12 ' A' ' 62' ' ' ILE . 4.1 t80 -138.53 126.37 22.36 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -162.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.572 ' CD1' HG13 ' A' ' 27' ' ' VAL . 5.8 m95 -126.54 135.81 51.76 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.013 -170.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.564 HG22 ' HB3' ' A' ' 24' ' ' LYS . 20.8 p -135.88 153.77 51.36 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -178.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -158.85 164.15 35.98 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.875 0.845 . . . . 0.0 112.153 171.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 p -142.15 139.52 32.15 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.38 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.89 133.57 17.81 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -173.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.6 t -82.04 100.34 9.68 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 168.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.7 m -92.05 151.11 3.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.284 0.564 . . . . 0.0 110.574 -176.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -98.94 37.59 1.5 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.796 -177.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.63 116.26 3.96 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.551 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.848 HD11 ' HB2' ' A' ' 40' ' ' TYR . 4.2 tt -126.63 152.86 34.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.099 0.476 . . . . 0.0 110.494 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.813 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 17.6 tppt? -131.72 -42.46 1.02 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.22 -174.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 11.3 pt-20 -156.29 172.02 19.2 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-O 118.482 -0.77 . . . . 0.0 109.512 -176.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.75 ' HB3' ' HA ' ' A' ' 40' ' ' TYR . 55.4 p90 -173.01 178.15 2.59 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.427 ' O ' HG23 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -155.4 137.11 14.31 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 113.478 -1.692 . . . . 0.0 107.71 164.219 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.807 HD12 HG22 ' A' ' 38' ' ' VAL . 22.8 mm -91.1 137.31 22.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 O-C-N 121.637 -0.665 . . . . 0.0 109.86 -175.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.41 ' HG2' ' CD1' ' A' ' 94' ' ' TYR . 41.0 mtmt -92.97 129.49 38.87 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 122.048 0.928 . . . . 0.0 111.318 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.7 ' HD2' ' HD2' ' A' ' 93' ' ' TYR . 20.5 t80 -98.65 99.61 10.75 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 113.517 -1.674 . . . . 0.0 107.548 168.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.786 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . 4.2 tt0 -117.13 135.46 53.74 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -176.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.557 ' C ' ' H ' ' A' ' 90' ' ' GLY . 0.4 OUTLIER -146.72 162.61 8.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -178.679 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.1 t -72.39 32.71 0.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 122.066 0.936 . . . . 0.0 110.769 -174.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -147.28 -53.43 0.02 OUTLIER Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 114.638 -1.165 . . . . 0.0 111.34 175.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.493 ' H ' HG13 ' A' ' 88' ' ' VAL . 29.2 mmtp -132.01 -175.83 3.86 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.904 0.859 . . . . 0.0 113.158 -176.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.507 HG23 ' HG3' ' A' ' 87' ' ' GLU . 7.1 m -151.5 141.96 22.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.209 -1.36 . . . . 0.0 110.481 175.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.7 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 18.1 m-85 -145.16 -170.65 3.48 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.41 ' CD1' ' HG2' ' A' ' 85' ' ' LYS . 79.4 m-85 -149.11 127.17 11.97 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.235 0.334 . . . . 0.0 111.526 -173.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -80.51 79.05 7.18 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 167.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -118.55 -70.05 0.81 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.065 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 100' ' ' ALA . 0.7 OUTLIER 148.35 -53.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 -172.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.9 t30 175.82 -56.26 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.225 -1.807 . . . . 0.0 106.993 174.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.5 p -156.73 43.63 0.38 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.501 173.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -106.9 -53.37 2.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.788 -172.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 5.9 m-20 72.19 128.73 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.56 0.537 . . . . 0.0 110.079 -175.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 96.6 m-85 -74.27 118.68 17.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.239 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -78.83 124.52 28.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.998 0.428 . . . . 0.0 110.501 177.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.47 HG21 HD13 ' A' ' 79' ' ' ILE . 41.6 t -79.71 144.16 11.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 173.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.4 t -84.81 65.74 9.29 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.222 0.534 . . . . 0.0 110.66 -172.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.482 -0.77 . . . . 0.0 110.769 178.377 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.3 p -52.44 116.09 2.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.31 0.576 . . . . 0.0 110.899 178.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.673 HG23 ' HD3' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -69.55 -40.36 14.06 Favored Pre-proline 0 N--CA 1.435 -1.224 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.494 -178.165 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.673 ' HD3' HG23 ' A' ' 3' ' ' ILE . 58.6 Cg_endo -73.18 134.83 21.78 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.133 1.222 . . . . 0.0 111.072 171.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.5 t -150.85 -55.89 0.16 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.796 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.3 m -69.18 -77.7 0.08 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -175.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.33 -165.2 2.21 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 122.251 -0.281 . . . . 0.0 110.605 -177.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.542 ' HA ' ' HE2' ' A' ' 28' ' ' LYS . 14.6 m -69.39 -18.16 63.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.374 0.607 . . . . 0.0 110.334 176.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.605 HG11 ' HB2' ' A' ' 86' ' ' TYR . 2.8 p -149.68 147.33 16.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -143.99 143.76 31.36 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.753 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.546 HD11 ' HD2' ' A' ' 14' ' ' TYR . 3.8 tp -69.49 132.99 47.17 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.908 0.385 . . . . 0.0 110.685 172.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.63 -64.94 1.08 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 169.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.4 m -166.45 153.19 9.14 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.993 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.546 ' HD2' HD11 ' A' ' 11' ' ' LEU . 20.3 p90 -142.34 157.82 44.39 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 173.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -119.56 157.44 28.37 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.794 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.686 ' HA ' ' O ' ' A' ' 20' ' ' THR . 50.3 t80 -137.92 146.6 43.47 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 172.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -179.25 114.94 0.06 Allowed 'General case' 0 C--N 1.315 -0.924 0 O-C-N 123.683 0.615 . . . . 0.0 109.733 -174.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.73 -103.36 0.31 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -168.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.651 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 24.8 m -124.3 88.47 2.91 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 165.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.686 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 89.4 m -143.6 135.64 26.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.638 176.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.533 ' HZ ' HG11 ' A' ' 38' ' ' VAL . 11.4 t80 -134.01 145.02 49.07 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 120.732 0.301 . . . . 0.0 110.596 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.491 ' HA ' ' HB2' ' A' ' 14' ' ' TYR . 48.1 m 94.6 178.4 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 164.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -171.98 -78.61 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.573 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.607 ' HB3' HG22 ' A' ' 71' ' ' THR . 0.4 OUTLIER -166.55 169.02 14.13 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.977 0.418 . . . . 0.0 111.406 176.724 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 53.4 mt -132.07 154.0 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.577 -170.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -116.13 105.82 13.03 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -178.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 p -125.91 145.17 33.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 O-C-N 121.772 -0.58 . . . . 0.0 112.56 -165.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.542 ' HE2' ' HA ' ' A' ' 8' ' ' SER . 16.3 ttmm -86.41 151.75 23.28 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -101.97 117.63 35.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.415 0.626 . . . . 0.0 111.126 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.614 HG12 ' OH ' ' A' ' 86' ' ' TYR . 28.2 mm -88.24 -48.61 14.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.38 -154.03 0.61 Allowed 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 171.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -104.69 -48.72 3.71 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.25 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.1 m -74.41 80.01 1.9 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.033 176.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.611 ' HE2' ' CZ2' ' A' ' 70' ' ' TRP . 30.3 mtmm -103.74 157.59 16.97 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.597 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 24.9 mtpp -127.66 123.74 36.29 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.06 0.457 . . . . 0.0 109.889 176.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.7 t -117.13 125.53 73.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . 1.008 ' HB ' HD11 ' A' ' 53' ' ' ILE . 0.8 OUTLIER -138.64 129.44 26.48 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.014 -169.619 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.904 ' HB ' HG22 ' A' ' 54' ' ' ILE . 7.1 t -95.53 124.09 47.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.518 0.675 . . . . 0.0 110.742 -178.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.61 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -102.97 108.4 24.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 114.482 -1.236 . . . . 0.0 107.842 177.091 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.681 ' HB2' HG13 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -101.71 147.97 25.83 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-O 122.688 1.232 . . . . 0.0 112.448 174.454 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.787 ' HB3' ' HG2' ' A' ' 81' ' ' GLU . . . -86.07 93.98 9.13 Favored 'General case' 0 N--CA 1.407 -2.577 0 CA-C-N 113.431 -1.713 . . . . 0.0 106.382 165.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.458 ' CG ' ' H ' ' A' ' 43' ' ' GLY . 12.0 t70 -54.53 -163.79 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 111.441 -2.618 . . . . 0.0 112.778 -172.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.458 ' H ' ' CG ' ' A' ' 42' ' ' ASP . . . -58.1 -15.7 22.97 Favored Glycine 0 C--N 1.333 0.361 0 N-CA-C 111.981 -0.448 . . . . 0.0 111.981 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.5 t -58.98 -26.06 64.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 122.408 0.283 . . . . 0.0 110.357 173.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.8 t0 70.21 14.97 7.59 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-O 122.155 0.979 . . . . 0.0 109.243 174.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -159.89 152.49 21.22 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.737 -169.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.499 ' CE3' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -95.82 95.39 8.25 Favored 'General case' 0 N--CA 1.419 -2.009 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.217 173.041 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.63 ' OD1' ' HB2' ' A' ' 50' ' ' ASN . 5.1 p30 -82.97 22.61 0.92 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.498 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 51.19 65.88 1.35 Allowed 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.321 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.63 ' HB2' ' OD1' ' A' ' 48' ' ' ASN . 14.2 t30 -115.66 -61.75 1.69 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.874 -172.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.37 74.9 0.12 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -175.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.66 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 65.9 m-20 -117.34 83.91 2.06 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -175.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 1.008 HD11 ' HB ' ' A' ' 37' ' ' THR . 8.0 tp -119.38 149.93 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-O 121.446 0.641 . . . . 0.0 112.344 -171.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.904 HG22 ' HB ' ' A' ' 38' ' ' VAL . 8.5 tp -128.0 137.62 57.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 169.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.93 140.88 32.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.228 0.537 . . . . 0.0 111.773 -175.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.467 ' HA ' ' HB3' ' A' ' 72' ' ' PHE . . . -94.57 146.62 23.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.552 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.2 p -109.43 148.41 31.19 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.489 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -71.7 141.77 49.84 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -176.752 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.563 ' C ' ' HD2' ' A' ' 61' ' ' PRO . 23.0 t -114.95 -45.2 2.98 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.428 ' N ' ' HD2' ' A' ' 61' ' ' PRO . . . 116.6 -68.31 0.29 Allowed Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.924 -0.931 . . . . 0.0 114.594 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.563 ' HD2' ' C ' ' A' ' 59' ' ' SER . 13.9 Cg_exo -12.71 -42.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.384 1 C-N-CA 128.244 5.963 . . . . 0.0 120.362 -166.168 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.754 HG13 ' HB2' ' A' ' 69' ' ' TYR . 7.2 mt -71.08 88.34 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 119.353 0.979 . . . . 0.0 110.441 -177.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.6 t -114.32 163.56 15.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.494 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.13 21.66 78.77 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.638 ' HB3' HD12 ' A' ' 3' ' ' ILE . 55.6 m -155.68 174.16 15.68 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -178.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -92.32 32.38 1.19 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.068 0.461 . . . . 0.0 110.372 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.551 ' HE1' ' HB3' ' A' ' 4' ' ' PRO . 6.4 m-85 -129.76 -179.33 5.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.207 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -153.4 151.77 30.29 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.303 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.754 ' HB2' HG13 ' A' ' 62' ' ' ILE . 3.2 t80 -104.54 128.93 52.63 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -174.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.611 ' CZ2' ' HE2' ' A' ' 34' ' ' LYS . 15.6 m0 -124.38 151.21 44.68 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.607 HG22 ' HB3' ' A' ' 24' ' ' LYS . 7.7 p -129.94 147.3 51.68 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 -178.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.467 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -160.79 142.35 12.12 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.549 177.621 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 42.1 m -124.85 146.49 49.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.375 176.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.15 112.99 9.03 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -174.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.9 t -78.5 100.47 6.9 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 169.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.651 ' O ' ' HB3' ' A' ' 19' ' ' SER . 30.0 m -103.83 156.44 5.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.397 -177.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.811 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -102.9 -7.42 21.53 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.551 174.67 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 172.6 142.09 3.67 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.615 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.681 HG13 ' HB2' ' A' ' 40' ' ' TYR . 6.0 tt -160.26 142.14 4.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 177.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -121.87 -46.79 2.21 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.594 -174.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.787 ' HG2' ' HB3' ' A' ' 41' ' ' ALA . 9.8 pt-20 -152.51 162.22 41.5 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -176.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.61 ' HB2' ' O ' ' A' ' 39' ' ' VAL . 42.5 p90 -170.79 173.62 5.21 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.7 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.424 ' O ' HG23 ' A' ' 39' ' ' VAL . 0.1 OUTLIER -155.69 153.78 30.51 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 172.524 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.408 HG22 ' N ' ' A' ' 85' ' ' LYS . 2.5 mt -92.6 151.91 3.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.562 0.696 . . . . 0.0 112.219 -170.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.408 ' N ' HG22 ' A' ' 84' ' ' ILE . 18.8 mmtp -107.46 114.09 27.87 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.341 176.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.797 ' HD2' ' HD2' ' A' ' 93' ' ' TYR . 14.9 t80 -91.59 101.29 13.93 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 174.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 23.2 tt0 -105.83 111.17 23.73 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.47 0.652 . . . . 0.0 109.693 -172.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.617 ' HB ' ' H ' ' A' ' 91' ' ' LYS . 14.6 t -108.94 159.84 8.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.211 -176.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.9 t -79.3 33.67 0.24 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 122.002 0.906 . . . . 0.0 109.046 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -164.23 -47.43 0.02 OUTLIER Glycine 0 N--CA 1.436 -1.338 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.805 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.617 ' H ' ' HB ' ' A' ' 88' ' ' VAL . 30.5 mmmt -127.0 -173.87 3.0 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.926 0.869 . . . . 0.0 112.284 -176.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.9 m -150.79 140.79 22.02 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.167 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.797 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 48.5 m-85 -144.43 -166.07 2.29 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -144.26 160.32 41.19 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.75 0.31 . . . . 0.0 111.029 -174.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.463 ' HB2' HG13 ' A' ' 9' ' ' VAL . 25.8 t70 -126.24 115.93 20.5 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 162.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -146.95 -66.89 0.27 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.039 -170.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 155.53 -56.91 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -173.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 50.0 t30 176.14 -48.95 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 112.871 -1.968 . . . . 0.0 106.614 176.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.6 t -170.84 64.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.586 170.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -126.38 -44.85 1.69 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.49 -173.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 91.1 m-20 70.9 144.63 0.06 Allowed 'General case' 0 N--CA 1.471 0.602 0 O-C-N 123.677 0.61 . . . . 0.0 110.597 -175.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.539 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 98.3 m-85 -79.95 111.27 16.12 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.759 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.87 110.69 15.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.094 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.424 HG21 HD13 ' A' ' 79' ' ' ILE . 25.3 t -79.76 142.12 14.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.205 -177.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.8 t -90.96 106.3 18.42 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -176.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.667 -0.683 . . . . 0.0 110.87 -174.94 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 121.026 0.441 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.7 p -97.91 130.33 44.79 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.069 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.639 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 38.7 mm -62.4 -48.85 86.12 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.338 174.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.639 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 51.2 Cg_exo -55.83 140.23 84.91 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.195 1.93 . . . . 0.0 112.231 175.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.9 t -130.69 -67.21 0.73 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.328 -0.397 . . . . 0.0 109.999 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.7 t -88.57 -68.96 0.73 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.231 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.49 -159.05 0.93 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.57 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.1 m -62.98 -32.68 74.07 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.553 0.692 . . . . 0.0 109.622 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.868 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.3 p -115.95 150.42 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.574 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.455 ' O ' ' HB3' ' A' ' 26' ' ' TYR . 63.3 tt0 -145.66 125.24 13.25 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.988 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.543 HD21 ' CD2' ' A' ' 14' ' ' TYR . 15.4 tp -68.18 131.66 45.79 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.209 0.528 . . . . 0.0 110.856 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.416 ' OD1' ' HE2' ' A' ' 24' ' ' LYS . 16.0 t70 -81.14 -61.83 1.84 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.853 176.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.6 p -175.95 160.03 2.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.938 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.543 ' CD2' HD21 ' A' ' 11' ' ' LEU . 12.7 p90 -152.04 161.39 42.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.808 177.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -129.29 165.3 21.7 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.734 0.302 . . . . 0.0 110.681 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.601 ' HD1' ' HD1' ' A' ' 21' ' ' PHE . 51.7 t80 -145.6 153.08 40.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.142 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -177.63 129.23 0.15 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.12 -102.56 0.36 Allowed Glycine 0 C--N 1.331 0.275 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -173.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.2 m -136.83 85.66 2.15 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 163.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.56 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 6.5 m -144.8 131.05 19.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.354 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.601 ' HD1' ' HD1' ' A' ' 16' ' ' TYR . 1.4 t80 -133.44 102.47 5.54 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.689 0.757 . . . . 0.0 109.302 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.6 m -134.65 160.08 39.23 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.809 -174.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.28 -143.32 8.66 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.447 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.563 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -162.56 159.96 25.39 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.093 0.473 . . . . 0.0 110.966 178.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.463 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 20.9 mt -122.25 155.53 27.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.179 -173.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.455 ' HB3' ' O ' ' A' ' 10' ' ' GLN . 7.5 t80 -129.05 101.56 6.1 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -172.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.868 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 2.0 m -135.35 145.65 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 O-C-N 121.493 -0.754 . . . . 0.0 112.52 -171.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 67' ' ' TYR . 40.1 ttmt -68.43 133.41 48.6 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.186 177.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.524 ' HB3' ' HB2' ' A' ' 68' ' ' GLU . 24.1 p-10 -95.18 84.51 4.09 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.752 0.787 . . . . 0.0 110.544 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.5 mp -63.72 -47.74 89.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 175.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.44 -176.12 2.83 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.697 171.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -109.99 -55.82 2.4 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.465 -177.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.8 m -75.8 73.58 2.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.379 0.609 . . . . 0.0 110.43 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.405 ' HE2' ' CZ2' ' A' ' 70' ' ' TRP . 28.9 mtmm -102.75 -171.63 1.99 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.761 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -151.63 144.4 24.37 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.9 t -125.53 120.24 57.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.524 0.678 . . . . 0.0 110.552 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.64 ' HB ' HG13 ' A' ' 53' ' ' ILE . 2.1 p -116.17 110.34 18.69 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.261 -176.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 1.058 ' HB ' HG22 ' A' ' 54' ' ' ILE . 81.0 t -83.28 108.35 15.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.78 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.672 HG12 ' HB ' ' A' ' 53' ' ' ILE . 26.5 m -108.77 121.19 61.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.226 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.419 ' HB2' HG13 ' A' ' 79' ' ' ILE . 7.6 p90 -118.39 148.59 42.37 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.631 0.729 . . . . 0.0 111.7 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.727 ' HB3' ' HG2' ' A' ' 81' ' ' GLU . . . -81.59 83.87 6.92 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 171.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -48.59 -166.47 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 111.337 -2.665 . . . . 0.0 113.932 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.2 -21.17 46.07 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-N 116.259 -0.428 . . . . 0.0 113.062 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -65.91 -19.86 66.02 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.654 -0.321 . . . . 0.0 110.526 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.2 t70 72.85 21.98 3.21 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.444 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -168.3 148.96 4.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.493 -175.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.437 ' CZ3' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -87.81 83.74 7.1 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 173.654 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' A' ' 50' ' ' ASN . 6.4 t-20 -78.11 55.49 1.49 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.2 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.0 t30 69.04 -26.77 0.15 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.204 0.601 . . . . 0.0 110.865 -176.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.542 ' H ' ' C ' ' A' ' 48' ' ' ASN . 4.6 p30 -62.14 -43.17 99.43 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.374 174.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 49.97 62.5 4.92 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -176.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 28.8 m-80 -41.78 106.76 0.06 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.882 0.873 . . . . 0.0 111.982 -174.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.672 ' HB ' HG12 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -117.3 138.48 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.833 0.825 . . . . 0.0 112.658 -171.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 1.058 HG22 ' HB ' ' A' ' 38' ' ' VAL . 5.2 tp -111.37 133.99 55.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 168.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.61 113.24 22.34 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.263 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.84 154.47 29.79 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -130.48 130.83 44.71 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.74 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 38.0 p90 -78.27 137.66 38.21 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.902 0.858 . . . . 0.0 111.013 -178.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.9 t -87.1 -26.77 23.49 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.276 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.88 168.91 18.87 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.508 172.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.554 ' HA ' ' HA ' ' A' ' 68' ' ' GLU . 26.1 Cg_exo -63.39 141.87 83.01 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.676 2.251 . . . . 0.0 111.42 174.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.49 HG12 ' HB2' ' A' ' 69' ' ' TYR . 21.8 mt -84.62 109.25 17.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.337 -177.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.6 m -63.11 126.18 26.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.869 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.34 -7.28 34.58 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.166 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.7 m -151.26 165.47 33.9 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -92.71 52.58 1.89 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.953 0.882 . . . . 0.0 109.124 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 4.0 m-85 -130.21 169.24 15.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.536 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 61' ' ' PRO . 9.0 tt0 -125.2 171.54 10.25 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.585 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.49 ' HB2' HG12 ' A' ' 62' ' ' ILE . 3.1 t80 -138.86 111.15 7.43 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -163.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.74 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 11.8 m95 -112.57 130.47 56.01 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.985 -168.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 p -120.26 144.27 47.86 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -155.34 155.9 34.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.848 0.832 . . . . 0.0 112.549 177.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.6 p -142.51 142.46 32.26 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.011 174.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.512 ' HB2' HG12 ' A' ' 54' ' ' ILE . . . -152.68 138.76 18.22 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -175.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 31.3 t -90.58 101.23 13.97 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 166.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.0 m -89.66 160.48 2.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.42 -171.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.55 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -90.37 29.72 1.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.638 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.29 146.23 13.35 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -170.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.419 HG13 ' HB2' ' A' ' 40' ' ' TYR . 2.8 tt -143.28 126.81 13.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.775 0.798 . . . . 0.0 111.409 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 103' ' ' GLN . 28.0 mmtp -93.5 -41.45 9.77 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.22 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.727 ' HG2' ' HB3' ' A' ' 41' ' ' ALA . 13.8 pt-20 -160.68 168.27 25.22 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -169.39 172.76 6.95 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.657 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.472 ' HD2' ' HB3' ' A' ' 96' ' ' ASN . 0.1 OUTLIER -164.72 150.04 9.89 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.573 -1.194 . . . . 0.0 107.854 175.116 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.946 HD12 HG22 ' A' ' 38' ' ' VAL . 9.6 mm -93.3 136.29 25.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.017 -172.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.809 ' HD2' ' HE1' ' A' ' 94' ' ' TYR . 15.6 mmmt -94.4 104.95 16.92 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.602 ' CD2' ' HD2' ' A' ' 93' ' ' TYR . 23.9 t80 -86.76 102.14 13.98 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.338 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -114.42 123.15 48.73 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.638 0.732 . . . . 0.0 109.952 -173.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.506 ' C ' ' H ' ' A' ' 90' ' ' GLY . 9.4 t -112.76 163.79 9.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 t -72.25 20.79 0.06 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.197 0.523 . . . . 0.0 111.082 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -162.85 -40.88 0.02 OUTLIER Glycine 0 N--CA 1.438 -1.232 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.891 178.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.402 ' H ' ' HB ' ' A' ' 88' ' ' VAL . 19.6 tptm -117.35 167.6 11.1 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -174.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.1 m -146.05 145.5 30.6 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.602 ' HD2' ' CD2' ' A' ' 86' ' ' TYR . 60.9 m-85 -142.58 -168.28 2.71 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 175.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.809 ' HE1' ' HD2' ' A' ' 85' ' ' LYS . 21.5 m-85 -146.42 140.39 26.26 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.551 -173.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -110.12 96.24 6.1 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.557 ' O ' ' HB2' ' A' ' 97' ' ' ASN . 27.0 p-10 -137.55 39.17 2.44 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.763 -174.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.557 ' HB2' ' O ' ' A' ' 96' ' ' ASN . 21.8 m-80 70.95 -62.88 0.44 Allowed 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.737 0.648 . . . . 0.0 109.907 -169.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -177.67 -55.78 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 52.8 m -157.02 59.58 0.52 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.448 170.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.611 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -137.86 -49.16 0.57 Allowed 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -170.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.611 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 12.9 m-20 74.14 143.22 0.07 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -169.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.678 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 3.4 m-85 -91.46 97.29 10.98 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 2.5 pm0 -76.95 110.82 11.88 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.427 HG11 ' HE1' ' A' ' 21' ' ' PHE . 22.0 t -79.71 148.84 5.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.742 -167.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.5 m -86.85 81.35 8.18 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.211 176.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.516 HG22 ' CZ ' ' A' ' 16' ' ' TYR . 0.6 OUTLIER . . . . . 0 C--O 1.254 1.302 0 CA-C-O 118.495 -0.764 . . . . 0.0 111.13 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.757 0.313 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.9 m -112.03 141.95 45.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.155 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.6 mt -49.46 129.33 18.35 Favored Pre-proline 0 N--CA 1.466 0.338 0 O-C-N 123.495 0.497 . . . . 0.0 111.207 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.12 133.3 52.19 Favored 'Trans proline' 0 C--O 1.237 0.458 0 C-N-CA 122.866 2.377 . . . . 0.0 111.886 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.5 t -95.67 -64.03 1.1 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.643 -174.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.0 t -81.95 -49.74 9.94 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.44 151.33 46.61 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.224 178.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.429 ' HB3' HD11 ' A' ' 30' ' ' ILE . 17.0 m -93.36 -7.79 43.75 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.649 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.78 HG23 HG12 ' A' ' 27' ' ' VAL . 1.7 p -148.44 151.74 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.321 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -142.96 151.67 41.16 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.488 HD11 ' HD2' ' A' ' 14' ' ' TYR . 2.5 tp -77.37 142.59 39.24 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.459 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 31.7 t70 -93.1 -64.54 1.08 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 175.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.906 ' HB2' ' HE3' ' A' ' 24' ' ' LYS . 41.4 m -166.75 155.54 10.48 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.259 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.488 ' HD2' HD11 ' A' ' 11' ' ' LEU . 18.6 p90 -157.17 150.97 24.44 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.635 177.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -130.33 157.54 42.26 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.661 ' HA ' ' O ' ' A' ' 20' ' ' THR . 4.3 m-85 -137.53 153.78 49.94 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.702 -175.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -137.98 75.84 1.55 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.52 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.76 -84.29 0.67 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -171.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.1 m -132.41 86.01 2.29 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.57 0.7 . . . . 0.0 109.414 163.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.661 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 26.1 m -146.79 126.02 13.01 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 170.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 1.005 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 36.7 t80 -107.2 133.48 51.72 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.436 0.636 . . . . 0.0 110.078 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.2 p -153.65 151.26 29.48 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.832 173.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.414 ' C ' ' HD3' ' A' ' 24' ' ' LYS . . . 159.08 -151.33 22.23 Favored Glycine 0 CA--C 1.506 -0.522 0 C-N-CA 119.09 -1.528 . . . . 0.0 113.391 -178.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.906 ' HE3' ' HB2' ' A' ' 13' ' ' SER . 0.2 OUTLIER -166.34 168.83 14.68 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.745 0.418 . . . . 0.0 110.409 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.523 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 17.0 mt -131.61 160.76 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.732 -172.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.458 ' N ' HG22 ' A' ' 25' ' ' ILE . 4.0 t80 -130.59 98.56 4.7 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.349 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.78 HG12 HG23 ' A' ' 9' ' ' VAL . 0.7 OUTLIER -118.56 156.7 20.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.956 -176.723 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -94.72 141.68 28.34 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.424 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.719 HD21 ' HB2' ' A' ' 68' ' ' GLU . 46.1 m-80 -89.79 101.02 13.72 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.823 0.344 . . . . 0.0 111.561 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.547 HD13 ' HE2' ' A' ' 86' ' ' TYR . 4.1 mp -88.64 -34.5 7.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 173.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.422 ' HB3' ' CG1' ' A' ' 88' ' ' VAL . . . -139.95 -178.96 5.68 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.874 174.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -109.86 -15.52 14.08 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.474 -173.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.8 m -100.0 85.55 3.07 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.4 mtmt -110.36 153.61 24.69 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.721 -174.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.593 ' CG ' ' HB3' ' A' ' 87' ' ' GLU . 18.4 ptpt -130.84 129.52 42.44 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 166.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.5 t -119.55 115.75 48.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-O 121.74 0.781 . . . . 0.0 109.604 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.744 ' HB ' HG13 ' A' ' 53' ' ' ILE . 11.0 p -131.91 114.0 14.13 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.449 -170.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.734 HG22 HD12 ' A' ' 84' ' ' ILE . 54.6 t -79.66 125.43 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.467 HG12 ' HB ' ' A' ' 53' ' ' ILE . 29.9 m -122.06 120.89 62.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.894 -176.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.652 ' HB3' ' HB3' ' A' ' 82' ' ' PHE . 9.9 p90 -125.97 148.29 49.29 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.399 -171.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.863 ' HB2' ' CZ2' ' A' ' 47' ' ' TRP . . . -72.18 97.56 1.98 Allowed 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 170.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.468 ' HA ' ' HE1' ' A' ' 40' ' ' TYR . 0.9 OUTLIER -48.84 -178.55 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.469 -1.696 . . . . 0.0 112.119 171.232 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.36 -22.89 52.35 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.956 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.1 t -85.94 -15.76 40.59 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 122.274 0.23 . . . . 0.0 111.441 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.657 ' HA ' ' HB1' ' A' ' 41' ' ' ALA . 3.7 m-20 68.42 30.25 5.43 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.535 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -106.7 99.09 8.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.335 -173.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.863 ' CZ2' ' HB2' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -90.92 110.64 21.88 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 168.835 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -66.8 -139.84 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 170.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -55.3 -45.83 76.25 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 158.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -138.08 -59.06 0.65 Allowed 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 113.343 -1.753 . . . . 0.0 108.435 159.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.27 -50.88 4.4 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.158 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.419 ' ND2' ' H ' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -123.39 105.57 9.93 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.348 0.594 . . . . 0.0 110.729 -177.355 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.744 HG13 ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -138.4 141.72 36.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.886 -174.062 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.723 HG22 ' HB ' ' A' ' 38' ' ' VAL . 9.4 tp -115.43 118.37 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.24 136.16 37.72 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.529 -177.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.47 ' HA ' ' CE1' ' A' ' 72' ' ' PHE . . . -78.02 150.93 33.77 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.653 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -108.07 131.54 54.49 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -70.9 137.92 49.7 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.265 0.555 . . . . 0.0 110.377 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.2 t -106.57 -43.18 4.8 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 146.49 165.42 11.57 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.5 173.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.5 135.69 62.6 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.217 1.944 . . . . 0.0 110.795 175.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.58 HD12 ' HB2' ' A' ' 67' ' ' TYR . 55.5 mt -68.29 108.86 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.8 m -52.46 117.78 3.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.224 -171.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.65 2.58 49.9 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.423 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.583 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 63.6 m -146.84 170.75 16.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.226 0.536 . . . . 0.0 111.318 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -96.12 19.79 11.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.344 1.069 . . . . 0.0 109.459 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.583 ' CD2' ' HB3' ' A' ' 65' ' ' SER . 14.2 m-85 -100.24 157.22 16.75 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.402 178.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.719 ' HB2' HD21 ' A' ' 29' ' ' ASN . 13.2 tt0 -126.03 168.64 13.68 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.571 -175.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -130.11 125.69 35.75 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -167.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.575 ' NE1' HG13 ' A' ' 27' ' ' VAL . 5.9 m95 -127.59 126.43 42.07 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -172.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 p -110.49 152.43 26.36 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 117.909 0.322 . . . . 0.0 111.825 -172.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.544 ' CD2' ' HE1' ' A' ' 21' ' ' PHE . 10.5 m-85 -128.52 152.84 47.81 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 -175.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.7 m -163.18 121.84 2.05 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 111.525 -2.58 . . . . 0.0 107.381 165.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 1.005 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -149.2 132.54 16.54 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.679 -167.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.8 t -98.56 99.25 10.37 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 169.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.2 m -89.82 144.35 9.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.211 0.529 . . . . 0.0 110.809 -172.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -89.19 32.45 0.83 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.835 -173.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.66 142.13 12.87 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -176.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.42 HD11 ' CD2' ' A' ' 82' ' ' PHE . 7.8 tt -153.68 144.13 14.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.379 0.609 . . . . 0.0 111.693 -175.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -104.64 -53.5 2.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.109 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.77 ' HB2' ' HA ' ' A' ' 102' ' ' TYR . 12.8 pt-20 -156.54 161.37 39.99 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.448 -175.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.895 ' HE1' ' HA ' ' A' ' 101' ' ' ASN . 0.1 OUTLIER -145.15 168.0 21.41 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 119.362 0.983 . . . . 0.0 112.594 177.517 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.482 ' HB3' ' HE1' ' A' ' 102' ' ' TYR . 0.3 OUTLIER -152.23 158.42 42.81 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 165.073 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.734 HD12 HG22 ' A' ' 38' ' ' VAL . 5.1 mm -101.12 145.58 11.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 119.359 -0.936 . . . . 0.0 112.194 -165.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 37' ' ' THR . 13.9 mmmt -102.93 108.38 19.54 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.223 -178.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.547 ' HE2' HD13 ' A' ' 30' ' ' ILE . 13.4 t80 -99.34 99.75 10.73 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 173.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.593 ' HB3' ' CG ' ' A' ' 35' ' ' LYS . 28.5 tt0 -116.51 131.04 57.05 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.962 -175.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.422 ' CG1' ' HB3' ' A' ' 31' ' ' ALA . 2.8 t -121.37 165.59 16.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.007 -171.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.41 ' H ' HG12 ' A' ' 88' ' ' VAL . 1.5 p -46.99 -37.43 9.11 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -126.83 -18.34 2.16 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.514 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -118.52 167.11 11.91 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 117.488 0.644 . . . . 0.0 110.465 -174.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.4 m -148.76 145.88 27.8 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 172.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.513 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 37.5 m-85 -136.19 -177.85 4.89 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 174.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.429 ' CE1' ' HD2' ' A' ' 85' ' ' LYS . 71.0 m-85 -150.4 126.97 10.85 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.625 -173.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -131.29 143.92 50.89 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.099 0.475 . . . . 0.0 111.038 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -127.34 10.54 6.8 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 62.89 -75.16 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.902 -173.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.0 t30 173.38 -62.15 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.6 m -139.6 19.77 2.53 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.192 173.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.44 -36.2 15.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.644 0.735 . . . . 0.0 109.617 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.895 ' HA ' ' HE1' ' A' ' 82' ' ' PHE . 15.6 m120 -91.66 178.81 5.82 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.248 173.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.77 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 2.6 m-85 73.02 -111.48 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 124.495 1.122 . . . . 0.0 110.614 -173.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.26 106.79 0.26 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.03 0.919 . . . . 0.0 112.471 -171.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.449 HG12 HG22 ' A' ' 106' ' ' THR . 97.4 t -79.95 114.05 20.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.016 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.4 m -92.01 104.67 17.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.449 HG22 HG12 ' A' ' 104' ' ' VAL . 9.6 t . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.688 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.7 m -98.79 113.8 26.06 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.744 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 34.6 mm -78.87 -53.52 1.16 Allowed Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.707 -175.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.744 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 11.5 Cg_endo -90.93 141.0 2.96 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.265 1.977 . . . . 0.0 112.504 175.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.1 t -150.69 -71.41 0.17 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.885 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.6 m -124.61 -44.82 1.95 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.081 0.467 . . . . 0.0 110.538 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.5 136.25 33.02 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.477 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.7 m -81.85 -16.94 49.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.832 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.702 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.7 p -144.91 149.81 16.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.704 -176.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -143.36 131.29 21.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.024 177.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.663 HD13 HD11 ' A' ' 84' ' ' ILE . 51.4 tp -69.55 132.54 46.42 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.393 0.616 . . . . 0.0 110.216 175.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -80.24 -61.04 2.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.38 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.1 p -177.58 162.24 1.79 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.202 -174.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.579 ' CD2' HD21 ' A' ' 11' ' ' LEU . 47.7 p90 -158.16 163.41 37.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.849 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -148.73 162.03 40.59 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.217 0.532 . . . . 0.0 110.254 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.582 ' HD1' ' HD1' ' A' ' 21' ' ' PHE . 30.2 t80 -124.59 142.9 51.02 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.736 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -161.2 124.12 3.18 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.64 -103.96 0.43 Allowed Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -169.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.1 t -137.75 82.65 1.93 Allowed 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 163.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 56.7 m -148.04 140.67 24.57 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.377 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.582 ' HD1' ' HD1' ' A' ' 16' ' ' TYR . 2.5 t80 -128.16 108.18 10.41 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.979 0.895 . . . . 0.0 109.302 176.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.0 p -137.2 148.76 46.75 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.918 -173.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.8 -144.61 5.54 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.874 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.523 ' HB3' HG22 ' A' ' 71' ' ' THR . 5.0 ptmm? -164.71 168.24 18.18 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.981 0.42 . . . . 0.0 111.014 -177.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.744 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 8.3 mt -138.58 158.17 30.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.87 -167.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -133.02 97.18 3.94 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.338 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.702 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 1.5 m -136.16 149.33 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 O-C-N 121.499 -0.75 . . . . 0.0 112.135 -172.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.488 ' HD3' ' CE1' ' A' ' 67' ' ' TYR . 6.7 ttpm? -99.53 133.49 43.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.888 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -87.88 119.9 28.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.0 0.429 . . . . 0.0 111.775 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.525 HG12 ' OH ' ' A' ' 86' ' ' TYR . 32.8 mm -63.66 -45.25 97.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 122.199 0.999 . . . . 0.0 108.634 173.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.592 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . -137.48 143.87 41.96 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 172.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.411 ' HE1' ' OE1' ' A' ' 68' ' ' GLU . 40.6 t80 -60.16 -42.62 95.33 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -164.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.9 m -80.07 69.44 6.46 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.649 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 1.046 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -87.0 -175.4 5.34 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.077 0.465 . . . . 0.0 110.97 176.77 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.862 ' HG3' ' HB3' ' A' ' 87' ' ' GLU . 18.7 ptmt -148.32 126.55 12.19 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.3 t -119.71 121.41 66.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-O 121.655 0.741 . . . . 0.0 110.983 -171.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.622 ' OG1' ' HE3' ' A' ' 85' ' ' LYS . 72.4 p -128.15 117.78 22.2 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.754 -172.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.96 HG22 HD13 ' A' ' 84' ' ' ILE . 16.5 t -82.91 129.14 37.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.14 176.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.3 m -122.35 125.01 72.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.393 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.468 ' HB2' HG13 ' A' ' 79' ' ' ILE . 2.0 p90 -115.77 149.99 37.61 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.357 0.598 . . . . 0.0 112.038 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.683 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . . . -80.45 62.1 4.43 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.056 175.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.731 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 6.6 t70 34.88 -139.51 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 O-C-N 126.357 2.286 . . . . 0.0 111.095 173.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.34 1.26 31.05 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 168.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.528 ' O ' ' HB3' ' A' ' 45' ' ' ASP . 34.4 t -103.55 -17.33 15.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.026 -0.587 . . . . 0.0 112.568 -170.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.567 ' OD1' ' HG3' ' A' ' 81' ' ' GLU . 25.4 t70 77.22 55.96 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -173.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -158.7 141.58 14.54 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.522 -1.217 . . . . 0.0 108.952 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.516 ' CZ2' ' HB2' ' A' ' 41' ' ' ALA . 5.0 m95 -106.39 81.47 1.61 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.268 1.033 . . . . 0.0 109.041 -178.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -88.8 153.67 20.88 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.81 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -74.48 48.79 0.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.596 0.712 . . . . 0.0 110.548 176.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.523 ' HB3' ' OD1' ' A' ' 52' ' ' ASN . 26.7 t30 -86.48 -21.03 27.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.63 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.13 44.89 1.54 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -171.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.523 ' OD1' ' HB3' ' A' ' 50' ' ' ASN . 10.0 m-20 -89.98 40.05 0.99 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.939 -0.63 . . . . 0.0 110.736 -171.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -126.25 144.62 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.53 -176.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.933 HG22 ' HB ' ' A' ' 38' ' ' VAL . 6.6 tp -128.53 136.15 60.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 174.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.27 132.0 34.67 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.638 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.87 161.59 14.43 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.517 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.8 t -130.63 138.32 50.04 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.683 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 33.7 p90 -90.89 143.66 26.49 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.068 0.461 . . . . 0.0 110.18 176.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.5 m -94.86 -22.73 17.83 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.423 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 157.01 173.29 25.25 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.972 173.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 68' ' ' GLU . 16.1 Cg_exo -68.13 147.29 72.8 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.564 2.176 . . . . 0.0 111.31 176.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.5 HG12 ' HB2' ' A' ' 69' ' ' TYR . 28.9 mt -85.28 95.9 4.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.3 m -57.14 127.93 34.43 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.214 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.82 6.8 60.39 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.605 -177.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.0 m -148.8 173.17 13.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.716 0.293 . . . . 0.0 110.222 178.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -94.79 4.24 54.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.277 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.488 ' CE1' ' HD3' ' A' ' 28' ' ' LYS . 3.8 m-85 -108.7 167.44 10.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.667 0.746 . . . . 0.0 111.838 -172.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.439 ' HG3' ' H ' ' A' ' 69' ' ' TYR . 1.7 tt0 -108.85 169.94 8.36 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.447 -1.252 . . . . 0.0 108.883 175.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.5 ' HB2' HG12 ' A' ' 62' ' ' ILE . 1.1 t80 -128.37 111.04 12.91 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -164.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.744 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 9.0 m95 -114.68 145.81 41.61 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.537 -168.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.523 HG22 ' HB3' ' A' ' 24' ' ' LYS . 10.4 p -138.3 134.86 34.84 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -137.03 147.4 46.17 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.824 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.5 p -126.23 142.96 51.32 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.921 175.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.523 ' HB2' HG12 ' A' ' 54' ' ' ILE . . . -150.67 114.22 4.93 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.086 0.469 . . . . 0.0 110.939 -174.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.5 t -78.28 99.78 6.43 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 171.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.9 m -101.89 149.29 6.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.296 -173.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -75.34 -21.9 58.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.916 0.865 . . . . 0.0 108.817 173.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.12 172.93 28.0 Favored Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 114.086 -1.415 . . . . 0.0 109.617 -175.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.731 ' HA ' ' O ' ' A' ' 42' ' ' ASP . 3.8 tt -169.92 125.79 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.849 0.833 . . . . 0.0 110.967 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -97.99 -56.74 2.4 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.698 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.683 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 11.7 mm-40 -131.15 170.29 14.75 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.544 ' CE2' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -173.43 158.61 3.53 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 119.271 0.941 . . . . 0.0 111.669 -179.5 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.743 ' HB3' ' HB3' ' A' ' 96' ' ' ASN . 1.5 p90 -159.91 158.04 30.08 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 168.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.96 HD13 HG22 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -94.79 142.75 13.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.505 -172.754 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.622 ' HE3' ' OG1' ' A' ' 37' ' ' THR . 16.7 mtmt -96.81 123.38 40.49 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.138 172.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.525 ' OH ' HG12 ' A' ' 30' ' ' ILE . 18.6 t80 -93.96 100.76 12.85 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 170.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.862 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . 6.7 tp10 -103.65 130.9 51.19 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.451 0.643 . . . . 0.0 109.282 -172.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.959 HG13 ' HE2' ' A' ' 34' ' ' LYS . 21.8 t -127.19 163.18 30.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.581 -173.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.403 ' N ' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -74.42 26.77 0.08 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.32 0.648 . . . . 0.0 111.111 -178.919 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -170.69 -37.36 0.03 OUTLIER Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.595 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.48 ' HG3' ' N ' ' A' ' 92' ' ' THR . 26.8 tptp -127.85 168.29 15.38 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -173.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.48 ' N ' ' HG3' ' A' ' 91' ' ' LYS . 4.0 m -138.06 146.36 42.87 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 172.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.512 ' HD1' ' HD2' ' A' ' 86' ' ' TYR . 33.3 m-85 -137.22 -174.36 3.72 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 171.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -149.22 141.57 24.18 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.062 -174.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -122.67 121.2 35.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.298 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.743 ' HB3' ' HB3' ' A' ' 83' ' ' TYR . 10.9 p30 -145.14 -103.21 0.11 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.925 177.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -113.5 -50.13 2.86 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 122.107 0.956 . . . . 0.0 108.723 -175.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -172.27 -48.56 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.2 p -160.73 47.52 0.23 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.748 172.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.79 -109.24 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.136 -174.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 174.84 142.1 0.05 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.793 -167.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.537 ' CE2' ' HA ' ' A' ' 96' ' ' ASN . 84.2 m-85 -78.39 142.31 37.71 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 173.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.22 125.0 53.67 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.7 0.762 . . . . 0.0 110.517 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.504 HG21 HG12 ' A' ' 79' ' ' ILE . 3.7 t -94.36 129.96 43.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.7 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.9 t -66.89 95.32 0.36 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.124 0.488 . . . . 0.0 110.626 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.128 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.763 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.1 p -69.87 134.19 48.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.09 0.471 . . . . 0.0 111.179 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.609 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 46.9 mm -70.6 -55.58 7.18 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.902 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.609 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 37.5 Cg_endo -73.56 135.21 21.66 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.656 1.571 . . . . 0.0 111.926 177.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.5 t -110.38 -85.93 0.54 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.666 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.0 m -96.58 -64.26 1.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.654 0.264 . . . . 0.0 110.639 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.48 -174.13 2.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.975 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.422 ' HB3' ' HB3' ' A' ' 28' ' ' LYS . 26.1 m -76.52 -31.96 57.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.091 0.472 . . . . 0.0 110.362 177.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.906 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.2 p -114.68 150.65 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 121.352 0.596 . . . . 0.0 111.818 -173.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -143.05 141.25 31.26 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.667 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.485 HD11 ' HD2' ' A' ' 14' ' ' TYR . 3.5 tp -69.43 140.39 54.1 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.021 0.438 . . . . 0.0 110.107 175.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.406 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 28.2 t70 -90.94 -67.86 0.83 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.579 172.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.7 m -167.18 157.82 11.53 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.868 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.485 ' HD2' HD11 ' A' ' 11' ' ' LEU . 34.3 p90 -156.87 155.82 32.1 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.705 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -130.25 163.19 27.3 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.834 0.35 . . . . 0.0 111.084 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.635 ' HE2' HG23 ' A' ' 106' ' ' THR . 1.7 t80 -128.74 147.06 50.74 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -154.89 101.55 2.29 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -175.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.24 -96.69 0.14 Allowed Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 -168.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.503 ' HA ' ' CE1' ' A' ' 16' ' ' TYR . 10.4 t -136.2 89.51 2.48 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 158.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 16.1 m -144.38 139.64 28.56 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.501 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.829 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 17.8 t80 -108.58 129.27 55.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.8 p -151.39 123.7 8.3 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.074 0.464 . . . . 0.0 109.974 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 14' ' ' TYR . . . -177.91 -157.93 19.73 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.262 -0.97 . . . . 0.0 112.155 -176.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.668 ' HB3' HG22 ' A' ' 71' ' ' THR . 21.2 pttm -159.81 162.3 34.74 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.215 0.531 . . . . 0.0 111.214 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.622 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 11.0 mt -124.67 159.5 30.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.573 -170.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -131.44 100.19 5.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -174.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.906 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 1.9 m -135.77 147.93 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.706 -169.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 79.0 tttt -79.55 131.32 35.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.029 177.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.17 122.61 33.95 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.294 0.569 . . . . 0.0 110.349 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.403 HG12 ' OH ' ' A' ' 86' ' ' TYR . 25.3 mm -76.76 -56.82 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.016 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.649 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . . . -107.34 -80.96 0.56 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.864 173.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -166.47 -73.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.666 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.415 ' C ' ' HD2' ' A' ' 34' ' ' LYS . 20.1 m -83.59 68.73 9.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.309 0.576 . . . . 0.0 110.691 -178.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.654 ' HG3' HG13 ' A' ' 88' ' ' VAL . 6.3 mmmt -94.97 172.51 8.1 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.854 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 89.7 mttt -101.19 129.36 47.1 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.765 -173.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 65.3 t -121.44 107.92 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-O 121.873 0.844 . . . . 0.0 109.288 171.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.574 HG22 HD11 ' A' ' 53' ' ' ILE . 3.1 p -120.3 116.03 24.74 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.552 -173.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.91 HG22 HD12 ' A' ' 84' ' ' ILE . 72.2 t -77.02 136.64 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.006 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.152 176.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.41 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -124.29 107.79 19.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.53 176.811 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.535 ' HA ' ' CB ' ' A' ' 82' ' ' PHE . 0.9 OUTLIER -111.71 137.17 49.97 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 122.58 1.181 . . . . 0.0 110.387 174.736 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.571 ' HB2' ' CE3' ' A' ' 47' ' ' TRP . . . -89.76 97.02 10.95 Favored 'General case' 0 N--CA 1.412 -2.371 0 CA-C-N 113.086 -1.87 . . . . 0.0 107.101 178.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.722 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 1.3 p30 -44.01 163.36 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 O-C-N 124.767 1.292 . . . . 0.0 112.541 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.39 -13.04 14.71 Favored Glycine 0 N--CA 1.464 0.537 0 CA-C-N 115.536 -0.756 . . . . 0.0 114.358 -167.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -110.47 -18.87 13.12 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.426 ' OD1' ' HA ' ' A' ' 47' ' ' TRP . 48.1 t0 -74.03 -92.47 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.084 -1.416 . . . . 0.0 112.278 -173.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 51.95 98.58 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -159.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.571 ' CE3' ' HB2' ' A' ' 41' ' ' ALA . 7.1 m-90 -42.7 113.13 0.43 Allowed 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 -152.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -84.03 31.98 0.49 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 113.364 -1.744 . . . . 0.0 108.484 161.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.5 t30 59.35 46.42 12.63 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 122.19 0.995 . . . . 0.0 108.449 -164.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -83.4 -57.59 3.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.647 -174.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.426 ' H ' ' HD1' ' A' ' 47' ' ' TRP . . . 93.85 96.68 1.55 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.304 -0.951 . . . . 0.0 113.216 174.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 40' ' ' TYR . 86.8 m-20 -135.02 106.69 6.92 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.574 HD11 HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -117.91 144.45 25.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.381 0.61 . . . . 0.0 111.94 -172.06 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.617 HG23 ' HB ' ' A' ' 38' ' ' VAL . 8.1 tp -132.61 116.34 27.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.398 171.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.18 137.96 45.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.889 0.376 . . . . 0.0 111.425 -174.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.31 163.37 23.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.548 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.6 m -121.22 141.57 50.74 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -70.75 139.88 51.19 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.372 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.8 t -108.78 -39.13 5.44 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.45 154.77 7.14 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.545 173.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.36 136.13 49.62 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.198 1.932 . . . . 0.0 111.447 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.589 HD12 ' HB3' ' A' ' 67' ' ' TYR . 67.9 mt -80.59 91.92 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.8 p -60.65 120.92 10.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.642 -172.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 132.65 -34.53 2.47 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.515 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.2 m -134.9 172.53 12.86 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.65 39.15 0.46 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.956 0.407 . . . . 0.0 110.999 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.589 ' HB3' HD12 ' A' ' 62' ' ' ILE . 3.9 m-85 -115.27 159.25 21.24 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.719 0.771 . . . . 0.0 111.369 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -131.12 170.38 14.61 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.11 -178.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.23 122.7 26.98 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -165.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.702 ' CD1' HG13 ' A' ' 27' ' ' VAL . 20.8 m95 -121.9 134.82 54.86 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.813 -169.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.668 HG22 ' HB3' ' A' ' 24' ' ' LYS . 18.0 p -138.21 150.63 46.92 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.508 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 6.6 p90 -173.3 164.1 4.65 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.451 0.643 . . . . 0.0 111.928 172.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.4 p -124.56 144.24 50.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.271 173.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.829 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -137.56 126.5 24.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.573 -174.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.5 t -81.98 99.41 9.1 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 170.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.429 HG11 ' HB2' ' A' ' 21' ' ' PHE . 21.0 m -92.35 154.28 3.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.884 -176.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -116.99 48.22 1.35 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.04 126.18 4.42 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.857 -174.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.639 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 4.8 tt -136.3 128.33 44.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.592 0.711 . . . . 0.0 111.034 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.722 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -83.82 -61.7 1.76 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.947 -175.858 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 16.1 mt-10 -150.83 176.17 11.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.13 -1.395 . . . . 0.0 107.994 -177.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.535 ' CB ' ' HA ' ' A' ' 40' ' ' TYR . 30.3 p90 -169.43 173.47 6.51 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 119.12 -1.032 . . . . 0.0 113.484 174.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.49 154.17 24.4 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.08 173.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.91 HD12 HG22 ' A' ' 38' ' ' VAL . 16.3 mm -99.2 151.82 4.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.438 ' HE3' ' OG1' ' A' ' 37' ' ' THR . 49.4 pttt -131.32 149.54 52.51 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 121.88 0.848 . . . . 0.0 110.413 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.699 ' HD2' ' HD1' ' A' ' 93' ' ' TYR . 21.8 t80 -114.63 108.36 16.72 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 113.78 -1.554 . . . . 0.0 109.675 -174.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.854 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 31.1 tt0 -105.8 116.78 32.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.173 0.511 . . . . 0.0 109.958 -175.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.654 HG13 ' HG3' ' A' ' 34' ' ' LYS . 1.3 t -123.29 166.28 18.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.994 -175.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m -48.15 -46.45 34.5 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.492 0.495 . . . . 0.0 111.553 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -120.79 -9.22 7.69 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.305 -0.95 . . . . 0.0 113.749 -176.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.3 mmtm -128.11 173.81 9.77 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 86' ' ' TYR . 8.3 m -152.9 143.78 22.92 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 113.226 -1.807 . . . . 0.0 109.43 176.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.699 ' HD1' ' HD2' ' A' ' 86' ' ' TYR . 28.1 m-85 -144.01 -173.53 4.02 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -150.14 148.08 28.53 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.437 -174.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -118.18 90.24 3.29 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 169.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -131.14 31.05 4.47 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.957 -172.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 68.3 -59.84 0.43 Allowed 'General case' 0 CA--C 1.532 0.259 0 O-C-N 123.733 0.646 . . . . 0.0 110.535 -172.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -179.68 -53.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.4 t -172.69 69.24 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.191 -1.368 . . . . 0.0 107.518 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.64 -37.87 0.2 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.969 -170.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 70.05 149.08 0.08 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -171.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 95.9 m-85 -83.67 106.32 15.29 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 175.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -68.61 116.06 8.7 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.043 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.566 HG21 HG12 ' A' ' 79' ' ' ILE . 2.8 t -100.21 133.65 42.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.1 t -151.5 148.65 28.3 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.635 HG23 ' HE2' ' A' ' 16' ' ' TYR . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.572 -0.728 . . . . 0.0 110.331 177.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 120.407 0.146 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -62.53 156.7 22.31 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.857 0.36 . . . . 0.0 111.364 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 67.1 mt -83.61 121.81 76.49 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.442 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.403 ' HB3' ' HB2' ' A' ' 10' ' ' GLN . 36.9 Cg_endo -65.77 145.0 79.74 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.709 2.273 . . . . 0.0 112.08 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.6 t -122.03 -28.32 4.43 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.301 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.9 p -70.23 -73.63 0.16 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.761 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.83 174.5 7.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.283 0.564 . . . . 0.0 111.567 -176.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.659 ' HB3' HD11 ' A' ' 30' ' ' ILE . 20.3 m -80.53 -15.53 56.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.07 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.752 HG23 HG12 ' A' ' 27' ' ' VAL . 2.2 p -140.7 151.42 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 120.758 0.313 . . . . 0.0 110.343 -178.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 4' ' ' PRO . 15.1 tt0 -145.16 128.87 17.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.242 -176.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.566 HD21 ' CD2' ' A' ' 14' ' ' TYR . 26.0 tp -69.8 137.22 51.66 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 172.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.59 -49.04 6.07 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.909 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.8 p 174.82 160.02 0.19 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 123.705 0.628 . . . . 0.0 111.744 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.566 ' CD2' HD21 ' A' ' 11' ' ' LEU . 30.4 p90 -156.33 159.67 39.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.726 177.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -151.89 164.22 37.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.618 0.247 . . . . 0.0 110.442 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 19' ' ' SER . 5.3 t80 -115.96 143.33 45.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.034 -174.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -144.17 101.67 3.75 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -175.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.4 -97.78 0.25 Allowed Glycine 0 C--N 1.333 0.368 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -170.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 16' ' ' TYR . 71.4 m -134.43 85.73 2.21 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 158.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 13.8 m -146.51 138.52 24.84 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.088 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.818 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 20.4 t80 -95.52 140.37 30.46 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 171.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 85.7 p -155.58 126.01 6.78 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 174.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.8 -161.85 29.94 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.159 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -160.05 162.75 34.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.835 0.35 . . . . 0.0 110.947 -176.82 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.594 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 25.9 mt -132.38 156.51 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.894 -172.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -126.14 115.83 20.4 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.752 HG12 HG23 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -128.67 149.73 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.022 179.288 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.491 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 92.9 mttt -80.26 152.14 29.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.498 174.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -94.74 85.02 4.33 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.773 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.659 HD11 ' HB3' ' A' ' 8' ' ' SER . 3.8 mm -64.51 -56.84 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.65 -150.7 0.47 Allowed 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 106.725 -1.584 . . . . 0.0 106.725 168.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.467 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 42.9 t80 -112.31 -56.89 2.34 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.514 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.2 t -65.4 111.45 3.06 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 123.301 0.376 . . . . 0.0 110.412 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.54 ' HB2' ' HH2' ' A' ' 70' ' ' TRP . 12.4 mmtp -112.62 167.61 10.33 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 121.121 0.486 . . . . 0.0 110.473 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.755 ' HG3' ' HB3' ' A' ' 87' ' ' GLU . 0.6 OUTLIER -151.88 111.15 3.91 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 171.785 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.4 t -106.7 112.27 39.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-O 121.817 0.818 . . . . 0.0 110.435 -173.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.742 HG22 HD11 ' A' ' 53' ' ' ILE . 14.0 p -119.07 107.99 14.17 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.653 -172.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.992 HG22 HD12 ' A' ' 84' ' ' ILE . 71.7 t -76.45 111.01 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.463 175.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.647 ' HB ' ' CZ2' ' A' ' 47' ' ' TRP . 0.0 OUTLIER -102.62 113.66 39.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.122 170.781 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.657 ' HA ' ' CB ' ' A' ' 82' ' ' PHE . 0.6 OUTLIER -108.24 145.14 34.73 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 122.075 0.941 . . . . 0.0 110.385 171.742 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.709 ' HB2' ' CE3' ' A' ' 47' ' ' TRP . . . -85.67 99.08 11.06 Favored 'General case' 0 N--CA 1.409 -2.498 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.368 169.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -40.27 165.2 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 112.893 -1.958 . . . . 0.0 112.875 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 80' ' ' LYS . . . -62.22 2.18 1.17 Allowed Glycine 0 C--N 1.334 0.426 0 CA-C-N 114.956 -1.02 . . . . 0.0 114.656 -167.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.8 t -80.87 -22.7 39.62 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 116.954 0.377 . . . . 0.0 110.321 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.7 t70 77.52 43.85 0.1 Allowed 'General case' 0 C--N 1.351 0.641 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -142.64 146.47 34.51 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.351 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.709 ' CE3' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -122.16 120.66 34.87 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 119.399 -0.92 . . . . 0.0 112.438 173.177 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -90.93 16.02 10.28 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 169.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 67.03 4.02 3.4 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.354 -1.293 . . . . 0.0 111.6 -175.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -168.8 179.34 4.22 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -171.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.11 27.48 64.13 Favored Glycine 0 CA--C 1.505 -0.536 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.093 178.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -166.57 56.67 0.09 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.263 0.554 . . . . 0.0 109.975 -175.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.742 HD11 HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -133.92 131.15 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-O 122.048 0.928 . . . . 0.0 109.643 -174.071 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.517 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 10.4 mm -110.92 129.76 65.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.982 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.11 96.35 7.77 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 118.263 -1.375 . . . . 0.0 108.255 167.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -47.63 153.88 0.53 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.76 170.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -115.55 131.71 56.85 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.716 -174.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -71.32 143.85 50.14 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.254 177.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.9 t -106.4 -37.51 6.49 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 145.82 173.68 17.3 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.356 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -53.86 134.58 59.8 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 123.037 2.491 . . . . 0.0 111.633 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 1.069 HG12 ' HB2' ' A' ' 69' ' ' TYR . 4.7 mt -83.92 119.07 32.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.695 -172.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.5 p -62.77 118.37 7.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.019 0.438 . . . . 0.0 110.251 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 117.46 -12.44 13.87 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -176.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.5 m -151.94 -179.53 7.55 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -112.11 30.21 7.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.652 0.739 . . . . 0.0 109.9 177.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.491 ' CD1' ' HA ' ' A' ' 28' ' ' LYS . 17.2 m-85 -105.0 -178.37 3.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.792 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.488 ' O ' HD11 ' A' ' 62' ' ' ILE . 15.6 tp10 -111.84 150.9 29.73 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.7 -171.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 1.069 ' HB2' HG12 ' A' ' 62' ' ' ILE . 8.7 t80 -125.2 116.52 22.13 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -165.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.662 ' HE1' HG22 ' A' ' 27' ' ' VAL . 12.7 m95 -108.68 133.43 52.77 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.469 -170.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.42 ' O ' ' HB3' ' A' ' 72' ' ' PHE . 22.5 p -139.76 148.53 42.39 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -176.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.464 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 3.3 p90 -174.02 151.67 1.78 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.913 0.863 . . . . 0.0 112.409 170.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.2 p -117.81 137.55 52.67 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.277 -1.329 . . . . 0.0 107.923 166.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.818 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -129.51 122.14 28.65 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.891 -168.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.71 99.45 1.33 Allowed 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 171.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.407 HG11 ' HB2' ' A' ' 21' ' ' PHE . 28.6 m -103.3 150.24 6.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.659 -175.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.676 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -104.62 38.12 1.97 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.614 0.721 . . . . 0.0 109.65 175.47 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 112.71 149.82 10.8 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.054 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.534 HG13 ' HB2' ' A' ' 40' ' ' TYR . 9.7 tt -154.88 156.41 5.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.466 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 18.2 tptm -140.67 -47.4 0.42 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.953 0.406 . . . . 0.0 111.26 -176.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.443 ' O ' ' HB3' ' A' ' 82' ' ' PHE . 20.8 mt-10 -141.7 162.27 35.88 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -178.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.657 ' CB ' ' HA ' ' A' ' 40' ' ' TYR . 43.1 p90 -172.63 179.26 2.47 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 119.101 -1.039 . . . . 0.0 112.76 169.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.568 ' HB3' ' HB3' ' A' ' 96' ' ' ASN . 0.2 OUTLIER -160.94 143.15 12.43 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 113.519 -1.673 . . . . 0.0 108.38 171.808 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.992 HD12 HG22 ' A' ' 38' ' ' VAL . 14.2 mm -90.48 132.45 35.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.783 -177.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.511 ' HB2' ' OG1' ' A' ' 37' ' ' THR . 1.1 mtmp? -89.8 107.0 18.84 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.719 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.683 ' HB2' HG11 ' A' ' 9' ' ' VAL . 20.2 t80 -85.99 99.16 11.25 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.755 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . 7.9 tt0 -116.73 124.12 48.88 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.072 -174.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 23.1 t -104.6 162.62 4.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.8 t -59.09 -11.48 3.69 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -143.62 2.46 1.48 Allowed Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.834 177.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.8 tptt -141.65 163.6 32.48 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 117.823 0.811 . . . . 0.0 110.438 -176.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.8 m -144.73 142.89 30.39 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.163 0.506 . . . . 0.0 110.874 174.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.497 ' HD2' ' CD2' ' A' ' 86' ' ' TYR . 49.1 m-85 -141.35 -168.62 2.68 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -144.99 143.71 30.65 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.711 0.291 . . . . 0.0 111.246 -174.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.425 ' OD2' ' HB2' ' A' ' 11' ' ' LEU . 29.6 t70 -122.19 98.69 6.05 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 169.068 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.568 ' HB3' ' HB3' ' A' ' 83' ' ' TYR . 4.9 p30 -123.18 -45.25 2.12 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.754 -173.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.519 ' HB3' ' O ' ' A' ' 96' ' ' ASN . 26.4 p-10 166.23 -37.67 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 175.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 178.58 -44.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.4 t -174.09 38.95 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.286 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.26 -90.54 0.11 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 p30 178.77 158.7 0.55 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.845 0.355 . . . . 0.0 110.458 -171.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -90.52 100.65 13.45 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 169.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.558 ' H ' ' CD ' ' A' ' 103' ' ' GLN . 3.1 pm0 -81.06 107.52 13.94 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.513 0.673 . . . . 0.0 110.18 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.5 t -91.43 114.86 29.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.963 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 21.8 m -69.72 102.54 1.92 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.698 -0.668 . . . . 0.0 110.876 -177.592 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.1 m -60.11 148.74 34.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.128 0.489 . . . . 0.0 110.462 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.613 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 44.2 mm -71.32 -49.34 12.18 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.621 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.613 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 39.5 Cg_exo -58.01 142.43 96.73 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 122.064 1.843 . . . . 0.0 112.42 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.9 t -157.94 -60.08 0.08 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.895 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.9 t -78.35 -74.49 0.27 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.519 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -141.22 -160.32 1.07 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -68.48 -30.99 69.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.804 HG23 HG12 ' A' ' 27' ' ' VAL . 2.1 p -128.0 151.43 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.816 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -143.26 129.51 19.85 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.277 178.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.585 HD21 ' CD2' ' A' ' 14' ' ' TYR . 15.2 tp -69.07 140.04 54.85 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.066 0.46 . . . . 0.0 110.08 174.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -88.37 -63.85 1.24 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.101 178.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.0 m -170.58 159.84 6.95 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.196 -176.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.585 ' CD2' HD21 ' A' ' 11' ' ' LEU . 12.4 p90 -158.11 155.92 30.05 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.407 174.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -113.43 154.75 26.46 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 120.829 0.347 . . . . 0.0 110.873 175.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.808 ' CZ ' HG21 ' A' ' 79' ' ' ILE . 1.1 m-85 -160.03 139.21 10.89 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 124.71 1.256 . . . . 0.0 110.412 -175.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 16.8 t70 -175.54 71.31 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.973 167.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 51.7 38.9 45.42 Favored Glycine 0 CA--C 1.507 -0.455 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -170.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.6 m -155.58 158.99 39.3 Favored 'General case' 0 N--CA 1.394 -3.268 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 -161.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.516 HG23 ' HA ' ' A' ' 75' ' ' SER . 52.9 m -60.32 143.78 52.14 Favored 'General case' 0 C--N 1.263 -3.191 0 CA-C-N 112.899 -1.955 . . . . 0.0 111.219 -173.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.659 ' HD2' ' CZ ' ' A' ' 16' ' ' TYR . 2.1 t80 -78.59 141.87 37.74 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.6 m -161.54 124.89 3.19 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.736 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.73 -153.03 9.95 Favored Glycine 0 N--CA 1.438 -1.167 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -176.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.754 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -160.05 163.61 33.82 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.014 0.435 . . . . 0.0 111.371 -177.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.726 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 24.9 mt -127.55 156.81 39.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.645 -170.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -132.77 107.29 8.27 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.114 0.565 . . . . 0.0 109.647 -172.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.804 HG12 HG23 ' A' ' 9' ' ' VAL . 0.7 OUTLIER -133.95 151.89 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.208 -0.932 . . . . 0.0 112.178 -172.062 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.446 ' HD3' ' CE1' ' A' ' 67' ' ' TYR . 23.8 tptm -76.35 129.29 36.4 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 172.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.611 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 23.7 p-10 -86.6 103.86 15.49 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.574 0.702 . . . . 0.0 110.376 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.512 HG12 ' OH ' ' A' ' 86' ' ' TYR . 16.3 mm -72.99 -60.3 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-N 115.47 -0.787 . . . . 0.0 108.882 -176.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.78 -135.05 0.35 Allowed 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.148 172.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -120.54 -52.4 2.14 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.022 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.5 t -78.16 116.21 18.45 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.784 ' HB2' ' HH2' ' A' ' 70' ' ' TRP . 27.5 mmtm -116.76 167.33 11.19 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.24 0.543 . . . . 0.0 110.619 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.537 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 9.0 mtpm? -138.42 97.72 3.43 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.786 173.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.9 t -98.75 124.44 51.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.9 0.857 . . . . 0.0 110.713 -178.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.784 ' HB ' HG13 ' A' ' 53' ' ' ILE . 45.2 p -132.69 116.4 16.57 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.286 -1.324 . . . . 0.0 110.638 -170.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.901 HG22 HD13 ' A' ' 84' ' ' ILE . 44.9 t -84.92 132.75 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-O 121.322 0.582 . . . . 0.0 109.514 173.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.701 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -118.9 111.61 34.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.161 175.015 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.62 ' HA ' ' CB ' ' A' ' 82' ' ' PHE . 5.1 p90 -115.05 139.58 49.76 Favored 'General case' 0 CA--C 1.485 -1.528 0 CA-C-O 122.667 1.222 . . . . 0.0 110.901 175.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.518 ' HB2' ' CZ3' ' A' ' 47' ' ' TRP . . . -86.2 103.0 14.43 Favored 'General case' 0 N--CA 1.405 -2.714 0 CA-C-N 112.69 -2.05 . . . . 0.0 107.462 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.521 ' HB2' ' OD1' ' A' ' 52' ' ' ASN . 3.4 t70 -48.15 -168.49 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 111.694 -2.503 . . . . 0.0 113.796 -174.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.53 -17.9 28.2 Favored Glycine 0 C--N 1.335 0.5 0 O-C-N 122.106 -0.371 . . . . 0.0 112.513 -177.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 41.6 t -65.83 -16.59 63.96 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 122.825 0.45 . . . . 0.0 110.823 175.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.495 ' HB3' ' HG3' ' A' ' 80' ' ' LYS . 3.7 p30 51.46 33.77 10.91 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.632 1.173 . . . . 0.0 110.632 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -163.63 139.76 6.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.436 -169.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.518 ' CZ3' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -91.33 88.94 7.06 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 120.029 -0.668 . . . . 0.0 112.326 174.516 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.63 47.3 1.35 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.641 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 60.12 31.63 20.63 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.113 -172.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -92.37 127.4 37.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.231 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -96.37 60.43 1.3 Allowed Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.56 -174.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.521 ' OD1' ' HB2' ' A' ' 42' ' ' ASP . 13.5 m120 -76.78 75.9 3.41 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.795 0.331 . . . . 0.0 110.431 175.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.784 HG13 ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -109.23 136.21 45.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.331 0.586 . . . . 0.0 110.737 178.751 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.73 HG22 ' HB ' ' A' ' 38' ' ' VAL . 8.0 tp -117.24 121.92 68.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.638 174.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.66 134.01 37.17 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.912 0.387 . . . . 0.0 110.411 -176.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.07 161.2 18.28 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.977 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 m -114.44 176.05 5.22 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.741 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 0.4 OUTLIER -139.22 146.47 40.53 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.782 0.801 . . . . 0.0 111.517 -174.167 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.8 t -88.39 -36.11 16.75 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.329 -1.305 . . . . 0.0 108.712 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 143.46 -172.08 24.96 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.288 174.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -65.85 138.25 52.41 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.75 2.3 . . . . 0.0 111.404 175.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.644 HG12 ' HB2' ' A' ' 69' ' ' TYR . 20.0 mt -81.24 109.84 16.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.408 -176.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.5 p -65.64 135.48 55.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.272 0.558 . . . . 0.0 111.274 -176.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.89 -4.64 81.81 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.459 -0.657 . . . . 0.0 111.459 -177.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.6 m -140.72 171.52 13.98 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -108.31 46.29 0.97 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.17 0.509 . . . . 0.0 110.002 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.502 ' HB3' HD12 ' A' ' 62' ' ' ILE . 2.3 m-85 -125.88 172.33 9.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.425 -178.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 29' ' ' ASN . 17.5 tt0 -120.39 167.07 12.72 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.644 ' HB2' HG12 ' A' ' 62' ' ' ILE . 4.3 t80 -141.59 121.72 13.81 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -164.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.784 ' HH2' ' HB2' ' A' ' 34' ' ' LYS . 25.4 m95 -118.46 145.55 45.17 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.798 -168.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.533 HG22 ' HB3' ' A' ' 24' ' ' LYS . 1.4 p -147.29 142.38 27.1 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 123.744 0.652 . . . . 0.0 109.527 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.406 ' HB3' ' O ' ' A' ' 71' ' ' THR . 2.7 p90 -173.99 159.49 3.33 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.442 0.639 . . . . 0.0 112.585 173.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.3 p -117.67 143.98 45.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.416 172.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -142.25 106.09 4.71 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -171.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.516 ' HA ' HG23 ' A' ' 20' ' ' THR . 13.3 t -68.6 109.13 3.62 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 174.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.578 HG21 ' HE1' ' A' ' 16' ' ' TYR . 12.2 m -100.52 155.59 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.002 -173.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -86.36 -24.01 25.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.21 -175.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.36 107.08 0.35 Allowed Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -177.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.808 HG21 ' CZ ' ' A' ' 16' ' ' TYR . 8.9 tt -112.34 138.04 42.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.418 0.628 . . . . 0.0 111.722 -172.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.495 ' HG3' ' HB3' ' A' ' 45' ' ' ASP . 74.5 mmtt -117.0 -47.42 2.69 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.213 -176.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.473 ' OE1' ' HB3' ' A' ' 103' ' ' GLN . 11.7 mm-40 -146.21 154.02 41.28 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -175.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.701 ' HB2' ' O ' ' A' ' 39' ' ' VAL . 3.9 p90 -172.14 -179.06 2.24 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 118.521 -1.272 . . . . 0.0 114.032 174.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.582 ' HA ' ' CE1' ' A' ' 102' ' ' TYR . 0.2 OUTLIER -162.17 164.7 27.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 113.48 -1.691 . . . . 0.0 108.644 176.632 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.901 HD13 HG22 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -104.23 144.24 14.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.958 -177.993 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.531 ' HB2' ' OG1' ' A' ' 37' ' ' THR . 6.6 mtmp? -104.86 130.07 53.07 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 121.069 0.461 . . . . 0.0 109.905 176.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.715 ' HD2' ' HD2' ' A' ' 93' ' ' TYR . 19.4 t80 -102.63 102.17 12.37 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.46 177.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.537 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 28.5 tt0 -108.64 129.35 55.33 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.566 ' C ' ' H ' ' A' ' 90' ' ' GLY . 2.6 t -122.06 166.47 16.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -174.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.8 p -66.45 28.08 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.344 0.592 . . . . 0.0 112.262 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . 171.96 -34.61 0.14 Allowed Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.851 177.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.531 ' HA ' ' HE3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -102.44 164.47 11.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.841 0.353 . . . . 0.0 111.338 -177.33 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.4 m -148.59 142.92 26.21 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 173.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.715 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 47.3 m-85 -141.41 -168.1 2.56 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.6 133.87 15.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.628 -170.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -118.98 94.92 4.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.225 0.536 . . . . 0.0 109.995 172.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.468 ' O ' ' HB2' ' A' ' 97' ' ' ASN . 28.9 p-10 -125.36 27.62 6.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.275 -178.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 96' ' ' ASN . 2.9 m-20 72.65 -58.06 0.61 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.748 -172.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.2 t30 177.69 -48.95 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 176.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.1 p -164.89 29.69 0.06 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.124 174.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -104.27 -37.45 7.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.411 -171.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.2 p30 47.49 101.56 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 O-C-N 123.965 0.79 . . . . 0.0 112.891 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.582 ' CE1' ' HA ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -50.78 116.49 1.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.91 -168.694 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.473 ' HB3' ' OE1' ' A' ' 81' ' ' GLU . 0.4 OUTLIER -88.85 124.96 34.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.533 0.682 . . . . 0.0 110.292 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.476 HG21 HG12 ' A' ' 79' ' ' ILE . 3.4 t -97.38 148.65 5.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.722 -1.127 . . . . 0.0 110.564 -174.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.2 m -95.38 75.36 3.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.418 0.628 . . . . 0.0 110.275 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.9 m . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.307 -0.854 . . . . 0.0 109.653 178.032 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.855 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.3 m -96.47 163.95 12.83 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.287 -178.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.718 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 23.0 mm -53.12 -54.0 49.39 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.718 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 36.2 Cg_exo -60.09 138.27 80.78 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.078 1.852 . . . . 0.0 112.331 178.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.8 t -129.72 -54.17 1.15 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.683 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.9 t -108.42 -74.99 0.64 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.772 -0.194 . . . . 0.0 110.617 -178.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.77 -173.13 2.25 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.523 0.201 . . . . 0.0 111.186 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.9 m -65.44 -36.07 82.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.217 0.532 . . . . 0.0 110.528 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.698 HG23 HG12 ' A' ' 27' ' ' VAL . 1.7 p -123.8 152.11 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.5 -176.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -142.57 132.5 24.31 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.094 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.482 HD21 ' CD2' ' A' ' 14' ' ' TYR . 34.8 tp -71.13 136.04 47.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.064 0.459 . . . . 0.0 110.304 176.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -88.12 -58.86 2.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.94 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.3 p -179.54 160.46 0.96 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.8 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.482 ' CD2' HD21 ' A' ' 11' ' ' LEU . 44.1 p90 -157.54 163.14 38.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.481 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -133.46 158.57 42.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.929 0.395 . . . . 0.0 110.623 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.733 ' CE2' ' HB ' ' A' ' 106' ' ' THR . 0.5 OUTLIER -139.53 138.42 36.29 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.57 -179.041 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -166.5 130.59 2.07 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.78 -104.18 0.36 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -168.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.2 t -140.86 85.05 1.97 Allowed 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 161.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.528 ' O ' ' HD1' ' A' ' 16' ' ' TYR . 88.9 m -147.31 130.23 16.24 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.411 173.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.462 ' HD1' ' CD1' ' A' ' 16' ' ' TYR . 3.5 t80 -128.3 104.05 7.51 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.567 0.699 . . . . 0.0 109.56 -174.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.6 m -138.32 150.1 46.28 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.797 -176.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.32 -141.5 3.75 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 -178.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 2.6 ptpp? -162.6 166.82 24.17 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.825 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.709 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 38.3 mt -133.66 157.16 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 -170.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -133.03 110.14 10.03 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.31 0.644 . . . . 0.0 109.657 -173.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.698 HG12 HG23 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -137.97 151.49 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.206 -0.934 . . . . 0.0 113.101 -172.393 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 46.4 tptt -78.83 140.86 38.11 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.899 174.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.537 ' OD1' ' HB2' ' A' ' 68' ' ' GLU . 7.2 m-20 -88.31 96.76 10.7 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.696 0.284 . . . . 0.0 110.783 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.606 HG12 ' OH ' ' A' ' 86' ' ' TYR . 7.7 mm -75.98 -54.84 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 176.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.89 -157.5 0.62 Allowed 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.201 -1.363 . . . . 0.0 107.906 172.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -113.33 -59.03 2.07 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.603 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.6 m -76.85 87.82 3.44 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 175.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.454 ' HE2' ' CZ2' ' A' ' 70' ' ' TRP . 27.9 mtmm -104.34 158.4 16.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.456 -174.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.766 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 47.8 mttp -123.79 138.46 54.5 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 175.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.1 t -128.0 115.52 39.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.331 0.586 . . . . 0.0 110.115 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.903 ' HB ' HG13 ' A' ' 53' ' ' ILE . 69.1 p -119.74 120.3 36.15 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.494 -171.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 1.005 ' HB ' HG22 ' A' ' 54' ' ' ILE . 79.6 t -88.52 110.42 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.703 177.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.706 HG21 ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -97.13 120.29 46.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 170.686 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.612 ' HA ' ' HZ2' ' A' ' 47' ' ' TRP . 5.3 p90 -119.99 138.23 53.61 Favored 'General case' 0 CA--C 1.49 -1.347 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.032 171.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.603 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . . . -76.9 88.06 3.47 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 113.133 -1.849 . . . . 0.0 108.017 -175.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' A' ' 43' ' ' GLY . 42.8 t0 -43.75 -170.37 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 109.221 -3.627 . . . . 0.0 113.007 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.502 ' H ' ' CG ' ' A' ' 42' ' ' ASP . . . -61.5 -10.39 22.98 Favored Glycine 0 CA--C 1.522 0.469 0 O-C-N 121.983 -0.448 . . . . 0.0 112.721 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -76.11 -14.19 60.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.904 0.383 . . . . 0.0 110.148 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 76.06 12.59 2.8 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.122 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -170.81 179.35 3.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.951 -178.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.612 ' HZ2' ' HA ' ' A' ' 40' ' ' TYR . 23.0 m-90 -105.19 107.93 19.18 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.501 169.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -76.45 -162.82 0.27 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 170.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -75.11 58.31 0.89 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.438 0.637 . . . . 0.0 109.72 171.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -128.58 -50.68 1.26 Allowed 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.187 -174.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.66 76.2 0.95 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.95 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.402 ' H ' ' HD1' ' A' ' 47' ' ' TRP . 3.5 m-20 -77.94 80.11 4.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.903 HG13 ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -119.58 138.45 50.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.555 0.693 . . . . 0.0 112.822 -170.312 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 1.005 HG22 ' HB ' ' A' ' 38' ' ' VAL . 8.4 tp -112.31 133.47 57.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 169.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.65 126.7 34.13 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.614 -177.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.56 158.85 22.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.461 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.0 t -130.04 133.44 46.73 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.624 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 31.2 p90 -76.29 141.11 41.73 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 121.456 0.646 . . . . 0.0 110.267 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.4 t -93.48 -26.36 17.21 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.842 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 160.52 171.08 25.96 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.796 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.37 144.23 61.06 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.447 2.098 . . . . 0.0 110.843 174.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.743 HD12 ' HB3' ' A' ' 67' ' ' TYR . 20.7 mt -79.98 109.74 14.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.198 0.523 . . . . 0.0 109.9 -178.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.5 p -66.54 122.74 18.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.692 -175.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.02 -2.37 30.05 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.5 m -153.28 179.34 8.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -107.1 38.68 2.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.937 0.875 . . . . 0.0 109.899 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.743 ' HB3' HD12 ' A' ' 62' ' ' ILE . 1.8 m-85 -102.41 168.76 9.11 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.222 177.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.537 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . 10.0 tt0 -124.02 165.1 18.05 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.579 ' HB2' HG12 ' A' ' 62' ' ' ILE . 2.0 t80 -136.32 111.25 8.84 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -161.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.709 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 8.0 m95 -111.56 144.92 40.02 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.288 -166.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.439 ' HA ' ' HB2' ' A' ' 24' ' ' LYS . 5.0 p -133.04 131.86 41.14 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -132.6 151.06 52.06 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 118.884 -1.126 . . . . 0.0 111.733 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.2 m -131.68 141.29 49.54 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.053 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -150.56 113.74 4.85 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.069 0.461 . . . . 0.0 111.167 -175.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.2 t -77.7 99.07 5.69 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 168.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.6 m -95.15 157.22 3.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.416 0.627 . . . . 0.0 111.26 -169.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -96.42 -16.77 21.03 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.018 -175.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.17 82.63 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.942 -0.646 . . . . 0.0 111.969 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.471 HG12 HG21 ' A' ' 104' ' ' VAL . 4.5 tt -90.49 133.19 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.485 0.66 . . . . 0.0 111.108 -178.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -114.47 -40.38 3.63 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.298 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.603 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 37.0 mm-40 -141.37 167.19 22.76 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.443 ' HZ ' ' CE2' ' A' ' 14' ' ' TYR . 28.2 p90 -172.1 170.71 5.17 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 119.338 0.972 . . . . 0.0 111.864 174.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.683 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 0.7 OUTLIER -162.9 150.7 13.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.235 168.09 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.979 HD12 HG22 ' A' ' 38' ' ' VAL . 10.2 mm -100.94 139.46 22.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.673 -174.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.706 ' HE3' HG21 ' A' ' 39' ' ' VAL . 88.8 mttt -103.86 151.83 22.65 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.471 0.653 . . . . 0.0 110.269 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.655 ' HD2' ' HD2' ' A' ' 93' ' ' TYR . 25.0 t80 -123.24 106.66 10.92 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.765 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.766 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -103.19 128.47 50.15 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.304 0.573 . . . . 0.0 110.218 -176.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.452 ' HB ' ' H ' ' A' ' 91' ' ' LYS . 11.4 t -126.54 158.04 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.735 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.9 m -67.32 -3.18 7.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -176.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -136.61 -27.87 0.37 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.512 176.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.452 ' H ' ' HB ' ' A' ' 88' ' ' VAL . 28.1 mmtt -129.73 177.62 7.11 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 122.189 0.995 . . . . 0.0 112.483 -174.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.5 m -150.39 141.9 23.47 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.232 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.655 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 33.0 m-85 -143.82 -172.73 3.8 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -150.47 148.43 28.72 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.187 -174.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -119.79 98.82 6.29 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 169.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.683 ' HB3' ' HB2' ' A' ' 83' ' ' TYR . 23.0 p-10 -145.01 61.9 1.31 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.418 -174.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 71.13 -65.4 0.34 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.933 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -157.91 -53.81 0.07 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 174.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.6 m -157.17 44.69 0.37 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.706 -1.133 . . . . 0.0 110.001 169.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.42 -109.08 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -176.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 176.07 146.26 0.09 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.777 0.831 . . . . 0.0 108.831 -168.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -85.54 142.84 28.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.656 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -92.88 106.66 18.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.348 -175.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.471 HG21 HG12 ' A' ' 79' ' ' ILE . 22.0 t -94.39 107.44 19.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.7 m -90.66 57.62 3.65 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -171.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.733 ' HB ' ' CE2' ' A' ' 16' ' ' TYR . 87.9 m . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.689 175.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 120.65 0.262 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.9 m -87.63 81.91 7.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.393 1.092 . . . . 0.0 110.532 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 66.4 mt -117.58 135.7 23.35 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.429 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.609 ' HG3' ' CE1' ' A' ' 26' ' ' TYR . 13.5 Cg_endo -57.54 156.94 24.51 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.936 2.424 . . . . 0.0 112.69 176.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.4 t -85.85 49.61 1.81 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.761 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.519 ' OG ' ' HB2' ' A' ' 10' ' ' GLN . 13.6 t -108.45 -175.4 2.76 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.244 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.21 -151.0 0.27 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.294 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.1 -29.54 69.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.125 0.488 . . . . 0.0 110.603 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.629 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.3 p -150.24 149.06 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.725 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.519 ' HB2' ' OG ' ' A' ' 6' ' ' SER . 10.9 tt0 -138.75 154.78 48.56 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.597 HD21 ' CD2' ' A' ' 14' ' ' TYR . 16.4 tp -85.55 143.11 28.69 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.025 0.44 . . . . 0.0 110.012 172.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -87.41 -65.66 0.99 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.602 173.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.2 p -177.68 160.38 1.54 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.587 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.597 ' CD2' HD21 ' A' ' 11' ' ' LEU . 43.5 p90 -152.12 162.25 41.4 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.269 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -132.6 157.12 45.58 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -133.17 146.61 51.69 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.159 -174.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 18' ' ' GLY . 13.8 t70 -123.56 -150.35 0.45 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.671 -1.149 . . . . 0.0 107.954 -177.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.413 ' H ' ' CG ' ' A' ' 17' ' ' ASP . . . -50.61 -64.43 3.69 Favored Glycine 0 N--CA 1.458 0.111 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 171.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.2 t -145.63 86.76 1.75 Allowed 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 161.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.6 m -146.42 140.3 26.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.033 178.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.838 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 12.2 t80 -116.38 139.55 50.29 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.4 m -163.17 133.93 4.66 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 174.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 14' ' ' TYR . . . 172.86 -150.34 12.37 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.116 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.599 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 18.5 pttp -159.41 168.74 25.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.185 0.517 . . . . 0.0 111.451 -177.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.776 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 12.9 mt -132.78 160.78 42.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.644 -167.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.609 ' CE1' ' HG3' ' A' ' 4' ' ' PRO . 5.6 t80 -132.5 96.23 3.8 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 122.769 0.428 . . . . 0.0 110.317 -173.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.741 HG13 ' CD1' ' A' ' 70' ' ' TRP . 1.8 m -136.99 151.92 27.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 121.166 -0.959 . . . . 0.0 112.022 -170.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -72.69 143.88 47.92 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.746 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -102.28 95.03 6.03 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.732 0.777 . . . . 0.0 111.096 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.408 HD12 HG21 ' A' ' 88' ' ' VAL . 62.6 mt -75.78 -57.8 5.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.464 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.81 -160.87 0.75 Allowed 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.456 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 18.9 t80 -116.48 -23.48 8.26 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.838 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.0 m -78.02 68.2 4.01 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 169.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.456 ' HE2' ' HA ' ' A' ' 32' ' ' TYR . 27.6 mtmt -90.9 125.55 35.79 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.874 -176.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.514 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 9.4 mtpm? -126.28 113.57 17.13 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 69.9 t -113.24 113.41 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-O 121.781 0.801 . . . . 0.0 110.375 -173.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.867 ' HB ' HG13 ' A' ' 53' ' ' ILE . 6.6 p -122.42 111.61 17.07 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.364 -173.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 1.058 ' HB ' HG22 ' A' ' 54' ' ' ILE . 95.0 t -79.66 111.62 16.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.375 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 51' ' ' GLY . 1.0 OUTLIER -107.66 110.08 30.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.663 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.799 ' CE1' ' HB2' ' A' ' 42' ' ' ASP . 0.3 OUTLIER -105.19 154.48 20.15 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.915 0.865 . . . . 0.0 112.875 -174.779 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.728 ' HB2' ' CZ2' ' A' ' 47' ' ' TRP . . . -78.26 76.29 4.77 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 168.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.799 ' HB2' ' CE1' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -54.08 159.06 1.94 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 112.351 -2.204 . . . . 0.0 112.399 176.732 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.49 -109.29 1.88 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 113.744 -1.571 . . . . 0.0 113.455 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.491 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 16.0 m -89.41 -48.0 7.63 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 -175.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 44' ' ' SER . 6.1 p-10 170.69 28.73 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.523 0.729 . . . . 0.0 110.29 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -107.15 114.68 28.89 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -163.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.728 ' CZ2' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -101.93 83.9 2.45 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -74.95 44.3 0.23 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.886 -178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 51.09 33.52 9.35 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.664 0.745 . . . . 0.0 110.785 -176.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -110.73 -16.68 13.54 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.696 ' O ' HG13 ' A' ' 39' ' ' VAL . . . 77.12 -60.18 3.52 Favored Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.487 -174.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.56 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 82.6 m-20 74.83 73.57 0.1 Allowed 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.867 HG13 ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -109.0 138.84 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.943 -163.009 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 1.058 HG22 ' HB ' ' A' ' 38' ' ' VAL . 8.9 tp -116.12 127.9 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 114.322 -1.308 . . . . 0.0 108.03 168.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.5 129.84 34.99 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.888 -176.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -97.45 158.39 15.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.986 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 99.0 p -123.94 175.57 6.86 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.732 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 19.3 p90 -127.97 145.6 50.92 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.266 0.555 . . . . 0.0 111.472 -178.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.1 m -84.08 -37.7 21.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.11 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 157.35 161.73 11.07 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.315 175.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.898 ' HA ' ' HA ' ' A' ' 68' ' ' GLU . 28.5 Cg_endo -58.19 152.16 54.53 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 123.065 2.51 . . . . 0.0 112.028 177.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 23.9 mt -86.75 103.56 13.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.177 -175.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.5 p -62.93 120.54 11.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.211 0.529 . . . . 0.0 111.063 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.66 -7.54 29.9 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -175.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -141.87 171.37 14.15 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -105.21 38.19 2.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.641 0.734 . . . . 0.0 110.133 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -120.3 177.37 5.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.747 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.898 ' HA ' ' HA ' ' A' ' 61' ' ' PRO . 12.3 tt0 -128.3 166.98 17.58 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.347 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -124.58 114.81 19.87 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 -169.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.776 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 14.4 m95 -111.88 148.05 34.49 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.818 -167.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.592 HG22 ' HB3' ' A' ' 24' ' ' LYS . 1.6 p -150.51 146.37 26.56 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.322 0.388 . . . . 0.0 110.496 -172.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.414 ' HB3' ' O ' ' A' ' 71' ' ' THR . 4.2 p90 -175.19 157.57 2.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.578 0.704 . . . . 0.0 112.016 172.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.1 p -114.62 146.31 40.97 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.838 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -139.02 113.68 9.1 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -173.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.5 m -72.87 100.49 2.92 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 169.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.7 m -103.45 157.27 5.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.341 -176.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.18 14.44 10.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.495 0.664 . . . . 0.0 110.482 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.66 138.93 2.56 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.974 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.567 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 14.9 tt -171.49 153.23 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.216 0.532 . . . . 0.0 110.25 177.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 44' ' ' SER . 16.2 tppt? -135.64 -47.97 0.69 Allowed 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.725 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 14.3 pt-20 -149.2 176.42 10.52 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.454 ' CB ' ' HA ' ' A' ' 40' ' ' TYR . 55.5 p90 -170.02 168.68 8.42 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 119.382 0.992 . . . . 0.0 112.316 -178.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.91 ' HB3' ' HB3' ' A' ' 96' ' ' ASN . 0.2 OUTLIER -146.48 143.93 29.3 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.542 169.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.951 HD12 HG22 ' A' ' 38' ' ' VAL . 17.6 mm -89.43 138.76 18.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.225 -174.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.477 ' HE2' ' HE1' ' A' ' 94' ' ' TYR . 32.3 mmtp -97.7 107.75 20.32 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.438 0.637 . . . . 0.0 109.289 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.594 ' O ' ' HA ' ' A' ' 92' ' ' THR . 8.4 t80 -89.28 100.9 13.59 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.656 -1.157 . . . . 0.0 109.917 -177.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 91' ' ' LYS . 26.4 tt0 -104.24 113.88 27.73 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.818 -176.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.408 HG21 HD12 ' A' ' 30' ' ' ILE . 5.2 t -119.9 105.69 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.609 -177.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.6 t 50.95 27.14 3.02 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 123.646 0.591 . . . . 0.0 111.155 177.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.58 -18.09 17.8 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.335 -176.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 87' ' ' GLU . 21.2 mmtm -81.81 176.8 9.3 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 117.598 0.699 . . . . 0.0 111.508 -176.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 86' ' ' TYR . 18.0 m -150.59 141.06 22.47 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.662 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.446 ' HD2' ' CD2' ' A' ' 86' ' ' TYR . 63.8 m-85 -146.05 -171.71 3.77 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 170.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.477 ' HE1' ' HE2' ' A' ' 85' ' ' LYS . 51.0 m-85 -146.19 141.23 27.23 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.895 0.379 . . . . 0.0 111.601 -172.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.524 ' HB2' HG13 ' A' ' 9' ' ' VAL . 35.5 t70 -130.16 112.92 13.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.461 167.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.91 ' HB3' ' HB3' ' A' ' 83' ' ' TYR . 36.3 p-10 -130.09 -29.68 2.04 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.15 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.561 HD21 ' HB3' ' A' ' 100' ' ' ALA . 26.1 p-10 159.12 -42.9 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.544 1.137 . . . . 0.0 108.198 172.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 175.49 -37.13 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.421 174.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.2 p -178.06 23.94 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.561 ' HB3' HD21 ' A' ' 97' ' ' ASN . . . -138.06 -17.14 1.23 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -175.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.768 ' HA ' ' HB2' ' A' ' 96' ' ' ASN . 77.5 m-20 87.73 142.65 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.894 0.478 . . . . 0.0 110.739 173.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.562 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 85.0 m-85 -71.76 120.96 18.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.969 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -83.71 129.61 34.95 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 174.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.59 153.39 4.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.1 p -74.71 56.75 0.72 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.459 0.647 . . . . 0.0 111.824 -177.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.31 177.544 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 121.049 0.452 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -91.28 -175.78 4.36 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.845 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.504 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 21.4 mm -54.63 -55.64 35.73 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.345 177.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 3' ' ' ILE . 9.4 Cg_endo -54.74 134.88 65.05 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.241 1.96 . . . . 0.0 112.928 -177.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.9 t -166.35 -51.92 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.912 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.7 m -83.65 -77.35 0.26 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.194 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -139.4 -173.89 3.73 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 120.645 0.259 . . . . 0.0 111.208 -176.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -67.26 -30.91 70.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.42 0.629 . . . . 0.0 109.962 177.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.667 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.4 p -140.68 148.89 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.299 -178.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -140.9 129.35 22.55 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.859 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.586 HD21 ' HD2' ' A' ' 14' ' ' TYR . 23.7 tp -69.06 141.94 54.65 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.213 0.53 . . . . 0.0 110.957 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.497 ' HB3' ' O ' ' A' ' 24' ' ' LYS . 30.0 t70 -85.68 -68.77 0.71 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.752 175.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.7 p -175.94 164.74 2.9 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.741 -177.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.586 ' HD2' HD21 ' A' ' 11' ' ' LEU . 53.2 p90 -156.64 154.42 30.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.564 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -130.55 159.9 35.77 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.125 0.488 . . . . 0.0 110.468 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 20' ' ' THR . 10.4 t80 -122.33 138.25 54.58 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 170.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -153.76 115.06 4.14 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.234 -174.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.01 -95.78 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -168.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.639 ' OG ' ' HA ' ' A' ' 77' ' ' LYS . 10.4 t -139.6 88.13 2.23 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 162.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 87.8 m -146.35 139.97 26.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.47 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.73 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 24.3 t80 -115.06 99.25 7.31 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-O 121.672 0.749 . . . . 0.0 109.278 176.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 17.7 p -126.42 150.01 48.92 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.27 -175.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.86 -162.3 36.07 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.723 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 0.6 OUTLIER -158.42 163.66 37.0 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -177.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.605 HD12 HG11 ' A' ' 36' ' ' VAL . 24.7 mt -135.79 160.29 39.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.927 0.394 . . . . 0.0 111.774 -168.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.418 ' N ' HG22 ' A' ' 25' ' ' ILE . 6.4 t80 -132.85 103.09 5.91 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.433 0.693 . . . . 0.0 109.798 -174.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.667 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 1.5 m -136.65 151.89 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 121.39 -0.819 . . . . 0.0 111.492 -172.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -76.45 152.95 36.01 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 178.317 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -104.6 121.94 44.57 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.345 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.478 HD12 ' OH ' ' A' ' 86' ' ' TYR . 7.1 mt -106.98 -52.83 6.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.823 0.821 . . . . 0.0 109.561 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.72 152.34 51.85 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 105.283 -2.118 . . . . 0.0 105.283 173.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.418 ' O ' ' C ' ' A' ' 33' ' ' SER . 12.1 m-85 -59.04 -83.93 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 117.768 -1.11 . . . . 0.0 113.068 -170.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 32' ' ' TYR . 24.8 m -21.85 104.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 124.49 1.119 . . . . 0.0 111.647 -174.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.751 ' HB3' ' CH2' ' A' ' 70' ' ' TRP . 84.5 mttt -94.77 111.43 23.21 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 124.882 2.277 . . . . 0.0 115.88 -148.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.806 ' HD3' HG13 ' A' ' 88' ' ' VAL 0.489 4.6 pttm -56.84 79.93 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.006 1 CA-C-N 108.264 -4.062 . . . . 0.0 120.545 169.8 . . . . . . . . 4 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.605 HG11 HD12 ' A' ' 25' ' ' ILE . 52.1 t -142.47 113.65 3.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-O 121.5 0.667 . . . . 0.0 111.599 154.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.628 ' HB ' HG13 ' A' ' 53' ' ' ILE . 2.5 p -131.53 102.79 6.07 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.804 173.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.95 ' HB ' HG22 ' A' ' 54' ' ' ILE . 61.4 t -73.83 104.2 2.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.377 -176.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.621 HG12 ' HB ' ' A' ' 53' ' ' ILE . 4.5 m -102.94 110.28 29.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -105.18 150.86 24.72 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.14 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.663 ' HB2' ' CZ2' ' A' ' 47' ' ' TRP . . . -74.22 82.58 1.84 Allowed 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 172.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -49.95 -172.48 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 113.065 -1.879 . . . . 0.0 113.669 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -54.35 -28.98 45.27 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 116.046 -0.524 . . . . 0.0 113.784 -175.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.2 t -72.11 -16.83 62.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.834 0.317 . . . . 0.0 111.069 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.7 t70 67.57 36.01 3.9 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.819 0.819 . . . . 0.0 109.072 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -147.75 160.67 42.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.263 -176.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.663 ' CZ2' ' HB2' ' A' ' 41' ' ' ALA . 5.7 m95 -115.9 82.31 1.75 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.669 0.747 . . . . 0.0 110.38 -176.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.503 ' OD1' ' HB2' ' A' ' 50' ' ' ASN . 1.7 p30 -116.45 168.94 9.71 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.239 173.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -79.51 57.53 2.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.942 0.877 . . . . 0.0 111.062 -175.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.503 ' HB2' ' OD1' ' A' ' 48' ' ' ASN . 59.3 t30 -88.93 11.75 17.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.32 -177.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.67 33.32 52.16 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -176.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -93.63 34.49 1.18 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.551 0.691 . . . . 0.0 110.526 -175.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.692 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -122.15 139.32 49.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.881 179.23 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.95 HG22 ' HB ' ' A' ' 38' ' ' VAL . 5.8 tp -116.2 126.51 73.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 170.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -89.6 126.58 35.67 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.673 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.61 168.69 17.9 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.931 -174.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.7 t -128.0 132.87 49.12 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -77.75 145.81 36.27 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.39 0.614 . . . . 0.0 110.921 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.3 m -92.16 -33.37 14.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.97 172.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 160.84 169.2 23.78 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.455 172.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 68' ' ' GLU . 16.5 Cg_exo -68.49 133.6 28.47 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.562 2.175 . . . . 0.0 110.152 171.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 65' ' ' SER . 42.4 mt -71.03 122.13 22.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 120.981 0.42 . . . . 0.0 110.729 -172.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.5 p -58.03 128.1 35.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.915 -174.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 70.85 15.56 73.93 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.355 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.541 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 26.4 m -130.46 166.54 20.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.958 0.409 . . . . 0.0 110.671 -178.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -102.47 17.77 22.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.554 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 5.7 m-85 -120.18 169.32 10.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.326 -176.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 61' ' ' PRO . 19.6 tt0 -117.33 170.74 8.46 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.002 -1.454 . . . . 0.0 108.705 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -138.15 110.4 7.37 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -162.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.751 ' CH2' ' HB3' ' A' ' 34' ' ' LYS . 18.7 m95 -111.86 147.67 35.29 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.063 -168.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.47 ' HA ' ' HB2' ' A' ' 24' ' ' LYS . 5.7 p -141.74 142.96 33.28 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -154.07 169.45 23.5 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.099 -1.041 . . . . 0.0 112.913 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.6 p -144.24 137.29 27.2 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.179 173.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.73 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -134.09 120.82 20.65 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.436 -173.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.8 t -78.42 99.36 6.37 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 172.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.464 HG13 ' HB3' ' A' ' 21' ' ' PHE . 4.8 m -120.16 151.5 22.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -176.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.639 ' HA ' ' OG ' ' A' ' 19' ' ' SER . 0.2 OUTLIER -141.35 31.33 1.72 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.46 0.648 . . . . 0.0 110.366 174.413 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.09 95.52 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.725 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.8 tt -151.82 141.77 15.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.36 0.6 . . . . 0.0 110.276 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -115.18 -54.32 2.56 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.956 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.487 ' OE1' ' HB3' ' A' ' 103' ' ' GLN . 13.2 mm-40 -135.08 176.8 8.33 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -173.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.436 ' HZ ' ' CD2' ' A' ' 14' ' ' TYR . 28.3 p90 -168.7 160.53 10.69 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.703 171.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.446 ' HB3' HD22 ' A' ' 96' ' ' ASN . 0.1 OUTLIER -147.22 144.03 28.61 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.434 168.681 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.909 HD12 HG22 ' A' ' 38' ' ' VAL . 14.4 mm -91.28 134.81 28.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.687 -172.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.578 ' HB2' ' OG1' ' A' ' 37' ' ' THR . 4.5 mtmp? -88.3 114.87 25.35 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.61 0.719 . . . . 0.0 109.857 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.608 ' CD2' ' HD1' ' A' ' 93' ' ' TYR . 9.5 t80 -86.15 100.04 11.94 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.327 -1.306 . . . . 0.0 107.518 178.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.519 ' C ' ' HB3' ' A' ' 35' ' ' LYS . 30.1 tt0 -124.04 104.23 8.76 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 122.108 0.956 . . . . 0.0 113.043 -162.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.806 HG13 ' HD3' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -110.1 164.53 6.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.408 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.3 m -77.06 40.17 0.25 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.856 0.836 . . . . 0.0 111.235 -177.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . 177.5 -34.07 0.08 OUTLIER Glycine 0 N--CA 1.436 -1.332 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.517 175.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.478 ' O ' HG23 ' A' ' 88' ' ' VAL . 12.9 mptt -110.98 149.43 30.69 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 120.794 0.331 . . . . 0.0 111.325 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.3 m -149.3 138.44 21.37 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.358 0.599 . . . . 0.0 110.965 174.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.608 ' HD1' ' CD2' ' A' ' 86' ' ' TYR . 18.6 m-85 -146.5 -166.65 2.54 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 176.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -144.03 140.47 29.57 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.885 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -96.19 92.89 6.61 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 168.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.446 HD22 ' HB3' ' A' ' 83' ' ' TYR . 3.6 t-20 -129.56 18.53 5.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.097 -174.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 65.97 -68.12 0.13 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.278 -171.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -159.01 -56.07 0.06 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.0 t -167.74 38.72 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 170.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -99.41 -37.99 9.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.09 -169.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 93.0 m-20 72.62 142.28 0.06 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.351 0.596 . . . . 0.0 110.496 -174.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -95.1 100.18 12.05 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.169 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.487 ' HB3' ' OE1' ' A' ' 81' ' ' GLU . 2.3 pm0 -76.61 131.98 39.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.436 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.8 t -85.24 152.08 3.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.985 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.3 t -83.83 71.42 10.45 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.8 p . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.87 176.909 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo . . . . . 0 C--O 1.233 0.272 0 CA-C-O 120.913 0.297 . . . . 0.0 112.768 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.7 t -152.77 -63.88 0.16 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.324 -176.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.6 m -69.31 -62.69 1.28 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.122 0.487 . . . . 0.0 110.041 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.99 -158.2 0.89 Allowed 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.8 m -64.79 -24.82 67.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.563 0.697 . . . . 0.0 109.221 173.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.853 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.5 p -129.24 155.43 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.584 -178.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -143.81 137.97 28.38 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.451 HD21 ' HD2' ' A' ' 14' ' ' TYR . 34.8 tp -70.55 126.54 29.91 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.121 0.486 . . . . 0.0 111.175 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -74.21 -62.22 1.59 Allowed 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.825 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.2 p 176.55 167.25 0.48 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.214 -175.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.483 ' HA ' ' O ' ' A' ' 22' ' ' SER . 49.0 p90 -157.8 160.34 37.69 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.306 -1.315 . . . . 0.0 107.8 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -126.09 163.24 23.52 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.979 0.419 . . . . 0.0 110.326 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.486 ' HA ' ' O ' ' A' ' 20' ' ' THR . 37.5 t80 -152.5 149.59 28.7 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.284 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -179.76 126.14 0.08 Allowed 'General case' 0 C--N 1.321 -0.644 0 O-C-N 123.715 0.634 . . . . 0.0 109.376 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.44 -105.8 0.99 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 -170.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.542 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 20.4 m -133.35 86.08 2.27 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 166.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 96.2 m -148.07 136.07 21.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.709 177.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.728 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 23.8 t80 -117.32 138.88 51.47 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 171.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 25.9 p -150.04 109.87 4.08 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 14' ' ' TYR . . . -133.77 149.47 19.72 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.15 -1.024 . . . . 0.0 113.057 -166.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.662 ' HB3' HG22 ' A' ' 71' ' ' THR . 24.3 pttm -140.34 154.69 46.85 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.63 HD13 HG21 ' A' ' 84' ' ' ILE . 19.0 mt -134.91 154.63 36.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.071 -165.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -123.24 99.32 6.29 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.255 -174.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.853 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 1.7 m -136.25 149.95 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.337 0.589 . . . . 0.0 112.372 -170.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.633 ' HB2' ' CE1' ' A' ' 67' ' ' TYR . 7.7 ttmm -81.25 144.19 31.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.642 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -82.96 103.82 12.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.65 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.663 HG12 ' OH ' ' A' ' 86' ' ' TYR . 19.0 mm -81.68 -59.29 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.43 -151.86 0.49 Allowed 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 114.033 -1.44 . . . . 0.0 107.706 174.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -109.04 -44.95 3.86 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.049 -0.661 . . . . 0.0 111.46 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.4 t -76.93 82.27 3.48 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.589 0.709 . . . . 0.0 109.898 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 34' ' ' LYS . 28.1 mtmt -110.67 152.41 26.55 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.968 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -142.31 110.12 5.83 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 122.277 1.037 . . . . 0.0 109.021 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.0 t -92.12 124.73 44.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.593 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.763 ' HB ' HG13 ' A' ' 53' ' ' ILE . 59.2 p -123.27 117.4 25.18 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.244 -170.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.811 HG11 ' CD2' ' A' ' 40' ' ' TYR . 57.3 t -73.38 141.24 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.019 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 170.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -124.6 100.1 7.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 159.102 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.811 ' CD2' HG11 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -119.21 126.08 50.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 122.218 1.009 . . . . 0.0 110.684 179.112 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.51 ' HB2' ' CZ3' ' A' ' 47' ' ' TRP . . . -86.59 151.13 23.72 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.768 -164.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.454 ' C ' ' H ' ' A' ' 44' ' ' SER . 2.8 m-20 -72.85 177.5 4.83 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.154 -1.839 . . . . 0.0 110.863 -166.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.36 33.8 1.34 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.805 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.454 ' H ' ' C ' ' A' ' 42' ' ' ASP . 22.7 t -112.26 -10.52 13.82 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 175.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 16.6 t70 76.58 91.26 0.07 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 113.535 -1.666 . . . . 0.0 110.341 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.446 ' HB3' ' O ' ' A' ' 45' ' ' ASP . 22.9 t-20 84.69 154.64 0.09 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.996 170.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.617 ' HE1' ' HB2' ' A' ' 52' ' ' ASN . 8.2 m-90 -72.48 124.47 25.25 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -172.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -78.22 74.25 4.76 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.264 -1.334 . . . . 0.0 108.691 167.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.1 t30 47.86 34.08 3.71 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.676 0.75 . . . . 0.0 110.781 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -119.15 174.46 6.32 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -173.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -141.78 77.32 0.3 Allowed Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 119.808 -1.187 . . . . 0.0 112.213 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.617 ' HB2' ' HE1' ' A' ' 47' ' ' TRP . 78.3 m-20 -79.84 95.11 5.95 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 121.229 0.538 . . . . 0.0 111.515 -178.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.763 HG13 ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -108.49 142.64 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.006 -177.18 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.495 ' CG2' ' HB ' ' A' ' 38' ' ' VAL . 17.5 tt -135.99 122.74 32.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.307 173.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.52 134.5 43.85 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.024 0.44 . . . . 0.0 111.756 -170.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -91.32 164.83 13.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.691 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -128.36 140.13 52.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.062 0.458 . . . . 0.0 110.063 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -71.46 145.58 49.15 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.231 0.539 . . . . 0.0 110.642 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.1 t -107.59 -44.26 4.32 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.888 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.44 170.52 36.35 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.969 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -70.13 140.84 42.23 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.855 2.37 . . . . 0.0 111.666 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.661 HD12 ' HB3' ' A' ' 67' ' ' TYR . 28.8 mt -78.71 105.99 8.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.097 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.7 m -65.85 117.09 7.75 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.365 0.603 . . . . 0.0 110.636 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.28 -14.69 9.4 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.41 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.9 m -150.25 164.76 34.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.955 0.407 . . . . 0.0 110.711 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -89.89 62.07 5.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.429 0.633 . . . . 0.0 109.443 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.661 ' HB3' HD12 ' A' ' 62' ' ' ILE . 1.7 m-85 -138.52 169.59 17.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.466 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -122.09 171.6 8.86 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.554 ' HB2' HG12 ' A' ' 62' ' ' ILE . 1.5 t80 -140.28 122.11 15.46 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -163.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.647 ' CD1' HG13 ' A' ' 27' ' ' VAL . 7.1 m95 -121.28 144.56 48.56 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.015 -165.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.662 HG22 ' HB3' ' A' ' 24' ' ' LYS . 21.3 p -145.81 153.45 40.92 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 122.9 0.125 . . . . 0.0 110.74 -178.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -173.01 155.72 3.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.219 0.533 . . . . 0.0 111.209 167.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.2 m -112.15 145.21 40.23 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.543 175.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.728 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -137.51 144.89 42.4 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.36 -175.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.3 t -99.95 99.15 9.88 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 173.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.542 ' O ' ' HB3' ' A' ' 19' ' ' SER . 3.9 m -103.48 138.34 28.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 3.7 mptp? -101.95 -11.4 18.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.233 -173.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 42' ' ' ASP . . . -179.66 105.98 0.2 Allowed Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.494 HG12 HG21 ' A' ' 104' ' ' VAL . 11.1 tt -128.92 158.36 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.495 ' HE2' ' HA ' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -147.56 -42.07 0.17 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.289 -178.146 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 82' ' ' PHE . 23.0 mm-40 -135.32 164.69 27.16 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 118.56 -0.733 . . . . 0.0 109.086 -171.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.518 ' CB ' ' HA ' ' A' ' 40' ' ' TYR . 36.4 p90 -173.36 178.85 2.29 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 119.378 -0.929 . . . . 0.0 113.379 171.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.667 ' O ' HG23 ' A' ' 39' ' ' VAL . 1.0 OUTLIER -164.28 144.99 8.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.412 -1.722 . . . . 0.0 107.704 167.368 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.63 HG21 HD13 ' A' ' 25' ' ' ILE . 28.3 mm -103.23 137.0 33.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.56 -174.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -104.13 146.12 29.2 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.774 0.797 . . . . 0.0 110.925 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.665 ' HB2' HG11 ' A' ' 9' ' ' VAL . 10.3 t80 -108.89 100.17 9.42 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.454 175.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -110.38 120.79 43.55 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.628 0.728 . . . . 0.0 109.38 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.538 ' C ' ' H ' ' A' ' 90' ' ' GLY . 86.4 t -121.72 155.92 26.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.207 -174.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.9 t -77.01 31.95 0.14 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 122.019 0.914 . . . . 0.0 109.677 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.538 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -158.83 -33.14 0.02 OUTLIER Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.91 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.445 ' HE3' ' H ' ' A' ' 92' ' ' THR . 13.3 mmmt -145.66 178.8 7.87 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.82 0.819 . . . . 0.0 112.138 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.445 ' H ' ' HE3' ' A' ' 91' ' ' LYS . 5.6 m -149.27 143.62 25.97 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.086 174.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.448 ' CD1' ' HD2' ' A' ' 86' ' ' TYR . 25.9 m-85 -143.36 -172.26 3.66 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -145.24 138.44 26.46 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.609 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -111.25 104.24 12.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 165.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 98' ' ' ASN . 49.6 t30 -151.93 87.45 1.35 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.613 -171.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.565 HD21 ' HB3' ' A' ' 100' ' ' ALA . 13.4 p-10 42.22 -68.2 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.465 1.906 . . . . 0.0 115.343 168.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 96' ' ' ASN . 54.8 t30 -159.92 -49.6 0.05 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -177.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.0 p -174.48 20.31 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.859 175.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.565 ' HB3' HD21 ' A' ' 97' ' ' ASN . . . -129.15 -87.31 0.54 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -174.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -169.17 147.84 3.87 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.348 0.659 . . . . 0.0 109.812 -169.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.463 ' CE2' ' HA ' ' A' ' 96' ' ' ASN . 77.1 m-85 -85.88 122.96 30.68 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 170.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -77.26 122.48 25.14 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.494 HG21 HG12 ' A' ' 79' ' ' ILE . 47.5 t -78.16 132.21 32.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.8 m -73.47 77.07 1.43 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.15 0.5 . . . . 0.0 110.913 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 m . . . . . 0 C--O 1.246 0.9 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.49 176.31 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.63 ' HG2' ' CZ ' ' A' ' 67' ' ' TYR . 45.4 Cg_endo . . . . . 0 CA--C 1.528 0.196 0 CA-C-O 121.021 0.342 . . . . 0.0 112.365 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.7 t -128.81 -13.43 4.67 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.354 0.597 . . . . 0.0 109.987 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.1 m -90.1 -6.77 55.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.113 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.34 28.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.576 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.494 ' HB3' HD11 ' A' ' 30' ' ' ILE . 1.6 m -92.88 -27.23 17.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.558 0.694 . . . . 0.0 109.228 175.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.758 HG23 ' HB ' ' A' ' 27' ' ' VAL . 2.2 p -149.89 146.64 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.015 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -135.7 128.76 31.58 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.497 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.502 HD21 ' CD1' ' A' ' 14' ' ' TYR . 36.9 tp -71.85 133.56 45.55 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.172 174.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -81.27 -64.02 1.27 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.969 177.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.6 p 177.32 166.52 0.6 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.851 -177.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.502 ' CD1' HD21 ' A' ' 11' ' ' LEU . 50.3 p90 -157.47 163.9 37.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.056 -177.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -153.18 163.89 39.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.938 0.399 . . . . 0.0 110.989 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.548 ' HD1' ' HD1' ' A' ' 21' ' ' PHE . 35.6 t80 -131.38 149.39 52.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.668 -176.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -174.71 117.82 0.2 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.226 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.0 -99.77 0.34 Allowed Glycine 0 CA--C 1.511 -0.208 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.6 t -135.47 83.46 2.02 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 164.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 62.6 m -148.42 134.33 19.08 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.503 172.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.548 ' HD1' ' HD1' ' A' ' 16' ' ' TYR . 7.8 t80 -132.74 102.34 5.63 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 169.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.4 t -139.04 167.42 22.1 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.952 -171.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.22 -154.35 25.33 Favored Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.564 ' HB3' HG22 ' A' ' 71' ' ' THR . 0.0 OUTLIER -155.64 173.49 16.65 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.433 0.635 . . . . 0.0 112.007 179.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.643 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 83.4 mt -136.53 153.37 30.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.58 -167.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -130.58 100.39 5.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.93 -174.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.758 ' HB ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -141.79 145.77 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -169.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.633 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 21.2 ptmt -97.62 154.56 17.47 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.805 -175.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.918 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 20.1 p-10 -75.1 115.7 15.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.96 177.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.659 HG12 ' OH ' ' A' ' 86' ' ' TYR . 34.4 mm -77.81 -56.07 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 167.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.49 -86.4 0.41 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.778 171.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -163.77 -68.47 0.04 OUTLIER 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 172.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m -80.71 124.33 28.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.861 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.918 ' HE3' ' HA ' ' A' ' 29' ' ' ASN . 37.8 mttp -122.81 176.66 5.86 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.341 0.591 . . . . 0.0 111.166 -172.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.856 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 96.4 mttt -121.14 136.54 54.96 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 166.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.3 t -127.66 113.63 32.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 122.014 0.911 . . . . 0.0 109.739 171.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 1.116 ' HB ' HD11 ' A' ' 53' ' ' ILE . 1.0 OUTLIER -131.48 136.14 47.67 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.148 -1.387 . . . . 0.0 110.413 -175.142 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 1.018 ' HB ' HG22 ' A' ' 54' ' ' ILE . 69.3 t -93.4 132.71 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.451 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.569 ' O ' ' HH2' ' A' ' 47' ' ' TRP . 2.7 m -112.8 104.77 17.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 165.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.719 ' CD1' HG12 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -122.18 120.87 35.46 Favored 'General case' 0 N--CA 1.4 -2.974 0 CA-C-N 114.902 -1.044 . . . . 0.0 110.054 -170.107 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.649 ' HB2' ' CE3' ' A' ' 47' ' ' TRP . . . -76.5 129.0 35.87 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.53 -169.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -67.42 179.91 1.19 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.523 -1.672 . . . . 0.0 111.354 -168.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.604 ' HA2' ' HG2' ' A' ' 80' ' ' LYS . . . -68.0 -0.28 14.02 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.079 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.0 m -66.45 -22.75 66.21 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.013 0.435 . . . . 0.0 110.044 174.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 t70 64.69 37.66 7.47 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.133 -0.939 . . . . 0.0 108.98 177.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -173.86 140.28 0.73 Allowed 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -172.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.649 ' CE3' ' HB2' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -89.39 85.88 6.66 Favored 'General case' 0 N--CA 1.421 -1.893 0 C-N-CA 118.608 -1.237 . . . . 0.0 112.516 -173.204 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -56.66 132.32 51.56 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.37 165.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -72.12 70.22 0.79 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.849 0.833 . . . . 0.0 111.317 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -112.74 -17.86 12.45 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.652 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.47 -58.34 3.05 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.709 -176.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 92.4 m-20 59.83 76.3 0.37 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.655 -0.773 . . . . 0.0 110.144 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 1.116 HD11 ' HB ' ' A' ' 37' ' ' THR . 5.7 tp -109.07 148.89 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-O 121.816 0.817 . . . . 0.0 112.044 -176.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 1.018 HG22 ' HB ' ' A' ' 38' ' ' VAL . 3.4 tp -133.03 140.34 47.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.494 -1.23 . . . . 0.0 107.712 167.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -92.84 116.42 29.01 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.287 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.12 156.28 39.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.215 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.8 t -114.83 144.8 42.94 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -174.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -71.25 142.06 50.56 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.283 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.4 t -109.12 -42.27 4.46 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.81 171.8 21.94 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.569 173.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.15 142.75 42.58 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.403 2.068 . . . . 0.0 110.637 173.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.55 HG12 ' HB2' ' A' ' 69' ' ' TYR . 9.7 mt -83.63 83.83 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.8 m -53.5 126.41 21.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.385 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 113.31 -32.42 6.11 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.252 -173.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -127.24 165.99 18.61 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -95.43 55.01 1.66 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.135 0.493 . . . . 0.0 110.863 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.633 ' CE1' ' HB3' ' A' ' 28' ' ' LYS . 2.4 m-85 -137.04 159.3 42.31 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.328 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -107.29 173.59 6.26 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.922 176.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.55 ' HB2' HG12 ' A' ' 62' ' ' ILE . 3.1 t80 -143.5 120.84 11.61 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -165.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.643 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 20.6 m95 -127.79 138.65 52.81 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.922 -166.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.564 HG22 ' HB3' ' A' ' 24' ' ' LYS . 6.5 p -124.33 133.25 53.51 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -125.93 136.97 53.64 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.488 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.7 p -125.7 139.44 53.54 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.236 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.97 118.99 5.43 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.782 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.9 t -82.57 99.4 9.5 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.429 ' CG2' ' HE1' ' A' ' 16' ' ' TYR . 13.8 m -99.48 144.66 11.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.375 -173.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.01 8.39 43.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.279 0.562 . . . . 0.0 110.563 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 156.81 145.8 4.3 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.639 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.602 HG12 HG21 ' A' ' 104' ' ' VAL . 7.3 tt -168.09 142.47 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.309 0.576 . . . . 0.0 110.873 177.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.604 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 3.7 mmmp? -125.48 -38.7 2.24 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.28 -177.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 29.4 mt-10 -141.65 167.22 22.67 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.635 ' HB2' ' HA ' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -171.89 170.45 5.44 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.017 -0.673 . . . . 0.0 112.056 172.197 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.651 ' HD2' ' HB3' ' A' ' 96' ' ' ASN . 0.1 OUTLIER -159.46 148.54 18.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.195 169.092 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.904 HD12 HG22 ' A' ' 38' ' ' VAL . 21.5 mm -95.01 140.76 16.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.706 -169.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.6 mtmt -90.7 114.09 26.33 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.157 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.659 ' OH ' HG12 ' A' ' 30' ' ' ILE . 10.5 t80 -91.95 99.72 12.51 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 172.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.856 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 9.3 tt0 -109.63 107.84 18.04 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.63 0.729 . . . . 0.0 110.206 -174.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.469 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 20.6 t -87.21 164.02 2.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.061 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.429 ' N ' HG12 ' A' ' 88' ' ' VAL . 1.1 m -43.51 -40.86 4.11 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.405 0.44 . . . . 0.0 111.156 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -136.37 23.64 3.28 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.185 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.469 ' HB2' ' HB ' ' A' ' 88' ' ' VAL . 16.5 mmtp -141.74 175.44 9.7 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.772 0.796 . . . . 0.0 111.758 177.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.8 m -149.19 138.83 21.78 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.614 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.421 ' HD2' ' CD2' ' A' ' 86' ' ' TYR . 60.7 m-85 -140.6 -169.25 2.75 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -148.07 145.49 28.46 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.147 0.498 . . . . 0.0 111.503 -173.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.417 ' OD2' ' HB2' ' A' ' 11' ' ' LEU . 17.6 t70 -107.78 97.68 7.37 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 167.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.651 ' HB3' ' HD2' ' A' ' 83' ' ' TYR . 34.0 p30 -144.03 31.98 1.25 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -172.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 67.88 -67.6 0.18 Allowed 'General case' 0 CA--C 1.532 0.275 0 O-C-N 123.629 0.58 . . . . 0.0 111.403 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -171.66 40.25 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -175.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.6 t 63.64 46.6 4.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.954 -167.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -102.3 -38.55 7.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.99 -176.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 7.3 m-20 67.94 115.1 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.781 0.676 . . . . 0.0 110.282 -174.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 7.9 m-85 -77.14 133.21 39.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.437 -174.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -79.19 129.63 34.65 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.602 HG21 HG12 ' A' ' 79' ' ' ILE . 96.3 t -79.25 133.84 29.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.677 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.1 p -77.14 77.01 3.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.725 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.248 1.008 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.177 178.652 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo . . . . . 0 N--CA 1.456 -0.687 0 CA-C-O 121.028 0.345 . . . . 0.0 112.014 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.4 m -128.44 -54.96 1.25 Allowed 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.33 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.6 m -106.09 -68.62 0.87 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.351 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.28 -172.8 2.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 120.908 0.385 . . . . 0.0 111.862 -173.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 m -64.86 -26.56 68.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.214 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.728 ' CB ' ' HB ' ' A' ' 27' ' ' VAL . 2.2 p -120.57 148.31 23.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.382 0.61 . . . . 0.0 112.015 -174.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.425 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 28.0 tt0 -143.72 132.22 22.26 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.474 173.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.671 HD21 ' CD1' ' A' ' 14' ' ' TYR . 40.5 tp -70.03 130.76 43.02 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.099 0.476 . . . . 0.0 110.238 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -76.84 -63.9 1.25 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.901 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.5 m -178.96 159.87 1.04 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.622 -174.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.671 ' CD1' HD21 ' A' ' 11' ' ' LEU . 53.7 p90 -157.95 163.49 37.78 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.654 -177.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -151.32 164.95 35.5 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -176.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.61 ' HA ' ' O ' ' A' ' 20' ' ' THR . 97.6 m-85 -138.92 138.34 37.28 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.754 -176.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -136.53 124.62 22.95 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.54 -99.44 0.18 Allowed Glycine 0 C--N 1.331 0.265 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -167.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.1 t -139.86 87.85 2.19 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 163.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.61 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 73.0 m -145.96 133.3 20.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.422 177.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.957 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 14.8 t80 -90.57 126.49 35.96 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 174.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.9 p -144.92 126.19 14.78 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.593 175.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.422 ' HA3' ' HA ' ' A' ' 14' ' ' TYR . . . 173.68 -154.14 19.14 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.384 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.609 ' HB3' HG22 ' A' ' 71' ' ' THR . 0.4 OUTLIER -161.85 166.07 26.86 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.196 0.522 . . . . 0.0 111.018 -177.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 33.8 mt -127.72 156.04 39.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.16 -172.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -126.9 96.32 4.59 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.866 -172.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.728 ' HB ' ' CB ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -147.91 143.23 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -172.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.553 ' HE3' ' CE1' ' A' ' 67' ' ' TYR . 17.0 ptpt -85.05 148.43 26.17 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.365 176.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.422 HD22 ' CD ' ' A' ' 68' ' ' GLU . 4.4 p30 -86.64 132.58 33.85 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.998 176.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.466 HG12 ' OH ' ' A' ' 86' ' ' TYR . 39.0 mm -80.33 -55.28 9.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.486 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.819 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . . . -103.84 -81.18 0.52 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.026 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -159.31 -73.25 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.285 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.611 ' C ' ' HE2' ' A' ' 34' ' ' LYS . 10.0 t -95.87 62.78 2.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.34 0.591 . . . . 0.0 109.913 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.926 ' HD2' HG13 ' A' ' 88' ' ' VAL . 6.3 mmpt? -80.68 157.1 26.02 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.496 ' HG3' ' HB3' ' A' ' 87' ' ' GLU . 18.3 pttp -124.81 141.34 52.18 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.167 -175.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.3 t -115.73 116.57 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.787 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.616 HG22 HD11 ' A' ' 53' ' ' ILE . 5.4 p -114.17 119.43 37.04 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.866 -170.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.824 HG22 HD12 ' A' ' 84' ' ' ILE . 96.8 t -84.19 113.63 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.89 176.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 0.3 OUTLIER -107.6 107.09 21.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 172.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.649 ' HA ' ' HB3' ' A' ' 82' ' ' PHE . 4.3 p90 -109.26 137.61 46.88 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-O 122.494 1.14 . . . . 0.0 110.075 177.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.717 ' HB2' ' CZ3' ' A' ' 47' ' ' TRP . . . -89.38 110.67 21.45 Favored 'General case' 0 N--CA 1.401 -2.894 0 CA-C-N 112.863 -1.971 . . . . 0.0 107.599 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -40.7 167.22 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 112.484 -2.143 . . . . 0.0 112.081 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.78 ' HA2' ' HB2' ' A' ' 80' ' ' LYS . . . -67.69 1.69 7.23 Favored Glycine 0 CA--C 1.518 0.264 0 CA-C-N 115.241 -0.891 . . . . 0.0 114.849 -163.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 30.7 t -87.49 -12.72 45.15 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 117.088 0.444 . . . . 0.0 111.009 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.616 ' OD1' ' HG2' ' A' ' 80' ' ' LYS . 5.3 m-20 74.27 48.75 0.12 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 124.038 0.836 . . . . 0.0 110.271 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -155.51 134.3 11.99 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.198 -171.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.717 ' CZ3' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -105.03 85.7 2.32 Favored 'General case' 0 N--CA 1.425 -1.705 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.681 178.019 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -71.85 145.43 48.59 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 167.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -61.71 90.8 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.301 0.572 . . . . 0.0 110.75 -176.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -152.22 147.12 26.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.092 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.03 59.46 4.94 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.897 -176.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -71.36 56.71 0.24 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.357 0.598 . . . . 0.0 109.843 172.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.629 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -116.25 141.1 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.436 -176.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.82 HG22 ' HB ' ' A' ' 38' ' ' VAL . 8.5 tp -121.76 130.3 74.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.034 -0.984 . . . . 0.0 108.372 173.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.71 128.62 34.84 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.011 -173.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.74 158.36 28.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.977 178.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 t -122.63 121.93 37.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 29.1 p90 -82.4 138.29 34.49 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 121.708 0.766 . . . . 0.0 111.363 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.402 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 65.8 m -97.03 -41.32 8.43 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 172.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.584 ' O ' ' HA ' ' A' ' 68' ' ' GLU . . . 118.55 -87.5 0.42 Allowed Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.18 -0.918 . . . . 0.0 113.541 170.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.402 ' HD2' ' O ' ' A' ' 59' ' ' SER . 18.6 Cg_endo -52.98 119.66 6.44 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 124.295 3.33 . . . . 0.0 115.959 -167.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.462 ' HB ' ' O ' ' A' ' 67' ' ' TYR . 21.6 mt -124.05 90.57 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.217 162.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.5 m -71.52 117.8 13.53 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.804 -174.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.68 -14.01 6.1 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.965 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -155.5 167.01 31.79 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -92.13 66.4 4.88 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.716 0.769 . . . . 0.0 109.438 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.553 ' CE1' ' HE3' ' A' ' 28' ' ' LYS . 2.2 m-85 -136.52 153.15 51.09 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.732 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 7.4 mp0 -106.44 174.78 5.74 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.888 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -137.55 115.75 11.75 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -166.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.689 ' NE1' HG13 ' A' ' 27' ' ' VAL . 8.0 m95 -116.16 121.85 43.32 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.649 -164.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.609 HG22 ' HB3' ' A' ' 24' ' ' LYS . 2.9 p -128.94 147.74 50.87 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 110.562 -0.162 . . . . 0.0 110.562 -171.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.503 ' HZ ' HG21 ' A' ' 38' ' ' VAL . 2.5 p90 -174.58 159.72 2.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.444 0.64 . . . . 0.0 112.202 174.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.2 m -115.24 146.45 41.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.54 169.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.957 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -138.77 128.84 25.38 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -174.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.0 t -81.76 100.9 9.79 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 172.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' A' ' 21' ' ' PHE . 22.4 m -98.32 151.88 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.921 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.42 11.49 38.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.042 0.449 . . . . 0.0 111.032 -172.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 124.99 102.55 1.4 Allowed Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.844 HG12 HG21 ' A' ' 104' ' ' VAL . 12.3 tt -115.6 156.38 16.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 120.657 0.265 . . . . 0.0 110.986 -174.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.78 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 4.8 tppp? -139.66 -45.86 0.45 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.145 0.497 . . . . 0.0 111.75 -177.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.709 ' HG3' ' HB3' ' A' ' 41' ' ' ALA . 4.7 pt-20 -147.77 156.86 43.19 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.315 -176.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.649 ' HB3' ' HA ' ' A' ' 40' ' ' TYR . 55.7 p90 -171.86 179.27 2.79 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 119.774 -0.77 . . . . 0.0 112.815 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.46 149.83 30.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.503 167.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.824 HD12 HG22 ' A' ' 38' ' ' VAL . 25.6 mm -102.57 130.83 51.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.42 -177.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -96.42 147.61 23.64 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.845 0.831 . . . . 0.0 111.073 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.603 ' HD2' ' HD2' ' A' ' 93' ' ' TYR . 12.0 t80 -109.91 101.21 10.07 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.245 -1.343 . . . . 0.0 107.893 172.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.496 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . 10.8 tt0 -103.85 107.79 18.82 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 122.002 0.906 . . . . 0.0 110.702 -169.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.926 HG13 ' HD2' ' A' ' 34' ' ' LYS . 15.2 t -110.63 162.22 8.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.271 -1.331 . . . . 0.0 108.369 -177.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.5 m -70.22 -14.93 62.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.756 0.313 . . . . 0.0 111.389 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.35 -3.61 2.71 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.061 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.4 ' H ' ' HB ' ' A' ' 88' ' ' VAL . 1.7 mmtm -142.11 160.44 40.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.099 0.476 . . . . 0.0 111.435 -177.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 86' ' ' TYR . 7.5 m -148.99 143.58 26.21 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.909 172.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.603 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 20.4 m-85 -137.67 -172.07 3.15 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 175.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -148.03 127.07 12.82 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.781 -175.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.425 ' OD1' ' HA ' ' A' ' 10' ' ' GLN . 23.2 t70 -93.26 94.02 8.55 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 166.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.443 ' C ' ' H ' ' A' ' 98' ' ' ASN . 30.4 p-10 -128.12 41.72 3.45 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.851 -164.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 71.83 -33.58 0.27 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.325 1.05 . . . . 0.0 112.087 178.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.443 ' H ' ' C ' ' A' ' 96' ' ' ASN . 28.4 t-20 171.42 -59.55 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 65.2 m -160.25 26.95 0.17 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.586 174.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.1 -92.1 0.19 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -174.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.448 ' ND2' HE22 ' A' ' 103' ' ' GLN . 0.3 OUTLIER -174.25 150.49 1.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.069 -168.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.581 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 81.5 m-85 -88.98 140.79 29.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.294 175.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.448 HE22 ' ND2' ' A' ' 101' ' ' ASN . 1.8 mp0 -97.28 120.43 37.63 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 123.612 0.57 . . . . 0.0 109.905 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.844 HG21 HG12 ' A' ' 79' ' ' ILE . 86.9 t -83.5 126.27 40.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.062 0.458 . . . . 0.0 111.234 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.3 p -87.71 67.3 9.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.892 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.494 HG23 HG12 ' A' ' 104' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.601 -0.714 . . . . 0.0 111.116 178.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 N--CA 1.446 -1.265 0 N-CA-C 111.231 -0.334 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.2 t -145.61 -66.7 0.3 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.2 m -103.74 -30.95 10.09 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 173.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -122.6 174.75 6.88 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.302 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.475 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 70.3 m -96.75 11.36 35.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.571 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.728 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 0.9 OUTLIER -149.92 152.53 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.736 -175.056 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.445 ' O ' ' HB3' ' A' ' 26' ' ' TYR . 8.0 tt0 -149.83 112.1 4.67 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.123 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.639 ' CD1' HG12 ' A' ' 25' ' ' ILE . 7.8 tt -67.82 132.32 47.18 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.983 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.469 ' OD1' ' HE2' ' A' ' 24' ' ' LYS . 15.5 t70 -68.85 -61.43 1.81 Allowed 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.293 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.436 ' N ' HD23 ' A' ' 11' ' ' LEU . 32.2 m -168.35 154.45 7.11 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.087 -168.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.46 ' HA ' ' HA3' ' A' ' 23' ' ' GLY . 42.1 p90 -157.08 152.66 26.72 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.396 -1.274 . . . . 0.0 109.198 177.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -127.86 164.74 21.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.094 0.473 . . . . 0.0 110.927 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.515 ' HA ' ' O ' ' A' ' 20' ' ' THR . 56.1 t80 -145.56 151.95 38.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.838 176.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -172.85 121.94 0.4 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.759 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.71 -98.28 0.12 Allowed Glycine 0 CA--C 1.51 -0.265 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -172.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.499 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 49.3 m -139.47 85.84 2.08 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 161.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 3.9 m -145.52 140.09 27.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.114 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.909 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 25.0 t80 -118.25 139.59 51.08 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 172.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 p -160.22 126.48 4.2 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.668 176.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 14' ' ' TYR . . . 177.82 -159.17 24.79 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 119.798 -1.191 . . . . 0.0 112.917 -178.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.636 ' HB3' HG22 ' A' ' 71' ' ' THR . 0.0 OUTLIER -160.49 160.22 31.75 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.342 0.591 . . . . 0.0 110.721 -178.51 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.639 HG12 ' CD1' ' A' ' 11' ' ' LEU . 31.2 mt -128.94 156.11 41.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.635 -170.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.445 ' HB3' ' O ' ' A' ' 10' ' ' GLN . 4.2 t80 -130.7 115.88 17.28 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -175.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.728 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 1.0 OUTLIER -139.4 149.15 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 121.679 -0.638 . . . . 0.0 111.513 -177.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 8' ' ' SER . 0.0 OUTLIER -93.45 152.69 18.93 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.374 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -79.66 126.21 30.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.786 -176.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.662 HG12 ' OH ' ' A' ' 86' ' ' TYR . 26.6 mm -93.29 -48.64 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 167.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.05 -156.13 0.73 Allowed 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.949 -1.478 . . . . 0.0 107.868 174.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -110.3 -51.78 2.84 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.44 -177.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.4 m -82.35 85.46 6.87 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.224 0.535 . . . . 0.0 110.096 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.496 ' HB2' ' HE3' ' A' ' 34' ' ' LYS . 25.7 mtmt -102.9 174.86 5.69 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.084 0.468 . . . . 0.0 110.903 -174.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.853 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 88.7 mttt -131.63 139.16 49.06 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.133 174.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 68.8 t -130.83 108.51 15.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 121.954 0.883 . . . . 0.0 109.919 171.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.529 HG22 HD11 ' A' ' 53' ' ' ILE . 19.4 p -122.39 122.99 40.31 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.523 -174.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.827 HG22 HD12 ' A' ' 84' ' ' ILE . 84.6 t -83.58 135.17 25.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.871 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.8 m -135.21 122.03 34.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.779 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.697 ' HE1' ' HA ' ' A' ' 42' ' ' ASP . 5.3 p90 -115.9 171.14 7.96 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 119.599 -0.841 . . . . 0.0 112.192 -174.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.756 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -93.36 86.58 5.32 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 170.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.723 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 38.0 t70 6.53 -95.42 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 O-C-N 127.336 2.898 . . . . 0.0 114.846 174.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.57 -28.37 0.35 Allowed Glycine 0 C--N 1.316 -0.542 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.692 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.2 t -109.6 -60.75 1.73 Allowed 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 174.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.645 ' HA ' ' HB1' ' A' ' 41' ' ' ALA . 8.0 p-10 175.46 38.28 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.135 -176.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -91.68 113.2 25.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.076 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.756 ' CH2' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -124.17 118.74 27.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.545 0.688 . . . . 0.0 110.062 167.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.467 ' O ' ' HB3' ' A' ' 49' ' ' ASN . 66.3 t30 -81.59 56.76 3.09 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 170.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 48' ' ' ASN . 33.8 t30 69.07 -55.61 0.55 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -154.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -124.83 -72.34 0.67 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.308 164.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.417 ' CA ' ' HB3' ' A' ' 48' ' ' ASN . . . 86.85 -40.53 3.08 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.248 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -134.49 98.91 4.2 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.484 0.659 . . . . 0.0 110.969 -175.464 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -122.42 143.91 33.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.682 -178.055 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.592 HG22 ' HB ' ' A' ' 38' ' ' VAL . 20.1 tt -131.57 128.45 60.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.195 173.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.23 132.95 35.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.781 0.324 . . . . 0.0 110.801 -176.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.79 159.66 33.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.614 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.3 m -112.3 128.98 56.43 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.444 ' H ' ' HD1' ' A' ' 58' ' ' PHE . 2.1 m-85 -71.5 138.74 49.17 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.276 -177.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.8 m -99.55 -46.14 5.56 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 170.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.73 175.26 21.82 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.583 173.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.76 134.55 58.05 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.248 1.965 . . . . 0.0 110.945 174.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.597 HD12 ' HB2' ' A' ' 67' ' ' TYR . 62.9 mt -75.82 106.63 5.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 28.4 m -49.66 125.24 11.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.063 -174.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.89 7.08 60.12 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.168 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.521 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 50.8 m -151.68 172.27 16.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.137 0.494 . . . . 0.0 111.124 -178.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -101.65 20.37 16.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.225 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.597 ' HB2' HD12 ' A' ' 62' ' ' ILE . 6.7 m-85 -103.71 154.95 18.98 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -114.14 162.58 16.33 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.414 ' HB2' HG12 ' A' ' 62' ' ' ILE . 8.8 t80 -122.6 119.44 30.81 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -167.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.559 ' NE1' HG13 ' A' ' 27' ' ' VAL . 3.7 m95 -116.28 126.76 54.01 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.491 -173.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.636 HG22 ' HB3' ' A' ' 24' ' ' LYS . 40.2 p -134.51 152.9 52.09 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.426 ' HB3' ' O ' ' A' ' 71' ' ' THR . 3.1 p90 -174.22 150.78 1.55 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.703 0.763 . . . . 0.0 111.79 168.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.0 m -112.43 138.42 49.19 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.014 169.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.909 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -132.64 135.78 46.08 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.936 0.398 . . . . 0.0 111.865 -168.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.9 t -88.31 98.18 11.45 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 170.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 19' ' ' SER . 20.1 m -104.21 139.94 23.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -177.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 3.8 mptp? -106.3 39.82 1.73 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.433 0.635 . . . . 0.0 109.93 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 129.71 136.77 4.12 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.063 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.723 ' HA ' ' O ' ' A' ' 42' ' ' ASP . 12.8 tt -160.78 143.8 4.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.014 0.435 . . . . 0.0 110.137 176.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -114.85 -56.16 2.41 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.985 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.644 ' HG2' ' HB3' ' A' ' 41' ' ' ALA . 12.6 pt-20 -150.78 174.51 12.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 117.889 -1.053 . . . . 0.0 108.735 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.562 ' CB ' ' HA ' ' A' ' 40' ' ' TYR . 46.8 p90 -172.76 179.95 2.25 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 120.413 1.461 . . . . 0.0 113.51 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.624 ' CB ' ' HB3' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -161.39 154.67 21.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 113.558 -1.655 . . . . 0.0 108.704 174.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.827 HD12 HG22 ' A' ' 38' ' ' VAL . 20.4 mm -99.98 147.43 7.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.979 -173.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.519 ' HD3' ' HE1' ' A' ' 94' ' ' TYR . 3.6 mmmp? -102.06 106.52 17.43 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.833 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.662 ' OH ' HG12 ' A' ' 30' ' ' ILE . 17.2 t80 -86.84 101.07 13.01 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 174.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.853 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 17.5 tt0 -109.5 117.58 34.35 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.383 0.611 . . . . 0.0 110.534 -173.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.1 t -115.47 106.22 20.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.393 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.8 t 53.8 23.92 4.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.419 0.628 . . . . 0.0 110.869 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.49 5.4 48.75 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.927 -177.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.733 ' O ' ' HA ' ' A' ' 87' ' ' GLU . 19.8 tptp -99.24 150.91 21.6 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.9 m -126.28 141.39 51.93 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 122.27 1.033 . . . . 0.0 112.842 -174.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.492 ' HD2' ' CD2' ' A' ' 86' ' ' TYR . 29.4 m-85 -134.8 -174.63 3.65 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 113.286 -1.779 . . . . 0.0 106.791 167.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.519 ' HE1' ' HD3' ' A' ' 85' ' ' LYS . 61.9 m-85 -144.58 137.03 26.47 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -169.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -127.99 112.54 14.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.567 171.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.624 ' HB3' ' CB ' ' A' ' 83' ' ' TYR . 29.4 p-10 -139.31 -43.35 0.45 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.484 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.606 ' HB3' ' O ' ' A' ' 96' ' ' ASN . 4.0 p-10 159.82 -45.18 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 168.15 -65.06 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 65.8 m -158.97 51.18 0.38 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.398 174.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.55 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -137.36 -31.74 0.8 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.55 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 95.7 m-20 84.18 150.77 0.08 Allowed 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.836 0.71 . . . . 0.0 110.156 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 78.3 m-85 -69.68 101.33 1.64 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.242 177.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.06 124.88 28.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.908 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.6 HG21 HG12 ' A' ' 79' ' ' ILE . 15.6 t -94.97 147.24 5.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.015 0.436 . . . . 0.0 110.487 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.4 m -93.75 112.41 24.27 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.791 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.251 1.153 0 CA-C-O 119.264 -0.398 . . . . 0.0 111.001 -177.734 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo . . . . . 0 N--CA 1.461 -0.392 0 N-CA-C 111.052 -0.403 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.7 t 68.19 7.41 5.88 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.181 0.593 . . . . 0.0 111.664 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.6 m -113.92 -64.69 1.27 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 172.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -153.55 -167.32 2.65 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.546 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 5.0 m -84.4 -17.42 39.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.623 0.725 . . . . 0.0 109.17 173.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.64 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.5 p -148.97 153.57 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.287 -176.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -143.01 127.97 18.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.333 177.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.524 HD21 ' CD2' ' A' ' 14' ' ' TYR . 42.9 tp -69.39 137.8 53.09 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.968 0.413 . . . . 0.0 110.319 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.512 ' OD1' ' HE2' ' A' ' 24' ' ' LYS . 12.9 t70 -83.58 -61.78 1.75 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.366 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.2 p -178.86 164.13 1.47 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.735 -176.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.524 ' CD2' HD21 ' A' ' 11' ' ' LEU . 45.9 p90 -158.33 163.14 37.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.772 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -143.81 166.5 24.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.825 0.345 . . . . 0.0 111.287 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.713 ' HD1' ' HD1' ' A' ' 21' ' ' PHE . 8.1 t80 -129.45 141.86 50.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.446 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -150.63 97.87 2.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.079 -176.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.98 -98.26 0.35 Allowed Glycine 0 CA--C 1.508 -0.379 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -172.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -129.64 84.26 2.2 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 162.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 95.5 m -147.45 134.72 20.6 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.065 175.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.713 ' HD1' ' HD1' ' A' ' 16' ' ' TYR . 2.9 t80 -132.88 109.54 9.68 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.0 m -135.6 149.63 49.43 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.926 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 179.6 -167.93 38.11 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.564 ' HB3' HG22 ' A' ' 71' ' ' THR . 0.0 OUTLIER -150.99 160.83 43.68 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.046 0.451 . . . . 0.0 111.307 -179.046 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 17.6 mt -127.3 153.23 36.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.072 -170.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -124.97 111.85 15.89 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.64 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 0.9 OUTLIER -133.3 155.23 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.902 -176.021 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' A' ' 8' ' ' SER . 17.6 ptpt -93.49 152.19 19.23 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.029 175.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -94.92 102.17 13.99 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.756 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.557 HD13 ' HE2' ' A' ' 86' ' ' TYR . 3.8 mp -80.79 -44.52 21.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 172.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.494 ' HB3' ' CG2' ' A' ' 88' ' ' VAL . . . -132.64 159.95 38.09 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.461 -1.245 . . . . 0.0 107.65 174.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -85.26 -29.78 24.33 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.176 -0.466 . . . . 0.0 112.033 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 p -91.67 96.92 10.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.17 0.51 . . . . 0.0 110.274 176.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -111.78 171.09 7.7 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.442 -174.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.786 ' HG3' ' HB3' ' A' ' 87' ' ' GLU . 17.0 ptmt -155.73 103.95 2.3 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.0 0.905 . . . . 0.0 109.578 174.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.7 t -98.21 129.14 48.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-O 121.407 0.622 . . . . 0.0 109.979 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 1.081 ' HB ' HD11 ' A' ' 53' ' ' ILE . 1.2 p -137.52 134.91 36.23 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.764 -172.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 1.02 ' HB ' HG22 ' A' ' 54' ' ' ILE . 78.2 t -91.96 135.46 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.202 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.441 HG12 ' CZ3' ' A' ' 47' ' ' TRP . 0.1 OUTLIER -114.96 75.3 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 170.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.953 ' CD2' HG11 ' A' ' 38' ' ' VAL 0.256 0.1 OUTLIER -102.65 118.36 36.68 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 122.398 1.094 . . . . 0.0 111.081 -176.749 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.917 ' HA ' ' CZ2' ' A' ' 47' ' ' TRP . . . -76.36 146.0 39.08 Favored 'General case' 0 CA--C 1.497 -1.073 0 CA-C-N 113.719 -1.582 . . . . 0.0 112.357 -168.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -79.34 163.7 24.65 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.607 -172.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.813 ' HA2' ' HB2' ' A' ' 80' ' ' LYS . . . -73.17 41.71 0.92 Allowed Glycine 0 C--N 1.329 0.146 0 O-C-N 123.421 0.451 . . . . 0.0 113.694 -171.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.0 m -121.29 -16.58 7.88 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.952 0.405 . . . . 0.0 110.502 176.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.531 ' OD1' ' HG2' ' A' ' 80' ' ' LYS . 3.8 m-20 66.39 47.5 1.73 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.671 177.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.498 ' O ' ' HD1' ' A' ' 47' ' ' TRP . 12.3 t-20 -143.22 87.84 1.99 Allowed 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.837 -171.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.917 ' CZ2' ' HA ' ' A' ' 41' ' ' ALA . 2.4 m0 -124.0 92.73 3.73 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -170.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -101.71 71.53 1.32 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.79 173.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.3 t30 49.52 24.1 1.05 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.504 0.669 . . . . 0.0 111.469 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -69.19 -36.76 77.65 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 173.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 57.97 70.22 1.05 Allowed Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 114.171 -1.377 . . . . 0.0 114.008 168.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.733 ' HB2' ' HZ2' ' A' ' 47' ' ' TRP . 38.2 m-80 -64.83 108.1 1.66 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 174.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 1.081 HD11 ' HB ' ' A' ' 37' ' ' THR . 5.4 tp -107.68 152.51 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 121.56 0.695 . . . . 0.0 112.031 -169.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 1.02 HG22 ' HB ' ' A' ' 38' ' ' VAL . 13.0 tt -142.29 140.5 29.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.031 167.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.45 130.14 35.26 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.723 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.06 153.72 36.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.667 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -105.2 130.66 53.3 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.431 0.634 . . . . 0.0 110.287 -176.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.449 ' H ' ' HD1' ' A' ' 58' ' ' PHE . 1.5 m-85 -71.21 143.16 50.55 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.389 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.0 m -114.65 -37.97 4.12 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 171.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.6 -178.25 17.99 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.773 172.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.02 138.62 78.92 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.461 2.107 . . . . 0.0 111.305 175.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.957 HG12 ' HB2' ' A' ' 69' ' ' TYR . 10.6 mt -81.78 126.56 39.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.63 -174.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.3 m -64.09 117.11 6.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.97 0.414 . . . . 0.0 109.989 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.0 -17.26 32.38 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.657 -176.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.433 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 19.8 m -128.05 173.23 10.23 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -107.56 4.9 26.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.273 0.559 . . . . 0.0 110.429 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.439 ' CE1' ' HB2' ' A' ' 28' ' ' LYS . 20.7 m-85 -100.79 -178.56 3.81 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.329 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' A' ' 69' ' ' TYR . 22.1 tt0 -113.54 170.69 8.06 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.54 -170.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.957 ' HB2' HG12 ' A' ' 62' ' ' ILE . 4.1 t80 -138.53 126.37 22.36 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -162.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.572 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 5.8 m95 -126.54 135.81 51.76 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.013 -170.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.564 HG22 ' HB3' ' A' ' 24' ' ' LYS . 20.8 p -135.88 153.77 51.36 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -178.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -158.85 164.15 35.98 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.875 0.845 . . . . 0.0 112.153 171.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 p -142.15 139.52 32.15 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.38 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.89 133.57 17.81 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -173.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.6 t -82.04 100.34 9.68 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 168.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.7 m -92.05 151.11 3.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.284 0.564 . . . . 0.0 110.574 -176.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -98.94 37.59 1.5 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.796 -177.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.63 116.26 3.96 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.551 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.848 HD11 ' HB2' ' A' ' 40' ' ' TYR . 4.2 tt -126.63 152.86 34.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.099 0.476 . . . . 0.0 110.494 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.813 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 17.6 tppt? -131.72 -42.46 1.02 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.22 -174.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 11.3 pt-20 -156.29 172.02 19.2 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-O 118.482 -0.77 . . . . 0.0 109.512 -176.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.75 ' HB3' ' HA ' ' A' ' 40' ' ' TYR . 55.4 p90 -173.01 178.15 2.59 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.427 ' O ' HG23 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -155.4 137.11 14.31 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 113.478 -1.692 . . . . 0.0 107.71 164.219 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.807 HD12 HG22 ' A' ' 38' ' ' VAL . 22.8 mm -91.1 137.31 22.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 O-C-N 121.637 -0.665 . . . . 0.0 109.86 -175.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.41 ' HG2' ' CD1' ' A' ' 94' ' ' TYR . 41.0 mtmt -92.97 129.49 38.87 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 122.048 0.928 . . . . 0.0 111.318 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.7 ' HD2' ' HD2' ' A' ' 93' ' ' TYR . 20.5 t80 -98.65 99.61 10.75 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 113.517 -1.674 . . . . 0.0 107.548 168.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.786 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . 4.2 tt0 -117.13 135.46 53.74 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -176.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.557 ' C ' ' H ' ' A' ' 90' ' ' GLY . 0.4 OUTLIER -146.72 162.61 8.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -178.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.1 t -72.39 32.71 0.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 122.066 0.936 . . . . 0.0 110.769 -174.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -147.28 -53.43 0.02 OUTLIER Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 114.638 -1.165 . . . . 0.0 111.34 175.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.493 ' H ' HG13 ' A' ' 88' ' ' VAL . 29.2 mmtp -132.01 -175.83 3.86 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.904 0.859 . . . . 0.0 113.158 -176.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.507 HG23 ' HG3' ' A' ' 87' ' ' GLU . 7.1 m -151.5 141.96 22.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.209 -1.36 . . . . 0.0 110.481 175.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.7 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 18.1 m-85 -145.16 -170.65 3.48 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.41 ' CD1' ' HG2' ' A' ' 85' ' ' LYS . 79.4 m-85 -149.11 127.17 11.97 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.235 0.334 . . . . 0.0 111.526 -173.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -80.51 79.05 7.18 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 167.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -118.55 -70.05 0.81 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.065 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 100' ' ' ALA . 0.7 OUTLIER 148.35 -53.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 -172.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.9 t30 175.82 -56.26 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.225 -1.807 . . . . 0.0 106.993 174.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.5 p -156.73 43.63 0.38 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.501 173.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -106.9 -53.37 2.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.788 -172.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 5.9 m-20 72.19 128.73 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.56 0.537 . . . . 0.0 110.079 -175.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 96.6 m-85 -74.27 118.68 17.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.239 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.83 124.52 28.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.998 0.428 . . . . 0.0 110.501 177.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.47 HG21 HD13 ' A' ' 79' ' ' ILE . 41.6 t -79.71 144.16 11.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 173.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.4 t -84.81 65.74 9.29 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.222 0.534 . . . . 0.0 110.66 -172.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.482 -0.77 . . . . 0.0 110.769 178.377 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.551 ' HB3' ' HE1' ' A' ' 67' ' ' TYR . 58.6 Cg_endo . . . . . 0 N--CA 1.463 -0.301 0 N-CA-C 111.072 -0.395 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.5 t -150.85 -55.89 0.16 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.796 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.3 m -69.18 -77.7 0.08 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -175.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.33 -165.2 2.21 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 122.251 -0.281 . . . . 0.0 110.605 -177.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.542 ' HA ' ' HE2' ' A' ' 28' ' ' LYS . 14.6 m -69.39 -18.16 63.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.374 0.607 . . . . 0.0 110.334 176.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.605 HG11 ' HB2' ' A' ' 86' ' ' TYR . 2.8 p -149.68 147.33 16.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -143.99 143.76 31.36 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.753 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.546 HD11 ' HD2' ' A' ' 14' ' ' TYR . 3.8 tp -69.49 132.99 47.17 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.908 0.385 . . . . 0.0 110.685 172.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.63 -64.94 1.08 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 169.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.4 m -166.45 153.19 9.14 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.993 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.546 ' HD2' HD11 ' A' ' 11' ' ' LEU . 20.3 p90 -142.34 157.82 44.39 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 173.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -119.56 157.44 28.37 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.794 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.686 ' HA ' ' O ' ' A' ' 20' ' ' THR . 50.3 t80 -137.92 146.6 43.47 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 172.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -179.25 114.94 0.06 Allowed 'General case' 0 C--N 1.315 -0.924 0 O-C-N 123.683 0.615 . . . . 0.0 109.733 -174.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.73 -103.36 0.31 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -168.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.651 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 24.8 m -124.3 88.47 2.91 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 165.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.686 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 89.4 m -143.6 135.64 26.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.638 176.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.533 ' HZ ' HG11 ' A' ' 38' ' ' VAL . 11.4 t80 -134.01 145.02 49.07 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 120.732 0.301 . . . . 0.0 110.596 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.491 ' HA ' ' HB2' ' A' ' 14' ' ' TYR . 48.1 m 94.6 178.4 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 164.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -171.98 -78.61 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.573 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.607 ' HB3' HG22 ' A' ' 71' ' ' THR . 0.4 OUTLIER -166.55 169.02 14.13 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.977 0.418 . . . . 0.0 111.406 176.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 53.4 mt -132.07 154.0 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.577 -170.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -116.13 105.82 13.03 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -178.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 p -125.91 145.17 33.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 O-C-N 121.772 -0.58 . . . . 0.0 112.56 -165.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.542 ' HE2' ' HA ' ' A' ' 8' ' ' SER . 16.3 ttmm -86.41 151.75 23.28 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -101.97 117.63 35.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.415 0.626 . . . . 0.0 111.126 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.614 HG12 ' OH ' ' A' ' 86' ' ' TYR . 28.2 mm -88.24 -48.61 14.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.38 -154.03 0.61 Allowed 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 171.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -104.69 -48.72 3.71 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.25 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.1 m -74.41 80.01 1.9 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.033 176.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.611 ' HE2' ' CZ2' ' A' ' 70' ' ' TRP . 30.3 mtmm -103.74 157.59 16.97 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.597 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 24.9 mtpp -127.66 123.74 36.29 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.06 0.457 . . . . 0.0 109.889 176.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.7 t -117.13 125.53 73.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 1.008 ' HB ' HD11 ' A' ' 53' ' ' ILE . 0.8 OUTLIER -138.64 129.44 26.48 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.014 -169.619 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.904 ' HB ' HG22 ' A' ' 54' ' ' ILE . 7.1 t -95.53 124.09 47.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.518 0.675 . . . . 0.0 110.742 -178.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.61 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -102.97 108.4 24.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 114.482 -1.236 . . . . 0.0 107.842 177.091 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.681 ' HB2' HG13 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -101.71 147.97 25.83 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-O 122.688 1.232 . . . . 0.0 112.448 174.454 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.787 ' HB3' ' HG2' ' A' ' 81' ' ' GLU . . . -86.07 93.98 9.13 Favored 'General case' 0 N--CA 1.407 -2.577 0 CA-C-N 113.431 -1.713 . . . . 0.0 106.382 165.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.458 ' CG ' ' H ' ' A' ' 43' ' ' GLY . 12.0 t70 -54.53 -163.79 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 111.441 -2.618 . . . . 0.0 112.778 -172.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.458 ' H ' ' CG ' ' A' ' 42' ' ' ASP . . . -58.1 -15.7 22.97 Favored Glycine 0 C--N 1.333 0.361 0 N-CA-C 111.981 -0.448 . . . . 0.0 111.981 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.5 t -58.98 -26.06 64.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 122.408 0.283 . . . . 0.0 110.357 173.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.8 t0 70.21 14.97 7.59 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-O 122.155 0.979 . . . . 0.0 109.243 174.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -159.89 152.49 21.22 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.737 -169.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.499 ' CE3' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -95.82 95.39 8.25 Favored 'General case' 0 N--CA 1.419 -2.009 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.217 173.041 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.63 ' OD1' ' HB2' ' A' ' 50' ' ' ASN . 5.1 p30 -82.97 22.61 0.92 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.498 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 51.19 65.88 1.35 Allowed 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.321 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.63 ' HB2' ' OD1' ' A' ' 48' ' ' ASN . 14.2 t30 -115.66 -61.75 1.69 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.874 -172.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.37 74.9 0.12 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -175.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.66 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 65.9 m-20 -117.34 83.91 2.06 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -175.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 1.008 HD11 ' HB ' ' A' ' 37' ' ' THR . 8.0 tp -119.38 149.93 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-O 121.446 0.641 . . . . 0.0 112.344 -171.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.904 HG22 ' HB ' ' A' ' 38' ' ' VAL . 8.5 tp -128.0 137.62 57.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 169.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.93 140.88 32.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.228 0.537 . . . . 0.0 111.773 -175.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.467 ' HA ' ' HB3' ' A' ' 72' ' ' PHE . . . -94.57 146.62 23.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.552 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.2 p -109.43 148.41 31.19 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -71.7 141.77 49.84 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -176.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.563 ' C ' ' HD2' ' A' ' 61' ' ' PRO . 23.0 t -114.95 -45.2 2.98 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.428 ' N ' ' HD2' ' A' ' 61' ' ' PRO . . . 116.6 -68.31 0.29 Allowed Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.924 -0.931 . . . . 0.0 114.594 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.563 ' HD2' ' C ' ' A' ' 59' ' ' SER . 13.9 Cg_exo -12.71 -42.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.384 1 C-N-CA 128.244 5.963 . . . . 0.0 120.362 -166.168 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.754 HG13 ' HB2' ' A' ' 69' ' ' TYR . 7.2 mt -71.08 88.34 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 119.353 0.979 . . . . 0.0 110.441 -177.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.6 t -114.32 163.56 15.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.494 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.13 21.66 78.77 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.6 m -155.68 174.16 15.68 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -92.32 32.38 1.19 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.068 0.461 . . . . 0.0 110.372 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.551 ' HE1' ' HB3' ' A' ' 4' ' ' PRO . 6.4 m-85 -129.76 -179.33 5.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.207 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -153.4 151.77 30.29 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.303 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.754 ' HB2' HG13 ' A' ' 62' ' ' ILE . 3.2 t80 -104.54 128.93 52.63 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -174.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.611 ' CZ2' ' HE2' ' A' ' 34' ' ' LYS . 15.6 m0 -124.38 151.21 44.68 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.607 HG22 ' HB3' ' A' ' 24' ' ' LYS . 7.7 p -129.94 147.3 51.68 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 -178.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.467 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -160.79 142.35 12.12 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.549 177.621 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 42.1 m -124.85 146.49 49.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.375 176.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.15 112.99 9.03 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -174.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.9 t -78.5 100.47 6.9 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 169.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.651 ' O ' ' HB3' ' A' ' 19' ' ' SER . 30.0 m -103.83 156.44 5.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.397 -177.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.811 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -102.9 -7.42 21.53 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.551 174.67 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 172.6 142.09 3.67 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.615 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.681 HG13 ' HB2' ' A' ' 40' ' ' TYR . 6.0 tt -160.26 142.14 4.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 177.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -121.87 -46.79 2.21 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.594 -174.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.787 ' HG2' ' HB3' ' A' ' 41' ' ' ALA . 9.8 pt-20 -152.51 162.22 41.5 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -176.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.61 ' HB2' ' O ' ' A' ' 39' ' ' VAL . 42.5 p90 -170.79 173.62 5.21 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.7 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.424 ' O ' HG23 ' A' ' 39' ' ' VAL . 0.1 OUTLIER -155.69 153.78 30.51 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 172.524 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.408 HG22 ' N ' ' A' ' 85' ' ' LYS . 2.5 mt -92.6 151.91 3.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.562 0.696 . . . . 0.0 112.219 -170.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.408 ' N ' HG22 ' A' ' 84' ' ' ILE . 18.8 mmtp -107.46 114.09 27.87 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.341 176.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.797 ' HD2' ' HD2' ' A' ' 93' ' ' TYR . 14.9 t80 -91.59 101.29 13.93 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 174.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 23.2 tt0 -105.83 111.17 23.73 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.47 0.652 . . . . 0.0 109.693 -172.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.617 ' HB ' ' H ' ' A' ' 91' ' ' LYS . 14.6 t -108.94 159.84 8.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.211 -176.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.9 t -79.3 33.67 0.24 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 122.002 0.906 . . . . 0.0 109.046 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -164.23 -47.43 0.02 OUTLIER Glycine 0 N--CA 1.436 -1.338 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.805 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.617 ' H ' ' HB ' ' A' ' 88' ' ' VAL . 30.5 mmmt -127.0 -173.87 3.0 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.926 0.869 . . . . 0.0 112.284 -176.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.9 m -150.79 140.79 22.02 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.167 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.797 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 48.5 m-85 -144.43 -166.07 2.29 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -144.26 160.32 41.19 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.75 0.31 . . . . 0.0 111.029 -174.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.463 ' HB2' HG13 ' A' ' 9' ' ' VAL . 25.8 t70 -126.24 115.93 20.5 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 162.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -146.95 -66.89 0.27 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.039 -170.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 155.53 -56.91 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -173.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 50.0 t30 176.14 -48.95 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 112.871 -1.968 . . . . 0.0 106.614 176.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.6 t -170.84 64.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.586 170.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -126.38 -44.85 1.69 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.49 -173.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 91.1 m-20 70.9 144.63 0.06 Allowed 'General case' 0 N--CA 1.471 0.602 0 O-C-N 123.677 0.61 . . . . 0.0 110.597 -175.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.539 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 98.3 m-85 -79.95 111.27 16.12 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.759 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.617 HE21 ' N ' ' A' ' 103' ' ' GLN . 0.0 OUTLIER -79.87 110.69 15.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.094 178.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.424 HG21 HD13 ' A' ' 79' ' ' ILE . 25.3 t -79.76 142.12 14.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.205 -177.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.8 t -90.96 106.3 18.42 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -176.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.667 -0.683 . . . . 0.0 110.87 -174.94 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo . . . . . 0 C--O 1.233 0.26 0 CA-C-O 120.884 0.285 . . . . 0.0 112.231 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.9 t -130.69 -67.21 0.73 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.328 -0.397 . . . . 0.0 109.999 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.7 t -88.57 -68.96 0.73 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.231 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.49 -159.05 0.93 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.57 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.1 m -62.98 -32.68 74.07 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.553 0.692 . . . . 0.0 109.622 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.868 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.3 p -115.95 150.42 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.574 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.455 ' O ' ' HB3' ' A' ' 26' ' ' TYR . 9.3 tt0 -145.66 125.24 13.25 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.988 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.543 HD21 ' CD2' ' A' ' 14' ' ' TYR . 15.4 tp -68.18 131.66 45.79 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.209 0.528 . . . . 0.0 110.856 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.416 ' OD1' ' HE2' ' A' ' 24' ' ' LYS . 16.0 t70 -81.14 -61.83 1.84 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.853 176.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.6 p -175.95 160.03 2.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.938 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.543 ' CD2' HD21 ' A' ' 11' ' ' LEU . 12.7 p90 -152.04 161.39 42.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.808 177.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -129.29 165.3 21.7 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.734 0.302 . . . . 0.0 110.681 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.601 ' HD1' ' HD1' ' A' ' 21' ' ' PHE . 51.7 t80 -145.6 153.08 40.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.142 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -177.63 129.23 0.15 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.12 -102.56 0.36 Allowed Glycine 0 C--N 1.331 0.275 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -173.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.2 m -136.83 85.66 2.15 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 163.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.56 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 6.5 m -144.8 131.05 19.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.354 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.601 ' HD1' ' HD1' ' A' ' 16' ' ' TYR . 1.4 t80 -133.44 102.47 5.54 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.689 0.757 . . . . 0.0 109.302 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.6 m -134.65 160.08 39.23 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.809 -174.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.28 -143.32 8.66 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.447 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.563 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -162.56 159.96 25.39 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.093 0.473 . . . . 0.0 110.966 178.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.463 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 20.9 mt -122.25 155.53 27.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.179 -173.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.455 ' HB3' ' O ' ' A' ' 10' ' ' GLN . 7.5 t80 -129.05 101.56 6.1 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -172.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.868 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 2.0 m -135.35 145.65 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 O-C-N 121.493 -0.754 . . . . 0.0 112.52 -171.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 67' ' ' TYR . 40.1 ttmt -68.43 133.41 48.6 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.186 177.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.524 ' HB3' ' HB2' ' A' ' 68' ' ' GLU . 24.1 p-10 -95.18 84.51 4.09 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.752 0.787 . . . . 0.0 110.544 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.5 mp -63.72 -47.74 89.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 175.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.44 -176.12 2.83 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.697 171.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -109.99 -55.82 2.4 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.465 -177.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.8 m -75.8 73.58 2.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.379 0.609 . . . . 0.0 110.43 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.405 ' HE2' ' CZ2' ' A' ' 70' ' ' TRP . 28.9 mtmm -102.75 -171.63 1.99 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.761 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -151.63 144.4 24.37 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.9 t -125.53 120.24 57.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.524 0.678 . . . . 0.0 110.552 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.64 ' HB ' HG13 ' A' ' 53' ' ' ILE . 2.1 p -116.17 110.34 18.69 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.261 -176.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 1.058 ' HB ' HG22 ' A' ' 54' ' ' ILE . 81.0 t -83.28 108.35 15.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.78 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.672 HG12 ' HB ' ' A' ' 53' ' ' ILE . 26.5 m -108.77 121.19 61.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.226 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.419 ' HB2' HG13 ' A' ' 79' ' ' ILE . 7.6 p90 -118.39 148.59 42.37 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.631 0.729 . . . . 0.0 111.7 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.727 ' HB3' ' HG2' ' A' ' 81' ' ' GLU . . . -81.59 83.87 6.92 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 171.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -48.59 -166.47 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 111.337 -2.665 . . . . 0.0 113.932 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.2 -21.17 46.07 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-N 116.259 -0.428 . . . . 0.0 113.062 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -65.91 -19.86 66.02 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.654 -0.321 . . . . 0.0 110.526 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.2 t70 72.85 21.98 3.21 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.444 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -168.3 148.96 4.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.493 -175.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.437 ' CZ3' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -87.81 83.74 7.1 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 173.654 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' A' ' 50' ' ' ASN . 6.4 t-20 -78.11 55.49 1.49 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.2 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.0 t30 69.04 -26.77 0.15 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.204 0.601 . . . . 0.0 110.865 -176.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.542 ' H ' ' C ' ' A' ' 48' ' ' ASN . 4.6 p30 -62.14 -43.17 99.43 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.374 174.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 49.97 62.5 4.92 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -176.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 28.8 m-80 -41.78 106.76 0.06 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.882 0.873 . . . . 0.0 111.982 -174.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.672 ' HB ' HG12 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -117.3 138.48 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.833 0.825 . . . . 0.0 112.658 -171.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 1.058 HG22 ' HB ' ' A' ' 38' ' ' VAL . 5.2 tp -111.37 133.99 55.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 168.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.61 113.24 22.34 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.263 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.84 154.47 29.79 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -130.48 130.83 44.71 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.74 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 38.0 p90 -78.27 137.66 38.21 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.902 0.858 . . . . 0.0 111.013 -178.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.9 t -87.1 -26.77 23.49 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.276 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.88 168.91 18.87 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.508 172.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.554 ' HA ' ' HA ' ' A' ' 68' ' ' GLU . 26.1 Cg_exo -63.39 141.87 83.01 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.676 2.251 . . . . 0.0 111.42 174.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.49 HG12 ' HB2' ' A' ' 69' ' ' TYR . 21.8 mt -84.62 109.25 17.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.337 -177.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.6 m -63.11 126.18 26.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.869 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.34 -7.28 34.58 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.166 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.7 m -151.26 165.47 33.9 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -92.71 52.58 1.89 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.953 0.882 . . . . 0.0 109.124 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 4.0 m-85 -130.21 169.24 15.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.536 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 61' ' ' PRO . 9.0 tt0 -125.2 171.54 10.25 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.585 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.49 ' HB2' HG12 ' A' ' 62' ' ' ILE . 3.1 t80 -138.86 111.15 7.43 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -163.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.74 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 11.8 m95 -112.57 130.47 56.01 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.985 -168.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 p -120.26 144.27 47.86 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -155.34 155.9 34.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.848 0.832 . . . . 0.0 112.549 177.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.6 p -142.51 142.46 32.26 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.011 174.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.512 ' HB2' HG12 ' A' ' 54' ' ' ILE . . . -152.68 138.76 18.22 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -175.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 31.3 t -90.58 101.23 13.97 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 166.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.0 m -89.66 160.48 2.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.42 -171.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.55 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -90.37 29.72 1.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.638 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.29 146.23 13.35 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -170.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.419 HG13 ' HB2' ' A' ' 40' ' ' TYR . 2.8 tt -143.28 126.81 13.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.775 0.798 . . . . 0.0 111.409 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 103' ' ' GLN . 28.0 mmtp -93.5 -41.45 9.77 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.22 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.727 ' HG2' ' HB3' ' A' ' 41' ' ' ALA . 13.8 pt-20 -160.68 168.27 25.22 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -169.39 172.76 6.95 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.657 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.472 ' HD2' ' HB3' ' A' ' 96' ' ' ASN . 0.1 OUTLIER -164.72 150.04 9.89 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.573 -1.194 . . . . 0.0 107.854 175.116 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.946 HD12 HG22 ' A' ' 38' ' ' VAL . 9.6 mm -93.3 136.29 25.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.017 -172.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.809 ' HD2' ' HE1' ' A' ' 94' ' ' TYR . 15.6 mmmt -94.4 104.95 16.92 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.602 ' CD2' ' HD2' ' A' ' 93' ' ' TYR . 23.9 t80 -86.76 102.14 13.98 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.338 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -114.42 123.15 48.73 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.638 0.732 . . . . 0.0 109.952 -173.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.506 ' C ' ' H ' ' A' ' 90' ' ' GLY . 9.4 t -112.76 163.79 9.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 t -72.25 20.79 0.06 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.197 0.523 . . . . 0.0 111.082 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -162.85 -40.88 0.02 OUTLIER Glycine 0 N--CA 1.438 -1.232 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.891 178.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.402 ' H ' ' HB ' ' A' ' 88' ' ' VAL . 19.6 tptm -117.35 167.6 11.1 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -174.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.1 m -146.05 145.5 30.6 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.602 ' HD2' ' CD2' ' A' ' 86' ' ' TYR . 60.9 m-85 -142.58 -168.28 2.71 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 175.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.809 ' HE1' ' HD2' ' A' ' 85' ' ' LYS . 21.5 m-85 -146.42 140.39 26.26 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.551 -173.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -110.12 96.24 6.1 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.557 ' O ' ' HB2' ' A' ' 97' ' ' ASN . 27.0 p-10 -137.55 39.17 2.44 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.763 -174.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.557 ' HB2' ' O ' ' A' ' 96' ' ' ASN . 21.8 m-80 70.95 -62.88 0.44 Allowed 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.737 0.648 . . . . 0.0 109.907 -169.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -177.67 -55.78 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 52.8 m -157.02 59.58 0.52 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.448 170.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.611 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -137.86 -49.16 0.57 Allowed 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -170.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.611 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 12.9 m-20 74.14 143.22 0.07 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -169.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.678 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 3.4 m-85 -91.46 97.29 10.98 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -76.95 110.82 11.88 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.427 HG11 ' HE1' ' A' ' 21' ' ' PHE . 22.0 t -79.71 148.84 5.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.742 -167.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.5 m -86.85 81.35 8.18 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.211 176.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.516 HG22 ' CZ ' ' A' ' 16' ' ' TYR . 0.6 OUTLIER . . . . . 0 C--O 1.254 1.302 0 CA-C-O 118.495 -0.764 . . . . 0.0 111.13 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--O 1.237 0.458 0 CA-C-O 121.234 0.431 . . . . 0.0 111.886 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.5 t -95.67 -64.03 1.1 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.643 -174.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.0 t -81.95 -49.74 9.94 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.44 151.33 46.61 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.224 178.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.429 ' HB3' HD11 ' A' ' 30' ' ' ILE . 17.0 m -93.36 -7.79 43.75 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.649 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.78 HG23 HG12 ' A' ' 27' ' ' VAL . 1.7 p -148.44 151.74 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.321 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -142.96 151.67 41.16 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.488 HD11 ' HD2' ' A' ' 14' ' ' TYR . 2.5 tp -77.37 142.59 39.24 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.459 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 31.7 t70 -93.1 -64.54 1.08 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 175.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.906 ' HB2' ' HE3' ' A' ' 24' ' ' LYS . 41.4 m -166.75 155.54 10.48 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.259 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.488 ' HD2' HD11 ' A' ' 11' ' ' LEU . 18.6 p90 -157.17 150.97 24.44 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.635 177.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -130.33 157.54 42.26 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.661 ' HA ' ' O ' ' A' ' 20' ' ' THR . 4.3 m-85 -137.53 153.78 49.94 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.702 -175.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -137.98 75.84 1.55 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.52 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.76 -84.29 0.67 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -171.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.1 m -132.41 86.01 2.29 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.57 0.7 . . . . 0.0 109.414 163.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.661 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 26.1 m -146.79 126.02 13.01 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 170.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 1.005 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 36.7 t80 -107.2 133.48 51.72 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.436 0.636 . . . . 0.0 110.078 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.2 p -153.65 151.26 29.48 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.832 173.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.414 ' C ' ' HD3' ' A' ' 24' ' ' LYS . . . 159.08 -151.33 22.23 Favored Glycine 0 CA--C 1.506 -0.522 0 C-N-CA 119.09 -1.528 . . . . 0.0 113.391 -178.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.906 ' HE3' ' HB2' ' A' ' 13' ' ' SER . 0.2 OUTLIER -166.34 168.83 14.68 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.745 0.418 . . . . 0.0 110.409 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.523 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 17.0 mt -131.61 160.76 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.732 -172.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.458 ' N ' HG22 ' A' ' 25' ' ' ILE . 4.0 t80 -130.59 98.56 4.7 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.349 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.78 HG12 HG23 ' A' ' 9' ' ' VAL . 0.7 OUTLIER -118.56 156.7 20.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.956 -176.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -94.72 141.68 28.34 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.424 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.719 HD21 ' HB2' ' A' ' 68' ' ' GLU . 46.1 m-80 -89.79 101.02 13.72 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.823 0.344 . . . . 0.0 111.561 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.547 HD13 ' HE2' ' A' ' 86' ' ' TYR . 4.1 mp -88.64 -34.5 7.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 173.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.422 ' HB3' ' CG1' ' A' ' 88' ' ' VAL . . . -139.95 -178.96 5.68 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.874 174.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -109.86 -15.52 14.08 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.474 -173.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.8 m -100.0 85.55 3.07 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.4 mtmt -110.36 153.61 24.69 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.721 -174.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.593 ' CG ' ' HB3' ' A' ' 87' ' ' GLU . 18.4 ptpt -130.84 129.52 42.44 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 166.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.5 t -119.55 115.75 48.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-O 121.74 0.781 . . . . 0.0 109.604 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.744 ' HB ' HG13 ' A' ' 53' ' ' ILE . 11.0 p -131.91 114.0 14.13 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.449 -170.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.734 HG22 HD12 ' A' ' 84' ' ' ILE . 54.6 t -79.66 125.43 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.467 HG12 ' HB ' ' A' ' 53' ' ' ILE . 29.9 m -122.06 120.89 62.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.894 -176.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.652 ' HB3' ' HB3' ' A' ' 82' ' ' PHE . 9.9 p90 -125.97 148.29 49.29 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.399 -171.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.863 ' HB2' ' CZ2' ' A' ' 47' ' ' TRP . . . -72.18 97.56 1.98 Allowed 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 170.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.468 ' HA ' ' HE1' ' A' ' 40' ' ' TYR . 0.9 OUTLIER -48.84 -178.55 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.469 -1.696 . . . . 0.0 112.119 171.232 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.36 -22.89 52.35 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.956 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.1 t -85.94 -15.76 40.59 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 122.274 0.23 . . . . 0.0 111.441 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.657 ' HA ' ' HB1' ' A' ' 41' ' ' ALA . 3.7 m-20 68.42 30.25 5.43 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.535 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -106.7 99.09 8.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.335 -173.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.863 ' CZ2' ' HB2' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -90.92 110.64 21.88 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 168.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -66.8 -139.84 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 170.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -55.3 -45.83 76.25 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 158.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -138.08 -59.06 0.65 Allowed 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 113.343 -1.753 . . . . 0.0 108.435 159.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.27 -50.88 4.4 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.158 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.419 ' H ' ' ND2' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -123.39 105.57 9.93 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.348 0.594 . . . . 0.0 110.729 -177.355 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.744 HG13 ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -138.4 141.72 36.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.886 -174.062 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.723 HG22 ' HB ' ' A' ' 38' ' ' VAL . 9.4 tp -115.43 118.37 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.24 136.16 37.72 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.529 -177.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.47 ' HA ' ' CE1' ' A' ' 72' ' ' PHE . . . -78.02 150.93 33.77 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.653 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -108.07 131.54 54.49 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -70.9 137.92 49.7 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.265 0.555 . . . . 0.0 110.377 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.2 t -106.57 -43.18 4.8 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 146.49 165.42 11.57 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.5 173.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.5 135.69 62.6 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.217 1.944 . . . . 0.0 110.795 175.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.58 HD12 ' HB2' ' A' ' 67' ' ' TYR . 55.5 mt -68.29 108.86 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.8 m -52.46 117.78 3.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.224 -171.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.65 2.58 49.9 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.423 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.583 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 63.6 m -146.84 170.75 16.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.226 0.536 . . . . 0.0 111.318 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -96.12 19.79 11.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.344 1.069 . . . . 0.0 109.459 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.583 ' CD2' ' HB3' ' A' ' 65' ' ' SER . 14.2 m-85 -100.24 157.22 16.75 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.402 178.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.719 ' HB2' HD21 ' A' ' 29' ' ' ASN . 13.2 tt0 -126.03 168.64 13.68 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.571 -175.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -130.11 125.69 35.75 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -167.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.575 ' NE1' HG13 ' A' ' 27' ' ' VAL . 5.9 m95 -127.59 126.43 42.07 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -172.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 p -110.49 152.43 26.36 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 117.909 0.322 . . . . 0.0 111.825 -172.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.544 ' CD2' ' HE1' ' A' ' 21' ' ' PHE . 10.5 m-85 -128.52 152.84 47.81 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 -175.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.7 m -163.18 121.84 2.05 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 111.525 -2.58 . . . . 0.0 107.381 165.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 1.005 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -149.2 132.54 16.54 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.679 -167.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.8 t -98.56 99.25 10.37 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 169.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.2 m -89.82 144.35 9.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.211 0.529 . . . . 0.0 110.809 -172.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -89.19 32.45 0.83 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.835 -173.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.66 142.13 12.87 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -176.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.42 HD11 ' CD2' ' A' ' 82' ' ' PHE . 7.8 tt -153.68 144.13 14.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.379 0.609 . . . . 0.0 111.693 -175.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -104.64 -53.5 2.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.109 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.77 ' HB2' ' HA ' ' A' ' 102' ' ' TYR . 12.8 pt-20 -156.54 161.37 39.99 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.448 -175.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.895 ' HE1' ' HA ' ' A' ' 101' ' ' ASN . 0.1 OUTLIER -145.15 168.0 21.41 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 119.362 0.983 . . . . 0.0 112.594 177.517 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.482 ' HB3' ' HE1' ' A' ' 102' ' ' TYR . 0.3 OUTLIER -152.23 158.42 42.81 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 165.073 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.734 HD12 HG22 ' A' ' 38' ' ' VAL . 5.1 mm -101.12 145.58 11.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 119.359 -0.936 . . . . 0.0 112.194 -165.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 37' ' ' THR . 13.9 mmmt -102.93 108.38 19.54 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.223 -178.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.547 ' HE2' HD13 ' A' ' 30' ' ' ILE . 13.4 t80 -99.34 99.75 10.73 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 173.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.593 ' HB3' ' CG ' ' A' ' 35' ' ' LYS . 28.5 tt0 -116.51 131.04 57.05 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.962 -175.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.422 ' CG1' ' HB3' ' A' ' 31' ' ' ALA . 2.8 t -121.37 165.59 16.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.007 -171.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.41 ' H ' HG12 ' A' ' 88' ' ' VAL . 1.5 p -46.99 -37.43 9.11 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -126.83 -18.34 2.16 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.514 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -118.52 167.11 11.91 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 117.488 0.644 . . . . 0.0 110.465 -174.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.4 m -148.76 145.88 27.8 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 172.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.513 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 37.5 m-85 -136.19 -177.85 4.89 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 174.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.429 ' CE1' ' HD2' ' A' ' 85' ' ' LYS . 71.0 m-85 -150.4 126.97 10.85 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.625 -173.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -131.29 143.92 50.89 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.099 0.475 . . . . 0.0 111.038 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -127.34 10.54 6.8 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 62.89 -75.16 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.902 -173.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.0 t30 173.38 -62.15 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.6 m -139.6 19.77 2.53 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.192 173.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.44 -36.2 15.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.644 0.735 . . . . 0.0 109.617 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.895 ' HA ' ' HE1' ' A' ' 82' ' ' PHE . 15.6 m120 -91.66 178.81 5.82 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.248 173.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.77 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 2.6 m-85 73.02 -111.48 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 124.495 1.122 . . . . 0.0 110.614 -173.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.26 106.79 0.26 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.03 0.919 . . . . 0.0 112.471 -171.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.449 HG12 HG22 ' A' ' 106' ' ' THR . 97.4 t -79.95 114.05 20.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.016 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.4 m -92.01 104.67 17.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.449 HG22 HG12 ' A' ' 104' ' ' VAL . 9.6 t . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.688 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo . . . . . 0 N--CA 1.452 -0.935 0 CA-C-O 120.842 0.268 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.1 t -150.69 -71.41 0.17 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.885 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.6 m -124.61 -44.82 1.95 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.081 0.467 . . . . 0.0 110.538 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.5 136.25 33.02 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.477 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.7 m -81.85 -16.94 49.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.832 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.702 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.7 p -144.91 149.81 16.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.704 -176.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -143.36 131.29 21.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.024 177.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.663 HD13 HD11 ' A' ' 84' ' ' ILE . 51.4 tp -69.55 132.54 46.42 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.393 0.616 . . . . 0.0 110.216 175.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -80.24 -61.04 2.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.38 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.1 p -177.58 162.24 1.79 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.202 -174.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.579 ' CD2' HD21 ' A' ' 11' ' ' LEU . 47.7 p90 -158.16 163.41 37.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.849 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -148.73 162.03 40.59 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.217 0.532 . . . . 0.0 110.254 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.582 ' HD1' ' HD1' ' A' ' 21' ' ' PHE . 30.2 t80 -124.59 142.9 51.02 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.736 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -161.2 124.12 3.18 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.64 -103.96 0.43 Allowed Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -169.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.1 t -137.75 82.65 1.93 Allowed 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 163.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 56.7 m -148.04 140.67 24.57 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.377 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.582 ' HD1' ' HD1' ' A' ' 16' ' ' TYR . 2.5 t80 -128.16 108.18 10.41 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.979 0.895 . . . . 0.0 109.302 176.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.0 p -137.2 148.76 46.75 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.918 -173.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.8 -144.61 5.54 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.874 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.523 ' HB3' HG22 ' A' ' 71' ' ' THR . 5.0 ptmm? -164.71 168.24 18.18 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.981 0.42 . . . . 0.0 111.014 -177.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.744 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 8.3 mt -138.58 158.17 30.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.87 -167.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -133.02 97.18 3.94 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.338 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.702 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 1.5 m -136.16 149.33 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 O-C-N 121.499 -0.75 . . . . 0.0 112.135 -172.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.488 ' HD3' ' CE1' ' A' ' 67' ' ' TYR . 6.7 ttpm? -99.53 133.49 43.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.888 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -87.88 119.9 28.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.0 0.429 . . . . 0.0 111.775 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.525 HG12 ' OH ' ' A' ' 86' ' ' TYR . 32.8 mm -63.66 -45.25 97.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 122.199 0.999 . . . . 0.0 108.634 173.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.592 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . -137.48 143.87 41.96 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 172.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.411 ' HE1' ' OE1' ' A' ' 68' ' ' GLU . 40.6 t80 -60.16 -42.62 95.33 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -164.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.9 m -80.07 69.44 6.46 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.649 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 1.046 ' HE3' ' HA ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -87.0 -175.4 5.34 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.077 0.465 . . . . 0.0 110.97 176.77 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.862 ' HG3' ' HB3' ' A' ' 87' ' ' GLU . 18.7 ptmt -148.32 126.55 12.19 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.3 t -119.71 121.41 66.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-O 121.655 0.741 . . . . 0.0 110.983 -171.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.622 ' OG1' ' HE3' ' A' ' 85' ' ' LYS . 72.4 p -128.15 117.78 22.2 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.754 -172.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.96 HG22 HD13 ' A' ' 84' ' ' ILE . 16.5 t -82.91 129.14 37.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.14 176.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.3 m -122.35 125.01 72.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.393 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.468 ' HB2' HG13 ' A' ' 79' ' ' ILE . 2.0 p90 -115.77 149.99 37.61 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.357 0.598 . . . . 0.0 112.038 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.683 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . . . -80.45 62.1 4.43 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.056 175.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.731 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 6.6 t70 34.88 -139.51 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 O-C-N 126.357 2.286 . . . . 0.0 111.095 173.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.34 1.26 31.05 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 168.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.528 ' O ' ' HB3' ' A' ' 45' ' ' ASP . 34.4 t -103.55 -17.33 15.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.026 -0.587 . . . . 0.0 112.568 -170.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.567 ' OD1' ' HG3' ' A' ' 81' ' ' GLU . 25.4 t70 77.22 55.96 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -173.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -158.7 141.58 14.54 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.522 -1.217 . . . . 0.0 108.952 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.516 ' CZ2' ' HB2' ' A' ' 41' ' ' ALA . 5.0 m95 -106.39 81.47 1.61 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.268 1.033 . . . . 0.0 109.041 -178.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -88.8 153.67 20.88 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.81 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -74.48 48.79 0.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.596 0.712 . . . . 0.0 110.548 176.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.523 ' HB3' ' OD1' ' A' ' 52' ' ' ASN . 26.7 t30 -86.48 -21.03 27.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.63 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.13 44.89 1.54 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -171.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.523 ' OD1' ' HB3' ' A' ' 50' ' ' ASN . 10.0 m-20 -89.98 40.05 0.99 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.939 -0.63 . . . . 0.0 110.736 -171.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -126.25 144.62 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.53 -176.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.933 HG22 ' HB ' ' A' ' 38' ' ' VAL . 6.6 tp -128.53 136.15 60.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 174.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.27 132.0 34.67 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.638 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.87 161.59 14.43 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.517 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.8 t -130.63 138.32 50.04 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.683 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 33.7 p90 -90.89 143.66 26.49 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.068 0.461 . . . . 0.0 110.18 176.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.5 m -94.86 -22.73 17.83 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.423 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 157.01 173.29 25.25 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.972 173.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 68' ' ' GLU . 16.1 Cg_exo -68.13 147.29 72.8 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.564 2.176 . . . . 0.0 111.31 176.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.5 HG12 ' HB2' ' A' ' 69' ' ' TYR . 28.9 mt -85.28 95.9 4.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.3 m -57.14 127.93 34.43 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.214 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.82 6.8 60.39 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.605 -177.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.0 m -148.8 173.17 13.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.716 0.293 . . . . 0.0 110.222 178.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -94.79 4.24 54.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.277 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.488 ' CE1' ' HD3' ' A' ' 28' ' ' LYS . 3.8 m-85 -108.7 167.44 10.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.667 0.746 . . . . 0.0 111.838 -172.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.439 ' HG3' ' H ' ' A' ' 69' ' ' TYR . 1.7 tt0 -108.85 169.94 8.36 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.447 -1.252 . . . . 0.0 108.883 175.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.5 ' HB2' HG12 ' A' ' 62' ' ' ILE . 1.1 t80 -128.37 111.04 12.91 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -164.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.744 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 9.0 m95 -114.68 145.81 41.61 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.537 -168.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.523 HG22 ' HB3' ' A' ' 24' ' ' LYS . 10.4 p -138.3 134.86 34.84 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -137.03 147.4 46.17 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.824 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.5 p -126.23 142.96 51.32 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.921 175.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.523 ' HB2' HG12 ' A' ' 54' ' ' ILE . . . -150.67 114.22 4.93 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.086 0.469 . . . . 0.0 110.939 -174.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.5 t -78.28 99.78 6.43 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 171.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.9 m -101.89 149.29 6.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.296 -173.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -75.34 -21.9 58.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.916 0.865 . . . . 0.0 108.817 173.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.12 172.93 28.0 Favored Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 114.086 -1.415 . . . . 0.0 109.617 -175.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.731 ' HA ' ' O ' ' A' ' 42' ' ' ASP . 3.8 tt -169.92 125.79 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.849 0.833 . . . . 0.0 110.967 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -97.99 -56.74 2.4 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.698 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.683 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 11.7 mm-40 -131.15 170.29 14.75 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.544 ' CE2' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -173.43 158.61 3.53 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 119.271 0.941 . . . . 0.0 111.669 -179.5 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.743 ' HB3' ' HB3' ' A' ' 96' ' ' ASN . 1.5 p90 -159.91 158.04 30.08 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 168.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.96 HD13 HG22 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -94.79 142.75 13.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.505 -172.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.622 ' HE3' ' OG1' ' A' ' 37' ' ' THR . 16.7 mtmt -96.81 123.38 40.49 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.138 172.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.525 ' OH ' HG12 ' A' ' 30' ' ' ILE . 18.6 t80 -93.96 100.76 12.85 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 170.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.862 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . 6.7 tp10 -103.65 130.9 51.19 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.451 0.643 . . . . 0.0 109.282 -172.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.959 HG13 ' HE2' ' A' ' 34' ' ' LYS . 21.8 t -127.19 163.18 30.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.581 -173.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.403 ' N ' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -74.42 26.77 0.08 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.32 0.648 . . . . 0.0 111.111 -178.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -170.69 -37.36 0.03 OUTLIER Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.595 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.48 ' HG3' ' N ' ' A' ' 92' ' ' THR . 26.8 tptp -127.85 168.29 15.38 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -173.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.48 ' N ' ' HG3' ' A' ' 91' ' ' LYS . 4.0 m -138.06 146.36 42.87 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 172.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.512 ' HD1' ' HD2' ' A' ' 86' ' ' TYR . 33.3 m-85 -137.22 -174.36 3.72 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 171.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -149.22 141.57 24.18 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.062 -174.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -122.67 121.2 35.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.298 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.743 ' HB3' ' HB3' ' A' ' 83' ' ' TYR . 10.9 p30 -145.14 -103.21 0.11 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.925 177.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -113.5 -50.13 2.86 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 122.107 0.956 . . . . 0.0 108.723 -175.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -172.27 -48.56 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.2 p -160.73 47.52 0.23 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.748 172.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.79 -109.24 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.136 -174.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 174.84 142.1 0.05 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.793 -167.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.537 ' CE2' ' HA ' ' A' ' 96' ' ' ASN . 84.2 m-85 -78.39 142.31 37.71 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 173.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.22 125.0 53.67 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.7 0.762 . . . . 0.0 110.517 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.504 HG21 HG12 ' A' ' 79' ' ' ILE . 3.7 t -94.36 129.96 43.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.7 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.9 t -66.89 95.32 0.36 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.124 0.488 . . . . 0.0 110.626 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.128 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.763 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo . . . . . 0 N--CA 1.459 -0.528 0 CA-C-O 121.161 0.4 . . . . 0.0 111.926 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.5 t -110.38 -85.93 0.54 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.666 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.0 m -96.58 -64.26 1.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.654 0.264 . . . . 0.0 110.639 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.48 -174.13 2.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.975 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.422 ' HB3' ' HB3' ' A' ' 28' ' ' LYS . 26.1 m -76.52 -31.96 57.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.091 0.472 . . . . 0.0 110.362 177.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.906 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.2 p -114.68 150.65 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 121.352 0.596 . . . . 0.0 111.818 -173.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -143.05 141.25 31.26 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.667 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.485 HD11 ' HD2' ' A' ' 14' ' ' TYR . 3.5 tp -69.43 140.39 54.1 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.021 0.438 . . . . 0.0 110.107 175.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.406 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 28.2 t70 -90.94 -67.86 0.83 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.579 172.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.7 m -167.18 157.82 11.53 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.868 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.485 ' HD2' HD11 ' A' ' 11' ' ' LEU . 34.3 p90 -156.87 155.82 32.1 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.705 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -130.25 163.19 27.3 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.834 0.35 . . . . 0.0 111.084 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.635 ' HE2' HG23 ' A' ' 106' ' ' THR . 1.7 t80 -128.74 147.06 50.74 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -154.89 101.55 2.29 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -175.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.24 -96.69 0.14 Allowed Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 -168.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.503 ' HA ' ' CE1' ' A' ' 16' ' ' TYR . 10.4 t -136.2 89.51 2.48 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 158.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 16.1 m -144.38 139.64 28.56 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.501 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.829 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 17.8 t80 -108.58 129.27 55.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.8 p -151.39 123.7 8.3 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.074 0.464 . . . . 0.0 109.974 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 14' ' ' TYR . . . -177.91 -157.93 19.73 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.262 -0.97 . . . . 0.0 112.155 -176.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.668 ' HB3' HG22 ' A' ' 71' ' ' THR . 21.2 pttm -159.81 162.3 34.74 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.215 0.531 . . . . 0.0 111.214 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.622 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 11.0 mt -124.67 159.5 30.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.573 -170.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -131.44 100.19 5.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -174.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.906 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 1.9 m -135.77 147.93 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.706 -169.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 79.0 tttt -79.55 131.32 35.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.029 177.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.633 HD22 ' HB2' ' A' ' 68' ' ' GLU . 7.3 p30 -91.17 122.61 33.95 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.294 0.569 . . . . 0.0 110.349 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.403 HG12 ' OH ' ' A' ' 86' ' ' TYR . 25.3 mm -76.76 -56.82 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.016 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.649 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . . . -107.34 -80.96 0.56 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.864 173.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -166.47 -73.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.666 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.415 ' C ' ' HD2' ' A' ' 34' ' ' LYS . 20.1 m -83.59 68.73 9.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.309 0.576 . . . . 0.0 110.691 -178.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.654 ' HG3' HG13 ' A' ' 88' ' ' VAL . 6.3 mmmt -94.97 172.51 8.1 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.854 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 89.7 mttt -101.19 129.36 47.1 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.765 -173.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 65.3 t -121.44 107.92 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-O 121.873 0.844 . . . . 0.0 109.288 171.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.574 HG22 HD11 ' A' ' 53' ' ' ILE . 3.1 p -120.3 116.03 24.74 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.552 -173.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.91 HG22 HD12 ' A' ' 84' ' ' ILE . 72.2 t -77.02 136.64 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.006 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.152 176.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.41 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -124.29 107.79 19.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.53 176.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.535 ' HA ' ' CB ' ' A' ' 82' ' ' PHE . 0.9 OUTLIER -111.71 137.17 49.97 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 122.58 1.181 . . . . 0.0 110.387 174.736 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.571 ' HB2' ' CE3' ' A' ' 47' ' ' TRP . . . -89.76 97.02 10.95 Favored 'General case' 0 N--CA 1.412 -2.371 0 CA-C-N 113.086 -1.87 . . . . 0.0 107.101 178.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.722 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 1.3 p30 -44.01 163.36 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 O-C-N 124.767 1.292 . . . . 0.0 112.541 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.39 -13.04 14.71 Favored Glycine 0 N--CA 1.464 0.537 0 CA-C-N 115.536 -0.756 . . . . 0.0 114.358 -167.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -110.47 -18.87 13.12 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.426 ' OD1' ' HA ' ' A' ' 47' ' ' TRP . 48.1 t0 -74.03 -92.47 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.084 -1.416 . . . . 0.0 112.278 -173.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 51.95 98.58 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -159.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.571 ' CE3' ' HB2' ' A' ' 41' ' ' ALA . 7.1 m-90 -42.7 113.13 0.43 Allowed 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 -152.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.475 ' ND2' ' HB2' ' A' ' 50' ' ' ASN . 9.0 p30 -84.03 31.98 0.49 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 113.364 -1.744 . . . . 0.0 108.484 161.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.5 t30 59.35 46.42 12.63 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 122.19 0.995 . . . . 0.0 108.449 -164.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.475 ' HB2' ' ND2' ' A' ' 48' ' ' ASN . 49.9 t30 -83.4 -57.59 3.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.647 -174.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.426 ' H ' ' HD1' ' A' ' 47' ' ' TRP . . . 93.85 96.68 1.55 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.304 -0.951 . . . . 0.0 113.216 174.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 40' ' ' TYR . 86.8 m-20 -135.02 106.69 6.92 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.574 HD11 HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -117.91 144.45 25.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.381 0.61 . . . . 0.0 111.94 -172.06 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.617 HG23 ' HB ' ' A' ' 38' ' ' VAL . 8.1 tp -132.61 116.34 27.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.398 171.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.18 137.96 45.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.889 0.376 . . . . 0.0 111.425 -174.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.31 163.37 23.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.548 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.6 m -121.22 141.57 50.74 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -70.75 139.88 51.19 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.372 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.8 t -108.78 -39.13 5.44 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.45 154.77 7.14 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.545 173.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.36 136.13 49.62 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.198 1.932 . . . . 0.0 111.447 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.589 HD12 ' HB3' ' A' ' 67' ' ' TYR . 67.9 mt -80.59 91.92 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.8 p -60.65 120.92 10.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.642 -172.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 132.65 -34.53 2.47 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.515 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.2 m -134.9 172.53 12.86 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.65 39.15 0.46 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.956 0.407 . . . . 0.0 110.999 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.589 ' HB3' HD12 ' A' ' 62' ' ' ILE . 3.9 m-85 -115.27 159.25 21.24 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.719 0.771 . . . . 0.0 111.369 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.633 ' HB2' HD22 ' A' ' 29' ' ' ASN . 11.2 tt0 -131.12 170.38 14.61 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.11 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.23 122.7 26.98 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -165.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.702 ' CD1' HG13 ' A' ' 27' ' ' VAL . 20.8 m95 -121.9 134.82 54.86 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.813 -169.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.668 HG22 ' HB3' ' A' ' 24' ' ' LYS . 18.0 p -138.21 150.63 46.92 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.508 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 6.6 p90 -173.3 164.1 4.65 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.451 0.643 . . . . 0.0 111.928 172.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.4 p -124.56 144.24 50.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.271 173.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.829 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -137.56 126.5 24.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.573 -174.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.5 t -81.98 99.41 9.1 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 170.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.429 HG11 ' HB2' ' A' ' 21' ' ' PHE . 21.0 m -92.35 154.28 3.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.884 -176.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -116.99 48.22 1.35 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.04 126.18 4.42 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.857 -174.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.639 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 4.8 tt -136.3 128.33 44.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.592 0.711 . . . . 0.0 111.034 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.722 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -83.82 -61.7 1.76 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.947 -175.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 16.1 mt-10 -150.83 176.17 11.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.13 -1.395 . . . . 0.0 107.994 -177.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.535 ' CB ' ' HA ' ' A' ' 40' ' ' TYR . 30.3 p90 -169.43 173.47 6.51 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 119.12 -1.032 . . . . 0.0 113.484 174.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.49 154.17 24.4 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.08 173.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.91 HD12 HG22 ' A' ' 38' ' ' VAL . 16.3 mm -99.2 151.82 4.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.438 ' HE3' ' OG1' ' A' ' 37' ' ' THR . 49.4 pttt -131.32 149.54 52.51 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 121.88 0.848 . . . . 0.0 110.413 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.699 ' HD2' ' HD1' ' A' ' 93' ' ' TYR . 21.8 t80 -114.63 108.36 16.72 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 113.78 -1.554 . . . . 0.0 109.675 -174.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.854 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 31.1 tt0 -105.8 116.78 32.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.173 0.511 . . . . 0.0 109.958 -175.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.654 HG13 ' HG3' ' A' ' 34' ' ' LYS . 1.3 t -123.29 166.28 18.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.994 -175.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m -48.15 -46.45 34.5 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.492 0.495 . . . . 0.0 111.553 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -120.79 -9.22 7.69 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.305 -0.95 . . . . 0.0 113.749 -176.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.3 mmtm -128.11 173.81 9.77 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 86' ' ' TYR . 8.3 m -152.9 143.78 22.92 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 113.226 -1.807 . . . . 0.0 109.43 176.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.699 ' HD1' ' HD2' ' A' ' 86' ' ' TYR . 28.1 m-85 -144.01 -173.53 4.02 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -150.14 148.08 28.53 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.437 -174.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -118.18 90.24 3.29 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 169.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -131.14 31.05 4.47 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.957 -172.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 68.3 -59.84 0.43 Allowed 'General case' 0 CA--C 1.532 0.259 0 O-C-N 123.733 0.646 . . . . 0.0 110.535 -172.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -179.68 -53.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.4 t -172.69 69.24 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.191 -1.368 . . . . 0.0 107.518 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.64 -37.87 0.2 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.969 -170.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 70.05 149.08 0.08 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -171.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 95.9 m-85 -83.67 106.32 15.29 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 175.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -68.61 116.06 8.7 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.043 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.566 HG21 HG12 ' A' ' 79' ' ' ILE . 2.8 t -100.21 133.65 42.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.1 t -151.5 148.65 28.3 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.635 HG23 ' HE2' ' A' ' 16' ' ' TYR . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.572 -0.728 . . . . 0.0 110.331 177.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.403 ' HB3' ' HB2' ' A' ' 10' ' ' GLN . 36.9 Cg_endo . . . . . 0 C--O 1.233 0.239 0 CA-C-O 120.849 0.27 . . . . 0.0 112.08 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.6 t -122.03 -28.32 4.43 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.301 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.9 p -70.23 -73.63 0.16 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.761 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.83 174.5 7.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.283 0.564 . . . . 0.0 111.567 -176.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.659 ' HB3' HD11 ' A' ' 30' ' ' ILE . 20.3 m -80.53 -15.53 56.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.07 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.752 HG23 HG12 ' A' ' 27' ' ' VAL . 2.2 p -140.7 151.42 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 120.758 0.313 . . . . 0.0 110.343 -178.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 4' ' ' PRO . 15.1 tt0 -145.16 128.87 17.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.242 -176.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.566 HD21 ' CD2' ' A' ' 14' ' ' TYR . 26.0 tp -69.8 137.22 51.66 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 172.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.59 -49.04 6.07 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.909 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.8 p 174.82 160.02 0.19 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 123.705 0.628 . . . . 0.0 111.744 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.566 ' CD2' HD21 ' A' ' 11' ' ' LEU . 30.4 p90 -156.33 159.67 39.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.726 177.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -151.89 164.22 37.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.618 0.247 . . . . 0.0 110.442 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 19' ' ' SER . 5.3 t80 -115.96 143.33 45.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.034 -174.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -144.17 101.67 3.75 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -175.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.4 -97.78 0.25 Allowed Glycine 0 C--N 1.333 0.368 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -170.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 16' ' ' TYR . 71.4 m -134.43 85.73 2.21 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 158.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 13.8 m -146.51 138.52 24.84 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.088 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.818 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 20.4 t80 -95.52 140.37 30.46 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 171.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 85.7 p -155.58 126.01 6.78 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 174.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.8 -161.85 29.94 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.159 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -160.05 162.75 34.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.835 0.35 . . . . 0.0 110.947 -176.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.594 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 25.9 mt -132.38 156.51 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.894 -172.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -126.14 115.83 20.4 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.752 HG12 HG23 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -128.67 149.73 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.022 179.288 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.491 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 92.9 mttt -80.26 152.14 29.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.498 174.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -94.74 85.02 4.33 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.773 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.659 HD11 ' HB3' ' A' ' 8' ' ' SER . 3.8 mm -64.51 -56.84 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.65 -150.7 0.47 Allowed 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 106.725 -1.584 . . . . 0.0 106.725 168.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.467 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 42.9 t80 -112.31 -56.89 2.34 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.514 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.2 t -65.4 111.45 3.06 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 123.301 0.376 . . . . 0.0 110.412 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.54 ' HB2' ' HH2' ' A' ' 70' ' ' TRP . 12.4 mmtp -112.62 167.61 10.33 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 121.121 0.486 . . . . 0.0 110.473 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.755 ' HG3' ' HB3' ' A' ' 87' ' ' GLU . 0.6 OUTLIER -151.88 111.15 3.91 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 171.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.4 t -106.7 112.27 39.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-O 121.817 0.818 . . . . 0.0 110.435 -173.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.742 HG22 HD11 ' A' ' 53' ' ' ILE . 14.0 p -119.07 107.99 14.17 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.653 -172.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.992 HG22 HD12 ' A' ' 84' ' ' ILE . 71.7 t -76.45 111.01 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.463 175.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.647 ' HB ' ' CZ2' ' A' ' 47' ' ' TRP . 0.0 OUTLIER -102.62 113.66 39.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.122 170.781 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.657 ' HA ' ' CB ' ' A' ' 82' ' ' PHE . 0.6 OUTLIER -108.24 145.14 34.73 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 122.075 0.941 . . . . 0.0 110.385 171.742 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.709 ' HB2' ' CE3' ' A' ' 47' ' ' TRP . . . -85.67 99.08 11.06 Favored 'General case' 0 N--CA 1.409 -2.498 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.368 169.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -40.27 165.2 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 112.893 -1.958 . . . . 0.0 112.875 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 80' ' ' LYS . . . -62.22 2.18 1.17 Allowed Glycine 0 C--N 1.334 0.426 0 CA-C-N 114.956 -1.02 . . . . 0.0 114.656 -167.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.8 t -80.87 -22.7 39.62 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 116.954 0.377 . . . . 0.0 110.321 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.7 t70 77.52 43.85 0.1 Allowed 'General case' 0 C--N 1.351 0.641 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -142.64 146.47 34.51 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.351 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.709 ' CE3' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -122.16 120.66 34.87 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 119.399 -0.92 . . . . 0.0 112.438 173.177 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -90.93 16.02 10.28 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 169.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 67.03 4.02 3.4 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.354 -1.293 . . . . 0.0 111.6 -175.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.431 HD22 ' HA ' ' A' ' 50' ' ' ASN . 0.1 OUTLIER -168.8 179.34 4.22 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -171.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.11 27.48 64.13 Favored Glycine 0 CA--C 1.505 -0.536 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.093 178.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -166.57 56.67 0.09 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.263 0.554 . . . . 0.0 109.975 -175.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.742 HD11 HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -133.92 131.15 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-O 122.048 0.928 . . . . 0.0 109.643 -174.071 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.517 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 10.4 mm -110.92 129.76 65.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.982 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.11 96.35 7.77 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 118.263 -1.375 . . . . 0.0 108.255 167.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -47.63 153.88 0.53 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.76 170.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -115.55 131.71 56.85 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.716 -174.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -71.32 143.85 50.14 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.254 177.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.9 t -106.4 -37.51 6.49 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 145.82 173.68 17.3 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.356 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -53.86 134.58 59.8 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 123.037 2.491 . . . . 0.0 111.633 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 1.069 HG12 ' HB2' ' A' ' 69' ' ' TYR . 4.7 mt -83.92 119.07 32.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.695 -172.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.5 p -62.77 118.37 7.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.019 0.438 . . . . 0.0 110.251 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 117.46 -12.44 13.87 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -176.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.5 m -151.94 -179.53 7.55 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -112.11 30.21 7.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.652 0.739 . . . . 0.0 109.9 177.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.491 ' CD1' ' HA ' ' A' ' 28' ' ' LYS . 17.2 m-85 -105.0 -178.37 3.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.792 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.488 ' O ' HD11 ' A' ' 62' ' ' ILE . 15.6 tp10 -111.84 150.9 29.73 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.7 -171.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 1.069 ' HB2' HG12 ' A' ' 62' ' ' ILE . 8.7 t80 -125.2 116.52 22.13 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -165.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.662 ' HE1' HG22 ' A' ' 27' ' ' VAL . 12.7 m95 -108.68 133.43 52.77 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.469 -170.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.42 ' O ' ' HB3' ' A' ' 72' ' ' PHE . 22.5 p -139.76 148.53 42.39 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -176.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.464 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 3.3 p90 -174.02 151.67 1.78 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.913 0.863 . . . . 0.0 112.409 170.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.2 p -117.81 137.55 52.67 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.277 -1.329 . . . . 0.0 107.923 166.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.818 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -129.51 122.14 28.65 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.891 -168.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.71 99.45 1.33 Allowed 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 171.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.407 HG11 ' HB2' ' A' ' 21' ' ' PHE . 28.6 m -103.3 150.24 6.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.659 -175.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.676 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -104.62 38.12 1.97 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.614 0.721 . . . . 0.0 109.65 175.47 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 112.71 149.82 10.8 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.054 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.534 HG13 ' HB2' ' A' ' 40' ' ' TYR . 9.7 tt -154.88 156.41 5.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.466 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 18.2 tptm -140.67 -47.4 0.42 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.953 0.406 . . . . 0.0 111.26 -176.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.443 ' O ' ' HB3' ' A' ' 82' ' ' PHE . 20.8 mt-10 -141.7 162.27 35.88 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -178.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.657 ' CB ' ' HA ' ' A' ' 40' ' ' TYR . 43.1 p90 -172.63 179.26 2.47 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 119.101 -1.039 . . . . 0.0 112.76 169.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.568 ' HB3' ' HB3' ' A' ' 96' ' ' ASN . 0.2 OUTLIER -160.94 143.15 12.43 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 113.519 -1.673 . . . . 0.0 108.38 171.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.992 HD12 HG22 ' A' ' 38' ' ' VAL . 14.2 mm -90.48 132.45 35.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.783 -177.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.511 ' HB2' ' OG1' ' A' ' 37' ' ' THR . 1.1 mtmp? -89.8 107.0 18.84 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.719 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.683 ' HB2' HG11 ' A' ' 9' ' ' VAL . 20.2 t80 -85.99 99.16 11.25 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.755 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . 7.9 tt0 -116.73 124.12 48.88 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.072 -174.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 23.1 t -104.6 162.62 4.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.8 t -59.09 -11.48 3.69 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -143.62 2.46 1.48 Allowed Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.834 177.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.8 tptt -141.65 163.6 32.48 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 117.823 0.811 . . . . 0.0 110.438 -176.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.8 m -144.73 142.89 30.39 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.163 0.506 . . . . 0.0 110.874 174.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.497 ' HD2' ' CD2' ' A' ' 86' ' ' TYR . 49.1 m-85 -141.35 -168.62 2.68 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -144.99 143.71 30.65 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.711 0.291 . . . . 0.0 111.246 -174.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.425 ' OD2' ' HB2' ' A' ' 11' ' ' LEU . 29.6 t70 -122.19 98.69 6.05 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 169.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.568 ' HB3' ' HB3' ' A' ' 83' ' ' TYR . 4.9 p30 -123.18 -45.25 2.12 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.754 -173.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.519 ' HB3' ' O ' ' A' ' 96' ' ' ASN . 26.4 p-10 166.23 -37.67 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 175.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 178.58 -44.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.4 t -174.09 38.95 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.286 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.26 -90.54 0.11 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 p30 178.77 158.7 0.55 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.845 0.355 . . . . 0.0 110.458 -171.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -90.52 100.65 13.45 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 169.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.558 ' H ' ' CD ' ' A' ' 103' ' ' GLN . 0.0 OUTLIER -81.06 107.52 13.94 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.513 0.673 . . . . 0.0 110.18 179.579 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.5 t -91.43 114.86 29.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.963 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 21.8 m -69.72 102.54 1.92 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.698 -0.668 . . . . 0.0 110.876 -177.592 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.976 0.323 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.9 t -157.94 -60.08 0.08 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.895 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.9 t -78.35 -74.49 0.27 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.519 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -141.22 -160.32 1.07 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -68.48 -30.99 69.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.804 HG23 HG12 ' A' ' 27' ' ' VAL . 2.1 p -128.0 151.43 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.816 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -143.26 129.51 19.85 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.277 178.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.585 HD21 ' CD2' ' A' ' 14' ' ' TYR . 15.2 tp -69.07 140.04 54.85 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.066 0.46 . . . . 0.0 110.08 174.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -88.37 -63.85 1.24 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.101 178.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.0 m -170.58 159.84 6.95 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.196 -176.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.585 ' CD2' HD21 ' A' ' 11' ' ' LEU . 12.4 p90 -158.11 155.92 30.05 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.407 174.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -113.43 154.75 26.46 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 120.829 0.347 . . . . 0.0 110.873 175.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.808 ' CZ ' HG21 ' A' ' 79' ' ' ILE . 1.1 m-85 -160.03 139.21 10.89 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 124.71 1.256 . . . . 0.0 110.412 -175.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 16.8 t70 -175.54 71.31 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.973 167.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 51.7 38.9 45.42 Favored Glycine 0 CA--C 1.507 -0.455 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -170.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.6 m -155.58 158.99 39.3 Favored 'General case' 0 N--CA 1.394 -3.268 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 -161.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.516 HG23 ' HA ' ' A' ' 75' ' ' SER . 52.9 m -60.32 143.78 52.14 Favored 'General case' 0 C--N 1.263 -3.191 0 CA-C-N 112.899 -1.955 . . . . 0.0 111.219 -173.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.659 ' HD2' ' CZ ' ' A' ' 16' ' ' TYR . 2.1 t80 -78.59 141.87 37.74 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.6 m -161.54 124.89 3.19 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.736 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.73 -153.03 9.95 Favored Glycine 0 N--CA 1.438 -1.167 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -176.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.754 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -160.05 163.61 33.82 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.014 0.435 . . . . 0.0 111.371 -177.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.726 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 24.9 mt -127.55 156.81 39.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.645 -170.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -132.77 107.29 8.27 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.114 0.565 . . . . 0.0 109.647 -172.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.804 HG12 HG23 ' A' ' 9' ' ' VAL . 0.7 OUTLIER -133.95 151.89 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.208 -0.932 . . . . 0.0 112.178 -172.062 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.446 ' HD3' ' CE1' ' A' ' 67' ' ' TYR . 23.8 tptm -76.35 129.29 36.4 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 172.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.611 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 23.7 p-10 -86.6 103.86 15.49 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.574 0.702 . . . . 0.0 110.376 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.512 HG12 ' OH ' ' A' ' 86' ' ' TYR . 16.3 mm -72.99 -60.3 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-N 115.47 -0.787 . . . . 0.0 108.882 -176.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.78 -135.05 0.35 Allowed 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.148 172.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -120.54 -52.4 2.14 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.022 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.5 t -78.16 116.21 18.45 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.784 ' HB2' ' HH2' ' A' ' 70' ' ' TRP . 27.5 mmtm -116.76 167.33 11.19 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.24 0.543 . . . . 0.0 110.619 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.537 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 9.0 mtpm? -138.42 97.72 3.43 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.786 173.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.9 t -98.75 124.44 51.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.9 0.857 . . . . 0.0 110.713 -178.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.784 ' HB ' HG13 ' A' ' 53' ' ' ILE . 45.2 p -132.69 116.4 16.57 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.286 -1.324 . . . . 0.0 110.638 -170.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.901 HG22 HD13 ' A' ' 84' ' ' ILE . 44.9 t -84.92 132.75 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-O 121.322 0.582 . . . . 0.0 109.514 173.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.701 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -118.9 111.61 34.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.161 175.015 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.62 ' HA ' ' CB ' ' A' ' 82' ' ' PHE . 5.1 p90 -115.05 139.58 49.76 Favored 'General case' 0 CA--C 1.485 -1.528 0 CA-C-O 122.667 1.222 . . . . 0.0 110.901 175.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.518 ' HB2' ' CZ3' ' A' ' 47' ' ' TRP . . . -86.2 103.0 14.43 Favored 'General case' 0 N--CA 1.405 -2.714 0 CA-C-N 112.69 -2.05 . . . . 0.0 107.462 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.671 ' HB2' ' ND2' ' A' ' 52' ' ' ASN . 3.4 t70 -48.15 -168.49 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 111.694 -2.503 . . . . 0.0 113.796 -174.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.53 -17.9 28.2 Favored Glycine 0 C--N 1.335 0.5 0 O-C-N 122.106 -0.371 . . . . 0.0 112.513 -177.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 41.6 t -65.83 -16.59 63.96 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 122.825 0.45 . . . . 0.0 110.823 175.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.495 ' HB3' ' HG3' ' A' ' 80' ' ' LYS . 3.7 p30 51.46 33.77 10.91 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.632 1.173 . . . . 0.0 110.632 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -163.63 139.76 6.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.436 -169.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.518 ' CZ3' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -91.33 88.94 7.06 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 120.029 -0.668 . . . . 0.0 112.326 174.516 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.63 47.3 1.35 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.641 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 60.12 31.63 20.63 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.113 -172.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -92.37 127.4 37.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.231 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -96.37 60.43 1.3 Allowed Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.56 -174.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.671 ' ND2' ' HB2' ' A' ' 42' ' ' ASP . 87.2 m-20 -76.78 75.9 3.41 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.795 0.331 . . . . 0.0 110.431 175.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.784 HG13 ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -109.23 136.21 45.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.331 0.586 . . . . 0.0 110.737 178.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.73 HG22 ' HB ' ' A' ' 38' ' ' VAL . 8.0 tp -117.24 121.92 68.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.638 174.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.66 134.01 37.17 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.912 0.387 . . . . 0.0 110.411 -176.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.07 161.2 18.28 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.977 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 m -114.44 176.05 5.22 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.741 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 0.4 OUTLIER -139.22 146.47 40.53 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.782 0.801 . . . . 0.0 111.517 -174.167 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.8 t -88.39 -36.11 16.75 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.329 -1.305 . . . . 0.0 108.712 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 143.46 -172.08 24.96 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.288 174.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -65.85 138.25 52.41 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.75 2.3 . . . . 0.0 111.404 175.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.644 HG12 ' HB2' ' A' ' 69' ' ' TYR . 20.0 mt -81.24 109.84 16.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.408 -176.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.5 p -65.64 135.48 55.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.272 0.558 . . . . 0.0 111.274 -176.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.89 -4.64 81.81 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.459 -0.657 . . . . 0.0 111.459 -177.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.6 m -140.72 171.52 13.98 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -108.31 46.29 0.97 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.17 0.509 . . . . 0.0 110.002 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.502 ' HB3' HD12 ' A' ' 62' ' ' ILE . 2.3 m-85 -125.88 172.33 9.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.425 -178.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 29' ' ' ASN . 17.5 tt0 -120.39 167.07 12.72 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.644 ' HB2' HG12 ' A' ' 62' ' ' ILE . 4.3 t80 -141.59 121.72 13.81 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -164.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.784 ' HH2' ' HB2' ' A' ' 34' ' ' LYS . 25.4 m95 -118.46 145.55 45.17 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.798 -168.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.533 HG22 ' HB3' ' A' ' 24' ' ' LYS . 1.4 p -147.29 142.38 27.1 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 123.744 0.652 . . . . 0.0 109.527 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.406 ' HB3' ' O ' ' A' ' 71' ' ' THR . 2.7 p90 -173.99 159.49 3.33 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.442 0.639 . . . . 0.0 112.585 173.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.3 p -117.67 143.98 45.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.416 172.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -142.25 106.09 4.71 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -171.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.516 ' HA ' HG23 ' A' ' 20' ' ' THR . 13.3 t -68.6 109.13 3.62 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 174.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.578 HG21 ' HE1' ' A' ' 16' ' ' TYR . 12.2 m -100.52 155.59 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.002 -173.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -86.36 -24.01 25.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.21 -175.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.36 107.08 0.35 Allowed Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -177.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.808 HG21 ' CZ ' ' A' ' 16' ' ' TYR . 8.9 tt -112.34 138.04 42.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.418 0.628 . . . . 0.0 111.722 -172.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.495 ' HG3' ' HB3' ' A' ' 45' ' ' ASP . 74.5 mmtt -117.0 -47.42 2.69 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.213 -176.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.473 ' OE1' ' HB3' ' A' ' 103' ' ' GLN . 11.7 mm-40 -146.21 154.02 41.28 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -175.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.701 ' HB2' ' O ' ' A' ' 39' ' ' VAL . 3.9 p90 -172.14 -179.06 2.24 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 118.521 -1.272 . . . . 0.0 114.032 174.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.582 ' HA ' ' CE1' ' A' ' 102' ' ' TYR . 0.2 OUTLIER -162.17 164.7 27.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 113.48 -1.691 . . . . 0.0 108.644 176.632 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.901 HD13 HG22 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -104.23 144.24 14.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.958 -177.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.531 ' HB2' ' OG1' ' A' ' 37' ' ' THR . 6.6 mtmp? -104.86 130.07 53.07 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 121.069 0.461 . . . . 0.0 109.905 176.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.715 ' HD2' ' HD2' ' A' ' 93' ' ' TYR . 19.4 t80 -102.63 102.17 12.37 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.46 177.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.537 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 28.5 tt0 -108.64 129.35 55.33 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.566 ' C ' ' H ' ' A' ' 90' ' ' GLY . 2.6 t -122.06 166.47 16.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -174.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.8 p -66.45 28.08 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.344 0.592 . . . . 0.0 112.262 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . 171.96 -34.61 0.14 Allowed Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.851 177.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.531 ' HE3' ' HA ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -102.44 164.47 11.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.841 0.353 . . . . 0.0 111.338 -177.33 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.4 m -148.59 142.92 26.21 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 173.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.715 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 47.3 m-85 -141.41 -168.1 2.56 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.6 133.87 15.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.628 -170.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -118.98 94.92 4.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.225 0.536 . . . . 0.0 109.995 172.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.468 ' O ' ' HB2' ' A' ' 97' ' ' ASN . 28.9 p-10 -125.36 27.62 6.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.275 -178.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 96' ' ' ASN . 2.9 m-20 72.65 -58.06 0.61 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.748 -172.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 177.69 -48.95 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 176.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.1 p -164.89 29.69 0.06 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.124 174.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -104.27 -37.45 7.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.411 -171.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.457 HD22 ' HB3' ' A' ' 81' ' ' GLU . 2.0 p-10 47.49 101.56 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 O-C-N 123.965 0.79 . . . . 0.0 112.891 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.582 ' CE1' ' HA ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -50.78 116.49 1.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.91 -168.694 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.473 ' HB3' ' OE1' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -88.85 124.96 34.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.533 0.682 . . . . 0.0 110.292 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.476 HG21 HG12 ' A' ' 79' ' ' ILE . 3.4 t -97.38 148.65 5.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.722 -1.127 . . . . 0.0 110.564 -174.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.2 m -95.38 75.36 3.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.418 0.628 . . . . 0.0 110.275 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.9 m . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.307 -0.854 . . . . 0.0 109.653 178.032 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo . . . . . 0 C--O 1.234 0.298 0 CA-C-O 120.919 0.3 . . . . 0.0 112.331 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.8 t -129.72 -54.17 1.15 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.683 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.9 t -108.42 -74.99 0.64 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.772 -0.194 . . . . 0.0 110.617 -178.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.77 -173.13 2.25 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.523 0.201 . . . . 0.0 111.186 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.9 m -65.44 -36.07 82.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.217 0.532 . . . . 0.0 110.528 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.698 HG23 HG12 ' A' ' 27' ' ' VAL . 1.7 p -123.8 152.11 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.5 -176.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -142.57 132.5 24.31 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.094 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.482 HD21 ' CD2' ' A' ' 14' ' ' TYR . 34.8 tp -71.13 136.04 47.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.064 0.459 . . . . 0.0 110.304 176.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -88.12 -58.86 2.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.94 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.3 p -179.54 160.46 0.96 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.8 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.482 ' CD2' HD21 ' A' ' 11' ' ' LEU . 44.1 p90 -157.54 163.14 38.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.481 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -133.46 158.57 42.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.929 0.395 . . . . 0.0 110.623 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.733 ' CE2' ' HB ' ' A' ' 106' ' ' THR . 0.5 OUTLIER -139.53 138.42 36.29 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.57 -179.041 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -166.5 130.59 2.07 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.78 -104.18 0.36 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -168.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.2 t -140.86 85.05 1.97 Allowed 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 161.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.528 ' O ' ' HD1' ' A' ' 16' ' ' TYR . 88.9 m -147.31 130.23 16.24 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.411 173.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.462 ' HD1' ' CD1' ' A' ' 16' ' ' TYR . 3.5 t80 -128.3 104.05 7.51 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.567 0.699 . . . . 0.0 109.56 -174.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.6 m -138.32 150.1 46.28 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.797 -176.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.32 -141.5 3.75 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 -178.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 2.6 ptpp? -162.6 166.82 24.17 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.825 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.709 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 38.3 mt -133.66 157.16 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 -170.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -133.03 110.14 10.03 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.31 0.644 . . . . 0.0 109.657 -173.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.698 HG12 HG23 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -137.97 151.49 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.206 -0.934 . . . . 0.0 113.101 -172.393 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 46.4 tptt -78.83 140.86 38.11 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.899 174.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.537 ' OD1' ' HB2' ' A' ' 68' ' ' GLU . 7.2 m-20 -88.31 96.76 10.7 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.696 0.284 . . . . 0.0 110.783 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.606 HG12 ' OH ' ' A' ' 86' ' ' TYR . 7.7 mm -75.98 -54.84 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 176.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.89 -157.5 0.62 Allowed 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.201 -1.363 . . . . 0.0 107.906 172.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -113.33 -59.03 2.07 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.603 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.6 m -76.85 87.82 3.44 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 175.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.454 ' HE2' ' CZ2' ' A' ' 70' ' ' TRP . 27.9 mtmm -104.34 158.4 16.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.456 -174.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.766 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 47.8 mttp -123.79 138.46 54.5 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 175.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.1 t -128.0 115.52 39.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.331 0.586 . . . . 0.0 110.115 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.903 ' HB ' HG13 ' A' ' 53' ' ' ILE . 69.1 p -119.74 120.3 36.15 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.494 -171.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 1.005 ' HB ' HG22 ' A' ' 54' ' ' ILE . 79.6 t -88.52 110.42 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.703 177.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.706 HG21 ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -97.13 120.29 46.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 170.686 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.612 ' HA ' ' HZ2' ' A' ' 47' ' ' TRP . 5.3 p90 -119.99 138.23 53.61 Favored 'General case' 0 CA--C 1.49 -1.347 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.032 171.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.603 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . . . -76.9 88.06 3.47 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 113.133 -1.849 . . . . 0.0 108.017 -175.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' A' ' 43' ' ' GLY . 42.8 t0 -43.75 -170.37 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 109.221 -3.627 . . . . 0.0 113.007 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.502 ' H ' ' CG ' ' A' ' 42' ' ' ASP . . . -61.5 -10.39 22.98 Favored Glycine 0 CA--C 1.522 0.469 0 O-C-N 121.983 -0.448 . . . . 0.0 112.721 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -76.11 -14.19 60.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.904 0.383 . . . . 0.0 110.148 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 76.06 12.59 2.8 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.122 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -170.81 179.35 3.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.951 -178.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.612 ' HZ2' ' HA ' ' A' ' 40' ' ' TYR . 23.0 m-90 -105.19 107.93 19.18 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.501 169.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -76.45 -162.82 0.27 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 170.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -75.11 58.31 0.89 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.438 0.637 . . . . 0.0 109.72 171.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -128.58 -50.68 1.26 Allowed 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.187 -174.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.66 76.2 0.95 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.95 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.402 ' H ' ' HD1' ' A' ' 47' ' ' TRP . 3.5 m-20 -77.94 80.11 4.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.903 HG13 ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -119.58 138.45 50.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.555 0.693 . . . . 0.0 112.822 -170.312 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 1.005 HG22 ' HB ' ' A' ' 38' ' ' VAL . 8.4 tp -112.31 133.47 57.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 169.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.65 126.7 34.13 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.614 -177.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.56 158.85 22.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.461 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.0 t -130.04 133.44 46.73 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.624 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 31.2 p90 -76.29 141.11 41.73 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 121.456 0.646 . . . . 0.0 110.267 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.4 t -93.48 -26.36 17.21 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.842 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 160.52 171.08 25.96 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.796 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.37 144.23 61.06 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.447 2.098 . . . . 0.0 110.843 174.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.743 HD12 ' HB3' ' A' ' 67' ' ' TYR . 20.7 mt -79.98 109.74 14.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.198 0.523 . . . . 0.0 109.9 -178.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.5 p -66.54 122.74 18.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.692 -175.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.02 -2.37 30.05 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.5 m -153.28 179.34 8.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -107.1 38.68 2.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.937 0.875 . . . . 0.0 109.899 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.743 ' HB3' HD12 ' A' ' 62' ' ' ILE . 1.8 m-85 -102.41 168.76 9.11 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.222 177.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.537 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . 10.0 tt0 -124.02 165.1 18.05 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.579 ' HB2' HG12 ' A' ' 62' ' ' ILE . 2.0 t80 -136.32 111.25 8.84 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -161.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.709 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 8.0 m95 -111.56 144.92 40.02 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.288 -166.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.439 ' HA ' ' HB2' ' A' ' 24' ' ' LYS . 5.0 p -133.04 131.86 41.14 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -132.6 151.06 52.06 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 118.884 -1.126 . . . . 0.0 111.733 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.2 m -131.68 141.29 49.54 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.053 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -150.56 113.74 4.85 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.069 0.461 . . . . 0.0 111.167 -175.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.2 t -77.7 99.07 5.69 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 168.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.6 m -95.15 157.22 3.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.416 0.627 . . . . 0.0 111.26 -169.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -96.42 -16.77 21.03 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.018 -175.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.17 82.63 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.942 -0.646 . . . . 0.0 111.969 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.471 HG12 HG21 ' A' ' 104' ' ' VAL . 4.5 tt -90.49 133.19 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.485 0.66 . . . . 0.0 111.108 -178.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -114.47 -40.38 3.63 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.298 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.603 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 37.0 mm-40 -141.37 167.19 22.76 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.443 ' HZ ' ' CE2' ' A' ' 14' ' ' TYR . 28.2 p90 -172.1 170.71 5.17 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 119.338 0.972 . . . . 0.0 111.864 174.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.683 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 0.7 OUTLIER -162.9 150.7 13.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.235 168.09 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.979 HD12 HG22 ' A' ' 38' ' ' VAL . 10.2 mm -100.94 139.46 22.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.673 -174.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.706 ' HE3' HG21 ' A' ' 39' ' ' VAL . 88.8 mttt -103.86 151.83 22.65 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.471 0.653 . . . . 0.0 110.269 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.655 ' HD2' ' HD2' ' A' ' 93' ' ' TYR . 25.0 t80 -123.24 106.66 10.92 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.765 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.766 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -103.19 128.47 50.15 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.304 0.573 . . . . 0.0 110.218 -176.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.452 ' HB ' ' H ' ' A' ' 91' ' ' LYS . 11.4 t -126.54 158.04 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.735 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.9 m -67.32 -3.18 7.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -176.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -136.61 -27.87 0.37 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.512 176.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.452 ' H ' ' HB ' ' A' ' 88' ' ' VAL . 28.1 mmtt -129.73 177.62 7.11 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 122.189 0.995 . . . . 0.0 112.483 -174.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.5 m -150.39 141.9 23.47 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.232 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.655 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 33.0 m-85 -143.82 -172.73 3.8 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -150.47 148.43 28.72 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.187 -174.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -119.79 98.82 6.29 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 169.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.683 ' HB3' ' HB2' ' A' ' 83' ' ' TYR . 23.0 p-10 -145.01 61.9 1.31 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.418 -174.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 71.13 -65.4 0.34 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.933 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -157.91 -53.81 0.07 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 174.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.6 m -157.17 44.69 0.37 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.706 -1.133 . . . . 0.0 110.001 169.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.42 -109.08 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -176.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 176.07 146.26 0.09 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.777 0.831 . . . . 0.0 108.831 -168.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -85.54 142.84 28.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.656 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -92.88 106.66 18.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.348 -175.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.471 HG21 HG12 ' A' ' 79' ' ' ILE . 22.0 t -94.39 107.44 19.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.7 m -90.66 57.62 3.65 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -171.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.733 ' HB ' ' CE2' ' A' ' 16' ' ' TYR . 87.9 m . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.689 175.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.609 ' HG3' ' CE1' ' A' ' 26' ' ' TYR . 13.5 Cg_endo . . . . . 0 N--CA 1.46 -0.487 0 CA-C-O 121.637 0.599 . . . . 0.0 112.69 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.4 t -85.85 49.61 1.81 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.761 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.519 ' OG ' ' HB2' ' A' ' 10' ' ' GLN . 13.6 t -108.45 -175.4 2.76 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.244 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.21 -151.0 0.27 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.294 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.1 -29.54 69.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.125 0.488 . . . . 0.0 110.603 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.629 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.3 p -150.24 149.06 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.725 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.519 ' HB2' ' OG ' ' A' ' 6' ' ' SER . 10.9 tt0 -138.75 154.78 48.56 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.597 HD21 ' CD2' ' A' ' 14' ' ' TYR . 16.4 tp -85.55 143.11 28.69 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.025 0.44 . . . . 0.0 110.012 172.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -87.41 -65.66 0.99 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.602 173.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.2 p -177.68 160.38 1.54 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.587 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.597 ' CD2' HD21 ' A' ' 11' ' ' LEU . 43.5 p90 -152.12 162.25 41.4 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.269 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -132.6 157.12 45.58 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -133.17 146.61 51.69 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.159 -174.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 18' ' ' GLY . 13.8 t70 -123.56 -150.35 0.45 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.671 -1.149 . . . . 0.0 107.954 -177.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.413 ' H ' ' CG ' ' A' ' 17' ' ' ASP . . . -50.61 -64.43 3.69 Favored Glycine 0 N--CA 1.458 0.111 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 171.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.2 t -145.63 86.76 1.75 Allowed 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 161.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.6 m -146.42 140.3 26.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.033 178.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.838 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 12.2 t80 -116.38 139.55 50.29 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.4 m -163.17 133.93 4.66 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 174.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 14' ' ' TYR . . . 172.86 -150.34 12.37 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.116 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.599 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 18.5 pttp -159.41 168.74 25.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.185 0.517 . . . . 0.0 111.451 -177.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.776 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 12.9 mt -132.78 160.78 42.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.644 -167.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.609 ' CE1' ' HG3' ' A' ' 4' ' ' PRO . 5.6 t80 -132.5 96.23 3.8 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 122.769 0.428 . . . . 0.0 110.317 -173.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.741 HG13 ' CD1' ' A' ' 70' ' ' TRP . 1.8 m -136.99 151.92 27.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 121.166 -0.959 . . . . 0.0 112.022 -170.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -72.69 143.88 47.92 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.746 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -102.28 95.03 6.03 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.732 0.777 . . . . 0.0 111.096 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.408 HD12 HG21 ' A' ' 88' ' ' VAL . 62.6 mt -75.78 -57.8 5.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.464 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.81 -160.87 0.75 Allowed 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.456 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 18.9 t80 -116.48 -23.48 8.26 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.838 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.0 m -78.02 68.2 4.01 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 169.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.456 ' HE2' ' HA ' ' A' ' 32' ' ' TYR . 27.6 mtmt -90.9 125.55 35.79 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.874 -176.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.514 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 9.4 mtpm? -126.28 113.57 17.13 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 69.9 t -113.24 113.41 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-O 121.781 0.801 . . . . 0.0 110.375 -173.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.867 ' HB ' HG13 ' A' ' 53' ' ' ILE . 6.6 p -122.42 111.61 17.07 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.364 -173.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 1.058 ' HB ' HG22 ' A' ' 54' ' ' ILE . 95.0 t -79.66 111.62 16.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.375 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 51' ' ' GLY . 1.0 OUTLIER -107.66 110.08 30.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.663 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.799 ' CE1' ' HB2' ' A' ' 42' ' ' ASP . 0.3 OUTLIER -105.19 154.48 20.15 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.915 0.865 . . . . 0.0 112.875 -174.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.728 ' HB2' ' CZ2' ' A' ' 47' ' ' TRP . . . -78.26 76.29 4.77 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 168.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.799 ' HB2' ' CE1' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -54.08 159.06 1.94 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 112.351 -2.204 . . . . 0.0 112.399 176.732 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.49 -109.29 1.88 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 113.744 -1.571 . . . . 0.0 113.455 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.491 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 16.0 m -89.41 -48.0 7.63 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 -175.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 44' ' ' SER . 6.1 p-10 170.69 28.73 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.523 0.729 . . . . 0.0 110.29 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -107.15 114.68 28.89 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -163.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.728 ' CZ2' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -101.93 83.9 2.45 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -74.95 44.3 0.23 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.886 -178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 51.09 33.52 9.35 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.664 0.745 . . . . 0.0 110.785 -176.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -110.73 -16.68 13.54 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.696 ' O ' HG13 ' A' ' 39' ' ' VAL . . . 77.12 -60.18 3.52 Favored Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.487 -174.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.56 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 82.6 m-20 74.83 73.57 0.1 Allowed 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.867 HG13 ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -109.0 138.84 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.943 -163.009 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 1.058 HG22 ' HB ' ' A' ' 38' ' ' VAL . 8.9 tp -116.12 127.9 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 114.322 -1.308 . . . . 0.0 108.03 168.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.5 129.84 34.99 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.888 -176.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -97.45 158.39 15.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.986 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 99.0 p -123.94 175.57 6.86 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.732 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 19.3 p90 -127.97 145.6 50.92 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.266 0.555 . . . . 0.0 111.472 -178.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.1 m -84.08 -37.7 21.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.11 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 157.35 161.73 11.07 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.315 175.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.898 ' HA ' ' HA ' ' A' ' 68' ' ' GLU . 28.5 Cg_endo -58.19 152.16 54.53 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 123.065 2.51 . . . . 0.0 112.028 177.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 23.9 mt -86.75 103.56 13.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.177 -175.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.5 p -62.93 120.54 11.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.211 0.529 . . . . 0.0 111.063 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.66 -7.54 29.9 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -175.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -141.87 171.37 14.15 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -105.21 38.19 2.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.641 0.734 . . . . 0.0 110.133 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -120.3 177.37 5.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.747 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.898 ' HA ' ' HA ' ' A' ' 61' ' ' PRO . 12.3 tt0 -128.3 166.98 17.58 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.347 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -124.58 114.81 19.87 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 -169.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.776 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 14.4 m95 -111.88 148.05 34.49 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.818 -167.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.592 HG22 ' HB3' ' A' ' 24' ' ' LYS . 1.6 p -150.51 146.37 26.56 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.322 0.388 . . . . 0.0 110.496 -172.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.414 ' HB3' ' O ' ' A' ' 71' ' ' THR . 4.2 p90 -175.19 157.57 2.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.578 0.704 . . . . 0.0 112.016 172.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.1 p -114.62 146.31 40.97 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.838 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -139.02 113.68 9.1 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -173.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.5 m -72.87 100.49 2.92 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 169.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.7 m -103.45 157.27 5.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.341 -176.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.18 14.44 10.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.495 0.664 . . . . 0.0 110.482 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.66 138.93 2.56 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.974 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.567 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 14.9 tt -171.49 153.23 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.216 0.532 . . . . 0.0 110.25 177.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 44' ' ' SER . 16.2 tppt? -135.64 -47.97 0.69 Allowed 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.725 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 14.3 pt-20 -149.2 176.42 10.52 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.454 ' CB ' ' HA ' ' A' ' 40' ' ' TYR . 55.5 p90 -170.02 168.68 8.42 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 119.382 0.992 . . . . 0.0 112.316 -178.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.91 ' HB3' ' HB3' ' A' ' 96' ' ' ASN . 0.2 OUTLIER -146.48 143.93 29.3 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.542 169.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.951 HD12 HG22 ' A' ' 38' ' ' VAL . 17.6 mm -89.43 138.76 18.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.225 -174.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.477 ' HE2' ' HE1' ' A' ' 94' ' ' TYR . 32.3 mmtp -97.7 107.75 20.32 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.438 0.637 . . . . 0.0 109.289 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.594 ' O ' ' HA ' ' A' ' 92' ' ' THR . 8.4 t80 -89.28 100.9 13.59 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.656 -1.157 . . . . 0.0 109.917 -177.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 91' ' ' LYS . 26.4 tt0 -104.24 113.88 27.73 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.818 -176.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.408 HG21 HD12 ' A' ' 30' ' ' ILE . 5.2 t -119.9 105.69 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.609 -177.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.6 t 50.95 27.14 3.02 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 123.646 0.591 . . . . 0.0 111.155 177.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.58 -18.09 17.8 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.335 -176.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 87' ' ' GLU . 21.2 mmtm -81.81 176.8 9.3 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 117.598 0.699 . . . . 0.0 111.508 -176.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 86' ' ' TYR . 18.0 m -150.59 141.06 22.47 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.662 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.446 ' HD2' ' CD2' ' A' ' 86' ' ' TYR . 63.8 m-85 -146.05 -171.71 3.77 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 170.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.477 ' HE1' ' HE2' ' A' ' 85' ' ' LYS . 51.0 m-85 -146.19 141.23 27.23 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.895 0.379 . . . . 0.0 111.601 -172.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.524 ' HB2' HG13 ' A' ' 9' ' ' VAL . 35.5 t70 -130.16 112.92 13.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.461 167.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.91 ' HB3' ' HB3' ' A' ' 83' ' ' TYR . 36.3 p-10 -130.09 -29.68 2.04 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.15 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.561 HD21 ' HB3' ' A' ' 100' ' ' ALA . 26.1 p-10 159.12 -42.9 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.544 1.137 . . . . 0.0 108.198 172.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 175.49 -37.13 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.421 174.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.2 p -178.06 23.94 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.561 ' HB3' HD21 ' A' ' 97' ' ' ASN . . . -138.06 -17.14 1.23 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -175.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.768 ' HA ' ' HB2' ' A' ' 96' ' ' ASN . 77.5 m-20 87.73 142.65 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.894 0.478 . . . . 0.0 110.739 173.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.562 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 85.0 m-85 -71.76 120.96 18.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.969 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.439 HE21 ' HB3' ' A' ' 81' ' ' GLU . 1.1 mp0 -83.71 129.61 34.95 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 174.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.59 153.39 4.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.1 p -74.71 56.75 0.72 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.459 0.647 . . . . 0.0 111.824 -177.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.31 177.544 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo . . . . . 0 C--O 1.233 0.258 0 CA-C-O 121.283 0.451 . . . . 0.0 112.928 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.9 t -166.35 -51.92 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.912 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.7 m -83.65 -77.35 0.26 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.194 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -139.4 -173.89 3.73 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 120.645 0.259 . . . . 0.0 111.208 -176.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -67.26 -30.91 70.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.42 0.629 . . . . 0.0 109.962 177.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.667 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.4 p -140.68 148.89 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.299 -178.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -140.9 129.35 22.55 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.859 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.586 HD21 ' HD2' ' A' ' 14' ' ' TYR . 23.7 tp -69.06 141.94 54.65 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.213 0.53 . . . . 0.0 110.957 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.497 ' HB3' ' O ' ' A' ' 24' ' ' LYS . 30.0 t70 -85.68 -68.77 0.71 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.752 175.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.7 p -175.94 164.74 2.9 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.741 -177.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.586 ' HD2' HD21 ' A' ' 11' ' ' LEU . 53.2 p90 -156.64 154.42 30.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.564 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -130.55 159.9 35.77 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.125 0.488 . . . . 0.0 110.468 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 20' ' ' THR . 10.4 t80 -122.33 138.25 54.58 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 170.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -153.76 115.06 4.14 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.234 -174.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.01 -95.78 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -168.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.639 ' OG ' ' HA ' ' A' ' 77' ' ' LYS . 10.4 t -139.6 88.13 2.23 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 162.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 87.8 m -146.35 139.97 26.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.47 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.73 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 24.3 t80 -115.06 99.25 7.31 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-O 121.672 0.749 . . . . 0.0 109.278 176.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 17.7 p -126.42 150.01 48.92 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.27 -175.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.86 -162.3 36.07 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.723 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 0.6 OUTLIER -158.42 163.66 37.0 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -177.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.605 HD12 HG11 ' A' ' 36' ' ' VAL . 24.7 mt -135.79 160.29 39.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.927 0.394 . . . . 0.0 111.774 -168.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.418 ' N ' HG22 ' A' ' 25' ' ' ILE . 6.4 t80 -132.85 103.09 5.91 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.433 0.693 . . . . 0.0 109.798 -174.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.667 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 1.5 m -136.65 151.89 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 121.39 -0.819 . . . . 0.0 111.492 -172.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -76.45 152.95 36.01 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 178.317 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -104.6 121.94 44.57 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.345 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.478 HD12 ' OH ' ' A' ' 86' ' ' TYR . 7.1 mt -106.98 -52.83 6.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.823 0.821 . . . . 0.0 109.561 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.72 152.34 51.85 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 105.283 -2.118 . . . . 0.0 105.283 173.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.418 ' O ' ' C ' ' A' ' 33' ' ' SER . 12.1 m-85 -59.04 -83.93 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 117.768 -1.11 . . . . 0.0 113.068 -170.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 32' ' ' TYR . 24.8 m -21.85 104.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 124.49 1.119 . . . . 0.0 111.647 -174.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.751 ' HB3' ' CH2' ' A' ' 70' ' ' TRP . 84.5 mttt -94.77 111.43 23.21 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 124.882 2.277 . . . . 0.0 115.88 -148.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.806 ' HD3' HG13 ' A' ' 88' ' ' VAL 0.489 4.6 pttm -56.84 79.93 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.006 1 CA-C-N 108.264 -4.062 . . . . 0.0 120.545 169.8 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.605 HG11 HD12 ' A' ' 25' ' ' ILE . 52.1 t -142.47 113.65 3.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-O 121.5 0.667 . . . . 0.0 111.599 154.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.628 ' HB ' HG13 ' A' ' 53' ' ' ILE . 2.5 p -131.53 102.79 6.07 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.804 173.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.95 ' HB ' HG22 ' A' ' 54' ' ' ILE . 61.4 t -73.83 104.2 2.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.377 -176.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.621 HG12 ' HB ' ' A' ' 53' ' ' ILE . 4.5 m -102.94 110.28 29.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -105.18 150.86 24.72 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.14 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.663 ' HB2' ' CZ2' ' A' ' 47' ' ' TRP . . . -74.22 82.58 1.84 Allowed 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 172.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -49.95 -172.48 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 113.065 -1.879 . . . . 0.0 113.669 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -54.35 -28.98 45.27 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 116.046 -0.524 . . . . 0.0 113.784 -175.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.2 t -72.11 -16.83 62.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.834 0.317 . . . . 0.0 111.069 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.7 t70 67.57 36.01 3.9 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.819 0.819 . . . . 0.0 109.072 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -147.75 160.67 42.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.263 -176.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.663 ' CZ2' ' HB2' ' A' ' 41' ' ' ALA . 5.7 m95 -115.9 82.31 1.75 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.669 0.747 . . . . 0.0 110.38 -176.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.638 ' ND2' ' HB2' ' A' ' 50' ' ' ASN . 2.5 p-10 -116.45 168.94 9.71 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.239 173.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -79.51 57.53 2.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.942 0.877 . . . . 0.0 111.062 -175.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.638 ' HB2' ' ND2' ' A' ' 48' ' ' ASN . 59.3 t30 -88.93 11.75 17.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.32 -177.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.67 33.32 52.16 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -176.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -93.63 34.49 1.18 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.551 0.691 . . . . 0.0 110.526 -175.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.692 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -122.15 139.32 49.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.881 179.23 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.95 HG22 ' HB ' ' A' ' 38' ' ' VAL . 5.8 tp -116.2 126.51 73.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 170.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -89.6 126.58 35.67 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.673 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.61 168.69 17.9 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.931 -174.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.7 t -128.0 132.87 49.12 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -77.75 145.81 36.27 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.39 0.614 . . . . 0.0 110.921 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.3 m -92.16 -33.37 14.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.97 172.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 160.84 169.2 23.78 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.455 172.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 68' ' ' GLU . 16.5 Cg_exo -68.49 133.6 28.47 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.562 2.175 . . . . 0.0 110.152 171.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 65' ' ' SER . 42.4 mt -71.03 122.13 22.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 120.981 0.42 . . . . 0.0 110.729 -172.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.5 p -58.03 128.1 35.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.915 -174.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 70.85 15.56 73.93 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.355 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.541 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 26.4 m -130.46 166.54 20.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.958 0.409 . . . . 0.0 110.671 -178.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -102.47 17.77 22.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.554 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 5.7 m-85 -120.18 169.32 10.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.326 -176.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 61' ' ' PRO . 19.6 tt0 -117.33 170.74 8.46 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.002 -1.454 . . . . 0.0 108.705 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -138.15 110.4 7.37 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -162.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.751 ' CH2' ' HB3' ' A' ' 34' ' ' LYS . 18.7 m95 -111.86 147.67 35.29 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.063 -168.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.47 ' HA ' ' HB2' ' A' ' 24' ' ' LYS . 5.7 p -141.74 142.96 33.28 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -154.07 169.45 23.5 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.099 -1.041 . . . . 0.0 112.913 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.6 p -144.24 137.29 27.2 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.179 173.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.73 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -134.09 120.82 20.65 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.436 -173.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.8 t -78.42 99.36 6.37 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 172.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.464 HG13 ' HB3' ' A' ' 21' ' ' PHE . 4.8 m -120.16 151.5 22.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -176.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.639 ' HA ' ' OG ' ' A' ' 19' ' ' SER . 0.2 OUTLIER -141.35 31.33 1.72 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.46 0.648 . . . . 0.0 110.366 174.413 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.09 95.52 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.725 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.8 tt -151.82 141.77 15.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.36 0.6 . . . . 0.0 110.276 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -115.18 -54.32 2.56 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.956 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.487 ' OE1' ' HB3' ' A' ' 103' ' ' GLN . 13.2 mm-40 -135.08 176.8 8.33 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -173.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.436 ' HZ ' ' CD2' ' A' ' 14' ' ' TYR . 28.3 p90 -168.7 160.53 10.69 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.703 171.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.446 ' HB3' HD22 ' A' ' 96' ' ' ASN . 0.1 OUTLIER -147.22 144.03 28.61 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.434 168.681 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.909 HD12 HG22 ' A' ' 38' ' ' VAL . 14.4 mm -91.28 134.81 28.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.687 -172.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.578 ' HB2' ' OG1' ' A' ' 37' ' ' THR . 4.5 mtmp? -88.3 114.87 25.35 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.61 0.719 . . . . 0.0 109.857 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.608 ' CD2' ' HD1' ' A' ' 93' ' ' TYR . 9.5 t80 -86.15 100.04 11.94 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.327 -1.306 . . . . 0.0 107.518 178.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.519 ' C ' ' HB3' ' A' ' 35' ' ' LYS . 30.1 tt0 -124.04 104.23 8.76 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 122.108 0.956 . . . . 0.0 113.043 -162.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.806 HG13 ' HD3' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -110.1 164.53 6.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.408 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.3 m -77.06 40.17 0.25 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.856 0.836 . . . . 0.0 111.235 -177.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . 177.5 -34.07 0.08 OUTLIER Glycine 0 N--CA 1.436 -1.332 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.517 175.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.478 ' O ' HG23 ' A' ' 88' ' ' VAL . 12.9 mptt -110.98 149.43 30.69 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 120.794 0.331 . . . . 0.0 111.325 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.3 m -149.3 138.44 21.37 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.358 0.599 . . . . 0.0 110.965 174.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.608 ' HD1' ' CD2' ' A' ' 86' ' ' TYR . 18.6 m-85 -146.5 -166.65 2.54 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 176.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -144.03 140.47 29.57 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.885 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -96.19 92.89 6.61 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 168.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.446 HD22 ' HB3' ' A' ' 83' ' ' TYR . 3.6 t-20 -129.56 18.53 5.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.097 -174.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 65.97 -68.12 0.13 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.278 -171.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -159.01 -56.07 0.06 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.0 t -167.74 38.72 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 170.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -99.41 -37.99 9.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.09 -169.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 93.0 m-20 72.62 142.28 0.06 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.351 0.596 . . . . 0.0 110.496 -174.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -95.1 100.18 12.05 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.169 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.487 ' HB3' ' OE1' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -76.61 131.98 39.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.436 179.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.8 t -85.24 152.08 3.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.985 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.3 t -83.83 71.42 10.45 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.8 p . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.87 176.909 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.038 0 CA-C-O 120.794 0.33 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.4 m -102.42 112.84 25.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.124 0.488 . . . . 0.0 110.103 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.63 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 47.7 mm -78.94 -53.86 1.1 Allowed Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.265 -178.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.63 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 73.3 Cg_exo -50.01 135.3 36.83 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 122.211 1.941 . . . . 0.0 112.768 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.7 t -152.77 -63.88 0.16 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.324 -176.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.6 m -69.31 -62.69 1.28 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.122 0.487 . . . . 0.0 110.041 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.99 -158.2 0.89 Allowed 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.8 m -64.79 -24.82 67.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.563 0.697 . . . . 0.0 109.221 173.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.853 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.5 p -129.24 155.43 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.584 -178.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -143.81 137.97 28.38 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.451 HD21 ' HD2' ' A' ' 14' ' ' TYR . 34.8 tp -70.55 126.54 29.91 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.121 0.486 . . . . 0.0 111.175 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -74.21 -62.22 1.59 Allowed 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.825 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.2 p 176.55 167.25 0.48 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.214 -175.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.483 ' HA ' ' O ' ' A' ' 22' ' ' SER . 49.0 p90 -157.8 160.34 37.69 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.306 -1.315 . . . . 0.0 107.8 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -126.09 163.24 23.52 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.979 0.419 . . . . 0.0 110.326 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.486 ' HA ' ' O ' ' A' ' 20' ' ' THR . 37.5 t80 -152.5 149.59 28.7 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.284 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -179.76 126.14 0.08 Allowed 'General case' 0 C--N 1.321 -0.644 0 O-C-N 123.715 0.634 . . . . 0.0 109.376 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.44 -105.8 0.99 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 -170.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.542 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 20.4 m -133.35 86.08 2.27 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 166.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 96.2 m -148.07 136.07 21.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.709 177.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.728 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 23.8 t80 -117.32 138.88 51.47 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 171.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 25.9 p -150.04 109.87 4.08 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 14' ' ' TYR . . . -133.77 149.47 19.72 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.15 -1.024 . . . . 0.0 113.057 -166.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.662 ' HB3' HG22 ' A' ' 71' ' ' THR . 24.3 pttm -140.34 154.69 46.85 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.63 HD13 HG21 ' A' ' 84' ' ' ILE . 19.0 mt -134.91 154.63 36.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.071 -165.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -123.24 99.32 6.29 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.255 -174.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.853 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 1.7 m -136.25 149.95 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.337 0.589 . . . . 0.0 112.372 -170.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.633 ' HB2' ' CE1' ' A' ' 67' ' ' TYR . 7.7 ttmm -81.25 144.19 31.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.642 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -82.96 103.82 12.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.65 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.663 HG12 ' OH ' ' A' ' 86' ' ' TYR . 19.0 mm -81.68 -59.29 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.43 -151.86 0.49 Allowed 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 114.033 -1.44 . . . . 0.0 107.706 174.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -109.04 -44.95 3.86 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.049 -0.661 . . . . 0.0 111.46 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.4 t -76.93 82.27 3.48 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.589 0.709 . . . . 0.0 109.898 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 34' ' ' LYS . 28.1 mtmt -110.67 152.41 26.55 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.968 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -142.31 110.12 5.83 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 122.277 1.037 . . . . 0.0 109.021 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.0 t -92.12 124.73 44.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.593 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.763 ' HB ' HG13 ' A' ' 53' ' ' ILE . 59.2 p -123.27 117.4 25.18 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.244 -170.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.811 HG11 ' CD2' ' A' ' 40' ' ' TYR . 57.3 t -73.38 141.24 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.019 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 170.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -124.6 100.1 7.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 159.102 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.811 ' CD2' HG11 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -119.21 126.08 50.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 122.218 1.009 . . . . 0.0 110.684 179.112 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.51 ' HB2' ' CZ3' ' A' ' 47' ' ' TRP . . . -86.59 151.13 23.72 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.768 -164.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.454 ' C ' ' H ' ' A' ' 44' ' ' SER . 2.8 m-20 -72.85 177.5 4.83 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.154 -1.839 . . . . 0.0 110.863 -166.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.36 33.8 1.34 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.805 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.454 ' H ' ' C ' ' A' ' 42' ' ' ASP . 22.7 t -112.26 -10.52 13.82 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 175.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 16.6 t70 76.58 91.26 0.07 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 113.535 -1.666 . . . . 0.0 110.341 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.446 ' HB3' ' O ' ' A' ' 45' ' ' ASP . 22.9 t-20 84.69 154.64 0.09 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.996 170.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.617 ' HE1' ' HB2' ' A' ' 52' ' ' ASN . 8.2 m-90 -72.48 124.47 25.25 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -172.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -78.22 74.25 4.76 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.264 -1.334 . . . . 0.0 108.691 167.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.1 t30 47.86 34.08 3.71 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.676 0.75 . . . . 0.0 110.781 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -119.15 174.46 6.32 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -173.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -141.78 77.32 0.3 Allowed Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 119.808 -1.187 . . . . 0.0 112.213 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.617 ' HB2' ' HE1' ' A' ' 47' ' ' TRP . 78.3 m-20 -79.84 95.11 5.95 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 121.229 0.538 . . . . 0.0 111.515 -178.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.763 HG13 ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -108.49 142.64 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.006 -177.18 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.495 ' CG2' ' HB ' ' A' ' 38' ' ' VAL . 17.5 tt -135.99 122.74 32.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.307 173.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.52 134.5 43.85 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.024 0.44 . . . . 0.0 111.756 -170.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -91.32 164.83 13.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.691 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -128.36 140.13 52.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.062 0.458 . . . . 0.0 110.063 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -71.46 145.58 49.15 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.231 0.539 . . . . 0.0 110.642 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.1 t -107.59 -44.26 4.32 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.888 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.44 170.52 36.35 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.969 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -70.13 140.84 42.23 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.855 2.37 . . . . 0.0 111.666 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.661 HD12 ' HB3' ' A' ' 67' ' ' TYR . 28.8 mt -78.71 105.99 8.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.097 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.7 m -65.85 117.09 7.75 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.365 0.603 . . . . 0.0 110.636 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.28 -14.69 9.4 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.41 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.9 m -150.25 164.76 34.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.955 0.407 . . . . 0.0 110.711 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -89.89 62.07 5.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.429 0.633 . . . . 0.0 109.443 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.661 ' HB3' HD12 ' A' ' 62' ' ' ILE . 1.7 m-85 -138.52 169.59 17.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.466 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -122.09 171.6 8.86 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.554 ' HB2' HG12 ' A' ' 62' ' ' ILE . 1.5 t80 -140.28 122.11 15.46 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -163.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.647 ' CD1' HG13 ' A' ' 27' ' ' VAL . 7.1 m95 -121.28 144.56 48.56 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.015 -165.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.662 HG22 ' HB3' ' A' ' 24' ' ' LYS . 21.3 p -145.81 153.45 40.92 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 122.9 0.125 . . . . 0.0 110.74 -178.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -173.01 155.72 3.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.219 0.533 . . . . 0.0 111.209 167.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.2 m -112.15 145.21 40.23 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.543 175.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.728 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -137.51 144.89 42.4 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.36 -175.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.3 t -99.95 99.15 9.88 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 173.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.542 ' O ' ' HB3' ' A' ' 19' ' ' SER . 3.9 m -103.48 138.34 28.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 3.7 mptp? -101.95 -11.4 18.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.233 -173.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 42' ' ' ASP . . . -179.66 105.98 0.2 Allowed Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.494 HG12 HG21 ' A' ' 104' ' ' VAL . 11.1 tt -128.92 158.36 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.495 ' HE2' ' HA ' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -147.56 -42.07 0.17 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.289 -178.146 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 82' ' ' PHE . 23.0 mm-40 -135.32 164.69 27.16 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 118.56 -0.733 . . . . 0.0 109.086 -171.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.518 ' CB ' ' HA ' ' A' ' 40' ' ' TYR . 36.4 p90 -173.36 178.85 2.29 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 119.378 -0.929 . . . . 0.0 113.379 171.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.667 ' O ' HG23 ' A' ' 39' ' ' VAL . 1.0 OUTLIER -164.28 144.99 8.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.412 -1.722 . . . . 0.0 107.704 167.368 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.63 HG21 HD13 ' A' ' 25' ' ' ILE . 28.3 mm -103.23 137.0 33.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.56 -174.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -104.13 146.12 29.2 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.774 0.797 . . . . 0.0 110.925 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.665 ' HB2' HG11 ' A' ' 9' ' ' VAL . 10.3 t80 -108.89 100.17 9.42 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.454 175.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -110.38 120.79 43.55 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.628 0.728 . . . . 0.0 109.38 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.538 ' C ' ' H ' ' A' ' 90' ' ' GLY . 86.4 t -121.72 155.92 26.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.207 -174.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.9 t -77.01 31.95 0.14 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 122.019 0.914 . . . . 0.0 109.677 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.538 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -158.83 -33.14 0.02 OUTLIER Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.91 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.445 ' HE3' ' H ' ' A' ' 92' ' ' THR . 13.3 mmmt -145.66 178.8 7.87 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.82 0.819 . . . . 0.0 112.138 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.445 ' H ' ' HE3' ' A' ' 91' ' ' LYS . 5.6 m -149.27 143.62 25.97 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.086 174.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.448 ' CD1' ' HD2' ' A' ' 86' ' ' TYR . 25.9 m-85 -143.36 -172.26 3.66 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -145.24 138.44 26.46 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.609 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -111.25 104.24 12.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 165.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 98' ' ' ASN . 49.6 t30 -151.93 87.45 1.35 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.613 -171.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.565 HD21 ' HB3' ' A' ' 100' ' ' ALA . 13.4 p-10 42.22 -68.2 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.465 1.906 . . . . 0.0 115.343 168.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 96' ' ' ASN . 54.8 t30 -159.92 -49.6 0.05 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -177.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.0 p -174.48 20.31 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.859 175.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.565 ' HB3' HD21 ' A' ' 97' ' ' ASN . . . -129.15 -87.31 0.54 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -174.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -169.17 147.84 3.87 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.348 0.659 . . . . 0.0 109.812 -169.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.463 ' CE2' ' HA ' ' A' ' 96' ' ' ASN . 77.1 m-85 -85.88 122.96 30.68 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 170.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -77.26 122.48 25.14 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.494 HG21 HG12 ' A' ' 79' ' ' ILE . 47.5 t -78.16 132.21 32.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.8 m -73.47 77.07 1.43 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.15 0.5 . . . . 0.0 110.913 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 m . . . . . 0 C--O 1.246 0.9 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.49 176.31 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.7 m -66.29 158.49 28.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.706 0.288 . . . . 0.0 110.74 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.448 ' N ' HD12 ' A' ' 3' ' ' ILE . 3.7 mp -103.56 107.34 55.85 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.908 0.385 . . . . 0.0 110.602 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.63 ' HG2' ' CZ ' ' A' ' 67' ' ' TYR . 45.4 Cg_endo -68.16 143.26 58.64 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 123.036 2.49 . . . . 0.0 112.365 175.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.7 t -128.81 -13.43 4.67 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.354 0.597 . . . . 0.0 109.987 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.1 m -90.1 -6.77 55.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.113 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.34 28.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.576 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.494 ' HB3' HD11 ' A' ' 30' ' ' ILE . 1.6 m -92.88 -27.23 17.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.558 0.694 . . . . 0.0 109.228 175.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.758 HG23 ' HB ' ' A' ' 27' ' ' VAL . 2.2 p -149.89 146.64 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.015 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -135.7 128.76 31.58 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.497 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.502 HD21 ' CD1' ' A' ' 14' ' ' TYR . 36.9 tp -71.85 133.56 45.55 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.172 174.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -81.27 -64.02 1.27 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.969 177.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.6 p 177.32 166.52 0.6 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.851 -177.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.502 ' CD1' HD21 ' A' ' 11' ' ' LEU . 50.3 p90 -157.47 163.9 37.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.056 -177.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -153.18 163.89 39.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.938 0.399 . . . . 0.0 110.989 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.548 ' HD1' ' HD1' ' A' ' 21' ' ' PHE . 35.6 t80 -131.38 149.39 52.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.668 -176.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -174.71 117.82 0.2 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.226 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.0 -99.77 0.34 Allowed Glycine 0 CA--C 1.511 -0.208 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.6 t -135.47 83.46 2.02 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 164.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 62.6 m -148.42 134.33 19.08 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.503 172.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.548 ' HD1' ' HD1' ' A' ' 16' ' ' TYR . 7.8 t80 -132.74 102.34 5.63 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 169.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.4 t -139.04 167.42 22.1 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.952 -171.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.22 -154.35 25.33 Favored Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.564 ' HB3' HG22 ' A' ' 71' ' ' THR . 0.0 OUTLIER -155.64 173.49 16.65 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.433 0.635 . . . . 0.0 112.007 179.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.643 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 83.4 mt -136.53 153.37 30.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.58 -167.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -130.58 100.39 5.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.93 -174.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.758 ' HB ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -141.79 145.77 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -169.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.633 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . 21.2 ptmt -97.62 154.56 17.47 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.805 -175.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.918 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 20.1 p-10 -75.1 115.7 15.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.96 177.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.659 HG12 ' OH ' ' A' ' 86' ' ' TYR . 34.4 mm -77.81 -56.07 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 167.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.49 -86.4 0.41 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.778 171.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -163.77 -68.47 0.04 OUTLIER 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 172.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m -80.71 124.33 28.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.861 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.918 ' HE3' ' HA ' ' A' ' 29' ' ' ASN . 37.8 mttp -122.81 176.66 5.86 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.341 0.591 . . . . 0.0 111.166 -172.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.856 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 96.4 mttt -121.14 136.54 54.96 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 166.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.3 t -127.66 113.63 32.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 122.014 0.911 . . . . 0.0 109.739 171.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 1.116 ' HB ' HD11 ' A' ' 53' ' ' ILE . 1.0 OUTLIER -131.48 136.14 47.67 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.148 -1.387 . . . . 0.0 110.413 -175.142 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 1.018 ' HB ' HG22 ' A' ' 54' ' ' ILE . 69.3 t -93.4 132.71 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.451 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.569 ' O ' ' HH2' ' A' ' 47' ' ' TRP . 2.7 m -112.8 104.77 17.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 165.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.719 ' CD1' HG12 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -122.18 120.87 35.46 Favored 'General case' 0 N--CA 1.4 -2.974 0 CA-C-N 114.902 -1.044 . . . . 0.0 110.054 -170.107 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.649 ' HB2' ' CE3' ' A' ' 47' ' ' TRP . . . -76.5 129.0 35.87 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.53 -169.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -67.42 179.91 1.19 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.523 -1.672 . . . . 0.0 111.354 -168.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.604 ' HA2' ' HG2' ' A' ' 80' ' ' LYS . . . -68.0 -0.28 14.02 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.079 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.0 m -66.45 -22.75 66.21 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.013 0.435 . . . . 0.0 110.044 174.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 t70 64.69 37.66 7.47 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.133 -0.939 . . . . 0.0 108.98 177.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -173.86 140.28 0.73 Allowed 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -172.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.649 ' CE3' ' HB2' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -89.39 85.88 6.66 Favored 'General case' 0 N--CA 1.421 -1.893 0 C-N-CA 118.608 -1.237 . . . . 0.0 112.516 -173.204 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -56.66 132.32 51.56 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.37 165.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -72.12 70.22 0.79 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.849 0.833 . . . . 0.0 111.317 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -112.74 -17.86 12.45 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.652 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.47 -58.34 3.05 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.709 -176.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 92.4 m-20 59.83 76.3 0.37 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.655 -0.773 . . . . 0.0 110.144 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 1.116 HD11 ' HB ' ' A' ' 37' ' ' THR . 5.7 tp -109.07 148.89 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-O 121.816 0.817 . . . . 0.0 112.044 -176.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 1.018 HG22 ' HB ' ' A' ' 38' ' ' VAL . 3.4 tp -133.03 140.34 47.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.494 -1.23 . . . . 0.0 107.712 167.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -92.84 116.42 29.01 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.287 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.12 156.28 39.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.215 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.8 t -114.83 144.8 42.94 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -174.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -71.25 142.06 50.56 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.283 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.4 t -109.12 -42.27 4.46 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.81 171.8 21.94 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.569 173.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.15 142.75 42.58 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.403 2.068 . . . . 0.0 110.637 173.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.55 HG12 ' HB2' ' A' ' 69' ' ' TYR . 9.7 mt -83.63 83.83 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.8 m -53.5 126.41 21.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.385 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 113.31 -32.42 6.11 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.252 -173.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -127.24 165.99 18.61 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -95.43 55.01 1.66 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.135 0.493 . . . . 0.0 110.863 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.633 ' CE1' ' HB3' ' A' ' 28' ' ' LYS . 2.4 m-85 -137.04 159.3 42.31 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.328 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -107.29 173.59 6.26 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.922 176.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.55 ' HB2' HG12 ' A' ' 62' ' ' ILE . 3.1 t80 -143.5 120.84 11.61 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -165.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.643 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 20.6 m95 -127.79 138.65 52.81 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.922 -166.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.564 HG22 ' HB3' ' A' ' 24' ' ' LYS . 6.5 p -124.33 133.25 53.51 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -125.93 136.97 53.64 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.488 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.7 p -125.7 139.44 53.54 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.236 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.97 118.99 5.43 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.782 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.9 t -82.57 99.4 9.5 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.429 ' CG2' ' HE1' ' A' ' 16' ' ' TYR . 13.8 m -99.48 144.66 11.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.375 -173.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.01 8.39 43.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.279 0.562 . . . . 0.0 110.563 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 156.81 145.8 4.3 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.639 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.602 HG12 HG21 ' A' ' 104' ' ' VAL . 7.3 tt -168.09 142.47 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.309 0.576 . . . . 0.0 110.873 177.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.604 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 3.7 mmmp? -125.48 -38.7 2.24 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.28 -177.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 29.4 mt-10 -141.65 167.22 22.67 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.635 ' HB2' ' HA ' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -171.89 170.45 5.44 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.017 -0.673 . . . . 0.0 112.056 172.197 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.651 ' HD2' ' HB3' ' A' ' 96' ' ' ASN . 0.1 OUTLIER -159.46 148.54 18.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.195 169.092 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.904 HD12 HG22 ' A' ' 38' ' ' VAL . 21.5 mm -95.01 140.76 16.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.706 -169.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.6 mtmt -90.7 114.09 26.33 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.157 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.659 ' OH ' HG12 ' A' ' 30' ' ' ILE . 10.5 t80 -91.95 99.72 12.51 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 172.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.856 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 9.3 tt0 -109.63 107.84 18.04 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.63 0.729 . . . . 0.0 110.206 -174.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.469 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 20.6 t -87.21 164.02 2.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.061 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.429 ' N ' HG12 ' A' ' 88' ' ' VAL . 1.1 m -43.51 -40.86 4.11 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.405 0.44 . . . . 0.0 111.156 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -136.37 23.64 3.28 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.185 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.469 ' HB2' ' HB ' ' A' ' 88' ' ' VAL . 16.5 mmtp -141.74 175.44 9.7 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.772 0.796 . . . . 0.0 111.758 177.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.8 m -149.19 138.83 21.78 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.614 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.421 ' HD2' ' CD2' ' A' ' 86' ' ' TYR . 60.7 m-85 -140.6 -169.25 2.75 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -148.07 145.49 28.46 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.147 0.498 . . . . 0.0 111.503 -173.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.417 ' OD2' ' HB2' ' A' ' 11' ' ' LEU . 17.6 t70 -107.78 97.68 7.37 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 167.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.651 ' HB3' ' HD2' ' A' ' 83' ' ' TYR . 34.0 p30 -144.03 31.98 1.25 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -172.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 67.88 -67.6 0.18 Allowed 'General case' 0 CA--C 1.532 0.275 0 O-C-N 123.629 0.58 . . . . 0.0 111.403 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -171.66 40.25 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -175.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.6 t 63.64 46.6 4.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.954 -167.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -102.3 -38.55 7.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.99 -176.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 7.3 m-20 67.94 115.1 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.781 0.676 . . . . 0.0 110.282 -174.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 7.9 m-85 -77.14 133.21 39.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.437 -174.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -79.19 129.63 34.65 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.602 HG21 HG12 ' A' ' 79' ' ' ILE . 96.3 t -79.25 133.84 29.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.677 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.1 p -77.14 77.01 3.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.725 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.248 1.008 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.177 178.652 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.904 0.383 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.9 p -105.18 168.79 8.83 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.881 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.812 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 3.4 mp -72.74 -59.8 2.21 Favored Pre-proline 0 C--N 1.323 -0.562 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.635 178.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.812 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 1.9 Cg_endo -84.22 144.8 10.68 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.42 2.08 . . . . 0.0 112.014 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.4 m -128.44 -54.96 1.25 Allowed 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.33 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.6 m -106.09 -68.62 0.87 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.351 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.28 -172.8 2.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 120.908 0.385 . . . . 0.0 111.862 -173.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 m -64.86 -26.56 68.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.214 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.728 ' CB ' ' HB ' ' A' ' 27' ' ' VAL . 2.2 p -120.57 148.31 23.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.382 0.61 . . . . 0.0 112.015 -174.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.425 ' HA ' ' OD1' ' A' ' 95' ' ' ASP . 28.0 tt0 -143.72 132.22 22.26 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.474 173.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.671 HD21 ' CD1' ' A' ' 14' ' ' TYR . 40.5 tp -70.03 130.76 43.02 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.099 0.476 . . . . 0.0 110.238 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -76.84 -63.9 1.25 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.901 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.5 m -178.96 159.87 1.04 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.622 -174.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.671 ' CD1' HD21 ' A' ' 11' ' ' LEU . 53.7 p90 -157.95 163.49 37.78 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.654 -177.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -151.32 164.95 35.5 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -176.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.61 ' HA ' ' O ' ' A' ' 20' ' ' THR . 97.6 m-85 -138.92 138.34 37.28 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.754 -176.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -136.53 124.62 22.95 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 174.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.54 -99.44 0.18 Allowed Glycine 0 C--N 1.331 0.265 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -167.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.1 t -139.86 87.85 2.19 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 163.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.61 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 73.0 m -145.96 133.3 20.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.422 177.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.957 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 14.8 t80 -90.57 126.49 35.96 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 174.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.9 p -144.92 126.19 14.78 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.593 175.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.422 ' HA3' ' HA ' ' A' ' 14' ' ' TYR . . . 173.68 -154.14 19.14 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.384 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.609 ' HB3' HG22 ' A' ' 71' ' ' THR . 0.4 OUTLIER -161.85 166.07 26.86 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.196 0.522 . . . . 0.0 111.018 -177.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 33.8 mt -127.72 156.04 39.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.16 -172.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -126.9 96.32 4.59 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.866 -172.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.728 ' HB ' ' CB ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -147.91 143.23 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -172.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.553 ' HE3' ' CE1' ' A' ' 67' ' ' TYR . 17.0 ptpt -85.05 148.43 26.17 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.365 176.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.422 HD22 ' CD ' ' A' ' 68' ' ' GLU . 4.4 p30 -86.64 132.58 33.85 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.998 176.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.466 HG12 ' OH ' ' A' ' 86' ' ' TYR . 39.0 mm -80.33 -55.28 9.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.486 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.819 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . . . -103.84 -81.18 0.52 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.026 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -159.31 -73.25 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.285 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.611 ' C ' ' HE2' ' A' ' 34' ' ' LYS . 10.0 t -95.87 62.78 2.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.34 0.591 . . . . 0.0 109.913 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.926 ' HD2' HG13 ' A' ' 88' ' ' VAL . 6.3 mmpt? -80.68 157.1 26.02 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.496 ' HG3' ' HB3' ' A' ' 87' ' ' GLU . 18.3 pttp -124.81 141.34 52.18 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.167 -175.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.3 t -115.73 116.57 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.787 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.616 HG22 HD11 ' A' ' 53' ' ' ILE . 5.4 p -114.17 119.43 37.04 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.866 -170.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.824 HG22 HD12 ' A' ' 84' ' ' ILE . 96.8 t -84.19 113.63 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.89 176.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 0.3 OUTLIER -107.6 107.09 21.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 172.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.649 ' HA ' ' HB3' ' A' ' 82' ' ' PHE . 4.3 p90 -109.26 137.61 46.88 Favored 'General case' 0 CA--C 1.481 -1.699 0 CA-C-O 122.494 1.14 . . . . 0.0 110.075 177.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.717 ' HB2' ' CZ3' ' A' ' 47' ' ' TRP . . . -89.38 110.67 21.45 Favored 'General case' 0 N--CA 1.401 -2.894 0 CA-C-N 112.863 -1.971 . . . . 0.0 107.599 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -40.7 167.22 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 112.484 -2.143 . . . . 0.0 112.081 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.78 ' HA2' ' HB2' ' A' ' 80' ' ' LYS . . . -67.69 1.69 7.23 Favored Glycine 0 CA--C 1.518 0.264 0 CA-C-N 115.241 -0.891 . . . . 0.0 114.849 -163.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 30.7 t -87.49 -12.72 45.15 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 117.088 0.444 . . . . 0.0 111.009 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.616 ' OD1' ' HG2' ' A' ' 80' ' ' LYS . 5.3 m-20 74.27 48.75 0.12 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 124.038 0.836 . . . . 0.0 110.271 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -155.51 134.3 11.99 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.198 -171.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.717 ' CZ3' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -105.03 85.7 2.32 Favored 'General case' 0 N--CA 1.425 -1.705 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.681 178.019 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -71.85 145.43 48.59 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 167.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -61.71 90.8 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.301 0.572 . . . . 0.0 110.75 -176.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -152.22 147.12 26.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.092 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.03 59.46 4.94 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.897 -176.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -71.36 56.71 0.24 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.357 0.598 . . . . 0.0 109.843 172.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.629 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -116.25 141.1 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.436 -176.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.82 HG22 ' HB ' ' A' ' 38' ' ' VAL . 8.5 tp -121.76 130.3 74.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.034 -0.984 . . . . 0.0 108.372 173.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.71 128.62 34.84 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.011 -173.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.74 158.36 28.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.977 178.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 t -122.63 121.93 37.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 29.1 p90 -82.4 138.29 34.49 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 121.708 0.766 . . . . 0.0 111.363 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.402 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 65.8 m -97.03 -41.32 8.43 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 172.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.584 ' O ' ' HA ' ' A' ' 68' ' ' GLU . . . 118.55 -87.5 0.42 Allowed Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.18 -0.918 . . . . 0.0 113.541 170.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.402 ' HD2' ' O ' ' A' ' 59' ' ' SER . 18.6 Cg_endo -52.98 119.66 6.44 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 124.295 3.33 . . . . 0.0 115.959 -167.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.462 ' HB ' ' O ' ' A' ' 67' ' ' TYR . 21.6 mt -124.05 90.57 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.217 162.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.5 m -71.52 117.8 13.53 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.804 -174.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.68 -14.01 6.1 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.965 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -155.5 167.01 31.79 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -92.13 66.4 4.88 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.716 0.769 . . . . 0.0 109.438 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.553 ' CE1' ' HE3' ' A' ' 28' ' ' LYS . 2.2 m-85 -136.52 153.15 51.09 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.732 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 7.4 mp0 -106.44 174.78 5.74 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.888 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -137.55 115.75 11.75 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -166.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.689 ' NE1' HG13 ' A' ' 27' ' ' VAL . 8.0 m95 -116.16 121.85 43.32 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.649 -164.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.609 HG22 ' HB3' ' A' ' 24' ' ' LYS . 2.9 p -128.94 147.74 50.87 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 110.562 -0.162 . . . . 0.0 110.562 -171.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.503 ' HZ ' HG21 ' A' ' 38' ' ' VAL . 2.5 p90 -174.58 159.72 2.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.444 0.64 . . . . 0.0 112.202 174.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.2 m -115.24 146.45 41.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.54 169.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.957 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -138.77 128.84 25.38 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -174.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.0 t -81.76 100.9 9.79 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 172.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' A' ' 21' ' ' PHE . 22.4 m -98.32 151.88 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.921 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.42 11.49 38.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.042 0.449 . . . . 0.0 111.032 -172.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 124.99 102.55 1.4 Allowed Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.844 HG12 HG21 ' A' ' 104' ' ' VAL . 12.3 tt -115.6 156.38 16.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 120.657 0.265 . . . . 0.0 110.986 -174.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.78 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 4.8 tppp? -139.66 -45.86 0.45 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.145 0.497 . . . . 0.0 111.75 -177.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.709 ' HG3' ' HB3' ' A' ' 41' ' ' ALA . 4.7 pt-20 -147.77 156.86 43.19 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.315 -176.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.649 ' HB3' ' HA ' ' A' ' 40' ' ' TYR . 55.7 p90 -171.86 179.27 2.79 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 119.774 -0.77 . . . . 0.0 112.815 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.46 149.83 30.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.503 167.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.824 HD12 HG22 ' A' ' 38' ' ' VAL . 25.6 mm -102.57 130.83 51.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.42 -177.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -96.42 147.61 23.64 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.845 0.831 . . . . 0.0 111.073 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.603 ' HD2' ' HD2' ' A' ' 93' ' ' TYR . 12.0 t80 -109.91 101.21 10.07 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.245 -1.343 . . . . 0.0 107.893 172.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.496 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . 10.8 tt0 -103.85 107.79 18.82 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 122.002 0.906 . . . . 0.0 110.702 -169.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.926 HG13 ' HD2' ' A' ' 34' ' ' LYS . 15.2 t -110.63 162.22 8.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.271 -1.331 . . . . 0.0 108.369 -177.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.5 m -70.22 -14.93 62.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.756 0.313 . . . . 0.0 111.389 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.35 -3.61 2.71 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.061 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.4 ' H ' ' HB ' ' A' ' 88' ' ' VAL . 1.7 mmtm -142.11 160.44 40.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.099 0.476 . . . . 0.0 111.435 -177.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 86' ' ' TYR . 7.5 m -148.99 143.58 26.21 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.909 172.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.603 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 20.4 m-85 -137.67 -172.07 3.15 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 175.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -148.03 127.07 12.82 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.781 -175.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.425 ' OD1' ' HA ' ' A' ' 10' ' ' GLN . 23.2 t70 -93.26 94.02 8.55 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 166.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.443 ' C ' ' H ' ' A' ' 98' ' ' ASN . 30.4 p-10 -128.12 41.72 3.45 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.851 -164.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 71.83 -33.58 0.27 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.325 1.05 . . . . 0.0 112.087 178.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.443 ' H ' ' C ' ' A' ' 96' ' ' ASN . 28.4 t-20 171.42 -59.55 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 65.2 m -160.25 26.95 0.17 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.586 174.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.1 -92.1 0.19 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -174.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.448 ' ND2' HE22 ' A' ' 103' ' ' GLN . 0.3 OUTLIER -174.25 150.49 1.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.069 -168.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.581 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 81.5 m-85 -88.98 140.79 29.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.294 175.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.448 HE22 ' ND2' ' A' ' 101' ' ' ASN . 1.8 mp0 -97.28 120.43 37.63 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 123.612 0.57 . . . . 0.0 109.905 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.844 HG21 HG12 ' A' ' 79' ' ' ILE . 86.9 t -83.5 126.27 40.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.062 0.458 . . . . 0.0 111.234 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.3 p -87.71 67.3 9.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.892 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.494 HG23 HG12 ' A' ' 104' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.601 -0.714 . . . . 0.0 111.116 178.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.2 t -147.05 -176.32 5.16 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.811 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 3.0 mp -57.47 -56.53 33.15 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 123.39 0.431 . . . . 0.0 110.454 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.811 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 40.8 Cg_endo -92.82 137.28 1.49 Allowed 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 122.068 1.845 . . . . 0.0 111.231 170.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.2 t -145.61 -66.7 0.3 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.2 m -103.74 -30.95 10.09 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 173.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -122.6 174.75 6.88 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.302 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.475 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 70.3 m -96.75 11.36 35.84 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.571 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.728 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 0.9 OUTLIER -149.92 152.53 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.736 -175.056 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.445 ' O ' ' HB3' ' A' ' 26' ' ' TYR . 8.0 tt0 -149.83 112.1 4.67 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.123 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.639 ' CD1' HG12 ' A' ' 25' ' ' ILE . 7.8 tt -67.82 132.32 47.18 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.983 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.469 ' OD1' ' HE2' ' A' ' 24' ' ' LYS . 15.5 t70 -68.85 -61.43 1.81 Allowed 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.293 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.436 ' N ' HD23 ' A' ' 11' ' ' LEU . 32.2 m -168.35 154.45 7.11 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.087 -168.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.46 ' HA ' ' HA3' ' A' ' 23' ' ' GLY . 42.1 p90 -157.08 152.66 26.72 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.396 -1.274 . . . . 0.0 109.198 177.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -127.86 164.74 21.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.094 0.473 . . . . 0.0 110.927 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.515 ' HA ' ' O ' ' A' ' 20' ' ' THR . 56.1 t80 -145.56 151.95 38.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.838 176.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -172.85 121.94 0.4 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.759 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.71 -98.28 0.12 Allowed Glycine 0 CA--C 1.51 -0.265 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -172.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.499 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 49.3 m -139.47 85.84 2.08 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 161.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 3.9 m -145.52 140.09 27.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.114 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.909 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 25.0 t80 -118.25 139.59 51.08 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 172.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 p -160.22 126.48 4.2 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.668 176.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 14' ' ' TYR . . . 177.82 -159.17 24.79 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 119.798 -1.191 . . . . 0.0 112.917 -178.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.636 ' HB3' HG22 ' A' ' 71' ' ' THR . 0.0 OUTLIER -160.49 160.22 31.75 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.342 0.591 . . . . 0.0 110.721 -178.51 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.639 HG12 ' CD1' ' A' ' 11' ' ' LEU . 31.2 mt -128.94 156.11 41.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.635 -170.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.445 ' HB3' ' O ' ' A' ' 10' ' ' GLN . 4.2 t80 -130.7 115.88 17.28 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -175.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.728 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 1.0 OUTLIER -139.4 149.15 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 121.679 -0.638 . . . . 0.0 111.513 -177.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 8' ' ' SER . 0.0 OUTLIER -93.45 152.69 18.93 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.374 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -79.66 126.21 30.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.786 -176.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.662 HG12 ' OH ' ' A' ' 86' ' ' TYR . 26.6 mm -93.29 -48.64 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 167.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.05 -156.13 0.73 Allowed 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.949 -1.478 . . . . 0.0 107.868 174.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -110.3 -51.78 2.84 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.44 -177.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.4 m -82.35 85.46 6.87 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.224 0.535 . . . . 0.0 110.096 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.496 ' HB2' ' HE3' ' A' ' 34' ' ' LYS . 25.7 mtmt -102.9 174.86 5.69 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.084 0.468 . . . . 0.0 110.903 -174.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.853 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 88.7 mttt -131.63 139.16 49.06 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.133 174.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 68.8 t -130.83 108.51 15.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 121.954 0.883 . . . . 0.0 109.919 171.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.529 HG22 HD11 ' A' ' 53' ' ' ILE . 19.4 p -122.39 122.99 40.31 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.523 -174.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.827 HG22 HD12 ' A' ' 84' ' ' ILE . 84.6 t -83.58 135.17 25.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.871 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.8 m -135.21 122.03 34.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.779 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.697 ' HE1' ' HA ' ' A' ' 42' ' ' ASP . 5.3 p90 -115.9 171.14 7.96 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 119.599 -0.841 . . . . 0.0 112.192 -174.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.756 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . . . -93.36 86.58 5.32 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 170.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.723 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 38.0 t70 6.53 -95.42 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 O-C-N 127.336 2.898 . . . . 0.0 114.846 174.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.57 -28.37 0.35 Allowed Glycine 0 C--N 1.316 -0.542 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.692 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.2 t -109.6 -60.75 1.73 Allowed 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 174.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.645 ' HA ' ' HB1' ' A' ' 41' ' ' ALA . 8.0 p-10 175.46 38.28 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.135 -176.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -91.68 113.2 25.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.076 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.756 ' CH2' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -124.17 118.74 27.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.545 0.688 . . . . 0.0 110.062 167.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.467 ' O ' ' HB3' ' A' ' 49' ' ' ASN . 66.3 t30 -81.59 56.76 3.09 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 170.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 48' ' ' ASN . 33.8 t30 69.07 -55.61 0.55 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -154.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -124.83 -72.34 0.67 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.308 164.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.417 ' CA ' ' HB3' ' A' ' 48' ' ' ASN . . . 86.85 -40.53 3.08 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.248 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -134.49 98.91 4.2 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.484 0.659 . . . . 0.0 110.969 -175.464 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -122.42 143.91 33.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.682 -178.055 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.592 HG22 ' HB ' ' A' ' 38' ' ' VAL . 20.1 tt -131.57 128.45 60.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.195 173.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.23 132.95 35.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.781 0.324 . . . . 0.0 110.801 -176.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.79 159.66 33.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.614 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.3 m -112.3 128.98 56.43 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.444 ' H ' ' HD1' ' A' ' 58' ' ' PHE . 2.1 m-85 -71.5 138.74 49.17 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.276 -177.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.8 m -99.55 -46.14 5.56 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 170.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.73 175.26 21.82 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.583 173.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.76 134.55 58.05 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.248 1.965 . . . . 0.0 110.945 174.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.597 HD12 ' HB2' ' A' ' 67' ' ' TYR . 62.9 mt -75.82 106.63 5.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 28.4 m -49.66 125.24 11.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.063 -174.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.89 7.08 60.12 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.168 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.521 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 50.8 m -151.68 172.27 16.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.137 0.494 . . . . 0.0 111.124 -178.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -101.65 20.37 16.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.225 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.597 ' HB2' HD12 ' A' ' 62' ' ' ILE . 6.7 m-85 -103.71 154.95 18.98 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -114.14 162.58 16.33 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.414 ' HB2' HG12 ' A' ' 62' ' ' ILE . 8.8 t80 -122.6 119.44 30.81 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -167.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.559 ' NE1' HG13 ' A' ' 27' ' ' VAL . 3.7 m95 -116.28 126.76 54.01 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.491 -173.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.636 HG22 ' HB3' ' A' ' 24' ' ' LYS . 40.2 p -134.51 152.9 52.09 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.426 ' HB3' ' O ' ' A' ' 71' ' ' THR . 3.1 p90 -174.22 150.78 1.55 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.703 0.763 . . . . 0.0 111.79 168.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.0 m -112.43 138.42 49.19 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.014 169.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.909 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -132.64 135.78 46.08 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.936 0.398 . . . . 0.0 111.865 -168.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.9 t -88.31 98.18 11.45 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 170.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 19' ' ' SER . 20.1 m -104.21 139.94 23.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -177.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 3.8 mptp? -106.3 39.82 1.73 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.433 0.635 . . . . 0.0 109.93 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 129.71 136.77 4.12 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.063 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.723 ' HA ' ' O ' ' A' ' 42' ' ' ASP . 12.8 tt -160.78 143.8 4.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.014 0.435 . . . . 0.0 110.137 176.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -114.85 -56.16 2.41 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.985 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.644 ' HG2' ' HB3' ' A' ' 41' ' ' ALA . 12.6 pt-20 -150.78 174.51 12.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 117.889 -1.053 . . . . 0.0 108.735 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.562 ' CB ' ' HA ' ' A' ' 40' ' ' TYR . 46.8 p90 -172.76 179.95 2.25 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 120.413 1.461 . . . . 0.0 113.51 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.624 ' CB ' ' HB3' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -161.39 154.67 21.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 113.558 -1.655 . . . . 0.0 108.704 174.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.827 HD12 HG22 ' A' ' 38' ' ' VAL . 20.4 mm -99.98 147.43 7.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.979 -173.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.519 ' HD3' ' HE1' ' A' ' 94' ' ' TYR . 3.6 mmmp? -102.06 106.52 17.43 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.833 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.662 ' OH ' HG12 ' A' ' 30' ' ' ILE . 17.2 t80 -86.84 101.07 13.01 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 174.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.853 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 17.5 tt0 -109.5 117.58 34.35 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.383 0.611 . . . . 0.0 110.534 -173.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.1 t -115.47 106.22 20.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.393 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.8 t 53.8 23.92 4.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.419 0.628 . . . . 0.0 110.869 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.49 5.4 48.75 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.927 -177.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.733 ' O ' ' HA ' ' A' ' 87' ' ' GLU . 19.8 tptp -99.24 150.91 21.6 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.9 m -126.28 141.39 51.93 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 122.27 1.033 . . . . 0.0 112.842 -174.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.492 ' HD2' ' CD2' ' A' ' 86' ' ' TYR . 29.4 m-85 -134.8 -174.63 3.65 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 113.286 -1.779 . . . . 0.0 106.791 167.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.519 ' HE1' ' HD3' ' A' ' 85' ' ' LYS . 61.9 m-85 -144.58 137.03 26.47 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -169.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -127.99 112.54 14.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.567 171.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.624 ' HB3' ' CB ' ' A' ' 83' ' ' TYR . 29.4 p-10 -139.31 -43.35 0.45 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.484 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.606 ' HB3' ' O ' ' A' ' 96' ' ' ASN . 4.0 p-10 159.82 -45.18 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 168.15 -65.06 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 65.8 m -158.97 51.18 0.38 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.398 174.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.55 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -137.36 -31.74 0.8 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.55 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 95.7 m-20 84.18 150.77 0.08 Allowed 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.836 0.71 . . . . 0.0 110.156 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 78.3 m-85 -69.68 101.33 1.64 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.242 177.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.06 124.88 28.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.908 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.6 HG21 HG12 ' A' ' 79' ' ' ILE . 15.6 t -94.97 147.24 5.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.015 0.436 . . . . 0.0 110.487 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.4 m -93.75 112.41 24.27 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.791 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.251 1.153 0 CA-C-O 119.264 -0.398 . . . . 0.0 111.001 -177.734 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.856 0.36 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 p -102.27 130.33 48.94 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.664 -178.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.982 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 3.8 mp -89.6 -58.86 0.25 Allowed Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 174.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.982 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 15.4 Cg_exo -69.91 155.24 65.94 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.03 1.82 . . . . 0.0 111.052 172.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.7 t 68.19 7.41 5.88 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.181 0.593 . . . . 0.0 111.664 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.6 m -113.92 -64.69 1.27 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 172.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -153.55 -167.32 2.65 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.546 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 5.0 m -84.4 -17.42 39.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.623 0.725 . . . . 0.0 109.17 173.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.64 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.5 p -148.97 153.57 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.287 -176.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -143.01 127.97 18.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.333 177.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.524 HD21 ' CD2' ' A' ' 14' ' ' TYR . 42.9 tp -69.39 137.8 53.09 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.968 0.413 . . . . 0.0 110.319 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.512 ' OD1' ' HE2' ' A' ' 24' ' ' LYS . 12.9 t70 -83.58 -61.78 1.75 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.366 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.2 p -178.86 164.13 1.47 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.735 -176.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.524 ' CD2' HD21 ' A' ' 11' ' ' LEU . 45.9 p90 -158.33 163.14 37.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.772 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -143.81 166.5 24.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.825 0.345 . . . . 0.0 111.287 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.713 ' HD1' ' HD1' ' A' ' 21' ' ' PHE . 8.1 t80 -129.45 141.86 50.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.446 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -150.63 97.87 2.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.079 -176.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.98 -98.26 0.35 Allowed Glycine 0 CA--C 1.508 -0.379 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -172.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -129.64 84.26 2.2 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 162.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 95.5 m -147.45 134.72 20.6 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.065 175.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.713 ' HD1' ' HD1' ' A' ' 16' ' ' TYR . 2.9 t80 -132.88 109.54 9.68 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.0 m -135.6 149.63 49.43 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.926 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 179.6 -167.93 38.11 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.564 ' HB3' HG22 ' A' ' 71' ' ' THR . 0.0 OUTLIER -150.99 160.83 43.68 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.046 0.451 . . . . 0.0 111.307 -179.046 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 17.6 mt -127.3 153.23 36.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.072 -170.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.548 ' CE1' HG12 ' A' ' 3' ' ' ILE . 0.7 OUTLIER -124.97 111.85 15.89 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.64 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 0.9 OUTLIER -133.3 155.23 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.902 -176.021 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' A' ' 8' ' ' SER . 17.6 ptpt -93.49 152.19 19.23 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.029 175.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -94.92 102.17 13.99 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.756 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.557 HD13 ' HE2' ' A' ' 86' ' ' TYR . 3.8 mp -80.79 -44.52 21.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 172.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.494 ' HB3' ' CG2' ' A' ' 88' ' ' VAL . . . -132.64 159.95 38.09 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.461 -1.245 . . . . 0.0 107.65 174.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -85.26 -29.78 24.33 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.176 -0.466 . . . . 0.0 112.033 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 p -91.67 96.92 10.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.17 0.51 . . . . 0.0 110.274 176.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -111.78 171.09 7.7 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.442 -174.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.786 ' HG3' ' HB3' ' A' ' 87' ' ' GLU . 17.0 ptmt -155.73 103.95 2.3 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.0 0.905 . . . . 0.0 109.578 174.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.7 t -98.21 129.14 48.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-O 121.407 0.622 . . . . 0.0 109.979 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 1.081 ' HB ' HD11 ' A' ' 53' ' ' ILE . 1.2 p -137.52 134.91 36.23 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.764 -172.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 1.02 ' HB ' HG22 ' A' ' 54' ' ' ILE . 78.2 t -91.96 135.46 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.202 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.441 HG12 ' CZ3' ' A' ' 47' ' ' TRP . 0.1 OUTLIER -114.96 75.3 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 170.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.953 ' CD2' HG11 ' A' ' 38' ' ' VAL 0.256 0.1 OUTLIER -102.65 118.36 36.68 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 122.398 1.094 . . . . 0.0 111.081 -176.749 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.917 ' HA ' ' CZ2' ' A' ' 47' ' ' TRP . . . -76.36 146.0 39.08 Favored 'General case' 0 CA--C 1.497 -1.073 0 CA-C-N 113.719 -1.582 . . . . 0.0 112.357 -168.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -79.34 163.7 24.65 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.607 -172.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.813 ' HA2' ' HB2' ' A' ' 80' ' ' LYS . . . -73.17 41.71 0.92 Allowed Glycine 0 C--N 1.329 0.146 0 O-C-N 123.421 0.451 . . . . 0.0 113.694 -171.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.0 m -121.29 -16.58 7.88 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.952 0.405 . . . . 0.0 110.502 176.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.531 ' OD1' ' HG2' ' A' ' 80' ' ' LYS . 3.8 m-20 66.39 47.5 1.73 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.671 177.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.498 ' O ' ' HD1' ' A' ' 47' ' ' TRP . 12.3 t-20 -143.22 87.84 1.99 Allowed 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.837 -171.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.917 ' CZ2' ' HA ' ' A' ' 41' ' ' ALA . 2.4 m0 -124.0 92.73 3.73 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -170.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -101.71 71.53 1.32 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.79 173.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.3 t30 49.52 24.1 1.05 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.504 0.669 . . . . 0.0 111.469 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -69.19 -36.76 77.65 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 173.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 57.97 70.22 1.05 Allowed Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 114.171 -1.377 . . . . 0.0 114.008 168.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.733 ' HB2' ' HZ2' ' A' ' 47' ' ' TRP . 38.2 m-80 -64.83 108.1 1.66 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 174.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 1.081 HD11 ' HB ' ' A' ' 37' ' ' THR . 5.4 tp -107.68 152.51 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 121.56 0.695 . . . . 0.0 112.031 -169.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 1.02 HG22 ' HB ' ' A' ' 38' ' ' VAL . 13.0 tt -142.29 140.5 29.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.031 167.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.45 130.14 35.26 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.723 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.06 153.72 36.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.667 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -105.2 130.66 53.3 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.431 0.634 . . . . 0.0 110.287 -176.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.449 ' H ' ' HD1' ' A' ' 58' ' ' PHE . 1.5 m-85 -71.21 143.16 50.55 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.389 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.0 m -114.65 -37.97 4.12 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 171.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.6 -178.25 17.99 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.773 172.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.02 138.62 78.92 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.461 2.107 . . . . 0.0 111.305 175.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.957 HG12 ' HB2' ' A' ' 69' ' ' TYR . 10.6 mt -81.78 126.56 39.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.63 -174.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.3 m -64.09 117.11 6.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.97 0.414 . . . . 0.0 109.989 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.0 -17.26 32.38 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.657 -176.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.433 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 19.8 m -128.05 173.23 10.23 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -107.56 4.9 26.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.273 0.559 . . . . 0.0 110.429 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.439 ' CE1' ' HB2' ' A' ' 28' ' ' LYS . 20.7 m-85 -100.79 -178.56 3.81 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.329 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' A' ' 69' ' ' TYR . 22.1 tt0 -113.54 170.69 8.06 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.54 -170.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.957 ' HB2' HG12 ' A' ' 62' ' ' ILE . 4.1 t80 -138.53 126.37 22.36 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -162.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.572 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 5.8 m95 -126.54 135.81 51.76 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.013 -170.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.564 HG22 ' HB3' ' A' ' 24' ' ' LYS . 20.8 p -135.88 153.77 51.36 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -178.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -158.85 164.15 35.98 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.875 0.845 . . . . 0.0 112.153 171.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 p -142.15 139.52 32.15 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.38 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.89 133.57 17.81 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -173.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.6 t -82.04 100.34 9.68 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 168.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.7 m -92.05 151.11 3.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.284 0.564 . . . . 0.0 110.574 -176.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -98.94 37.59 1.5 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.796 -177.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.63 116.26 3.96 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.551 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.848 HD11 ' HB2' ' A' ' 40' ' ' TYR . 4.2 tt -126.63 152.86 34.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.099 0.476 . . . . 0.0 110.494 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.813 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 17.6 tppt? -131.72 -42.46 1.02 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.22 -174.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 11.3 pt-20 -156.29 172.02 19.2 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-O 118.482 -0.77 . . . . 0.0 109.512 -176.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.75 ' HB3' ' HA ' ' A' ' 40' ' ' TYR . 55.4 p90 -173.01 178.15 2.59 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.427 ' O ' HG23 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -155.4 137.11 14.31 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 113.478 -1.692 . . . . 0.0 107.71 164.219 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.807 HD12 HG22 ' A' ' 38' ' ' VAL . 22.8 mm -91.1 137.31 22.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 O-C-N 121.637 -0.665 . . . . 0.0 109.86 -175.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.41 ' HG2' ' CD1' ' A' ' 94' ' ' TYR . 41.0 mtmt -92.97 129.49 38.87 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 122.048 0.928 . . . . 0.0 111.318 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.7 ' HD2' ' HD2' ' A' ' 93' ' ' TYR . 20.5 t80 -98.65 99.61 10.75 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 113.517 -1.674 . . . . 0.0 107.548 168.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.786 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . 4.2 tt0 -117.13 135.46 53.74 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -176.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.557 ' C ' ' H ' ' A' ' 90' ' ' GLY . 0.4 OUTLIER -146.72 162.61 8.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -178.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.1 t -72.39 32.71 0.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 122.066 0.936 . . . . 0.0 110.769 -174.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -147.28 -53.43 0.02 OUTLIER Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 114.638 -1.165 . . . . 0.0 111.34 175.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.493 ' H ' HG13 ' A' ' 88' ' ' VAL . 29.2 mmtp -132.01 -175.83 3.86 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.904 0.859 . . . . 0.0 113.158 -176.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.507 HG23 ' HG3' ' A' ' 87' ' ' GLU . 7.1 m -151.5 141.96 22.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.209 -1.36 . . . . 0.0 110.481 175.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.7 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 18.1 m-85 -145.16 -170.65 3.48 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.41 ' CD1' ' HG2' ' A' ' 85' ' ' LYS . 79.4 m-85 -149.11 127.17 11.97 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.235 0.334 . . . . 0.0 111.526 -173.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -80.51 79.05 7.18 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 167.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -118.55 -70.05 0.81 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.065 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 100' ' ' ALA . 0.7 OUTLIER 148.35 -53.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 -172.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.9 t30 175.82 -56.26 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.225 -1.807 . . . . 0.0 106.993 174.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.5 p -156.73 43.63 0.38 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.501 173.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -106.9 -53.37 2.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.788 -172.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 5.9 m-20 72.19 128.73 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.56 0.537 . . . . 0.0 110.079 -175.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 96.6 m-85 -74.27 118.68 17.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.239 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.83 124.52 28.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.998 0.428 . . . . 0.0 110.501 177.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.47 HG21 HD13 ' A' ' 79' ' ' ILE . 41.6 t -79.71 144.16 11.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 173.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.4 t -84.81 65.74 9.29 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.222 0.534 . . . . 0.0 110.66 -172.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.482 -0.77 . . . . 0.0 110.769 178.377 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.3 p -52.44 116.09 2.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.31 0.576 . . . . 0.0 110.899 178.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.673 HG23 ' HD3' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -69.55 -40.36 14.06 Favored Pre-proline 0 N--CA 1.435 -1.224 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.494 -178.165 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.673 ' HD3' HG23 ' A' ' 3' ' ' ILE . 58.6 Cg_endo -73.18 134.83 21.78 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.133 1.222 . . . . 0.0 111.072 171.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.5 t -150.85 -55.89 0.16 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.796 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.3 m -69.18 -77.7 0.08 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -175.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.33 -165.2 2.21 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 122.251 -0.281 . . . . 0.0 110.605 -177.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.542 ' HA ' ' HE2' ' A' ' 28' ' ' LYS . 14.6 m -69.39 -18.16 63.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.374 0.607 . . . . 0.0 110.334 176.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.605 HG11 ' HB2' ' A' ' 86' ' ' TYR . 2.8 p -149.68 147.33 16.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -143.99 143.76 31.36 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.753 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.546 HD11 ' HD2' ' A' ' 14' ' ' TYR . 3.8 tp -69.49 132.99 47.17 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.908 0.385 . . . . 0.0 110.685 172.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.63 -64.94 1.08 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 169.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.4 m -166.45 153.19 9.14 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.993 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.546 ' HD2' HD11 ' A' ' 11' ' ' LEU . 20.3 p90 -142.34 157.82 44.39 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 173.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -119.56 157.44 28.37 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.794 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.686 ' HA ' ' O ' ' A' ' 20' ' ' THR . 50.3 t80 -137.92 146.6 43.47 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 172.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -179.25 114.94 0.06 Allowed 'General case' 0 C--N 1.315 -0.924 0 O-C-N 123.683 0.615 . . . . 0.0 109.733 -174.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.73 -103.36 0.31 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -168.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.651 ' HB3' ' O ' ' A' ' 76' ' ' VAL . 24.8 m -124.3 88.47 2.91 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 165.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.686 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 89.4 m -143.6 135.64 26.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.638 176.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.533 ' HZ ' HG11 ' A' ' 38' ' ' VAL . 11.4 t80 -134.01 145.02 49.07 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 120.732 0.301 . . . . 0.0 110.596 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.491 ' HA ' ' HB2' ' A' ' 14' ' ' TYR . 48.1 m 94.6 178.4 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 164.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -171.98 -78.61 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.573 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.607 ' HB3' HG22 ' A' ' 71' ' ' THR . 0.4 OUTLIER -166.55 169.02 14.13 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.977 0.418 . . . . 0.0 111.406 176.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 53.4 mt -132.07 154.0 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.577 -170.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -116.13 105.82 13.03 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -178.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 p -125.91 145.17 33.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 O-C-N 121.772 -0.58 . . . . 0.0 112.56 -165.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.542 ' HE2' ' HA ' ' A' ' 8' ' ' SER . 16.3 ttmm -86.41 151.75 23.28 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -101.97 117.63 35.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.415 0.626 . . . . 0.0 111.126 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.614 HG12 ' OH ' ' A' ' 86' ' ' TYR . 28.2 mm -88.24 -48.61 14.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.38 -154.03 0.61 Allowed 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 171.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -104.69 -48.72 3.71 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.25 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.1 m -74.41 80.01 1.9 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.033 176.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.611 ' HE2' ' CZ2' ' A' ' 70' ' ' TRP . 30.3 mtmm -103.74 157.59 16.97 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.597 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 24.9 mtpp -127.66 123.74 36.29 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.06 0.457 . . . . 0.0 109.889 176.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.7 t -117.13 125.53 73.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 1.008 ' HB ' HD11 ' A' ' 53' ' ' ILE . 0.8 OUTLIER -138.64 129.44 26.48 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.014 -169.619 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.904 ' HB ' HG22 ' A' ' 54' ' ' ILE . 7.1 t -95.53 124.09 47.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.518 0.675 . . . . 0.0 110.742 -178.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.61 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -102.97 108.4 24.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 114.482 -1.236 . . . . 0.0 107.842 177.091 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.681 ' HB2' HG13 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -101.71 147.97 25.83 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-O 122.688 1.232 . . . . 0.0 112.448 174.454 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.787 ' HB3' ' HG2' ' A' ' 81' ' ' GLU . . . -86.07 93.98 9.13 Favored 'General case' 0 N--CA 1.407 -2.577 0 CA-C-N 113.431 -1.713 . . . . 0.0 106.382 165.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.458 ' CG ' ' H ' ' A' ' 43' ' ' GLY . 12.0 t70 -54.53 -163.79 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 111.441 -2.618 . . . . 0.0 112.778 -172.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.458 ' H ' ' CG ' ' A' ' 42' ' ' ASP . . . -58.1 -15.7 22.97 Favored Glycine 0 C--N 1.333 0.361 0 N-CA-C 111.981 -0.448 . . . . 0.0 111.981 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.5 t -58.98 -26.06 64.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 122.408 0.283 . . . . 0.0 110.357 173.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.8 t0 70.21 14.97 7.59 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-O 122.155 0.979 . . . . 0.0 109.243 174.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -159.89 152.49 21.22 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.737 -169.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.499 ' CE3' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -95.82 95.39 8.25 Favored 'General case' 0 N--CA 1.419 -2.009 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.217 173.041 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.63 ' OD1' ' HB2' ' A' ' 50' ' ' ASN . 5.1 p30 -82.97 22.61 0.92 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.498 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 51.19 65.88 1.35 Allowed 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.321 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.63 ' HB2' ' OD1' ' A' ' 48' ' ' ASN . 14.2 t30 -115.66 -61.75 1.69 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.874 -172.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.37 74.9 0.12 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -175.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.66 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 65.9 m-20 -117.34 83.91 2.06 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -175.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 1.008 HD11 ' HB ' ' A' ' 37' ' ' THR . 8.0 tp -119.38 149.93 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-O 121.446 0.641 . . . . 0.0 112.344 -171.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.904 HG22 ' HB ' ' A' ' 38' ' ' VAL . 8.5 tp -128.0 137.62 57.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 169.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.93 140.88 32.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.228 0.537 . . . . 0.0 111.773 -175.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.467 ' HA ' ' HB3' ' A' ' 72' ' ' PHE . . . -94.57 146.62 23.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.552 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.2 p -109.43 148.41 31.19 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -71.7 141.77 49.84 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -176.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.563 ' C ' ' HD2' ' A' ' 61' ' ' PRO . 23.0 t -114.95 -45.2 2.98 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.428 ' N ' ' HD2' ' A' ' 61' ' ' PRO . . . 116.6 -68.31 0.29 Allowed Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.924 -0.931 . . . . 0.0 114.594 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.563 ' HD2' ' C ' ' A' ' 59' ' ' SER . 13.9 Cg_exo -12.71 -42.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.384 1 C-N-CA 128.244 5.963 . . . . 0.0 120.362 -166.168 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.754 HG13 ' HB2' ' A' ' 69' ' ' TYR . 7.2 mt -71.08 88.34 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 119.353 0.979 . . . . 0.0 110.441 -177.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.6 t -114.32 163.56 15.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.494 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.13 21.66 78.77 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.638 ' HB3' HD12 ' A' ' 3' ' ' ILE . 55.6 m -155.68 174.16 15.68 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -178.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -92.32 32.38 1.19 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.068 0.461 . . . . 0.0 110.372 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.551 ' HE1' ' HB3' ' A' ' 4' ' ' PRO . 6.4 m-85 -129.76 -179.33 5.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.207 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -153.4 151.77 30.29 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.303 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.754 ' HB2' HG13 ' A' ' 62' ' ' ILE . 3.2 t80 -104.54 128.93 52.63 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -174.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.611 ' CZ2' ' HE2' ' A' ' 34' ' ' LYS . 15.6 m0 -124.38 151.21 44.68 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.607 HG22 ' HB3' ' A' ' 24' ' ' LYS . 7.7 p -129.94 147.3 51.68 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 -178.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.467 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -160.79 142.35 12.12 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.549 177.621 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 42.1 m -124.85 146.49 49.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.375 176.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.15 112.99 9.03 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -174.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.9 t -78.5 100.47 6.9 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 169.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.651 ' O ' ' HB3' ' A' ' 19' ' ' SER . 30.0 m -103.83 156.44 5.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.397 -177.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.811 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -102.9 -7.42 21.53 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.551 174.67 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 172.6 142.09 3.67 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.615 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.681 HG13 ' HB2' ' A' ' 40' ' ' TYR . 6.0 tt -160.26 142.14 4.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 177.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -121.87 -46.79 2.21 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.594 -174.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.787 ' HG2' ' HB3' ' A' ' 41' ' ' ALA . 9.8 pt-20 -152.51 162.22 41.5 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -176.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.61 ' HB2' ' O ' ' A' ' 39' ' ' VAL . 42.5 p90 -170.79 173.62 5.21 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.7 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.424 ' O ' HG23 ' A' ' 39' ' ' VAL . 0.1 OUTLIER -155.69 153.78 30.51 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 172.524 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.408 HG22 ' N ' ' A' ' 85' ' ' LYS . 2.5 mt -92.6 151.91 3.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.562 0.696 . . . . 0.0 112.219 -170.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.408 ' N ' HG22 ' A' ' 84' ' ' ILE . 18.8 mmtp -107.46 114.09 27.87 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.341 176.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.797 ' HD2' ' HD2' ' A' ' 93' ' ' TYR . 14.9 t80 -91.59 101.29 13.93 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 174.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 23.2 tt0 -105.83 111.17 23.73 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.47 0.652 . . . . 0.0 109.693 -172.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.617 ' HB ' ' H ' ' A' ' 91' ' ' LYS . 14.6 t -108.94 159.84 8.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.211 -176.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.9 t -79.3 33.67 0.24 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 122.002 0.906 . . . . 0.0 109.046 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -164.23 -47.43 0.02 OUTLIER Glycine 0 N--CA 1.436 -1.338 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.805 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.617 ' H ' ' HB ' ' A' ' 88' ' ' VAL . 30.5 mmmt -127.0 -173.87 3.0 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.926 0.869 . . . . 0.0 112.284 -176.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.9 m -150.79 140.79 22.02 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.167 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.797 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 48.5 m-85 -144.43 -166.07 2.29 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -144.26 160.32 41.19 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.75 0.31 . . . . 0.0 111.029 -174.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.463 ' HB2' HG13 ' A' ' 9' ' ' VAL . 25.8 t70 -126.24 115.93 20.5 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 162.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -146.95 -66.89 0.27 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.039 -170.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 155.53 -56.91 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -173.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 50.0 t30 176.14 -48.95 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 112.871 -1.968 . . . . 0.0 106.614 176.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.6 t -170.84 64.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.586 170.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -126.38 -44.85 1.69 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.49 -173.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 91.1 m-20 70.9 144.63 0.06 Allowed 'General case' 0 N--CA 1.471 0.602 0 O-C-N 123.677 0.61 . . . . 0.0 110.597 -175.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.539 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 98.3 m-85 -79.95 111.27 16.12 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.759 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.617 HE21 ' N ' ' A' ' 103' ' ' GLN . 0.0 OUTLIER -79.87 110.69 15.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.094 178.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.424 HG21 HD13 ' A' ' 79' ' ' ILE . 25.3 t -79.76 142.12 14.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.205 -177.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.8 t -90.96 106.3 18.42 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -176.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.667 -0.683 . . . . 0.0 110.87 -174.94 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 121.026 0.441 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.7 p -97.91 130.33 44.79 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.069 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.639 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 38.7 mm -62.4 -48.85 86.12 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.338 174.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.639 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 51.2 Cg_exo -55.83 140.23 84.91 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.195 1.93 . . . . 0.0 112.231 175.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.9 t -130.69 -67.21 0.73 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.328 -0.397 . . . . 0.0 109.999 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.7 t -88.57 -68.96 0.73 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.231 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.49 -159.05 0.93 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.57 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.1 m -62.98 -32.68 74.07 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.553 0.692 . . . . 0.0 109.622 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.868 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.3 p -115.95 150.42 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.574 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.455 ' O ' ' HB3' ' A' ' 26' ' ' TYR . 9.3 tt0 -145.66 125.24 13.25 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.988 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.543 HD21 ' CD2' ' A' ' 14' ' ' TYR . 15.4 tp -68.18 131.66 45.79 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.209 0.528 . . . . 0.0 110.856 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.416 ' OD1' ' HE2' ' A' ' 24' ' ' LYS . 16.0 t70 -81.14 -61.83 1.84 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.853 176.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.6 p -175.95 160.03 2.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.938 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.543 ' CD2' HD21 ' A' ' 11' ' ' LEU . 12.7 p90 -152.04 161.39 42.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.808 177.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -129.29 165.3 21.7 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.734 0.302 . . . . 0.0 110.681 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.601 ' HD1' ' HD1' ' A' ' 21' ' ' PHE . 51.7 t80 -145.6 153.08 40.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.142 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -177.63 129.23 0.15 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.12 -102.56 0.36 Allowed Glycine 0 C--N 1.331 0.275 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -173.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.2 m -136.83 85.66 2.15 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 163.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.56 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 6.5 m -144.8 131.05 19.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.354 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.601 ' HD1' ' HD1' ' A' ' 16' ' ' TYR . 1.4 t80 -133.44 102.47 5.54 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.689 0.757 . . . . 0.0 109.302 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.6 m -134.65 160.08 39.23 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.809 -174.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.28 -143.32 8.66 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.447 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.563 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -162.56 159.96 25.39 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.093 0.473 . . . . 0.0 110.966 178.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.463 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 20.9 mt -122.25 155.53 27.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.179 -173.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.455 ' HB3' ' O ' ' A' ' 10' ' ' GLN . 7.5 t80 -129.05 101.56 6.1 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -172.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.868 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 2.0 m -135.35 145.65 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 O-C-N 121.493 -0.754 . . . . 0.0 112.52 -171.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 67' ' ' TYR . 40.1 ttmt -68.43 133.41 48.6 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.186 177.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.524 ' HB3' ' HB2' ' A' ' 68' ' ' GLU . 24.1 p-10 -95.18 84.51 4.09 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.752 0.787 . . . . 0.0 110.544 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.5 mp -63.72 -47.74 89.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 175.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.44 -176.12 2.83 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.697 171.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -109.99 -55.82 2.4 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.465 -177.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.8 m -75.8 73.58 2.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.379 0.609 . . . . 0.0 110.43 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.405 ' HE2' ' CZ2' ' A' ' 70' ' ' TRP . 28.9 mtmm -102.75 -171.63 1.99 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.761 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -151.63 144.4 24.37 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.9 t -125.53 120.24 57.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.524 0.678 . . . . 0.0 110.552 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.64 ' HB ' HG13 ' A' ' 53' ' ' ILE . 2.1 p -116.17 110.34 18.69 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.261 -176.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 1.058 ' HB ' HG22 ' A' ' 54' ' ' ILE . 81.0 t -83.28 108.35 15.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.78 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.672 HG12 ' HB ' ' A' ' 53' ' ' ILE . 26.5 m -108.77 121.19 61.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.226 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.419 ' HB2' HG13 ' A' ' 79' ' ' ILE . 7.6 p90 -118.39 148.59 42.37 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.631 0.729 . . . . 0.0 111.7 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.727 ' HB3' ' HG2' ' A' ' 81' ' ' GLU . . . -81.59 83.87 6.92 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 171.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -48.59 -166.47 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 111.337 -2.665 . . . . 0.0 113.932 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.2 -21.17 46.07 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-N 116.259 -0.428 . . . . 0.0 113.062 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -65.91 -19.86 66.02 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.654 -0.321 . . . . 0.0 110.526 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.2 t70 72.85 21.98 3.21 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.444 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -168.3 148.96 4.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.493 -175.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.437 ' CZ3' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -87.81 83.74 7.1 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 173.654 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' A' ' 50' ' ' ASN . 6.4 t-20 -78.11 55.49 1.49 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.2 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.0 t30 69.04 -26.77 0.15 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.204 0.601 . . . . 0.0 110.865 -176.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.542 ' H ' ' C ' ' A' ' 48' ' ' ASN . 4.6 p30 -62.14 -43.17 99.43 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.374 174.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 49.97 62.5 4.92 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -176.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 28.8 m-80 -41.78 106.76 0.06 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.882 0.873 . . . . 0.0 111.982 -174.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.672 ' HB ' HG12 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -117.3 138.48 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.833 0.825 . . . . 0.0 112.658 -171.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 1.058 HG22 ' HB ' ' A' ' 38' ' ' VAL . 5.2 tp -111.37 133.99 55.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 168.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.61 113.24 22.34 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.263 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.84 154.47 29.79 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -130.48 130.83 44.71 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.74 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 38.0 p90 -78.27 137.66 38.21 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.902 0.858 . . . . 0.0 111.013 -178.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.9 t -87.1 -26.77 23.49 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.276 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.88 168.91 18.87 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.508 172.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.554 ' HA ' ' HA ' ' A' ' 68' ' ' GLU . 26.1 Cg_exo -63.39 141.87 83.01 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.676 2.251 . . . . 0.0 111.42 174.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.49 HG12 ' HB2' ' A' ' 69' ' ' TYR . 21.8 mt -84.62 109.25 17.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.337 -177.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.6 m -63.11 126.18 26.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.869 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.34 -7.28 34.58 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.166 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.7 m -151.26 165.47 33.9 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -92.71 52.58 1.89 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.953 0.882 . . . . 0.0 109.124 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 4.0 m-85 -130.21 169.24 15.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.536 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 61' ' ' PRO . 9.0 tt0 -125.2 171.54 10.25 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.585 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.49 ' HB2' HG12 ' A' ' 62' ' ' ILE . 3.1 t80 -138.86 111.15 7.43 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -163.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.74 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 11.8 m95 -112.57 130.47 56.01 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.985 -168.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 p -120.26 144.27 47.86 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -155.34 155.9 34.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.848 0.832 . . . . 0.0 112.549 177.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.6 p -142.51 142.46 32.26 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.011 174.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.512 ' HB2' HG12 ' A' ' 54' ' ' ILE . . . -152.68 138.76 18.22 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -175.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 31.3 t -90.58 101.23 13.97 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 166.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.0 m -89.66 160.48 2.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.42 -171.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.55 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -90.37 29.72 1.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.638 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.29 146.23 13.35 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -170.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.419 HG13 ' HB2' ' A' ' 40' ' ' TYR . 2.8 tt -143.28 126.81 13.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.775 0.798 . . . . 0.0 111.409 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 103' ' ' GLN . 28.0 mmtp -93.5 -41.45 9.77 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.22 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.727 ' HG2' ' HB3' ' A' ' 41' ' ' ALA . 13.8 pt-20 -160.68 168.27 25.22 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -169.39 172.76 6.95 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.657 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.472 ' HD2' ' HB3' ' A' ' 96' ' ' ASN . 0.1 OUTLIER -164.72 150.04 9.89 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.573 -1.194 . . . . 0.0 107.854 175.116 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.946 HD12 HG22 ' A' ' 38' ' ' VAL . 9.6 mm -93.3 136.29 25.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.017 -172.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.809 ' HD2' ' HE1' ' A' ' 94' ' ' TYR . 15.6 mmmt -94.4 104.95 16.92 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.602 ' CD2' ' HD2' ' A' ' 93' ' ' TYR . 23.9 t80 -86.76 102.14 13.98 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.338 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -114.42 123.15 48.73 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.638 0.732 . . . . 0.0 109.952 -173.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.506 ' C ' ' H ' ' A' ' 90' ' ' GLY . 9.4 t -112.76 163.79 9.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 t -72.25 20.79 0.06 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.197 0.523 . . . . 0.0 111.082 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -162.85 -40.88 0.02 OUTLIER Glycine 0 N--CA 1.438 -1.232 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.891 178.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.402 ' H ' ' HB ' ' A' ' 88' ' ' VAL . 19.6 tptm -117.35 167.6 11.1 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -174.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.1 m -146.05 145.5 30.6 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.602 ' HD2' ' CD2' ' A' ' 86' ' ' TYR . 60.9 m-85 -142.58 -168.28 2.71 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 175.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.809 ' HE1' ' HD2' ' A' ' 85' ' ' LYS . 21.5 m-85 -146.42 140.39 26.26 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.551 -173.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -110.12 96.24 6.1 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.557 ' O ' ' HB2' ' A' ' 97' ' ' ASN . 27.0 p-10 -137.55 39.17 2.44 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.763 -174.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.557 ' HB2' ' O ' ' A' ' 96' ' ' ASN . 21.8 m-80 70.95 -62.88 0.44 Allowed 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.737 0.648 . . . . 0.0 109.907 -169.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -177.67 -55.78 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 52.8 m -157.02 59.58 0.52 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.448 170.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.611 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -137.86 -49.16 0.57 Allowed 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -170.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.611 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 12.9 m-20 74.14 143.22 0.07 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -169.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.678 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 3.4 m-85 -91.46 97.29 10.98 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -76.95 110.82 11.88 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.427 HG11 ' HE1' ' A' ' 21' ' ' PHE . 22.0 t -79.71 148.84 5.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.742 -167.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.5 m -86.85 81.35 8.18 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.211 176.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.516 HG22 ' CZ ' ' A' ' 16' ' ' TYR . 0.6 OUTLIER . . . . . 0 C--O 1.254 1.302 0 CA-C-O 118.495 -0.764 . . . . 0.0 111.13 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.757 0.313 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.9 m -112.03 141.95 45.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.155 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.6 mt -49.46 129.33 18.35 Favored Pre-proline 0 N--CA 1.466 0.338 0 O-C-N 123.495 0.497 . . . . 0.0 111.207 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.12 133.3 52.19 Favored 'Trans proline' 0 C--O 1.237 0.458 0 C-N-CA 122.866 2.377 . . . . 0.0 111.886 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.5 t -95.67 -64.03 1.1 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.643 -174.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.0 t -81.95 -49.74 9.94 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.44 151.33 46.61 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.224 178.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.429 ' HB3' HD11 ' A' ' 30' ' ' ILE . 17.0 m -93.36 -7.79 43.75 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.649 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.78 HG23 HG12 ' A' ' 27' ' ' VAL . 1.7 p -148.44 151.74 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.321 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -142.96 151.67 41.16 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.488 HD11 ' HD2' ' A' ' 14' ' ' TYR . 2.5 tp -77.37 142.59 39.24 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.459 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 31.7 t70 -93.1 -64.54 1.08 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 175.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.906 ' HB2' ' HE3' ' A' ' 24' ' ' LYS . 41.4 m -166.75 155.54 10.48 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.259 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.488 ' HD2' HD11 ' A' ' 11' ' ' LEU . 18.6 p90 -157.17 150.97 24.44 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.635 177.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -130.33 157.54 42.26 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.661 ' HA ' ' O ' ' A' ' 20' ' ' THR . 4.3 m-85 -137.53 153.78 49.94 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.702 -175.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -137.98 75.84 1.55 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.52 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.76 -84.29 0.67 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -171.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.1 m -132.41 86.01 2.29 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.57 0.7 . . . . 0.0 109.414 163.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.661 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 26.1 m -146.79 126.02 13.01 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 170.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 1.005 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 36.7 t80 -107.2 133.48 51.72 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.436 0.636 . . . . 0.0 110.078 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.2 p -153.65 151.26 29.48 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.832 173.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.414 ' C ' ' HD3' ' A' ' 24' ' ' LYS . . . 159.08 -151.33 22.23 Favored Glycine 0 CA--C 1.506 -0.522 0 C-N-CA 119.09 -1.528 . . . . 0.0 113.391 -178.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.906 ' HE3' ' HB2' ' A' ' 13' ' ' SER . 0.2 OUTLIER -166.34 168.83 14.68 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.745 0.418 . . . . 0.0 110.409 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.523 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 17.0 mt -131.61 160.76 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.732 -172.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.458 ' N ' HG22 ' A' ' 25' ' ' ILE . 4.0 t80 -130.59 98.56 4.7 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.349 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.78 HG12 HG23 ' A' ' 9' ' ' VAL . 0.7 OUTLIER -118.56 156.7 20.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.956 -176.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -94.72 141.68 28.34 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.424 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.719 HD21 ' HB2' ' A' ' 68' ' ' GLU . 46.1 m-80 -89.79 101.02 13.72 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.823 0.344 . . . . 0.0 111.561 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.547 HD13 ' HE2' ' A' ' 86' ' ' TYR . 4.1 mp -88.64 -34.5 7.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 173.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.422 ' HB3' ' CG1' ' A' ' 88' ' ' VAL . . . -139.95 -178.96 5.68 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.874 174.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -109.86 -15.52 14.08 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.474 -173.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.8 m -100.0 85.55 3.07 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.4 mtmt -110.36 153.61 24.69 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.721 -174.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.593 ' CG ' ' HB3' ' A' ' 87' ' ' GLU . 18.4 ptpt -130.84 129.52 42.44 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 166.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.5 t -119.55 115.75 48.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-O 121.74 0.781 . . . . 0.0 109.604 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.744 ' HB ' HG13 ' A' ' 53' ' ' ILE . 11.0 p -131.91 114.0 14.13 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.449 -170.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.734 HG22 HD12 ' A' ' 84' ' ' ILE . 54.6 t -79.66 125.43 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.467 HG12 ' HB ' ' A' ' 53' ' ' ILE . 29.9 m -122.06 120.89 62.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.894 -176.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.652 ' HB3' ' HB3' ' A' ' 82' ' ' PHE . 9.9 p90 -125.97 148.29 49.29 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.399 -171.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.863 ' HB2' ' CZ2' ' A' ' 47' ' ' TRP . . . -72.18 97.56 1.98 Allowed 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 170.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.468 ' HA ' ' HE1' ' A' ' 40' ' ' TYR . 0.9 OUTLIER -48.84 -178.55 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.469 -1.696 . . . . 0.0 112.119 171.232 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.36 -22.89 52.35 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.956 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.1 t -85.94 -15.76 40.59 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 122.274 0.23 . . . . 0.0 111.441 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.657 ' HA ' ' HB1' ' A' ' 41' ' ' ALA . 3.7 m-20 68.42 30.25 5.43 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.535 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -106.7 99.09 8.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.335 -173.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.863 ' CZ2' ' HB2' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -90.92 110.64 21.88 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 168.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -66.8 -139.84 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 170.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -55.3 -45.83 76.25 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 158.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -138.08 -59.06 0.65 Allowed 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 113.343 -1.753 . . . . 0.0 108.435 159.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.27 -50.88 4.4 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.158 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.419 ' H ' ' ND2' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -123.39 105.57 9.93 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.348 0.594 . . . . 0.0 110.729 -177.355 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.744 HG13 ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -138.4 141.72 36.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.886 -174.062 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.723 HG22 ' HB ' ' A' ' 38' ' ' VAL . 9.4 tp -115.43 118.37 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.24 136.16 37.72 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.529 -177.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.47 ' HA ' ' CE1' ' A' ' 72' ' ' PHE . . . -78.02 150.93 33.77 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.653 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -108.07 131.54 54.49 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -70.9 137.92 49.7 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.265 0.555 . . . . 0.0 110.377 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.2 t -106.57 -43.18 4.8 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 146.49 165.42 11.57 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.5 173.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.5 135.69 62.6 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.217 1.944 . . . . 0.0 110.795 175.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.58 HD12 ' HB2' ' A' ' 67' ' ' TYR . 55.5 mt -68.29 108.86 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.8 m -52.46 117.78 3.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.224 -171.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.65 2.58 49.9 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.423 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.583 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 63.6 m -146.84 170.75 16.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.226 0.536 . . . . 0.0 111.318 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -96.12 19.79 11.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.344 1.069 . . . . 0.0 109.459 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.583 ' CD2' ' HB3' ' A' ' 65' ' ' SER . 14.2 m-85 -100.24 157.22 16.75 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.402 178.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.719 ' HB2' HD21 ' A' ' 29' ' ' ASN . 13.2 tt0 -126.03 168.64 13.68 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.571 -175.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -130.11 125.69 35.75 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -167.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.575 ' NE1' HG13 ' A' ' 27' ' ' VAL . 5.9 m95 -127.59 126.43 42.07 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -172.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 p -110.49 152.43 26.36 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 117.909 0.322 . . . . 0.0 111.825 -172.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.544 ' CD2' ' HE1' ' A' ' 21' ' ' PHE . 10.5 m-85 -128.52 152.84 47.81 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 -175.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.7 m -163.18 121.84 2.05 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 111.525 -2.58 . . . . 0.0 107.381 165.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 1.005 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -149.2 132.54 16.54 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.679 -167.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.8 t -98.56 99.25 10.37 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 169.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.2 m -89.82 144.35 9.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.211 0.529 . . . . 0.0 110.809 -172.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -89.19 32.45 0.83 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.835 -173.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.66 142.13 12.87 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -176.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.42 HD11 ' CD2' ' A' ' 82' ' ' PHE . 7.8 tt -153.68 144.13 14.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.379 0.609 . . . . 0.0 111.693 -175.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -104.64 -53.5 2.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.109 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.77 ' HB2' ' HA ' ' A' ' 102' ' ' TYR . 12.8 pt-20 -156.54 161.37 39.99 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.448 -175.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.895 ' HE1' ' HA ' ' A' ' 101' ' ' ASN . 0.1 OUTLIER -145.15 168.0 21.41 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 119.362 0.983 . . . . 0.0 112.594 177.517 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.482 ' HB3' ' HE1' ' A' ' 102' ' ' TYR . 0.3 OUTLIER -152.23 158.42 42.81 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 165.073 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.734 HD12 HG22 ' A' ' 38' ' ' VAL . 5.1 mm -101.12 145.58 11.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 119.359 -0.936 . . . . 0.0 112.194 -165.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 37' ' ' THR . 13.9 mmmt -102.93 108.38 19.54 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.223 -178.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.547 ' HE2' HD13 ' A' ' 30' ' ' ILE . 13.4 t80 -99.34 99.75 10.73 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 173.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.593 ' HB3' ' CG ' ' A' ' 35' ' ' LYS . 28.5 tt0 -116.51 131.04 57.05 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.962 -175.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.422 ' CG1' ' HB3' ' A' ' 31' ' ' ALA . 2.8 t -121.37 165.59 16.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.007 -171.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.41 ' H ' HG12 ' A' ' 88' ' ' VAL . 1.5 p -46.99 -37.43 9.11 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -126.83 -18.34 2.16 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.514 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -118.52 167.11 11.91 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 117.488 0.644 . . . . 0.0 110.465 -174.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.4 m -148.76 145.88 27.8 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 172.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.513 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 37.5 m-85 -136.19 -177.85 4.89 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 174.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.429 ' CE1' ' HD2' ' A' ' 85' ' ' LYS . 71.0 m-85 -150.4 126.97 10.85 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.625 -173.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -131.29 143.92 50.89 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.099 0.475 . . . . 0.0 111.038 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -127.34 10.54 6.8 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 62.89 -75.16 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.902 -173.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.0 t30 173.38 -62.15 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.6 m -139.6 19.77 2.53 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.192 173.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.44 -36.2 15.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.644 0.735 . . . . 0.0 109.617 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.895 ' HA ' ' HE1' ' A' ' 82' ' ' PHE . 15.6 m120 -91.66 178.81 5.82 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.248 173.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.77 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 2.6 m-85 73.02 -111.48 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 124.495 1.122 . . . . 0.0 110.614 -173.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.26 106.79 0.26 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.03 0.919 . . . . 0.0 112.471 -171.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.449 HG12 HG22 ' A' ' 106' ' ' THR . 97.4 t -79.95 114.05 20.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.016 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.4 m -92.01 104.67 17.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.449 HG22 HG12 ' A' ' 104' ' ' VAL . 9.6 t . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.688 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.7 m -98.79 113.8 26.06 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.744 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 34.6 mm -78.87 -53.52 1.16 Allowed Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.707 -175.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.744 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 11.5 Cg_endo -90.93 141.0 2.96 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.265 1.977 . . . . 0.0 112.504 175.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.1 t -150.69 -71.41 0.17 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.885 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.6 m -124.61 -44.82 1.95 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.081 0.467 . . . . 0.0 110.538 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.5 136.25 33.02 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.477 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.7 m -81.85 -16.94 49.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.832 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.702 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.7 p -144.91 149.81 16.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.704 -176.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -143.36 131.29 21.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.024 177.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.663 HD13 HD11 ' A' ' 84' ' ' ILE . 51.4 tp -69.55 132.54 46.42 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.393 0.616 . . . . 0.0 110.216 175.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -80.24 -61.04 2.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.38 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.1 p -177.58 162.24 1.79 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.202 -174.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.579 ' CD2' HD21 ' A' ' 11' ' ' LEU . 47.7 p90 -158.16 163.41 37.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.849 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -148.73 162.03 40.59 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.217 0.532 . . . . 0.0 110.254 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.582 ' HD1' ' HD1' ' A' ' 21' ' ' PHE . 30.2 t80 -124.59 142.9 51.02 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.736 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -161.2 124.12 3.18 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.64 -103.96 0.43 Allowed Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -169.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.1 t -137.75 82.65 1.93 Allowed 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 163.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 56.7 m -148.04 140.67 24.57 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.377 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.582 ' HD1' ' HD1' ' A' ' 16' ' ' TYR . 2.5 t80 -128.16 108.18 10.41 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.979 0.895 . . . . 0.0 109.302 176.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.0 p -137.2 148.76 46.75 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.918 -173.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.8 -144.61 5.54 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.874 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.523 ' HB3' HG22 ' A' ' 71' ' ' THR . 5.0 ptmm? -164.71 168.24 18.18 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.981 0.42 . . . . 0.0 111.014 -177.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.744 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 8.3 mt -138.58 158.17 30.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.87 -167.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -133.02 97.18 3.94 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.338 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.702 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 1.5 m -136.16 149.33 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 O-C-N 121.499 -0.75 . . . . 0.0 112.135 -172.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.488 ' HD3' ' CE1' ' A' ' 67' ' ' TYR . 6.7 ttpm? -99.53 133.49 43.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.888 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -87.88 119.9 28.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.0 0.429 . . . . 0.0 111.775 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.525 HG12 ' OH ' ' A' ' 86' ' ' TYR . 32.8 mm -63.66 -45.25 97.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 122.199 0.999 . . . . 0.0 108.634 173.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.592 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . -137.48 143.87 41.96 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 172.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.411 ' HE1' ' OE1' ' A' ' 68' ' ' GLU . 40.6 t80 -60.16 -42.62 95.33 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -164.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.9 m -80.07 69.44 6.46 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.649 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 1.046 ' HE3' ' HA ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -87.0 -175.4 5.34 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.077 0.465 . . . . 0.0 110.97 176.77 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.862 ' HG3' ' HB3' ' A' ' 87' ' ' GLU . 18.7 ptmt -148.32 126.55 12.19 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.3 t -119.71 121.41 66.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-O 121.655 0.741 . . . . 0.0 110.983 -171.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.622 ' OG1' ' HE3' ' A' ' 85' ' ' LYS . 72.4 p -128.15 117.78 22.2 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.754 -172.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.96 HG22 HD13 ' A' ' 84' ' ' ILE . 16.5 t -82.91 129.14 37.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.14 176.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.3 m -122.35 125.01 72.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.393 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.468 ' HB2' HG13 ' A' ' 79' ' ' ILE . 2.0 p90 -115.77 149.99 37.61 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.357 0.598 . . . . 0.0 112.038 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.683 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . . . -80.45 62.1 4.43 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.056 175.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.731 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 6.6 t70 34.88 -139.51 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 O-C-N 126.357 2.286 . . . . 0.0 111.095 173.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.34 1.26 31.05 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 168.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.528 ' O ' ' HB3' ' A' ' 45' ' ' ASP . 34.4 t -103.55 -17.33 15.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.026 -0.587 . . . . 0.0 112.568 -170.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.567 ' OD1' ' HG3' ' A' ' 81' ' ' GLU . 25.4 t70 77.22 55.96 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -173.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -158.7 141.58 14.54 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.522 -1.217 . . . . 0.0 108.952 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.516 ' CZ2' ' HB2' ' A' ' 41' ' ' ALA . 5.0 m95 -106.39 81.47 1.61 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.268 1.033 . . . . 0.0 109.041 -178.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -88.8 153.67 20.88 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.81 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -74.48 48.79 0.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.596 0.712 . . . . 0.0 110.548 176.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.523 ' HB3' ' OD1' ' A' ' 52' ' ' ASN . 26.7 t30 -86.48 -21.03 27.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.63 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.13 44.89 1.54 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -171.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.523 ' OD1' ' HB3' ' A' ' 50' ' ' ASN . 10.0 m-20 -89.98 40.05 0.99 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.939 -0.63 . . . . 0.0 110.736 -171.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -126.25 144.62 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.53 -176.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.933 HG22 ' HB ' ' A' ' 38' ' ' VAL . 6.6 tp -128.53 136.15 60.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 174.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.27 132.0 34.67 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.638 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.87 161.59 14.43 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.517 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.8 t -130.63 138.32 50.04 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.683 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 33.7 p90 -90.89 143.66 26.49 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.068 0.461 . . . . 0.0 110.18 176.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.5 m -94.86 -22.73 17.83 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.423 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 157.01 173.29 25.25 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.972 173.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 68' ' ' GLU . 16.1 Cg_exo -68.13 147.29 72.8 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.564 2.176 . . . . 0.0 111.31 176.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.5 HG12 ' HB2' ' A' ' 69' ' ' TYR . 28.9 mt -85.28 95.9 4.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.3 m -57.14 127.93 34.43 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.214 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.82 6.8 60.39 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.605 -177.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.0 m -148.8 173.17 13.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.716 0.293 . . . . 0.0 110.222 178.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -94.79 4.24 54.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.277 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.488 ' CE1' ' HD3' ' A' ' 28' ' ' LYS . 3.8 m-85 -108.7 167.44 10.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.667 0.746 . . . . 0.0 111.838 -172.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.439 ' HG3' ' H ' ' A' ' 69' ' ' TYR . 1.7 tt0 -108.85 169.94 8.36 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.447 -1.252 . . . . 0.0 108.883 175.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.5 ' HB2' HG12 ' A' ' 62' ' ' ILE . 1.1 t80 -128.37 111.04 12.91 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -164.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.744 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 9.0 m95 -114.68 145.81 41.61 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.537 -168.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.523 HG22 ' HB3' ' A' ' 24' ' ' LYS . 10.4 p -138.3 134.86 34.84 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -137.03 147.4 46.17 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.824 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.5 p -126.23 142.96 51.32 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.921 175.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.523 ' HB2' HG12 ' A' ' 54' ' ' ILE . . . -150.67 114.22 4.93 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.086 0.469 . . . . 0.0 110.939 -174.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.5 t -78.28 99.78 6.43 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 171.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.9 m -101.89 149.29 6.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.296 -173.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -75.34 -21.9 58.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.916 0.865 . . . . 0.0 108.817 173.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.12 172.93 28.0 Favored Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 114.086 -1.415 . . . . 0.0 109.617 -175.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.731 ' HA ' ' O ' ' A' ' 42' ' ' ASP . 3.8 tt -169.92 125.79 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.849 0.833 . . . . 0.0 110.967 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -97.99 -56.74 2.4 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.698 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.683 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 11.7 mm-40 -131.15 170.29 14.75 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.544 ' CE2' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -173.43 158.61 3.53 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 119.271 0.941 . . . . 0.0 111.669 -179.5 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.743 ' HB3' ' HB3' ' A' ' 96' ' ' ASN . 1.5 p90 -159.91 158.04 30.08 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 168.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.96 HD13 HG22 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -94.79 142.75 13.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.505 -172.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.622 ' HE3' ' OG1' ' A' ' 37' ' ' THR . 16.7 mtmt -96.81 123.38 40.49 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.138 172.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.525 ' OH ' HG12 ' A' ' 30' ' ' ILE . 18.6 t80 -93.96 100.76 12.85 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 170.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.862 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . 6.7 tp10 -103.65 130.9 51.19 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.451 0.643 . . . . 0.0 109.282 -172.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.959 HG13 ' HE2' ' A' ' 34' ' ' LYS . 21.8 t -127.19 163.18 30.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.581 -173.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.403 ' N ' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -74.42 26.77 0.08 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.32 0.648 . . . . 0.0 111.111 -178.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -170.69 -37.36 0.03 OUTLIER Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.595 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.48 ' HG3' ' N ' ' A' ' 92' ' ' THR . 26.8 tptp -127.85 168.29 15.38 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -173.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.48 ' N ' ' HG3' ' A' ' 91' ' ' LYS . 4.0 m -138.06 146.36 42.87 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 172.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.512 ' HD1' ' HD2' ' A' ' 86' ' ' TYR . 33.3 m-85 -137.22 -174.36 3.72 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 171.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -149.22 141.57 24.18 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.062 -174.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -122.67 121.2 35.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.298 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.743 ' HB3' ' HB3' ' A' ' 83' ' ' TYR . 10.9 p30 -145.14 -103.21 0.11 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.925 177.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -113.5 -50.13 2.86 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 122.107 0.956 . . . . 0.0 108.723 -175.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -172.27 -48.56 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.2 p -160.73 47.52 0.23 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.748 172.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.79 -109.24 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.136 -174.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 174.84 142.1 0.05 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.793 -167.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.537 ' CE2' ' HA ' ' A' ' 96' ' ' ASN . 84.2 m-85 -78.39 142.31 37.71 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 173.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.22 125.0 53.67 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.7 0.762 . . . . 0.0 110.517 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.504 HG21 HG12 ' A' ' 79' ' ' ILE . 3.7 t -94.36 129.96 43.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.7 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.9 t -66.89 95.32 0.36 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.124 0.488 . . . . 0.0 110.626 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.128 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.763 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.1 p -69.87 134.19 48.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.09 0.471 . . . . 0.0 111.179 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.609 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 46.9 mm -70.6 -55.58 7.18 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.902 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.609 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 37.5 Cg_endo -73.56 135.21 21.66 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.656 1.571 . . . . 0.0 111.926 177.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.5 t -110.38 -85.93 0.54 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.666 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.0 m -96.58 -64.26 1.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.654 0.264 . . . . 0.0 110.639 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.48 -174.13 2.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.975 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.422 ' HB3' ' HB3' ' A' ' 28' ' ' LYS . 26.1 m -76.52 -31.96 57.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.091 0.472 . . . . 0.0 110.362 177.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.906 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.2 p -114.68 150.65 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 121.352 0.596 . . . . 0.0 111.818 -173.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -143.05 141.25 31.26 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.667 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.485 HD11 ' HD2' ' A' ' 14' ' ' TYR . 3.5 tp -69.43 140.39 54.1 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.021 0.438 . . . . 0.0 110.107 175.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.406 ' N ' ' HG ' ' A' ' 11' ' ' LEU . 28.2 t70 -90.94 -67.86 0.83 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.579 172.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.7 m -167.18 157.82 11.53 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.868 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.485 ' HD2' HD11 ' A' ' 11' ' ' LEU . 34.3 p90 -156.87 155.82 32.1 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.705 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -130.25 163.19 27.3 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.834 0.35 . . . . 0.0 111.084 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.635 ' HE2' HG23 ' A' ' 106' ' ' THR . 1.7 t80 -128.74 147.06 50.74 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -154.89 101.55 2.29 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -175.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.24 -96.69 0.14 Allowed Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 -168.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.503 ' HA ' ' CE1' ' A' ' 16' ' ' TYR . 10.4 t -136.2 89.51 2.48 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 158.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 16.1 m -144.38 139.64 28.56 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.501 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.829 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 17.8 t80 -108.58 129.27 55.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.8 p -151.39 123.7 8.3 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.074 0.464 . . . . 0.0 109.974 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 14' ' ' TYR . . . -177.91 -157.93 19.73 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.262 -0.97 . . . . 0.0 112.155 -176.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.668 ' HB3' HG22 ' A' ' 71' ' ' THR . 21.2 pttm -159.81 162.3 34.74 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.215 0.531 . . . . 0.0 111.214 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.622 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 11.0 mt -124.67 159.5 30.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.573 -170.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -131.44 100.19 5.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -174.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.906 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 1.9 m -135.77 147.93 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.706 -169.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 79.0 tttt -79.55 131.32 35.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.029 177.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.633 HD22 ' HB2' ' A' ' 68' ' ' GLU . 7.3 p30 -91.17 122.61 33.95 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.294 0.569 . . . . 0.0 110.349 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.403 HG12 ' OH ' ' A' ' 86' ' ' TYR . 25.3 mm -76.76 -56.82 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.016 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.649 ' HB3' ' HD3' ' A' ' 34' ' ' LYS . . . -107.34 -80.96 0.56 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.864 173.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -166.47 -73.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.666 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.415 ' C ' ' HD2' ' A' ' 34' ' ' LYS . 20.1 m -83.59 68.73 9.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.309 0.576 . . . . 0.0 110.691 -178.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.654 ' HG3' HG13 ' A' ' 88' ' ' VAL . 6.3 mmmt -94.97 172.51 8.1 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.854 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 89.7 mttt -101.19 129.36 47.1 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.765 -173.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 65.3 t -121.44 107.92 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-O 121.873 0.844 . . . . 0.0 109.288 171.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.574 HG22 HD11 ' A' ' 53' ' ' ILE . 3.1 p -120.3 116.03 24.74 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.552 -173.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.91 HG22 HD12 ' A' ' 84' ' ' ILE . 72.2 t -77.02 136.64 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.006 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.152 176.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.41 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -124.29 107.79 19.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.53 176.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.535 ' HA ' ' CB ' ' A' ' 82' ' ' PHE . 0.9 OUTLIER -111.71 137.17 49.97 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 122.58 1.181 . . . . 0.0 110.387 174.736 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.571 ' HB2' ' CE3' ' A' ' 47' ' ' TRP . . . -89.76 97.02 10.95 Favored 'General case' 0 N--CA 1.412 -2.371 0 CA-C-N 113.086 -1.87 . . . . 0.0 107.101 178.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.722 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 1.3 p30 -44.01 163.36 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 O-C-N 124.767 1.292 . . . . 0.0 112.541 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.39 -13.04 14.71 Favored Glycine 0 N--CA 1.464 0.537 0 CA-C-N 115.536 -0.756 . . . . 0.0 114.358 -167.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -110.47 -18.87 13.12 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.426 ' OD1' ' HA ' ' A' ' 47' ' ' TRP . 48.1 t0 -74.03 -92.47 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.084 -1.416 . . . . 0.0 112.278 -173.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 51.95 98.58 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -159.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.571 ' CE3' ' HB2' ' A' ' 41' ' ' ALA . 7.1 m-90 -42.7 113.13 0.43 Allowed 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 -152.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.475 ' ND2' ' HB2' ' A' ' 50' ' ' ASN . 9.0 p30 -84.03 31.98 0.49 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 113.364 -1.744 . . . . 0.0 108.484 161.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.5 t30 59.35 46.42 12.63 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 122.19 0.995 . . . . 0.0 108.449 -164.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.475 ' HB2' ' ND2' ' A' ' 48' ' ' ASN . 49.9 t30 -83.4 -57.59 3.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.647 -174.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.426 ' H ' ' HD1' ' A' ' 47' ' ' TRP . . . 93.85 96.68 1.55 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.304 -0.951 . . . . 0.0 113.216 174.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 40' ' ' TYR . 86.8 m-20 -135.02 106.69 6.92 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.574 HD11 HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -117.91 144.45 25.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.381 0.61 . . . . 0.0 111.94 -172.06 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.617 HG23 ' HB ' ' A' ' 38' ' ' VAL . 8.1 tp -132.61 116.34 27.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.398 171.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.18 137.96 45.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.889 0.376 . . . . 0.0 111.425 -174.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.31 163.37 23.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.548 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.6 m -121.22 141.57 50.74 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -70.75 139.88 51.19 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.372 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.8 t -108.78 -39.13 5.44 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.45 154.77 7.14 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.545 173.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.36 136.13 49.62 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.198 1.932 . . . . 0.0 111.447 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.589 HD12 ' HB3' ' A' ' 67' ' ' TYR . 67.9 mt -80.59 91.92 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.8 p -60.65 120.92 10.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.642 -172.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 132.65 -34.53 2.47 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.515 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.2 m -134.9 172.53 12.86 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.65 39.15 0.46 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.956 0.407 . . . . 0.0 110.999 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.589 ' HB3' HD12 ' A' ' 62' ' ' ILE . 3.9 m-85 -115.27 159.25 21.24 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.719 0.771 . . . . 0.0 111.369 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.633 ' HB2' HD22 ' A' ' 29' ' ' ASN . 11.2 tt0 -131.12 170.38 14.61 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.11 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.23 122.7 26.98 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -165.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.702 ' CD1' HG13 ' A' ' 27' ' ' VAL . 20.8 m95 -121.9 134.82 54.86 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.813 -169.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.668 HG22 ' HB3' ' A' ' 24' ' ' LYS . 18.0 p -138.21 150.63 46.92 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.508 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 6.6 p90 -173.3 164.1 4.65 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.451 0.643 . . . . 0.0 111.928 172.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.4 p -124.56 144.24 50.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.271 173.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.829 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -137.56 126.5 24.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.573 -174.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.5 t -81.98 99.41 9.1 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 170.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.429 HG11 ' HB2' ' A' ' 21' ' ' PHE . 21.0 m -92.35 154.28 3.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.884 -176.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -116.99 48.22 1.35 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.04 126.18 4.42 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.857 -174.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.639 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 4.8 tt -136.3 128.33 44.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.592 0.711 . . . . 0.0 111.034 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.722 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -83.82 -61.7 1.76 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.947 -175.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 16.1 mt-10 -150.83 176.17 11.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.13 -1.395 . . . . 0.0 107.994 -177.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.535 ' CB ' ' HA ' ' A' ' 40' ' ' TYR . 30.3 p90 -169.43 173.47 6.51 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 119.12 -1.032 . . . . 0.0 113.484 174.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.49 154.17 24.4 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.08 173.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.91 HD12 HG22 ' A' ' 38' ' ' VAL . 16.3 mm -99.2 151.82 4.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.438 ' HE3' ' OG1' ' A' ' 37' ' ' THR . 49.4 pttt -131.32 149.54 52.51 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 121.88 0.848 . . . . 0.0 110.413 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.699 ' HD2' ' HD1' ' A' ' 93' ' ' TYR . 21.8 t80 -114.63 108.36 16.72 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 113.78 -1.554 . . . . 0.0 109.675 -174.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.854 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 31.1 tt0 -105.8 116.78 32.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.173 0.511 . . . . 0.0 109.958 -175.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.654 HG13 ' HG3' ' A' ' 34' ' ' LYS . 1.3 t -123.29 166.28 18.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.994 -175.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m -48.15 -46.45 34.5 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.492 0.495 . . . . 0.0 111.553 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -120.79 -9.22 7.69 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.305 -0.95 . . . . 0.0 113.749 -176.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.3 mmtm -128.11 173.81 9.77 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 86' ' ' TYR . 8.3 m -152.9 143.78 22.92 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 113.226 -1.807 . . . . 0.0 109.43 176.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.699 ' HD1' ' HD2' ' A' ' 86' ' ' TYR . 28.1 m-85 -144.01 -173.53 4.02 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 175.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -150.14 148.08 28.53 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.437 -174.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -118.18 90.24 3.29 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 169.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -131.14 31.05 4.47 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.957 -172.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 68.3 -59.84 0.43 Allowed 'General case' 0 CA--C 1.532 0.259 0 O-C-N 123.733 0.646 . . . . 0.0 110.535 -172.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -179.68 -53.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.4 t -172.69 69.24 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.191 -1.368 . . . . 0.0 107.518 175.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.64 -37.87 0.2 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.969 -170.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 70.05 149.08 0.08 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -171.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 95.9 m-85 -83.67 106.32 15.29 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 175.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -68.61 116.06 8.7 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.043 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.566 HG21 HG12 ' A' ' 79' ' ' ILE . 2.8 t -100.21 133.65 42.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.1 t -151.5 148.65 28.3 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.635 HG23 ' HE2' ' A' ' 16' ' ' TYR . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.572 -0.728 . . . . 0.0 110.331 177.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 120.407 0.146 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -62.53 156.7 22.31 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.857 0.36 . . . . 0.0 111.364 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 67.1 mt -83.61 121.81 76.49 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.442 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.403 ' HB3' ' HB2' ' A' ' 10' ' ' GLN . 36.9 Cg_endo -65.77 145.0 79.74 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.709 2.273 . . . . 0.0 112.08 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.6 t -122.03 -28.32 4.43 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.301 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.9 p -70.23 -73.63 0.16 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.761 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.83 174.5 7.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.283 0.564 . . . . 0.0 111.567 -176.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.659 ' HB3' HD11 ' A' ' 30' ' ' ILE . 20.3 m -80.53 -15.53 56.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.07 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.752 HG23 HG12 ' A' ' 27' ' ' VAL . 2.2 p -140.7 151.42 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 120.758 0.313 . . . . 0.0 110.343 -178.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 4' ' ' PRO . 15.1 tt0 -145.16 128.87 17.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.242 -176.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.566 HD21 ' CD2' ' A' ' 14' ' ' TYR . 26.0 tp -69.8 137.22 51.66 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 172.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.59 -49.04 6.07 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.909 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.8 p 174.82 160.02 0.19 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 123.705 0.628 . . . . 0.0 111.744 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.566 ' CD2' HD21 ' A' ' 11' ' ' LEU . 30.4 p90 -156.33 159.67 39.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.726 177.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -151.89 164.22 37.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.618 0.247 . . . . 0.0 110.442 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 19' ' ' SER . 5.3 t80 -115.96 143.33 45.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.034 -174.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -144.17 101.67 3.75 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -175.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.4 -97.78 0.25 Allowed Glycine 0 C--N 1.333 0.368 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -170.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 16' ' ' TYR . 71.4 m -134.43 85.73 2.21 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 158.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 13.8 m -146.51 138.52 24.84 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.088 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.818 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 20.4 t80 -95.52 140.37 30.46 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 171.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 85.7 p -155.58 126.01 6.78 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 174.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.8 -161.85 29.94 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.159 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -160.05 162.75 34.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.835 0.35 . . . . 0.0 110.947 -176.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.594 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 25.9 mt -132.38 156.51 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.894 -172.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -126.14 115.83 20.4 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.752 HG12 HG23 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -128.67 149.73 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.022 179.288 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.491 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 92.9 mttt -80.26 152.14 29.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.498 174.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -94.74 85.02 4.33 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.773 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.659 HD11 ' HB3' ' A' ' 8' ' ' SER . 3.8 mm -64.51 -56.84 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.65 -150.7 0.47 Allowed 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 106.725 -1.584 . . . . 0.0 106.725 168.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.467 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 42.9 t80 -112.31 -56.89 2.34 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.514 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.2 t -65.4 111.45 3.06 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 123.301 0.376 . . . . 0.0 110.412 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.54 ' HB2' ' HH2' ' A' ' 70' ' ' TRP . 12.4 mmtp -112.62 167.61 10.33 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 121.121 0.486 . . . . 0.0 110.473 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.755 ' HG3' ' HB3' ' A' ' 87' ' ' GLU . 0.6 OUTLIER -151.88 111.15 3.91 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 171.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.4 t -106.7 112.27 39.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-O 121.817 0.818 . . . . 0.0 110.435 -173.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.742 HG22 HD11 ' A' ' 53' ' ' ILE . 14.0 p -119.07 107.99 14.17 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.653 -172.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.992 HG22 HD12 ' A' ' 84' ' ' ILE . 71.7 t -76.45 111.01 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.463 175.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.647 ' HB ' ' CZ2' ' A' ' 47' ' ' TRP . 0.0 OUTLIER -102.62 113.66 39.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.122 170.781 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.657 ' HA ' ' CB ' ' A' ' 82' ' ' PHE . 0.6 OUTLIER -108.24 145.14 34.73 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 122.075 0.941 . . . . 0.0 110.385 171.742 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.709 ' HB2' ' CE3' ' A' ' 47' ' ' TRP . . . -85.67 99.08 11.06 Favored 'General case' 0 N--CA 1.409 -2.498 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.368 169.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -40.27 165.2 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 112.893 -1.958 . . . . 0.0 112.875 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 80' ' ' LYS . . . -62.22 2.18 1.17 Allowed Glycine 0 C--N 1.334 0.426 0 CA-C-N 114.956 -1.02 . . . . 0.0 114.656 -167.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.8 t -80.87 -22.7 39.62 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 116.954 0.377 . . . . 0.0 110.321 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.7 t70 77.52 43.85 0.1 Allowed 'General case' 0 C--N 1.351 0.641 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -142.64 146.47 34.51 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.351 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.709 ' CE3' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -122.16 120.66 34.87 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 119.399 -0.92 . . . . 0.0 112.438 173.177 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -90.93 16.02 10.28 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 169.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 67.03 4.02 3.4 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.354 -1.293 . . . . 0.0 111.6 -175.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.431 HD22 ' HA ' ' A' ' 50' ' ' ASN . 0.1 OUTLIER -168.8 179.34 4.22 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -171.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.11 27.48 64.13 Favored Glycine 0 CA--C 1.505 -0.536 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.093 178.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -166.57 56.67 0.09 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.263 0.554 . . . . 0.0 109.975 -175.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.742 HD11 HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -133.92 131.15 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-O 122.048 0.928 . . . . 0.0 109.643 -174.071 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.517 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 10.4 mm -110.92 129.76 65.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.982 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.11 96.35 7.77 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 118.263 -1.375 . . . . 0.0 108.255 167.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -47.63 153.88 0.53 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.76 170.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -115.55 131.71 56.85 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.716 -174.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -71.32 143.85 50.14 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.254 177.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.9 t -106.4 -37.51 6.49 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 145.82 173.68 17.3 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.356 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -53.86 134.58 59.8 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 123.037 2.491 . . . . 0.0 111.633 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 1.069 HG12 ' HB2' ' A' ' 69' ' ' TYR . 4.7 mt -83.92 119.07 32.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.695 -172.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.5 p -62.77 118.37 7.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.019 0.438 . . . . 0.0 110.251 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 117.46 -12.44 13.87 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -176.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.5 m -151.94 -179.53 7.55 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -112.11 30.21 7.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.652 0.739 . . . . 0.0 109.9 177.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.491 ' CD1' ' HA ' ' A' ' 28' ' ' LYS . 17.2 m-85 -105.0 -178.37 3.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.792 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.488 ' O ' HD11 ' A' ' 62' ' ' ILE . 15.6 tp10 -111.84 150.9 29.73 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.7 -171.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 1.069 ' HB2' HG12 ' A' ' 62' ' ' ILE . 8.7 t80 -125.2 116.52 22.13 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -165.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.662 ' HE1' HG22 ' A' ' 27' ' ' VAL . 12.7 m95 -108.68 133.43 52.77 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.469 -170.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.42 ' O ' ' HB3' ' A' ' 72' ' ' PHE . 22.5 p -139.76 148.53 42.39 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -176.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.464 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 3.3 p90 -174.02 151.67 1.78 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.913 0.863 . . . . 0.0 112.409 170.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.2 p -117.81 137.55 52.67 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.277 -1.329 . . . . 0.0 107.923 166.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.818 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -129.51 122.14 28.65 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.891 -168.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.71 99.45 1.33 Allowed 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 171.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.407 HG11 ' HB2' ' A' ' 21' ' ' PHE . 28.6 m -103.3 150.24 6.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.659 -175.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.676 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -104.62 38.12 1.97 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.614 0.721 . . . . 0.0 109.65 175.47 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 112.71 149.82 10.8 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.054 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.534 HG13 ' HB2' ' A' ' 40' ' ' TYR . 9.7 tt -154.88 156.41 5.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.466 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 18.2 tptm -140.67 -47.4 0.42 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.953 0.406 . . . . 0.0 111.26 -176.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.443 ' O ' ' HB3' ' A' ' 82' ' ' PHE . 20.8 mt-10 -141.7 162.27 35.88 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -178.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.657 ' CB ' ' HA ' ' A' ' 40' ' ' TYR . 43.1 p90 -172.63 179.26 2.47 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 119.101 -1.039 . . . . 0.0 112.76 169.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.568 ' HB3' ' HB3' ' A' ' 96' ' ' ASN . 0.2 OUTLIER -160.94 143.15 12.43 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 113.519 -1.673 . . . . 0.0 108.38 171.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.992 HD12 HG22 ' A' ' 38' ' ' VAL . 14.2 mm -90.48 132.45 35.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.783 -177.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.511 ' HB2' ' OG1' ' A' ' 37' ' ' THR . 1.1 mtmp? -89.8 107.0 18.84 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.719 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.683 ' HB2' HG11 ' A' ' 9' ' ' VAL . 20.2 t80 -85.99 99.16 11.25 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.755 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . 7.9 tt0 -116.73 124.12 48.88 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.072 -174.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 23.1 t -104.6 162.62 4.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.8 t -59.09 -11.48 3.69 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -143.62 2.46 1.48 Allowed Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.834 177.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.8 tptt -141.65 163.6 32.48 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 117.823 0.811 . . . . 0.0 110.438 -176.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.8 m -144.73 142.89 30.39 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.163 0.506 . . . . 0.0 110.874 174.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.497 ' HD2' ' CD2' ' A' ' 86' ' ' TYR . 49.1 m-85 -141.35 -168.62 2.68 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -144.99 143.71 30.65 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.711 0.291 . . . . 0.0 111.246 -174.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.425 ' OD2' ' HB2' ' A' ' 11' ' ' LEU . 29.6 t70 -122.19 98.69 6.05 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 169.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.568 ' HB3' ' HB3' ' A' ' 83' ' ' TYR . 4.9 p30 -123.18 -45.25 2.12 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.754 -173.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.519 ' HB3' ' O ' ' A' ' 96' ' ' ASN . 26.4 p-10 166.23 -37.67 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 175.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 178.58 -44.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.4 t -174.09 38.95 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.286 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.26 -90.54 0.11 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 p30 178.77 158.7 0.55 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.845 0.355 . . . . 0.0 110.458 -171.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -90.52 100.65 13.45 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 169.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.558 ' H ' ' CD ' ' A' ' 103' ' ' GLN . 0.0 OUTLIER -81.06 107.52 13.94 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.513 0.673 . . . . 0.0 110.18 179.579 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.5 t -91.43 114.86 29.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.963 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 21.8 m -69.72 102.54 1.92 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.698 -0.668 . . . . 0.0 110.876 -177.592 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.1 m -60.11 148.74 34.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.128 0.489 . . . . 0.0 110.462 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.613 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 44.2 mm -71.32 -49.34 12.18 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.621 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.613 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 39.5 Cg_exo -58.01 142.43 96.73 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 122.064 1.843 . . . . 0.0 112.42 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.9 t -157.94 -60.08 0.08 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.895 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.9 t -78.35 -74.49 0.27 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.519 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -141.22 -160.32 1.07 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -68.48 -30.99 69.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.804 HG23 HG12 ' A' ' 27' ' ' VAL . 2.1 p -128.0 151.43 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.816 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -143.26 129.51 19.85 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.277 178.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.585 HD21 ' CD2' ' A' ' 14' ' ' TYR . 15.2 tp -69.07 140.04 54.85 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.066 0.46 . . . . 0.0 110.08 174.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -88.37 -63.85 1.24 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.101 178.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.0 m -170.58 159.84 6.95 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.196 -176.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.585 ' CD2' HD21 ' A' ' 11' ' ' LEU . 12.4 p90 -158.11 155.92 30.05 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.407 174.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -113.43 154.75 26.46 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 120.829 0.347 . . . . 0.0 110.873 175.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.808 ' CZ ' HG21 ' A' ' 79' ' ' ILE . 1.1 m-85 -160.03 139.21 10.89 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 124.71 1.256 . . . . 0.0 110.412 -175.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 16' ' ' TYR . 16.8 t70 -175.54 71.31 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.973 167.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 51.7 38.9 45.42 Favored Glycine 0 CA--C 1.507 -0.455 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -170.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.6 m -155.58 158.99 39.3 Favored 'General case' 0 N--CA 1.394 -3.268 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 -161.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.516 HG23 ' HA ' ' A' ' 75' ' ' SER . 52.9 m -60.32 143.78 52.14 Favored 'General case' 0 C--N 1.263 -3.191 0 CA-C-N 112.899 -1.955 . . . . 0.0 111.219 -173.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.659 ' HD2' ' CZ ' ' A' ' 16' ' ' TYR . 2.1 t80 -78.59 141.87 37.74 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.6 m -161.54 124.89 3.19 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.736 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.73 -153.03 9.95 Favored Glycine 0 N--CA 1.438 -1.167 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -176.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.754 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -160.05 163.61 33.82 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.014 0.435 . . . . 0.0 111.371 -177.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.726 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 24.9 mt -127.55 156.81 39.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.645 -170.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -132.77 107.29 8.27 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.114 0.565 . . . . 0.0 109.647 -172.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.804 HG12 HG23 ' A' ' 9' ' ' VAL . 0.7 OUTLIER -133.95 151.89 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.208 -0.932 . . . . 0.0 112.178 -172.062 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.446 ' HD3' ' CE1' ' A' ' 67' ' ' TYR . 23.8 tptm -76.35 129.29 36.4 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 172.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.611 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 23.7 p-10 -86.6 103.86 15.49 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.574 0.702 . . . . 0.0 110.376 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.512 HG12 ' OH ' ' A' ' 86' ' ' TYR . 16.3 mm -72.99 -60.3 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-N 115.47 -0.787 . . . . 0.0 108.882 -176.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.78 -135.05 0.35 Allowed 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.148 172.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -120.54 -52.4 2.14 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.022 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.5 t -78.16 116.21 18.45 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.784 ' HB2' ' HH2' ' A' ' 70' ' ' TRP . 27.5 mmtm -116.76 167.33 11.19 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.24 0.543 . . . . 0.0 110.619 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.537 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 9.0 mtpm? -138.42 97.72 3.43 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.786 173.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.9 t -98.75 124.44 51.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.9 0.857 . . . . 0.0 110.713 -178.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.784 ' HB ' HG13 ' A' ' 53' ' ' ILE . 45.2 p -132.69 116.4 16.57 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.286 -1.324 . . . . 0.0 110.638 -170.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.901 HG22 HD13 ' A' ' 84' ' ' ILE . 44.9 t -84.92 132.75 30.92 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-O 121.322 0.582 . . . . 0.0 109.514 173.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.701 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -118.9 111.61 34.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.161 175.015 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.62 ' HA ' ' CB ' ' A' ' 82' ' ' PHE . 5.1 p90 -115.05 139.58 49.76 Favored 'General case' 0 CA--C 1.485 -1.528 0 CA-C-O 122.667 1.222 . . . . 0.0 110.901 175.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.518 ' HB2' ' CZ3' ' A' ' 47' ' ' TRP . . . -86.2 103.0 14.43 Favored 'General case' 0 N--CA 1.405 -2.714 0 CA-C-N 112.69 -2.05 . . . . 0.0 107.462 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.671 ' HB2' ' ND2' ' A' ' 52' ' ' ASN . 3.4 t70 -48.15 -168.49 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 111.694 -2.503 . . . . 0.0 113.796 -174.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.53 -17.9 28.2 Favored Glycine 0 C--N 1.335 0.5 0 O-C-N 122.106 -0.371 . . . . 0.0 112.513 -177.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 41.6 t -65.83 -16.59 63.96 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 122.825 0.45 . . . . 0.0 110.823 175.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.495 ' HB3' ' HG3' ' A' ' 80' ' ' LYS . 3.7 p30 51.46 33.77 10.91 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.632 1.173 . . . . 0.0 110.632 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -163.63 139.76 6.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.436 -169.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.518 ' CZ3' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -91.33 88.94 7.06 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 120.029 -0.668 . . . . 0.0 112.326 174.516 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.63 47.3 1.35 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.641 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 60.12 31.63 20.63 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.113 -172.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -92.37 127.4 37.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.231 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -96.37 60.43 1.3 Allowed Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.56 -174.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.671 ' ND2' ' HB2' ' A' ' 42' ' ' ASP . 87.2 m-20 -76.78 75.9 3.41 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.795 0.331 . . . . 0.0 110.431 175.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.784 HG13 ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -109.23 136.21 45.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.331 0.586 . . . . 0.0 110.737 178.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.73 HG22 ' HB ' ' A' ' 38' ' ' VAL . 8.0 tp -117.24 121.92 68.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.638 174.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.66 134.01 37.17 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.912 0.387 . . . . 0.0 110.411 -176.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.07 161.2 18.28 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.977 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 m -114.44 176.05 5.22 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.741 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 0.4 OUTLIER -139.22 146.47 40.53 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.782 0.801 . . . . 0.0 111.517 -174.167 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.8 t -88.39 -36.11 16.75 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.329 -1.305 . . . . 0.0 108.712 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 143.46 -172.08 24.96 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.288 174.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -65.85 138.25 52.41 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.75 2.3 . . . . 0.0 111.404 175.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.644 HG12 ' HB2' ' A' ' 69' ' ' TYR . 20.0 mt -81.24 109.84 16.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.408 -176.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.5 p -65.64 135.48 55.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.272 0.558 . . . . 0.0 111.274 -176.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.89 -4.64 81.81 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.459 -0.657 . . . . 0.0 111.459 -177.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.6 m -140.72 171.52 13.98 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -108.31 46.29 0.97 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.17 0.509 . . . . 0.0 110.002 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.502 ' HB3' HD12 ' A' ' 62' ' ' ILE . 2.3 m-85 -125.88 172.33 9.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.425 -178.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 29' ' ' ASN . 17.5 tt0 -120.39 167.07 12.72 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.644 ' HB2' HG12 ' A' ' 62' ' ' ILE . 4.3 t80 -141.59 121.72 13.81 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -164.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.784 ' HH2' ' HB2' ' A' ' 34' ' ' LYS . 25.4 m95 -118.46 145.55 45.17 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.798 -168.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.533 HG22 ' HB3' ' A' ' 24' ' ' LYS . 1.4 p -147.29 142.38 27.1 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 123.744 0.652 . . . . 0.0 109.527 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.406 ' HB3' ' O ' ' A' ' 71' ' ' THR . 2.7 p90 -173.99 159.49 3.33 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.442 0.639 . . . . 0.0 112.585 173.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.3 p -117.67 143.98 45.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.416 172.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -142.25 106.09 4.71 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -171.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.516 ' HA ' HG23 ' A' ' 20' ' ' THR . 13.3 t -68.6 109.13 3.62 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 174.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.578 HG21 ' HE1' ' A' ' 16' ' ' TYR . 12.2 m -100.52 155.59 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.002 -173.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -86.36 -24.01 25.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.21 -175.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 151.36 107.08 0.35 Allowed Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -177.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.808 HG21 ' CZ ' ' A' ' 16' ' ' TYR . 8.9 tt -112.34 138.04 42.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.418 0.628 . . . . 0.0 111.722 -172.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.495 ' HG3' ' HB3' ' A' ' 45' ' ' ASP . 74.5 mmtt -117.0 -47.42 2.69 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.213 -176.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.473 ' OE1' ' HB3' ' A' ' 103' ' ' GLN . 11.7 mm-40 -146.21 154.02 41.28 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -175.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.701 ' HB2' ' O ' ' A' ' 39' ' ' VAL . 3.9 p90 -172.14 -179.06 2.24 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 118.521 -1.272 . . . . 0.0 114.032 174.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.582 ' HA ' ' CE1' ' A' ' 102' ' ' TYR . 0.2 OUTLIER -162.17 164.7 27.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 113.48 -1.691 . . . . 0.0 108.644 176.632 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.901 HD13 HG22 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -104.23 144.24 14.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.958 -177.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.531 ' HB2' ' OG1' ' A' ' 37' ' ' THR . 6.6 mtmp? -104.86 130.07 53.07 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 121.069 0.461 . . . . 0.0 109.905 176.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.715 ' HD2' ' HD2' ' A' ' 93' ' ' TYR . 19.4 t80 -102.63 102.17 12.37 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.46 177.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.537 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 28.5 tt0 -108.64 129.35 55.33 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.566 ' C ' ' H ' ' A' ' 90' ' ' GLY . 2.6 t -122.06 166.47 16.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -174.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.8 p -66.45 28.08 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.344 0.592 . . . . 0.0 112.262 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . 171.96 -34.61 0.14 Allowed Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.851 177.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.531 ' HE3' ' HA ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -102.44 164.47 11.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.841 0.353 . . . . 0.0 111.338 -177.33 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.4 m -148.59 142.92 26.21 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 173.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.715 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 47.3 m-85 -141.41 -168.1 2.56 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.6 133.87 15.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.628 -170.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -118.98 94.92 4.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.225 0.536 . . . . 0.0 109.995 172.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.468 ' O ' ' HB2' ' A' ' 97' ' ' ASN . 28.9 p-10 -125.36 27.62 6.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.275 -178.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 96' ' ' ASN . 2.9 m-20 72.65 -58.06 0.61 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.748 -172.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 177.69 -48.95 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 176.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.1 p -164.89 29.69 0.06 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.124 174.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -104.27 -37.45 7.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.411 -171.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.457 HD22 ' HB3' ' A' ' 81' ' ' GLU . 2.0 p-10 47.49 101.56 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 O-C-N 123.965 0.79 . . . . 0.0 112.891 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.582 ' CE1' ' HA ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -50.78 116.49 1.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.91 -168.694 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.473 ' HB3' ' OE1' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -88.85 124.96 34.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.533 0.682 . . . . 0.0 110.292 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.476 HG21 HG12 ' A' ' 79' ' ' ILE . 3.4 t -97.38 148.65 5.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.722 -1.127 . . . . 0.0 110.564 -174.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.2 m -95.38 75.36 3.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.418 0.628 . . . . 0.0 110.275 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.9 m . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.307 -0.854 . . . . 0.0 109.653 178.032 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.855 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.3 m -96.47 163.95 12.83 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.287 -178.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.718 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 23.0 mm -53.12 -54.0 49.39 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.718 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 36.2 Cg_exo -60.09 138.27 80.78 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.078 1.852 . . . . 0.0 112.331 178.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.8 t -129.72 -54.17 1.15 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.683 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.9 t -108.42 -74.99 0.64 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.772 -0.194 . . . . 0.0 110.617 -178.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.77 -173.13 2.25 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.523 0.201 . . . . 0.0 111.186 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.9 m -65.44 -36.07 82.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.217 0.532 . . . . 0.0 110.528 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.698 HG23 HG12 ' A' ' 27' ' ' VAL . 1.7 p -123.8 152.11 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.5 -176.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -142.57 132.5 24.31 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.094 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.482 HD21 ' CD2' ' A' ' 14' ' ' TYR . 34.8 tp -71.13 136.04 47.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.064 0.459 . . . . 0.0 110.304 176.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -88.12 -58.86 2.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.94 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.3 p -179.54 160.46 0.96 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.8 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.482 ' CD2' HD21 ' A' ' 11' ' ' LEU . 44.1 p90 -157.54 163.14 38.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.481 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -133.46 158.57 42.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.929 0.395 . . . . 0.0 110.623 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.733 ' CE2' ' HB ' ' A' ' 106' ' ' THR . 0.5 OUTLIER -139.53 138.42 36.29 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.57 -179.041 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -166.5 130.59 2.07 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.78 -104.18 0.36 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -168.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.2 t -140.86 85.05 1.97 Allowed 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 161.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.528 ' O ' ' HD1' ' A' ' 16' ' ' TYR . 88.9 m -147.31 130.23 16.24 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.411 173.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.462 ' HD1' ' CD1' ' A' ' 16' ' ' TYR . 3.5 t80 -128.3 104.05 7.51 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.567 0.699 . . . . 0.0 109.56 -174.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.6 m -138.32 150.1 46.28 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.797 -176.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.32 -141.5 3.75 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 -178.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 2.6 ptpp? -162.6 166.82 24.17 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.825 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.709 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 38.3 mt -133.66 157.16 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 -170.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -133.03 110.14 10.03 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.31 0.644 . . . . 0.0 109.657 -173.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.698 HG12 HG23 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -137.97 151.49 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.206 -0.934 . . . . 0.0 113.101 -172.393 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . 46.4 tptt -78.83 140.86 38.11 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.899 174.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.537 ' OD1' ' HB2' ' A' ' 68' ' ' GLU . 7.2 m-20 -88.31 96.76 10.7 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.696 0.284 . . . . 0.0 110.783 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.606 HG12 ' OH ' ' A' ' 86' ' ' TYR . 7.7 mm -75.98 -54.84 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 176.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.89 -157.5 0.62 Allowed 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.201 -1.363 . . . . 0.0 107.906 172.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -113.33 -59.03 2.07 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.603 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.6 m -76.85 87.82 3.44 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 175.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.454 ' HE2' ' CZ2' ' A' ' 70' ' ' TRP . 27.9 mtmm -104.34 158.4 16.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.456 -174.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.766 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 47.8 mttp -123.79 138.46 54.5 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 175.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.1 t -128.0 115.52 39.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.331 0.586 . . . . 0.0 110.115 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.903 ' HB ' HG13 ' A' ' 53' ' ' ILE . 69.1 p -119.74 120.3 36.15 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.494 -171.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 1.005 ' HB ' HG22 ' A' ' 54' ' ' ILE . 79.6 t -88.52 110.42 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.703 177.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.706 HG21 ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -97.13 120.29 46.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 170.686 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.612 ' HA ' ' HZ2' ' A' ' 47' ' ' TRP . 5.3 p90 -119.99 138.23 53.61 Favored 'General case' 0 CA--C 1.49 -1.347 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.032 171.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.603 ' HB3' ' HB2' ' A' ' 81' ' ' GLU . . . -76.9 88.06 3.47 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 113.133 -1.849 . . . . 0.0 108.017 -175.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' A' ' 43' ' ' GLY . 42.8 t0 -43.75 -170.37 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 109.221 -3.627 . . . . 0.0 113.007 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.502 ' H ' ' CG ' ' A' ' 42' ' ' ASP . . . -61.5 -10.39 22.98 Favored Glycine 0 CA--C 1.522 0.469 0 O-C-N 121.983 -0.448 . . . . 0.0 112.721 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -76.11 -14.19 60.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.904 0.383 . . . . 0.0 110.148 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 76.06 12.59 2.8 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.122 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -170.81 179.35 3.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.951 -178.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.612 ' HZ2' ' HA ' ' A' ' 40' ' ' TYR . 23.0 m-90 -105.19 107.93 19.18 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.501 169.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -76.45 -162.82 0.27 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 170.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -75.11 58.31 0.89 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.438 0.637 . . . . 0.0 109.72 171.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -128.58 -50.68 1.26 Allowed 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.187 -174.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.66 76.2 0.95 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.95 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.402 ' H ' ' HD1' ' A' ' 47' ' ' TRP . 3.5 m-20 -77.94 80.11 4.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.903 HG13 ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -119.58 138.45 50.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.555 0.693 . . . . 0.0 112.822 -170.312 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 1.005 HG22 ' HB ' ' A' ' 38' ' ' VAL . 8.4 tp -112.31 133.47 57.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 169.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.65 126.7 34.13 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.614 -177.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.56 158.85 22.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.461 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.0 t -130.04 133.44 46.73 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.624 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 31.2 p90 -76.29 141.11 41.73 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 121.456 0.646 . . . . 0.0 110.267 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.4 t -93.48 -26.36 17.21 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.842 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 160.52 171.08 25.96 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.796 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.37 144.23 61.06 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.447 2.098 . . . . 0.0 110.843 174.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.743 HD12 ' HB3' ' A' ' 67' ' ' TYR . 20.7 mt -79.98 109.74 14.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.198 0.523 . . . . 0.0 109.9 -178.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.5 p -66.54 122.74 18.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.692 -175.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.02 -2.37 30.05 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.5 m -153.28 179.34 8.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -107.1 38.68 2.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.937 0.875 . . . . 0.0 109.899 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.743 ' HB3' HD12 ' A' ' 62' ' ' ILE . 1.8 m-85 -102.41 168.76 9.11 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.222 177.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.537 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . 10.0 tt0 -124.02 165.1 18.05 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.579 ' HB2' HG12 ' A' ' 62' ' ' ILE . 2.0 t80 -136.32 111.25 8.84 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -161.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.709 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 8.0 m95 -111.56 144.92 40.02 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.288 -166.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.439 ' HA ' ' HB2' ' A' ' 24' ' ' LYS . 5.0 p -133.04 131.86 41.14 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -132.6 151.06 52.06 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 118.884 -1.126 . . . . 0.0 111.733 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.2 m -131.68 141.29 49.54 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.053 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 21' ' ' PHE . . . -150.56 113.74 4.85 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.069 0.461 . . . . 0.0 111.167 -175.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.2 t -77.7 99.07 5.69 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 168.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.6 m -95.15 157.22 3.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.416 0.627 . . . . 0.0 111.26 -169.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -96.42 -16.77 21.03 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.018 -175.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.17 82.63 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.942 -0.646 . . . . 0.0 111.969 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.471 HG12 HG21 ' A' ' 104' ' ' VAL . 4.5 tt -90.49 133.19 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.485 0.66 . . . . 0.0 111.108 -178.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -114.47 -40.38 3.63 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.298 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.603 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 37.0 mm-40 -141.37 167.19 22.76 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.443 ' HZ ' ' CE2' ' A' ' 14' ' ' TYR . 28.2 p90 -172.1 170.71 5.17 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 119.338 0.972 . . . . 0.0 111.864 174.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.683 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 0.7 OUTLIER -162.9 150.7 13.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.235 168.09 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.979 HD12 HG22 ' A' ' 38' ' ' VAL . 10.2 mm -100.94 139.46 22.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.673 -174.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.706 ' HE3' HG21 ' A' ' 39' ' ' VAL . 88.8 mttt -103.86 151.83 22.65 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.471 0.653 . . . . 0.0 110.269 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.655 ' HD2' ' HD2' ' A' ' 93' ' ' TYR . 25.0 t80 -123.24 106.66 10.92 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.765 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.766 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -103.19 128.47 50.15 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.304 0.573 . . . . 0.0 110.218 -176.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.452 ' HB ' ' H ' ' A' ' 91' ' ' LYS . 11.4 t -126.54 158.04 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.735 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.9 m -67.32 -3.18 7.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -176.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -136.61 -27.87 0.37 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.512 176.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.452 ' H ' ' HB ' ' A' ' 88' ' ' VAL . 28.1 mmtt -129.73 177.62 7.11 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 122.189 0.995 . . . . 0.0 112.483 -174.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.5 m -150.39 141.9 23.47 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.232 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.655 ' HD2' ' HD2' ' A' ' 86' ' ' TYR . 33.0 m-85 -143.82 -172.73 3.8 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -150.47 148.43 28.72 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.187 -174.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -119.79 98.82 6.29 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 169.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.683 ' HB3' ' HB2' ' A' ' 83' ' ' TYR . 23.0 p-10 -145.01 61.9 1.31 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.418 -174.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 71.13 -65.4 0.34 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.933 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -157.91 -53.81 0.07 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 174.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.6 m -157.17 44.69 0.37 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.706 -1.133 . . . . 0.0 110.001 169.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.42 -109.08 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -176.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 176.07 146.26 0.09 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.777 0.831 . . . . 0.0 108.831 -168.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -85.54 142.84 28.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.656 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -92.88 106.66 18.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.348 -175.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.471 HG21 HG12 ' A' ' 79' ' ' ILE . 22.0 t -94.39 107.44 19.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.7 m -90.66 57.62 3.65 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -171.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.733 ' HB ' ' CE2' ' A' ' 16' ' ' TYR . 87.9 m . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.689 175.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 120.65 0.262 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.9 m -87.63 81.91 7.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.393 1.092 . . . . 0.0 110.532 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.473 HD11 HD22 ' A' ' 66' ' ' ASN . 66.4 mt -117.58 135.7 23.35 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.429 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.609 ' HG3' ' CE1' ' A' ' 26' ' ' TYR . 13.5 Cg_endo -57.54 156.94 24.51 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.936 2.424 . . . . 0.0 112.69 176.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.4 t -85.85 49.61 1.81 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.761 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.519 ' OG ' ' HB2' ' A' ' 10' ' ' GLN . 13.6 t -108.45 -175.4 2.76 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.244 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.21 -151.0 0.27 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.294 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.1 -29.54 69.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.125 0.488 . . . . 0.0 110.603 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.629 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.3 p -150.24 149.06 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.725 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.519 ' HB2' ' OG ' ' A' ' 6' ' ' SER . 10.9 tt0 -138.75 154.78 48.56 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.597 HD21 ' CD2' ' A' ' 14' ' ' TYR . 16.4 tp -85.55 143.11 28.69 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.025 0.44 . . . . 0.0 110.012 172.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -87.41 -65.66 0.99 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.602 173.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.2 p -177.68 160.38 1.54 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.587 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.597 ' CD2' HD21 ' A' ' 11' ' ' LEU . 43.5 p90 -152.12 162.25 41.4 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.269 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -132.6 157.12 45.58 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -133.17 146.61 51.69 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.159 -174.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 18' ' ' GLY . 13.8 t70 -123.56 -150.35 0.45 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.671 -1.149 . . . . 0.0 107.954 -177.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.413 ' H ' ' CG ' ' A' ' 17' ' ' ASP . . . -50.61 -64.43 3.69 Favored Glycine 0 N--CA 1.458 0.111 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 171.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.2 t -145.63 86.76 1.75 Allowed 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 161.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.6 m -146.42 140.3 26.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.033 178.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.838 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 12.2 t80 -116.38 139.55 50.29 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.4 m -163.17 133.93 4.66 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 174.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 14' ' ' TYR . . . 172.86 -150.34 12.37 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.116 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.599 ' HB2' ' O ' ' A' ' 70' ' ' TRP . 18.5 pttp -159.41 168.74 25.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.185 0.517 . . . . 0.0 111.451 -177.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.776 ' HB ' ' HB2' ' A' ' 70' ' ' TRP . 12.9 mt -132.78 160.78 42.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.644 -167.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.609 ' CE1' ' HG3' ' A' ' 4' ' ' PRO . 5.6 t80 -132.5 96.23 3.8 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 122.769 0.428 . . . . 0.0 110.317 -173.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.741 HG13 ' CD1' ' A' ' 70' ' ' TRP . 1.8 m -136.99 151.92 27.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 121.166 -0.959 . . . . 0.0 112.022 -170.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -72.69 143.88 47.92 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.746 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -102.28 95.03 6.03 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.732 0.777 . . . . 0.0 111.096 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.408 HD12 HG21 ' A' ' 88' ' ' VAL . 62.6 mt -75.78 -57.8 5.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.464 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.81 -160.87 0.75 Allowed 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.456 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 18.9 t80 -116.48 -23.48 8.26 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.838 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.0 m -78.02 68.2 4.01 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 169.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.456 ' HE2' ' HA ' ' A' ' 32' ' ' TYR . 27.6 mtmt -90.9 125.55 35.79 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.874 -176.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.514 ' HB2' ' HB3' ' A' ' 87' ' ' GLU . 9.4 mtpm? -126.28 113.57 17.13 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 69.9 t -113.24 113.41 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-O 121.781 0.801 . . . . 0.0 110.375 -173.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.867 ' HB ' HG13 ' A' ' 53' ' ' ILE . 6.6 p -122.42 111.61 17.07 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.364 -173.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 1.058 ' HB ' HG22 ' A' ' 54' ' ' ILE . 95.0 t -79.66 111.62 16.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.375 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 51' ' ' GLY . 1.0 OUTLIER -107.66 110.08 30.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.663 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.799 ' CE1' ' HB2' ' A' ' 42' ' ' ASP . 0.3 OUTLIER -105.19 154.48 20.15 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.915 0.865 . . . . 0.0 112.875 -174.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.728 ' HB2' ' CZ2' ' A' ' 47' ' ' TRP . . . -78.26 76.29 4.77 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 168.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.799 ' HB2' ' CE1' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -54.08 159.06 1.94 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 112.351 -2.204 . . . . 0.0 112.399 176.732 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.49 -109.29 1.88 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 113.744 -1.571 . . . . 0.0 113.455 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.491 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 16.0 m -89.41 -48.0 7.63 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 -175.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 44' ' ' SER . 6.1 p-10 170.69 28.73 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.523 0.729 . . . . 0.0 110.29 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -107.15 114.68 28.89 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -163.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.728 ' CZ2' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -101.93 83.9 2.45 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -74.95 44.3 0.23 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.886 -178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 51.09 33.52 9.35 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.664 0.745 . . . . 0.0 110.785 -176.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -110.73 -16.68 13.54 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.696 ' O ' HG13 ' A' ' 39' ' ' VAL . . . 77.12 -60.18 3.52 Favored Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.487 -174.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.56 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 82.6 m-20 74.83 73.57 0.1 Allowed 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.867 HG13 ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -109.0 138.84 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.943 -163.009 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 1.058 HG22 ' HB ' ' A' ' 38' ' ' VAL . 8.9 tp -116.12 127.9 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 114.322 -1.308 . . . . 0.0 108.03 168.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.5 129.84 34.99 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.888 -176.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -97.45 158.39 15.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.986 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 99.0 p -123.94 175.57 6.86 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.732 ' HA ' ' HA ' ' A' ' 70' ' ' TRP . 19.3 p90 -127.97 145.6 50.92 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.266 0.555 . . . . 0.0 111.472 -178.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.1 m -84.08 -37.7 21.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.11 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 157.35 161.73 11.07 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.315 175.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.898 ' HA ' ' HA ' ' A' ' 68' ' ' GLU . 28.5 Cg_endo -58.19 152.16 54.53 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 123.065 2.51 . . . . 0.0 112.028 177.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 23.9 mt -86.75 103.56 13.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.177 -175.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.5 p -62.93 120.54 11.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.211 0.529 . . . . 0.0 111.063 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.66 -7.54 29.9 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -175.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -141.87 171.37 14.15 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.473 HD22 HD11 ' A' ' 3' ' ' ILE . 39.1 m-80 -105.21 38.19 2.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.641 0.734 . . . . 0.0 110.133 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -120.3 177.37 5.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.747 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.898 ' HA ' ' HA ' ' A' ' 61' ' ' PRO . 12.3 tt0 -128.3 166.98 17.58 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.347 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -124.58 114.81 19.87 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 -169.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.776 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 14.4 m95 -111.88 148.05 34.49 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.818 -167.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.592 HG22 ' HB3' ' A' ' 24' ' ' LYS . 1.6 p -150.51 146.37 26.56 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.322 0.388 . . . . 0.0 110.496 -172.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.414 ' HB3' ' O ' ' A' ' 71' ' ' THR . 4.2 p90 -175.19 157.57 2.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.578 0.704 . . . . 0.0 112.016 172.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.1 p -114.62 146.31 40.97 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.838 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -139.02 113.68 9.1 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -173.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.5 m -72.87 100.49 2.92 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 169.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.7 m -103.45 157.27 5.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.341 -176.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.18 14.44 10.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.495 0.664 . . . . 0.0 110.482 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.66 138.93 2.56 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.974 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.567 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 14.9 tt -171.49 153.23 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.216 0.532 . . . . 0.0 110.25 177.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 44' ' ' SER . 16.2 tppt? -135.64 -47.97 0.69 Allowed 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.725 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 14.3 pt-20 -149.2 176.42 10.52 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.454 ' CB ' ' HA ' ' A' ' 40' ' ' TYR . 55.5 p90 -170.02 168.68 8.42 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 119.382 0.992 . . . . 0.0 112.316 -178.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.91 ' HB3' ' HB3' ' A' ' 96' ' ' ASN . 0.2 OUTLIER -146.48 143.93 29.3 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.542 169.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.951 HD12 HG22 ' A' ' 38' ' ' VAL . 17.6 mm -89.43 138.76 18.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.225 -174.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.477 ' HE2' ' HE1' ' A' ' 94' ' ' TYR . 32.3 mmtp -97.7 107.75 20.32 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.438 0.637 . . . . 0.0 109.289 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.594 ' O ' ' HA ' ' A' ' 92' ' ' THR . 8.4 t80 -89.28 100.9 13.59 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.656 -1.157 . . . . 0.0 109.917 -177.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 91' ' ' LYS . 26.4 tt0 -104.24 113.88 27.73 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.818 -176.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.408 HG21 HD12 ' A' ' 30' ' ' ILE . 5.2 t -119.9 105.69 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.609 -177.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.6 t 50.95 27.14 3.02 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 123.646 0.591 . . . . 0.0 111.155 177.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.58 -18.09 17.8 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.335 -176.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 87' ' ' GLU . 21.2 mmtm -81.81 176.8 9.3 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 117.598 0.699 . . . . 0.0 111.508 -176.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 86' ' ' TYR . 18.0 m -150.59 141.06 22.47 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.662 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.446 ' HD2' ' CD2' ' A' ' 86' ' ' TYR . 63.8 m-85 -146.05 -171.71 3.77 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 170.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.477 ' HE1' ' HE2' ' A' ' 85' ' ' LYS . 51.0 m-85 -146.19 141.23 27.23 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.895 0.379 . . . . 0.0 111.601 -172.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.524 ' HB2' HG13 ' A' ' 9' ' ' VAL . 35.5 t70 -130.16 112.92 13.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.461 167.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.91 ' HB3' ' HB3' ' A' ' 83' ' ' TYR . 36.3 p-10 -130.09 -29.68 2.04 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.15 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.561 HD21 ' HB3' ' A' ' 100' ' ' ALA . 26.1 p-10 159.12 -42.9 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.544 1.137 . . . . 0.0 108.198 172.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 175.49 -37.13 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.421 174.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.2 p -178.06 23.94 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.561 ' HB3' HD21 ' A' ' 97' ' ' ASN . . . -138.06 -17.14 1.23 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -175.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.768 ' HA ' ' HB2' ' A' ' 96' ' ' ASN . 77.5 m-20 87.73 142.65 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.894 0.478 . . . . 0.0 110.739 173.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.562 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 85.0 m-85 -71.76 120.96 18.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.969 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.439 HE21 ' HB3' ' A' ' 81' ' ' GLU . 1.1 mp0 -83.71 129.61 34.95 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 174.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.59 153.39 4.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.1 p -74.71 56.75 0.72 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.459 0.647 . . . . 0.0 111.824 -177.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.31 177.544 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 121.049 0.452 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -91.28 -175.78 4.36 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.845 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.504 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 21.4 mm -54.63 -55.64 35.73 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.345 177.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 3' ' ' ILE . 9.4 Cg_endo -54.74 134.88 65.05 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.241 1.96 . . . . 0.0 112.928 -177.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.9 t -166.35 -51.92 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.912 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.7 m -83.65 -77.35 0.26 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.194 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -139.4 -173.89 3.73 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 120.645 0.259 . . . . 0.0 111.208 -176.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -67.26 -30.91 70.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.42 0.629 . . . . 0.0 109.962 177.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.667 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 1.4 p -140.68 148.89 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.299 -178.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -140.9 129.35 22.55 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.859 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.586 HD21 ' HD2' ' A' ' 14' ' ' TYR . 23.7 tp -69.06 141.94 54.65 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.213 0.53 . . . . 0.0 110.957 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.497 ' HB3' ' O ' ' A' ' 24' ' ' LYS . 30.0 t70 -85.68 -68.77 0.71 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.752 175.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.7 p -175.94 164.74 2.9 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.741 -177.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.586 ' HD2' HD21 ' A' ' 11' ' ' LEU . 53.2 p90 -156.64 154.42 30.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.564 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -130.55 159.9 35.77 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.125 0.488 . . . . 0.0 110.468 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 20' ' ' THR . 10.4 t80 -122.33 138.25 54.58 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 170.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -153.76 115.06 4.14 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.234 -174.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.01 -95.78 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -168.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.639 ' OG ' ' HA ' ' A' ' 77' ' ' LYS . 10.4 t -139.6 88.13 2.23 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 162.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 16' ' ' TYR . 87.8 m -146.35 139.97 26.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.47 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.73 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 24.3 t80 -115.06 99.25 7.31 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-O 121.672 0.749 . . . . 0.0 109.278 176.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 14' ' ' TYR . 17.7 p -126.42 150.01 48.92 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.27 -175.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.86 -162.3 36.07 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.723 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 0.6 OUTLIER -158.42 163.66 37.0 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -177.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.605 HD12 HG11 ' A' ' 36' ' ' VAL . 24.7 mt -135.79 160.29 39.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.927 0.394 . . . . 0.0 111.774 -168.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.418 ' N ' HG22 ' A' ' 25' ' ' ILE . 6.4 t80 -132.85 103.09 5.91 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.433 0.693 . . . . 0.0 109.798 -174.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.667 ' HB ' ' HB ' ' A' ' 9' ' ' VAL . 1.5 m -136.65 151.89 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 121.39 -0.819 . . . . 0.0 111.492 -172.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -76.45 152.95 36.01 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 178.317 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -104.6 121.94 44.57 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.345 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.478 HD12 ' OH ' ' A' ' 86' ' ' TYR . 7.1 mt -106.98 -52.83 6.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.823 0.821 . . . . 0.0 109.561 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.72 152.34 51.85 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 105.283 -2.118 . . . . 0.0 105.283 173.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.418 ' O ' ' C ' ' A' ' 33' ' ' SER . 12.1 m-85 -59.04 -83.93 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 117.768 -1.11 . . . . 0.0 113.068 -170.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 32' ' ' TYR . 24.8 m -21.85 104.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 124.49 1.119 . . . . 0.0 111.647 -174.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.751 ' HB3' ' CH2' ' A' ' 70' ' ' TRP . 84.5 mttt -94.77 111.43 23.21 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 124.882 2.277 . . . . 0.0 115.88 -148.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.806 ' HD3' HG13 ' A' ' 88' ' ' VAL 0.489 4.6 pttm -56.84 79.93 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.006 1 CA-C-N 108.264 -4.062 . . . . 0.0 120.545 169.8 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.605 HG11 HD12 ' A' ' 25' ' ' ILE . 52.1 t -142.47 113.65 3.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-O 121.5 0.667 . . . . 0.0 111.599 154.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.628 ' HB ' HG13 ' A' ' 53' ' ' ILE . 2.5 p -131.53 102.79 6.07 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.804 173.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.95 ' HB ' HG22 ' A' ' 54' ' ' ILE . 61.4 t -73.83 104.2 2.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.377 -176.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.621 HG12 ' HB ' ' A' ' 53' ' ' ILE . 4.5 m -102.94 110.28 29.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -105.18 150.86 24.72 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.14 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.663 ' HB2' ' CZ2' ' A' ' 47' ' ' TRP . . . -74.22 82.58 1.84 Allowed 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 172.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -49.95 -172.48 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 113.065 -1.879 . . . . 0.0 113.669 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -54.35 -28.98 45.27 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 116.046 -0.524 . . . . 0.0 113.784 -175.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.2 t -72.11 -16.83 62.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.834 0.317 . . . . 0.0 111.069 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.7 t70 67.57 36.01 3.9 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.819 0.819 . . . . 0.0 109.072 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -147.75 160.67 42.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.263 -176.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.663 ' CZ2' ' HB2' ' A' ' 41' ' ' ALA . 5.7 m95 -115.9 82.31 1.75 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.669 0.747 . . . . 0.0 110.38 -176.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.638 ' ND2' ' HB2' ' A' ' 50' ' ' ASN . 2.5 p-10 -116.45 168.94 9.71 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.239 173.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -79.51 57.53 2.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.942 0.877 . . . . 0.0 111.062 -175.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.638 ' HB2' ' ND2' ' A' ' 48' ' ' ASN . 59.3 t30 -88.93 11.75 17.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.32 -177.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.67 33.32 52.16 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -176.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -93.63 34.49 1.18 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.551 0.691 . . . . 0.0 110.526 -175.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.692 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -122.15 139.32 49.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.881 179.23 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.95 HG22 ' HB ' ' A' ' 38' ' ' VAL . 5.8 tp -116.2 126.51 73.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 170.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -89.6 126.58 35.67 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.673 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.61 168.69 17.9 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.931 -174.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.7 t -128.0 132.87 49.12 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -77.75 145.81 36.27 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.39 0.614 . . . . 0.0 110.921 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.3 m -92.16 -33.37 14.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.97 172.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 160.84 169.2 23.78 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.455 172.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 68' ' ' GLU . 16.5 Cg_exo -68.49 133.6 28.47 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.562 2.175 . . . . 0.0 110.152 171.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 65' ' ' SER . 42.4 mt -71.03 122.13 22.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 120.981 0.42 . . . . 0.0 110.729 -172.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.5 p -58.03 128.1 35.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.915 -174.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 70.85 15.56 73.93 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.355 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.541 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 26.4 m -130.46 166.54 20.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.958 0.409 . . . . 0.0 110.671 -178.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -102.47 17.77 22.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.554 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 5.7 m-85 -120.18 169.32 10.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.326 -176.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 61' ' ' PRO . 19.6 tt0 -117.33 170.74 8.46 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.002 -1.454 . . . . 0.0 108.705 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -138.15 110.4 7.37 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -162.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.751 ' CH2' ' HB3' ' A' ' 34' ' ' LYS . 18.7 m95 -111.86 147.67 35.29 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.063 -168.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.47 ' HA ' ' HB2' ' A' ' 24' ' ' LYS . 5.7 p -141.74 142.96 33.28 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -154.07 169.45 23.5 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.099 -1.041 . . . . 0.0 112.913 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.6 p -144.24 137.29 27.2 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.179 173.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.73 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . . . -134.09 120.82 20.65 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.436 -173.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.8 t -78.42 99.36 6.37 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 172.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.464 HG13 ' HB3' ' A' ' 21' ' ' PHE . 4.8 m -120.16 151.5 22.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -176.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.639 ' HA ' ' OG ' ' A' ' 19' ' ' SER . 0.2 OUTLIER -141.35 31.33 1.72 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.46 0.648 . . . . 0.0 110.366 174.413 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.09 95.52 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.725 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.8 tt -151.82 141.77 15.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.36 0.6 . . . . 0.0 110.276 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -115.18 -54.32 2.56 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.956 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.487 ' OE1' ' HB3' ' A' ' 103' ' ' GLN . 13.2 mm-40 -135.08 176.8 8.33 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -173.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.436 ' HZ ' ' CD2' ' A' ' 14' ' ' TYR . 28.3 p90 -168.7 160.53 10.69 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.703 171.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.446 ' HB3' HD22 ' A' ' 96' ' ' ASN . 0.1 OUTLIER -147.22 144.03 28.61 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.434 168.681 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.909 HD12 HG22 ' A' ' 38' ' ' VAL . 14.4 mm -91.28 134.81 28.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.687 -172.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.578 ' HB2' ' OG1' ' A' ' 37' ' ' THR . 4.5 mtmp? -88.3 114.87 25.35 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.61 0.719 . . . . 0.0 109.857 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.608 ' CD2' ' HD1' ' A' ' 93' ' ' TYR . 9.5 t80 -86.15 100.04 11.94 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.327 -1.306 . . . . 0.0 107.518 178.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.519 ' C ' ' HB3' ' A' ' 35' ' ' LYS . 30.1 tt0 -124.04 104.23 8.76 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 122.108 0.956 . . . . 0.0 113.043 -162.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.806 HG13 ' HD3' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -110.1 164.53 6.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.408 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.3 m -77.06 40.17 0.25 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.856 0.836 . . . . 0.0 111.235 -177.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . 177.5 -34.07 0.08 OUTLIER Glycine 0 N--CA 1.436 -1.332 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.517 175.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.478 ' O ' HG23 ' A' ' 88' ' ' VAL . 12.9 mptt -110.98 149.43 30.69 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 120.794 0.331 . . . . 0.0 111.325 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.3 m -149.3 138.44 21.37 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.358 0.599 . . . . 0.0 110.965 174.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.608 ' HD1' ' CD2' ' A' ' 86' ' ' TYR . 18.6 m-85 -146.5 -166.65 2.54 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 176.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -144.03 140.47 29.57 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.885 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -96.19 92.89 6.61 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 168.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.446 HD22 ' HB3' ' A' ' 83' ' ' TYR . 3.6 t-20 -129.56 18.53 5.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.097 -174.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 65.97 -68.12 0.13 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.278 -171.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -159.01 -56.07 0.06 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.0 t -167.74 38.72 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 170.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -99.41 -37.99 9.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.09 -169.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 93.0 m-20 72.62 142.28 0.06 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.351 0.596 . . . . 0.0 110.496 -174.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -95.1 100.18 12.05 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.169 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.487 ' HB3' ' OE1' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -76.61 131.98 39.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.436 179.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.8 t -85.24 152.08 3.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.985 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.3 t -83.83 71.42 10.45 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.8 p . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.87 176.909 . . . . . . . . 0 0 . 1 stop_ save_